
<SEC-DOCUMENT>0001477932-14-004914.txt : 20140905
<SEC-HEADER>0001477932-14-004914.hdr.sgml : 20140905
<ACCEPTANCE-DATETIME>20140905160919
ACCESSION NUMBER:
CONFORMED SUBMISSION TYPE:
PUBLIC DOCUMENT COUNT:
FILED AS OF DATE:
DATE AS OF CHANGE:
S-1
11
20140905
0001477932-14-004914
20140905
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME:
CENTRAL INDEX KEY:
STANDARD INDUSTRIAL CLASSIFICATION: OIL AND GAS FIELD EXPLORATION
RenovaCare, Inc.
0001016708
SERVICES [1382]
IRS NUMBER:
STATE OF INCORPORATION:
FISCAL YEAR END:
980170247
NV
1231
FILING VALUES:
FORM TYPE:
SEC ACT:
SEC FILE NUMBER: 333-198600
FILM NUMBER:
S-1
1933 Act
141086076
BUSINESS ADDRESS:
STREET 1:
STREET 2:
CITY:
STATE:
ZIP:
BUSINESS PHONE:
430 PARK AVE.
SUITE 702
NEW YORK
NY
10022
(800) 755-5815
MAIL ADDRESS:
STREET 1:
STREET 2:
CITY:
STATE:
ZIP:
FORMER COMPANY:
430 PARK AVE.
SUITE 702
NEW YORK
NY
10022
FORMER CONFORMED NAME: Janus Resources, Inc.
DATE OF NAME CHANGE:
20110110
FORMER COMPANY:
FORMER CONFORMED NAME: ENTHEOS TECHNOLOGIES INC
DATE OF NAME CHANGE:
20001002
FORMER COMPANY:
FORMER CONFORMED NAME: WHATSONLINE COM INC
DATE OF NAME CHANGE:
19990722
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>rcar_s1.htm
<DESCRIPTION>FORM S-1
<TEXT>
<html>
<head></head>
<body style="font: 10pt TIMES NEW ROMAN; text-align: justify; margin: 0px 7% 0px
7%;">
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center"><b>As filed with the U.S. Securities and Exchange Commission on 
September 5, 2014</b></p>
<p style="text-align: right; margin: 0px;" align="center"><b></b><b>Registration
No. 333-</b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<div style="font-size: 1px; width: 100%; border-bottom: #000000 4px solid; 
margin: 0px; text-indent: 30px;"></div>
<div style="font-size: 1pt; width: 100%; border-bottom: #000000 1px solid; text-
align: justify; margin-top: 2px; text-indent: 30px;"></div>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center"><font style="font-size: 12pt;"><b>U.S. SECURITIES AND EXCHANGE 
COMMISSION</b></font></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;"><font style="font-size: 12pt;"><b>Washington, D.C. 20549</b></font></p>
<p style="text-align: center; margin: 0px; text-indent: 30px;"><font 
style="font-size: 12pt;">&#160;</font></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center"><font style="font-size: 18pt;"><b>FORM S-1</b></font></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;">&#160;</p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center"><font style="font-size: 10pt;"><b>REGISTRATION STATEMENT UNDER 
THE SECURITIES ACT OF 1933</b></font></p>
<p style="text-align: center; margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid0" style="width: 40%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto; text-indent: 30px;" cellspacing="0" cellpadding="0" 
align="center" border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="top" width="638">
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center"><font style="font-size: 18pt;"><b>RenovaCare, Inc.</b></font></p>
</td>
</tr>
<tr height="15">
<td valign="top" width="638">
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center">(Exact name of registrant as specified in its charter)</p>
</td>
</tr>
</table>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid1" style="width: 85%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto; text-indent: 30px;" cellspacing="0" cellpadding="0" 
align="center" border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="top" width="30%">
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center"><b>Nevada</b></p>
</td>
<td valign="bottom" width="5%">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="top" width="30%" 
colspan="2">
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center"><b>7389</b></p>
</td>
<td valign="bottom" width="5%">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="top" width="30%">
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center"><b>98-0384030</b></p>
</td>
</tr>
<tr height="15">
<td valign="top">
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center">(State or other jurisdiction of</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top" colspan="2">
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;" 
align="center">(Primary Standard Industrial</p>
</td>
<td valign="bottom">&#160;</td>
<td style="padding-left: 0px; margin-left: 0px; text-indent: 0px;" valign="top">
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center">(I.R.S. Employer</p>
</td>
</tr>
<tr height="15">
<td valign="top">
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 0px;"
align="center">incorporation or organization)</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top" colspan="2">
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;" 
align="center">Classification Code number)</p>
</td>
<td valign="bottom">&#160;</td>
<td style="padding-left: 0px; margin-left: 0px; text-indent: 0px;" valign="top">
<p style="margin: 0px;" align="center">Identification No.)</p>
</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 0px; text-
indent: 30px;">&#160;</p>
<table id="tableid2" style="width: 85%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="bottom" width="48%">
<p style="text-align: center; padding-left: 0px; margin: 0pt;" 
align="center"><b>RenovaCare, Inc.</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0pt;" 
align="center"><b>430 Park Avenue, Suite 702</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0pt;" 
align="center"><b>New York, New York 10022</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0pt;" 
align="center"><b>(800) 755-5815</b></p>
</td>
<td valign="top" width="4%">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="top" width="48%">
<p style="text-align: center; padding-left: 0px; margin: 0pt 0pt 0pt 0px; text-
indent: 0px;" align="center"><b>Thomas Bold</b></p>
<p style="text-align: center; margin: 0pt;" align="center"><b>RenovaCare, 
Inc.</b></p>
<p style="text-align: center; margin: 0pt;" align="center"><b>430 Park Avenue, 
Suite 702</b></p>
<p style="text-align: center; margin: 0pt;" align="center"><b>New York, New York
10022</b></p>
<p style="text-align: center; margin: 0pt;" align="center"><b>(800) 755-
5815</b></p>
</td>
</tr>
<tr height="15">
<td valign="top">
<p style="text-align: center; margin: 0pt;" align="center">(Address and 
telephone number of principal executive offices)</p>
</td>
<td valign="top">&#160;</td>
<td valign="top">
<p style="text-align: center; margin: 0pt;" align="center">(Name, address and 
telephone number of agent for service)</p>
</td>
</tr>
</table>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;">&#160;<b>Copies to:</b></p>
<p style="text-align: center; margin: 0px; text-indent: 30px;"><b></b>&#160;</p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;"><b>Joseph Sierchio, Esq.</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;"><b>Elishama Rudolph, Esq.</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;"><b>Sierchio &amp; Company, LLP</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;"><b>430 Park Avenue</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;">&#160;<b>Suite 702</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;">&#160;<b>New York, New York 10022</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;">&#160;<b>Telephone: (212) 246-3030</b></p>
<p style="text-align: center; padding-left: 0px; margin: 0px; text-indent: 
0px;">&#160;<b>Facsimile: (212) 246-3039</b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b>Approximate date
of commencement of proposed sale to the public</b>: As soon as practicable after
this registration statement becomes effective.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">If any of the securities being registered on this Form 
are to be offered on a delayed or continuous basis pursuant to Rule 415 under 
the Securities Act of 1933 check the following box.. <font style="font-size: 
10pt; font-family: Wingdings;">x</font></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">If this Form is filed to register additional securities 
for an offering pursuant to Rule 462(b) under the 1933 Act, please check the 
following box and list the 1933 Act registration statement number of the earlier
effective registration statement for the same offering. <font style="font-size: 
10pt; font-family: Wingdings;">&#168;</font></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">If this Form is a post-effective amendment filed 
pursuant to Rule 462(c) under the 1933 Act, check the following box and list the
1933 Act registration statement number of the earlier effective registration 
statement for the same offering.&#160;<font style="font-size: 10pt; font-family:
Wingdings;">&#168;</font></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">If this Form is a post-effective amendment filed 
pursuant to Rule 462(d) under the 1933 Act, check the following box and list the
1933 Act registration statement number of the earlier effective registration 
statement for the same offering.&#160;<font style="font-size: 10pt; font-family:
Wingdings;">&#168;</font></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of &#8220;large accelerated filer,&#8221;
&#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in 
Rule 12b-2 of the Securities Exchange Act of 1934. (Check one):</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<table id="tableid3" style="width: 85%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15">
<td valign="top" width="21%">
<p style="margin: 0pt;">Large accelerated filer &#61551;</p>
</td>
<td valign="top"><font style="font-size: 10pt; font-family: 
Wingdings;">&#168;</font></td>
<td valign="top" width="35%">
<p style="text-align: left; padding-left: 0px; margin: 0pt;" align="center">Non-
accelerated filer &#61472;</p>
</td>
<td valign="top"><font style="font-size: 10pt; font-family: 
Wingdings;">&#168;</font></td>
</tr>
<tr height="15">
<td valign="top" width="21%">
<p style="margin: 0pt;">Accelerated filer &#61551;</p>
</td>
<td valign="top"><font style="font-size: 10pt; font-family: 
Wingdings;">&#168;</font></td>
<td valign="top" width="35%">
<p style="text-align: left; margin: 0pt;" align="center">Smaller reporting 
company</p>
</td>
<td valign="top"><font style="font-size: 10pt; font-family: 
Wingdings;">x</font></td>
</tr>
<tr height="15">
<td valign="top" width="21%" colspan="2">
<p style="margin: 0pt;">(Do not check if a smaller reporting company)</p>
</td>
<td valign="top" width="35%">
<p style="margin: 0pt;" align="center">&#160;</p>
</td>
<td valign="top"></td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<div style="font-size: 1pt; width: 100%; border-bottom: #000000 1px solid; 
margin: 0px;"></div>
<div style="font-size: 1pt; width: 100%; border-bottom: #000000 4px solid; page-
break-after: always; margin-top: 2px;"></div>
<p style="text-align: center; margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b></b>&#160;</p>
<p style="margin: 0px;" align="center"><b><u style="line-height: 
1;"></u></b>&#160;</p>
<p style="margin: 0px;" align="center"><b><u style="line-height: 1;">Calculation
of Registration Fee</u></b></p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid5" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto; border: 0px;" cellspacing="0" cellpadding="0" 
border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>Title of each class
of securities to be registered</b></p>
</td>
<td style="text-align: center;" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" colspan="2" align="center"><b>Amount to be registered 
<sup>(1)</sup></b></td>
<td style="padding-bottom: 1px; text-align: center;" valign="bottom" 
align="left">
<p style="margin: 0pt;"></p>
</td>
<td style="text-align: center;" align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Proposed maximum offering price per share</b></td>
<td style="text-align: center;" align="left">&#160;</td>
<td style="text-align: center;" align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Proposed maximum aggregate offering price</b></td>
<td style="text-align: center;" align="left">&#160;</td>
<td style="text-align: center;" align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Amount of registration fee</b></td>
<td style="text-align: center;" align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Common stock, par value $0.00001 <sup>(2)</sup></p>
</td>
<td width="2%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">3,500,000</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="text-align: right;" valign="bottom" width="9%" 
align="right">
<p style="margin: 0px;">1.07 <sup>(3)</sup></p>
</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;"></p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">3,745,000</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">482</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Common stock, par value $0.00001 <sup>(4)</sup></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">240,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="text-align: right;" valign="bottom" 
align="right">
<p style="margin: 0px;">0.35 <sup>(5)</sup></p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;"></p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">87,500</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">11</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Common stock, par value $0.00001 <sup>(6)</sup></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">3,500,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="text-align: right;" valign="bottom" 
align="right">
<p style="margin: 0px;">0.43 <sup>(7)</sup></p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;"></p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,505,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">194</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Common stock, par value $0.00001 <sup>(8)</sup></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">3,500,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0px;">0.43 <sup>(9)</sup></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0pt;"></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,505,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">194</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Total</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">10,740,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right"></td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">6,839,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0px;">881 <sup>(10)</sup></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0pt;"></p>
</td>
</tr>
</table>
<p style="margin: 0px;">______________</p>
<p style="text-align: justify; margin: 0px;"><sup>(1)</sup> In the event of a 
stock split, stock dividend or similar transaction involving our common stock, 
in order to prevent dilution, the number of shares registered shall be 
automatically increased to cover the additional shares in accordance with Rule 
416(a) under the Securities Act of 1933, as amended.</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><sup>(2)</sup> Represents shares of
our common stock previously acquired by and issued to the Selling Stockholders 
in a private transaction directly with us.</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><sup>(3)</sup> The proposed maximum
offering price per share is estimated solely for the purposes of calculating the
registration fee in accordance with Rule 457(c) under the Securities Act, using 
the closing price of our common stock as reported on the OTC Markets Group, Inc.
QB tier on September 4, 2014, a date within five trading days prior to the date 
of the filing of this registration statement.</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><sup>(4) </sup>Represents shares of
our common stock, par value $0.00001 per share, which have vested and may be 
issued upon exercise of an outstanding Series A Stock Purchase Warrant (the 
&#8220;<b>Series A Warrant</b>&#8221;), allowing the holder to purchase shares 
of our common stock at an exercise price of $0.35 per share through July 12, 
2019.</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><sup>(5)</sup> The proposed maximum
offering price per share is estimated solely for the purposes of calculating the
registration fee in accordance with Rule 457(g) using the price at which the 
warrants may be exercised.</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><sup>(6)</sup> Represents shares of
our common stock, par value $0.00001 per share, which may be issued upon
exercise of an outstanding Series B Stock Purchase Warrant (the &#8220;<b>Series
B Warrant</b>&#8221;), allowing the holder to purchase shares of our common 
stock at an exercise price of $0.43 per share if exercised on or before May 29, 
2015, or $0.46 per share if exercised after May 29, 2015, through November 29, 
2018.</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><sup>(7)</sup> The proposed maximum
offering price per share is estimated solely for the purposes of calculating the
registration fee in accordance with Rule 457(g) using the price at which the 
warrants may be exercised.</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><sup>(8)</sup> Represents shares of
our common stock, par value $0.00001 per share, which may be issued upon 
exercise of an outstanding Series C Stock Purchase Warrant (the &#8220;<b>Series
C Warrant</b>&#8221;), allowing the holder to purchase shares of our common 
stock at an exercise price of $0.43 per share if exercised on or before May 29, 
2015, or $0.49 per share if exercised after May 29, 2015, through November 29, 
2018.</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><sup>(9)</sup> The proposed maximum
offering price per share is estimated solely for the purposes of calculating the
registration fee in accordance with Rule 457(g) using the price at which the 
warrants may be exercised.</p>
<p style="text-align: justify; margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><sup>(10)</sup> Paid herewith.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid5" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">2</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><b>The registrant hereby amends 
this registration statement on such date or dates as may be necessary to delay 
its effective date until the registrant shall file a further amendment which 
specifically states that this registration statement shall thereafter become 
effective in accordance with Section 8(a) of the Securities Act of 1933 or until
the registration statement shall become effective on such date as the 
Commission, acting pursuant to said Section 8(a), may determine.</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: center; margin: 0px;"><b>SUBJECT TO COMPLETION, DATED 
SEPTEMBER 5, 2014</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px;"><b>The information in this 
prospectus is not complete and may be changed. These securities may not be sold 
until the registration statement filed with the Securities and Exchange 
Commission is effective. This prospectus is not an offer to sell these
securities and we are not soliciting offers to buy these securities in any state
where the offer or sales is not permitted.</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>10,740,000 SHARES</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><img src="img001.jpg" ></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>RENOVACARE, INC. COMMON STOCK</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">This prospectus 
relates to the resale by certain of our stockholders and holders of warrants to 
purchase our stock named in the section of this prospectus titled &#8220;Selling
Stockholders&#8221; (collectively, the &#8220;<b>Selling 
Stockholders</b>&#8221;) of up to 10,740,000 shares (collectively, the 
&#8220;<b>Shares</b>&#8221;) of our common stock, par value $0.00001. The Shares
being offered under this prospectus are comprised of: (a) 3,500,000 shares of 
common stock that were purchased by a Selling Stockholder in a private placement
with us pursuant to exemptions from the registration requirements of the 
Securities Act of 1933, as amended (the &#8220;<b>Securities Act</b>&#8221;); 
(b) 240,000 shares of common stock that vest on July 12, 2014 and are issuable 
upon exercise of a Series A Warrant allowing the holder to purchase shares of 
common stock at an exercise price of $0.35 per share through July 12, 2019; (c) 
3,500,000 shares of common stock issuable upon exercise of a Series B Warrant 
allowing the holder to purchase shares of common stock at an exercise price of 
$0.43 per share if exercised on or before May 29, 2015, or $0.46 per share if 
exercised after May 29, 2015, through November 29, 2018; and (d) 3,500,000 
shares of common stock issuable upon exercise of a Series C Warrant allowing the
holder to purchase shares of common stock at an exercise price of $0.43 per 
share if exercised on or before May 29, 2015, or $0.49 per share if exercised 
after May 29, 2015, through November 29, 2018.</p>
<p style="margin: 0px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">Although we will 
pay substantially all the expenses incident to the registration of the Shares, 
we will not receive any proceeds from the sales by the Selling Stockholders. 
&#160; The Selling Stockholders and any underwriter, broker-dealer or agent that
participates in the sale of the Shares or interests therein may be deemed 
&#8220;underwriters&#8221; within the meaning of Section 2(11) of the Securities
Act. Any discounts, commissions, concessions, profit or other compensation any 
of them earns on any sale or resale of the shares, directly or indirectly, may 
be underwriting discounts and commissions under the Securities Act. The Selling 
Stockholders who are &#8220;underwriters&#8221; within the meaning of Section 
2(11) of the Securities Act will be subject to the prospectus delivery 
requirements of the Securities Act.</p>
<p style="margin: 0px; text-indent: 60px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">Our common stock 
is presently quoted for trading under the symbol &#8220;<b>RCAR</b>&#8221; on 
the OTC Markets Group Inc. QB<sup>TM</sup> tier (the 
&#8220;<b>OTCQB</b>&#8221;). On September 2, 2014, the closing price of the 
common stock, as reported on the OTCQB was $1.07 per share. The Selling 
Stockholders have advised us that they will sell the shares of common stock 
registered hereunder from time to time in the open market, on the OTCQB, in 
privately negotiated transactions or a combination of these methods, at market 
prices prevailing at the time of sale, at prices related to the prevailing 
market prices, at negotiated prices, or otherwise as described under the section
of this prospectus titled &#8220;<b>Plan of Distribution</b>.&#8221;</p>
<p style="margin: 0px; text-indent: 60px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">&#160;The purchase
of the Shares offered through this prospectus involves a high degree of risk. 
<b>Please refer to &#8220;Risk Factors&#8221; beginning on page 9.</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: justify; padding-left: 0px; margin: 0px; text-indent: 
30px;"><b>Neither the Securities and Exchange Commission nor any state 
securities commission has approved or disapproved of these securities or passed 
upon the adequacy or accuracy of this prospectus. Any representation to the
contrary is a criminal offense.</b></p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid6" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">3</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>Table of Contents</b></p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid7" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="top" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Page #</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Prospectus Summar</b><b>y</b></p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">5</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>The Offering</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">6</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Risk Factor</b><b>s</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">9</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>Note Regarding Forward-Looking 
Statement</b><b>s</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">22</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Use of Proceed</b><b>s</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">23</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>Determination of Offering Price</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">23</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Market Price of and Dividends On Our Common Stock and
Related Stockholder Matters</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">24</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>Management&#8217;s Discussion and Analysis of 
Financial Condition and</b><b> Results of Operations</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">25</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Description of Our Business and Property</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">28</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>Directors, Executive Officers and Control 
Persons</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">35</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Executive Compensation</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">40</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>Security Ownership of Certain Beneficial Owners and 
Management</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">42</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Transactions With Related Persons, Promoters and 
Certain Control Persons</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">43</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>Description of Our Securities</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">44</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>The Selling Stockholders</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">47</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>Plan of Distribution</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">48</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Legal Matters</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">50</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>Experts</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">50</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Where You Can Find </b><b>Additional 
Information</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">50</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b>Index </b><b>To Consolidated Financial 
Statements</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">51</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b>Consolidated Financial Statement</b><b>s</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">F-1</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid8" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">4</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>You should rely only on the information contained in 
this prospectus or any related prospectus supplement. We have not authorized 
anyone to provide you with different information. If anyone provides you with 
different or inconsistent information, you should not rely on it. The 
information contained in this prospectus or incorporated by reference herein is 
accurate only on the date of this prospectus. Our business, financial condition,
results of operations and prospects may have changed since such date. Other than
as required under the federal securities laws, we undertake no obligation to 
publicly update or revise such information, whether as a result of new 
information, future events or any other reason.</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>This prospectus is not an offer to sell, nor is it an
offer to buy, these securities in any jurisdiction where the offer or sale is 
not permitted.</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>PROSPECTUS SUMMARY</b></p>
<p style="margin: 0px;" align="center"><b><i></i></b>&#160;</p>
<p style="text-align: justify; padding-left: 0px; margin: 0px; text-indent: 
30px;" align="center"><b><i>This summary highlights certain information that we 
present more fully in the rest of this prospectus. This summary does not contain
all of the information you should consider before investing in the securities 
offered pursuant to this prospectus. You should read the entire prospectus 
carefully, including the &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s 
Discussion and Analysis of Financial Condition and Results of Operations&#8221;
and our financial statements and related notes, before making an investment 
decision.</i></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;"><b><i>Except where
the context otherwise requires and for purposes of this prospectus only, 
&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; 
&#8220;our Company,&#8221; and &#8220;RenovaCare&#8221; refer to RenovaCare, 
Inc., a Nevada corporation, and its consolidated subsidiaries.</i></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Our Company</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">We were 
incorporated under the laws of the State of Utah on July 14, 1983, under the 
name &#8220;Far West Gold, Inc.&#8221; On May 9, 1996, our stockholders 
authorized a name change to &#8220;Far West Resources, Inc.&#8221; On June 30, 
1997, the stockholders authorized a name change to &#8220;American Alliance 
Corporation&#8221; and authorized a change in the state of domicile from Utah to
Nevada. On January 7, 2014, we filed a Certificate of Amendment to Articles of 
Incorporation changing our name from &#8220;Janus Resources, Inc.&#8221; to 
&#8220;RenovaCare, Inc.&#8221; so as to more fully reflect our operations. We 
have an authorized capital of 500,000,000 shares of common stock, par value 
$0.00001 of which 66,575,122 shares are outstanding as of the date of this 
prospectus, and 10,000,000 shares of $0.0001 par value preferred stock, of which
none are outstanding.</p>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: left; padding-left: 0px; margin: 0px; text-indent: 
0px;"><b>Description of Business</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We are a development-stage company 
focusing on the acquisition, research, development and, if warranted, 
commercialization of autologous (using a patient&#8217;s own cells) cellular 
therapies that can be used for medical and aesthetic applications. On July 12, 
2013, we, through our wholly owned subsidiary, RenovaCare Sciences Corp., 
completed the acquisition of our flagship technology, a treatment methodology 
for skin isolation, spraying and associated equipment for the regeneration of 
human skin cells (the &#8220;<b>Cell Deposition Device</b>&#8221;), which has 
been shown in early human clinical use in the United States to naturally 
regenerate and heal skin for burn victims, along with the associated United 
States and foreign patents and patent applications. The development of our Cell 
Deposition Device is in the early stage and we anticipate that we will be 
required to expend significant time and resources to further develop our 
technology and determine whether a commercially viable product can be developed.
Research and development of new technologies involves a high degree of risk and 
there is no assurance that our development activities will result in a 
commercially viable product. The long-term profitability of our operations will 
be, in part, directly related to the cost and success of our development 
programs, which may be affected by a number of factors.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The average adult human has a skin 
surface area of between 16 - 21 square feet, which protects all other organs 
against the external environment. When a person&#8217;s skin is assailed by 
trauma or exposed to extreme heat, the skin&#8217;s various layers may be 
destroyed and depending on the severity of the injury, might cause life-
threatening conditions. Currently, severe trauma to the skin, such as second or 
third degree burns, requires surgical mesh-grafting of skin, whereby healthy 
skin is removed from one area of the patient&#8217;s body (a &#8220;<b>donor 
site</b>&#8221;) and implanted on the damaged area.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid9" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">5</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">While mesh grafting is often the 
method of choice, there are significant deficiencies with this method. The 
surgical procedure to remove healthy skin from the donor site can be painful and
leaves the patient with a new wound that must also be attended to. In many 
instances the aesthetic results are not satisfying, as the color of the skin 
from the donor site may not match the skin color of the damaged skin. 
Additionally, since the ratio between the size of the wound area and the size of
the donor site is quite low, i.e. the size of the skin removed must be 
substantially equal in size to the size of the damaged skin, the mesh-grafting 
approach is in many cases limited. Donor and injury sites can take weeks to 
heal, requiring expensive hospital stays, ongoing wound dressing management, and
ever-changing anti-infection strategies.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We are currently evaluating the 
efficacy and potential of our Cell Deposition Device, in combination with our 
unique cell isolation method, in the treatment of tissue that has been subject 
to severe trauma such as second and third degree burns. In small scale clinical 
trials, the Cell Deposition Device and cell isolation methodology have shown the
ability to regenerate a more natural and thicker skin. The Cell Deposition 
Device utilizes the patient&#8217;s own skin stem cells and is able to address 
much larger treatment areas and at the same time reduce the size of the donor 
site. Furthermore, we believe the Cell Deposition Device enables the effective 
treatment of other skin disorders with minimal scarring compared to skin 
grafting.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px;"><b>Corporate Information</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our corporate headquarters is located
at 430 Park Avenue, Suite 702, New York, New York 10022. Our telephone number is
(800) 755-5815. Our website is www.renovacareinc.com. Information contained on 
our web site (or any other website) does not constitute part of this 
prospectus.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b><u style="line-height: 1;">Risk Factors</u></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our business operations are subject 
to numerous risks, including the risk of delays in, or discontinuation of, our 
research and development due to lack of financing, poor results, inability to 
commercialize our technologies or to obtain necessary regulatory approvals to 
market the products, unforeseen safety issues relating to the products and 
dependence on third party collaborators to conduct research and development of 
the products. Because we are an early stage company with a limited history of 
operations, we are also subject to many risks associated with early-stage 
companies. For a more detailed discussion of some of the risks you should 
consider, you are urged to carefully review and consider the section titled 
&#8220;<b>Risk Factors</b>&#8221; beginning on page&#160;9 of this 
prospectus.</p>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: center; margin: 0px;"><b><b>THE OFFERING</b></b></p>
<p style="margin: 0px;" align="center">&#160;</p>
<table id="tableid10" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>Securities Being Registered:</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top" colspan="2">
<p style="margin: 0px;">10,740,000 shares of common stock, consisting of:</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top" colspan="2">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top" width="25%">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom" width="3%"></td>
<td valign="top" width="3%">(a)&#160;</td>
<td valign="top" width="69%">
<p style="text-align: justify; margin: 0px;">3,500,000 shares of common stock 
that were purchased by a Selling Stockholder in transactions with us or with our
affiliates pursuant to exemptions from the registration requirements of the 
Securities Act;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top"></td>
<td valign="top">
<p style="text-align: justify; margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">(b)&#160;</td>
<td valign="top">
<p style="margin: 0px;">240,000 shares of common stock that vest on July 12, 
2014 and are issuable upon exercise of a Series A Warrant allowing the holder to
purchase shares of common stock at an exercise price of $0.35 per share through 
July 12, 2019;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">(c)&#160;</td>
<td valign="top">
<p style="margin: 0px;">3,500,000 shares of common stock issuable upon exercise 
of a Series B Warrant allowing the holder to purchase shares of common stock at 
an exercise price of $0.43 per share if exercised on or before May 29, 2015, or 
$0.46 per share if exercised after May 29, 2015, through November 29, 2018; 
and</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">(d)&#160;</td>
<td valign="top">
<p style="margin: 0px;">3,500,000 shares of common stock issuable upon exercise 
of a Series C Warrant allowing the holder to purchase shares of common stock at 
an exercise price of $0.43 per share if exercised on or before May 29, 2015, or 
$0.49 per share if exercised after May 29, 2015, through November 29, 2018</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top" colspan="2">
<p style="margin: 0px;">Each of the Series A Warrant, Series B Warrant and 
Series C Warrant (collectively, the &#8220;<b>Warrants</b>&#8221;) may be 
exercised on a &#8220;cashless basis&#8221; as further set forth therein.</p>
</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<table id="tableid11" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">6</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid12" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15" bgcolor="#cceeff">
<td valign="top" width="25%">
<p style="margin: 0px;"><b><i>Offering Price:</i></b></p>
</td>
<td valign="bottom" width="3%">&#160;</td>
<td valign="top" width="72%">
<p style="margin: 0px;">The Selling Stockholders will determine at what price 
they may sell the offered shares, and such sales may be made at prevailing 
market prices, or at privately negotiated prices.</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>Selling Stockholders:</i></b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">The Selling Stockholders are existing stockholders, or 
holders of warrants to purchase shares of our stock, who purchased shares of our
common stock, or received warrants to purchase shares of our common stock, from 
us in private transactions pursuant to exemptions from the registration 
requirements of the Securities Act. Please refer to the section titled 
&#8220;<b>Selling Stockholders</b>&#8221; of this prospectus.</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="text-align: left; margin: 0px;"><b><i>Shares Outstanding Prior to 
Completion of the Offering:</i></b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">66,575,122</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>Authorized Capital Stock:</i></b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Our authorized capital stock consists of stock of 
500,000,000 shares of common stock, par value of $0.00001, and 10,000,000 shares
of preferred stock, par value of $0.0001. No preferred shares are issued and 
outstanding.</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="text-align: left; margin: 0px;"><b><i>Shares Outstanding upon Closing 
of the Offering:</i></b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Upon completion of the offering, we will have 66,575,122
shares outstanding, without giving effect to the exercise of any outstanding 
options or the Warrants.</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>OTCQB Symbol:</i></b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">RCAR</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>Transfer Agent:</i></b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Worldwide Stock Transfer, LLC, One University Plaza, 
Suite 505, Hackensack, NJ 07601.</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>Risk Factors:</i></b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Our business operations are subject to numerous risks, 
including the risk of delays in, or discontinuation of, our research and 
development due to lack of financing, poor results, inability to commercialize 
our technologies or to obtain necessary regulatory approvals to market the 
products, unforeseen safety issues relating to the products and dependence on 
third party collaborators to conduct research and development of the products. 
Because we are an early stage company with a limited history of operations, we 
are also subject to many risks associated with early-stage companies. For a more
detailed discussion of some of the risks you should consider, you are urged to 
carefully review and consider the section titled &#8220;<b>Risk 
Factors</b>&#8221; beginning on page&#160;9 of this prospectus.</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>Use of Proceeds:</i></b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Although we will pay substantially all the expenses 
incident to the registration of the Shares, we will not receive any proceeds 
from the sales by the Selling Stockholders. We may, however, receive proceeds 
from the exercise of the Warrants; if such proceeds are received by us, they 
will be used to fund the research and development of the Cell Deposition Device,
and for working capital and general corporate purposes. See &#8220;<b>Use of 
Proceeds</b>.&#8221;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>Duration of Offering:</i></b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Pursuant to the terms of the Asset Purchase Agreement we
entered into with one of the Selling Stockholders, Dr. J&#246;rg Gerlach, we 
agreed to keep the registration statement, of which this prospectus is a part 
of, effective under the earlier of: (i) 24 months after the date on which it is 
declared effective, or (ii) the date on which all the shares issuable upon 
exercise of the Series A Warrant may be resold without restriction pursuant to 
Rule 144.</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><b><i>&#160;</i></b></p>
</td>
<td valign="bottom"></td>
<td valign="top">
<p style="margin: 0px;">Pursuant to the terms of a Registration Rights Agreement
(the &#8220;<b>Registration Rights Agreement</b>&#8221;) we entered into with 
one of the Selling Stockholders, Kalen Capital Corporation, we agreed to keep
the registration statement, of which this prospectus is a part of, effective 
until the earlier of: (a) the date the investor&#8217;s securities have been 
sold in accordance with Rule 144, as promulgated under the Securities Act 
(&#8220;<b>Rule 144</b>&#8221;); (b) such securities become eligible for resale 
without volume or manner-of-sale restrictions and without current public 
information pursuant to Rule 144 as set forth in a written opinion letter to 
such effect, addressed, delivered and acceptable to our transfer agent as 
reasonably determined by us, upon the advice of our counsel; or (c) such 
securities have otherwise been disposed of by the investor pursuant to an 
exemption from the registration requirements of the Securities Act.</p>
</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<table id="tableid13" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">7</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Selected Financial Data</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The following tables set forth a 
summary of certain selected consolidated financial data for the six month 
periods ended June 30, 2014 and 2013 and for the fiscal years ended December 31,
2013 and 2012. Historical results are not necessarily indicative of the results 
that may be expected for any future period. The consolidated financial data 
below should be read in conjunction with &#8220;<b>Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations</b>&#8221; and the
consolidated financial statements and notes included elsewhere in this 
prospectus.</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid14" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>Statements of 
Operations Data</b></p>
</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>For the Six Months Ended June 30, 2014</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>For the Six Months Ended June 30, 2013</b></td>
<td align="left">&#160;</td>
</tr>
<tr style="background-color: white;" height="15">
<td valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
<td width="1%"></td>
<td valign="bottom" width="1%" colspan="2" align="left">
<p style="text-align: center; margin: 0pt;"><strong>(Unaudited)</strong></p>
</td>
<td style="text-align: center;" valign="bottom" width="1%"></td>
<td style="text-align: center;" width="1%"></td>
<td style="text-align: center;" valign="bottom" width="1%" colspan="2" 
align="left">
<p style="text-align: center; margin: 0pt;"><strong>(Unaudited)</strong></p>
</td>
<td valign="bottom" width="1%"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Revenue</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">0</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">0</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Loss from continuing operations</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(601,703</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(144,230</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Net loss</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(601,703</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(144,230</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Basic and diluted net loss per share</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(0.01</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(0.00</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Weighted average shares outstanding used in basic and 
diluted net loss per share calculation</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">66,575,122</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">63,075,122</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid15" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>Statements of 
Operations Data</b></p>
</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center">
<p style="margin: 0cm 0cm 0pt;"><b>For the Year Ended December 31,<br 
></b><b>2013</b></p>
</td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>For the Year Ended December 31,<br >2012</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="center"><b>&#160;</b></td>
<td align="left"></td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="center"><b>&#160;</b></td>
<td align="left"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Revenue</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">0</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">0</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Loss from continuing operations</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(628,545</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(229,539</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Net loss</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(1,032,788</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(243,959</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Basic and diluted net loss per share</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(0.02</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(0.00</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Weighted average shares outstanding used in basic and 
diluted net loss per share calculation</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">63,401,149</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">63,075,122</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid16" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>Balance Sheet 
Data</b></p>
</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>As of <br >June 30, <br >2014 </b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>As of <br >December 31,<br >2013</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>As of <br >December 31,<br >2012</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td align="left"></td>
<td valign="bottom" colspan="2" 
align="center"><strong>(Unaudited)</strong><strong>&#160;</strong></td>
<td align="left"></td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="center"><b>&#160;</b></td>
<td align="left"></td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="center"><b>&#160;</b></td>
<td align="left"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Cash and cash equivalents</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">1,168,093</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">1,508,843</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">513,595</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Working capital</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,067,617</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,454,633</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">481,414</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Total assets</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,436,884</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,752,927</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,065,834</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Total liabilities</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">126,413</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">55,441</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">98,075</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Total stockholders&#8217; equity</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,310,471</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,697,486</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">967,759</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid17" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">8</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>RISK FACTORS</b></p>
<p style="margin: 0px;" align="center"><b><i></i></b>&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;" 
align="center"><b><i>An investment in our securities involves a high degree of 
risk. You should carefully consider the risks described below before purchasing 
any of the Shares. If any of the following risks actually occur, our business, 
financial condition, or results of operations could be materially adversely 
affected, the trading price of our common stock could decline, and you may lose 
all or part of your investment. You should acquire the shares to which this 
prospectus relates only if you can afford to lose your entire investment. You 
should also refer to the other information contained in this prospectus, 
including our financial statements and the notes to those statements, and the 
information set forth under the caption &#8220;Note Regarding Forward-Looking 
Statements.&#8221; The risks described below and contained in our other periodic
reports are not the only ones that we face. Additional risks not presently known
to us or that we currently deem immaterial may also adversely affect our 
business operations.</i></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Risks Related To Our Business</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We have experienced significant
losses, have not generated any revenues and expect losses to continue for the 
foreseeable future.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We are a development-stage company. 
We do not have any commercialized products and have not generated any revenue 
since inception and do not expect to generate any revenue for the foreseeable 
future. We had a net loss from continuing operations of $628,545 and $229,539 
for our fiscal years ended December 31, 2013 and 2012, respectively, and we have
incurred a cumulative deficit of $6.1 million through June 30, 2014. We 
anticipate incurring losses through at least June 30, 2015.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We may require additional 
financing to expand, accelerate or sustain our current level of operations 
beyond our current fiscal year, and failure to obtain such financing would have 
a material adverse effect on our business, operating results, financial 
condition and prospects.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of June 30, 2014, we had cash and 
cash equivalents of $1,168,093. We anticipate that we will remain engaged in 
research and product development activities through at least June 30, 2015. 
Based upon our current level of operations and expenditures, we believe that 
absent any modification or expansion of our existing research, development and 
testing activities, cash on hand should be sufficient to enable us to continue 
operations into our fiscal quarter ending March 31, 2015. There is no assurance 
that we will be able to generate revenue and achieve profitability or secure 
additional financing once our current cash balance is depleted. Any significant 
expansion in scope or acceleration in timing of our current research and 
development activities, or commencement of any marketing and sales activities, 
will require additional funds.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">If adequate funds, including 
proceeds, if any, from this offering are not available on reasonable terms or at
all, it would result in a material adverse effect on our business, operating 
results, financial condition and prospects. In particular, we may be required to
delay, reduce the scope of or terminate one or more of our research programs, 
sell rights to our Cell Deposition Device or other technologies or products 
based upon such technologies, or license the rights to such technologies or 
products on terms that are less favorable to us than might otherwise be 
available. If we raise additional funds by issuing equity or debt securities, 
further dilution to stockholders may result and new investors could have rights 
superior to existing stockholders.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid18" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">9</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Even if financing is available 
to us, because we cannot currently estimate the amount of funds or time required
to commercialize our technologies, we may secure less funding than is actually 
required to effectuate our business plan.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We cannot accurately predict the 
amount of funding or the time required to successfully commercialize our Cell 
Deposition Device, or any products derived therefrom. The actual cost and time 
required to commercialize this technology may vary significantly depending on, 
among other things, the results of our research and development efforts, the 
cost of developing, acquiring, or licensing various enabling technologies, 
changes in the focus and direction of our research and development programs, 
competitive and technological advances, the cost of filing, prosecuting, 
defending and enforcing claims with respect to patents, the regulatory approval 
process and manufacturing, marketing and other costs associated with 
commercialization of these technologies. Because of this uncertainty, even if 
financing is available to us, we may secure insufficient funding to effectuate 
our business plan.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>The success of our research and
development activities is uncertain. If such efforts are not successful, we will
be unable to generate revenues from our operations and we may</i></b><i> <b>have
to cease doing business.</b></i></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Commercialization of our Cell 
Deposition Device will require significant further research, development and 
testing as we must ascertain whether the Cell Deposition Device can form the 
basis for a commercially viable technology or product. If our research and 
development fails to prove commercial viability of the Cell Deposition Device, 
we may need to abandon our business model and/or cease doing business, in which 
case our shares may have no value and you may lose your investment. We 
anticipate we will remain engaged in research and development, through at least 
June 2015.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We may not be eligible to 
receive certain grants because of our foreign ownership.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In order to fund the ongoing research
and development of our Cell Deposition Device we may apply for grants. In order 
to be eligible to receive certain of these grants, particularly those 
administered by the United States federal government, at least 50% of the 
outstanding shares of a company must be owned by residents of the United States.
Because our majority shareholder is not a United States resident we may not be 
eligible to receive such grants.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>The development of our 
</i></b><b><i>Cell Deposition Device</i></b> <b><i>is subject to the risks of 
failure inherent in the development of any novel technology</i></b><i>.</i></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Ultimately, the development and 
commercialization of our Cell Deposition Device is subject to a number of risks 
that are particular to the development and commercialization of any novel 
technology. These risks include, but are not limited to, the following:</p>
<ul>
<li style="text-align: justify;">we may fail to develop, acquire, or license 
various enabling technologies that may be integral to the commercialization of 
the Cell Deposition Device (or any derivatives);</li>
<li style="text-align: justify;">the Cell Deposition Device may ultimately prove
to be ineffective, unsafe or otherwise fail to receive necessary regulatory 
approvals;</li>
<li style="text-align: justify;">the Cell Deposition Device (or any 
derivatives), even if safe and effective, may be difficult to manufacture on a
large scale or uneconomical to market;</li>
<li style="text-align: justify;">our marketing license or proprietary rights to 
products derived from the Cell Deposition Device may not be sufficient to 
protect our products from competitors;</li>
<li style="text-align: justify;">the proprietary rights of third parties may 
preclude us or our collaborators from making, using or marketing products 
utilizing the Cell Deposition Device; or,</li>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">third parties may market superior, more effective, or less 
expensive technologies or products having comparable results to the Cell 
Deposition Device (or any derivatives).</li>
</ul>
<table id="tableid19" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">10</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;"><b><i></i></b>&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>If we fail to manage our growth
effectively, our business could be disrupted.</i></b></p>
<table id="tableid20" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px; text-indent: 
30px;">&#160;</p>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px; text-indent: 30px;">Our 
future financial performance and ability to successfully commercialize our 
products, of which there is no guarantee, and to compete effectively will 
depend, in part, on our ability to manage any future growth effectively. We 
expect to make significant investments to enable our future growth through, 
among other things, new product development, clinical trials for new indications
and expansion of our marketing and sales infrastructure. Any failure to manage 
future growth effectively could have a material adverse effect on our business 
and results of operations.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We could be subject to product 
liability lawsuits, which could result in costly and time-consuming litigation 
and significant liabilities.</i></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The development of biopharmaceutical 
products, such as our Cell Deposition Device, involves an inherent risk of 
product liability claims and associated adverse publicity. Any products we may 
develop may be found to be harmful or to contain harmful substances. This 
exposes us to substantial risk of litigation and liability or may force us to 
discontinue production of certain products. There can be no assurance that we 
will be able to obtain or maintain insurance on reasonable terms or to otherwise
protect ourselves against potential product liability claims that could impede 
or prevent commercialization of any products we may develop and commercialize. 
Furthermore, a product liability claim could damage our reputation, whether or 
not such claims are covered by insurance or are with or without merit. A product
liability claim against us or the withdrawal of a product from the market could 
have a material adverse effect on our business or financial condition. 
Furthermore, product liability lawsuits, regardless of their success, would 
likely be time consuming and expensive to resolve and would divert management's 
time and attention, which could seriously harm our business.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>In addition to patented 
technology, we rely on our unpatented proprietary technology, trade secrets, 
processes and know-how.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">We rely on 
proprietary information (such as trade secrets, know-how and confidential 
information) to protect intellectual property that may not be patentable, or 
that we believe is best protected by means that do not require public 
disclosure. We generally seek to protect this proprietary information by 
entering into confidentiality agreements, or consulting, services or employment 
agreements that contain non-disclosure and non-use provisions with our 
employees, consultants, contractors, scientific advisors and third parties. 
However, we may fail to enter into the necessary agreements, and even if entered
into, these agreements may be breached or otherwise fail to prevent disclosure, 
third-party infringement or misappropriation of our proprietary information, may
be limited as to their term and may not provide an adequate remedy in the event 
of unauthorized disclosure or use of proprietary information.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We have limited control over the 
protection of trade secrets used by our suppliers and service providers and 
could lose future trade secret protection if any unauthorized disclosure of such
information occurs. In addition, our proprietary information may otherwise 
become known or be independently developed by our competitors or other third 
parties. To the extent that our employees, consultants, contractors, scientific 
advisors and other third parties use intellectual property owned by others in 
their work for us, disputes may arise as to the rights in related or resulting 
know-how and inventions. Costly and time-consuming litigation could be necessary
to enforce and determine the scope of our and relevant third parties&#8217; 
proprietary rights, failure to obtain or maintain protection for our proprietary
information could adversely affect our competitive business position and if 
third parties are able to establish that we are using their proprietary 
information without their permission, we may be required to obtain a license to 
that information, or if such a license is not available, re-design our products 
to avoid any such unauthorized use or temporarily delay or permanently stop 
manufacturing or sales of the affected products. Furthermore, laws regarding 
trade secret rights in certain markets where we may operate may afford little or
no protection to our trade secrets.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid21" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">11</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>In seeking to acquire or 
develop technologies,</i> <i>we</i> <i>are operating in highly competitive 
markets and our competitors enjoy numerous competitive advantages over 
us.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">Our commercial 
success will depend on our ability to compete effectively in product development
areas such as, but not limited to, safety, efficacy, ease of use, customer 
compliance, price, marketing and distribution. Our competitors may succeed in 
developing products that are more effective than any products derived from our 
research and development efforts or that would render such products obsolete and
non-competitive. The skin care and wound care industry is characterized by 
intense competition, rapid product development and technological change. Most of
the competition that we encounter is expected to come from companies, research 
institutions and universities who are researching and developing technologies 
and products similar to or competitive with any we may develop.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">These companies enjoy numerous 
competitive advantages, including:</p>
<ul>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">significantly greater name recognition;</li>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">established relations with customers;</li>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">established distribution networks;</li>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">more advanced technologies and product development;</li>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">additional lines of products, and the ability to offer rebates, 
higher discounts or incentives to gain a competitive advantage;</li>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">greater experience in conducting research and development, 
manufacturing, obtaining regulatory approval for products, and marketing 
approved products;</li>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">greater financial and human resources for product development, 
sales and marketing, and</li>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">the ability to endure potentially prolonged patent 
litigation.</li>
</ul>
<p style="margin: 0px; text-indent: 30px;">As a result, we may not be able to 
compete effectively against these companies or their products.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>To the extent we are able to 
develop and commercialize products based upon or derived from our Cell 
Deposition Device and underlying technology, if such products do not gain market
acceptance, we may not achieve sales and market share.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Even if we are able to develop and 
commercialize one or more products based upon or derived from the Cell 
Deposition Device and underlying technology, of which there is no guarantee, the
development of a successful market for our products may be adversely affected by
a number of factors, some of which are beyond our control, including:</p>
<ul>
<li style="text-align: justify;">customer acceptance of our products;</li>
<li style="text-align: justify;">obtaining third-party coverage or reimbursement
for our products;</li>
<li style="text-align: justify;">performance and reliability of our products as 
compared with other alternative products;</li>
<li style="text-align: justify;">the ability to offer our products for sale at 
an attractive value and the willingness of physicians to administer our products
and their acceptance as part of the medical department routine;</li>
<li style="text-align: justify;">the prevalence and severity of any side 
effects;</li>
<li style="text-align: justify;">the efficacy, potential advantages and timing 
of introduction to the market of alternative treatments; and</li>
<li style="text-align: justify;">our failure to develop and maintain successful 
relationships with health care professionals, manufacturers, distributors, and 
other resellers, as well as strategic partners.</li>
</ul>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">Failure to 
achieve market acceptance for any of our products, if and when they are approved
for commercial sale, will have a material adverse effect on our business, 
financial condition and results of operations.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid22" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">12</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We may be unsuccessful in 
commercializing our products due to unfavorable pricing regulations, third-party
coverage and reimbursement policies or healthcare reform 
initiatives.</i></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">We cannot predict 
the pricing and reimbursement of any products we may develop and commercialize. 
The regulations that govern marketing approvals, pricing and reimbursement for 
new products vary widely from country to country. In some foreign jurisdictions,
including the European Union, the pricing of medical devices and treatments is 
subject to governmental control. In these jurisdictions, pricing negotiations 
with governmental authorities can take considerable time after the receipt of 
marketing approval for a product candidate.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As a result, we might obtain 
regulatory approval for a product in a particular country, but then be subject 
to price regulations that delay our commercial launch of the product and 
negatively impact the revenue we are able to generate from the sale of the 
product in that country. Adverse pricing limitations may hinder our ability to 
recoup our investment in any products we may develop and commercialize, even 
after obtaining regulatory approval.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Additionally, we cannot be sure that 
reimbursement will be available for any products we may develop and 
commercialize, or if reimbursement is available, what the level of reimbursement
will be. Reimbursement may affect the demand for, or the price of, any product 
for which we obtain marketing approval. Obtaining reimbursement for any products
we may develop and commercialize may be particularly difficult because of the 
higher prices often associated with products administered under the supervision 
of a physician. If reimbursement is not available or is available only at 
limited levels, we may not be able to successfully commercialize any products 
that we successfully develop. Eligibility for reimbursement does not imply that 
any product will be paid for in all cases or at a rate that covers our costs. 
Interim payments for new products, if applicable, may also not be sufficient to 
cover our costs and may not be made permanent. Payment rates may vary according 
to the use of the product and the clinical setting in which it is used, may be 
based on payments allowed for lower cost products that are already reimbursed 
and may be incorporated into existing payments for other services.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Clinical </i></b><b><i>medical 
device</i></b><b><i> development is a lengthy and expensive process, with an 
uncertain outcome.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We intend to develop and 
commercialize pipeline products based on our Cell Deposition Device and 
underlying technology. However, before obtaining regulatory approval for the 
sale of for any products we may develop and commercialize, we must conduct, at 
our own expense, clinical studies to demonstrate that the products are safe and 
effective.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Preclinical and clinical testing is 
expensive, difficult to design and implement, can take many years to complete 
and is uncertain as to outcome. A failure of one or more of our clinical trials 
can occur at any stage of testing. We may experience numerous unforeseen events 
during, or as a result of, preclinical testing and the clinical trial process. 
Even if preclinical or clinical trials are successful, we still may be unable to
commercialize the product, as success in preclinical trials, early clinical 
trials, or later clinical trials, does not ensure commercial acceptance.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid23" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">13</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Similar or other events could delay 
or prevent our ability to complete necessary clinical trials for our pipeline 
products, including:&#160;</p>
<ul>
<li style="text-align: justify;">regulators may not authorize us to conduct a 
clinical trial within a country or at a prospective trial site or may change the
design of a study;</li>
<li style="text-align: justify;">delays may occur in reaching agreement on 
acceptable clinical trial terms with regulatory authorities or prospective 
sites, or obtaining institutional review board approval;</li>
<li style="text-align: justify;">our preclinical tests or clinical trials may 
produce negative or inconclusive results, and we may decide, or regulators may 
require us, to conduct additional trials or to abandon strategic projects;</li>
<li style="text-align: justify;">the number of patients required for our 
clinical trials may be larger than we anticipate, enrollment in our clinical 
trials may be slower or more difficult than we expect, or patients may not 
participate in necessary follow-up visits to obtain required data, any of which 
would result in significant delays in our clinical testing process;</li>
<li style="text-align: justify;">our third-party contractors, such as a research
institution, may fail to comply with regulatory requirements or meet their 
contractual obligations to us;</li>
<li style="text-align: justify;">we may be forced to suspend or terminate our 
clinical trials if the participants are being exposed, or are thought to be 
exposed, to unacceptable health risks or if any participant experiences an 
unexpected serious adverse event;</li>
<li style="text-align: justify;">regulators or institutional review boards may 
require that we hold, suspend or terminate clinical research for various 
reasons, including noncompliance with regulatory requirements;</li>
<li style="text-align: justify;">undetected or concealed fraudulent activity by 
a clinical researcher, if discovered, could preclude the submission of clinical 
data prepared by that researcher, lead to the suspension or substantive 
scientific review of one or more of our marketing applications by regulatory 
agencies, and result in the recall of any approved product distributed pursuant 
to data determined to be fraudulent;</li>
<li style="text-align: justify;">the cost of our clinical trials may be 
significantly greater than we anticipate;</li>
<li style="text-align: justify;">an audit of preclinical or clinical studies by 
regulatory authorities may reveal noncompliance with applicable protocols or 
regulations, which could lead to disqualification of the results and the need to
perform additional studies; and</li>
<li style="text-align: justify;">delays may occur in obtaining our clinical 
materials.</li>
</ul>
<p style="margin: 0px; text-indent: 30px;">Moreover, we do not know whether 
preclinical tests or clinical trials will begin or be completed as planned or 
will need to be restructured. Significant delays could also shorten the patent 
protection period during which we may have the exclusive right to commercialize 
our products or could allow our competitors to bring products to the market 
before we do, impairing our ability to commercialize our products.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Development and 
commercialization of </i></b><b><i>a</i></b><b><i>ny</i></b><b><i> products 
requires successful completion of the regulatory approval process, and may 
suffer delays or fail.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In the United States, as well as 
other jurisdictions, we will be required to apply for and receive marketing 
authorization before we can market our products. This process can be time 
consuming and complicated and may result in unanticipated delays. To secure 
marketing authorization, an applicant generally is required to submit an 
application that includes the data supporting preclinical and clinical safety 
and efficacy as well as detailed information on the manufacturing and control of
the product, proposed labeling and other additional information. Before 
marketing authorization is granted, regulatory authorities generally require the
inspection of the manufacturing facility or facilities and quality systems 
(including those of third parties) at which the product candidate is 
manufactured and tested, as well as potential audits of the non-clinical and
clinical trial sites that generated the data cited in the marketing 
authorization application.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid24" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">14</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We cannot predict how long the 
applicable regulatory authority or agency will take to grant marketing 
authorization or whether any such authorizations will ultimately be granted. 
Regulatory agencies, including the Food and Drug Administration (the 
&#8220;<b>FDA</b>&#8221;), have substantial discretion in the approval process, 
and the approval process and the requirements governing clinical trials vary 
from country to country. The policies of the FDA or other regulatory authorities
may change or may not be explicit, and additional government regulations may be 
enacted that could prevent, limit or delay regulatory approval of any products 
we may develop and commercialize. We cannot predict the likelihood, nature or 
extent of government regulation that may arise from future legislation or 
administrative action, either in the United States, Europe or elsewhere. If we 
are slow or unable to adapt to changes in existing requirements or the adoption 
of new requirements or policies, or if we are not able to maintain regulatory 
compliance, we may lose any marketing approval that we may have obtained and we 
may not achieve or sustain profitability.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Additionally, any regulatory approval
that we receive may also contain requirements for potentially costly post-
marketing testing and surveillance to monitor the safety and efficacy of the 
product candidate. Once a product is approved, the manufacturing processes, 
labeling, packaging, distribution, adverse event reporting, storage, 
advertising, promotion, import, export and recordkeeping for the product will be
subject to extensive and ongoing regulatory requirements. These requirements 
include submission of safety and other post-marketing information and reports, 
registration and continued compliance with good manufacturing practices for any 
clinical trials that we conduct post-approval.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Our product candidates may 
cause undesirable side effects or have other properties that could delay or 
prevent their regulatory approval or result in significant negative consequences
following marketing approval, if any.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Undesirable side effects caused by 
our product candidates could cause us or regulatory authorities to interrupt, 
delay or halt clinical trials and could result in a more restrictive label or 
the delay or denial of regulatory approval by the FDA or other comparable 
foreign authorities. Results of our trials could reveal a high and unacceptable
severity and prevalence of side effects. In such an event, our trials could be 
suspended or terminated and the FDA or comparable foreign regulatory authorities
could order us to cease further development of or deny approval for our product 
candidates for any or all targeted indications. Any related side effects could 
affect patient recruitment or the ability of enrolled patients to complete the 
trial or result in potential product liability claims. Any of these occurrences 
may harm our business, financial condition and prospects significantly.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Additionally, if one or more of our 
product candidates receives marketing approval, and we or others later identify 
undesirable side effects caused by such products, a number of potentially 
significant negative consequences could result, including:</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid25" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="3%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">regulatory authorities may 
withdraw approvals of such product;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">regulatory authorities may 
require additional warnings on the label;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">we may be required to create
a medication guide outlining the risks of such side effects for distribution to 
patients;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">we could be sued and held 
liable for harm caused to patients; and</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">our reputation may 
suffer.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<table id="tableid26" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">15</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We may be subject to product 
liability claims and we </i></b><b><i>do not currently maintain</i></b><b><i> 
product liability insurance.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The manufacture and sale of medical 
devices and other therapeutic products involve an inherent risk of product 
liability claims and associated adverse publicity. If we manage to commercialize
the Cell Deposition Device or its underlying technology we may become subject to
product liability claims or liabilities in the future, including if patients 
die, or suffer some other serious adverse effect whether or not such patients 
were predisposed to adverse outcomes.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Any product liability claims could 
have a material negative effect on the market acceptance and sales of our 
products. We currently do not maintain any product liability insurance. We do 
not know if we will be able to obtain product liability insurance on acceptable 
terms or with adequate coverage against potential liabilities. This type of 
insurance is expensive and may not be available on acceptable terms or at all. 
If we are unable to obtain or maintain sufficient insurance coverage on 
reasonable terms or to otherwise protect against potential product liability 
claims, we may be unable to continue to develop or commercialize our products or
any product candidates that may receive regulatory approval in the future. A 
successful product liability claim brought against us in excess of our insurance
coverage, if any, may require us to make substantial payments. This could 
adversely affect our cash position and results of operations and could increase 
the volatility of our stock price.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Obtaining and maintaining 
</i></b><b><i>regulatory approval for a product candidate in one jurisdiction
does not mean that we will be successful in obtaining regulatory approval for 
that product candidate in other jurisdictions.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Obtaining and maintaining regulatory 
approval for a product candidate in one jurisdiction does not guarantee that we 
will be able to obtain or maintain regulatory approval in any other 
jurisdiction, while a failure or delay in obtaining regulatory approval in one 
jurisdiction may have a negative effect on the regulatory approval process in 
others. For example, even if the FDA grants marketing approval for a product 
candidate, comparable regulatory authorities in foreign jurisdictions must also 
approve the manufacturing, marketing and promotion of the product candidate in 
those countries. Approval procedures vary among jurisdictions and can involve 
requirements and administrative review periods different from, and greater than,
those in the United States, including additional preclinical studies or clinical
trials as clinical trials conducted in one jurisdiction may not be accepted by 
regulatory authorities in other jurisdictions. In many jurisdictions outside the
United States, a drug candidate must be approved for reimbursement before it can
be approved for sale in that jurisdiction. In some cases, the price that we 
intend to charge for our products is also subject to approval.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;&#160;</p>
<table id="tableid27" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">16</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We may fail to 
</i></b><b><i>obtain regulatory approval for our product candidates.</i></b></p>
<p style="margin: 0px; text-indent: 30px;"><b><i></i></b>&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our potential product candidates 
could fail to receive regulatory approval for many reasons, including one or 
more of the following:</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid28" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="3%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="text-align: justify; font: 10pt TIMES NEW ROMAN; margin: 0px;">the FDA
or comparable foreign regulatory authorities may disagree with the design or 
implementation of our clinical trials or the validation of our caregiver and
patient reported outcome instruments;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="margin: 0px;"><font style="font-size: 10pt; font-family: 
Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">we may be unable to 
demonstrate to the satisfaction of the FDA or comparable foreign regulatory 
authorities that a product candidate is safe and effective for any of its 
proposed indications;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">the results of clinical 
trials may not meet the level of statistical significance required by the FDA or
comparable foreign regulatory authorities for approval;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">we may be unable to 
demonstrate that a product candidate&#8217;s clinical and other benefits 
outweigh its safety risks;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">the FDA or comparable 
foreign regulatory authorities may disagree with our interpretation of data from
preclinical studies or clinical trials;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="text-align: justify; font: 10pt TIMES NEW ROMAN; margin: 0px;">the 
data collected from clinical trials of our Cell Deposition Device and its 
underlying technology may not be sufficient to satisfy the FDA or comparable 
foreign regulatory authorities to support our submission or to obtain regulatory
approval in the United States or elsewhere;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">the FDA or comparable 
foreign regulatory authorities may fail to approve the manufacturing processes 
or facilities of third-party manufacturers with which we contract for clinical 
and commercial supplies; and</p>
</td>
</tr>
<tr>
<td style="text-align: justify;" valign="top"><font style="font-family: TIMES 
NEW ROMAN;">&#160;</font></td>
<td style="text-align: justify;" valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="text-align: justify; font: 10pt TIMES NEW ROMAN; margin: 0px;">the 
approval policies or regulations of the FDA or comparable foreign regulatory 
authorities may significantly change in a manner rendering our clinical data 
insufficient for approval.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Healthcare legislative reform 
measures may have a material adverse effect on our business and results of 
operations.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In the United States, there have been
and continue to be a number of legislative initiatives to contain healthcare 
costs. For example, in March 2010, the Patient Protection and Affordable Care 
Act, as amended by the Health Care and Education Reconciliation Act, or the 
Health Care Reform Law, was passed, which substantially changes the way health 
care is financed by both governmental and private insurers, and significantly 
impacts the U.S. pharmaceutical industry. The Health Care Reform Law, among 
other things, (i) subjects biologic products to potential competition by lower-
cost biosimilars, (ii) addresses a new methodology by which rebates owed by 
manufacturers under the Medicaid Drug Rebate Program are calculated for drugs 
that are inhaled, infused, instilled, implanted, or injected, (iii) increases 
the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug 
Rebate Program and extends the rebate program to individuals enrolled in 
Medicaid managed care organizations, (iv) establishes annual fees and taxes on 
manufacturers of certain branded prescription drugs, and (v) promotes a new 
Medicare Part D coverage gap discount program.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In addition, other legislative 
changes have been proposed and adopted in the United States since the Health 
Care Reform Law was enacted. On August 2, 2011, the Budget Control Act of 2011, 
among other things, created measures for spending reductions by Congress. A 
Joint Select Committee on Deficit Reduction, tasked with recommending a targeted
deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was
unable to reach required goals, thereby triggering the legislation&#8217;s 
automatic reduction to several government programs. This includes aggregate 
reductions of Medicare payments to providers up to 2% per fiscal year. On 
January 2, 2013, President Obama signed into law the American Taxpayer Relief
Act of 2012, or the ATRA, which, among other things, delayed for another two 
months the budget cuts mandated by these sequestration provisions of the Budget 
Control Act of 2011. On March 1, 2013, the President signed an executive order 
implementing sequestration, and on April 1, 2013, the 2% Medicare payment 
reductions went into effect. We expect that additional state and federal 
healthcare reform measures will be adopted in the future, any of which could 
limit the amounts that federal and state governments will pay for healthcare 
products and services, which could result in reduced demand for our product 
candidates or additional pricing pressures.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid29" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">17</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We are subject to extensive 
environmental, health and safety, and other laws and regulations.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Although our business involves the 
controlled use of biological materials, the risk of accidental contamination or 
injury from these materials cannot be eliminated. If an accident, spill or 
release of any such chemicals or substances occurs, we could be held liable for 
resulting damages, including for investigation, remediation and monitoring of 
the contamination, including natural resource damages, the costs of which could 
be substantial. We are also subject to numerous environmental, health and 
workplace safety laws and regulations, including those governing laboratory 
procedures. Additional or more stringent laws and regulations affecting our 
operations may be adopted in the future. We may incur substantial capital costs 
and operating expenses and may be required to obtain consents to comply with any
of these or certain other laws or regulations and the terms and conditions of 
any permits required pursuant to such laws and regulations, including costs to 
install new or updated pollution control equipment, modify our operations or 
perform other corrective actions at our respective facilities. In addition, 
fines and penalties may be imposed for noncompliance with environmental, health 
and safety and other laws and regulations or for the failure to have, or comply 
with the terms and conditions of, required environmental or other permits or 
consents.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We face competition from the 
existing standard of care and potential changes in medical practice and 
technology and the possibility that our competitors may develop products, 
treatments or procedures that are similar, more advanced, safer or more 
effective than ours.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The medical, biotechnology and 
pharmaceutical industries are intensely competitive and subject to significant
technological and practice changes. We may face competition from many difference
sources with respect to any products we may develop and commercialize. Possible 
competitors may be medical practitioners, pharmaceutical and wound care 
companies, academic and medical institutions, governmental agencies and public 
and private research institutions, among others. Should any competitor&#8217;s 
product candidates receive regulatory or marketing approval prior to ours, they 
may establish a strong market position and be difficult to displace, or will 
diminish the need for our products.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our commercial opportunity could be 
reduced or eliminated if our competitors develop and commercialize products, 
treatments or procedures that are safer, more effective, have fewer or less 
severe side effects, are more convenient or are less expensive than any product 
that we may develop. Many of our current or future competitors may have 
significantly greater financial resources and expertise in research and 
development, manufacturing, preclinical testing, conducting clinical trials, 
obtaining regulatory approvals and marketing approved products than we may have.
Mergers and acquisitions in the pharmaceutical and biotechnology industries or 
wound care markets may result in even more resources being concentrated among a 
smaller number of our competitors. Other early stage companies may also prove to
be significant competitors, particularly through collaborative arrangements with
large and established companies. These companies compete with us in recruiting 
and retaining qualified scientific and management personnel, establishing 
clinical trial sites and patient registration for clinical trials, as well as in
acquiring technologies complementary to, or necessary for, our programs.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We may compete for the time and
efforts of our officers and directors.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Certain of our officers and directors
are also officers, directors, and employees of other companies and we may have 
to compete with the other companies for their time, attention and efforts. Our 
officers provide us their services on a part-time basis and none of our 
directors anticipate devoting more than approximately five (5%) percent of their
working time to our matters.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We maintain at-will consulting 
agreements with our officers that may be terminated by us or the respective 
officer at any time and for any reason.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We maintain at-will consulting 
agreements with our officers that may be terminated by us or the respective 
officer at any time and for any reason. If any of our officers terminate their 
consulting agreement it may have a material adverse effect on our business, 
financial condition or ability to operate.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid30" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">18</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Our growth and success 
depend</i></b><b><i>s</i></b><b><i> on our ability to attract and retain 
additional highly qualified and skilled sales and marketing, research and 
development, operational, managerial and finance personnel.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our growth and success depends on our
ability to attract and retain additional highly qualified and skilled sales and 
marketing, research and development, operational, managerial and finance 
personnel. Competition for skilled personnel is intense and the unexpected loss 
of an employee with a particular skill could materially adversely affect our 
operations until a replacement can be found and trained. If we cannot attract 
and retain skilled scientific and operational personnel, as required, for our 
research and development and manufacturing operations on acceptable terms, we 
may not be able to develop and commercialize any products we may develop and 
commercialize. Further, any failure to effectively integrate new personnel could
prevent us from successfully growing our company.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px;"><b>Risks Related To Ownership of Our Common 
Stock</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>The trading price of our common
stock historically has been volatile and may not reflect its actual 
value.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The trading price of our common stock
has, from time to time, fluctuated widely and in the future may be subject to 
similar fluctuations. The trading price may be affected by a number of factors 
including the risk factors set forth herein, as well as our operating results, 
financial condition, general economic our control. In recent years, broad stock 
market indices in general, and smaller capitalization companies in particular, 
have experienced substantial price fluctuations. In a volatile market, we may 
experience wide fluctuations in the market price of our common stock. These 
fluctuations may have a negative effect on the market price of our common stock.
In addition, the sale of our common stock into the public market upon the 
effectiveness of this registration statement could put downward pressure on the 
trading price of our common stock.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>The sale by our stockholders of
restricted shares, either pursuant to a resale prospectus or Rule 144, may 
adversely affect our ability to raise the funds we will require to effectuate 
our business plan.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of the date of this prospectus we 
had 66,575,122 shares issued and outstanding, of which 42,931,800 are deemed 
&#8220;restricted securities&#8221; within the meaning of Rule 144. The 
possibility that substantial amounts of our common stock may be sold into the 
public market, either under Rule 144, or pursuant to a resale registration 
statement, may adversely affect prevailing market prices for the common stock 
and could impair our ability to raise capital in the future through the sale of 
equity securities because of the perception that future resales could decrease 
our stock price and because of the availability of resale shares to those 
interested in investing in our common stock.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Our common stock is a penny 
stock and is not traded on a national securities exchange, therefore you may 
find it difficult to sell shares of our common stock you may acquire in this 
offering.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our common stock is traded on the
OTCQB. The OTCQB is viewed by most investors as a less desirable, and less 
liquid, marketplace. As a result, an investor may find it more difficult to 
purchase, dispose of or obtain accurate quotations as to the value of our common
stock.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Additionally, our common stock is 
subject to regulations of the SEC applicable to &#8220;penny stock.&#8221; Penny
stock includes any non-NASDAQ equity security that has a market price of less 
than $5.00 per share, subject to certain exceptions. Rules 15g-1 through 15g-9 
under the Securities Exchange Act of 1934, as amended (the &#8220;<b>Exchange 
Act</b>&#8221;), imposes certain sales practice requirements on broker-dealers 
who sell our common stock to persons other than established customers and 
&#8220;accredited investors&#8221; (as defined in Rule 501(a) of the Securities 
Act). For transactions covered by this rule, a broker-dealer must make a special
suitability determination for the purchaser and have received the 
purchaser&#8217;s written consent to the transaction prior to the sale. This 
rule adversely affects the ability of broker-dealers to sell our common stock 
and purchasers of our common stock to sell their shares of our common stock.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid31" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">19</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In addition, the penny stock 
regulations require that prior to any non-exempt buy/sell transaction in a penny
stock, a disclosure schedule proscribed by the SEC relating to the penny stock 
market must be delivered by a broker-dealer to the purchaser of such penny 
stock. This disclosure must include the amount of commissions payable to both 
the broker-dealer and the registered representative and current price quotations
for our common stock. The regulations also require that monthly statements be 
sent to holders of penny stock that disclose recent price information for the 
penny stock and information of the limited market for penny stocks. These 
requirements adversely affect the market liquidity of our common stock.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Although our common stock is 
currently quoted on the OTCQB, if we do not meet or comply with the recent rule 
changes to the OTCQB our shares may be delisted from the OTCQB and would likely 
be traded on the OTC Pink (aka the Pink Sheets).</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Although our common stock is 
currently quoted on the OTCQB, effective as of May 1, 2014, the OTC Markets 
Group, Inc. changed its rules for OTCQB eligibility. To be eligible for OTCQB, 
companies will be required to:</p>
<ul>
<li style="text-align: justify;">meet a minimum bid price test of $0.01.
Securities that do not meet the minimum bid price test will be downgraded to OTC
Pink;</li>
<li style="text-align: justify;">submit an application to OTCQB and pay an 
application and annual fee; and</li>
<li style="text-align: justify;">submit an OTCQB Annual Certification confirming
the Company Profile displayed on www.otcmarkets.com is current and complete and 
providing additional information on officers, directors, and controlling 
shareholders.</li>
</ul>
<p style="text-align: justify; text-indent: 30px;">Management has not yet 
determined whether it will submit the required application and pay the 
associated fees to remain quoted on the OTCQB. In the event we do not submit an 
application and pay those fees our common stock will likely be downgraded to the
OTC Pink, which could adversely affect the market liquidity of our common 
stock.&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Kalen Capital Corporation, a 
private corporation solely owned by Mr. Harmel Rayat, beneficially owns 
approximately 64% of our issued and outstanding stock. This ownership interest 
may permit Kalen Capital Corporation to influence significant corporate 
decisions.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of the date of this prospectus, 
Kalen Capital Corporation, a private corporation solely owned by Harmel S. 
Rayat, a former officer and director of ours, beneficially owned approximately 
42,564,800 shares (including shares issuable upon exercise of outstanding 
warrants), or approximately 64%, of our outstanding common stock. As a result, 
Mr. Rayat may be able to exercise significant influence over matters requiring 
stockholder approval, including the election of directors and approval of 
significant corporate transactions, and will have significant control over our 
management and policies. Mr. Rayat&#8217;s interests may be different from 
yours. For example, he may support proposals and actions with which you may 
disagree or which are not in your interest. This concentration of ownership 
could delay or prevent a change in control of our company or otherwise 
discourage a potential acquirer from attempting to obtain control of our 
company, which in turn could reduce the price of our common stock. In addition, 
Mr. Rayat could use his voting influence to maintain our existing management and
directors in office, or support or reject other management and board proposals 
that are subject to stockholder approval, such as the adoption of employee stock
plans and significant unregistered financing transactions.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid32" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">20</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>There are options to purchase
shares of our common stock currently outstanding.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of the date of this prospectus we 
have granted options to purchase shares of our common stock to various persons 
and entities, under which we could be obligated to issue up to 185,000 shares of
our common stock. The exercise prices of these options range from $0.65 to $1.05
per share. If issued, the shares underlying these options would increase the 
number of shares of our common stock currently outstanding and dilute the 
holdings and voting rights of our then-existing stockholders.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>There are warrants to purchase 
shares of our common stock currently outstanding.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of the date of this prospectus we 
have issued warrants to purchase shares of our common stock to various persons 
and entities, under which we could be obligated to issue up to 8,200,000 shares 
of common stock. The exercise prices of these warrants are $0.35 per share for 
the 1,200,000 Series A Warrant (240,000 shares have vested as of the date 
hereof), either $0.43 or $0.46 per share for the 3,500,000 shares issuable upon 
exercise of the Series B Warrant and either $0.43 or $0.49 for the 3,500,000 
shares issuable upon exercise of the Series C Warrant. If issued, the shares 
underlying the Warrants would increase the number of shares of our common stock 
currently outstanding and dilute the holdings and voting rights of our then-
existing stockholders.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We may issue preferred stock 
which may have greater rights than our common stock.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our Articles of Incorporation allow 
our Board of Directors (the &#8220;<b>Board</b>&#8221;) to issue up to 
10,000,000 shares of preferred stock. Currently, no shares of preferred stock 
are issued and outstanding. However, we can issue shares of our preferred stock 
in one or more series and can set the terms of the preferred stock without 
seeking any further approval from the holders of our common stock. Any preferred
stock that we issue may rank ahead of our common stock in terms of dividend 
priority or liquidation premiums and may have greater voting rights than our 
common stock. In addition, such preferred stock may contain provisions allowing 
it to be converted into shares of common stock, which could dilute the value of 
our common stock to then current stockholders and could adversely affect the 
market price, if any, of our common stock.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>We have entered into a 
registration rights agreement with Kalen Capital Corporation requiring us to 
register all the shares owned by Kalen Capital Corporation as of November 29, 
2013, including all shares issuable upon conversion of any warrants then owned 
by Kalen Capital Corporation. If we fail to timely file the registration 
statements we will be obligated to issue additional shares of our common stock 
to Kalen Capital Corporation.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">One November 29, 2013, as part of a 
private placement we completed with Kalen Capital Corporation (the 
&#8220;<b>11/29 Financing</b>&#8221;), we entered into the Registration Rights 
agreement with Kalen Capital Corporation pursuant to which we agreed to file 
such number of registration statements as required to register for resale with 
the SEC all the shares owned by Kalen Capital Corporation as of November 29, 
2013, including all shares issuable upon conversion of any warrants then owned 
by Kalen Capital Corporation. The first registration statement that we are 
obligated to file, of which this prospectus is a part, covers the shares and 
warrants issued to Kalen Capital Corporation as part of the 11/29 Financing. If 
we fail to timely file the registration statements we will be obligated to issue
additional shares of our common stock to Kalen Capital Corporation. In the event
the we fail to file a registration statement in the time period required, we 
will issue to Kalen Capital Corporation additional shares of our common stock 
equal to 5% of the shares of our common stock that were to be registered for
every thirty day period for which we fail to file such registration statement, 
subject to proration for any portion of such thirty day period and up to a 
maximum number of shares of our common stock equal to 25% of the number of 
shares of our common stock that were to be registered. Additionally, in the 
event we fail to cause a registration statement to be declared effective within 
ninety days from the date of filing, we will issue to Kalen Capital Corporation 
additional shares of our common stock equal to 2.5% of the shares of our common 
stock that were to be registered for every thirty day period for which we fail 
to cause the SEC to declare such registration statement effective, subject to 
proration for any portion of such thirty day period and up to a maximum number 
of shares of our common stock equal to 10% of the number of shares of common 
stock included in such registration statement.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid33" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">21</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Our compliance with changing 
laws and rules regarding corporate governance and public disclosure may result 
in additional expenses to us which, in turn, may adversely affect our ability to
continue our operations.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Keeping abreast of, and in compliance
with, changing laws, regulations and standards relating to corporate governance 
and public disclosure, including the Sarbanes-Oxley Act of 2002, new SEC 
regulations and, in the event we are ever approved for listing on a registered 
national exchange, such exchange&#8217;s rules, will require an increased amount
of management attention and external resources. We intend to continue to invest 
all reasonably necessary resources to comply with evolving standards, which may 
result in increased general and administrative expenses and a diversion of 
management time and attention from revenue-generating activities to compliance 
activities. Our failure to adequately comply with any of these laws, 
regulations, standards or rules may result in substantial fines or other 
penalties and could have an adverse impact on our ongoing operations.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>Because we do not intend to pay
dividends for the foreseeable future you should not purchase our shares if you 
are seeking dividend income.</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We currently intend to retain future 
earnings, if any, to support the development and expansion of our business and 
do not anticipate paying cash dividends in the foreseeable future. Our payment 
of any future dividends will be at the discretion of our Board after taking into
account various factors, including but not limited to our financial condition, 
operating results, cash needs, growth plans and the terms of any credit
agreements that we may be a party to at the time. Accordingly, investors must 
rely on sales of their common stock after price appreciation, which may never 
occur, as the only way to realize their investment. Investors seeking cash 
dividends should not purchase the shares offered by us pursuant to this 
prospectus. See &#8220;<b>Market Price of and Dividends On Our Common Stock and 
Related Stockholder Matters</b>.&#8221;</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>NOTE REGARDING FORWARD-LOOKING 
STATEMENTS</b></p>
<p style="margin: 0px;" align="center">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">This prospectus contains certain 
&#8220;forward-looking statements,&#8221; as well as information relating to the
Company and its subsidiaries that is based on management&#8217;s exercise of 
business judgment and assumptions made by and information currently available to
management. Although forward-looking statements in this prospectus reflect the 
good faith judgment of our management, such statements can only be based on 
facts and factors currently known by us. Consequently, forward-looking 
statements are inherently subject to risks and uncertainties and actual results 
and outcomes may differ materially from the results and outcomes discussed in or
anticipated by the forward-looking statements. When used in this document and 
other documents, releases and reports released by us, the words 
&#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; 
&#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;the facts suggest&#8221; and 
words of similar import, are intended to identify any forward-looking 
statements. You should not place undue reliance on these forward-looking 
statements. These statements reflect our current view of future events and are 
subject to certain risks and uncertainties as noted below. Should one or more of
these risks or uncertainties materialize, or should underlying assumptions prove
incorrect, our actual results could differ materially from those anticipated in 
these forward-looking statements. Actual events, transactions and results may 
materially differ from the anticipated events, transactions or results described
in such statements. Although we believe that our expectations are based on 
reasonable assumptions, we can give no assurance that our expectations will 
materialize. Many factors could cause actual results to differ materially from 
our forward-looking statements and unknown, unidentified or unpredictable 
factors could materially and adversely impact our future results. We undertake 
no obligation and do not intend to update, revise or otherwise publicly release 
any revisions to our forward-looking statements to reflect events or 
circumstances after the date hereof or to reflect the occurrence of any 
unanticipated events. Several of these factors include, without 
limitation:&#160;</p>
<ul>
<li>our ability to meet requisite regulations or receive regulatory approvals in
the United States, and our ability to retain any regulatory approvals that we 
may obtain; and the absence of adverse regulatory developments in the United 
States and abroad;</li>
</ul>
<table id="tableid34" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">22</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<ul>
<li>our ability to meet requisite regulations or receive regulatory approvals in
the United States, and our ability to retain any regulatory approvals that we 
may obtain; and the absence of adverse regulatory developments in the United 
States and abroad;</li>
<li>new entrance of competitive products or further penetration of existing 
products in our markets;</li>
<li style="text-align: justify;">the effect on us from adverse publicity related
to our products or the company itself; and</li>
<li style="text-align: justify;">any adverse claims relating to our intellectual
property.</li>
</ul>
<p style="margin: 0px; text-indent: 30px;">The reader is cautioned that no 
statements contained in this prospectus should be construed as a guarantee or 
assurance of future performance or results. Actual events or results may differ 
materially from those discussed in forward-looking statements as a result of 
various factors, including, without limitation, the risks described in this 
report and matters described in this report generally. In light of these risks 
and uncertainties, there can be no assurance that the forward-looking statements
contained in this filing will in fact occur.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b>We have little likelihood of long-
term success unless we are able to continue to raise capital from the sale of 
our securities or financing from other sources until, if ever, we generate 
positive cash flow from operations.</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>USE OF PROCEEDS</b></p>
<p style="margin: 0px;" align="center">&#160;</p>
<p style="text-align: justify; padding-left: 0px; margin: 0px; text-indent: 
30px;" align="center">This prospectus relates to the resale of certain shares of
our common stock that may be offered and sold from time to time by the Selling 
Stockholders. This prospectus also relates to shares of our common stock to be 
issued to the Selling Stockholders upon exercise of outstanding warrants. We 
will not receive any proceeds from the sale of shares of our common stock in 
this offering. We may, however, receive proceeds from the exercise of the 
Warrants, unless they are exercised on a &#8220;cashless basis.&#8221; We will 
use the proceeds, if any, from the exercise of the Warrants to fund the 
research, development and commercialization of the Cell Deposition Device and 
for general working capital.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>DETERMINATION OF OFFERING 
PRICE</b></p>
<p style="margin: 0px;" align="center">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">The Selling 
Stockholders will determine at what price they may sell the offered shares, and 
such sales may be made at prevailing market prices, or at privately negotiated 
prices. The Series A Warrant is exercisable at a per share price of $0.35, the 
Series B Warrant is exercisable at a per share price of $0.43 if exercised on or
before May 29, 2015, or $0.46 if exercised thereafter through November 29, 2018 
and the Series C Warrant is exercisable at a per share price of $0.43 if 
exercised on or before May 29, 2015, or $0.49 if exercised thereafter through 
November 29, 2018. The exercise price of the Warrants has been arbitrarily 
determined by us, and bears no significant relationship to our assets, earnings,
book value or any other objective standard of value. <b>Please refer to 
&#8220;Plan of Distribution.&#8221;</b></p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid35" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">23</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>MARKET PRICE AND RELATED STOCKHOLDER 
MATTERS</b></p>
<p style="margin: 0px;" align="center">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our common stock is quoted on the 
OTCQB under the symbol &#8220;<b>RCAR</b>.&#8221; Our warrants are not currently
traded on any market. The closing price of our common stock as quoted on the 
OTCQB on September 4, 2014&#160;was $1.07.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of the date of this prospectus 
there were 66,575,122 shares of our common stock outstanding and held by 
approximately 324 stockholders of record. A portion of our common stock is held 
in &#8220;street name&#8221; or by beneficial holders, whose shares are held of 
record by banks, brokers, and other financial institutions.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The following table sets forth the 
range of high and low bid prices for our common stock for each quarter during 
the past two fiscal years as reported on the OTCQB:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid35" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="top" align="left">
<p style="margin: 0px;"><u style="line-height: 1;"><b>Fiscal Year Ended December
31, 2013</b></u></p>
</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>High</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Low</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">First Quarter (January 1 - March 31, 2013)</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">0.38</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">0.33</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Second Quarter (April 1 &#8211; June 30, 2013)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.80</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.37</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Third Quarter (July 1 &#8211; September 30, 2013)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.74</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.55</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Fourth Quarter (October 1 &#8211; December 31, 2013)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1.37</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.56</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr style="background-color: white;" height="15">
<td style="text-indent: 30px;" valign="top"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;"><u style="line-height: 1;"><b>Fiscal Year Ended December
31, 2012</b></u></p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="text-align: center; margin: 0px;"><b>High</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="text-align: center; margin: 0px;"><b>Low</b></p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">First Quarter (January 1 - March 31, 2012)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.55</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.28</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Second Quarter (April 1 &#8211; June 30, 2012)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.58</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.40</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Third Quarter (July 1 &#8211; September 30, 2012)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.43</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.37</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Fourth Quarter (October 1 &#8211; December 31, 2012)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.37</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.33</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Dividend Policy</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We have not paid any dividends on our
common stock and our Board presently intends to continue a policy of retaining 
earnings, if any, for use in our operations. The declaration and payment of 
dividends in the future, of which there can be no assurance, will be determined 
by the Board in light of conditions then existing, including earnings, financial
condition, capital requirements and other factors.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The Nevada Revised Statutes prohibit 
us from declaring dividends where, if after giving effect to the distribution of
the dividend:</p>
<ul>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">we would not be able to pay our debts as they become due in the 
usual course of business; or</li>
</ul>
<ul>
<li style="text-align: justify; padding-left: 0px; margin-left: 0px; text-
indent: 0px;">our total assets would be less than the sum of our total 
liabilities plus the amount that would be needed to satisfy the rights of 
stockholders who have preferential rights superior to those receiving the 
distribution.</li>
</ul>
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">Except as set 
forth above, there are no restrictions that currently materially limit our 
ability to pay dividends or which we reasonably believe are likely to limit 
materially the future payment of dividends on common stock.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid37" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">24</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>MANAGEMENT&#8217;S DISCUSSION AND 
ANALYSIS OF</b></p>
<p style="margin: 0px;" align="center"><b><b><b>FINANCIAL CONDITION AND RESULTS 
OF OPERATIONS</b></b></b><br ><i></i></p>
<p style="margin: 0px;" align="center"><b><b><b></b></b></b>&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;" 
align="center"><i>The following discussion and analysis of our financial 
condition and results of operations should be read in conjunction with our 
financial statements and the related notes included elsewhere in this 
prospectus. In addition to historical financial information, the following 
discussion and analysis contains forward-looking statements that involve risks,
uncertainties and assumptions. Our results and the timing of selected events may
differ materially from those anticipated in these forward-looking statements as 
a result of many factors, including those discussed under &#8220;</i><b>Risk 
Factors</b><i>&#8221; and elsewhere in this prospectus.</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Overview</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We were incorporated under the laws 
of the State of Utah on July 14, 1983, under the name &#8220;Far West Gold, 
Inc.&#8221; On May 9, 1996, our stockholders authorized a name change to 
&#8220;Far West Resources, Inc.&#8221; On June 30, 1997, the stockholders 
authorized a name change to &#8220;American Alliance Corporation&#8221; and 
authorized a change in the state of domicile from Utah to Nevada. On January 7, 
2014, we filed a Certificate of Amendment to Articles of Incorporation changing 
our name from &#8220;Janus Resources, Inc.&#8221; to &#8220;RenovaCare, 
Inc.&#8221; so as to more fully reflect our operations as a biopharmaceutical 
company.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Results of Operations</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b><i>Three and Six Months Ended June 30, 2014 versus 
June 30, 2013</i></b></p>
<p style="margin: 0px;">&#160;</p>
<table id="ftableid37" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="bottom" rowspan="2">&#160;</td>
<td rowspan="2">&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="6">
<p style="margin: 0px;" align="center"><b>For the Three Months Ended<br >June 
30,</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom" colspan="2">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom" colspan="2">&#160;</td>
</tr>
<tr height="15">
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>2014</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0pt;" align="center"><b>2013</b></p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center">$ <b>change</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" colspan="2">
<p style="margin: 0px;" align="center"><b>% change</b></p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Operating expenses</p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px 0px 0px 30px;">General and administrative</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0pt;" align="right">333,682</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0pt;" align="right">83,358</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0pt;" align="right">250,324</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0pt;" align="right">300.3</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Net loss</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">(333,682</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">(83,358</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">(250,324</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">300.3</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="fffftableid38splitTwosplitTwo" style="width: 100%; text-align: 
justify; font: 10pt TIMES NEW ROMAN; margin: auto;" cellspacing="0" 
cellpadding="0" border="0">
<tr style="background-color: white;" height="15">
<td valign="bottom" align="left">
<p style="margin: 0px;">&#160;</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="7" 
align="right">
<p style="text-align: center; margin: 0pt;"><b>For the Six Months Ended <br 
></b><b>June 30,</b></p>
</td>
<td valign="bottom" colspan="6" align="left"></td>
<td valign="bottom" colspan="4" align="left">
<p style="text-align: center; margin: 0pt;"><b>&#160;</b></p>
</td>
<td valign="bottom" align="left"></td>
<td valign="bottom" colspan="2" align="left">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
</tr>
<tr style="background-color: white;" height="15">
<td valign="bottom" align="left">
<p style="margin: 0px;">&#160;</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" 
align="right">
<p style="text-align: center; margin: 0pt;"><b>2014</b></p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;"><b>&#160;</b></p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">&#160;</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="3" 
align="right">
<p style="text-align: center; margin: 0pt;"><b>2013</b></p>
</td>
<td valign="bottom" colspan="6" align="left"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="4" 
align="left">
<p style="text-align: center; margin: 0pt;"><b>$ change</b></p>
</td>
<td valign="bottom" align="left"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" 
align="left">
<p style="margin: 0px;" align="center"><b>% change</b></p>
</td>
</tr>
<tr style="background-color: white;" height="15">
<td valign="bottom" align="left">
<p style="margin: 0px;">Operating expenses</p>
</td>
<td valign="bottom" colspan="2" align="left">
<p style="margin: 0px;" align="center"><b></b>&#160;</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" colspan="2" align="left">
<p style="margin: 0px;" align="center"><b></b>&#160;</p>
</td>
<td valign="bottom" colspan="6" align="left"></td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" colspan="3" align="left">
<p style="margin: 0px;" align="center">&#160;</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0px;" align="center"><b></b>&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">General and administrative</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0pt;">$</p>
</td>
<td valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">601,703</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0pt;">$</p>
</td>
<td valign="bottom" width="9%" colspan="2" align="right">
<p style="margin: 0pt;">144,230</p>
</td>
<td valign="bottom" width="2%" colspan="6">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0pt;">$</p>
</td>
<td valign="bottom" width="9%" colspan="3" align="right">
<p style="margin: 0pt;">457,473</p>
</td>
<td valign="bottom" width="2%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="9%">
<p style="text-align: right; margin: 0pt;">317.2</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Net loss from continuing operations</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(601,703</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">)&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="2">
<p style="margin: 0px;" align="right">(144,230</p>
</td>
<td valign="bottom" colspan="6">
<p style="margin: 0px;">)</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="3">
<p style="margin: 0px;" align="right">457,473</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">
<p style="margin: 0px;" align="right">317.2</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Discontinued operations</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="2">&#160;</td>
<td valign="bottom" colspan="6">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="3">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Gain on disposal of oil and gas properties</p>
</td>
<td valign="bottom">&#160;</td>
<td style="text-align: right;" valign="bottom">&#160;-</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="2">
<p style="margin: 0px;" align="right">49,338</p>
</td>
<td valign="bottom" colspan="6">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="3">
<p style="margin: 0px;" align="right">49,338</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">
<p style="margin: 0px;" align="right">100.0</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;">Loss from 
discontinued operations</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom"></td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="right">49,338</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom" colspan="6">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="3">
<p style="margin: 0px;" align="right">(49,338</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">)&#160;</td>
<td style="border-bottom: black 1px solid; padding-bottom: 1px;" 
valign="bottom"></td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">100.0</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Net loss</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">(601,703</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;" align="right">)&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">&#160;</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="right">(94,892</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom" colspan="6">
<p style="margin: 0px;">)</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom" colspan="3">
<p style="margin: 0px;" align="right">(506,811</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">)</td>
<td style="border-bottom: black 3px double;" valign="bottom"></td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">534.1</p>
</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<table id="tableid40" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">25</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b><i>Continuing Operations</i></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our expenses consist primarily of 
professional fees and administrative costs. For the three months ended June 30, 
2014 and 2013, general and administrative expenses were $333,682 and $83,358, 
respectively. The increase in general and administrative fees in 2014 of 
$250,324 was due primarily to a $68,500 expense related to the Series A Warrant
issued in July 2013 and to newly incurred research and development expenses of 
$65,000 related to the development of our Cell Deposition Device. In addition, 
legal fees in the three months ended June 30, 2014 increased by $36,243 as a 
result of increased patent related and securities related activity.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As a result of the foregoing, net 
loss from continuing operations for three months ended June 30, 2014 and 2013 
was $(333,682) and $(83,358), respectively.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b><i>Discontinued Operations</i></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">There was no activity in discontinued
operations for the three months ended June 30, 2014 or June 30, 2013.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Net loss for the three months ended 
June 30, 2014 and 2013 was $(333,682) and $(83,358), respectively.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b><i>Year Ended 
Year Ended December 31, 2013 (Fiscal 2013) versus December 31, 2012 (Fiscal 
2012)</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="fffffffffffffffffffftableid40splitTwo" style="width: 100%; text-
align: justify; font: 10pt TIMES NEW ROMAN; margin: auto;" cellspacing="0" 
cellpadding="0" border="0">
<tr height="15">
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">&#160;</p>
</td>
<td align="left"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="6" 
align="center">
<p align="center"><strong>For the Years Ended <br >December 31,</strong></p>
</td>
<td align="left"></td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="center">
<p align="center"><strong>&#160;</strong></p>
</td>
<td align="left"></td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="center">
<p align="center"><strong>&#160;</strong></p>
</td>
<td align="left"></td>
</tr>
<tr height="15">
<td style="border-bottom: black 0pt solid;" valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">Operating expenses</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center">
<p align="center"><strong>2013</strong></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
align="left"><strong>&#160;</strong></td>
<td align="left"><strong>&#160;</strong></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center">
<p align="center"><strong>2012</strong></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
align="left"><strong>&#160;</strong></td>
<td align="left"><strong>&#160;</strong></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center">
<p align="center"><strong>$ change</strong></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
align="left"><strong>&#160;</strong></td>
<td align="left"><strong>&#160;</strong></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center">
<p align="center"><strong>% change</strong></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0cm 0cm 0pt; text-indent: 30px;">General and 
administrative</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0cm 0cm 0pt;">628,545</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0cm 0cm 0pt;">229,539</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0cm 0cm 0pt;">399,006</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0cm 0cm 0pt;">173.8</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0cm 0cm 0pt;">Net loss from continuing operations</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(628,545</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(229,539</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">399,006</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">173.8</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0cm 0cm 0pt; text-indent: 30px;">Discontinued operations</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0cm 0cm 0pt;">Income (loss) from discontinued operations</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(14,420</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(14,420</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">100.0</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0cm 0cm 0pt;">Gain (loss) on disposal of assets</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">49,338</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">49,338</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">100.0</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="padding-left: 0px; margin: 0cm 0cm 0pt 0px; text-indent: 0px;">Loss on
disposal of subsidiary</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(453,581</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(453,581</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">100.0</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0cm 0cm 0pt; text-indent: 30px;">Loss from discontinued 
operations</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(404,243</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(14,420</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(389,823</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0cm 0cm 0pt;">2,703.4</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0cm 0cm 0pt; text-indent: 30px;">Net loss</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(1,032,788</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(243,959</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0cm 0cm 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0cm 0cm 0pt;">(788,829</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0cm 0cm 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0cm 0cm 0pt;">323.3</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<p style="margin: 0px;"><b><i>Continuing Operations</i></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our expenses consist primarily of 
professional fees and administrative costs. For the years ended December 31, 
2013 and 2012, general and administrative expenses were $628,545 and $229,539, 
respectively. The increase in general and administrative expenses in 2013 of 
$399,006 was due primarily to a $263,399 increase in consulting fees, of which 
$237,971 represented non-cash stock based consulting expenses. In addition, 
legal fees in 2013 increased by $114,863 as a result of increased patent related
and financing activity.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As a result of the foregoing, net 
loss from continuing operations for twelve months ended December 31, 2013 and 
2012 was $(628,545) and $(229,539), respectively.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b><i>Discontinued 
Operations</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Income (loss) from oil and gas 
activities was $(14,420) for the year ended December 31, 2012. Gain on the 
disposal of our oil and gas properties for the year ended December 2013 was 
$49,338. Loss on disposal of the Fostung subsidiary in the year ended December 
31, 2013 was $(453,581). Net loss from discontinued operations for the years 
ended December 31, 2013 and 2012 was $(404,243) and $(14,420), respectively.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Net loss for the years ended December
31, 2013 and 2012 was $(1,032,788) and $(243,959), respectively.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid42" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">26</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b>Liquidity and 
Capital Resources</b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We currently finance our activities 
primarily by the private placement of our equity securities. There is no 
assurance that equity funding will be accessible to us at the times and in the 
amounts required to fund our ongoing operations. There are many conditions 
beyond our control which have a direct bearing on the level of investor interest
in the purchase of our securities. We do not have any agreements or 
understandings with any person as to additional financing.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">At June 30, 2014, we had cash of 
$1,168,093 (December 2013 - $1,508,843) and working capital of $1,067,617 
(December 2013 &#8211; $1,454,632). Total liabilities as of June 30, 2014 were 
$126,413 (December 2013 - $55,441).</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our consolidated financial statements
have been prepared in accordance with generally accepted accounting principles 
in the United States of America and applicable to a going concern which 
contemplates the realization of assets and the satisfaction of liabilities and 
commitments in the normal course of business. We require additional funds to 
meet our obligations and maintain our operations. We have sufficient working 
capital to (i) pay our administrative and general operating expenses through 
December 31, 2014, and (ii) to conduct our preliminary research and development 
programs. Without sufficient cash flow from operations, we may need to obtain 
additional funds (presumably through equity offerings and/or debt borrowing) in 
order, if warranted, to implement additional research and development programs 
on our Cell Deposition Device.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px;"><b>Cash Flow</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b>Operating activities:</b> We used 
cash of $340,750 for operating activities for the six months ended June 30, 2014
(2013 - $124,424). We have financed our operations through the sale of our 
equity securities, as discussed herein.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b>Investing Activities:</b> During 
the six months ended June 30, 2014, there were no investing activities. During 
the six months ended June 30, 2013 proceeds from the disposal of oil and gas 
properties was $3,000.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b>Financing Activities:</b> Cash 
flows from financing activities for the six months ended June 30, 2014 and 2013 
were $0 and $0, respectively.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Fair Value of Financial Instruments and Risks</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Fair value estimates of financial 
instruments are made at a specific point in time, based on relevant information 
about financial markets and specific financial instruments. As these estimates 
are subjective in nature, involving uncertainties and matters of significant 
judgment, they cannot be determined with precision. Changes in assumptions can 
significantly affect estimated fair value. The carrying value of cash and cash 
equivalents, accounts receivable, accounts payable and accrued liabilities, 
accounts payable &#8211; related parties, and warrant liability approximate 
their fair value because of the short-term nature of these instruments. 
Management is of the opinion that we are not exposed to significant interest or 
credit risks arising from these financial instruments.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Market Risk Disclosures</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We have not entered into derivative 
contracts either to hedge existing risks or for speculative purposes during or 
subsequent to the periods presented.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid43" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">27</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Off-balance Sheet Arrangements and Contractual 
Obligations</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We do not have any off-balance sheet 
arrangements or contractual obligations that are likely to have or are 
reasonably likely to have a material current or future effect on our financial 
condition, changes in financial condition, revenues or expenses, results of 
operations, liquidity, capital expenditures or capital resources that have not 
been disclosed in our consolidated financial statements.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Recently Issued Accounting Pronouncements</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In June 2014, the Financial 
Accounting Standards Board (&#8220;<b>FASB</b>&#8221;) issued Accounting 
Standards Update (&#8220;<b>ASU</b>&#8221;) 2014-10, Development Stage Entities 
(Topic 915): Elimination of Certain Financial Reporting Requirements. ASU 2014-
10 eliminates the distinction of a development stage entity and certain related 
disclosure requirements, including the elimination of inception-to-date 
information on the statements of operations, cash flows and stockholders&#8217; 
equity. The amendments in ASU 2014-10 will be effective prospectively for annual
reporting periods beginning after December 15, 2014, and interim periods within 
those annual periods, however early adoption is permitted. The Company adopted 
ASU 2014-10 during the quarter ended June 30, 2014, thereby no longer presenting
or disclosing any information required by Topic 915.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In May 2014, the FASB issued ASU 
2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the
revenue recognition requirements in Accounting Standards Codification 
(&#8220;<b>ASC</b>&#8221;) 605, Revenue Recognition. The new revenue recognition
standard requires entities to recognize revenue in a way that depicts the 
transfer of promised goods or services to customers in an amount that reflects 
the consideration to which the entity expects to be entitled to in exchange for 
those goods or services. ASU 2014-09 is effective for interim and annual 
reporting periods beginning after December 15, 2016 and is to be applied 
retrospectively. The Company does not currently have any revenue. As such, ASU 
2014-09 will not have any effect on the Company&#8217;s results of operations 
and financial position. If the Company begins generating revenue prior to the 
effective date of ASU 2014-09, it will evaluate the effect that ASU 2014-09 will
have on its results of operations and financial position.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>DESCRIPTION OF OUR BUSINESS AND 
PROPERTY</b></p>
<p style="margin: 0px;" align="center"><b></b>&#160;</p>
<p style="text-align: left; margin: 0px;" align="center"><b>Description of 
Business</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We are a development-stage company 
focusing on the acquisition, research, development and, if warranted, 
commercialization of autologous (using a patient&#8217;s own cells) cellular 
therapies that can be used for medical and aesthetic applications. On July 12, 
2013, we, through our wholly owned subsidiary, RenovaCare Sciences Corp., 
completed the acquisition of our flagship technology, a treatment methodology 
for skin isolation, spraying and associated equipment for the regeneration of 
human skin cells, the Cell Deposition Device, which has been shown in early 
human clinical use in the United States to naturally regenerate and heal skin
for burn victims, along with the associated United States and foreign patents 
and patent applications. The development of our Cell Deposition Device is in the
early stage and we anticipate that we will be required to expend significant 
time and resources to further develop our technology and determine whether a 
commercially viable product can be developed. Research and development of new 
technologies involves a high degree of risk and there is no assurance that our 
development activities will result in a commercially viable product. The long-
term profitability of our operations will be, in part, directly related to the 
cost and success of our development programs, which may be affected by a number 
of factors.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid44" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">28</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Skin is the body&#8217;s largest 
organ, representing approximately 15% of a person&#8217;s total bodyweight. The 
average adult human has a skin surface area of between 16 - 21 square feet, 
which protects all other organs against the external environment. When a 
person&#8217;s skin is assailed by trauma or exposed to extreme heat, the 
skin&#8217;s various layers may be destroyed and depending on the severity of 
the injury, might cause life-threatening conditions. Currently, severe trauma to
the skin, such as second or third degree burns, requires surgical mesh-grafting 
of skin, whereby healthy skin is removed from a donor site and implanted on the 
damaged area.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">While mesh grafting is often the 
method of choice, there are significant deficiencies with this method. The 
surgical procedure to remove healthy skin from the donor site can be painful and
leaves the patient with a new wound that must also be attended to. In many 
instances the aesthetic results are not satisfying, as the color of the skin 
from the donor site may not match the skin color of the damaged skin. 
Additionally, since the ratio between the size of the wound area and the size of
the donor site is quite low, i.e. the size of the skin removed must be 
substantially equal in size to the size of the damaged skin, the mesh-grafting 
approach is in many cases limited. Donor and injury sites can take weeks to 
heal, requiring expensive hospital stays, ongoing wound dressing management, and
ever-changing anti-infection strategies.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We are currently evaluating the 
efficacy and potential of our Cell Deposition Device, in combination with our 
unique cell isolation method, in the treatment of tissue that has been subject 
to severe trauma such as second and third degree burns. In small scale clinical 
trials, the Cell Deposition Device and cell isolation methodology have shown the
ability to regenerate a more natural and thicker skin. The Cell Deposition
Device utilizes the patient&#8217;s own skin stem cells and is able to address 
much larger treatment areas and at the same time reduce the size of the donor 
site. Furthermore, we believe the Cell Deposition Device enables the effective 
treatment of other skin disorders with minimal scarring compared to skin 
grafting.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b>Our Market 
Opportunity</b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">According to medical market research 
firm, Kalorma Information, the global market for wound care products is 
projected to grow from $16.8 billion in 2012, to approximately $21.0 billion by 
2015.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b><i>Burn 
Wounds</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Burns are one of the most common and 
devastating forms of trauma. Patients with serious thermal injury require 
immediate specialized care in order to minimize morbidity and mortality. Data 
from the National Center for Injury Prevention and Control in the United States 
show that approximately 2 million fires are reported each year which result in 
1.2 million people with burn injuries. Moderate to severe burn injuries 
requiring hospitalization account for approximately 100,000 of these cases, and 
about 5,000 patients die each year from burn-related complications. The survival
rates for burn patients have improved substantially in the past few decades due 
to advances in modern medical care in specialized burn centers. Severe burns 
require specialized care in hospitals or burn centers. According to Critical 
Care, an international clinical medical journal, burns are also among the most 
expensive traumatic injuries because of long and costly hospitalization, 
rehabilitation and wound and scar treatment. The prevalence of patients with 
severe burns is even higher in emerging economies. For example, according to an 
IMS study, approximately 400,000 patients are hospitalized every year with burns
in India.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Burn injuries account for a 
significant cost to the health care system in North America and worldwide. In 
the United States and Canada there are currently 167 centers specializing in 
burn care, with over 2,000 beds. Although the overall hospitalization rates from
less-serious burn injuries have declined by 50% since 1971, the proportion of 
patients admitted to burn centers has increased. Recent estimates in the United 
States show that 45,000 patients are admitted to acute-care hospitals annually 
with burn injuries, and in approximately 50% of these cases the extent of 
thermal injury is severe enough to warrant admission to a specialized burn 
center. Burn care centers in North America currently admit an average of more 
than 200 patients per year, whereas other hospital units admit an average of 
fewer than five burn patients per year.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid45" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">29</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Initial hospitalization costs and 
physicians&#8217; fees for specialized care of a patient with a major burn 
injury are currently estimated to be $200,000. Overall, costs escalate for major
burn cases because of repeated admissions for reconstruction and rehabilitation 
therapy. In the United States, current annual estimates show that more than $18 
billion is spent on specialized care of patients with major burn injuries.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Most burn injuries involve part or 
the entire thickness of the skin and in some cases, the deeper subcutaneous fat 
tissue or underlying structures. The severity of the burn depends on three main 
factors:</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid46" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(i)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">The extent of the surface 
the burn occupies is usually referred to as percent of total body surface area 
(&#8220;TBSA&#8221;). A burn on an adult&#8217;s entire palm would generally 
equal approximately 1% TBSA, and the average hospitalized patient has a burn 
covering approximately 10% TBSA. Burns covering more than 15-20% TBSA usually 
require hospitalization and may result in dehydration, shock and increased risk 
of mortality.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<table id="tableid47" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(ii)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">The depth of the burn, 
referred to in terms of &#8220;degree,&#8221; is generally classified into four 
categories:</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<table id="tableid48" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="8%"><font style="font-family: TIMES NEW
ROMAN;">&#160;</font></td>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">a.</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><i>Superficial or first 
degree burns</i>. Such burns do not penetrate the basal membrane and usually 
heal naturally, i.e. on their own.</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">b.</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><i>Dermal/partial thickness 
or second degree burns</i>. Such burns are characterized by varying amounts of 
damaged dermis and can be further subdivided into superficial and deep partial-
thickness burns. Superficial partial-thickness burns may heal spontaneously 
after removal of the covering thin eschar. The eschar is the burned tissue in 
the wound and is deprived of blood and isolated from all natural systemic 
defense mechanisms. Conversely, deep partial-thickness burns are often difficult
for physicians to accurately diagnose before eschar removal and may progress and
transform into full-thickness burns if not debrided in a timely manner, 
depending on the magnitude of latent tissue death of the surrounding skin. 
Debridement is the medical removal of dead, damaged, or infected tissue to 
improve the healing potential of the remaining healthy tissue.</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">c.</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><i>Full thickness or third 
degree burns</i>. Such burns are characterized by death of the entire dermal 
tissue down to the subcutaneous fat and must be debrided and treated by 
autografting, which is the process of harvesting skin from healthy donor sites 
on a patient&#8217;s body and transplanting it on the post-debridement, clean 
wound bed.</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">d.</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><i>Fourth degree burns</i>. 
Such burns, which are rare, extend beyond the subcutaneous fat tissue into the 
underlying structures, such as muscle or bone, and also require debridement and 
further substantial treatment.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<table id="tableid49" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(iii)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Other factors, which include
the age of the individual and the body part where the burn occurred.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">When patients are hospitalized for a 
severe burn, the first step in the treatment after patient stabilization and 
resuscitation is usually eschar removal. Additionally, debridement is an 
essential step in the treatment of patients with severe burns, allowing for the 
prevention of local infection, sepsis (a systemic inflammatory response caused 
by severe infection) and additional damage to surrounding viable tissue and the 
initiation of the body&#8217;s healing process and scar prevention.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid50" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">30</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Skin grafts are often employed after 
serious injuries when some of the body&#8217;s skin is damaged and refers to a 
procedure whereby skin is removed from one area of the body and transplanted to 
another. Surgical removal (excision or debridement) of the damaged skin is 
followed by skin grafting. The grafting serves two purposes: (a) reduce the 
course of treatment needed (and time in the hospital), and (b) improve the 
function and appearance of the area of the body which receives the skin 
graft.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">There are two types of skin grafts, 
the more common type is &#8220;partial thickness skin graft&#8221;, where a thin
layer is removed from a healthy part of the body (the donor section) like 
peeling a potato. The second type is a &#8220;full thickness skin graft&#8221;, 
which involves pitching and cutting skin away from the donor section. A full 
thickness skin graft is more risky, in terms of the body accepting the skin, yet
it leaves only a scar line on the donor section, similar to a Cesarean section 
scar.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b><i>Other 
Applications</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In addition to treating burn wounds, 
we intend to further research the applicability of our Cell Deposition Device 
and cell isolation methodology to treat scars, skin pigmentations disorders, 
such as vitiligo, and chronic wounds, such as diabetic ulcers.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b><i>Our 
Technology</i></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The Cell Deposition Device and its 
associated cell isolation methodology isolates stem cells from a biopsy of the 
patient&#8217;s healthy skin and, after inserting them into a solution, places 
the stem cells into a sterile syringe with a fitted nozzle, and sprays them 
directly through the nozzle into the wound. Using computer precision, the device
is intended to distribute the cells at a uniform velocity throughout the wound. 
Based upon small stage clinical trials the newly introduced stem cells were able
to regenerate and differentiate into their respective parts in a matter of days.
The first phase of gathering the patient&#8217;s stem cells, creating a 
solution, and applying the stem cells takes approximately 1.5&#8211;2 hours. 
Within a week, the wound dressing procedure allows the stem skin cells to fully 
generate normal skin, and after a couple of months the skin regains its color 
and texture.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The idea of regrowing skin 
isn&#8217;t new; oftentimes when treating burns a doctors will harvest skin 
cells and send them to an external lab where they are grown into a sheet of new 
skin, which can take 2&#8211;3 weeks to produce a skin sheet and harvest it from
an external lab. In contrast, it takes only hours to prepare and administer stem
cells with the Cell Deposition Device. Once the skin sheet has been attached to 
the wound, blisters can form under the newly attached skin, pushing the sheet 
up, damaging the wound and increasing the risk of infection. In contrast, the 
Cell Deposition Device applies the stem cells directly to the patient&#8217;s 
cells through an electronic, acqueous spray device which distributes the skin 
cells uniformly without damaging those skin cells. Patients feel as if they have
been sprayed with salt water, which is intended to alleviate the concern of 
further tissue damage. The artificial vascular system network also provides a 
reliable source of protection to the skin stem cells. After the wound has been 
treated, it often takes months for the skin sheet to heal over; however, it can 
take only days for the Cell Deposition Device to fulfill this healing 
function.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Because the skin cells in the Cell 
Deposition Device are actually the patient&#8217;s own cells, the skin that is 
regenerated looks more natural than skin grown from traditional methods. During
recovery, the skin cells grow into fully functional layers of the skin, 
including the dermis, epidermis, and blood vessels and the regenerated skin 
leaves minimal scarring.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid51" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">31</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b><i>The Cell Deposition Device 
remains an experimental, unproven methodology and we continue to evaluate its 
efficacy. There is no guarantee that we will able to develop a commercially 
viable product based upon the Cell Deposition Device and its underlying 
technology.</i></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b>Governmental 
Regulations</b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><i>Domestic 
Regulation</i></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Governmental authorities in the 
United States, at the federal, state and local level, and in other countries 
extensively regulate, among other things, the research, development, testing, 
manufacture, labeling, packaging, promotion, storage, advertising, distribution,
marketing and export and import of products or devices such as those we are 
attempting to develop. Our device candidates, to the extent they are developed, 
will be subject to either pre-market approval or 510(k) clearance by the FDA 
prior to their marketing for commercial use in the United States, and to any 
approvals required by foreign governmental entities prior to their marketing 
outside the United States. In addition, any changes or modifications to a device
that has received regulatory clearance or approval that could significantly 
affect its safety or effectiveness, or would constitute a major change in its 
intended use, and may require the submission of a new application in the United 
States for pre-market approval or 510(k) clearance, or for foreign regulatory 
approvals outside the United States. The process of obtaining foreign approvals,
can be expensive, time consuming and uncertain.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b><u style="line-
height: 1;">510(k) Clearance</u></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">If the Cell Deposition Device or any 
other device that we commercialize is deemed a Class I or Class II medical 
device, we may be required to file for 510(k) clearance. It generally takes from
four to twelve months from submission to obtain 510(k) clearance, and from one 
to three years from submission to obtain pre-market approval; however, it may
take longer and 510(k) clearance or pre-market approval may never be obtained. 
Delays in receipt of, or failure to obtain, clearances or approvals for future 
products, for tests on the Cell Deposition Device that are currently in design 
or development, would result in delayed, or no, realization of revenues from 
such products as well as in substantial additional costs which could decrease 
our profitability. Although we are currently preparing a 510(k) submission, we 
have not yet submitted any devices for 510(k) approval and there are no 
guarantees that we will make such a submission or that if we do make such a 
submission, that our submission will be approved.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b><u style="line-
height: 1;">Premarket Approval</u></b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We may be required to file for 
premarket approval (&#8220;<b>PMA</b>&#8221;) for the Cell Deposition Device or 
any other device that we commercialize if it is deemed a Class III medical 
device. PMA is the FDA process of scientific and regulatory review to evaluate 
the safety and effectiveness of Class III medical devices. Class III devices are
those that support or sustain human life, are of substantial importance in 
preventing impairment of human health, or which present a potential, 
unreasonable risk of illness or injury. Due to the level of risk associated with
Class III devices, the FDA has determined that general and special controls 
alone are insufficient to assure the safety and effectiveness of class III 
devices. Therefore, these devices require a PMA application under section 515 of
the Federal Food, Drug and Cosmetic Act in order to obtain marketing 
clearance.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">PMA is the most stringent type of 
device marketing application required by FDA. The applicant must receive FDA 
approval of its PMA application prior to marketing the device. PMA approval is 
based on a determination by FDA that the PMA contains sufficient valid 
scientific evidence to assure that the device is safe and effective for its 
intended use(s). An approved PMA is, in effect, a private license granting the 
applicant (or owner) permission to market the device. The PMA owner, however, 
can authorize use of its data by another.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid52" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">32</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><i>HIPAA 
Requirements</i></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Other federal legislation may affect 
our ability to obtain certain health information in conjunction with any
research activities we conduct. The Health Insurance Portability and 
Accountability Act of 1996 (&#8220;<b>HIPAA</b>&#8221;), mandates, among other 
things, the adoption of standards designed to safeguard the privacy and security
of individually identifiable health information. In relevant part, the U.S. 
Department of Health and Human Services (&#8220;<b>HHS</b>&#8221;), has released
two rules to date mandating the use of new standards with respect to such health
information. The first rule imposes new standards relating to the privacy of 
individually identifiable health information. These standards restrict the 
manner and circumstances under which covered entities may use and disclose 
protected health information so as to protect the privacy of that information. 
The second rule released by HHS establishes minimum standards for the security 
of electronic health information. While we do not believe we are directly 
regulated as a covered entity under HIPAA, the HIPAA standards impose 
requirements on covered entities conducting research activities regarding the 
use and disclosure of individually identifiable health information collected in 
the course of conducting the research. As a result, unless they meet these HIPAA
requirements, covered entities conducting clinical trials for us may not be able
to share with us any results from clinical trials that include such health 
information.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><i>Other U.S. 
Regulatory Requirements</i></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In the United States, the research, 
manufacturing, distribution, sale, and promotion of drug and biological products
are potentially subject to regulation by various federal, state and local 
authorities in addition to the FDA, including the Centers for Medicare and 
Medicaid Services (formerly the Health Care Financing Administration), other 
divisions of the U.S. Department of Health and Human Services (e.g., the Office 
of Inspector General), the U.S. Department of Justice and individual U.S. 
Attorney offices within the Department of Justice, and state and local 
governments. For example, sales, marketing and scientific/educational grant 
programs must comply with the anti-fraud and abuse provisions of the Social 
Security Act, the False Claims Act, and similar state laws, each as amended. 
Pricing and rebate programs must comply with the Medicaid rebate requirements of
the Omnibus Budget Reconciliation Act of 1990 and the Veterans Health Care Act 
of 1992, each as amended. If products are made available to authorized users of 
the Federal Supply Schedule of the General Services Administration, additional 
laws and requirements apply. All of these activities are also potentially 
subject to federal and state consumer protection, unfair competition, and other 
laws.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><i>International 
Regulation</i></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The regulation of any potential 
product candidates we may produce outside of the United States varies by 
country. Certain countries regulate human tissue products as a pharmaceutical 
product, which would require us to make extensive filings and obtain regulatory 
approvals before selling our product candidates. Certain other countries may 
classify our product candidates as human tissue for transplantation but may 
restrict its import or sale. Other countries have no application regulations 
regarding the import or sale of products similar to potential product 
candidates, creating uncertainty as to what standards we may be required to 
meet.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 
0px;"><b>Competition</b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The pharmaceutical and wound care 
industries are characterized by intense competition, rapid product development 
and technological change. Our Cell Deposition Device competes with a variety of 
companies in the wound care markets, many of which offer substantially different
treatments for similar problems. Currently Avita Medical Limited offers
ReCell<sup>&#174;</sup> Spray-On Skin<sup>&#8482;</sup>, a cell spray device and
a cell isolation procedure for autologous cells. Integra LifeSciences Holding 
Corp. sells Integra<sup>&#174;</sup> Dermal Regeneration Template, which does 
not use autologous cells, but instead uses mesh-grafted tissue. Other 
competitors include Fibrocell Science, Inc., Shire Plc and Organogenesis, 
Inc.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid53" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">33</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Many of our competitors are large, 
well-established pharmaceutical, chemical, cosmetic or health care companies 
with considerably greater financial, marketing, sales and technical resources 
than those available to us. Additionally, many of our present and potential 
competitors have research and development capabilities that may allow them to 
develop new or improved products that may compete with our product lines. Our 
potential products could be rendered obsolete or made uneconomical by the 
development of new products to treat the conditions addressed by our products, 
technological advances affecting the cost of production, or marketing or pricing
actions by one or more of our competitors.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b>Strategy</b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our ultimate goal is to leverage the 
potential of our Cell Deposition Device, together with our cell isolation 
method, as cutting edge treatments in skin therapy. Before we can do so, 
however, there are a number of steps we must first take, including:</p>
<ul>
<li style="text-align: justify;">initiating a series of clinical trials to 
determine the Cell Deposition Device&#8217;s efficacy for treating wounds and 
burns;</li>
<li style="text-align: justify;">formalizing collaborations with universities 
and scientific partners;</li>
<li style="text-align: justify;">creating a network of clinical and research 
partners;</li>
<li style="text-align: justify;">achieving FDA and other regulatory approval; 
and</li>
<li style="text-align: justify;">expanding the range of possible 
applications.</li>
</ul>
<p style="margin: 0px; text-indent: 30px;">Additionally, we will likely be 
required to raise significant capital in order to fund our ongoing research and 
development operations, and there is no guarantee that we will be able to raise 
on acceptable terms, if at all.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Discontinued Operations</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Sale of Fostung Resources Ltd.</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">On December 31, 2013, we entered into
a stock purchase agreement with Duke Mountain Resources, Inc. 
(&#8220;<b>Duke</b>&#8221;), a Nevada corporation, pursuant to which we sold to 
Duke 100% of the issued and outstanding shares of Fostung Resources Ltd. 
(&#8220;<b>Fostung Resources</b>&#8221;), a corporation organized under the laws
of Ontario, Canada and a wholly owned subsidiary of ours, in exchange for a 
promissory note in the amount of $80,000, which amount approximated the fair 
value of the leases and mining claims controlled by Fostung Resources, as 
concluded by an independent third-party geological consultant.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Sale of Oil and Gas Properties</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">On February 18, 2013, we completed 
the sale of our working interest in the Onnie Ray #1, Haile #1, Pearce #1 and 
Stahl #1 oil wells. We entered into an Assignment Agreement with Leexus Oil LLC,
the wells operator, whereby we assigned our right, title and interest in the 
oil, gas and mineral leases and the oil and gas wells. Payment for the 
assignment was the assumption of all outstanding liabilities and assumption of 
all future payments for any and all work performed on the wells. On February 19,
2013, we completed the sale of our working interest in the Cooke #6 well. We 
entered into an Assignment Agreement with Millennium Petro-Physics, the well 
operator, whereby we assigned our right, title and interest in the oil, gas and 
mineral leases and the oil and gas wells for a payment of $3,000.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid54" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">34</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Employees</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of the date of this prospectus, we
had one full time employee, Mr. Andrew Danielson, Director of Business 
Development, Grants and Administration. We maintain at-will consulting 
agreements with Mr. Thomas Bold, our President and Chief Executive Officer, Ms. 
Rhonda Rosen, our Chief Financial Officer and Ms. Patsy Trisler, our Vice 
President &#8211; Clinical &amp; Regulatory Affairs.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Our Office Facilities</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our corporate office is located at
430 Park Avenue, Suite 702, New York, New York 10022. This office space is 
provided to us on a complimentary basis by one of our directors. We also rent 
space in Pittsburgh, Pennsylvania for which we pay a monthly rent of $545. We 
believe that our office facilities are sufficient and adequate for our purposes 
given our present staff and research objectives.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Legal Proceedings</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We are not party to nor are we aware 
of any material pending lawsuit, litigation or proceeding.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>DIRECTORS, EXECUTIVE OFFICERS AND 
CONTROL PERSONS</b></p>
<p style="margin: 0px;" align="center"><b></b>&#160;</p>
<p style="text-align: justify; padding-left: 0px; margin: 0px; text-indent: 
30px;" align="center"><b></b>The following table sets forth the names and ages 
of all of our directors and executive officers. We have a Board comprised of 
three members. Each director holds office until a successor is duly elected or 
appointed. Executive officers serve at the discretion of the Board and are 
appointed by the Board. Also provided herein are brief descriptions of the 
business experience of each of the directors and officers during the past five 
years, and an indication of directorships held by each director in other 
companies subject to the reporting requirements under the Federal securities 
law.</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid48" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="border-bottom: black 1pt solid;" valign="top" width="30%" 
align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>Name</b></p>
</td>
<td width="2%" align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" width="14%"
align="center"><b>Age</b></td>
<td width="2%" align="left">&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="top" width="30%" 
align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>Current Position 
With Us</b></p>
</td>
<td valign="top" width="2%" align="left">&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="top" width="20%" 
align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>Director or Officer 
Since</b></p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Thomas Bold</p>
</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="text-align: center; margin: 0pt;">53</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">President and Chief Executive Officer</p>
</td>
<td valign="top">&#160;</td>
<td valign="top">
<p style="margin: 0px;">December 2013</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Rhonda B. Rosen</p>
</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="text-align: center; margin: 0pt;">57</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Chief Financial Officer</p>
</td>
<td valign="top">&#160;</td>
<td valign="top">
<p style="margin: 0px;">October 2013</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Patsy J. Trisler</p>
</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="text-align: center; margin: 0pt;">66</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Vice President &#8211; Clinical &amp; Regulatory 
Affairs</p>
</td>
<td valign="top">&#160;</td>
<td valign="top">
<p style="margin: 0px;">April 2014</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Kenneth Kirkland</p>
</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="text-align: center; margin: 0pt;">72</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Director</p>
</td>
<td valign="top">&#160;</td>
<td valign="top">
<p style="margin: 0px;">August 2013</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Joseph Sierchio</p>
</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="text-align: center; margin: 0pt;">64</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="top">
<p style="margin: 0px;">Director</p>
</td>
<td valign="top">&#160;</td>
<td valign="top">
<p style="margin: 0px;">August 2010</p>
</td>
</tr>
</table>
<p style="text-align: center; margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b><u style="line-height: 1;">Biographical 
Information</u></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Set forth below are the names of all 
of our directors and executive officers, all positions and offices held by each 
person, the period during which each has served as such, and the principal 
occupations and employment of such persons during at least the last five years, 
and other director positions held currently or during the last five years:</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid56" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">35</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Current Directors and Officers</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b>Thomas Bold.</b> Since 2013 Mr. 
Bold has been serving as a Business Consultant and Economic Advisor for StemCell
Systems, GmbH. In this position he serves as a member of the steering committee 
of a multinational research project sponsored by the European Commission. From 
2004 through 2012 Mr. Bold served as the CEO of StemCell Systems GmbH, a Berlin-
based biomedical company engaged in the development and commercialization of 
advanced cell culture bioreactors. During his time in this position Mr. Bold 
managed several national and international research and development projects for
the company. Mr. Bold has more than 15 years of professional business experience
in the field of medical biotechnology device manufacturing, stem cell culture 
technology platform development and regenerative medicine research project 
management and product development. Mr. Bold has co-founded several start-up 
companies in Germany and specializes in structuring and management of new 
ventures and organizations. He initiated and managed successful business/R&amp;D
collaborations between many company and university partners and has been 
involved in successful patent application processes and IP portfolio management.
Mr. Bold has assisted companies in securing millions of dollars of funding from 
local and national German research organizations and the European Commission and
managed national and international life science R&amp;D projects for Hybrid 
Organ GmbH, StemCell Systems GmbH and the Charit&#233; Medical Faculty of the
Berlin Universities, Germany. He initiated and managed several skin therapy 
project consortia on wound dressing development, skin cell isolation 
technologies and skin cell spray deposition devices. Mr. Bold received his 
Bachelor&#8217;s degree in Business Management from the University of Cologne, 
Germany and his Diplom-Kaufmann (Masters&#8217;) degree in Business Management, 
Economic Journalism and American Economy from the Freie Universit&#228;t 
Berlin.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b>Rhonda B. Rosen.</b> From June 
through September 2013, Ms. Rosen served as our President and Chief Executive 
Officer. From May 2012 through March 2013, Ms. Rosen served as the Chief 
Financial Officer of Armada Oil, Inc. and its wholly owned subsidiaries. From 
August 2010 through February 2012, Ms. Rosen was the Treasurer, Chief Financial 
Officer and Chief Administrative Officer of Tonix Pharmaceuticals Holding Corp. 
and its wholly owned subsidiaries. Ms. Rosen has also been a partner at Tatum, 
an executive services firm, since March 2010, where she provides executive level
financial consulting services. Between July 2007 and February 2010, Ms. Rosen 
served as the Treasurer and Chief Financial Officer of Validus Pharmaceuticals 
LLC and its predecessor companies, including Konanda Pharma Partners, LLC, 
Konanda Pharma Fund I, L.P, Validus Pharmaceuticals, Inc. and Fontus 
Pharmaceuticals, Inc. Between November 2006 and July 2007, Ms. Rosen was the 
Senior Vice President of Wood Creek Capital Management, the founding sponsor of 
Validus Pharmaceuticals LLC. Previously, Ms. Rosen was the Director of Sales at 
Liability Solutions Inc. (2004 to 2005); Managing Director of Insurance and 
Alternative Asset Management Investment Banking at Putnam Lovell NBF (1999 to 
2003); and Managing Director of Insurance Investment Banking at CIBC World 
Markets (formerly Oppenheimer &amp; Co.) (1992-1999). Ms. Rosen earned her MBA 
in Finance &amp; Accounting and her BS in Economics from The Wharton School of 
Business, where she graduated summa cum laude, and her MS in Taxation from the 
from the Fox School of Business. Ms. Rosen started her career with 
PricewaterhouseCoopers LLP and is a Certified Public Accountant in the State of 
Pennsylvania. Ms. Rosen was appointed to serve as our Chief Financial Officer 
due to her extensive accounting and finance experience.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b>Patsy J. Trisler, JD, RAC</b>. For
over 20 years Ms. Trisler has provided strategic regulatory guidance and 
clinical compliance consulting services to medical device companies, including 
advising on non-clinical and clinical testing requirements for a variety of 
product types; preparing FDA submissions; facilitating FDA meetings; training on
compliance with GCPs &amp; FDA regulatory requirements. Ms. Trisler has been a 
regulatory consultant since 1991 and has held senior level positions where she 
provided consulting services for pharmaceutical, biotechnology and medical 
device clients and was most recently an independent consultant for a number of 
clients within the medical products&#8217; industry. Prior to that Ms. Trisler 
served for nearly seven years at the FDA as a scientific reviewer and special 
assistant to the Director of the Office of Device Evaluation in developing 
medical device policies and guidances. She began her career as a biologist in a 
molecular biology laboratory at the National Cancer Institute. Ms. Trisler 
received her B.S. in biology and psychology from American University in 
Washington, DC, and her J.D. from the Potomac School of Law/Antioch Law School 
in Washington, DC. Ms. Trisler is regulatory affairs certified and a member of 
several professional groups including the Association of Clinical Research 
Professionals and Regulatory Affairs Professional Society.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid57" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">36</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b>Dr. Kenneth Kirkland.</b> From 
August 1998 through July 2010, Dr. Kirkland worked as an Executive Director at 
Iowa State University and most recently served as the University&#8217;s 
Executive Director of the Research Foundation and Director of the Office of 
Intellectual Property and Technology Transfer. While there, he was successful in
increasing the licensing of the University&#8217;s technologies to companies to 
achieve number one ranking among U.S. universities in the number of licenses 
executed. Dr. Kirkland also spearheaded successful litigation against infringers
of the Research Foundation&#8217;s intellectual property resulting in total 
settlements of $20 million. Dr. Kirkland completed his undergraduate studies in 
the U.K., and obtained his M.S. and Ph.D. degrees in Agronomic Crop Science from
Oregon State University. Dr. Kirkland was invited to join the Board due to his 
extensive experience in licensing intellectual property.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;"><b>Joseph Sierchio.</b> Mr. Sierchio 
earned his J.D. at Cornell University Law School in 1974, and a B.A., with 
Highest Distinction in Economics from Rutgers College at Rutgers University in 
1971. Since 2007 Mr. Sierchio has been engaged in the practice of law as a 
member of Sierchio &amp; Company, LLP, prior to which he was engaged in the 
practice of law as a member of Sierchio Greco &amp; Greco, LLP from January 2003
through May 2007. Prior thereto Mr. Sierchio was a partner at Eiseman Levine 
Learhaupt and Kakoyannis, PC. Since 1975, Mr. Sierchio has continuously 
practiced corporate and securities law in New York City, representing domestic 
and foreign corporations, investors, brokerage firms, entrepreneurs, and public 
and private companies in the U.S., Canada, United Kingdom, Germany, Italy, 
Switzerland, Australia, and Hong Kong. Mr. Sierchio is admitted in all New York 
state courts and federal courts in the Eastern, Northern, and Southern Districts
of the State of New York as well as the federal Court of Appeals for the Second 
Circuit. Mr. Sierchio is also a director of the following reporting companies: 
Ceres Ventures, Inc., which is developing an internet based financial services 
platform linking entrepreneurs with potential investors and New Energy 
Technologies, Inc., which is engaged in the research, development and eventual 
commercialization of emerging next-generation alternative and renewable energy 
technologies. Mr. Sierchio was invited to join the Board due to his experience 
representing corporations (public and private) and individuals in numerous and 
various organizational, compliance, administrative, governance, finance (equity 
and debt private and public offerings), regulatory and legal matters.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">All of our directors are elected 
annually to serve for one year or until their successors are duly elected and 
qualified.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b>Family 
Relationships and Other Matters</b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">There are no family relationships 
among or between any of our officers and directors.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;"><b>Legal 
Proceedings</b></p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">None of our directors or officers are
involved in any legal proceedings as described in Regulation S-K 
(&#167;229.401(f)).</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px;"><b>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING 
COMPLIANCE</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Pursuant to Section 16(a) of the 
Exchange Act of 1934, our executive officers and directors in addition to any 
person who owns more than 10% of our common stock are required to report their 
ownership of our common stock and changes to such ownership with the SEC. Based 
solely upon a review of the copies of the forms furnished to us, we believe that
during fiscal 2013, other than the Form 3 filed by Dr. Kenneth Kirkland that was
filed one day late, the Section 16(a) filing requirements applicable to our 
directors and executive officers were satisfied.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid58" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">37</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>CODE OF ETHICS</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We have adopted a Code of Ethics that
applies to all of our officers, directors and employees, including our Chief 
Executive Officer and Chief Financial Officer, which complies with the 
requirements of the Sarbanes-Oxley Act of 2002 and applicable FINRA listing 
standards. Accordingly, the Code of Ethics is designed to deter wrongdoing, and 
to promote, among other things, honest and ethical conduct, full, timely, 
accurate and clear public disclosures, compliance with all applicable laws, 
rules and regulations, the prompt internal reporting of violations of the Code 
of Ethics, and accountability. A copy of our Code of Ethics may be obtained at 
no charge by sending a written request to our President and Chief Executive 
Officer, Thomas Bold, 430 Park Avenue, Suite 702, New York, New York 10022.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>CORPORATE GOVERNANCE</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">We have adopted 
Corporate Governance Guidelines applicable to our Board. Our Corporate 
Governance Guidelines will be available on our website upon its completion. A 
copy of our Corporate Governance Guidelines may be obtained at no charge by 
sending a written request to our President and Chief Executive Officer, Thomas 
Bold, 430 Park Avenue, Suite 702, New York, New York 10022.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Director Independence</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We are not listed on a major U.S. 
securities exchange and, therefore, are not subject to the corporate governance 
requirements of any such exchange, including those related to the independence 
of directors. At this time, after considering all of the relevant facts and 
circumstances, our Board has determined that Dr. Kirkland is independent from 
our management and qualifies as an &#8220;independent director&#8221; under the 
standards of independence of the FINRA listing standards. We do not currently 
have a majority of independent directors as required by the FINRA listing 
standards. Upon our listing on any national securities exchange or any inter-
dealer quotation system, we will elect such independent directors as is 
necessary under the rules of any such securities exchange.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Board Leadership Structure</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We currently have three executive 
officers and two directors. Our Board has reviewed our current Board leadership 
structure in light of the composition of the Board, our size, the nature of our 
business, the regulatory framework under which we operate, our stockholder base,
our peer group and other relevant factors, and has determined that this 
structure is currently the most appropriate Board leadership structure for our 
company. Nevertheless, the Board intends to carefully evaluate from time to time
to determine what the Board believes is best for us and our stockholders.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Board Role in Risk Oversight</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Risk is inherent in every business, 
and how well a business manages risk can ultimately determine its success. We 
face a number of risks, including strategic risks, enterprise risks, financial 
risks, and regulatory risks. While our management is responsible for day to day 
management of various risks we face, the Board, as a whole, is responsible for 
evaluating our exposure to risk and to satisfy itself that the risk management 
processes designed and implemented by management are adequate and functioning as
designed. The Board reviews and discusses policies with respect to risk 
assessment and risk management. The Board also has oversight responsibility with
respect to the integrity of our financial reporting process and systems of 
internal control regarding finance and accounting, as well as its financial 
statements.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid59" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">38</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Board of Directors Meetings, Committees of the Board 
of Directors, and Annual Meeting Attendance</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">During the fiscal year ended December
31, 2013, the Board held a total of 7 meetings, including actions by written 
consent. All members of the Board attended 100% of all meetings of the Board. We
do not maintain a policy regarding director attendance at annual meetings and we
did not have an annual meeting during the fiscal year ended December 31, 
2013.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We do not currently have any standing
committees of the Board. The full Board is responsible for performing the 
functions of: (i) the Audit Committee, (ii) the Compensation Committee and (iii)
the Nominating Committee.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our Bylaws provide that the number of
Directors shall be fixed from time to time by the Board, but in no event shall 
be less than the minimum required by law. The Board should be large enough to 
maintain our required expertise but not too large so as not to function 
efficiently. Director nominees are recommended, reviewed and approved by the 
entire Board. The Board believes that this process is appropriate due to the 
relatively small number of directors on the Board and the opportunity to benefit
from a variety of opinions and perspectives in determining director nominees by 
involving the full Board.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">While the Board is solely responsible
for the selection and nomination of directors, the Board may consider nominees 
recommended by stockholders as it deems appropriate. The Board evaluates each 
potential nominee in the same manner regardless of the source of the potential 
nominee&#8217;s recommendation. Although we do not have a policy regarding 
diversity, the Board does take into consideration the value of diversity among 
Board members in background, experience, education and perspective in 
considering potential nominees for recommendation to the Board for selection. 
Stockholders who wish to recommend a nominee should send nominations to our 
Chief Executive Officer, Thomas Bold, 430 Park Avenue, Suite 702, New York, NY 
10022, that include all information relating to such person that is required to 
be disclosed in solicitations of proxies for the election of directors. The 
recommendation must be accompanied by a written consent of the individual to 
stand for election if nominated by the Board and to serve if elected.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Compensation Consultants</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We have not historically relied upon 
the advice of compensation consultants in determining Named Executive Officer 
compensation. Instead, the full Board reviews compensation levels and makes 
adjustments based on their personal knowledge of competition in the market 
place, publicly available information and informal surveys of human resource 
professionals.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Stockholder Communications</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Stockholders who wish to communicate 
with the Board may do so by addressing their correspondence to: RenovaCare, 
Inc., Attention: Board of Directors, 430 Park Avenue, Suite 702, New York, New 
York 10022. The Board will review and respond to all correspondence received, as
appropriate.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid60" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">39</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>COMPENSATION OF DIRECTORS</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our Board determines the non-employee
directors&#8217; compensation for serving on the Board and its committees. In 
establishing director compensation, the Board is guided by the following 
goals:</p>
<ul>
<li style="text-align: justify;">compensation should consist of a combination of
cash and equity awards that are designed to fairly pay the directors for work 
required for a company of our size and scope;</li>
<li style="text-align: justify;">compensation should align the directors&#8217; 
interests with the long-term interests of stockholders; and</li>
<li style="text-align: justify;">compensation should assist with attracting and 
retaining qualified directors.</li>
</ul>
<p style="margin: 0px; text-indent: 30px;">Effective as of August 1, 2013, we 
agreed to pay non-employee directors an annual fee of $6,000 for their services,
paid quarterly. Directors are entitled to participate in, and have been issued 
options under, our 2013 Long-Term Stock Incentive Plan.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The following table provides 
information regarding all compensation paid to our non-employee directors during
the fiscal years ended December 31, 2013 and 2012:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fffftableid49" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>Name</b></p>
</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="center"><b></b></td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" class="para" style="border-bottom: black 1px solid; text-align: 
center;" valign="bottom" colspan="2" align="center"><b>Fees earned or paid in 
cash <sup>(1)</sup></b></td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
align="left">&#160;</td>
<td style="border-bottom: black 0pt solid;" valign="bottom" align="left">
<p style="margin: 0px;"></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" 
align="left">
<p style="margin: 0px;" align="center"><b>Stock awards Aggregate Grant Date Fair
Value</b></p>
</td>
<td style="border-bottom: black 0pt solid;" valign="bottom"
align="left">&#160;</td>
<td valign="bottom" align="center"><b></b></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Option awards Aggregate Grant Date Fair Value</b></td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
align="left">&#160;</td>
<td style="border-bottom: black 0pt solid;" align="left">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" 
align="left">
<p style="margin: 0px;" align="center"><b>Non-equity<br >incentive plan 
compensation</b></p>
</td>
<td style="border-bottom: black 0pt solid;" valign="bottom" align="left"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" 
align="left">
<p style="margin: 0px;" align="center"><b>Nonqualified Deferred compensation 
earnings</b></p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" 
align="left">
<p style="margin: 0px;" align="center"><b>All other<br >compensation 
</b><strong><sup>(2)</sup></strong></p>
</td>
<td style="border-bottom: black 0pt solid;" valign="top" 
align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Total</b></td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom" width="23%">
<p style="margin: 0px;">Joseph Sierchio <sup>(3)</sup></p>
</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="8%" align="right">
<p style="text-align: center; margin: 0pt;">2013</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="8%" align="right">
<p style="margin: 0pt;">2,500</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">$</td>
<td valign="bottom" width="8%">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="8%" align="right">
<p style="margin: 0pt;">9,884</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">$</td>
<td valign="bottom" width="8%">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%">$</td>
<td valign="bottom" width="8%">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom" width="1%">
<p style="text-align: right; margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="1%">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="top" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="8%" align="right">
<p style="margin: 0pt;">9,884</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="text-align: center; margin: 0pt;">2012</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0px;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">Nil</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0px;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">Nil</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom"></td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">&#160;</p>
</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="top">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0px;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">Nil</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td></td>
<td valign="bottom" align="right">
<p style="text-align: center; margin: 0pt;">&#160;</p>
</td>
<td valign="bottom"></td>
<td></td>
<td valign="bottom" align="left">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0px;">&#160;</p>
</td>
<td></td>
<td></td>
<td valign="bottom"></td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">&#160;</p>
</td>
<td valign="bottom"></td>
<td></td>
<td valign="bottom" align="left">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0px;">&#160;</p>
</td>
<td></td>
<td></td>
<td valign="bottom"></td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">&#160;</p>
</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">&#160;</p>
</td>
<td valign="top"></td>
<td></td>
<td valign="bottom" align="left">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0px;">&#160;</p>
</td>
<td></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Kenneth Kirkland</p>
</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="text-align: center; margin: 0pt;">2013</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">2,500</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">9,884</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom"></td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">&#160;</p>
</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="top">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">9,884</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="text-align: center; margin: 0pt;">2012</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0px;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">Nil</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0px;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">Nil</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom"></td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">&#160;</p>
</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="text-align: right; margin: 0px;">Nil</p>
</td>
<td valign="top">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0px;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">Nil</p>
</td>
<td>&#160;</td>
</tr>
</table>
<p style="text-align: center; margin: 0px;">&#160;</p>
<table id="tableid62" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(1)</sup></p>
</td>
<td valign="top">
<p style="text-align: left; font: 10pt TIMES NEW ROMAN; margin: 0px;">The 
amounts in this column represent the quarterly compensation.</p>
</td>
</tr>
</table>
<table id="tableid63" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%">
<p style="text-align: left; font: 10pt TIMES NEW ROMAN; margin: 
0px;"><sup>(2)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">The amounts in this column 
represent stock-based compensation expense granted to Messrs. Kirkland and 
Sierchio (20,000 stock options each) for stock options granted on August 1, 
2013. The exercise price per share is $0.65; 10,000 options vested on the grant 
date and, subject to continued service as a member of our Board, the remaining 
10,000 options will vest on August 1, 2014.</p>
</td>
</tr>
</table>
<table id="tableid64" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(3)</sup></p>
</td>
<td valign="top">
<p style="text-align: justify; font: 10pt TIMES NEW ROMAN; margin: 0px;">The 
amounts set forth in this table do not include fees paid to Sierchio &amp; 
Company, LLP, the firm&#8217;s legal counsel, of which Mr. Sierchio is the 
managing partner.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<p style="text-align: center; font: 10pt TIMES NEW ROMAN; margin: 
0px;"><b><b>EXECUTIVE COMPENSATION</b></b></p>
<p style="margin: 0px;" align="center">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our Board is responsible for 
establishing the compensation and benefits for our executive officers. The Board
reviews the performance and total compensation package for our executive 
officers, and considers the modification of existing compensation and the 
adoption of new compensation plans. The board has not retained any compensation 
consultants.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid65" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">40</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The goals of our executive 
compensation program are to attract, motivate and retain individuals with the 
skills and qualities necessary to support and develop our business within the 
framework of our small size and available resources. We designed our executive 
compensation program to achieve the following objectives:</p>
<table id="tableid66" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<table id="tableid67" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="3%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">attract and retain 
executives experienced in developing and delivering products such as our 
own;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">motivate and reward 
executives whose experience and skills are critical to our success;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">reward performance; and</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">align the interests of our 
executive officers and stockholders by motivating executive officers to increase
stockholder value.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The following table and descriptive 
materials set forth information concerning compensation earned for services 
rendered to us by: the Chief Executive Officer (the &#8220;<b>CEO</b>&#8221;); 
the Chief Financial Officer (the &#8220;<b>CFO</b>&#8221;) and the other most 
highly-compensated executive officers other than the CEO and CFO who were 
serving as executive officers during the fiscal years ended December 31, 2013 
and 2012 (the &#8220;<b>Named Executive Officers</b>&#8221;).</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid68" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="text-align: left; margin: 0px;" align="center"><b>Name and 
principal</b></p>
<p style="text-align: left; margin: 0px;" align="center"><b>position 
(</b><b>a)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="text-align: left; margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="9%">
<p style="margin: 0px;" align="center"><b>Year</b></p>
<p style="margin: 0px;" align="center"><b>December </b><b>31,</b></p>
<p style="margin: 0px;" align="center"><b></b><b>(b)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="7%">
<p style="margin: 0px;" align="center"><b>Salary/</b></p>
<p style="margin: 0px;" align="center"><b>consulting fee</b></p>
<p style="margin: 0px;" align="center"><b>($) </b><b>(c)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="7%">
<p style="margin: 0px;" align="center"><b>Bonus</b></p>
<p style="margin: 0px;" align="center"><b>($) </b><b>(d)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="7%">
<p style="margin: 0px;" align="center"><b>Stock</b></p>
<p style="margin: 0px;" align="center"><b>awards</b></p>
<p style="margin: 0px;" align="center"><b>($) </b><b>(e)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="7%">
<p style="margin: 0px;" align="center"><b>Option</b></p>
<p style="margin: 0px;" align="center"><b>awards</b></p>
<p style="margin: 0px;" align="center"><b>($)</b><b>(f)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="7%">
<p style="margin: 0px;" align="center"><b>Non-equity</b></p>
<p style="margin: 0px;" align="center"><b>incentive</b></p>
<p style="margin: 0px;" align="center"><b>plan</b></p>
<p style="margin: 0px;" align="center"><b>compensation</b></p>
<p style="margin: 0px;" align="center"><b>($)</b><b>(g)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="7%">
<p style="margin: 0px;" align="center"><b>Non-qualified</b></p>
<p style="margin: 0px;" align="center"><b>deferred</b></p>
<p style="margin: 0px;" align="center"><b>compensation</b></p>
<p style="margin: 0px;" align="center"><b>earnings</b></p>
<p style="margin: 0px;" align="center"><b>($) </b><b>(h)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="7%">
<p style="margin: 0px;" align="center"><b>All other</b></p>
<p style="margin: 0px;" align="center"><b>compensation</b></p>
<p style="margin: 0px;" align="center"><b>($) </b><b>(i)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="7%">
<p style="margin: 0px;" align="center"><b>Total</b></p>
<p style="margin: 0px;" align="center"><b>($) </b><b>(j)</b></p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;" align="center"><b>&#160;</b></p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Thomas Bold <sup>(1)</sup></p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td style="text-align: center;" valign="bottom" align="right">
<p style="margin: 0pt;">2013</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">4,167</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">22,988</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">22,988</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">President &amp; CEO</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td style="text-align: center;" valign="bottom" align="right">
<p style="margin: 0pt;">2012</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="center">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td style="text-align: center;" valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Rhonda B. Rosen <sup>(2)</sup></p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td style="text-align: center;" valign="bottom" align="right">
<p style="margin: 0pt;">2013</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">37,200</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">37,200</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">CFO, Former President &amp; CEO, Director</p>
</td>
<td valign="bottom"></td>
<td style="text-align: center;" valign="bottom" align="right">
<p style="margin: 0pt;">2012</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="center">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td style="text-align: center;" valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Joseph Sierchio <sup>(3)</sup></p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td style="text-align: center;" valign="bottom" align="right">
<p style="margin: 0pt;">2013</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">2,500</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">9,884</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">9,884</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Director, Former Acting Interim President &amp; CEO</p>
</td>
<td valign="bottom"></td>
<td style="text-align: center;" valign="bottom" align="right">
<p style="margin: 0pt;">2012</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="center">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td style="text-align: center;" valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Derek Cooper <sup>(4)</sup></p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td style="text-align: center;" valign="bottom" align="right">
<p style="margin: 0pt;">2013</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="center">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">Former President, CEO and Director</td>
<td valign="bottom"></td>
<td style="text-align: center;" valign="bottom" align="right">
<p style="margin: 0pt;">2012</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">16,691</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;Nil</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">16,691</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
</tr>
</table>
<p style="margin: 0px;">____________________</p>
<table id="tableid69" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(1)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">On December 1, 2013, we 
appointed Mr. Bold as our President &amp; CEO and entered into a consulting 
agreement with Mr. Bold pursuant to which he serves on a part-time basis for an 
annual fee of $50,000, payable in 12 equal installments, which is prorated for 
any partial months. Effective as of August 1, 2014, Mr. Bold's annual fee was 
raised to $100,000.&#160;In addition to Mr. Bold&#8217;s fee, he was issued a 
stock option to purchase up to 40,000 shares at a price of $0.75 per share the 
closing price of our common stock as quoted on the OTCQB on November 29, 2013. 
The shares may be exercised on a &#8220;cashless basis&#8221; using the formula 
contained therein and, subject to Mr. Bold&#8217;s continued service as our 
President and Chief Executive Officer, vest as follows: (a) 20,000 shares vest 
on December 1, 2014; and (b) 20,000 shares vest on December 1, 2015.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(2)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Ms. Rosen served as our 
President &amp; CEO and as a director from June 20, 2013 through September 30, 
2013. On October 1, 2013, we appointed Ms. Rosen to serve as our CFO on a part-
time basis, for which she is paid a monthly fee of $2,400.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(3)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Mr. Sierchio served as our 
Acting Interim President and CEO from June 19, 2012 through June 20, 2013 and 
from October 1, 2013 through November 30; he has served as a director since 
August 26, 2010. Mr. Sierchio is not compensated for his service as an officer, 
but we retain Sierchio &amp; Company, LLP, a law firm of which Mr. Sierchio is 
the managing partner, to provide us with legal services. For information 
regarding fees paid to Sierchio &amp; Company, LLP.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(4)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">On January 12, 2012, we 
appointed Mr. Cooper as our President, CEO, CFO and director; on June 18, 2012, 
Mr. Cooper resigned from his positions.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<table id="tableid70" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">41</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>OUTSTANDING EQUITY AWARDS AT FISCAL-
YEAR END</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The following table sets forth 
information regarding equity awards that have been previously awarded to each of
the Named Executives and which remained outstanding as of December 31, 2013.</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid68" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="border-bottom: black 1pt solid;" valign="bottom" align="left">
<p style="text-align: left; margin: 0px;" align="center"><b>Name</b></p>
</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="center"><b>Number of Securities Underlying Unexercised Options (#) 
Exercisable</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="center"><b>Number of Securities Underlying Unexercised Options (#) 
Unexercisable</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="center"><b>Option<br >Exercise Price ($)</b></td>
<td align="left">&#160;</td>
<td align="left"></td>
<td style="border-bottom: black 1pt solid;" valign="bottom" align="left">
<p style="margin: 0px;" align="center"><b>Option<br >Expiration Date</b></p>
</td>
</tr>
<tr style="background-color: white;" height="15">
<td valign="top" width="50%">
<p style="margin: 0px;">&#160;</p>
</td>
<td width="1%"></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="10%" align="right">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td width="1%"></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="10%" align="right">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td width="1%"></td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" width="10%" align="right">
<p style="margin: 0pt;">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td valign="top" width="10%">
<p style="margin: 0px;" align="center">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top" width="50%">
<p style="margin: 0px;">Thomas Bold</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="10%" align="right">
<p style="margin: 0pt;">0</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="10%" align="right">
<p style="margin: 0pt;">40,000</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="10%" align="right">
<p style="margin: 0pt;">0.75</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td valign="top" width="10%">
<p style="margin: 0px;" align="center">12/01/2023</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>PAYMENTS UPON TERMINATION OR CHANGE IN
CONTROL</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">There are no understandings or 
agreements known by management at this time which would result in a change in 
control.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The following table summarizes 
information about stock options outstanding and exercisable at December 31, 
2013:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fffftableid74" style="width: 100%; text-align: left; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15">
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
colspan="10" align="center"><b>Stock Options 
Outstanding</b><b></b><b></b><b></b></td>
<td align="left">&#160;</td>
<td align="left"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
colspan="10" align="center"><b>Stock Options Exercisable 
</b><b></b><b></b><b></b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center">
<p style="text-align: center; margin: 0px;" align="center"><b>Range of Exercise 
</b><b>Prices</b>&#160;</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Number of OptionsOutstanding</b></td>
<td align="left">&#160;</td>
<td align="left"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Weighted Average Contractual Life (years)</b></td>
<td align="left">&#160;</td>
<td align="left"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Weighted Average Exercise Price </b></td>
<td align="left">&#160;</td>
<td align="left"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Number of Options Exercisable</b></td>
<td align="left">&#160;</td>
<td align="left"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Weighted Average Remaining Contractual Life (Years)</b></td>
<td align="left">&#160;</td>
<td align="left"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Weighted Average Exercise Price </b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom" width="9%" 
colspan="2" align="left">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">$ 0.70</p>
</td>
<td style="border-bottom: black 0pt solid;" width="2%">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="1%"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" width="9%" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">80,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
width="1%">&#160;</td>
<td style="border-bottom: black 0pt solid;" width="1%"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="1%"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" width="9%" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">9.75</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
width="1%">&#160;</td>
<td style="border-bottom: black 0pt solid;" width="1%"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="1%" 
align="left">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" width="9%" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">0.70</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
width="1%">&#160;</td>
<td style="border-bottom: black 0pt solid;" width="1%"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="1%"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" width="9%"
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">20,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
width="1%">&#160;</td>
<td style="border-bottom: black 0pt solid;" width="1%"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="1%"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" width="9%" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">9.50</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
width="1%">&#160;</td>
<td style="border-bottom: black 0pt solid;" width="1%"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" width="1%" 
align="left">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" width="9%" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">0.65</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" colspan="2">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Total</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">80,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;">&#160;</td>
<td style="border-bottom: black 0pt solid;"></td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">9.75</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;">&#160;</td>
<td style="border-bottom: black 0pt solid;"></td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">0.70</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;">&#160;</td>
<td style="border-bottom: black 0pt solid;"></td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">20,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;">&#160;</td>
<td style="border-bottom: black 0pt solid;"></td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">9.50</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;">&#160;</td>
<td style="border-bottom: black 0pt solid;"></td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0pt;">0.65</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="text-align: center; margin: 0px;"><b><b>SECURITY OWNERSHIP OF CERTAIN 
BENEFICIAL OWNERS AND MANAGEMENT</b></b></p>
<p style="text-align: center; margin: 0px;"><b><b></b></b>&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">The following 
table sets forth certain information as of the date of this prospectus by (i) 
all persons who are known by us to beneficially own more than 5% of our 
outstanding shares of common stock, (ii) each director, director nominee, and 
Named Executive Officer; and (iii) all executive officers and directors as a 
group:</p>
<p style="margin: 0px;">&#160;&#160;</p>
<table id="fftableid73" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="border-bottom: black 1px solid; text-indent: 30px;" valign="bottom" 
align="left">
<p style="text-align: left; padding-left: 0px; margin: 0px; text-indent: 0px;" 
align="center"><b>Name and Address of</b></p>
<p style="text-align: left; padding-left: 0px; margin: 0px; text-indent: 0px;" 
align="center"><b>Beneficial Owner </b><sup>(1)</sup><b></b></p>
</td>
<td align="left">&#160;</td>
<td align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" colspan="2" align="center"><b>Number of shares Beneficially 
Owned <sup>(2)</sup></b></td>
<td valign="bottom" align="left">
<p style="margin: 0px;"></p>
</td>
<td align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" colspan="2" align="center">
<p style="margin: 0cm 0cm 0pt;"><b>% of Class<br ></b><b>Owned 
<sup>(2)</sup></b></p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0px;"></p>
</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">
<p style="margin: 0px;"><u style="line-height: 1;"><b>Directors and 
Officers</b></u></p>
</td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top" align="left">
<p style="margin: 0px;">Thomas Bold <sup>(3)</sup></p>
</td>
<td align="left">&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0pt;">0</p>
</td>
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0px;">*</p>
</td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top" align="left">
<p style="margin: 0px;">Rhonda B. Rosen <sup>(4)</sup></p>
</td>
<td align="left">&#160;</td>
<td valign="bottom" align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0pt;">5,000</p>
</td>
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0px;">*</p>
</td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top" align="left">
<p style="margin: 0px;">Patsy J. Trisler <sup>(5)</sup></p>
</td>
<td align="left">&#160;</td>
<td valign="bottom" align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0pt;">0</p>
</td>
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0px;">*</p>
</td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top" align="left">
<p style="margin: 0px;">Kenneth Kirkland <sup>(6)</sup></p>
</td>
<td align="left">&#160;</td>
<td valign="bottom" align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0pt;">30,000</p>
</td>
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0px;">*</p>
</td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="top" align="left">
<p style="margin: 0px;">Joseph Sierchio <sup>(7)</sup></p>
</td>
<td style="border-bottom: black 0pt solid;" align="left">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" 
align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="right">
<p style="margin: 0pt;">580,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">&#160;</td>
<td style="border-bottom: black 1px solid;" align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="right">
<p style="margin: 0px;">*</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="top" align="left">
<p style="margin: 0px;">All Directors and Officers as a Group (5 people)</p>
</td>
<td style="border-bottom: black 0pt solid;" align="left">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" 
align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
colspan="2" align="right">
<p style="margin: 0pt;">615,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">&#160;</td>
<td style="border-bottom: black 3px double;" align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
colspan="2" align="right">
<p style="margin: 0px;">*</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom" align="left">
<p style="margin: 0px;"><u style="line-height: 1;"><b></b></u>&#160;</p>
</td>
<td align="left"></td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="left"></td>
<td align="left"></td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="left"></td>
<td align="left"></td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom" align="left">
<p style="margin: 0px;"><u style="line-height: 1;"><b>5% 
Shareholders</b></u></p>
</td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="left">&#160;</td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="left">&#160;</td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Kalen Capital Corporation <sup>(8)</sup></p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="right">&#160;</td>
<td id="ffc" valign="bottom" width="9%" colspan="2" align="right">
<p style="margin: 0pt;">42,564,800</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">63.9</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">The Kalen Capital Building</p>
<p style="margin: 0px;">688 West Hastings St.</p>
<p style="margin: 0px;">Suite 700</p>
<p style="margin: 0px;">Vancouver, BC V6B 1P1</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0px;" align="center">&#160;</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;" align="center">&#160;</p>
</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">_________________</p>
<table id="tableid74" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">*</p>
</td>
<td valign="top">less than 1%</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top"></td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(1)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Beneficial ownership is 
determined in accordance with SEC rules and generally includes voting or 
investment power with respect to securities. Each of the beneficial owners 
listed above has direct ownership of and sole voting power and investment power 
with respect to the shares of our common stock and except as indicated the 
address of each beneficial owner is 430 Park Avenue, Suite 702, New York, New 
York 10022.</p>
</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;&#160;</p>
<table id="tableid75" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">42</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid76" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(2)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Calculated pursuant to Rule 
13d-3(d) of the Exchange Act. Beneficial ownership is calculated based on 
66,575,122 shares of common stock issued and outstanding on a fully diluted 
basis as of the date of this prospectus. Under Rule 13d-3(d) of the Exchange 
Act, shares not outstanding which are subject to options, warrants, rights or 
conversion privileges exercisable within 60 days are deemed outstanding for the 
purpose of calculating the number and percentage owned by such person, but are 
not deemed outstanding for the purpose of calculating the percentage owned by 
each other person listed.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(3)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Mr. Bold was appointed as
our President &amp; CEO on December 1, 2013; as part of his appointment he was 
granted a stock option to purchase up to 40,000 shares of common stock. The 
option vests in two equal installments of 20,000 on December 1, 2014 and 2015, 
subject to his continued service with the Company.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(4)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Consists of vested options 
to purchase 5,000 shares of common stock. Does not include an option to purchase
5,000 shares of common stock that vests on August 14, 2015, subject to her 
continued service with the Company.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(5)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Ms Trisler was appointed as 
our Vice President &#8211; Clinical &amp; Regualtory Affairs on April 1, 2014; 
as part of her appointment she was granted a stock option to purchase up to 
50,000 shares of common stock. The option vests in five equal installments of 
10,000 on April 1, 2015-2019, subject to her continued service with the 
Company.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(6)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Consists of vested options 
to purchase 30,000 shares of common stock. Does not include an option to 
purchase 10,000 shares of common stock that vests on August 14, 2015, subject to
his continued service with the Company.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(7)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Includes 550,000 shares of 
common stock owned by Mr. Sierchio and vested options to purchase 30,000 shares 
of common stock. Does not include an option to purchase 10,000 shares of common 
stock that vests on August 14, 2015, subject to his continued service with the 
Company.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(8)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Kalen Capital Corporation is
a private Alberta corporation wholly owned by Mr. Harmel Rayat. In such 
capacity, Mr. Rayat may be deemed to have beneficial ownership of these shares. 
Consists of (a) 35,564,800 shares of common stock; (b) a Series B Warrant 
exercisable to purchase 3,500,000 shares of common stock at a price of $0.43 if 
purchased within the first eighteen (18) months or $0.46 per share if exercised
thereafter through November 29, 2018; and (c) a Series C Warrant exercisable to 
purchase 3,500,000 shares of common stock at a price of $0.43 if purchased 
within the first eighteen (18) months or $0.49 per share if exercised thereafter
through November 29, 2018. Does not include 3,000,000 shares held in separate 
trusts for the benefit of each Mr. Rayat&#8217;s two children (6,000,000 shares 
in the aggregate) over which Mr. Rayat has neither voting nor disposition 
authority; Mr. Rayat disclaims any beneficial ownership interest in and to such 
shares.</p>
</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>TRANSACTIONS WITH RELATED PERSONS, 
PROMOTERS</b></p>
<p style="margin: 0px;" align="center"></p>
<p>&#160;<b><b><b>AND CERTAIN CONTROL PERSONS</b></b></b></p>
<p style="text-indent: 30px;">We do not have a formal written policy for the 
review and approval of transactions with related parties. However, our Code of 
Ethics and Corporate Governance Principles require actual or potential conflict 
of interest to be reported to the Board. Our employees are expected to disclose 
personal interests that may conflict with ours and they may not engage in 
personal activities that conflict with their responsibilities and obligations to
us. Periodically, we inquire as to whether or not any of our directors have 
entered into any transactions, arrangements or relationships that constitute 
related party transactions. If any actual or potential conflict of interest is 
reported, our entire Board and outside legal counsel review the transaction and 
relationship disclosed and the Board makes a formal determination regarding each
director&#8217;s independence. If the transaction is deemed to present a 
conflict of interest, the Board will determine the appropriate action to be 
taken.</p>
<p style="margin: 0px;"><b>Review, Approval or Ratification of Transactions with
Related Persons</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our unwritten policy with regard to 
transactions with related persons is that all material transactions are to be 
reviewed by the entire Board for any possible conflicts of interest. In the 
event of a potential conflict of interest, the Board will generally evaluate the
transaction in terms of the following standards: (i) the benefits to us; (ii) 
the impact on a director&#8217;s independence in the event the related person is
a director, an immediate family member of a director or an entity in which a 
director is a partner, shareholder or executive officer; (iii) the availability 
of other sources for comparable products or services; (iv) the terms and 
conditions of the transaction; and (v) the terms available to unrelated parties 
or the employees generally. The Board will then document its findings and 
conclusion in written minutes</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Transactions with Related Persons</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">The Board is 
responsible for review, approval, or ratification of &#8220;related-person 
transactions&#8221; involving the Company and related persons. Under SEC rules 
(Section 404 (a) of Regulation S-K), a related person is a director, officer, 
nominee for director, or 5% stockholder of the company since the beginning of 
the previous fiscal year, and their immediate family members. We are required to
report any transaction or series of transactions in which we or a subsidiary is 
a participant, the amount involved exceeds $120,000, and a related person has a 
direct or indirect material interest.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid77" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">43</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The Board has determined that, 
barring additional facts or circumstances, a related person does not have a 
direct or indirect material interest in the following categories of 
transactions:</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid78" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="3%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">any transaction with another
company for which a related person&#8217;s only relationship is as an employee 
(other than an executive officer), director, or beneficial owner of less than 
10% of that company&#8217;s shares, if the amount involved does not exceed the 
greater of $1 million or 2% of that company&#8217;s total annual revenue;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">compensation to executive 
officers determined by the Board;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">compensation to directors 
determined by the Board;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">transactions in which all 
security holders receive proportional benefits; and</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">banking-related services 
involving a bank depository of funds, transfer agent, registrar, trustee under a
trust indenture, or similar service.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The Board reviews transactions 
involving related persons who are not included in one of the above categories 
and makes a determination whether the related person has a material interest in 
a transaction and may approve, ratify, rescind, or take other action with 
respect to the transaction in its discretion. The Board reviews all material 
facts related to the transaction and takes into account, among other factors it 
deems appropriate, whether the transaction is on terms no less favorable than 
terms generally available to an unaffiliated third party under the same or 
similar circumstances; the extent of the related person&#8217;s interest in the 
transaction; and, if applicable, the availability of other sources of comparable
products or services.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The following are related party 
transactions for the fiscal years ended December 31, 2013 and 2012:</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">On November 29, 2013, we completed 
the 11/29 Financing with Kalen Capital Corporation, a private Alberta 
corporation wholly owned by Mr. Harmel Rayat and a majority shareholder of ours,
pursuant to which we sold to Kalen Capital Corporation 3,500,000 Units at a 
purchase price of $0.43 per Unit, for an aggregate purchase amount of 
$1,505,000.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">On December 31, 2013, we completed 
the sale of 100% of the issued and outstanding shares of Fostung Resources to 
Duke for a promissory note in the amount of $80,000, which amount approximated 
the fair value of the leases and mining claims controlled by Fostung Resources, 
as concluded by an independent third-party geological consultant. Mr. Herdev S. 
Rayat, the majority shareholder of Duke, is the brother of Mr. Harmel S. Rayat, 
our majority shareholder.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">During the year ended December 31, 
2013, directors&#8217; fees of $2,500 (2012 - $0) were paid to our non-officer 
directors. Legal fees of $195,172 (2012 - $72,502) were paid or are due to 
Sierchio &amp; Company, LLP, of which Mr. Joseph Sierchio, a director, is the 
managing partner.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>DESCRIPTION OF OUR SECURITIES</b></p>
<p style="margin: 0px;" align="center"></p>
<p style="text-indent: 30px;">Our authorized capital stock consists of 
500,000,000 shares of common stock, par value $0.00001 per share, and 10,000,000
shares of preferred stock, par value $0.001 per share. As of the date of this 
prospectus, there were 66,575,122 shares of our common stock issued and 
outstanding and no shares of preferred stock issued and outstanding.</p>
<table id="tableid79" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">44</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">&#160;<b>Common Stock</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Subject to any special voting rights 
of any series of preferred stock that we may issue in the future, each holder is
entitled to one vote for each share held on all matters to be voted upon by the 
stockholders, including the election of directors. The shares of common stock do
not have cumulative voting rights. This means that the holders of more than 50% 
of the shares of common stock can elect all of our directors, subject to the 
rights of any outstanding series of preferred stock.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The holders of common stock are 
entitled to receive a pro-rata share of dividends, if any, as may be declared 
from time to time by the board out of funds legally available for the payment of
dividends, subject to any preferential dividend rights of any outstanding series
of preferred stock.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In the event of our liquidation, 
dissolution, or winding up, the holders of common stock are entitled to share 
pro-rata in all assets remaining after payment of our liabilities and subject to
the prior rights of any outstanding series of preferred stock. Shares of common 
stock have no preemptive, conversion, or other subscription rights. There are no
redemption or sinking fund provisions applicable to the common stock.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Preferred Stock</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our Board is authorized, subject to 
certain limitations prescribed by law, without further stockholder approval, to 
issue from time to time up to an aggregate of 10,000,000 shares of preferred 
stock in one or more series and to fix or alter the designations, preferences, 
rights and any qualifications, limitations or restrictions of the shares of each
such series thereof, including the dividend rights, dividend rates, conversion 
rights, voting rights and terms of redemption of shares constituting any series 
or designations of such series The rights of holders of our common stock may be 
subject to, and adversely affected by, the rights of the holders of any 
preferred stock that may be issued in the future. The issuance of preferred 
stock may have the effect of delaying, deferring or preventing a change of
control and may adversely affect the voting and other rights of holders of our 
common stock.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Warrants</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of the date of this prospectus, we
have issued the following warrants: (a) Series A Warrant to purchase 1,200,000 
shares of common stock exercisable at $0.35 per share through July 12, 2019. The
Series A Warrant vests in five equal installments of 240,000 on July 12, 2014-
2018 and expires on July 12, 2019; (b) Series B Warrant to purchase 3,500,000 
shares of common stock exercisable at $0.43 per share if exercised on or before 
May 29, 2015, or $0.46 if exercised after May 29, 2015, through November 29, 
2018; and (c) Series C Warrant to purchase 3,500,000 shares of common stock 
exercisable at $0.43 per share if exercised on or before May 29, 2015, or $0.49 
if exercised after May 29, 2015, through November 29, 2018. Each of the warrants
may be exercised on a &#8220;cashless basis&#8221; using the formula set forth 
therein.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Options</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of the date of this prospectus, 
there are options outstanding to purchase an aggregate of 185,000 shares of our 
common stock issued to various persons and entities at prices ranging between 
$0.65 and $1.05, 65,000 of which have vested. If issued, the shares underlying 
these options would increase the number of shares of our common stock currently 
outstanding and will dilute the holdings and voting rights of our then-existing 
shareholders.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid80" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">45</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><b>Registration Rights</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Pursuant to the terms of the Asset 
Purchase Agreement we entered into with Dr. J&#246;rg Gerlach for the purchase 
of the Cell Deposition Device, we agreed to register for resale the shares 
issuable upon exercise of the Series A Warrant we issued to him and to keep the 
registration statement, of which this prospectus is a part of, effective under 
the earlier of: (i) 24 months after the date on which it is declared effective, 
or (ii) the date on which all the shares issuable upon exercise of the Series A 
Warrant may be resold without restriction pursuant to Rule 144.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Pursuant to the terms of the 
Registration Rights Agreement we entered into with Kalen Capital Corporation as
part of the 11/29 Financing, we agreed to register for resale all of the shares 
owned by Kalen Capital Corporation, including shares issuable upon exercise of 
warrants and to keep the registration statement, of which this prospectus is a 
part of, until the earlier of: (a) the date the investor&#8217;s securities have
been sold in accordance with Rule 144; (b) such securities become eligible for 
resale without volume or manner-of-sale restrictions and without current public 
information pursuant to Rule 144 as set forth in a written opinion letter to 
such effect, addressed, delivered and acceptable to our transfer agent as 
reasonably determined by us, upon the advice of our counsel; or (c) such 
securities have otherwise been disposed of by the investor pursuant to an 
exemption from the registration requirements of the Securities Act. We further 
provided Kalen Capital Corporation with demand registration rights and our 
failure to file any required registration statements would result in penalties 
requiring us to issue additional shares of common stock, as further set forth in
the Registration Rights Agreement.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Shares Eligible for Resale</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">There is currently no liquid trading 
market for our common stock and one may not develop in the future. Future sales 
of substantial amounts of common stock, including shares of common stock issued 
upon exercise of outstanding options and exercise of the warrants offered in 
this prospectus in the public market, or the anticipation of those sales, could 
adversely affect market prices prevailing from time to time and could impair our
ability to raise capital through sales of our equity securities.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Rule 144</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As of the date of this prospectus 
there were 66,575,122 shares of our common stock issued and outstanding, of 
which 42,931,800 shares are deemed &#8220;restricted securities,&#8221; within 
the meaning of Rule 144. Absent registration under the Securities Act, the sale 
of such shares is subject to Rule 144, as promulgated under the Securities 
Act.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In general, under Rule 144, subject 
to the satisfaction of certain other conditions, a person deemed to be one of 
our affiliates, who has beneficially owned restricted shares of our common stock
for at least one year is permitted to sell in a brokerage transaction, within 
any three-month period, a number of shares that does not exceed the greater of 
1% of the total number of outstanding shares of the same class, or, if our 
common stock is quoted on a stock exchange, the average weekly trading volume 
during the four calendar weeks preceding the sale, if greater.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Rule 144 also permits a person who 
presently is not and who has not been an affiliate of ours for at least three 
months immediately preceding the sale and who has beneficially owned the shares 
of common stock for at least nine months to sell such shares without restriction
other than the requirement that there be current public information as set forth
in Rule 144. To the extent that Rule 144 is otherwise available, this provision 
is currently applicable to all of the restricted shares. If a non-affiliate has 
held the shares for more than one year, such person may make unlimited sales 
pursuant to Rule 144 without restriction.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid81" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">46</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The possibility that substantial 
amounts of our common stock may be sold under Rule 144 into the public market 
may adversely affect prevailing market prices for the common stock and could 
impair our ability to raise capital in the future through the sale of equity 
securities. Please refer to &#8220;<b>Risk Factors</b>.&#8221;</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>THE SELLING STOCKHOLDERS</b></p>
<p style="margin: 0px;" align="center"></p>
<p style="text-indent: 30px;">The following table presents information regarding
the Selling Stockholders. The Selling Stockholders may sell up to 10,740,000 
shares of common stock (including shares issuable upon exercise of outstanding 
warrants). The percentage of outstanding shares beneficially owned is based on 
66,575,122 shares of common stock issued and outstanding as of the date of this 
prospectus. Information with respect to beneficial ownership is based upon 
information provided to us by the Selling Stockholders. Except as may be 
otherwise described below, to the best of our knowledge, the named Selling 
Stockholders beneficially own and have sole voting and investment authority as 
to all of the shares set forth opposite his name, none of the Selling 
Stockholders is known to us to be a registered broker-dealer or an affiliate of 
a registered broker-dealer. Each of the Selling Stockholders has acquired his, 
hers or its shares solely for investment and not with a view to or for resale or
distribution of such securities.</p>
<table id="fftableid81" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0px;">&#160;</p>
<p style="text-align: left; margin: 0px;" align="center"><b>Selling 
Stockholders</b></p>
</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b># of Shares Beneficially Owned Prior to the Offering </b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" colspan="2" align="center"><b>% of Issued and Outstanding Shares
Owned Prior to the Offering (1)</b></td>
<td valign="bottom" align="left">
<p style="margin: 0px;"></p>
</td>
<td align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" colspan="2" align="center"><b># of Shares Registered and to be 
Sold in this Offering (2)</b></td>
<td valign="bottom" align="left">
<p style="margin: 0px;"></p>
</td>
<td align="left">&#160;</td>
<td align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" colspan="2" align="center"><b># of Shares Beneficially Owned 
After this Offering (2)</b></td>
<td valign="bottom" align="left">
<p style="margin: 0px;"></p>
</td>
<td align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" colspan="2" align="center"><b>% of Issued and Outstanding Shares
Owned After this Offering (2)</b></td>
<td valign="bottom" align="left">
<p style="margin: 0px;"></p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">J&#246;rg Gerlach, MD PhD<sup> (3)</sup></p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">240,000</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" colspan="2" align="right">
<p style="margin: 0px;" align="right">*</p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">240,000</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" colspan="2" align="right">
<p style="margin: 0pt;">-0-</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">-0-</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Kalen Capital Corporation <sup>(4)</sup></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" 
align="right">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">42,564,800</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="right">
<p style="margin: 0pt;">63.9</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">10,500,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="right">
<p style="margin: 0pt;">32,064,800</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">48.2</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;"><b>Total</b></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;"><b>42,804,800</b></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
colspan="2" align="right">
<p style="margin: 0pt;">64.3</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">
<p style="margin: 0pt;">%</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;"><b>10,740,000</b></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
colspan="2" align="right">
<p style="margin: 0pt;"><b>32,064,800</b></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;"><b>48.2</b></p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">__________________</p>
<table id="tableid83" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="4%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">*</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Less than 1%</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(1)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Calculated pursuant to Rule 
13d-3(d) of the Exchange Act. Beneficial ownership is calculated based on 
66,575,122 shares of common stock issued and outstanding as of the date of this 
prospectus. Under Rule 13d-3(d) of the Exchange Act, shares not outstanding 
which are subject to options, warrants, rights or conversion privileges 
exercisable within 60 days are deemed outstanding for the purpose of calculating
the number and percentage owned by such person, but are not deemed outstanding 
for the purpose of calculating the percentage owned by each other person 
listed.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Under Rule 13d-3, a 
beneficial owner of a security includes any person who, directly or indirectly,
through any contract, arrangement, understanding, relationship, or otherwise has
or shares: (i) voting power, which includes the power to vote, or to direct the 
voting of shares; and (ii) investment power, which includes the power to dispose
or direct the disposition of shares. Certain shares may be deemed to be 
beneficially owned by more than one person (if, for example, persons share the 
power to vote or the power to dispose of the shares). In addition, shares are 
deemed to be beneficially owned by a person if the person has the right to 
acquire the shares (for example, upon exercise of an option) within 60 days of 
the date as of which the information is provided. In computing the percentage 
ownership of any person, the amount of shares outstanding is deemed to include 
the amount of shares beneficially owned by such person (and only such person) by
reason of these acquisition rights. As a result, the percentage of outstanding 
shares of any person as shown in this table does not necessarily reflect the 
person&#8217;s actual ownership or voting power with respect to the number of 
shares of common stock actually outstanding as of the date of this 
prospectus.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(2)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">The Selling Stockholders may
offer and sell, from time to time, any or all of our common stock issued to them
and registered for resale. Because the Selling Stockholders may offer all or 
only some portion of the 10,750,000 shares of common stock registered, no exact 
number can be given as to the amount or percentage of these shares of common 
stock that will be held by the Selling Stockholders upon termination of the 
offering. We can only make estimates and assumptions. The number of shares 
listed in the category titled &#8220;% of Issued and Outstanding Shares Owned 
After This Offering,&#8221; in the table above, represent an estimate of the 
number of shares of common stock that will be held by the Selling Stockholders 
after the offering. To arrive at this estimate, we have assumed that the Selling
Stockholders will sell all of the shares to be registered pursuant to this 
offering and will not be acquiring any additional shares. <b>Please refer to 
&#8220;Plan of Distribution.&#8221;</b></p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(3)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">As part of our acquisition 
of the Cell Deposition Device from Dr. Gerlach we issued him a Series A Warrant 
to purchase up to 1,200,000 shares of our common stock at an exercise price of 
$0.35 per share. The Series A Warrant vests in five equal installments of 
240,000 on July 12, 2014-2018 and expires on July 12, 2019.</p>
</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><sup>(4)</sup></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">On November 29, 2013, we 
completed the 11/29 Financing with Kalen Capital Corporation pursuant to which 
we sold Kalen Capital Corporation 3,500,000 Units, consisting of (a) one share 
of common stock, (b) one Series B Warrant and (c) one Series C Warrant. As part 
of the 11/29 Financing we entered into the Lock-Up agreement with Kalen Capital 
Corporation pursuant to which it agreed not to sell any of its shares of common 
stock, including shares issuable upon exercise of outstanding warrants, for a 
period of nine months without our consent. Additionally, we entered into the 
Registration Rights Agreement pursuant to which we agreed to register for resale
all shares owned by Kalen Capital Corporation, including shares issuable upon 
exercise of outstanding warrants. This prospectus relates only to the shares 
purchased by Kalen Capital Corporation as part of the 11/29 Financing. Mr. Rayat
was our former Chief Executive Officer, Chief Financial Officer, Secretary and 
director. Mr. Rayat resigned from his positions with us on September 12, 
2008.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<table id="tableid84" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">47</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Other than the relationships 
described in the table and footnotes, none of the Selling Stockholders had or 
have any material relationship with us or any of our affiliates within the past 
three years. None of the Selling Stockholders is a broker-dealer or an affiliate
of a broker-dealer.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We may require the Selling 
Stockholders to suspend the sales of the securities offered by this prospectus 
upon the occurrence of any event that makes any statement in this prospectus or 
the related registration statement untrue in any material respect or that 
requires the changing of statements in these documents in order to make
statements in those documents not misleading.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>PLAN OF DISTRIBUTION<br ></b></p>
<p style="margin: 0px;" align="center"><b></b>&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;" 
align="center"><b></b>Each Selling Stockholder of the common stock and any of 
their pledgees, assignees and successors-in-interest may, from time to time, 
sell any or all of their shares of common stock on the OTCQB or any other stock 
exchange, market or trading facility on which the shares are traded or in 
private transactions. These sales may be at fixed or negotiated prices. A 
Selling Stockholder may use any one or more of the following methods when 
selling shares:</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;" 
align="center">&#160;</p>
<table id="tableid85" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="3%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">ordinary brokerage 
transactions and transactions in which the broker-dealer solicits purchasers; 
block trades in which the broker-dealer will attempt to sell the shares as agent
but may position and resell a portion of the block as principal to facilitate 
the transaction;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">purchases by a broker-dealer
as principal and resale by the broker-dealer for its account;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">an exchange distribution in 
accordance with the rules of the applicable exchange;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">privately negotiated 
transactions;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">settlement of short sales 
entered into after the effective date of the registration statement of which 
this prospectus is a part;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">a broker-dealer agreement 
with the Selling Stockholders to sell a specified number of such shares at a 
stipulated price per share;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">through the writing or 
settlement of options or other hedging transactions, whether through an options 
exchange or otherwise;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">a combination of any such 
methods of sale; or</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><font style="font-size: 
10pt; font-family: Symbol;">&#183;</font></p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">any other method permitted 
pursuant to applicable law.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px; text-indent: 30px;">The 
Selling Stockholders may also sell shares under Rule 144 under the Securities
Act, if available, rather than under this prospectus.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Broker-dealers engaged by the Selling
Stockholders may arrange for other broker-dealers to participate in sales. 
Broker-dealers may receive commissions or discounts from the Selling 
Stockholders (or, if any broker-dealer acts as agent for the purchaser of 
shares, from the purchaser) in amounts to be negotiated, but, except as set 
forth in a supplement to this prospectus, in the case of an agency transaction 
not in excess of a customary brokerage commission in compliance with FINRA NASD 
Rule 2440; and in the case of a principal transaction a markup or markdown in 
compliance with NASD IM-2440.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;&#160;</p>
<table id="tableid86" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">48</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In connection with the sale of the 
common stock or interests therein, the Selling Stockholders may enter into 
hedging transactions with broker-dealers or other financial institutions, which 
may in turn engage in short sales of the common stock in the course of hedging 
the positions they assume. The Selling Stockholders may also sell shares of the 
common stock short and deliver these securities to close out their short 
positions, or loan or pledge the common stock to broker-dealers that in turn may
sell these securities. The Selling Stockholders may also enter into option or 
other transactions with broker-dealers or other financial institutions or the 
creation of one or more derivative securities which require the delivery to such
broker-dealer or other financial institution of shares offered by this 
prospectus, which shares such broker-dealer or other financial institution may 
resell pursuant to this prospectus (as supplemented or amended to reflect such 
transaction).</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The Selling Stockholders and any 
broker-dealers or agents that are involved in selling the Shares may be deemed 
to be &#8220;underwriters&#8221; within the meaning of the Securities Act in 
connection with such sales. In such event, any commissions received by such 
broker-dealers or agents and any profit on the resale of the shares purchased by
them may be deemed to be underwriting commissions or discounts under the 
Securities Act. Each Selling Stockholder has informed us that it does not have 
any written or oral agreement or understanding, directly or indirectly, with any
person to distribute the common stock.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We are required to pay certain fees 
and expenses incurred by Selling Stockholders incident to the registration of 
the shares. We have agreed to indemnify the Selling Stockholders against certain
losses, claims, damages and liabilities, including liabilities under the
Securities Act.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Because Selling Stockholders may be 
deemed to be &#8220;underwriters&#8221; within the meaning of the Securities 
Act, they will be subject to the prospectus delivery requirements of the 
Securities Act including Rule 172 thereunder. In addition, any securities 
covered by this prospectus which qualify for sale pursuant to Rule 144 under the
Securities Act may be sold under Rule 144 rather than under this prospectus. 
There is no underwriter or coordinating broker-dealer acting in connection with 
the proposed sale of the shares by the Selling Stockholders.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Pursuant to the terms of the Asset 
Purchase Agreement we entered into with one of the Selling Stockholders, Dr. 
J&#246;rg Gerlach, we agreed to keep the registration statement, of which this 
prospectus is a part of, effective under the earlier of: (i) 24 months after the
date on which it is declared effective, or (ii) the date on which all the shares
issuable upon exercise of the Series A Warrant may be resold without restriction
pursuant to Rule 144.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Pursuant to the terms of a 
Registration Rights Agreement we agreed to keep the registration statement, of 
which this prospectus is a part of, until the earlier of: (a) the date the 
investor&#8217;s securities have been sold in accordance with Rule 144; (b) such
securities become eligible for resale without volume or manner-of-sale 
restrictions and without current public information pursuant to Rule 144 as set 
forth in a written opinion letter to such effect, addressed, delivered and 
acceptable to our transfer agent as reasonably determined by us, upon the advice
of our counsel; or (c) such securities have otherwise been disposed of by the 
investor pursuant to an exemption from the registration requirements of the 
Securities Act.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The Shares will be sold only through 
registered or licensed brokers or dealers if required under applicable state 
securities laws. In addition, in certain states, the Shares may not be sold 
unless they have been registered or qualified for sale in the applicable state 
or an exemption from the registration or qualification requirement is available 
and is complied with.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<table id="tableid87" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">49</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Under applicable rules and 
regulations under the Exchange Act, any person engaged in the distribution of 
the Shares may not simultaneously engage in market making activities with
respect to the common stock for the applicable restricted period, as defined in 
Regulation M, prior to the commencement of the distribution. In addition, the 
Selling Stockholders will be subject to applicable provisions of the Exchange 
Act and the rules and regulations thereunder, including Regulation M, which may 
limit the timing of purchases and sales of the Shares by the Selling 
Stockholders or any other person. We will make copies of this prospectus 
available to the Selling Stockholders and have informed them of the need to 
deliver a copy of this prospectus to each purchaser at or prior to the time of 
the sale (including by compliance with Rule 172 under the Securities Act).</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>LEGAL MATTERS</b></p>
<p style="margin: 0px;" align="center">&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;" 
align="center">The validity of the shares of common stock offered hereby will be
passed upon for us by Sierchio &amp; Company, LLP, 430 Park Avenue, 
7<sup>th</sup> Floor, New York, New York 10022. Joseph Sierchio, the managing 
partner of Sierchio &amp; Company, LLP, is one of our directors and the 
beneficial owner of 580,000 shares of our common stock.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b><b>EXPERTS</b></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our consolidated financial statements
for the fiscal years ended December 31, 2013 and 2012, appearing herein, have 
been audited by Peterson Sullivan LLP, an independent registered public 
accounting firm, as set forth in its report thereon appearing elsewhere herein, 
and are included in reliance upon such report given on the authority of such 
firm as experts in accounting and auditing.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>WHERE YOU CAN FIND ADDITIONAL 
INFORMATION</b></p>
<p style="margin: 0px;" align="center">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We file periodic reports with the 
SEC, including quarterly reports and annual reports which include our audited 
financial statements. This registration statement, including exhibits hereto, 
and all of our periodic reports may be inspected without charge at the Public 
Reference Room maintained by the SEC at 100 F Street, NE, Washington, D.C. 
20549. You may obtain copies of this registration statement, including the 
exhibits hereto, and all of our periodic reports after payment of the fees 
prescribed by the SEC. For additional information regarding the operation of the
Public Reference Room, you may call the SEC at 1-800-SEC-0330. The SEC also 
maintains a website which provides on-line access to reports and other 
information regarding registrants that file electronically with the SEC at: 
www.sec.gov. In addition, you may request a copy of any of our periodic reports 
filed with the Securities and Exchange Commission at no cost, by writing us at: 
RenovaCare, Inc., 430 Park Avenue, Suite 702, New York, NY 10022.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid88" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">50</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b>Index to Consolidated Financial 
Statements</b></p>
<p style="margin: 0px;">&#160;</p>
<table id="fffftableid88" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="text-indent: 30px;" align="left"></td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>Page #</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Consolidated Balance Sheets as of June 30, 2014 and 
December 31, 2013</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">F-1</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Consolidated Statement of Operations for the Three and 
Six Months Ended June 30, 2014 and 2013</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-2</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Consolidated Statements of Stockholders&#8217; Equity 
For the Six Months ended June 30, 2014 and the Year ended December 31, 2013</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-3</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Consolidated Statements of Cash Flows for the Six Months
Ended June 30, 2014 and 2013</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-4</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Notes to Consolidated Financial Statements for the Six 
Months Ended June 30, 2014 and 2013</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-5</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Report of Peterson Sullivan LLP</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-12</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Consolidated Balance Sheets as of December 31, 2013 and 
2012</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-13</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Consolidated Statements of Operations for the Years 
Ended December 31, 2013 and 2012 and the Cumulative Period from February 20, 
2013 (date of entering development stage) to December 31, 2013</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-14</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Consolidated Statements of Comprehensive Loss for the 
Years Ended December 31, 2013 and 2012 and the Cumulative Period from February 
20, 2013 (date of entering development stage) to December 31, 2013</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-15</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Consolidated Statements of Stockholders&#8217; Equity 
(Deficit) for the Years Ended December 31, 2013 and 2012</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-16</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Consolidated Statements of Cash Flows for the Years 
Ended December 31, 2013 and 2012 and the Cumulative Period from February 20, 
2013 (date of entering development stage) to December 31, 2013</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-17</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Notes to Consolidated Financial Statements for the Years
Ended December 31, 2013 and 2012</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">F-18</p>
</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid90" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="text-align: center;">&#160;51</td>
</tr>
<tr>
<td>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; text-align: center; 
margin: 0px;"></p>
<p style="text-align: center; margin: 0px;"><font style="font-size: 
10pt;"><b>RENOVACARE, INC.</b>&#160;</font></p>
<p style="text-align: center; margin: 0px;"><font style="font-size: 10pt;"><b>(A
Development Stage Company)</b>&#160;</font></p>
<p style="text-align: center; margin: 0px;"><font style="font-size: 
10pt;"><b>CONSOLIDATED BALANCE SHEETS</b>&#160;&#160;</font></p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 0px;"></p>
<table id="fffftableid90splitOne" style="width: 100%; text-align: justify; font:
10pt TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="text-indent: 30px;" valign="bottom" align="left"></td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>June 30,</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>December 31,</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td style="text-indent: 30px;" valign="bottom" align="left"></td>
<td valign="bottom" align="left"></td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="2" align="right"><b>2014</b></td>
<td valign="bottom" align="left"></td>
<td valign="bottom" align="left"></td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" 
align="right"><strong></strong>
<p style="text-align: center; margin: 0pt;"><b>2013</b></p>
</td>
<td valign="bottom" align="left"></td>
</tr>
<tr height="15">
<td style="text-indent: 30px;" valign="bottom" align="left"></td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="center">&#160;(unaudited)</td>
<td align="left"></td>
<td align="left"></td>
<td valign="bottom" colspan="2" align="center"><b>&#160;</b></td>
<td align="left"></td>
</tr>
<tr height="15">
<td valign="bottom" align="left">
<p style="margin: 0px;"><b>ASSETS</b></p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" align="right"></td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" align="right">&#160;</td>
<td width="1%">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">
<p style="margin: 0px;"><b>Current assets</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" style="text-indent: 30px;" valign="bottom" align="right"></td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="padding-left: 0px; margin: 0px; text-indent: 30px;">Cash and cash 
equivalents</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="1%" align="right">
<p style="margin: 0pt;">1,168,093</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">1,508,843</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Prepaid expenses</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">24,337</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,230</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Other receivables</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,600</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">-</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total current assets</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,194,030</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,510,073</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" style="text-indent: 30px;" valign="bottom" align="right"></td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Note receivable from Duke Mountain</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">80,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">80,000</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Intangible assets</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">162,854</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">162,854</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total assets</b></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,436,884</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom"></td>
<td style="border-bottom: black 0pt solid;"></td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,752,927</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" style="text-indent: 30px;" valign="bottom" align="right"></td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;"><b>LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" style="text-indent: 30px;" valign="bottom" align="right"></td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Current liabilities</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" style="text-indent: 30px;" valign="bottom" align="right"></td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Accounts payable and accrued
liabilities</p>
</td>
<td></td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">74,222</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">11,222</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Accrued expenses - related 
parties</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">52,191</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">44,219</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total current liabilities</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">126,413</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">55,441</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" style="text-indent: 30px;" valign="bottom" align="right"></td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;"><b>STOCKHOLDERS' EQUITY</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" style="text-indent: 30px;" valign="bottom" align="right"></td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;">Preferred stock: 
$0.0001 par value: Authorized: 10,000,000 shares</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" style="text-indent: 30px;" valign="bottom" align="right"></td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Issued and outstanding: nil</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="padding-left: 0px; margin: 0px; text-indent: 0px;">Common stock: 
$0.00001 par value: Authorized: 500,000,000</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" style="text-indent: 30px;" valign="bottom" align="right">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td>&#160;</td>
</tr>
<tr style="background-color: white;" height="15">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Issued and outstanding: 66,575,122 
shares</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">666</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">666</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Additional paid-in capital</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">7,435,300</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">7,220,612</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Accumulated deficit</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(6,125,495</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">)&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(5,523,792</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">)</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total stockholders&#8217; equity 
</b></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,310,471</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,697,486</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total liabilities and 
stockholders&#8217; equity</b></p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,436,884</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,752,927</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; text-align: center; 
margin: 0px;">(The accompanying notes are an integral part of these consolidated
financial statements)</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid92" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-1</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b>RENOVACARE, INC.</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>CONSOLIDATED STATEMENTS OF 
OPERATIONS</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>(unaudited)</b></p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid93" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" colspan="6">
<p style="margin: 0px;" align="center"><b>For the Three Months Ended June 
30,</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" colspan="6">
<p style="margin: 0px;" align="center"><b>For the Six Months Ended June 
30,</b></p>
</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" colspan="2">
<p style="margin: 0px;" align="center"><b>2014</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" colspan="2">
<p style="margin: 0px;" align="center"><b>2013</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" colspan="2">
<p style="margin: 0px;" align="center"><b>2014</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" colspan="2">
<p style="margin: 0px;" align="center"><b>2013</b></p>
</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td valign="bottom">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Revenue</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Expenses</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px; text-indent: 30px;">General and administrative 
expenses</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">333,682</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">83,358</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">601,703</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">144,230</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Total operating expenses</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">333,682</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">83,358</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">601,703</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">144,230</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;"><b>Net loss from continuing 
operations</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(333,682</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(83,358</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(601,703</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(144,230</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Discontinued operations</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Gain on disposal of oil and gas 
properties</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">49,338</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;"><b>Gain (Loss) on discontinued 
operations</b></p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">49,338</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Net loss </b></p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">(333,682</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">(83,358</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">(601,703</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">(94,892</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;"><b>Earnings per share - basic and diluted</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Loss per common share continuing 
operations</p>
</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(0.01</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(0.00</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(0.01</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(0.00</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Income (loss) per common share 
discontinued operations</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">0.00</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">0.00</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">0.00</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">0.00</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Loss per common share</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(0.01</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(0.00</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(0.01</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(0.00</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Weighted average shares 
outstanding</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">66,575,122</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">63,075,122</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">66,575,122</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">63,075,122</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center">(The accompanying notes are an integral 
part of these consolidated financial statements)</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid94" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-2</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b>RENOVACARE, INC.</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>CONSOLIDATED STATEMENTS OF 
STOCKHOLDERS&#8217; EQUITY</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>For the six months ended June 30, 2014
and the year ended December 31, 2013</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>(unaudited)</b></p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid95" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="top">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="6">
<p style="margin: 0px;" align="center"><b>Common Stock</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Additionalpaid-in</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Accumulated</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Accumulated other 
comprehensive</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom" colspan="2">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td valign="top">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Shares</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Amount</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>capital</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Deficit</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>(loss) </b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Total </b></p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Balance, December 31, 2012</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="8%">
<p style="margin: 0px;" align="right">63,075,122</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="8%">
<p style="margin: 0px;" align="right">631</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="8%">
<p style="margin: 0px;" align="right">5,462,236</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="8%">
<p style="margin: 0px;" align="right">(4,491,004</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">)</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="8%">
<p style="margin: 0px;" align="right">(4,104</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">)</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="8%">
<p style="margin: 0px;" align="right">967,759</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Stock based compensation -Series A Warrant</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">237,971</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">237,971</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Stock based compensation - options</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">15,440</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">15,440</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Issuance of Units</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">3,500,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">35</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">1,504,965</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">1,505,000</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Reclassification adjustment on disposal of 
subsidiary</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">4,104</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">4,104</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Net loss December 31, 2013</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(1,032,788)</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(1,032,788</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Balance, December 31, 2013</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">66,575,122</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">666</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">7,220,612</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(5,523,792</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">1,697,486</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Stock based compensation - Series A Warrant</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">195,333</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">195,333</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Stock based compensation &#8211; options</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">19,355</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">19,355</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Net loss, June 30, 2014</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(601,703</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(601,703</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Balance, June 30, 2014</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">66,575,122</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">666</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">7,435,300</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">(6,125,495</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">1,310,471</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center">(The accompanying notes are an integral 
part of these consolidated financial statements)</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid96" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-3</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b>RENOVACARE, INC.</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>CONSOLIDATED STATEMENTS OF CASH 
FLOWS</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>(unaudited)</b></p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid97" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="6">
<p style="margin: 0px;" align="center"><b>For the Six Months Ended<br >June 
30,</b></p>
</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>2014</b></p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>2013</b></p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom">
<p style="margin: 0px;"><b>Cash flows from operating activities:</b></p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="9%">&#160;</td>
<td width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Net loss</p>
</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(601,703</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(94,892</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Adjustments to reconcile net loss to net cash flows from
operating activities:</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Stock based compensation expense</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">19,355</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">829</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Stock based consulting expense</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">195,333</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Gain on disposal of oil and gas 
properties</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(49,338</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Changes in operating assets and liabilities:</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Decrease (increase) in 
receivables</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(1,600</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">800</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Decrease (increase) in prepaid 
expenses</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(23,107</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">7,562</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">(Decrease) increase in accounts 
payable and accrued expenses</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">70,972</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">10,615</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Net cash flows from operating 
activities</b></p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(340,750</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(124,424</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Cash flows from investing activities:</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Proceeds from disposal of oil and gas properties</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">3,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Net cash flows from investing 
activities</b></p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">3,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Change in cash and cash equivalents</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(340,750</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(121,424</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Cash and cash equivalents, beginning of period</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom">
<p style="margin: 0px;" align="right">1,508,843</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom">
<p style="margin: 0px;" align="right">513,595</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Cash and cash equivalents</b>, end of period</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">1,168,093</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">392,171</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center">(The accompanying notes are an integral 
part of these consolidated financial statements)</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid98" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-4</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b>RENOVACARE, INC.</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>NOTES TO CONSOLIDATED FINANCIAL 
STATEMENTS</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>1. Organization, Nature and Continuance of 
Operations</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">RenovaCare, Inc., together with its wholly owned 
subsidiary (the &#8220;Company&#8221;), focuses on the acquisition, research, 
development and, if warranted, commercialization of autologous (using a 
patient&#8217;s own cells) cellular therapies that can be used for medical and 
aesthetic applications. The Company was previously involved in the exploration 
and development of both mineral exploration properties and oil and gas 
properties.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On July 12, 2013, the Company, together with its wholly 
owned subsidiary, RenovaCare Sciences Corp. (&#8220;RenovaCare Sciences&#8221;),
a Nevada corporation formerly known as Janus Acquisition Corp., entered into an 
asset purchase agreement with Dr. J&#246;rg Gerlach, MD, PhD, pursuant to which 
RenovaCare Sciences purchased all of Dr. Gerlach&#8217;s rights, title and 
interest to a treatment methodology for skin isolation, spraying and associated 
equipment for the regeneration of human skin cells (the &#8220;Cell Deposition 
Device&#8221;), along with the associated US and foreign patents and patent 
applications. The development of the Cell Deposition Device is in the early 
stages and the Company anticipates that significant time and financial resources
will be required to further develop the technology and determine whether a 
commercially viable product can be developed.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company has recently incurred net operating losses 
and operating cash flow deficits. As of June 30, 2014, the Company&#8217;s total
accumulated deficit is $6.1 million. The Company does not currently generate 
revenues and will continue to incur losses from operations and operating cash 
flow deficits in the future. Management believes that the Company&#8217;s cash 
and cash equivalent balances, anticipated cash flows from operations and other 
external sources of capital will be sufficient to meet the Company&#8217;s cash 
requirements through December 31, 2014. The future of the Company after December
2014 will depend in large part on its ability to successfully raise capital from
external sources to fund operations.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>2. Significant Accounting Policies</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Basis of Presentation and Principles of 
Accounting</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The interim consolidated financial statements included 
herein have been prepared by the Company, without audit, in accordance with the 
rules and regulations of the Securities and Exchange Commission 
(&#8220;SEC&#8221;) pursuant to Part 210 of Regulation S-X. Certain information 
and footnote disclosures normally included in financial statements prepared in 
accordance with accounting principles generally accepted in the United States of
America (&#8220;GAAP&#8221;) have been condensed or omitted pursuant to such SEC
rules and regulations, although the Company believes that the disclosures 
included are adequate to make the information presented not misleading.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">In management&#8217;s opinion, the unaudited 
consolidated financial statements contained herein reflect all adjustments, 
consisting solely of normal recurring items, which are necessary for the fair 
presentation of the Company&#8217;s financial position, results of operations, 
and cash flows on a basis consistent with that of the Company&#8217;s prior 
audited consolidated financial statements. The Company has evaluated information
about subsequent events that became available to us through the date the 
financial statements were issued. This information relates to events, 
transactions or changes in circumstances that would require us to adjust the 
amounts reported in the financial statements or to disclose information about 
those events, transactions or changes in circumstances. However, the results of 
operations for interim periods may not be indicative of results to be expected 
for the full fiscal year. Therefore, these financial statements should be read 
in conjunction with the Company&#8217;s audited financial statements, including 
the notes thereto for the year ended December 31, 2013, which may be found under
the Company&#8217;s profile on EDGAR.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Principles of Consolidation</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">These consolidated financial statements have been 
prepared in accordance with US GAAP and include the accounts of the Company and 
its wholly owned subsidiary, RenovaCare Sciences. All significant intercompany 
transactions and balances have been eliminated. RenovaCare Sciences was 
incorporated under the laws of the State of Nevada on June 12, 2013.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid99" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-5</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><i>Applicable Accounting Guidance</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Any reference in these notes to applicable accounting
guidance is meant to refer to the authoritative non-governmental US GAAP as 
found in the Financial Accounting Standards Board&#8217;s Accounting Standards 
Codification.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">In June 2014, the Financial Accounting Standards Board 
(&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 
2014-10, Development Stage Entities (Topic 915): Elimination of Certain 
Financial Reporting Requirements. ASU 2014-10 eliminates the distinction of a 
development stage entity and certain related disclosure requirements, including 
the elimination of inception-to-date information on the statements of 
operations, cash flows and stockholders&#8217; equity. The amendments in ASU 
2014-10 will be effective prospectively for annual reporting periods beginning 
after December 15, 2014, and interim periods within those annual periods, 
however early adoption is permitted. The Company adopted ASU 2014-10 during the 
quarter ended June 30, 2014, thereby no longer presenting or disclosing any 
information required by Topic 915.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">In May 2014, the FASB issued ASU 2014-09, Revenue from 
Contracts with Customers (Topic 606), which supersedes the revenue recognition 
requirements in Accounting Standards Codification (&#8220;ASC&#8221;) 605, 
Revenue Recognition. The new revenue recognition standard requires entities to 
recognize revenue in a way that depicts the transfer of promised goods or 
services to customers in an amount that reflects the consideration to which the 
entity expects to be entitled to in exchange for those goods or services. ASU 
2014-09 is effective for interim and annual reporting periods beginning after 
December 15, 2016 and is to be applied retrospectively. The Company does not 
currently have any revenue. As such, ASU 2014-09 will not have any effect on the
Company&#8217;s results of operations and financial position. If the Company 
begins generating revenue prior to the effective date of ASU 2014-09, it will 
evaluate the effect that ASU 2014-09 will have on its results of operations and 
financial position.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Accounting Estimates</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The preparation of consolidated financial statements in 
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the 
reported amounts of assets and liabilities and the reported amounts of revenues 
and expenses during the reporting period. Actual results, as determined by 
future events, may differ from these estimates.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Cash and Cash Equivalents</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company considers all highly liquid instruments 
purchased with an original maturity of three months or less to be cash 
equivalents. Cash and cash equivalents may at times exceed federally insured 
limits.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Note Receivable from Duke Mountain</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The note receivable from Duke Mountain Resources, Inc. 
(&#8220;Duke&#8221;) is unsecured, bears interest at 4.0% and principal and 
interest are due on December 31, 2015. The Company&#8217;s credit risk 
assessment is limited due to the related party nature of the arrangement.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Fair Value of Financial Instruments</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The carrying amounts for cash and cash equivalents and 
payables approximate fair value based on observable quoted prices for active 
markets &#8211; Level 1 inputs. The carrying amount of the note receivable from 
Duke approximates fair value based on similar market inputs for interest rates 
for a specific creditor &#8211; Level 2 inputs.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Research and Development Costs</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company intends to outsource its research and 
development efforts and expense related costs as incurred, including the cost of
manufacturing product for testing, licensing fees and costs associated with 
planning and conducting clinical trials. The value ascribed to patents and other
intellectual property acquired will be capitalized as it relates to particular 
research and development projects that may have alternative future uses.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid100" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-6</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><i>Intangible Assets</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The intangible asset consists primarily of Cell 
Deposition Device technology that the Company acquired during 2013 and is 
recorded at cost. At the time of acquisition the technology had not reached 
technological feasibility. The amount capitalized is accounted for as an 
indefinite-lived intangible asset, subject to impairment testing until 
completion or abandonment. Upon successful completion, a determination will be 
made as to the then useful life of the intangible asset, generally determined by
the period in which substantially all of the cash flows are expected to be 
generated, and begin amortization. The Company tests the intangible asset for 
impairment at least annually or more frequently if impairment indicators exist 
after performing a qualitative analysis. Management has multiple criteria that 
it considers when performing the qualitative analysis. The results of this 
review are then weighed and prioritized. If the totality of the relevant events 
and circumstances indicate that it is not more likely than not that the fair 
value of the intangible asset is less than its carrying amount, additional 
impairment tests are not necessary.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company assessed the following qualitative factors 
that could affect any change in the fair value of the intangible asset: analysis
of the technology&#8217;s current phase, additional testing necessary to bring 
the technology to market, development of competing products, changes in 
projections caused by delays, changes in regulations, changes in the market for 
the technology and changes in cost projections to bring the technology to 
market. Based on a qualitative assessment, management concluded that a positive 
assertion can be made from the qualitative assessment that it is not more likely
than not that the fair value of the intangible asset is less than its carrying 
amount.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Stock Options</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company measures all stock-based compensation awards
using a fair value method on the date of grant and recognizes such expense in 
its consolidated financial statements over the requisite service period. The 
Company uses the Black-Scholes pricing model to determine the fair value of 
stock-based compensation awards on the date of grant. The Black-Scholes pricing 
model requires management to make assumptions regarding option lives, expected 
volatility, and risk free interest rates.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Income Taxes</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company recognizes income taxes on an accrual basis 
based on tax positions taken, or expected to be taken, in tax returns. A tax 
position is defined as a position in a previously filed tax return or a position
expected to be taken in future tax filing that is reflected in measuring current
or deferred income tax assets and liabilities. Tax positions are recognized only
when it is more likely than not (i.e., likelihood of greater than 50%), based on
technical merits, that the position would be sustained upon examination by 
taxing authorities. Tax positions that meet the more likely than not threshold 
are measured using a probability-weighted approach as the largest amount of tax 
benefit that is greater than 50% likely of being realized upon settlement. 
Income taxes are accounted for using an asset and liability approach that 
requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in the 
Company&#8217;s financial statements or tax returns. A valuation allowance is 
established to reduce deferred tax assets if all, or some portion, of such 
assets will more than likely not be realized. Should they occur, the 
Company&#8217;s policy is to classify interest and penalties related to tax 
positions as interest expense. Since the Company&#8217;s inception, no such 
interest or penalties have been incurred. The Company did not record an income 
tax provision during the periods presented due to net taxable losses.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Discontinued Operations</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The results of the Company&#8217;s oil and gas and 
mineral assets are being reported as discontinued operations as a result of the 
sale of the oil and gas properties in February 2013 and the sale of the 
Company&#8217;s subsidiary which controlled various mineral leases and claims in
December 2013. Certain amounts reported in the prior periods presented have been
reclassified to conform to the current period financial statement presentation. 
These reclassifications have no effect on previously reported net income 
(loss).</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid101" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-7</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><i>Earnings (Loss) Per Share</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company presents both basic and diluted earnings per
share (&#8220;EPS&#8221;) amounts. Basic EPS is calculated by dividing net 
income (loss) by the weighted average number of common shares outstanding during
the period presented. Diluted EPS amounts are based upon the weighted average 
number of common and common equivalent shares outstanding during the period 
presented. Potentially dilutive shares of common stock consisted of warrants to 
purchase shares of common stock (8,200,000 shares as of June 30, 2014 and 
December 31, 2013) and options to purchase shares of common stock (135,000 
shares as of June 30, 2014 and 80,000 as of December 31, 2013). During the 
periods presented, potentially dilutive shares of common stock were not included
in the computation of dilutive loss per share as to do so would be anti-
dilutive.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Related Party Transactions</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">A related party is generally defined as (i) any person 
who holds 10% or more of the Company&#8217;s securities and their immediate 
families; (ii) the Company&#8217;s management; (iii) someone who directly or 
indirectly controls, is controlled by or is under common control with the 
Company; or (iv) anyone who can significantly influence the financial and 
operating decisions of the Company. A transaction is considered to be a related 
party transaction when there is a transfer of resources or obligations between 
related parties. See &#8220;Note 6. Related Party Transactions,&#8221; for 
further discussion.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Comprehensive Income (Loss)</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company has no items of other comprehensive income 
in any period presented.&#160; Therefore, net loss equals comprehensive 
loss.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>3. Intangible Assets &#8211; Intellectual 
Property</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On July 12, 2013, the Company, together with its wholly 
owned subsidiary, RenovaCare Sciences, entered into an asset purchase agreement 
with Dr. J&#246;rg Gerlach, MD, PhD, pursuant to which RenovaCare Sciences 
purchased all of Dr. Gerlach&#8217;s rights, title and interest in the Cell 
Deposition Device. The Company plans to further the development of the Cell 
Deposition Device, if commercially viable, bring the product to market. Pursuant
to the terms of the Asset Purchase Agreement, upon the closing of the 
transaction, the Company paid Dr. Gerlach $100,002 and issued to Dr. Gerlach a 
Series A Stock Purchase Warrant (the &#8220;Series A Warrant&#8221;) entitling 
him to purchase 1,200,000 shares (each a &#8220;Warrant Share&#8221;) of the 
Company&#8217;s common stock, subject to vesting milestones through July 11, 
2019, at an exercise price of $0.35 per share. Acquisition related costs 
amounted to $52,852 and were capitalized together with the cash payment. 
Additional costs capitalized during 2013, and which related to a wound cap 
technology, amounted to $10,000. No additional costs were capitalized during 
2014. At June 30, 2014, intangible assets amounted to $162,854.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Series A Warrant was issued in exchange for services
to be rendered in the future by Dr. Gerlach. An additional agreed upon cash sum 
amounting to $300,000 will be paid to Dr. Gerlach upon the Company attaining 
certain milestones related to the Regeneration Technology. The value of the 
Series A Warrant will be recognized as consulting expenses to the Company over 
the vesting term of the underlying warrant, subject to Dr. Gerlach providing 
ongoing consulting services to the Company with respect to the Regeneration 
Technology. As such, the measurement date for accounting purposes will be the 
date on which performance by Dr. Gerlach is completed. The fair value of each 
Warrant Share is estimated at the end of each reporting period during which Dr. 
Gerlach renders services using the Black-Scholes option pricing model. The fair
value of each Warrant Share was approximately $0.79 as of June 30, 2014. 
Assumptions required for the Black-Scholes model are as follows:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid101" style="width: 85%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15" bgcolor="#cceeff">
<td valign="bottom" align="left">
<p style="margin: 0px;">Weighted average risk-free interest rate</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">
<p style="margin: 0px;">1.62</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0px;">%</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom" align="left">
<p style="margin: 0px;">Expected life in years</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="left">
<p style="text-align: right; margin: 0px;" align="center">5.00 Years</p>
</td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Weighted Avg Expected Volatility</p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0px;">90.9</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">%</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Expected dividend yield</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;">0</p>
</td>
<td valign="bottom">
<p style="margin: 0cm 0cm 0pt;">%</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;">Consulting expense associated with the Series A Warrant 
amounted to $68,500 and $195,333 during the three and six months ended June 30, 
2014.</p>
<p style="margin: 0px;">&#160;&#160;</p>
<table id="tableid103" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-8</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>4. Common Stock Option</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Approval of the 2013 Long-Term Incentive Plan</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On June 20, 2013, the Board of Directors (the 
&#8220;Board&#8221;) adopted, subject to receiving shareholder approval, the 
2013 Long-Term Incentive Plan (the &#8220;Incentive Plan&#8221;). The Incentive 
Plan provides for the issuance of stock options of up to 20,000,000 shares 
(subject to adjustment) of the Company&#8217;s common stock to officers, 
directors, key employees and consultants of the Company. Options granted to 
employees under the Incentive Plan, including directors and officers who are 
employees, may be incentive stock options or non-qualified stock options; 
options granted to others under the Incentive Plan are limited to non-qualified 
stock options. On November 15, 2013, shareholders owning a majority of the 
Company&#8217;s issued and outstanding shares approved the Incentive Plan.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Incentive Plan is administered by the Board or a 
committee designated by the Board. Subject to the provisions of the Incentive 
Plan, the Board has the authority to determine the officers, employees and 
consultants to whom options will be granted, the number of shares covered by 
each option, vesting rights and the terms and conditions of each option that is 
granted to them; however, no person may be granted in any of the Company&#8217;s
fiscal year, options to purchase more than 2,000,000 shares under the Incentive 
Plan, and the aggregate fair market value (determined at the time the option is 
granted) of the shares with respect to which incentive stock options are 
exercisable for the first time by an optionee during any calendar year cannot 
exceed $100,000. Options granted pursuant to the Incentive Plan are exercisable 
no later than ten years after the date of grant.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The exercise price per share of common stock for options
granted under the Incentive Plan will be the fair market value of the 
Company&#8217;s common stock on the date of grant, using the closing price of 
the Company&#8217;s common stock on the last trading day prior to the date of 
grant, except for incentive stock options granted to a holder of ten percent or 
more of the Company&#8217;s common stock, for whom the exercise price per share 
will not be less than 110% of the fair market value. No option can be granted 
under the Incentive Plan after June 20, 2023.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">As of June 30, 2014, there were 19,865,000 shares 
available for grant.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Stock Option Activity</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On August 1, 2013, the Company granted to each of 
Messrs. Kirkland and Sierchio 20,000 stock options. The exercise price per share
is $0.65; 10,000 options vested on the grant date and, subject to continued 
service as a member of the Company&#8217;s Board, the remaining 10,000 options 
will vest on August 1, 2014 and may be exercised on a &#8220;cashless 
basis&#8221; using the formula contained therein.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Effective December 1, 2013, the Company appointed Mr. 
Bold as its President &amp; CEO and entered into an at-will consulting agreement
(the &#8220;Consulting Agreement&#8221;) with Mr. Bold. Pursuant to the terms of
the Consulting Agreement, Mr. Bold was issued a stock option to purchase up to 
40,000 shares of the Company&#8217;s common stock (the &#8220;Option 
Shares&#8221;) at a price of $0.75 per share the closing price of the 
Company&#8217;s common stock as quoted on the OTCQB on November 29, 2013. The 
Options Shares may be exercised on a &#8220;cashless basis&#8221; using the 
formula contained therein and, subject to Mr. Bold&#8217;s continued service as 
the Company&#8217;s President and Chief Executive Officer, the Options Shares 
vest as follows, 20,000 on: (a) December 1, 2014; and (b) December 1, 2015.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On April 1, 2014, the Company appointed Ms. Patsy 
Trisler as its Vice President &#8211; Clinical &amp; Regulatory Affairs and 
entered into an at-will consulting agreement (the &#8220;Trisler Consulting 
Agreement&#8221;) with Ms. Trisler. Pursuant to the terms of the Trisler 
Consulting Agreement, Ms. Trisler was issued Option Shares to purchase up to 
50,000 shares of the Company&#8217;s common stock at a price of $1.05 per share,
the closing price of the Company&#8217;s common stock as quoted on the OTCQB on 
April 1, 2014. The Options Shares may be exercised on a &#8220;cashless 
basis&#8221; using the formula contained therein and, subject to Ms. 
Trisler&#8217;s continued service as the Company&#8217;s Vice President &#8211; 
Clinical &amp; Regulatory Affairs, the Options Shares vest as follows, 10,000 
on: (a) April 1, 2015; (b) April 1, 2016; (c) April 1, 2017; (d) April 1, 2018; 
and (e) April 1, 2019.</p>
<p style="margin: 0px;">&#160;&#160;&#160;</p>
<p style="margin: 0px;">On April 20, 2014, the Company appointed Andrew 
Danielson as its Director of Business Development and issued Mr. Danielson 
Option Shares to purchase 5,000 shares of the Company&#8217;s common stock at a 
price of $1.05 per share, the closing price of the Company&#8217;s common stock 
as quoted on the OTCQB on April 17, 2014. The Options Shares may be exercised on
a &#8220;cashless basis&#8221; using the formula contained therein and, subject 
to Mr. Danielson&#8217;s continued service with the Company. The Options Shares 
vest on April 20, 2015.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid104" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-9</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;">The following table summarizes stock option activity for
the period ended June 30, 2014.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid105" style="width: 85%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15">
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Options</b></p>
<p style="margin: 0px;" align="center"><strong>Outstanding</strong></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Weighted</b></p>
<p style="margin: 0px;" align="center"><strong>Average</strong></p>
<p style="margin: 0px;" align="center"><strong>Exercise<br >Price</strong></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Weighted</b></p>
<p style="margin: 0px;" align="center"><strong>Average</strong></p>
<p style="margin: 0px;" align="center"><strong>Remaining</strong></p>
<p style="margin: 0px;" align="center"><strong>Contractual</strong></p>
<p style="margin: 0px;" align="center"><strong>Life (Years)</strong></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>Aggregate</b></p>
<p style="margin: 0px;" align="center"><strong>Intrinsic</strong></p>
<p style="margin: 0px;" align="center"><strong>Value</strong></p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Balance January 1, 2014</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="9%">
<p style="margin: 0px;" align="right">80,000</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="9%">
<p style="margin: 0px;" align="right">0.70</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="9%">
<p style="margin: 0px;" align="right">9.13</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="9%">
<p style="margin: 0px;" align="right">20,000</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Options granted</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">55,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">$</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">1.05</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">9.75</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">0</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Balance June 30, 2014</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">135,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">0.84</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">9.38</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">14,850</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Exercisable at June 30, 2014</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">20,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">0.70</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">9.13</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">5,000</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The fair value of each stock option is estimated at the 
date of grant using the Black-Scholes option pricing model. The weighted-average
fair value of stock options granted during 2013 was approximately $0.49 to $0.57
per share. The weighted average fair value of stock options granted during 2014 
was $1.05 per share. Assumptions regarding volatility, expected term, dividend 
yield and risk-free interest rate are required for the Black-Scholes model. The 
volatility assumption is based on the Company&#8217;s historical experience. The
risk-free interest rate is based on a U.S. treasury note with a maturity similar
to the option award&#8217;s expected life. The expected life represents the 
average period of time that options granted are expected to be outstanding. The 
assumptions for volatility, expected life, dividend yield and risk-free interest
rate are presented in the table below:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid105" style="width: 85%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15" bgcolor="#cceeff">
<td valign="bottom" align="left">
<p style="margin: 0px;">Weighted average risk-free interest rate</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="left">
<p style="text-align: right; margin: 0px;" align="center">1.43 &#8211; 1.62</p>
</td>
<td align="left">%</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom" align="left">
<p style="margin: 0px;">Expected life in years</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="left">
<p style="text-align: right; margin: 0px;" align="center">4.50 &#8211; 5.50</p>
</td>
<td align="left"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom" align="left">
<p style="margin: 0px;">Weighted Avg. Expected Volatility</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="left">
<p style="text-align: right; margin: 0px;" align="center">99.5%&#160;&#8211; 
105.3</p>
</td>
<td align="left">%</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Expected dividend yield</p>
</td>
<td width="1%">&#160;</td>
<td width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0px;">0</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0cm 0cm 0pt;">%</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;">During the three and six months ended June 30, 2014, 
stock-based compensation expense of $12,573 and $19,355, respectively, was 
recognized as general and administrative expenses. There were 20,000 stock 
options vested and 115,000 unvested, as of June 30, 2014. As of June 30, 2014, 
the Company had $55,387 of total unrecognized compensation cost related to 
unvested stock options, which is expected to be recognized by April 1, 2019.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company issues new shares when options are 
exercised.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>5. Commitments</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On August 1, 2013, the Company engaged Vector to assist 
the Company with identifying subject matter experts in the medical device and 
biotechnology industries and to assist the Company with its ongoing research, 
development and eventual commercialization of its Regeneration Technology 
(collectively, the &#8220;Services&#8221;). In consideration of the Services, 
the Company will pay Vector a monthly consulting fee of $5,000. The consulting 
agreement with Vector continues until December 31, 2014, unless earlier
terminated by either party upon 5 days prior written notice.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">In connection with the Company&#8217;s anticipated 
Section 510(k) submission of its proprietary Cell Deposition Device to the Food 
and Drug Administration, the Company has engaged StemCell System GmbH 
(&#8220;StemCell Systems&#8221;) to provide it with prototypes and related 
documents. The Company received a purchase order from StemCell Systems in the 
amount of $130,000, for which $65,000 was paid in the three months ended June 
30, 2014. The remaining payments are due prior to December 31, 2014, the exact 
timing of which is dependent on when the work is performed.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">See also &#8220;Note 6. Related Party 
Transactions.&#8221;</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid107" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-10</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><b>6. Related Party Transactions</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">As compensation for their service on the Board, Dr. 
Kirkland and Mr. Sierchio will receive an annual retainer of $6,000, payable in 
equal yearly installments in arrears and prorated for any partial years of 
service. Additionally, subject to their entering into a non-statutory stock 
option agreement with us, Dr. Kirkland and Mr. Sierchio were each issued 
incentive stock options to purchase up to 20,000 shares of the Company&#8217;s 
common stock at an exercise price of $0.65 per share, the closing price of the 
Company&#8217;s common stock as quoted on the OTC Markets Group Inc. QB tier 
(the &#8220;OTCQB&#8221;) on July 31, 2013, pursuant to the Incentive Plan. 
Subject to their continued service as a member of the Board, 10,000 of the 
option shares vest immediately and 10,000 of the option shares vest on the first
anniversary of date of grant.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Effective September 30, 2013, Ms. Rosen resigned as 
President and Chief Executive Officer and the Company entered into an At-Will 
Executive Services Agreement (the &#8220;Rosen Services Agreement&#8221;), 
pursuant to which Ms. Rosen will serve as the Company&#8217;s Chief Financial 
Officer. Pursuant to the Rosen Services Agreement, Ms. Rosen will provide the 
Company with services consistent with that of a Chief Financial Officer on a 
part-time basis, for which she will be paid a monthly fee of $2,400 and will be 
reimbursed for any business related expenses. The Rosen Services Agreement is 
terminable by either the Company or Ms. Rosen upon advance written notice.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On November 29, 2013, the Company entered into a 
subscription agreement with Kalen Capital Corporation (the
&#8220;Investor&#8221;), a private Alberta corporation wholly owned by Mr. 
Harmel S. Rayat and a majority shareholder of the Company&#8217;s, pursuant to 
which the Investor purchased 3,500,000 Units at a purchase price of $0.43 per 
Unit, for an aggregate purchase amount of $1,505,000. Each Unit consists of: (a)
one share of common stock; (b) one Series B Warrant exercisable for one share of
Common Stock at an exercise price of $0.43 per share if exercised within the 
first eighteen months or $0.46 per share if exercised after the first eighteen 
months and prior to expiration on November 29, 2018; and (c) one Series C 
Warrant exercisable for one share of common stock at an exercise price of $0.43 
per share if exercised within the first eighteen months or $0.49 per share if 
exercised after the first eighteen months and prior to expiration on November 
29, 2018. Each of the Series B Warrant and Series C Warrant contains a provision
allowing the holder to exercise the respective warrant on a cashless basis as 
further set forth therein. The Unit price of $0.43 represents a 30% discount to 
the 20 day average closing price of the Common Stock as quoted on the OTCQB as 
of October 31, 2013, the last trading date prior to us entering into a non-
binding term sheet with the Investor regarding the purchase of the Units.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On December 1, 2013, the Company appointed Mr. Bold as 
its President &amp; CEO and entered into the Consulting Agreement with Mr. Bold.
Pursuant to the terms of the Consulting Agreement, Mr. Bold is expected to serve
on a part-time basis and will receive an annual fee of $50,000, payable in 12 
equal installments, which is prorated for any partial months during the term of 
the Consulting Agreement. In addition to Mr. Bold&#8217;s fee, he was issued 
Option Shares to purchase up to 40,000 shares of the Company&#8217;s common 
stock at a price of $0.75 per share the closing price of the Company&#8217;s 
common stock as quoted on the OTCQB on November 29, 2013. The Options Shares may
be exercised on a cashless basis using the formula contained therein and, 
subject to Mr. Bold&#8217;s continued service as the Company&#8217;s President 
and Chief Executive Officer, vest as follows, 20,000 Options Shares on: (a) 
December 1, 2014; and (b) December 1, 2015.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On December 31, 2013, the Company completed the sale of 
100% of the issued and outstanding shares of Fostung Resources to Duke for a 
promissory note in the amount of $80,000, which amount approximated the fair 
value of the leases and mining claims controlled by Fostung Resources, as 
concluded by an independent third-party geological consultant. Principal and 
interest at 4.0% are payable on December 31, 2015. Mr. Herdev S. Rayat, the 
majority shareholder of Duke, is the brother of Mr. Harmel S. Rayat, the 
Company&#8217;s majority shareholder.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On April 1, 2014, the Company appointed Ms. Patsy 
Trisler as its Vice President &#8211; Clinical &amp; Regulatory Affairs and 
entered into the Trisler Consulting Agreement with Ms. Trisler. Pursuant to the 
terms of the Trisler Consulting Agreement, Ms. Trisler will receive a monthly 
fee of $5,000, which covers her services for up to 40 hours in any given month 
and will pay her an hourly fee of $125 for every hour in excess of forty, 
prorated for any partial hour. The Consulting Agreement may be terminated at any
time by either Ms. Trisler or the Company. In addition to Ms. Trisler&#8217;s 
fee, she was issued Option Shares to purchase up to 50,000 shares of the 
Company&#8217;s common stock at a price of $1.05 per share, the closing price of
the Company&#8217;s common stock as quoted on the OTCQB on March 31, 2014. The 
Options Shares may be exercised on a &#8220;cashless basis&#8221; using the 
formula contained therein and, subject to Ms. Trisler&#8217;s continued service 
as the Company&#8217;s Vice President &#8211; Clinical &amp; Regulatory Affairs,
vest as follows, 10,000 Options Shares on: (a) April 1, 2015; (b) April 1, 2016;
(c) April 1, 2017; (d) April 1, 2018; and (e) April 1, 2019.</p>
<p style="margin: 0px;">&#160;&#160;&#160;</p>
<p style="margin: 0px;">On April 20, 2014, the Company appointed Andrew 
Danielson as its Director of Business Development at an annual salary of 
$60,000. In addition Mr. Danielson was issued Option Shares to purchase 5,000 
shares of the Company&#8217;s common stock at a price of $1.05 per share, the 
closing price of the Company&#8217;s common stock as quoted on the OTCQB on 
April 17, 2014. The Options Shares may be exercised on a &#8220;cashless
basis&#8221; using the formula contained therein and, subject to Mr. 
Danielson&#8217;s continued service with the Company. The Options Shares vest on
April 20, 2015.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">For the three months ended June 30, 2014, 
directors&#8217; and management fees, consulting fees and reimbursement of 
expenses paid to officers and directors of the Company were $3,000 (2013: $0). 
For the&#160;six months ended June 30, 2014, directors&#8217; and management 
fees, consulting fees and reimbursement of expenses paid to officers and 
directors of the Company was $6,000 (2013: $0). Legal fees paid to one of the 
Company&#8217;s directors in the three months ended June 30, 2014 were $27,820 
(2013: $38,974). Legal fees paid to one of the Company&#8217;s directors in 
the&#160;six months ended June 30, 2014 were $82,185 (2013: $62,439). Amounts 
included in accounts payable and accrued expenses, and due to related parties, 
at June 30, 2014 were $36,080 (2013: $4,800).</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>7. Subsequent Events</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">There were no subsequent events to disclose as of the 
issue date of this report.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid108" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-11</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b><u style="line-height: 1;">REPORT OF 
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">To the Board of Directors&#160;</p>
<p style="margin: 0px;">RenovaCare, Inc.&#160;</p>
<p style="margin: 0px;">New York, New York</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">We have audited the accompanying consolidated balance 
sheets of RenovaCare, Inc. and Subsidiaries (a development stage company) 
(&#8220;the Company&#8221;) as of December 31, 2013 and 2012, and the related 
consolidated statements of operations, comprehensive income (loss), 
stockholders' equity, and cash flows for the years then ended and for the period
from February 20, 2013 (the date of entering the development stage) to December 
31, 2013. These consolidated financial statements are the responsibility of the 
Company's management. Our responsibility is to express an opinion on these 
consolidated financial statements based on our audits.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">We conducted our audits in accordance with the standards
of the Public Company Accounting Oversight Board (United States). Those 
standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material 
misstatement. The Company has determined that it is not required to have, nor 
were we engaged to perform, an audit of its internal control over financial 
reporting. Our audits included consideration of internal control over financial 
reporting as a basis for designing audit procedures that are appropriate in the 
circumstances, but not for the purpose of expressing an opinion on the 
effectiveness of the Company&#8217;s internal control over financial reporting. 
Accordingly, we express no such opinion. An audit includes examining, on a test 
basis, evidence supporting the amounts and disclosures in the financial 
statements. An audit also includes assessing the accounting principles used and 
significant estimates made by management, as well as evaluating the overall 
financial statement presentation. We believe that our audits provide a 
reasonable basis for our opinion.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">In our opinion, the consolidated financial statements 
referred to above present fairly, in all material respects, the financial 
position of RenovaCare, Inc. and Subsidiaries (a development stage company) as 
of December 31, 2013 and 2012, and the results of their operations and their 
cash flows for the years then ended and for the period from February 20, 2013 
(the date of entering the development stage) to December 31, 2013, in conformity
with accounting principles generally accepted in the United States.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><u style="line-height: 1;">/s/ PETERSON SULLIVAN 
LLP</u>&#160;</p>
<p style="margin: 0px;">Seattle, Washington&#160;</p>
<p style="margin: 0px;">March 28, 2014</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid109" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-12</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; text-align: center; 
margin: 0px;"></p>
<p style="text-align: center; margin: 0px;"><b>RENOVACARE, INC.</b>&#160;</p>
<p style="text-align: center; margin: 0px;"><b>(A Development Stage 
Company)</b>&#160;</p>
<p style="text-align: center; margin: 0px;"><b>CONSOLIDATED BALANCE 
SHEETS</b>&#160;</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 0px;"></p>
<table id="fftableid109splitOne" style="width: 100%; text-align: justify; font: 
10pt TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>December 31</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>December 31,</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td style="text-indent: 30px;" valign="bottom"></td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" 
align="right">
<p style="text-align: center; margin: 0pt;"><b>2013</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" 
align="right">
<p style="text-align: center; margin: 0pt;"><b>2012</b></p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom">
<p style="margin: 0px;"><b>ASSETS</b></p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" align="right">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" align="right">&#160;</td>
<td width="1%">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom">
<p style="margin: 0px;"><b>Current assets</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Cash and cash equivalents</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,508,843</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">513,595</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Prepaid expenses</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,230</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">7,562</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Current assets of discontinued 
operations</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">-</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">800</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total current assets</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">1,510,073</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">521,957</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Note receivable from Duke Mountain</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">80,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Long-term assets of discontinued operations</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">543,877</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Intangible Assets</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">162,854</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">-</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total assets</b></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,752,927</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,065,834</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr style="background-color: white;" height="15">
<td valign="bottom">
<p style="margin: 0px;"><b>LIABILITIES AND STOCKHOLDERS&#8217; EQUITY </b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;"><b>Current liabilities</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Accounts payable and accrued 
liabilities</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">11,221</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">17,973</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Accrued expenses - related 
parties</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">44,219</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">9,638</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Current liabilities of discontinued 
operations</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">-</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">12,932</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total current liabilities</b></p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">55,440</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">40,543</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Long-term liabilities of discontinued
operations</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">-</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">57,532</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total liabilities</b></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">55,440</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">98,075</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;"><b>STOCKHOLDERS' EQUITY</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Preferred stock: $0.0001 par value: Authorized: 
10,000,000 shares,</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Issued and outstanding: nil</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Common stock: $0.00001 par value: Authorized: 
500,000,000 and 200,000,000 shares, respectively</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td>&#160;</td>
</tr>
<tr style="background-color: white;" height="15">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Issued and outstanding: 66,575,122 
shares (2012: 63,075,122)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">666</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">631</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Additional paid-in capital</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">7,220,612</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">5,462,236</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Accumulated deficit</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(4,455,482</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(4,491,004</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Accumulated deficit since development stage</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(1,068,310</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Accumulated other comprehensive loss</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(4,104</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total stockholders&#8217; equity 
</b></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,697,486</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">967,759</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Total liabilities and 
stockholders&#8217; equity</b></p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,752,927</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,065,834</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<p style="text-align: center; margin: 0px;">(The accompanying notes are an 
integral part of these consolidated financial statements)</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid111" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-13</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="text-align: center; margin: 0px;">&#160;</p>
<p style="text-align: center; margin: 0px;">&#160;<b>RENOVACARE, INC.<br 
></b><b>(A Development Stage Company)<br ></b><b>CONSOLIDATED STATEMENTS OF 
OPERATIONS</b>&#160;&#160;</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<table id="fftableid112" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="bottom" align="left"></td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="6"
align="center"><b>For the Year Ended<br >December 31,</b><b></b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><strong>From February 
20, 2013 (Date of Entering Development Stage)</strong><strong>&#160;to<br 
>December 31, </strong></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>2013</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>2012</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>2013</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Revenue</b></p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Expenses</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="top">
<p style="margin: 0px; text-indent: 30px;">General and administrative 
expenses</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">628,545</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">229,539</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">614,729</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Total operating expenses</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">628,545</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;"
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">229,539</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">614,729</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Net loss from continuing 
operations</b></p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(628,545</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(229,539</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(614,729</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Discontinued operations</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom">
<p style="margin: 0px;">Income/(loss) from discontinued operations</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(14,420</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom">
<p style="margin: 0px;">Gain on disposal of assets (oil and gas)</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">49,338</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Loss on disposal of subsidiary (Fostung)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(453,581</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">-</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(453,581</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 90px;"><b>Loss on discontinued 
operations</b></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(404,243</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(14,420</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(453,581</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;"><b>Net loss </b></p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(1,032,788</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(243,959</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(1,068,310</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Earnings per share - basic and diluted</b></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom">
<p style="margin: 0px;">Loss per common share continuing operations</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(0.01</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left"></td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(0.00</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom">
<p style="margin: 0px;">Loss per common share discontinued operations</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1pt solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(0.01</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1pt solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(0.00</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Loss per common share</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(0.02</p>
</td>
<td style="padding-bottom: 2px;" valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(0.00</p>
</td>
<td style="padding-bottom: 2px;" valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="bottom"></td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="bottom">
<p style="margin: 0px;">Weighted average shares outstanding</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">63,401,149</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">63,075,122</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<p style="margin: 0px;" align="center">(The accompanying notes are an integral 
part of these consolidated financial statements)</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid113" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-14</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: center; margin: 0px;"><b>RENOVACARE, INC.<br 
></b><strong>(A Development Stage Company)</strong><br ><b>CONSOLIDATED 
STATEMENTS OF COMPREHENSIVE LOSS</b></p>
<p style="text-align: center; margin: 0px;"><b></b>&#160;</p>
<table id="fftableid115" style="width: 100%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td style="text-indent: 30px;" valign="top" align="left">
<p style="margin: 0px;">&#160;</p>
</td>
<td align="left">&#160;</td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="9" align="left"><b>For the Year Ended<br >December 
31,</b><b></b><b></b><b></b><b></b><b></b><b></b><b></b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>From February 20, 
2013 (Date of Entering Development Stage) to<br >December 31, </b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td style="text-indent: 30px;" valign="top">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
width="1%" colspan="3" align="right">
<p style="margin: 0pt;"><b>2013</b></p>
</td>
<td style="text-align: center;" valign="bottom" width="1%">&#160;</td>
<td style="text-align: center;" valign="bottom" width="1%">&#160;</td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
width="1%" colspan="4" align="right">
<p style="margin: 0pt;"><b>2012</b></p>
</td>
<td style="text-align: center;" valign="bottom" width="1%">&#160;</td>
<td style="text-align: center;" valign="bottom" width="1%">&#160;</td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
width="1%" colspan="2" align="right">
<p style="margin: 0pt;"><b>2013</b></p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15">
<td style="text-indent: 30px;" valign="top">
<p style="margin: 0px;"></p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" colspan="2" align="right">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" colspan="3" align="right">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Net loss</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" colspan="2" align="right">
<p style="margin: 0pt;">(1,032,788</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" colspan="3" align="right">
<p style="margin: 0pt;">(243,959</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(1,068,310</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Other comprehensive loss</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" colspan="3" align="right">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="top">
<p style="margin: 0px; text-indent: 30px;">Reclassification adjustment on 
disposal of subsidiary</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="right">
<p style="margin: 0pt;">4,104</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="3"
align="right">
<p style="margin: 0pt;">-</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">4,104</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Total comprehensive loss</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" colspan="2" align="right">
<p style="margin: 0pt;">(1,028,684</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" colspan="3" align="right">
<p style="margin: 0pt;">(243,959</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(1,064,206</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;</p>
<p style="text-align: center; margin: 0px;">(The accompanying notes are an 
integral part of these consolidated financial statements)</p>
<p style="text-align: center; margin: 0px;">&#160;</p>
<table id="tableid115" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-15</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="text-align: center; margin: 0px;"><b></b>&#160;</p>
<p style="text-align: center; margin: 0px;"><b>RENOVACARE, INC.</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>(A Development Stage 
Company)</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>CONSOLIDATED STATEMENTS OF 
STOCKHOLDERS' EQUITY (DEFICIT)</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>For the years ended December 31, 2012 
and 2013</b></p>
<p style="margin: 0px;" align="center"><b></b>&#160;</p>
<table id="tableid116" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="bottom"></td>
<td valign="bottom"></td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="6" align="center"><b>Common Stock</b></td>
<td style="text-align: center;" valign="bottom"></td>
<td style="text-align: center;" valign="bottom"></td>
<td valign="bottom" colspan="2" align="center">
<p style="margin: 0cm 0cm 0pt;"><b>Additional<br ></b><b>paid-in</b></p>
</td>
<td style="text-align: center;" valign="bottom"></td>
<td style="text-align: center;" valign="bottom"></td>
<td valign="bottom" colspan="2" align="center"><b>Accumulated</b></td>
<td style="text-align: center;" valign="bottom"></td>
<td style="text-align: center;" valign="bottom"></td>
<td valign="bottom" colspan="2" align="center"><b>From February 20, 2013 (Date 
of Entering Development Stage) Accumulated</b></td>
<td style="text-align: center;" valign="bottom"></td>
<td style="text-align: center;" valign="bottom"></td>
<td valign="bottom" colspan="2" align="center"><b>Accumulated other 
comprehensive</b></td>
<td style="text-align: center;" valign="bottom"></td>
<td style="text-align: center;" valign="bottom"></td>
<td valign="bottom" colspan="2" align="center"><b></b></td>
<td valign="bottom"></td>
</tr>
<tr height="15">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="2" align="center"><b>Shares</b></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="2" align="center"><b>Amount</b></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="2" align="center"><b>capital</b></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="2" align="center"><b>deficit</b></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="2" align="center"><b>deficit</b></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="2" align="center"><b>(loss)</b></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="text-align: center;" valign="bottom"><font style="font-size: 
10pt;">&#160;</font></td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="2" align="center"><b>Total</b></td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="7%">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="7%">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="7%">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="7%">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="7%">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="7%">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom" width="7%">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
<td valign="bottom" width="1%"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">Balance, December 31, 2011</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">63,075,122</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">631</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">5,462,236</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">(4,247,045</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">)</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">(4,104</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">)</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">1,211,718</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-align: left;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">Net loss</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">(243,959</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0pt;">)</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">(243,959</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-align: left;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">Balance, December 31, 2012</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">63,075,122</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">631</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">5,462,236</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">(4,491,004</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">)</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">(4,104</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">)</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">967,759</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-align: left;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">Stock based compensation - Series A Warrant</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">237,971</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">237,971</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-align: left;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">Stock based compensation - options</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">15,440</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">15,440</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom"></td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">&#160;</p>
</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">Issuance of Units</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">3,500,000</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">35</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">1,504,965</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">1,505,000</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-align: left;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">Reclassification adjustment on disposal of 
subsidiary</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">4,104</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" align="right">
<p style="margin: 0pt;" align="right">4,104</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-align: left;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">Net income (loss)</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">35,522</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">(1,068,310</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0pt;">)</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">(1,032,788</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-align: left;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-align: left;" valign="bottom">
<p style="margin: 0px;">Balance, December 31, 2013</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">66,575,122</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">666</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">7,220,612</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td class="para" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;" align="right">(4,455,482</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom" align="left">
<p style="margin: 0pt;" align="right">)</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td class="para" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;" align="right">(1,068,310</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom" align="left">
<p style="margin: 0pt;" align="right">)</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">-</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="right">
<p style="margin: 0pt;" align="right">1,697,486</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; text-align: center; 
margin: 0px;">&#160;</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; text-align: center; 
margin: 0px;">(The accompanying notes are an integral part of these consolidated
financial statements)</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; text-align: center; 
margin: 0px;">&#160;</p>
<table id="tableid117" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-16</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b>RENOVACARE, INC.</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>CONSOLIDATED STATEMENTS OF CASH 
FLOWS</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>(A Development Stage Company)</b></p>
<p style="margin: 0px;" align="center"><b></b>&#160;</p>
<table id="tableid118" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="6">
<p style="margin: 0px;" align="center"><b>For the Year Ended</b></p>
<p style="margin: 0px;" align="center"><b>December 31,</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="3">
<p style="margin: 0px;" align="center"><b>From</b></p>
<p style="margin: 0px;" align="center"><b>February 20,</b></p>
<p style="margin: 0px;" align="center"><b>2013</b></p>
<p style="margin: 0px;" align="center"><b>(Date of Entering</b></p>
<p style="margin: 0px;" align="center"><b>Development Stage) to </b></p>
<p style="margin: 0px;" align="center"><b>December 31, </b></p>
</td>
</tr>
<tr height="15">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>2013</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><b>2012</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid; text-align: center;" valign="bottom" 
colspan="3">&#160;<strong>2013</strong></td>
</tr>
<tr height="15">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="2">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="2">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="3">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom">
<p style="margin: 0px;"><b>Cash flows from operating activities:</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="2">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="2">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom" colspan="3">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Net loss</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="9%">
<p style="margin: 0px;" align="right">(1,032,788</p>
</td>
<td valign="bottom" width="1%">)</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="9%">
<p style="margin: 0px;" align="right">(243,959</p>
</td>
<td valign="bottom" width="1%">)</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom" width="9%">
<p style="margin: 0px;" align="right">(1,068,310</p>
</td>
<td valign="bottom" width="1%">
<p style="text-align: left; margin: 0px;" align="right">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Adjustments to reconcile net loss to net cash flows from
operating activities:</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Stock based compensation expense</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">15,440</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">15,440</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Stock based consulting expense</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">237,971</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">237,971</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Impairment and depreciation</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">1,527</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Accretion of asset retirement 
obligation</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">2,216</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Gain on disposal of oil and gas 
properties</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(49,338</p>
</td>
<td valign="bottom">)</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Loss on disposal of subsidiary</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">453,581</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">453,581</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Changes in operating assets and liabilities:</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Decrease (increase) in 
receivables</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">800</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">13,714</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">3,801</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Decrease (increase) in prepaid 
expenses</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">6,332</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(7,562</p>
</td>
<td valign="bottom">)</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">3,815</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">(Decrease) increase in accounts 
payable and accrued expenses</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">18,104</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(33,150</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">)</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">20,256</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Net cash flows from operating activities</b></p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(349,898</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">)</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(267,214</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">)</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(333,447</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="text-align: left; margin: 0px;" align="right">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Cash flows from investing activities:</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Acquisition of oil and gas 
properties</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(6,962</p>
</td>
<td valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Proceeds from disposal of oil and gas
properties</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">3,000</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Acquisition of intellectual 
property</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(162,854</p>
</td>
<td valign="bottom">)</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(162,854</p>
</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="text-align: left; margin: 0px;" align="right">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Net cash flows from investing activities</b></p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(159,854</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">)</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(6,962</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;">)</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(162,854</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Cash flows from financing activities:</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Sale of common stock and warrants</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">1,505,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">1,505,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Net cash flows from financing activities</b></p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">1,505,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">1,505,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Change in cash and cash equivalents</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">995,248</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">(274,176</p>
</td>
<td valign="bottom">)</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">1,008,699</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Cash and cash equivalents, beginning 
of period</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">513,595</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">787,771</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">500,144</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Cash and cash equivalents</b>, end of period</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">1,508,843</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">513,595</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">1,508,843</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;"><b>Supplemental disclosure of cash flow 
information:</b></p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Non-cash investing and financing 
activities</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 60px;">Note received on disposal of 
subsidiary</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">80,000</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center">(The accompanying notes are an integral 
part of these consolidated financial statements)</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid119" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-17</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b>RENOVACARE, INC.</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>NOTES TO CONSOLIDATED FINANCIAL 
STATEMENTS</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>1. Organization, Nature and Continuance of 
Operations</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">RenovaCare, Inc., together with its wholly owned 
subsidiary (the &#8220;Company&#8221;), focuses on the acquisition, research, 
development and, if warranted, commercialization of autologous (using a 
patient&#8217;s own cells) cellular therapies that can be used for medical and 
aesthetic applications. The Company was previously involved in the exploration 
and development of both mineral exploration properties and oil and gas 
properties. The Company sold its oil and gas properties on February 18 and 19, 
2013 and sold its subsidiary which controlled various mineral leases and mining 
claims on December 31, 2013. Effective February 20, 2013, the Company became a 
development stage company.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On July 12, 2013, the Company, together with its wholly 
owned subsidiary, RenovaCare Sciences Corp. (&#8220;RenovaCare Sciences&#8221;),
a Nevada corporation formerly known as Janus Acquisition Corp., entered into an 
asset purchase agreement with Dr. J&#246;rg Gerlach, MD, PhD, pursuant to which 
RenovaCare Sciences purchased all of Dr. Gerlach&#8217;s rights, title and 
interest to a treatment methodology for skin isolation , spraying and associated
equipment for the regeneration of human skin cells (the &#8220;Cell Deposition 
Device&#8221;), along with the associated US and foreign patents and patent 
applications. The development of the Cell Deposition Device is in the early 
stages and we anticipate that significant time and financial resources will be 
required to further develop the technology and determine whether a commercially 
viable product can be developed.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On December 31, 2013, we entered into a stock purchase 
agreement with Duke Mountain Resources, Inc. (&#8220;Duke&#8221;), a Nevada 
corporation, pursuant to which we sold to Duke 100% of the issued and 
outstanding shares of Fostung Resources Ltd. (&#8220;Fostung Resources&#8221;), 
a corporation organized under the laws of Ontario, Canada and a wholly owned 
subsidiary of ours, for a promissory note in the amount of $80,000, which amount
approximated the fair value of the leases and mining claims controlled by 
Fostung Resources, as concluded by an independent third-party geological 
consultant.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company has recently incurred net operating losses 
and operating cash flow deficits. The Company&#8217;s total accumulated deficit 
is $5.5 million as of December 31, 2013. The Company does not currently generate
revenues and will continue to incur losses from operations and operating cash 
flow deficits in the future. Management believes that the Company&#8217;s cash 
and cash equivalent balances, anticipated cash flows from operations and other 
external sources of capital will be sufficient to meet our cash requirements 
through December 31, 2014. The future of the Company after December 2014 will 
depend in large part on its ability to successfully raise capital from external 
sources to fund operations.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>2. Significant Accounting Policies</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Basis of Presentation and Principles of 
Accounting</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">As the Company is devoting substantially all of its 
efforts to establishing a new business, and while planned principal operations 
have commenced, there has been no revenue generated from sales, license fees or 
royalties, and as such, the Company is considered a development stage company. 
Accordingly, the Company&#8217;s consolidated financial statements are presented
in accordance with authoritative accounting guidance related to a development 
stage enterprise.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Principles of Consolidation</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">These consolidated financial statements have been 
prepared in accordance with US GAAP and include the accounts of the Company and 
its wholly owned subsidiary, RenovaCare Sciences. All significant intercompany 
transactions and balances have been eliminated. RenovaCare Sciences was 
incorporated under the laws of the State of Nevada on June 12, 2013.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Applicable Accounting Guidance</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Any reference in these notes to applicable accounting 
guidance is meant to refer to the authoritative non-governmental US GAAP as 
found in the Financial Accounting Standards Board&#8217;s Accounting Standards 
Codification.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid120" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-18</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><i>Accounting Estimates</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The preparation of consolidated financial statements in 
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the 
reported amounts of assets and liabilities and the reported amounts of revenues 
and expenses during the reporting period. Actual results, as determined by 
future events, may differ from these estimates.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Cash and Cash Equivalents</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company considers all highly liquid instruments 
purchased with an original maturity of three months or less to be cash 
equivalents. Cash and cash equivalents may at times exceed federally insured 
limits.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Note Receivable from Duke Mountain</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The note receivable from Duke Mountain is unsecured, 
bears interest at 4.0%, and principal and interest are due on December 31, 2015.
The Company&#8217;s credit risk assessment is limited due to the related party 
nature of the arrangement.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Fair Value of Financial Instruments</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The carrying amounts for cash and cash equivalents, and 
payables approximate fair value based on observable quoted prices for inactive 
markets &#8211; Level 1 inputs. The carrying amount of the note receivable from 
Duke Mountain approximates fair value based on observable market inputs for 
interest rates &#8211; Level 2 inputs.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Research and Development Costs</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company intends to outsource its research and 
development efforts and expense related costs as incurred, including the cost of
manufacturing product for testing, licensing fees and costs associated with 
planning and conducting clinical trials. The value ascribed to patents and other
intellectual property acquired will be capitalized as it relates to particular 
research and development projects that may have alternative future uses.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Intangible Assets</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The intangible asset consists primarily of Cell 
Deposition Device technology that the Company acquired during 2013 and is 
recorded at cost. At the time of acquisition, the technology had not reached 
technological feasibility. The amount capitalized is accounted for as an 
indefinite-lived intangible asset, subject to impairment testing until 
completion or abandonment. Upon successful completion, a determination will be 
made as to the then useful life of the intangible asset, generally determined by
the period in which substantially all of the cash flows are expected to be 
generated, and begin amortization. The Company tests the intangible asset for 
impairment at least annually or more frequently if impairment indicators exist 
after performing a qualitative analysis. Management has multiple criteria that 
it considers when performing the qualitative analysis. The results of this 
review are then weighed and prioritized. If the totality of the relevant events 
and circumstances indicate that it is not more likely than not that the fair 
value of the intangible asset is less than its carrying amount, additional 
impairment tests are not necessary.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company assessed the following qualitative factors 
that could affect any change in the fair value of the intangible asset: analysis
of the technology&#8217;s current phase, additional testing necessary to bring
the technology to market, development of competing products, changes in 
projections caused by delays, changes in regulations, changes in the market for 
the technology and changes in cost projections to bring the technology to 
market. Based on a qualitative assessment, management concluded that a positive 
assertion can be made from the qualitative assessment that it is not more likely
than not that the fair value of the intangible asset is less than its carrying 
amount.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid121" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-19</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><i>Stock Options</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company measures all stock-based compensation awards
using a fair value method on the date of grant and recognizes such expense in 
its consolidated financial statements over the requisite service period. The 
Company uses the Black-Scholes pricing model to determine the fair value of 
stock-based compensation awards on the date of grant. The Black-Scholes pricing 
model requires management to make assumptions regarding option lives, expected 
volatility, and risk free interest rates.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Income Taxes</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company recognizes income taxes on an accrual basis 
based on tax positions taken, or expected to be taken, in tax returns. A tax 
position is defined as a position in a previously filed tax return or a position
expected to be taken in future tax filing that is reflected in measuring current
or deferred income tax assets and liabilities. Tax positions are recognized only
when it is more likely than not (i.e., likelihood of greater than 50%), based on
technical merits, that the position would be sustained upon examination by 
taxing authorities. Tax positions that meet the more likely than not threshold 
are measured using a probability-weighted approach as the largest amount of tax 
benefit that is greater than 50% likely of being realized upon settlement. 
Income taxes are accounted for using an asset and liability approach that 
requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of events that have been recognized in our financial 
statements or tax returns. A valuation allowance is established to reduce 
deferred tax assets if all, or some portion, of such assets will more than 
likely not be realized. No provision for income taxes was recorded during the 
periods presented because the Company had a net taxable loss. Should they occur,
our policy is to classify interest and penalties related to tax positions as 
interest expense. Since our inception, no such interest or penalties have been 
incurred.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Discontinued Operations</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The assets and financial results of the Company&#8217;s 
oil and gas and mineral assets are being reported as discontinued operations as 
a result of the sale of the oil and gas properties in February 2013 and the sale
of the Company&#8217;s subsidiary which controlled various mineral leases and 
claims in December 2013. Certain amounts reported in the prior periods presented
have been reclassified to conform to the current period financial statement 
presentation. These reclassifications have no effect on previously reported net 
income (loss). See &#8220;Note 3. Discontinued Operations&#8221; for a summary 
of the amounts reclassified for the periods presented herein.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Earnings (Loss) Per Share</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company presents both basic and diluted earnings per
share (&#8220;EPS&#8221;) amounts. Basic EPS is calculated by dividing net 
income (loss) by the weighted average number of common shares outstanding during
the period presented. Diluted EPS amounts are based upon the weighted average 
number of common and common equivalent shares outstanding during the period 
presented. Potentially dilutive shares of common stock consisted of warrants to 
purchase shares of common stock (8,200,000 shares for 2013 and nil shares for 
2012) and options to purchase shares of common stock (80,000 shares for 2013 and
nil shares for 2012). During the periods presented, potentially dilutive shares 
of common stock were not included in the computation of dilutive loss per share 
as to do so would be anti-dilutive.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Comprehensive Income (Loss)</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Comprehensive loss is comprised of net loss,and a 
reclassification on disposal of subsidiary for the periods presented.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Related Party Transactions</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">A related party is generally defined as (i) any person 
who holds 10% or more of the Company&#8217;s securities and their immediate 
families; (ii) the Company&#8217;s management; (iii) someone who directly or 
indirectly controls, is controlled by or is under common control with the 
Company; or (iv) anyone who can significantly influence the financial and 
operating decisions of the Company. A transaction is considered to be a related 
party transaction when there is a transfer of resources or obligations between 
related parties. See &#8220;Note 7. Related Party Transactions,&#8221; for 
further discussion.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid122" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-20</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><b>3. Discontinued Operations</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On February 18, 2013, we completed the sale of our 
working interest in the Onnie Ray #1, Haile #1, Pearce #1 and Stahl #1 oil 
wells. We entered into an Assignment Agreement with Leexus Oil LLC, the wells 
operator, whereby the Company assigned its right, title and interest in the oil,
gas and mineral leases and the oil and gas wells. Consideration for the 
assignment was the assumption of all outstanding liabilities and assumption of 
all future payments for any and all work performed on the wells.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On February 19, 2013, we completed the sale of our 
working interest in the Cooke #6 well. We entered into an Assignment Agreement 
with Millennium Petro-Physics, the well operator, whereby we assigned the right,
title and interest in the oil, gas and mineral leases and the oil and gas wells.
Consideration for the assignment was $3,000 cash.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The carrying amount of the oil and gas properties was 
$24,127 on the date of disposal. The related asset retirement obligation 
amounted to $57,532 and liabilities assumed amounted to $12,932. Including the 
$3,000 cash received, the Company recognized a gain of $49,338 in the year ended
December 31, 2013, as a result of the disposal.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On December 31, 2013, we entered into a stock purchase 
agreement with Duke, pursuant to which we sold to Duke 100% of the issued and 
outstanding shares of Fostung Resources, a wholly owned subsidiary of ours, for 
a promissory note in the amount of $80,000, which amount approximated the fair 
value of the leases and mining claims controlled by Fostung Resources, as 
concluded by an independent third-party geological consultant. Principal and 
interest at 4.0% are payable on December 31, 2015. Including the $80,000 of 
consideration received, the Company recognized a loss on the disposal of the 
subsidiary of $453,581.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company&#8217;s revenue reported in discontinued 
operations for the years ended December 31, 2013 and December 31, 2012 were $nil
and $16,549, respectively. The Company&#8217;s net loss reported in discontinued
operations for the years ended December 31, 2013 and December 31, 2012 was 
$(404,243) and $(14,420), respectively. The Company has not recognized any 
revenue nor incurred expenses with respect to its previously owned oil and gas 
and mineral assets since their respective sales, and will not recognize any 
continuing cash flows with respect to these properties in the future.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Assets and liabilities of discontinued operations in the
accompanying balance sheets consist of the following:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid122" style="width: 85%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto; border: 0px;" cellspacing="0" cellpadding="0" 
align="center" border="0">
<tr height="15">
<td valign="top" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" colspan="2"
align="center"><b>December 31,<br >2012</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="top" align="left">
<p style="margin: 0px;"><strong>Assets:</strong></p>
</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="text-indent: 30px;" valign="top">
<p style="margin: 0px;">Oil and Gas Properties, net</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">24,127</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="top">
<p style="margin: 0px;">Mining properties</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">519,750</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="top">
<p style="margin: 0px;">Other current assets</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">800</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="top"></td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">544,677</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;"><strong>Liabilities</strong></p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="text-indent: 30px;" valign="top">
<p style="margin: 0px;">Accounts payable</p>
</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" valign="bottom" align="right">
<p style="margin: 0pt;">(12,932</p>
</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="top">
<p style="margin: 0px;">Asset retirement obligation</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(57,532</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="top"></td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" class="para" style="border-bottom: black 3px double;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(70,464</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>4. Intangible Assets &#8211; Intellectual 
Property</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On July 12, 2013, the Company, together with its wholly 
owned subsidiary, RenovaCare Sciences, entered into an asset purchase agreement 
with Dr. J&#246;rg Gerlach, MD, PhD, pursuant to which RenovaCare Sciences 
purchased all of Dr. Gerlach&#8217;s rights, title and interest in the Cell 
Deposition Device. The Company plans to further the development of the Cell 
Deposition Device, if commercially viable, bring the product to market. Pursuant
to the terms of the Asset Purchase Agreement, upon the closing of the 
transaction, the Company paid Dr. Gerlach $100,002 and issued to Dr. Gerlach a 
Series A Stock Purchase Warrant (the &#8220;Series A Warrant&#8221;) entitling 
him to purchase 1,200,000 shares (each a &#8220;Warrant Share&#8221;) of the 
Company&#8217;s common stock, subject to vesting milestones through July 11, 
2019, at an exercise price of $0.35 per share. Acquisition related costs 
amounted to $52,852 and were capitalized together with the cash payment. 
Additional costs capitalized during 2013, and which related to a wound cap 
technology, amounted to $10,000. At December 31, 2013, intangible assets 
amounted to $162,854.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid124" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-21</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;">The Series A Warrant was issued in exchange for services
to be rendered in the future by Dr. Gerlach. An additional agreed upon cash sum 
amounting to $300,000 will be paid to Dr. Gerlach upon the Company attaining 
certain milestones related to the Regeneration Technology. The value of the 
Series A Warrant will be recognized as consulting expenses to the Company over 
the vesting term of the underlying warrant, subject to Dr. Gerlach providing 
ongoing consulting services to the Company with respect to the Regeneration 
Technology. As such, the measurement date for accounting purposes will be the 
date on which performance by Dr. Gerlach is completed. The fair value of each 
Warrant Share is estimated at the end of each reporting period during which Dr. 
Gerlach renders services using the Black-Scholes option pricing model. The fair 
value of each Warrant Share was approximately $0.87 as of December 31, 2013. 
Assumptions required for the Black-Scholes model are as follows:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid124" style="width: 85%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td valign="bottom" align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="center"><b>2013</b></td>
<td valign="bottom" align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Weighted average risk-free interest rate</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">1.75</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0pt;">%</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Expected life in years</p>
</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="text-align: right; margin: 0px;" align="center">5.5 Years</p>
</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Weighted Avg Expected Volatility</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">102.0</p>
</td>
<td valign="bottom">
<p style="margin: 0pt;">%</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Expected dividend yield</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Consulting expense associated with the Series A Warrant 
amounted to $237,971 during 2013.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>5. Common Stock Options</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Approval of the 2013 Long-Term Incentive Plan</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On June 20, 2013, the Board of Directors (the 
&#8220;Board&#8221;) adopted, subject to receiving shareholder approval, the 
2013 Long-Term Incentive Plan (the &#8220;Incentive Plan&#8221;). The Incentive 
Plan provides for the issuance of stock options of up to 20,000,000 shares 
(subject to adjustment) of the Company&#8217;s common stock to officers, 
directors, key employees and consultants of the Company. Options granted to 
employees under the Incentive Plan, including directors and officers who are 
employees, may be incentive stock options or non-qualified stock options; 
options granted to others under the Incentive Plan are limited to non-qualified 
stock options.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Incentive Plan is administered by the Board or a 
committee designated by the Board. Subject to the provisions of the Incentive 
Plan, the Board has the authority to determine the officers, employees and 
consultants to whom options will be granted, the number of shares covered by 
each option, vesting rights and the terms and conditions of each option that is 
granted to them; however, no person may be granted in any of the Company&#8217;s
fiscal year, options to purchase more than 2,000,000 shares under the Incentive 
Plan, and the aggregate fair market value (determined at the time the option is 
granted) of the shares with respect to which incentive stock options are 
exercisable for the first time by an optionee during any calendar year cannot 
exceed $100,000. Options granted pursuant to the Incentive Plan are exercisable
no later than ten years after the date of grant.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The exercise price per share of common stock for options
granted under the Incentive Plan will be the fair market value of the 
Company&#8217;s common stock on the date of grant, using the closing price of 
the Company&#8217;s common stock on the last trading day prior to the date of 
grant, except for incentive stock options granted to a holder of ten percent or 
more of the Company&#8217;s common stock, for whom the exercise price per share 
will not be less than 110% of the fair market value. No option can be granted 
under the Incentive Plan after June 20, 2023.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">As of December 31, 2013, there were 19,920,000 shares 
available for grant.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Stock Option Activity</i></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On August 1, 2013, the Company granted to Messrs. 
Kirkland and Sierchio (20,000 stock options each) for stock options granted on 
August 1, 2013. The exercise price per share is $0.65; 10,000 options vested on 
the grant date and, subject to continued service as a member of our Board, the 
remaining 10,000 options will vest on August 1, 2014. The Options Shares may be 
exercised on a &#8220;cashless basis&#8221; using the formula contained 
therein.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid126" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-22</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;">Effective December 1, 2013, we appointed Mr. Bold as our
President &amp; CEO and entered into an at-will consulting agreement (the 
&#8220;Consulting Agreement&#8221;) with Mr. Bold. Pursuant to the terms of the 
Consulting Agreement, Mr. Bold is expected to serve on a part-time basis and 
will receive an annual fee of $50,000, payable in 12 equal installments, which 
is prorated for any partial months during the term of the Consulting Agreement. 
In addition to Mr. Bold&#8217;s fee, he was issued a stock option to purchase up
to 40,000 shares of our common stock (the &#8220;Option Shares&#8221;) at a 
price of $0.75 per share the closing price of our common stock as quoted on the 
OTCQB on November 29, 2013. The Options Shares may be exercised on a 
&#8220;cashless basis&#8221; using the formula contained therein and, subject to
Mr. Bold&#8217;s continued service as our President and Chief Executive Officer,
vest as follows: (a) 20,000 Options Shares vest on December 1, 2014; and (b) 
20,000 Options Shares vest on December 1, 2015.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The following table summarizes stock option activity for
the year ended December 31, 2013.</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid126" style="width: 95%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>Weighted</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" 
align="center"><strong>Weighted</strong></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>Average</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b></b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" 
align="center"><strong>Average</strong></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>Remaining</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>Aggregate</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>Options</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" 
align="center"><strong>Exercise</strong></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>Contractual</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center"><b>Intrinsic</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="center"><b>Outstanding</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="center"><b>Price</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="center"><b>Life (Years)</b></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="center"><b>Value</b></td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Balance January 1, 2013</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">-</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Options granted</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">430,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.72</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">9.55</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td>
<td id="ffc" valign="bottom" align="right">&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Options forfeited</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left"></td>
<td id="ffc" class="para" style="border-bottom: black 1px solid;" 
valign="bottom" align="right">
<p style="margin: 0pt;">(350,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" valign="bottom"
align="left">
<p style="margin: 0pt;">)</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">0.72</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">9.50</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">&#160;</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Balance December 31, 2013</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">80,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">0.70</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">9.75</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">23,200</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Exercisable at December 31, 2013</p>
</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">20,000</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">0.65</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom">&#160;</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">9.50</p>
</td>
<td valign="bottom">&#160;</td>
<td>&#160;</td>
<td valign="bottom" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">6,800</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The fair value of each stock option is estimated at the 
date of grant using the Black-Scholes option pricing model. The estimated 
weighted-average fair value of stock options granted during 2013 was 
approximately $0.49 to $0.57 per share. Assumptions regarding volatility, 
expected term, dividend yield and risk-free interest rate are required for the 
Black-Scholes model. The volatility assumption is based on the Company&#8217;s 
historical experience. The risk-free interest rate is based on a U.S. treasury 
note with a maturity similar to the option award&#8217;s expected life. The 
expected life represents the average period of time that options granted are 
expected to be outstanding. The assumptions for volatility, expected life, 
dividend yield and risk-free interest rate are presented in the table below:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid127" style="width: 85%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15">
<td valign="bottom" width="75%" align="left">&#160;</td>
<td valign="bottom" align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="center"><b>2013</b></td>
<td valign="bottom" align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom" width="75%" align="left">
<p style="margin: 0px;">Weighted average risk-free interest rate</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center">1.43 &#8211; 1.49%</td>
<td align="left"></td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom" width="75%" align="left">
<p style="margin: 0px;">Expected life in years</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center">5.0 &#8211; 5.5</td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom" width="75%" align="left">
<p style="margin: 0px;">Weighted Avg Expected Volatility</p>
</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="center">99.5% - 103.4%</td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom" width="75%">
<p style="margin: 0px;">Expected dividend yield</p>
</td>
<td width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="text-align: center; margin: 0pt;">0</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">During the year ended December 31, 2013, stock-based 
compensation expense of $15,440, was recognized as general and administrative 
expenses. There were 20,000 stock options vested and 60,000 unvested, as of 
December 31, 2013. There was no stock compensation expense recognized in 2012. 
As of December 31, 2013, the Company had $27,317 of total unrecognized 
compensation cost related to unvested stock options, which is expected to be 
recognized by December 31, 2015.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company issues new shares when options are 
exercised.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>6. Commitments</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On June 27, 2012, the Company entered into an At-Will 
Executive Services Agreement (the &#8220;Bien Services Agreement&#8221;) with 
Ms. Janet Bien, pursuant to which Ms. Bien was to serve as the Company&#8217;s 
Chief Financial Officer. Pursuant to the Bien Services Agreement, Ms. Bien was 
to provide the Company with services consistent with that of a Chief Financial 
Officer on a part-time basis, for which she was to be paid a monthly fee of 
$2,400 and was to be reimbursed for any business related expenses. The Bien 
Services Agreement was terminable by either the Company or Ms. Bien upon written
notice with or without cause. The Bien Services Agreement was terminated 
effective as of September 30, 2013.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid129" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-23</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;">On February 15, 2013, the Company entered into an 
agreement with Kenneth Kirkland, Ph.D. (the &#8220;Kirkland AB Agreement&#8221;)
pursuant to which Dr. Kirkland will serve as a member of the Company&#8217;s 
Advisory Board. The Kirkland AB Agreement provides for a monthly fee of $2,000 
and may be terminated by either party with a five day notice. The Kirkland AB 
Agreement was terminated effective as of June 30, 2013.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On August 1, 2013, the Company engaged Vector to assist 
the Company with identifying subject matter experts in the medical device and 
biotechnology industries and to assist the Company with its ongoing research, 
development and eventual commercialization of its Regeneration Technology 
(collectively, the &#8220;Services&#8221;). In consideration of the Services,
the Company will pay Vector a monthly consulting fee of Five Thousand Dollars 
($5,000). The consulting agreement with Vector continues until December 31, 
2014, unless earlier terminated by either party upon five (5) days prior written
notice.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On October 1, 2013, the Company entered into an At-Will 
Executive Services Agreement (the &#8220;Rosen Services Agreement&#8221;) with 
Ms. Rhonda Rosen, pursuant to which Ms. Rosen is to serve as the Company&#8217;s
Chief Financial Officer. Pursuant to the Rosen Services Agreement, Ms. Rosen was
to provide the Company with services consistent with that of a Chief Financial 
Officer on a part-time basis, for which is to be paid a monthly fee of $2,400 
and reimbursed for any business related expenses.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Effective December 1, 2013, we appointed Mr. Bold as our
President &amp; CEO and entered into the Consulting Agreement with Mr. Bold. 
Pursuant to the terms of the Consulting Agreement, Mr. Bold is expected to serve
on a part-time basis and will receive an annual fee of $50,000, payable in 12 
equal installments, which is prorated for any partial months during the term of 
the Consulting Agreement. In addition to Mr. Bold&#8217;s fee, he was issued 
Option Shares to purchase up to 40,000 shares of our common stock at a price of 
$0.75 per share the closing price of our common stock as quoted on the OTCQB on 
November 29, 2013. The Options Shares may be exercised on a &#8220;cashless 
basis&#8221; using the formula contained therein and, subject to Mr. 
Bold&#8217;s continued service as our President and Chief Executive Officer, 
vest as follows: (a) 20,000 Options Shares vest on December 1, 2014; and (b) 
20,000 Options Shares vest on December 1, 2015.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">See also Note 7. Related Party Transactions.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>7. Related Party Transactions</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Effective as of June 19, 2012, Mr. Joseph Sierchio, a 
member of the Company&#8217;s Board, was appointed as its Acting Interim 
President and Chief Executive Officer; and effective as of June 27, 2012, Ms. 
Janet Bien was appointed as the Company&#8217;s Chief Financial Officer.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On June 20, 2013, Mr. Joseph Sierchio, resigned as the 
Acting Interim President and Chief Executive Officer and remains a director; Ms.
Rhonda B. Rosen was appointed to serve as the President and Chief Executive 
Officer and a member of the Board and entered into an employment agreement for a
two year term (the &#8220;Rosen Employment Agreement&#8221;), subject to the 
earlier termination provisions contained therein. Pursuant to the terms of the 
Rosen Employment Agreement, Ms. Rosen was paid an annual salary of $120,000. In 
addition to Ms. Rosen&#8217;s salary, she was eligible to receive a cash bonus 
to be determined by our Board, in their sole discretion. The Rosen Employment 
Agreement also provides Ms. Rosen with a monthly stipend of no more than $1,500 
to cover medical insurance premiums until such time as the Company can make 
available an alternative medical insurance plan.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On July 29, 2013, the Board appointed Dr. Kenneth 
Kirkland to serve as a member of the Board effective August 1, 2013. Prior to 
this appointment, Dr. Kirkland resigned from the Company&#8217;s Advisory Board.
See &#8220;Note 6. Commitments.&#8221;</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">As compensation for their service on the Board, Dr. 
Kirkland and Mr. Sierchio will receive an annual retainer of $6,000, payable in 
equal yearly installments in arrears and prorated for any partial years of 
service. Additionally, subject to their entering into a non-statutory stock 
option agreement with us, Dr. Kirkland and Mr. Sierchio were each issued 
incentive stock options to purchase up to 20,000 shares of our common stock at 
an exercise price of $0.65 per share, the closing price of the Company&#8217;s 
common stock as quoted on the OTC Markets Group Inc. QB tier (the 
&#8220;OTCQB&#8221;) on July 31, 2013, pursuant to the Incentive Plan. Subject 
to their continued service as a member of the Board, 10,000 of the option shares
vest immediately and 10,000 of the option shares vest on the first anniversary 
of date of grant.</p>
<p style="margin: 0px;">&#160;&#160;</p>
<table id="tableid130" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-24</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Effective September 30, 2013, Ms. Bien resigned as the 
Company&#8217;s Chief Financial Officer. Effective September 30, 2013, Ms. Rosen
resigned as President and Chief Executive Officer, the Rosen Employment 
Agreement was terminated and the Company entered into an At-Will Executive 
Services Agreement (the &#8220;Rosen Services Agreement&#8221;), pursuant to 
which Ms. Rosen will serve as the Company&#8217;s Chief Financial Officer. 
Pursuant to the Rosen Services Agreement, Ms. Rosen will provide the Company 
with services consistent with that of a Chief Financial Officer on a part-time 
basis, for which she will be paid a monthly fee of $2,400 and will be reimbursed
for any business related expenses. The Rosen Services Agreement is terminable by
either the Company or Ms. Rosen upon advance written notice. The incentive stock
options to purchase up to 350,000 shares of the Company&#8217;s common stock at 
an exercise price of $0.72 per share, previously issued to Ms. Rosen, were 
forfeited effective September 30, 2013.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Effective September 30, 2013, Mr. Sierchio resumed the 
position of Acting Interim President and Chief Executive Officer.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On November 29, 2013, we entered into a subscription 
agreement with the Investor, a private Alberta corporation wholly owned by Mr. 
Harmel Rayat and a majority shareholder of ours, pursuant to which the Investor 
purchased 3,500,000 Units at a purchase price of $0.43 per Unit, for an 
aggregate purchase amount of $1,505,000. Each Unit consists of: (a) one share of
common stock; (b) one Series B Warrant exercisable for one share of common stock
at an exercise price of $0.43 per share if exercised within the first eighteen 
months or $0.46 per share if exercised after the first eighteen months and prior
to expiration on November 29, 2018; and (c) one Series C Warrant exercisable for
one share of common stock at an exercise price of $0.43 per share if exercised 
within the first eighteen months or $0.49 per share if exercised after the first
eighteen months and prior to expiration on November 29, 2018. Each of the Series
B Warrant and Series C Warrant contains a provision allowing the holder to 
exercise the respective warrant on a cashless basis as further set forth 
therein. The Unit price of $0.43 represents a 30% discount to the 20 day average
closing price of the common stock as quoted on the OTCQB as of October 31, 2013,
the last trading date prior to us entering into a non-binding term sheet with 
the Investor regarding the purchase of the Units.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On December 1, 2013, we appointed Mr. Bold as our
President &amp; CEO and entered into the Consulting Agreement with Mr. Bold. 
Pursuant to the terms of the Consulting Agreement, Mr. Bold is expected to serve
on a part-time basis and will receive an annual fee of $50,000, payable in 12 
equal installments, which is prorated for any partial months during the term of 
the Consulting Agreement. In addition to Mr. Bold&#8217;s fee, he was issued 
Option Shares to purchase up to 40,000 shares of our common stock at a price of 
$0.75 per share the closing price of our common stock as quoted on the OTCQB on 
November 29, 2013. The Options Shares may be exercised on a &#8220;cashless 
basis&#8221; using the formula contained therein and, subject to Mr. 
Bold&#8217;s continued service as our President and Chief Executive Officer, 
vest as follows: (a) 20,000 Options Shares vest on December 1, 2014; and (b) 
20,000 Options Shares vest on December 1, 2015.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">On December 31, 2013, we completed the sale of 100% of 
the issued and outstanding shares of Fostung Resources to Duke for a promissory 
note in the amount of $80,000, which amount approximated the fair value of the 
leases and mining claims controlled by Fostung Resources, as concluded by an 
independent third-party geological consultant. Principal and interest at 4.0% 
are payable on December 31, 2015. Mr. Herdev S. Rayat, the majority shareholder 
of Duke, is the brother of Mr. Harmel S. Rayat, our majority shareholder.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">For the year ended December 31, 2013, management fees, 
consulting fees and reimbursement of expenses paid to officers and directors of 
the Company were $49,097 (2012: $43,298). Legal fees paid to one of our 
directors in 2013 were $165,591 (2012: $72,503). Amounts included in accounts 
payable and due to related parties at December 31, 2013 were $44,219 (2012: 
$9,638). The total expense recognized during 2013 for legal fees was $197,609 
(including unpaid amounts of $32,018 as of December 31, 2013).</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>8. Income Taxes</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">There is no current or deferred tax expense for 2013 and
2012, due to the Company&#8217;s loss position. Realization of the future tax 
benefits related to the deferred tax assets is dependent on many factors, 
including the Company&#8217;s ability to generate taxable income within the net 
operating loss carryforward period. Management has considered these factors in 
reaching its conclusion as to the valuation allowance for financial reporting 
purposes and has recorded a full valuation allowance against the deferred tax 
asset. The income tax effect, utilizing a 34% income tax rate, of temporary 
differences comprising the deferred tax assets and deferred tax liabilities is a
result of the following at December 31:</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid131" style="width: 85%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="2">
<p style="margin: 0px;" align="center"><strong>2013</strong></p>
</td>
<td valign="bottom"><strong>&#160;</strong></td>
<td valign="bottom"><strong>&#160;</strong></td>
<td style="border-bottom: black 1pt solid;" valign="bottom" colspan="3">
<p style="margin: 0px;" align="center"><strong>2012</strong></p>
</td>
</tr>
<tr height="15">
<td valign="bottom">
<p style="margin: 0px;">Deferred tax assets:</p>
</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="10%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="1%">&#160;</td>
<td valign="bottom" width="10%">&#160;</td>
<td valign="bottom" width="1%"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Net operating loss carryforwards</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">2,027,000</p>
</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">1,852,000</p>
</td>
<td valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px; text-indent: 30px;">Other</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">86,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">106,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">2,113,000</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">1,958,000</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td valign="bottom"></td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Valuation allowance</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(2,113,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">)</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 1px solid;" valign="bottom">
<p style="margin: 0px;" align="right">(1,958,000</p>
</td>
<td style="padding-bottom: 1px;" valign="bottom">
<p style="text-align: left; margin: 0px;" align="right">)</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="bottom">
<p style="margin: 0px;">Net deferred tax assets</p>
</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">&#160;</td>
<td valign="bottom">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;">$</p>
</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0px;" align="right">-</p>
</td>
<td style="padding-bottom: 3px;" valign="bottom">
<p style="margin: 0px;" align="right">&#160;</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<table id="tableid132" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-25</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The 2013 increase in the valuation allowance was 
$155,000 (2012: $81,000).</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">The Company has available net operating loss 
carryforwards of approximately $5,961,000 for tax purposes to offset future 
taxable income which expires commencing 2014 through to the year 2033. Pursuant 
to the Tax Reform Act of 1986, annual utilization of the Company&#8217;s net 
operating loss carryforwards may be limited if a cumulative change in ownership 
of more than 50% is deemed to occur within any three-year period. The tax years 
2010 through 2013 remain open to examination by federal agencies and other 
jurisdictions in which it operates.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">A reconciliation between the statutory federal income 
tax rate (34%) and the effective rate of income tax expense for the years ended 
December 31 follows:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid132" style="width: 85%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid; text-align: center;" 
valign="bottom" colspan="2" align="left"><strong>2013</strong></td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" colspan="2"
align="right">
<p style="text-align: center; margin: 0px;"><strong>2012</strong></p>
</td>
<td align="left">&#160;</td>
</tr>
<tr height="15">
<td valign="bottom" align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="left">&#160;</td>
<td align="left">&#160;</td>
<td align="left">&#160;</td>
<td id="ffc" valign="bottom" colspan="2" align="left">&#160;</td>
<td align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="bottom">
<p style="margin: 0px;">Statutory federal income tax rate</p>
</td>
<td width="1%">&#160;</td>
<td width="1%"></td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0px;">34</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">%</p>
</td>
<td width="1%">&#160;</td>
<td width="1%">&#160;</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0px;">34</p>
</td>
<td valign="bottom" width="1%">
<p style="margin: 0px;">%</p>
</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td style="border-bottom: black 0pt solid;" valign="bottom">
<p style="margin: 0px;">Valuation allowance</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 1px solid;">&#160;</td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0px;">(34</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">)%</td>
<td style="border-bottom: black 0pt solid;" valign="bottom"></td>
<td style="border-bottom: black 1px solid;" valign="bottom"></td>
<td id="ffc" style="border-bottom: black 1px solid;" valign="bottom" 
align="right">
<p style="margin: 0px;">(34)</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 1px;" 
valign="bottom">%</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="bottom">&#160;</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0px;">0</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;">%</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;">&#160;</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0px;">0</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;">%</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>9. Subsequent Events</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">There were no subsequent events to disclose as of the 
issue date of this report.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid134" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">F-26</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b>PART </b><b>II</b>&#160;</p>
<p style="margin: 0px;" align="center"><b>INFORMATION NOT REQUIRED IN 
PROSPECTUS</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>ITEM 13. OTHER EXPENSES OF ISSUANCE AND 
DISTRIBUTION</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Our estimated expenses in connection 
with the issuance and distribution of the securities being registered are:</p>
<p style="margin: 0px;">&#160;</p>
<table id="fftableid134" style="width: 85%; text-align: justify; font: 10pt 
TIMES NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" align="center" 
border="0">
<tr height="15" bgcolor="#cceeff">
<td valign="top" align="left">
<p style="margin: 0px;">SEC filing fee</p>
</td>
<td width="1%" align="left">&#160;</td>
<td valign="bottom" width="1%" align="left">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" width="9%" align="right">
<p style="margin: 0pt;">1,000</p>
</td>
<td valign="bottom" width="1%" align="left">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Accounting fees and expenses</p>
</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">5,000</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td valign="top">
<p style="margin: 0px;">Legal fees and expenses</p>
</td>
<td>&#160;</td>
<td valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" valign="bottom" align="right">
<p style="margin: 0pt;">23,000</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#ffffff">
<td valign="top">
<p style="margin: 0px;">Miscellaneous</p>
</td>
<td>&#160;</td>
<td style="border-bottom: black 1pt solid;" valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 1pt solid;" valign="bottom" 
align="right">
<p style="margin: 0pt;">1,000</p>
</td>
<td valign="bottom">&#160;</td>
</tr>
<tr height="15" bgcolor="#cceeff">
<td style="border-bottom: black 0pt solid;" valign="top">
<p style="margin: 0px;">Total</p>
</td>
<td style="border-bottom: black 0pt solid;">&#160;</td>
<td style="border-bottom: black 3px double;" valign="bottom">
<p style="margin: 0pt;">$</p>
</td>
<td id="ffc" style="border-bottom: black 3px double;" valign="bottom" 
align="right">
<p style="margin: 0pt;">30,000</p>
</td>
<td style="border-bottom: black 0pt solid; padding-bottom: 3px;" 
valign="bottom">&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><b>ITEM 14. INDEMNIFICATION OF OFFICERS AND 
DIRECTORS</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Section 78.7502(1) of the Nevada 
Revised Statutes (&#8220;<b>NRS</b>&#8221;) authorizes a Nevada corporation to 
indemnify any director, officer, employee, or corporate agent &#8220;who was or 
is a party or is threatened to be made a party to any threatened, pending or 
completed action, suit or proceeding, whether civil, criminal, administrative or
investigative, except an action by or in the right of the corporation&#8221; due
to his or her corporate role. Section 78.7502(1) extends this protection 
&#8220;against expenses, including attorneys&#8217; fees, judgments, fines and 
amounts paid in settlement actually and reasonably incurred by him in connection
with the action, suit or proceeding if he acted in good faith and in a manner 
which he reasonably believed to be in or not opposed to the best interests of 
the corporation, and, with respect to any criminal action or proceeding, had no 
reasonable cause to believe his conduct was unlawful.&#8221;</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Section 78.7502(2) of the NRS also 
authorizes indemnification of the reasonable defense or settlement expenses of a
corporate director, officer, employee or agent who is sued, or is threatened 
with a suit, by or in the right of the corporation. The party must have been 
acting in good faith and with the reasonable belief that his or her actions were
in or not opposed to the corporation's best interests. Unless the court rules 
that the party is reasonably entitled to indemnification, the party seeking 
indemnification must not have been found liable to the corporation.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">To the extent that a corporate 
director, officer, employee, or agent is successful on the merits or otherwise 
in defending any action or proceeding referred to in Section 78.7502(1) or 
78.7502(2), Section 78.7502(3) of the NRS requires that he be indemnified 
&#8220;against expenses, including attorneys&#8217; fees, actually and 
reasonably incurred by him in connection with the defense.&#8221;</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Unless ordered by a court or advanced
pursuant to Section 78.751(2), Section 78.751(1) of the NRS limits 
indemnification under Section 78.7502 to situations in which either (1) the 
stockholders, (2) the majority of a disinterested quorum of directors, or (3) 
independent legal counsel determine that indemnification is proper under the 
circumstances.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">Section 
78.751(2) authorizes a corporation&#8217;s articles of incorporation, bylaws or 
agreement to provide that directors&#8217; and officers&#8217; expenses incurred
in defending a civil or criminal action must be paid by the corporation as 
incurred, rather than upon final disposition of the action, upon receipt by the 
director or officer to repay the amount if a court ultimately determines that he
is not entitled to indemnification.</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">Section 
78.751(3)(a) provides that the rights to indemnification and advancement of 
expenses shall not be deemed exclusive of any other rights under any bylaw, 
agreement, stockholder vote or vote of disinterested directors. Section 
78.751(3)(b) extends the rights to indemnification and advancement of expenses 
to former directors, officers, employees and agents, as well as their heirs, 
executors, and administrators.</p>
<p style="text-align: justify; margin: 0px;">&#160;&#160;&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">Regardless of 
whether a director, officer, employee or agent has the right to indemnity, 
Section 78.752 allows the corporation to purchase and maintain insurance on his 
behalf against liability resulting from his or her corporate role.</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">Our Bylaws also 
contain broad indemnification provisions. We have entered into indemnification 
agreements with each of our directors.</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">Insofar as 
indemnification for liabilities arising under the Securities Act may be 
permitted to our directors or officers pursuant to the foregoing provisions, or 
otherwise, we have been advised that in the opinion of the Securities Exchange 
Commission, this indemnification is against public policy as expressed in the 
Securities Act, and is therefore unenforceable.</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">&#160;</p>
<p style="text-align: justify; margin: 0px; text-indent: 30px;">There is no 
pending litigation or proceeding involving any of our directors, officers, 
employees, or other agents as to which indemnification is being sought, nor are 
we aware of any pending or threatened litigation that may result in claims for 
indemnification by any director, officer, employee, or other agent.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid136" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">52</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><b>ITEM 16. EXHIBITS</b></p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid137" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="border-bottom: black 1px solid;" valign="top" width="8%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><strong>Exhibit 
No</strong><b>.</b></p>
</td>
<td valign="top" width="2%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td style="border-bottom: black 1px solid;" valign="top" width="90%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><b>Description of 
Exhibit</b></p>
</td>
</tr>
<tr>
<td valign="top" width="8%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><strong>&#160;</strong></p>
</td>
<td valign="top" width="2%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top" width="90%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;"><b>&#160;</b></p>
</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top" width="8%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">3.1</p>
</td>
<td valign="top" width="2%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top" width="90%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Articles of Incorporation, 
as amended, of the Company, incorporated by reference and included in the 
Company&#8217;s Registration Statement on Form 10-SB 12g filed on May 11, 1999, 
SEC file number 000-30156-99616992.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">3.2</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Articles of Incorporation, 
as amended, of the Company incorporated by reference and included in the 
Company&#8217;s Form 8-K filed on January 10, 2011, SEC file number 000-30156-
11520181.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">3.3</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Articles of Incorporation, 
as amended, of the Company incorporated by reference and included in the 
Company&#8217;s Form 8-K filed on January 10, 2014, SEC file number 000-30156-
14521612.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">3.4</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">By-laws of the Company 
incorporated by reference and included in the Company&#8217;s Registration 
Statement on Form 10-SB 12g filed on May 11, 1999, SEC file number 000-30156-
99616992.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">4.1&#8224;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Form of Series A Common 
Stock Purchase Warrant dated July 12, 2013, incorporated by reference and 
included in the Company&#8217;s Form 8-K filed on July 18, 2013, as amended on 
November 21, 2013 and December 27, 2013, SEC file 0156-131300357.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">4.2</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Form of Stock Purchase 
Warrant, incorporated by reference and included in the Company&#8217;s Form 8-K 
filed on December 5, 2013, SEC file number 000-30156- 131259657.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">4.3</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Registration Rights 
Agreement dated November 29, 2013, between Kalen Capital Corporation and the 
Company, incorporated by reference and included in the Company&#8217;s Form 8-K 
filed on December 5, 2013, SEC file number 000-30156- 131259657.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">5.1</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Opinion of Sierchio &amp; 
Company, LLP regarding the legality of the securities being registered.*</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.1&#167;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Employment Agreement dated 
June 20, 2013, between Rhonda B. Rosen and the Company, incorporated by 
reference and included in the Company&#8217;s Form 8-K filed on June 26, 2013, 
SEC file number 000-30156-131259657.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.2&#8224;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Asset Purchase Agreement 
dated as of June 21, 2013, between J&#246;rg Gerlach, MD, PhD and the Company, 
incorporated by reference and included in the Company&#8217;s Form 8-K filed on 
July 18, 2013, as amended on November 21, 2013 and December 27, 2013, SEC file 
number 000-30156-131300357.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.3&#167;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Form of Stock Option 
Agreement, incorporated by reference and included in the Company&#8217;s Form 8-
K filed on June 26, 2013, SEC file number 000-30156- 131259657.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.4</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Finder&#8217;s Agreement 
dated August 13, 2013, between Vector Asset Management, Inc. and the Company, 
incorporated by reference and included in the Company&#8217;s Form 10-Q filed on
August 14, 2013, SEC file number 000-30156-13109753.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.5</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">At-Will Executive Services 
Agreement dated October 1, 2013, between Rhonda B. Rosen and the Company, 
incorporated by reference and included in the Company&#8217;s Form 10-Q filed on
November 14, 2013, SEC file number 000- 30156-13129717.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.6</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Subscription Agreement for 
3,500,000 units dated November 29, 2013, between Kalen Capital Corporation and 
the Company, incorporated by reference and included in the Company&#8217;s Form 
8-K filed on December 5, 2013, SEC file number 000-30156-131259657.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.7&#167;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">At-Will Consulting Agreement
effective as of December 1, 2013, between Thomas Bold and the Company, 
incorporated by reference and included in the Company&#8217;s Form 8-K filed on 
December 5, 2013, SEC file number 000-30156- 131259657.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.8</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Stock Purchase Agreement 
dated December 31, 2013, between Duke Mountain Resources, Inc., Fostung 
Resources Ltd. and the Company, incorporated by reference and included in the 
Company&#8217;s Form 8-K filed on January 7, 2014, SEC file number 000-30156-
14513586.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.9&#167;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">At-Will Consulting Agreement
effective as of April 1, 2014, between Patsy Trisler and the Company, 
incorporated by reference and included in the Company&#8217;s Form 8-K filed on 
April 7, 2014, SEC file number 000-30156- 14838542.</p>
</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;&#160;&#160;</p>
<table id="tableid138" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">53</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid139" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr bgcolor="#cceeff">
<td valign="top" width="8%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.10&#167;</p>
</td>
<td valign="top" width="2%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top" width="90%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Stock Option Agreement dated
April 1, 2014, between Patsy J. Trisler and the Company, incorporated by 
reference and included in the Company&#8217;s Form 8-K filed on April 7, 2014, 
SEC file number 000-30156-14838542.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">10.11&#167;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Stock Option Agreements 
dated August 14, 2014, between Kenneth Kirkland, Joseph Sierchio, Rhonda B. 
Rosen and the Company, incorporated by reference and included in the 
Company&#8217;s Form 8-K filed on August 20, 2014, SEC file number 000-30156-
141054256.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">14.1</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Code of Ethics, incorporated
by reference and included in the Company&#8217;s Form 10-K file on April 15, 
2009, SEC file number 000-30156-09750383.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">23.1</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Consent of Sierchio &amp; 
Company, LLP (included in Exhibit 5.1 hereto)*</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">23.2</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Consent of Peterson Sullivan
LLP*</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">24.1</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Power of Attorney*</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">99.1&#167;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">2013 Incentive Stock Option 
Plan, incorporated by reference and included in the Company&#8217;s Form 10-Q 
filed on November 14, 2013, SEC file number 000- 30156-13129717.</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">101.INS</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">XBRL Instance Document**</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">101.SCH</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">XBRL Taxonomy Extension - 
Schema Document**</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">101.CAL</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">XBRL Taxonomy Extension - 
Calculation Linkbase Document**</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">101.DEF</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">XBRL Taxonomy Extension - 
Definition Linkbase Document**</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">101.LAB</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">XBRL Taxonomy Extension - 
Label Linkbase Document**</p>
</td>
</tr>
<tr bgcolor="#ffffff">
<td valign="top">&#160;</td>
<td valign="top"></td>
<td valign="top">&#160;</td>
</tr>
<tr bgcolor="#cceeff">
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">101.PRE</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">XBRL Taxonomy Extension - 
Presentation Linkbase Document**</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 
0px;">_________________________</p>
<table id="tableid140" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="3%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">*</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Filed herewith.</p>
</td>
</tr>
<tr>
<td valign="top">&#160;</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#8224;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Portions of this exhibit 
have been omitted pursuant to a request for confidential treatment under Rule 
24b-2 of the Securities Exchange Act of 1934, as amended, and the omitted 
material have been separately filed with the Securities and Exchange 
Commission.</p>
</td>
</tr>
<tr>
<td valign="top">&#160;</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#167;</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Indicates a management 
contract or compensatory plan or arrangement.</p>
</td>
</tr>
<tr>
<td valign="top">&#160;</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">**</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Furnished herewith. XBRL 
(eXtensible Business Reporting Language) information is furnished and not filed 
or a part of a registration statement or prospectus for purposes of Sections 11 
or 12 of the Securities Act of 1933, as amended, is deemed not filed for 
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and 
otherwise is not subject to liability under these sections.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
<table id="tableid141" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">54</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;"><b>ITEM 17. UNDERTAKINGS</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The undersigned registrant hereby 
undertakes:</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 0px;"></p>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px; text-indent: 30px;">(1) To
file, during any period in which offers or sales are being made, a post-
effective amendment to this registration statement:</p>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 0px;"></p>
<table id="tableid142" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="5%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(i)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">To include any Prospectus 
required by Section 10(a)(3) of the Securities Act;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(ii)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">To reflect in the prospectus
any facts or events arising after the effective date of the registration 
statement (or the most recent post-effective amendment thereof) which, 
individually or in the aggregate, represent a fundamental change in the 
information set forth in the registration statement. Notwithstanding the 
foregoing, any increase or decrease in volume of securities offered (if the 
total dollar value of securities offered would not exceed that which was 
registered) and any deviation from the low or high end of the estimated maximum 
offering range may be reflected in the form of prospectus filed with the 
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume 
and price represent no more than a 20% change in the maximum aggregate offering 
price set forth in the &#8220;Calculation of Registration Fee&#8221; table in 
the effective registration statement; and</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(iii)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">To include any material 
information with respect to the plan of distribution not previously disclosed in
the registration statement or any material change to such information in the 
registration statement;</p>
</td>
</tr>
</table>
<p style="font-size: 10pt; font-family: TIMES NEW ROMAN; margin: 
0px;">&#160;&#160;</p>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px; text-indent: 30px;">(2) That,
for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement 
relating to the securities offered therein, and the offering of such securities 
at that time shall be deemed to be the initial bona fide offering thereof.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">(3) To remove from registration by 
means of a post-effective amendment any of the securities being registered which
remain unsold at the termination of the offering.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;&#160;</p>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px; text-indent: 30px;">(4) That,
for the purpose of determining liability under the Securities Act to any 
purchaser, each prospectus filed pursuant to Rule 424(b) as part of a 
registration statement relating to an offering, other than registration 
statements relying on Rule 430B or other than prospectuses filed in reliance on 
Rule 430A (&#167;230.430A of this chapter), shall be deemed to be part of and 
included in the registration statement as of the date it is first used after 
effectiveness. Provided, however, that no statement made in a registration 
statement or prospectus that is part of the registration statement or made in a 
document incorporated or deemed incorporated by reference into the registration 
statement or prospectus that is part of the registration statement will, as to a
purchaser with a time of contract of sale prior to such first use, supersede or 
modify any statement that was made in the registration statement or prospectus 
that was part of the registration statement or made in any such document 
immediately prior to such date of first use.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;&#160;</p>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px; text-indent: 30px;">(5) That,
for the purpose of determining liability of the registrant under the Securities 
Act to any purchaser in the initial distribution of the securities:</p>
<p style="margin: 0px; text-indent: 30px;">&#160;&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The undersigned registrant undertakes
that in a primary offering of securities of the undersigned registrant pursuant 
to this registration statement, regardless of the underwriting method used to 
sell the securities to the purchaser, if the securities are offered or sold to 
such purchaser by means of any of the following communications, the undersigned 
registrant will be a seller to the purchaser and will be considered to offer or 
sell such securities to such purchaser:</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid143" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td valign="top" width="5%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(i)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Any preliminary prospectus 
or prospectus of the undersigned registrant relating to the offering required to
be filed pursuant to Rule 424;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(ii)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Any free writing prospectus 
relating to the offering prepared by or on behalf of the undersigned registrant 
or used or referred to by the undersigned registrant;</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(iii)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">The portion of any other 
free writing prospectus relating to the offering containing material information
about the undersigned registrant or its securities provided by or on behalf of 
the undersigned registrant; and</p>
</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;</p>
</td>
<td valign="top">&#160;</td>
</tr>
<tr>
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">(iv)</p>
</td>
<td valign="top">
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">Any other communication that
is an offer in the offering made by the undersigned registrant to the 
purchaser.</p>
</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Insofar as indemnification for 
liabilities arising under the Securities Act may be permitted to directors, 
officers and controlling persons of the registrant pursuant to the foregoing 
provisions, or otherwise, the registrant has been advised that in the opinion of
the Securities and Exchange Commission such indemnification is against public 
policy as expressed in the Act and is, therefore, unenforceable. In the event 
that a claim for indemnification against such liabilities (other than the 
payment by the registrant of expenses incurred or paid by a director, officer or
controlling person of the registrant in the successful defense of any action, 
suit or proceeding) is asserted by such director, officer or controlling person 
in connection with the securities being registered, the registrant will, unless 
in the opinion of its counsel the matter has been settled by controlling 
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Act and 
will be governed by the final adjudication of such issue.</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid144" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">55</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" >
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;" align="center"><b>SIGNATURES</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Pursuant to the requirements of the Securities Act, the 
registrant has duly caused this registration statement to be signed on its 
behalf by the undersigned, thereunto duly authorized in the City of New York, 
State of New York, on September 5, 2014.</p>
<p style="margin: 0px;">&#160;&#160;&#160;</p>
<table id="tableid145" style="width: 100%; text-align: left; font: 10pt TIMES 
NEW ROMAN;" cellspacing="0" cellpadding="0" border="0">
<tr>
<td colspan="2"><font style="font: 10pt TIMES NEW 
ROMAN;"><strong></strong><strong>RenovaCare, Inc.</strong></font><font 
style="font: 10pt TIMES NEW ROMAN;"><b></b></font></td>
<td>&#160;</td>
</tr>
<tr>
<td width="5%">&#160;</td>
<td width="35%">&#160;</td>
<td>&#160;</td>
</tr>
<tr>
<td><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;"><em>/s/ Thomas Bold</em></td>
<td>&#160;</td>
</tr>
<tr>
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Thomas Bold</font></td>
<td>&#160;</td>
</tr>
<tr>
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">President and Chief Executive 
Officer</font></td>
<td>&#160;</td>
</tr>
<tr>
<td>&#160;</td>
<td>(Principal Executive Officer, Principal Accounting Officer and Principal 
Financial Officer)</td>
<td>&#160;</td>
</tr>
</table>
<p style="font: 10pt TIMES NEW ROMAN; margin: 0px;">&#160;&#160;&#160;</p>
<table id="tableid146" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%"><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;" width="35%"><em>/s/ Rhonda B. 
Rosen</em></td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Name:Rhonda B. Rosen</font></td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Title:Chief Financial 
Officer</font></td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>&#160;</td>
<td>(Principal Accounting Officer and Principal Financial Officer)</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Pursuant to the requirements of the 
Securities Act of 1933, this registration statement has been signed below by the
following persons in the capacities and on the dates indicated.</p>
<p style="margin: 0px;">&#160;&#160;</p>
<table id="tableid147" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%"><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;" width="35%"><em>/s/ Thomas 
Bold</em></td>
<td width="10%"></td>
<td width="50%">Dated: September 5, 2014</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Thomas Bold</font></td>
<td>&#160;</td>
<td></td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">President and Chief Executive 
Officer</font></td>
<td>&#160;</td>
<td></td>
</tr>
<tr height="15">
<td>&#160;</td>
<td>(Principal Executive Officer)</td>
<td>&#160;</td>
<td></td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid148" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%"><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;" width="35%"><em>/s/ Rhonda B. 
Rosen</em></td>
<td width="10%">&#160;</td>
<td width="50%">Dated: September 5, 2014</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Rhonda B. Rosen</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Chief Financial 
Officer</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>&#160;</td>
<td>(Principal Accounting Officer and Principal Financial Officer)</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;&#160;</p>
<table id="tableid149" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%"><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;" width="35%"><em>/s/ Patsy J. 
Trisler&#160;</em></td>
<td width="10%">&#160;</td>
<td width="50%">Dated: September 5, 2014</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Patsy Trisler</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Vice President &#8211; Clinical 
&amp; Regulatory Affairs</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;&#160;</p>
<table id="tableid150" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%"><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;" width="35%"><em>/s/ Kenneth 
Kirkland</em></td>
<td width="10%">&#160;</td>
<td width="50%">Dated: September 5, 2014</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Kenneth Kirkland</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Director</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<table id="tableid151" style="width: 100%; text-align: justify; font: 10pt TIMES
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%"><font style="font: 10pt TIMES NEW ROMAN;">By</font></td>
<td style="border-bottom: black 1px solid;" width="35%"><em>/s/ Joseph 
Sierchio</em></td>
<td width="10%">&#160;</td>
<td width="50%">Dated: September 5, 2014</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Joseph Sierchio</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Director</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;&#160;</p>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: center; margin: 0px;">56</p>
<hr color="#000000" size="2" width="100%" noshade="noshade" >
<p style="margin: 0px;">&#160;</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>rcar_ex51.htm
<DESCRIPTION>OPINION OF SIERCHIO & COMPANY, LLP
<TEXT>
<html>
<head></head>
<body style="font: 10pt TIMES NEW ROMAN; text-align: justify; margin: 0px 7% 0px
7%;">
<p style="text-align: right; margin: 0px;"><b>EXHIBIT 5.1</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>[LETTERHEAD]</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">September 5, 2014</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><b>Board of Directors</b>&#160;</p>
<p style="margin: 0px;"><b>RenovaCare, Inc.</b>&#160;&#160;</p>
<p style="margin: 0px;"><b>430 Park Avenue</b>&#160;&#160;</p>
<p style="margin: 0px;"><b>Suite 702</b>&#160;&#160;</p>
<p style="margin: 0px;"><b>New York, NY 10022</b></p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid0" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%">
<p style="margin: 0px;"><b>Re:</b></p>
</td>
<td>
<p style="margin: 0px;"><b>Registration Statement on Form S-1</b></p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Gentlemen:</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We have acted as counsel to 
RenovaCare, Inc., a Nevada corporation (the &#8220;<b>Company</b>&#8221;) in 
connection with the preparation and filing with the United States Securities and
Exchange Commission (the &#8220;<b>Commission</b>&#8221;) of the Company&#8217;s
Registration Statement on Form S-1 (the &#8220;<b>Registration 
Statement</b>&#8221;) under the Securities Act of 1933, as amended (the 
&#8220;<b>Securities Act</b>&#8221;). The Registration Statement relates to the 
registration for resale by the selling stockholder named therein (collectively, 
the &#8220;<b>Selling Stockholders</b>&#8221;) of up to 10,740,000 shares of the
Company&#8217;s common stock, par value $0.00001 per share (the &#8220;<b>Common
Stock</b>&#8221;), which consists of:</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid1" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="top" width="3%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="margin: 0px;">1)</p>
</td>
<td valign="top">
<p style="margin: 0px;">3,500,000 shares of Common Stock (the 
&#8220;<b>Shares</b>&#8221;) that were purchased by a Selling Stockholder in a 
transaction with the Company pursuant to exemptions from the registration 
requirements of the Securities Act; and</p>
</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">&#160;</td>
<td valign="top">&#160;</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="margin: 0px;">2)</p>
</td>
<td valign="top">
<p style="margin: 0px;">7,240,000shares of Common Stock issuable upon exercise 
of the following warrants (the &#8220;<b>Warrant Shares</b>&#8221;):</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid2" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="top" width="8%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="margin: 0px;">a.</p>
</td>
<td valign="top">
<p style="margin: 0px;">240,000 shares of Common Stock that have vested and are 
issuable upon exercise of a Series A Stock Purchase Warrant;</p>
</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">&#160;</td>
<td valign="top">&#160;</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="margin: 0px;">b.</p>
</td>
<td valign="top">
<p style="margin: 0px;">3,500,000 shares of Common Stock issuable upon exercise 
of a Series B Stock Purchase Warrant; and</p>
</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">&#160;</td>
<td valign="top">&#160;</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="margin: 0px;">c.</p>
</td>
<td valign="top">
<p style="margin: 0px;">3,500,000 shares of Common Stock issuable upon exercise 
of a Series C Stock Purchase Warrant (collectively, the 
&#8220;<b>Warrants</b>&#8221;) held by the Selling Stockholders.</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">All capitalized terms herein that are
not otherwise defined shall have the meaning ascribed thereto in the 
Registration Statement. In connection with this opinion, we have examined and 
relied upon the Company&#8217;s Articles of Incorporation, as amended, the 
Company&#8217;s Bylaws, and Registration Statement and related prospectus 
originals or copies certified or otherwise identified to our satisfaction of all
such corporate records of the Company and such other instruments and other 
certificates of public officials, officers and representatives of the Company 
and such other persons, and we have made such investigations of law, as we have 
deemed appropriate as a basis for the opinions expressed below. In addition, we 
have assumed and have not independently verified the accuracy as to factual 
matters of each document we have reviewed.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">For the purposes of rendering this 
opinion, we have examined originals or certified photostatic copies of such 
corporate records, agreements, instruments and other documents of the Company as
we have deemed relevant and necessary as a basis for the opinion hereinafter set
forth. In all such examinations, we have assumed the legal capacity of all 
natural persons, the genuineness of all signatures, the authenticity of original
and certified documents, the due authority of the parties signing such 
documents, and the conformity to original or certified documents of all copies 
submitted to us as conformed or reproduction copies.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">In making our examination of 
documents executed or to be executed by parties other than the Company, we have 
assumed that such parties had or will have the power, corporate or other, to 
enter into and perform all obligations thereunder and have also assumed the due 
authorization by all requisite action, corporate or other, and execution and 
delivery by such parties of such documents and the validity and binding effect 
thereof.</p>
<p style="margin: 0px;">&#160;&#160;</p>
<table id="tableid3" style="width: 100%; font: 10pt TIMES NEW ROMAN;" 
cellspacing="0" cellpadding="0" border="0">
<tr>
<td>&#160;</td>
</tr>
<tr>
<td>
<div class="rcpn" align="center"><font size="2" face="Times New Roman, Times, 
serif">1</font></div>
<div class="hpbhr" style="font-size: 1pt; width: 100%;"></div>
<hr color="#000000" size="1" width="100%" noshade="noshade" />
<div style="width: 100%; page-break-after: always; line-height: 0px;"></div>
</td>
</tr>
<tr>
<td>
<div class="hdr" style="font-size: 1pt; width: 100%;"></div>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">As to questions of fact relevant to 
the opinions expressed herein, we have relied without investigation upon, and 
assumed the accuracy of, certificates and oral or written statements and other 
information of or from representatives of the Company and others.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Based upon and subject to the 
foregoing, we are of the opinion that:</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid4" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td valign="top" width="3%"><font style="font-family: TIMES NEW 
ROMAN;">&#160;</font></td>
<td valign="top" width="3%">
<p style="margin: 0px;">(i)</p>
</td>
<td valign="top">
<p style="margin: 0px;">the Shares have been duly authorized, validly issued and
are fully paid and non-assessable;</p>
</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">&#160;</td>
<td valign="top">&#160;</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="margin: 0px;">(ii)</p>
</td>
<td valign="top">
<p style="margin: 0px;">the Warrants have been duly authorized for issuance and 
constitute valid and binding obligations of the Company, enforceable against the
Company in accordance with their terms; and</p>
</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">&#160;</td>
<td valign="top">&#160;</td>
</tr>
<tr height="15">
<td valign="top"><font style="font-family: TIMES NEW ROMAN;">&#160;</font></td>
<td valign="top">
<p style="margin: 0px;">(iii)</p>
</td>
<td valign="top">
<p style="margin: 0px;">the Warrant Shares have been duly authorized and upon 
receipt of the warrant exercise price in accordance with the terms of the 
Warrants, and when certificates for the same have been duly executed, 
countersigned and delivered, or other proper evidence of ownership issued, the 
Warrant Shares will be validly issued, fully paid and non-assessable.</p>
</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The opinions expressed herein are 
limited by bankruptcy, insolvency, reorganization, fraudulent transfer and 
fraudulent conveyance, voidable preference, moratorium or other similar laws and
related regulations and judicial doctrines from time to time in effect relating 
to or affecting creditors&#8217; rights generally, and by general equitable 
principles and public policy considerations, whether such principles and 
considerations are considered in a proceeding at law or at equity.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">The opinions expressed herein are 
limited exclusively to (i) the Nevada Revised Statutes (the 
&#8220;<b>NRS</b>&#8221;), applicable provisions of the Nevada Constitution and 
judicial decisions interpreting the NRS and such provisions of the Nevada 
Constitution and (ii) as to the enforceability of the Warrants against the 
Company, the laws of the State of New York, and we have not considered, and 
express no opinion on, any other laws or the laws of any other jurisdiction. We 
assume no obligation to supplement this opinion if any applicable laws change
after the date of this letter with possible retroactive effect, or if any facts 
or events occur or come to our attention after the date of this letter that 
might change any of the opinions expressed above.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">We consent to the filing of this 
legal opinion as an exhibit to the Registration Statement, and we further 
consent to the use of our name under the headings &#8220;Legal Matters&#8221; in
the prospectus that forms a part of the Registration Statement and &#8220;Legal 
Matters&#8221; in any prospectus supplement that will form a part of the 
Registration Statement. In giving such consent, we do not hereby concede that we
are within the category of persons whose consent is required under Section 7 of 
the Securities Act or the Rules and Regulations of the Commission thereunder. 
This opinion is furnished by us, as counsel to the Company, in accordance with 
the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act 
and, except as provided in this paragraph, is not to be used, circulated or 
quoted for any other purpose. This opinion supersedes and replaces all prior 
opinions regarding the subject matter hereof.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Very truly yours,</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;"><i>Sierchio &amp; Company, LLP</i></p>
<p style="margin: 0px;"><i></i>&#160;</p>
<p style="margin: 0px;">&#160;</p>
<p style="text-align: center; margin: 0px;">2</p>
<hr color="#000000" size="2" width="100%" noshade="noshade" />
<p style="margin: 0px;"><i></i>&#160;</p>
<p style="margin: 0px;">&#160;</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>rcar_ex232.htm
<DESCRIPTION>CONSENT OF PETERSON SULLIVAN LLP
<TEXT>
<html>
<head></head>
<body style="font: 10pt TIMES NEW ROMAN; text-align: justify; margin: 0px 7% 0px
7%;">
<p style="text-align: right; margin: 0px;"><b>EXHIBIT 23.2</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;" align="center"><b>CONSENT OF INDEPENDENT REGISTERED 
PUBLIC ACCOUNTING FIRM</b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">We consent to the inclusion in the Registration 
Statement on Form S-1 of RenovaCare, Inc. and Subsidiaries of our report dated 
March 28, 2014, on our audits of the consolidated balance sheets of RenovaCare, 
Inc. and Subsidiaries (a development stage company) (&#8220;the Company&#8221;) 
as of December 31, 2013 and 2012, and the related consolidated statements of 
operations, comprehensive income (loss), stockholders&#8217; equity, and cash 
flows for the years then ended and for the period from February 20, 2013 (the 
date of entering the development stage) to December 31, 2013. We also consent to
the reference to us under the heading &#8220;Experts&#8221; in the Registration 
Statement.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">/S/ PETERSON SULLIVAN LLP</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">Seattle, Washington&#160;</p>
<p style="margin: 0px;">September 5, 2014</p>
<p style="margin: 0px;">&#160;</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>4
<FILENAME>rcar_ex241.htm
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
<html>
<head></head>
<body style="font: 10pt TIMES NEW ROMAN; text-align: justify; margin: 0px 7% 0px
7%;">
<p style="text-align: right; margin: 0px;"><b><b>EXHIBIT 24.1</b></b></p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">KNOW ALL MEN BY THESE PRESENTS, that 
we, the undersigned officers and directors of RenovaCare, Inc., a Nevada 
corporation, do hereby constitute and appoint Thomas Bold, as his or her true 
and lawful attorney-in-fact and agent, with full power of substitution and re-
substitution, for him or and in his or her name, place, and stead, in any and 
all capacities, to sign any and all amendments (including post-effective 
amendments, exhibits thereto and other documents in connection therewith) to 
this Registration Statement and any subsequent registration statement filed by 
the registrant pursuant to Rule 462(b) of the Securities Act of 1933, as 
amended, which relates to this Registration Statement, and to file the same, 
with all exhibits thereto, and other documents in connection therewith, with the
Securities and Exchange Commission, granting unto said attorney-in-fact and 
agent full power and authority to do and perform each and every act and thing 
requisite and necessary to be done in connection therewith, as fully to all 
intents and purposes as he might or could do in person, hereby ratifying and 
confirming all that said attorney-in-fact and agent, or his substitute or 
substitutes, may lawfully do or cause to be done by virtue hereof.</p>
<p style="margin: 0px; text-indent: 30px;">&#160;</p>
<p style="margin: 0px; text-indent: 30px;">Pursuant to the requirements of the 
Securities Act of 1933, this registration statement has been signed below by the
following persons in the capacities and on the dates indicated.</p>
<p style="margin: 0px;">&#160;</p>
<p style="margin: 0px;">&#160;</p>
<table id="tableid0" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%">&#160;</td>
<td width="35%">&#160;</td>
<td width="10%">&#160;</td>
<td width="50%">&#160;</td>
</tr>
<tr height="15">
<td><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;"><em>/s/ Rhonda B. Rosen</em></td>
<td>&#160;</td>
<td>Dated: September 5, 2014</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Rhonda B. Rosen</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Chief Financial 
Officer</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid1" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%"><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;" width="35%"><em>/s/ Patsy J. 
Trisler&#160;</em></td>
<td width="10%">&#160;</td>
<td width="50%">Dated: September 5, 2014</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Patsy Trisler</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Vice President &#8211; Clinical 
&amp; Regulatory Affairs</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid2" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%"><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;" width="35%"><em>/s/ Kenneth 
Kirkland</em></td>
<td width="10%">&#160;</td>
<td width="50%">Dated: September 5, 2014</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Kenneth Kirkland</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Director</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
<table id="tableid3" style="width: 100%; text-align: justify; font: 10pt TIMES 
NEW ROMAN; margin: auto;" cellspacing="0" cellpadding="0" border="0">
<tr height="15">
<td width="5%"><font style="font: 10pt TIMES NEW ROMAN;">By:</font></td>
<td style="border-bottom: black 1px solid;" width="35%"><em>/s/ Joseph 
Sierchio</em></td>
<td width="10%">&#160;</td>
<td width="50%">Dated: September 5, 2014</td>
</tr>
<tr height="15">
<td>Name:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Joseph Sierchio</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
<tr height="15">
<td>Title:</td>
<td><font style="font: 10pt TIMES NEW ROMAN;">Director</font></td>
<td>&#160;</td>
<td>&#160;</td>
</tr>
</table>
<p style="margin: 0px;">&#160;</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>rcar-20140630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.0a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: rcar_S%2D1.xfr; Date: 
2014%2D09%2D05T15:06:51 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xmlns:xbrldt="http://xbrl.org/2005/xbrldt" 
xmlns:xbrldi="http://xbrl.org/2006/xbrldi" 
xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" 
xmlns:ref="http://www.xbrl.org/2006/ref" 
xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-
gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:us-roles="http://fasb.org/us-
roles/2013-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" 
xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-
types="http://fasb.org/us-types/2013-01-31" 
xmlns:rcar="http://janusresourcesinc.com/20140630">
    <link:schemaRef xlink:href="rcar-20140630.xsd" xlink:type="simple" />
    <xbrli:context id="From2014-01-01to2014-06-30">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="Context_As_Of_31-Dec-2011">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
<xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-04-01to2014-06-30_us-
gaap_OfficerMember_custom_FeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:FeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-04-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-04-01to2013-06-30_us-
gaap_OfficerMember_custom_FeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:FeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-04-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-04-01to2013-06-30_us-
gaap_DirectorMember_custom_LegalFeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:LegalFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-04-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
</xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-06-30">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-06-30">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
<xbrli:context id="From2013-01-01to2013-12-31_us-
gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_custom_OilAndGasPropertiesNetMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:PropertyPlantAndEquipmentByTypeAxis">rcar:OilAndGasPropertiesNetMember</xbr
ldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_custom_TotalLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:FairValueByLiabilityClassAxis">rcar:TotalLiabilitiesMember</xbrldi:explicit
Member>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-
31_custom_UnprovenPropertiesMember_custom_MiningPropertiesMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:PropertyPlantAndEquipmentByTypeAxis">rcar:MiningPropertiesMember</xbrldi:ex
plicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_custom_DepreciationAndImpairmentMember_us-
gaap_OtherCurrentAssetsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:PropertyPlantAndEquipmentByTypeAxis">us-
gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_us-gaap_AccountsPayableMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:FairValueByLiabilityClassAxis">us-
gaap:AccountsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_custom_AssetRetirementObligationMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:FairValueByLiabilityClassAxis">rcar:AssetRetirementObligationMember</xbrldi
:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
</xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_us-gaap_AssetsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:PropertyPlantAndEquipmentByTypeAxis">us-
gaap:AssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-06-30_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">us-
gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-06-30_us-gaap_StockOptionMember_us-
gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">us-
gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-
gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-06-30_us-gaap_StockOptionMember_us-
gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">us-
gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-
gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
<xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_custom_LegalFeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:LegalFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-04-01to2014-06-30_us-
gaap_DirectorMember_custom_LegalFeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:LegalFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-04-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-06-30_us-
gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
<xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_us-
gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-06-30_us-
gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
</xbrli:context>
    <xbrli:context id="AsOf2013-12-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-06-30_us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-04-01to2014-06-30">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-04-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-04-01to2013-06-30">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-04-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-06-30">
      <xbrli:entity>
        <xbrli:identifier
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-06-30_us-
gaap_OfficerMember_custom_FeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:FeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-06-30_us-
gaap_OfficerMember_custom_FeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:FeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-06-30_us-
gaap_OfficerMember_custom_LegalFeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:LegalFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-06-30_us-
gaap_OfficerMember_custom_LegalFeeMember">
      <xbrli:entity>
        <xbrli:identifier
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:LegalFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-12-31">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-02-20to2013-12-31">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-02-20</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-02-19">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-02-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">us-
gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_us-gaap_StockOptionMember_us-
gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
<xbrldi:explicitMember dimension="us-
gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">us-
gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-
gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_us-
gaap_StockOptionMember_custom_EmployeeMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">us-
gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-
gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_us-
gaap_OfficerMember_custom_FeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:FeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-12-31_custom_FeeMember_us-
gaap_OfficerMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:OfficerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:FeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-12-31</xbrli:endDate>
</xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_custom_LegalFeeMember_us-
gaap_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:LegalFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-12-31_us-
gaap_DirectorMember_custom_LegalFeeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001016708</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-
gaap:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-
gaap:TitleOfIndividualAxis">rcar:LegalFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USD_per_Share">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2014-01-01to2014-06-
30">Renovacare, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2014-01-01to2014-06-
30">0001016708</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2014-01-01to2014-06-30">S-
1</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2014-01-01to2014-06-30">2014-06-
30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2014-01-01to2014-06-
30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2014-01-01to2014-06-30">--12-
31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2014-01-01to2014-06-
30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2014-01-01to2014-06-
30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2014-01-01to2014-06-
30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2014-01-01to2014-06-30">Smaller 
Reporting Company</dei:EntityFilerCategory>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2013-12-31" 
unitRef="USD_per_Share" decimals="INF">0.0001</us-
gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2014-06-30" 
unitRef="USD_per_Share" decimals="INF">0.0001</us-
gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2012-12-31" 
unitRef="USD_per_Share" decimals="INF">0.0001</us-
gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2013-12-31" 
unitRef="shares" decimals="INF">10000000</us-
gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2014-06-30" 
unitRef="shares" decimals="INF">10000000</us-
gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2012-12-31" 
unitRef="shares" decimals="INF">10000000</us-
gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2013-12-31" 
unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2014-06-30" 
unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2012-12-31" 
unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2013-12-31" 
unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2014-06-30" 
unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2012-12-31" 
unitRef="shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2013-12-31" 
unitRef="USD_per_Share" decimals="INF">0.00001</us-
gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2014-06-30" 
unitRef="USD_per_Share" decimals="INF">0.00001</us-
gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2012-12-31" 
unitRef="USD_per_Share" decimals="INF">0.00001</us-
gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2013-12-31" 
unitRef="shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2014-06-30" 
unitRef="shares" decimals="INF">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2012-12-31" 
unitRef="shares" decimals="INF">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2013-12-31" 
unitRef="shares" decimals="INF">66575122</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2014-06-30" 
unitRef="shares" decimals="INF">66575122</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2012-12-31" 
unitRef="shares" decimals="INF">63075122</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding contextRef="AsOf2013-12-31" 
unitRef="shares" decimals="INF">66575122</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2014-06-30" 
unitRef="shares" decimals="INF">66575122</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2012-12-31" 
unitRef="shares" decimals="INF">63075122</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2014-04-01to2014-06-30_us-gaap_OfficerMember_custom_FeeMember" 
unitRef="USD" decimals="0">3000</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2013-04-01to2013-06-30_us-gaap_OfficerMember_custom_FeeMember" 
unitRef="USD" decimals="0">0</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2013-04-01to2013-06-30_us-
gaap_DirectorMember_custom_LegalFeeMember" unitRef="USD" decimals="0">38974</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2014-04-01to2014-06-30_us-
gaap_DirectorMember_custom_LegalFeeMember" unitRef="USD" decimals="0">27820</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2014-01-01to2014-06-30_us-gaap_OfficerMember_custom_FeeMember" 
unitRef="USD" decimals="0">6000</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2013-01-01to2013-06-30_us-gaap_OfficerMember_custom_FeeMember" 
unitRef="USD" decimals="0">0</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2014-01-01to2014-06-30_us-
gaap_OfficerMember_custom_LegalFeeMember" unitRef="USD" decimals="0">82185</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2013-01-01to2013-06-30_us-
gaap_OfficerMember_custom_LegalFeeMember" unitRef="USD" decimals="0">62439</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2013-01-01to2013-12-31_us-gaap_OfficerMember_custom_FeeMember" 
unitRef="USD" decimals="0">49097</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2012-01-01to2012-12-31_custom_FeeMember_us-gaap_OfficerMember" 
unitRef="USD" decimals="0">43298</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2013-01-01to2013-12-31_custom_LegalFeeMember_us-
gaap_DirectorMember" unitRef="USD" decimals="0">165591</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty 
contextRef="From2012-01-01to2012-12-31_us-
gaap_DirectorMember_custom_LegalFeeMember" unitRef="USD" decimals="0">72503</us-
gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <rcar:SharesAvailable contextRef="AsOf2013-12-31" unitRef="shares" 
decimals="INF">19920000</rcar:SharesAvailable>
    <rcar:SharesAvailable contextRef="AsOf2014-06-30" unitRef="shares" 
decimals="INF">19865000</rcar:SharesAvailable>
    <rcar:StockbasedCompensationAdministrativeExpense contextRef="From2014-01-
01to2014-06-30" unitRef="USD" 
decimals="0">19355</rcar:StockbasedCompensationAdministrativeExpense>
    <rcar:StockbasedCompensationAdministrativeExpense contextRef="From2013-01-
01to2013-12-31" unitRef="USD" 
decimals="0">15440</rcar:StockbasedCompensationAdministrativeExpense>
<rcar:StockbasedCompensationAdministrativeExpense contextRef="From2014-04-
01to2014-06-30" unitRef="USD" 
decimals="0">12573</rcar:StockbasedCompensationAdministrativeExpense>
    <rcar:UnrecognizedCompensationCost contextRef="AsOf2013-12-31" unitRef="USD"
decimals="0">27317</rcar:UnrecognizedCompensationCost>
    <rcar:UnrecognizedCompensationCost contextRef="AsOf2014-06-30" unitRef="USD"
decimals="0">55387</rcar:UnrecognizedCompensationCost>
    <rcar:StockBasedCompensation contextRef="From2014-01-01to2014-06-30" 
unitRef="USD" decimals="0">195333</rcar:StockBasedCompensation>
    <rcar:StockBasedCompensation contextRef="From2013-01-01to2013-12-31_us-
gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <rcar:StockBasedCompensation contextRef="From2013-01-01to2013-12-31_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" 
decimals="0">237971</rcar:StockBasedCompensation>
    <rcar:StockBasedCompensation contextRef="From2014-01-01to2014-06-30_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" 
decimals="0">195333</rcar:StockBasedCompensation>
    <rcar:StockBasedCompensation contextRef="From2013-01-01to2013-12-31_us-
gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <rcar:StockBasedCompensation contextRef="From2013-01-01to2013-12-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <rcar:StockBasedCompensation contextRef="From2013-01-01to2013-12-31" 
unitRef="USD" decimals="0">237971</rcar:StockBasedCompensation>
    <rcar:StockBasedCompensationOptions contextRef="From2014-01-01to2014-06-30" 
unitRef="USD" decimals="0">19355</rcar:StockBasedCompensationOptions>
    <rcar:StockBasedCompensationOptions contextRef="From2013-01-01to2013-12-
31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <rcar:StockBasedCompensationOptions contextRef="From2013-01-01to2013-12-
31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" 
decimals="0">15440</rcar:StockBasedCompensationOptions>
    <rcar:StockBasedCompensationOptions contextRef="From2014-01-01to2014-06-
30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" 
decimals="0">19355</rcar:StockBasedCompensationOptions>
    <rcar:StockBasedCompensationOptions contextRef="From2013-01-01to2013-12-
31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <rcar:StockBasedCompensationOptions contextRef="From2013-01-01to2013-12-
31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" 
xsi:nil="true" />
    <rcar:StockBasedCompensationOptions contextRef="From2013-01-01to2013-12-31" 
unitRef="USD" decimals="0">15440</rcar:StockBasedCompensationOptions>
    <rcar:CommonUnitIssuance contextRef="From2013-01-01to2013-12-31_us-
gaap_CommonStockMember" unitRef="USD" decimals="0">35</rcar:CommonUnitIssuance>
    <rcar:CommonUnitIssuance contextRef="From2013-01-01to2013-12-31_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" 
decimals="0">1504965</rcar:CommonUnitIssuance>
    <rcar:CommonUnitIssuance contextRef="From2013-01-01to2013-12-31_us-
gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <rcar:CommonUnitIssuance contextRef="From2013-01-01to2013-12-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <rcar:CommonUnitIssuance contextRef="From2013-01-01to2013-12-31" 
unitRef="USD" decimals="0">1505000</rcar:CommonUnitIssuance>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2014-01-
01to2014-06-30" unitRef="Pure" decimals="INF">0.0162</us-
gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2014-01-
01to2014-06-30_us-gaap_StockOptionMember_us-gaap_MinimumMember" unitRef="Pure" 
decimals="INF">0.0143</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2014-01-
01to2014-06-30_us-gaap_StockOptionMember_us-gaap_MaximumMember" unitRef="Pure" 
decimals="INF">0.0162</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2013-01-
01to2013-12-31" unitRef="Pure" decimals="INF">0.0175</us-
gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2013-01-
01to2013-12-31_us-gaap_StockOptionMember_us-gaap_MinimumMember" unitRef="Pure" 
decimals="INF">0.0143</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2013-01-
01to2013-12-31_us-gaap_StockOptionMember_custom_EmployeeMember_us-
gaap_MaximumMember" unitRef="Pure" decimals="INF">0.0149</us-
gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate 
contextRef="From2014-01-01to2014-06-30" unitRef="Pure" decimals="INF">0.909</us-
gaap:FairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate 
contextRef="From2014-01-01to2014-06-30_us-gaap_StockOptionMember_us-
gaap_MinimumMember" unitRef="Pure" decimals="INF">0.995</us-
gaap:FairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate 
contextRef="From2014-01-01to2014-06-30_us-gaap_StockOptionMember_us-
gaap_MaximumMember" unitRef="Pure" decimals="INF">1.053</us-
gaap:FairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate 
contextRef="From2013-01-01to2013-12-31" unitRef="Pure" 
decimals="INF">1.0200</us-
gaap:FairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate 
contextRef="From2013-01-01to2013-12-31_us-gaap_StockOptionMember_us-
gaap_MinimumMember" unitRef="Pure" decimals="INF">0.995</us-
gaap:FairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate 
contextRef="From2013-01-01to2013-12-31_us-
gaap_StockOptionMember_custom_EmployeeMember_us-gaap_MaximumMember" 
unitRef="Pure" decimals="INF">1.034</us-
gaap:FairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2014-01-01to2014-
06-30">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2014-01-01to2014-
06-30_us-gaap_StockOptionMember_us-gaap_MinimumMember">P4Y6M</us-
gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2014-01-01to2014-
06-30_us-gaap_StockOptionMember_us-gaap_MaximumMember">P5Y6M</us-
gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2013-01-01to2013-
12-31">P5Y6M</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2013-01-01to2013-
12-31_us-gaap_StockOptionMember_us-gaap_MinimumMember">P5Y</us-
gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2013-01-01to2013-
12-31_us-gaap_StockOptionMember_custom_EmployeeMember_us-
gaap_MaximumMember">P5Y6M</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2013-12-31" 
unitRef="USD" decimals="0">162854</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2014-06-30" 
unitRef="USD" decimals="0">162854</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:SharePrice contextRef="AsOf2013-12-31" unitRef="USD_per_Share" 
decimals="INF">0.87</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2014-06-30" unitRef="USD_per_Share" 
decimals="INF">0.79</us-gaap:SharePrice>
    <us-gaap:Assets contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">1752927</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2014-06-30" unitRef="USD" 
decimals="0">1436884</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2012-12-31" unitRef="USD" 
decimals="0">1065834</us-gaap:Assets>
    <us-gaap:AccountsAndNotesReceivableNet contextRef="AsOf2013-12-31" 
unitRef="USD" decimals="0">80000</us-gaap:AccountsAndNotesReceivableNet>
    <us-gaap:AccountsAndNotesReceivableNet contextRef="AsOf2014-06-30" 
unitRef="USD" decimals="0">80000</us-gaap:AccountsAndNotesReceivableNet>
<us-gaap:AccountsAndNotesReceivableNet contextRef="AsOf2012-12-31" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:AssetsCurrent contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">1510073</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2014-06-30" unitRef="USD" 
decimals="0">1194030</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2012-12-31" unitRef="USD" 
decimals="0">521957</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">1230</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2014-06-30" unitRef="USD" 
decimals="0">24337</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2012-12-31" unitRef="USD" 
decimals="0">7562</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">55441</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2014-06-30" unitRef="USD" 
decimals="0">126413</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2012-12-31" unitRef="USD" 
decimals="0">40543</us-gaap:LiabilitiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2014-06-30" 
unitRef="USD" decimals="0">52191</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2013-
12-31" unitRef="USD" decimals="0">11222</us-
gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2014-
06-30" unitRef="USD" decimals="0">74222</us-
gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2012-
12-31" unitRef="USD" decimals="0">17973</us-
gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2013-12-31" 
unitRef="USD" decimals="0">1752927</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2014-06-30" 
unitRef="USD" decimals="0">1436884</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2012-12-31" 
unitRef="USD" decimals="0">1065834</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">1697486</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-06-30" unitRef="USD" 
decimals="0">1310471</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-12-31_us-
gaap_CommonStockMember" unitRef="USD" decimals="0">631</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-12-31_us-
gaap_CommonStockMember" unitRef="USD" decimals="0">666</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-12-31_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">5462236</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-12-31_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7220612</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-12-31" unitRef="USD" 
decimals="0">967759</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-06-30_us-
gaap_CommonStockMember" unitRef="USD" decimals="0">666</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-06-30_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7435300</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-12-31_us-
gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-4491004</us-
gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2013-12-31_us-
gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-5523792</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-06-30_us-
gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-6125495</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-12-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-
4104</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-12-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2014-06-30_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2013-12-31" 
unitRef="USD" decimals="0">-5523792</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2014-06-30" 
unitRef="USD" decimals="0">-6125495</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2012-12-31" 
unitRef="USD" decimals="0">-4491004</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">7220612</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2014-06-30" unitRef="USD" 
decimals="0">7435300</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2012-12-31" unitRef="USD" 
decimals="0">5462236</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockValue contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">666</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2014-06-30" unitRef="USD" 
decimals="0">666</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2012-12-31" unitRef="USD" 
decimals="0">631</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2013-12-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2014-06-30" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2012-12-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">162854</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2014-06-30" unitRef="USD" 
decimals="0">162854</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2012-12-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2013-12-31" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2014-06-30" 
unitRef="USD" decimals="0">1600</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2012-12-31" 
unitRef="USD" decimals="0">800</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:NetIncomeLoss contextRef="From2014-01-01to2014-06-30" unitRef="USD"
decimals="0">-601703</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-01-01to2013-06-30" unitRef="USD"
decimals="0">-94892</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-01-01to2013-12-31_us-
gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2013-01-01to2013-12-31_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2013-01-01to2013-12-31_us-
gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-1032788</us-
gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-01-01to2014-06-30_us-
gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-601703</us-
gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-01-01to2013-12-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2013-01-01to2013-12-31" unitRef="USD"
decimals="0">-1032788</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-04-01to2014-06-30" unitRef="USD"
decimals="0">-333682</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-04-01to2013-06-30" unitRef="USD"
decimals="0">-83358</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2012-01-01to2012-12-31" unitRef="USD"
decimals="0">-243959</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-02-20to2013-12-31" unitRef="USD"
decimals="0">-1068310</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued contextRef="AsOf2012-12-31_us-gaap_CommonStockMember" 
unitRef="shares" decimals="INF">63075122</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2013-12-31_us-gaap_CommonStockMember" 
unitRef="shares" decimals="INF">66575122</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2014-06-30_us-gaap_CommonStockMember" 
unitRef="shares" decimals="INF">66575122</us-gaap:SharesIssued>
    <rcar:IssuanceOfUnits contextRef="From2013-01-01to2013-12-31_us-
gaap_CommonStockMember" unitRef="shares" 
decimals="INF">3500000</rcar:IssuanceOfUnits>
    <us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax contextRef="From2013-01-01to2013-12-31_us-gaap_CommonStockMember" 
unitRef="USD" xsi:nil="true" />
    <us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax contextRef="From2013-01-01to2013-12-31_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax contextRef="From2013-01-01to2013-12-31_us-
gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax contextRef="From2013-01-01to2013-12-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" 
decimals="0">4104</us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax>
    <us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax contextRef="From2013-01-01to2013-12-31" unitRef="USD" 
decimals="0">4104</us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax>
    <us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax contextRef="From2012-01-01to2012-12-31" unitRef="USD" xsi:nil="true"
/>
    <us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax contextRef="From2013-02-20to2013-12-31" unitRef="USD" 
decimals="0">4104</us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax>
    <us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares contextRef="From2014-01-01to2014-06-30" unitRef="shares" 
decimals="INF">20000</us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares>
    <rcar:StockOptionsUnvested contextRef="From2014-01-01to2014-06-30" 
unitRef="shares" decimals="INF">115000</rcar:StockOptionsUnvested>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
contextRef="AsOf2013-12-31" unitRef="USD" decimals="0">44219</us-
gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent 
contextRef="AsOf2014-06-30" unitRef="USD" decimals="0">36080</us-
gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent 
contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">9638</us-
gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2014-01-
01to2014-06-30" unitRef="Pure" decimals="INF">0.00</us-
gaap:FairValueAssumptionsExpectedDividendRate>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2014-01-
01to2014-06-30_us-gaap_StockOptionMember" unitRef="Pure" 
decimals="INF">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2013-01-
01to2013-12-31" unitRef="Pure" decimals="INF">0</us-
gaap:FairValueAssumptionsExpectedDividendRate>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2013-01-
01to2013-12-31_us-gaap_StockOptionMember" unitRef="Pure" 
decimals="INF">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="Context_As_Of_31-
Dec-2011" unitRef="USD" decimals="0">787771</us-
gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2013-12-31" 
unitRef="USD" decimals="0">1508843</us-
gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2014-06-30" 
unitRef="USD" decimals="0">1168093</us-
gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2012-12-31" 
unitRef="USD" decimals="0">513595</us-
gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2013-06-30" 
unitRef="USD" decimals="0">392171</us-
gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2013-02-19" 
unitRef="USD" decimals="0">500144</us-
gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2014-01-01to2014-06-
30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2013-01-01to2013-06-
30" unitRef="USD" decimals="0">49338</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2013-01-01to2013-12-
31" unitRef="USD" decimals="0">49338</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2014-04-01to2014-06-
30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2013-04-01to2013-06-
30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2012-01-01to2012-12-
31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2013-02-20to2013-12-
31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2014-01-
01to2014-06-30" unitRef="USD" decimals="0">-601703</us-
gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2013-01-
01to2013-06-30" unitRef="USD" decimals="0">-144230</us-
gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2013-01-
01to2013-12-31" unitRef="USD" decimals="0">-628545</us-
gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2014-04-
01to2014-06-30" unitRef="USD" decimals="0">-333682</us-
gaap:IncomeLossFromContinuingOperations>
<us-gaap:IncomeLossFromContinuingOperations contextRef="From2013-04-
01to2013-06-30" unitRef="USD" decimals="0">-83358</us-
gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2012-01-
01to2012-12-31" unitRef="USD" decimals="0">-229539</us-
gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2013-02-
20to2013-12-31" unitRef="USD" decimals="0">-614729</us-
gaap:IncomeLossFromContinuingOperations>
    <us-gaap:OperatingExpenses contextRef="From2014-01-01to2014-06-30" 
unitRef="USD" decimals="0">601703</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2013-01-01to2013-06-30" 
unitRef="USD" decimals="0">144230</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2013-01-01to2013-12-31" 
unitRef="USD" decimals="0">628545</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2014-04-01to2014-06-30" 
unitRef="USD" decimals="0">333682</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2013-04-01to2013-06-30" 
unitRef="USD" decimals="0">83358</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2012-01-01to2012-12-31" 
unitRef="USD" decimals="0">229539</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2013-02-20to2013-12-31" 
unitRef="USD" decimals="0">614729</us-gaap:OperatingExpenses>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2014-01-01to2014-
06-30" unitRef="USD" decimals="0">601703</us-
gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2013-01-01to2013-
06-30" unitRef="USD" decimals="0">144230</us-
gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2013-01-01to2013-
12-31" unitRef="USD" decimals="0">628545</us-
gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2014-04-01to2014-
06-30" unitRef="USD" decimals="0">333682</us-
gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2013-04-01to2013-
06-30" unitRef="USD" decimals="0">83358</us-
gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-01-01to2012-
12-31" unitRef="USD" decimals="0">229539</us-
gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2013-02-20to2013-
12-31" unitRef="USD" decimals="0">614729</us-
gaap:GeneralAndAdministrativeExpense>
    <us-gaap:Revenues contextRef="From2014-01-01to2014-06-30" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2013-01-01to2013-06-30" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2013-01-01to2013-12-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2014-04-01to2014-06-30" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2013-04-01to2013-06-30" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2012-01-01to2012-12-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2013-02-20to2013-12-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2014-01-01to2014-
06-30" unitRef="USD_per_Share" decimals="INF">-0.01</us-
gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2013-01-01to2013-
06-30" unitRef="USD_per_Share" decimals="INF">0.00</us-
gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2013-01-01to2013-
12-31" unitRef="USD_per_Share" decimals="INF">-0.02</us-
gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2014-04-01to2014-
06-30" unitRef="USD_per_Share" decimals="INF">-0.01</us-
gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2013-04-01to2013-
06-30" unitRef="USD_per_Share" decimals="INF">0.00</us-
gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2012-01-01to2012-
12-31" unitRef="USD_per_Share" decimals="INF">0</us-
gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare 
contextRef="From2014-01-01to2014-06-30" unitRef="USD_per_Share" 
decimals="INF">0.00</us-
gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare 
contextRef="From2013-01-01to2013-06-30" unitRef="USD_per_Share" 
decimals="INF">0.00</us-
gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare 
contextRef="From2013-01-01to2013-12-31" unitRef="USD_per_Share" decimals="INF">-
0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare 
contextRef="From2014-04-01to2014-06-30" unitRef="USD_per_Share" 
decimals="INF">0.00</us-
gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare 
contextRef="From2013-04-01to2013-06-30" unitRef="USD_per_Share" 
decimals="INF">0.00</us-
gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare 
contextRef="From2012-01-01to2012-12-31" unitRef="USD_per_Share" 
decimals="INF">0</us-
gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare 
contextRef="From2014-01-01to2014-06-30" unitRef="USD_per_Share" decimals="INF">-
0.01</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare 
contextRef="From2013-01-01to2013-06-30" unitRef="USD_per_Share" 
decimals="INF">0.00</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare 
contextRef="From2013-01-01to2013-12-31" unitRef="USD_per_Share" decimals="INF">-
0.01</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare 
contextRef="From2014-04-01to2014-06-30" unitRef="USD_per_Share" decimals="INF">-
0.01</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare 
contextRef="From2013-04-01to2013-06-30" unitRef="USD_per_Share" 
decimals="INF">0.00</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare 
contextRef="From2012-01-01to2012-12-31" unitRef="USD_per_Share" 
decimals="INF">0</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2014-
01-01to2014-06-30" unitRef="shares" decimals="INF">66575122</us-
gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2013-
01-01to2013-06-30" unitRef="shares" decimals="INF">63075122</us-
gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2013-
01-01to2013-12-31" unitRef="shares" decimals="INF">63401149</us-
gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2014-
04-01to2014-06-30" unitRef="shares" decimals="INF">66575122</us-
gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2013-
04-01to2013-06-30" unitRef="shares" decimals="INF">63075122</us-
gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2012-
01-01to2012-12-31" unitRef="shares" decimals="INF">63075122</us-
gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <rcar:StockBasedConsultingExpense contextRef="From2014-01-01to2014-06-30" 
unitRef="USD" decimals="0">195333</rcar:StockBasedConsultingExpense>
    <rcar:StockBasedConsultingExpense contextRef="From2013-01-01to2013-06-30" 
unitRef="USD" xsi:nil="true" />
    <rcar:StockBasedConsultingExpense contextRef="From2013-01-01to2013-12-31" 
unitRef="USD" decimals="0">237971</rcar:StockBasedConsultingExpense>
    <rcar:StockBasedConsultingExpense contextRef="From2012-01-01to2012-12-31" 
unitRef="USD" xsi:nil="true" />
    <rcar:StockBasedConsultingExpense contextRef="From2013-02-20to2013-12-31" 
unitRef="USD" decimals="0">237971</rcar:StockBasedConsultingExpense>
    <us-gaap:ShareBasedCompensation contextRef="From2014-01-01to2014-06-30" 
unitRef="USD" decimals="0">19355</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2013-01-01to2013-06-30" 
unitRef="USD" decimals="0">829</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2013-01-01to2013-12-31" 
unitRef="USD" decimals="0">15440</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-01-01to2012-12-31" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensation contextRef="From2013-02-20to2013-12-31" 
unitRef="USD" decimals="0">15440</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2014-01-
01to2014-06-30" unitRef="USD" decimals="0">1600</us-
gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2013-01-
01to2013-06-30" unitRef="USD" decimals="0">-800</us-
gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2013-01-
01to2013-12-31" unitRef="USD" decimals="0">-800</us-
gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2012-01-
01to2012-12-31" unitRef="USD" decimals="0">-13714</us-
gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2013-02-
20to2013-12-31" unitRef="USD" decimals="0">-3801</us-
gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2014-01-01to2014-
06-30" unitRef="USD" decimals="0">23107</us-
gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2013-01-01to2013-
06-30" unitRef="USD" decimals="0">-7562</us-
gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2013-01-01to2013-
12-31" unitRef="USD" decimals="0">-6332</us-
gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2012-01-01to2012-
12-31" unitRef="USD" decimals="0">7562</us-
gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2013-02-20to2013-
12-31" unitRef="USD" decimals="0">-3815</us-
gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 
contextRef="From2014-01-01to2014-06-30" unitRef="USD" decimals="0">70972</us-
gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 
contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">10615</us-
gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
contextRef="From2013-01-01to2013-12-31" unitRef="USD" decimals="0">18104</us-
gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 
contextRef="From2012-01-01to2012-12-31" unitRef="USD" decimals="0">-33150</us-
gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 
contextRef="From2013-02-20to2013-12-31" unitRef="USD" decimals="0">20256</us-
gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2014-01-
01to2014-06-30" unitRef="USD" decimals="0">-340750</us-
gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2013-01-
01to2013-06-30" unitRef="USD" decimals="0">-124424</us-
gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2013-01-
01to2013-12-31" unitRef="USD" decimals="0">-349898</us-
gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2012-01-
01to2012-12-31" unitRef="USD" decimals="0">-267214</us-
gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2013-02-
20to2013-12-31" unitRef="USD" decimals="0">-333447</us-
gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2014-
01-01to2014-06-30" unitRef="USD" decimals="0">-340750</us-
gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2013-
01-01to2013-06-30" unitRef="USD" decimals="0">-121424</us-
gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2013-
01-01to2013-12-31" unitRef="USD" decimals="0">995248</us-
gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2012-
01-01to2012-12-31" unitRef="USD" decimals="0">-274176</us-
gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2013-
02-20to2013-12-31" unitRef="USD" decimals="0">1008699</us-
gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2014-01-
01to2014-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2013-01-
01to2013-06-30" unitRef="USD" decimals="0">3000</us-
gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2013-01-
01to2013-12-31" unitRef="USD" decimals="0">-159854</us-
gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2012-01-
01to2012-12-31" unitRef="USD" decimals="0">-6962</us-
gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2013-02-
20to2013-12-31" unitRef="USD" decimals="0">-162854</us-
gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromSaleOfOilAndGasPropertyAndEquipment 
contextRef="From2014-01-01to2014-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromSaleOfOilAndGasPropertyAndEquipment 
contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">3000</us-
gaap:ProceedsFromSaleOfOilAndGasPropertyAndEquipment>
    <us-gaap:ProceedsFromSaleOfOilAndGasPropertyAndEquipment 
contextRef="From2013-01-01to2013-12-31" unitRef="USD" decimals="0">3000</us-
gaap:ProceedsFromSaleOfOilAndGasPropertyAndEquipment>
    <us-gaap:ProceedsFromSaleOfOilAndGasPropertyAndEquipment 
contextRef="From2012-01-01to2012-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromSaleOfOilAndGasPropertyAndEquipment 
contextRef="From2013-02-20to2013-12-31" unitRef="USD" xsi:nil="true" />
<us-gaap:NatureOfOperations contextRef="From2014-01-01to2014-06-30">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;RenovaCare, Inc., together with its wholly&#13;owned subsidiary (the
&amp;#147;Company&amp;#148;), focuses on the acquisition, research, development 
and, if warranted, commercialization&#13;of autologous (using a 
patient&amp;#146;s own cells) cellular therapies that can be used for medical 
and aesthetic applications.&#13;The Company was previously involved in the 
exploration and development of both mineral exploration properties and oil and 
gas&#13;properties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: 
justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 12, 2013, the 
Company, together with&#13;its wholly owned subsidiary, RenovaCare Sciences 
Corp. (&amp;#147;RenovaCare Sciences&amp;#148;), a Nevada corporation formerly 
known&#13;as Janus Acquisition Corp., entered into an asset purchase agreement 
with Dr. J&amp;#246;rg Gerlach, MD, PhD, pursuant to which 
RenovaCare&#13;Sciences purchased all of Dr. Gerlach&amp;#146;s rights, title 
and interest to a treatment methodology for skin isolation, spraying&#13;and 
associated equipment for the regeneration of human skin cells (the 
&amp;#147;Cell Deposition Device&amp;#148;), along with the associated&#13;US 
and foreign patents and patent applications. The development of the Cell 
Deposition Device is in the early stages and the Company&#13;anticipates that 
significant time and financial resources will be required to further develop the
technology and determine whether&#13;a commercially viable product can be 
developed.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;The Company has recently incurred net operating&#13;losses and 
operating cash flow deficits. As of June 30, 2014, the Company&amp;#146;s total 
accumulated deficit is $6.1 million. The&#13;Company does not currently generate
revenues and will continue to incur losses from operations and operating cash 
flow deficits&#13;in the future. Management believes that the Company&amp;#146;s
cash and cash equivalent balances, anticipated cash flows from 
operations&#13;and other external sources of capital will be sufficient to meet 
the Company&amp;#146;s cash requirements through December 31, 2014.&#13;The 
future of the Company after December 2014 will depend in large part on its 
ability to successfully raise capital from external&#13;sources to fund 
operations.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:NatureOfOperations contextRef="From2013-01-01to2013-12-31">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;RenovaCare,&#13;Inc., together with its wholly owned subsidiary (the 
&amp;#147;Company&amp;#148;), focuses on the acquisition, research, 
development&#13;and, if warranted, commercialization of autologous (using a 
patient&amp;#146;s own cells) cellular therapies that can be used 
for&#13;medical and aesthetic applications. The Company was previously involved 
in the exploration and development of both mineral exploration&#13;properties 
and oil and gas properties. The Company sold its oil and gas properties on 
February 18 and 19, 2013 and sold its subsidiary&#13;which controlled various 
mineral leases and mining claims on December 31, 2013. Effective February 20, 
2013, the Company became&#13;a development stage 
company.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;July 12, 2013, the 
Company, together with its wholly owned subsidiary, RenovaCare Sciences Corp. 
(&amp;#147;RenovaCare Sciences&amp;#148;),&#13;a Nevada corporation formerly 
known as Janus Acquisition Corp., entered into an asset purchase agreement with 
Dr. J&amp;#246;rg Gerlach,&#13;MD, PhD, pursuant to which RenovaCare Sciences 
purchased all of Dr. Gerlach&amp;#146;s rights, title and interest to a 
treatment&#13;methodology for skin isolation , spraying and associated equipment
for the regeneration of human skin cells (the &amp;#147;Cell
Deposition&#13;Device&amp;#148;), along with the associated US and foreign 
patents and patent applications. The development of the Cell 
Deposition&#13;Device is in the early stages and we anticipate that significant 
time and financial resources will be required to further develop&#13;the 
technology and determine whether a commercially viable product can be 
developed.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 31, 2013, we
entered into a stock purchase agreement with Duke Mountain Resources, Inc. 
(&amp;#147;Duke&amp;#148;), a Nevada&#13;corporation, pursuant to which we sold 
to Duke 100% of the issued and outstanding shares of Fostung Resources Ltd. 
(&amp;#147;Fostung&#13;Resources&amp;#148;), a corporation organized under the 
laws of Ontario, Canada and a wholly owned subsidiary of ours, for a 
promissory&#13;note in the amount of $80,000, which amount approximated the fair
value of the leases and mining claims controlled by Fostung&#13;Resources, as 
concluded by an independent third-party geological 
consultant.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; 
text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The Company has recently incurred&#13;net operating losses and 
operating cash flow deficits. The Company&amp;#146;s total accumulated deficit 
is $5.5 million as of December&#13;31, 2013. The Company does not currently 
generate revenues and will continue to incur losses from operations and 
operating cash&#13;flow deficits in the future. Management believes that the 
Company&amp;#146;s cash and cash equivalent balances, anticipated cash&#13;flows
from operations and other external sources of capital will be sufficient to meet
our cash requirements through December&#13;31, 2014. The future of the Company 
after December 2014 will depend in large part on its ability to successfully 
raise capital&#13;from external sources to fund 
operations.&lt;/font&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock 
contextRef="From2014-01-01to2014-06-30">&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&lt;i&gt;Basis&#13;of Presentation and 
Principles of Accounting&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;interim consolidated financial statements included herein have
been prepared by the Company, without audit, in accordance with&#13;the rules 
and regulations of the Securities and Exchange Commission 
(&amp;#147;SEC&amp;#148;) pursuant to Part 210 of Regulation S-X.&#13;Certain 
information and footnote disclosures normally included in financial statements 
prepared in accordance with accounting&#13;principles generally accepted in the 
United States of America (&amp;#147;GAAP&amp;#148;) have been condensed or 
omitted pursuant to such&#13;SEC rules and regulations, although the Company 
believes that the disclosures included are adequate to make the information 
presented&#13;not misleading.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font:
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;In&#13;management&amp;#146;s opinion, the
unaudited consolidated financial statements contained herein reflect all
adjustments, consisting&#13;solely of normal recurring items, which are 
necessary for the fair presentation of the Company&amp;#146;s financial 
position, results&#13;of operations, and cash flows on a basis consistent with 
that of the Company&amp;#146;s prior audited consolidated financial 
statements.&#13;The Company has evaluated information about subsequent events 
that became available to us through the date the financial statements&#13;were 
issued. This information relates to events, transactions or changes in 
circumstances that would require us to adjust the&#13;amounts reported in the 
financial statements or to disclose information about those events, transactions
or changes in circumstances.&#13;However, the results of operations for interim 
periods may not be indicative of results to be expected for the full fiscal 
year.&#13;Therefore, these financial statements should be read in conjunction 
with the Company&amp;#146;s audited financial statements, including&#13;the 
notes thereto for the year ended December 31, 2013, which may be found under the
Company&amp;#146;s profile on EDGAR.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Principles&#13;of 
Consolidation&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;These&#13;consolidated 
financial statements have been prepared in accordance with US GAAP and include 
the accounts of the Company and its&#13;wholly owned subsidiary, RenovaCare 
Sciences. All significant intercompany transactions and balances have been 
eliminated. RenovaCare&#13;Sciences was incorporated under the laws of the State
of Nevada on June 12, 2013.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Applicable&#13;Accounting 
Guidance&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Any&#13;reference in these 
notes to applicable accounting guidance is meant to refer to the authoritative 
non-governmental US GAAP as&#13;found in the Financial Accounting Standards 
Board&amp;#146;s Accounting Standards 
Codification.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif; background-color: 
white"&gt;In&#13;June 2014, the Financial Accounting Standards Board 
(&amp;#147;FASB&amp;#148;) issued Accounting Standards Update 
(&amp;#147;ASU&amp;#148;) 2014-10,&#13;Development Stage Entities (Topic 915): 
Elimination of Certain Financial Reporting Requirements. ASU 2014-10 eliminates 
the distinction&#13;of a development stage entity and certain related disclosure
requirements, including the elimination of inception-to-date information&#13;on 
the statements of operations, cash flows and stockholders&amp;#146; equity. The 
amendments in ASU 2014-10 will be effective prospectively&#13;for annual 
reporting periods beginning after December 15, 2014, and interim periods within
those annual periods, however early&#13;adoption is permitted. The Company 
adopted ASU 2014-10 during the quarter ended June 30, 2014, thereby no longer 
presenting or&#13;disclosing any information required by Topic 
915.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 9pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 9pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif; background-color: white"&gt;In&#13;May 2014,
the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), 
which supersedes the revenue recognition&#13;requirements in Accounting 
Standards Codification (&amp;#147;ASC&amp;#148;) 605, Revenue Recognition. The 
new revenue recognition standard&#13;requires entities to recognize revenue in a
way that depicts the transfer of promised goods or services to customers in an 
amount&#13;that reflects the consideration to which the entity expects to be 
entitled to in exchange for those goods or services. ASU 2014-09&#13;is 
effective for interim and annual reporting periods beginning after December 15, 
2016 and is to be applied retrospectively.&#13;The Company does not currently 
have any revenue. As such, ASU 2014-09 will not have any effect on the 
Company&amp;#146;s results of&#13;operations and financial position. If the 
Company begins generating revenue prior to the effective date of ASU 2014-09, it
will&#13;evaluate the effect that ASU 2014-09 will have on its results of 
operations and financial position.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; 
background-color: white"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Accounting&#13;Estimates&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13
;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;preparation of consolidated financial statements in conformity
with accounting principles generally accepted in the United States&#13;of 
America requires management to make estimates and assumptions that affect the 
reported amounts of assets and liabilities and&#13;the reported amounts of 
revenues and expenses during the reporting period. Actual results, as determined
by future events, may&#13;differ from these 
estimates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times,
 Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Cash&#13;and Cash 
Equivalents&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;Company considers all highly liquid instruments purchased with
an original maturity of three months or less to be cash equivalents.&#13;Cash 
and cash equivalents may at times exceed federally insured 
limits.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Note&#13;Receivable
from Duke Mountain&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;note receivable from Duke Mountain Resources, Inc. 
(&amp;#147;Duke&amp;#148;) is unsecured, bears interest at 4.0% and principal 
and interest&#13;are due on December 31, 2015. The Company&amp;#146;s credit 
risk assessment is limited due to the related party nature of the 
arrangement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Fair&#13;Value of 
Financial Instruments&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;carrying amounts for cash and cash equivalents and payables 
approximate fair value based on observable quoted prices for active&#13;markets 
&amp;#150; Level 1 inputs. The carrying amount of the note receivable from Duke 
approximates fair value based on similar market&#13;inputs for interest rates 
for a specific creditor &amp;#150; Level 2 
inputs.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Research&#13;and 
Development Costs&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;Company intends to outsource its research and development 
efforts and expense related costs as incurred, including the cost 
of&#13;manufacturing product for testing, licensing fees and costs associated 
with planning and conducting clinical trials. The value&#13;ascribed to patents 
and other intellectual property acquired will be capitalized as it relates to 
particular research and development&#13;projects that may have alternative 
future uses.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Intangible&#13;Assets&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#
13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align:
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;intangible asset consists primarily of Cell Deposition Device 
technology that the Company acquired during 2013 and is recorded&#13;at cost. At
the time of acquisition the technology had not reached technological 
feasibility. The amount capitalized is accounted&#13;for as an indefinite-lived 
intangible asset, subject to impairment testing until completion or abandonment.
Upon successful completion,&#13;a determination will be made as to the then
useful life of the intangible asset, generally determined by the period in which
substantially&#13;all of the cash flows are expected to be generated, and begin 
amortization. The Company tests the intangible asset for impairment&#13;at least
annually or more frequently if impairment indicators exist after performing a 
qualitative analysis. Management has multiple&#13;criteria that it considers 
when performing the qualitative analysis. The results of this review are then 
weighed and prioritized.&#13;If the totality of the relevant events and 
circumstances indicate that it is not more likely than not that the fair value 
of the&#13;intangible asset is less than its carrying amount, additional 
impairment tests are not necessary.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company assessed the
following qualitative factors that could affect any change in the fair value of 
the intangible asset: analysis&#13;of the technology&amp;#146;s current phase, 
additional testing necessary to bring the technology to market, development of 
competing&#13;products, changes in projections caused by delays, changes in 
regulations, changes in the market for the technology and changes&#13;in cost 
projections to bring the technology to market. Based on a qualitative 
assessment, management concluded that a positive&#13;assertion can be made from 
the qualitative assessment that it is not more likely than not that the fair 
value of the intangible&#13;asset is less than its carrying 
amount.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Stock&#13;Options&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&
lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;Company measures all stock-based compensation awards using a 
fair value method on the date of grant and recognizes such expense&#13;in its 
consolidated financial statements over the requisite service period. The Company
uses the Black-Scholes pricing model to&#13;determine the fair value of stock-
based compensation awards on the date of grant. The Black-Scholes pricing model 
requires management&#13;to make assumptions regarding option lives, expected 
volatility, and risk free interest rates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Income&#13;Taxes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&l
t;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;Company recognizes income taxes on an accrual basis based on 
tax positions taken, or expected to be taken, in tax returns.
 A tax&#13;position is defined as a position in a previously filed tax return or
a position expected to be taken in future tax filing that&#13;is reflected in 
measuring current or deferred income tax assets and liabilities. Tax positions 
are recognized only when it is&#13;more likely than not (i.e., likelihood of 
greater than 50%), based on technical merits, that the position would be 
sustained upon&#13;examination by taxing authorities. Tax positions that meet 
the more likely than not threshold are measured using a probability-
weighted&#13;approach as the largest amount of tax benefit that is greater than
50% likely of being realized upon settlement. Income taxes&#13;are accounted for
using an asset and liability approach that requires the recognition of deferred 
tax assets and liabilities for&#13;the expected future tax consequences of 
events that have been recognized in the Company&amp;#146;s financial statements 
or tax returns.&#13;A valuation allowance is established to reduce deferred tax 
assets if all, or some portion, of such assets will more than likely&#13;not be 
realized. Should they occur, the Company&amp;#146;s policy is to classify 
interest and penalties related to tax positions as&#13;interest expense. Since 
the Company&amp;#146;s inception, no such interest or penalties have been 
incurred. The Company did not record&#13;an income tax provision during the 
periods presented due to net taxable 
losses.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Discontinued&#13;Operations&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&
#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;results of the Company&amp;#146;s oil and gas and mineral 
assets are being reported as discontinued operations as a result of the&#13;sale
of the oil and gas properties in February 2013 and the sale of the 
Company&amp;#146;s subsidiary which controlled various mineral&#13;leases and 
claims in December 2013. Certain amounts reported in the prior periods presented
have been reclassified to conform&#13;to the current period financial statement 
presentation. These reclassifications have no effect on previously reported net 
income&#13;(loss).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Earnings&#13;(Loss) Per 
Share&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times 
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;&lt;/i&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;Company presents both basic and diluted earnings per share 
(&amp;#147;EPS&amp;#148;) amounts. Basic EPS is calculated by dividing 
net&#13;income (loss) by the weighted average number of common shares 
outstanding during the period presented. Diluted EPS amounts are&#13;based upon 
the weighted average number of common and common equivalent shares outstanding 
during the period presented. Potentially&#13;dilutive shares of common stock 
consisted of warrants to purchase shares of common stock (8,200,000 shares as of
June 30, 2014&#13;and December 31, 2013) and options to purchase shares of 
common stock (135,000 shares as of June 30, 2014 and 80,000 as of 
December&#13;31, 2013). During the periods presented, potentially dilutive 
shares of common stock were not included in the computation of dilutive&#13;loss
per share as to do so would be anti-
dilutive.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Related&#13;Party 
Transactions&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times,
Serif"&gt;&lt;i&gt;&lt;/i&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;A&#13;related party is generally defined as (i) any person who holds 
10% or more of the Company&amp;#146;s securities and their 
immediate&#13;families; (ii) the Company&amp;#146;s management; (iii) someone 
who directly or indirectly controls, is controlled by or is under&#13;common 
control with the Company; or (iv) anyone who can significantly influence the 
financial and operating decisions of the Company.&#13;A transaction is 
considered to be a related party transaction when there is a transfer of 
resources or obligations between related&#13;parties. See &amp;#147;Note 6. 
Related Party Transactions,&amp;#148; for further 
discussion.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Comprehensive 
Income (Loss)&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The 
Company has no items of other comprehensive&#13;income in any period 
presented.&amp;#160; Therefore, net loss equals comprehensive 
loss.&amp;#160;&lt;/p&gt;</us-
gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock 
contextRef="From2013-01-01to2013-12-31">&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&lt;i&gt;Basis&#13;of Presentation and 
Principles of Accounting&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;the Company is 
devoting substantially all of its efforts to establishing a new business, and 
while planned principal operations&#13;have commenced, there has been no revenue
generated from sales, license fees or royalties, and as such, the Company is 
considered&#13;a development stage company. Accordingly, the Company&amp;#146;s 
consolidated financial statements are presented in accordance 
with&#13;authoritative accounting guidance related to a development stage 
enterprise.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Principles&#13;of 
Consolidation&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;These&#13;consolidated 
financial statements have been prepared in accordance with US GAAP and include 
the accounts of the Company and its&#13;wholly owned subsidiary, RenovaCare 
Sciences. All significant intercompany transactions and balances have been 
eliminated. RenovaCare&#13;Sciences was incorporated under the laws of the State
of Nevada on June 12, 2013.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Applicable&#13;Accounting 
Guidance&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Any&#13;reference in these 
notes to applicable accounting guidance is meant to refer to the authoritative 
non-governmental US GAAP as&#13;found in the Financial Accounting Standards 
Board&amp;#146;s Accounting Standards 
Codification.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Accounting&#13;Estimates&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13
;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preparation of 
consolidated financial statements in conformity with accounting principles 
generally accepted in the United States&#13;of America requires management to 
make estimates and assumptions that affect the reported amounts of assets and 
liabilities and&#13;the reported amounts of revenues and expenses during the 
reporting period. Actual results, as determined by future events, may&#13;differ
from these estimates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Cash&#13;and Cash 
Equivalents&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company considers 
all highly liquid instruments purchased with an original maturity of three 
months or less to be cash equivalents.&#13;Cash and cash equivalents may at 
times exceed federally insured limits.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Note&#13;Receivable
from Duke Mountain&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;note receivable from
Duke Mountain is unsecured, bears interest at 4.0%, and principal and interest 
are due on December 31, 2015.&#13;The Company&amp;#146;s credit risk assessment 
is limited due to the related party nature of the 
arrangement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Fair&#13;Value of
Financial Instruments&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;carrying amounts for
cash and cash equivalents, and payables approximate fair value based on 
observable quoted prices for active&#13;markets &amp;#150; Level 1 inputs. The 
carrying amount of the note receivable from Duke Mountain approximates fair 
value based on&#13;observable market inputs for interest rates &amp;#150; Level 
2 inputs.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Research&#13;and 
Development Costs&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company intends to 
outsource its research and development efforts and expense related costs as 
incurred, including the cost of&#13;manufacturing product for testing, licensing
fees and costs associated with planning and conducting clinical trials. The 
value&#13;ascribed to patents and other intellectual property acquired will be 
capitalized as it relates to particular research and development&#13;projects 
that may have alternative future uses.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Intangible&#13;Assets&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#
13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align:
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font
 style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;intangible asset 
consists primarily of Cell Deposition Device technology that the Company 
acquired during 2013 and is recorded&#13;at cost. At the time of acquisition, 
the technology had not reached technological feasibility. The amount capitalized
is accounted&#13;for as an indefinite-lived intangible asset, subject to 
impairment testing until completion or abandonment. Upon successful 
completion,&#13;a determination will be made as to the then useful life of the 
intangible asset, generally determined by the period in which 
substantially&#13;all of the cash flows are expected to be generated, and begin 
amortization. The Company tests the intangible asset for impairment&#13;at least
annually or more frequently if impairment indicators exist after performing a 
qualitative analysis. Management has multiple&#13;criteria that it considers 
when performing the qualitative analysis. The results of this review are then 
weighed and prioritized.&#13;If the totality of the relevant events and 
circumstances indicate that it is not more likely than not that the fair value 
of the&#13;intangible asset is less than its carrying amount, additional 
impairment tests are not necessary.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company assessed the
following qualitative factors that could affect any change in the fair value of 
the intangible asset: analysis&#13;of the technology&amp;#146;s current phase, 
additional testing necessary to bring the technology to market, development of 
competing&#13;products, changes in projections caused by delays, changes in
regulations, changes in the market for the technology and changes&#13;in cost 
projections to bring the technology to market. Based on a qualitative 
assessment, management concluded that a positive&#13;assertion can be made from 
the qualitative assessment that it is not more likely than not that the fair 
value of the intangible&#13;asset is less than its carrying 
amount.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Stock&#13;Options&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&
lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company measures all
stock-based compensation awards using a fair value method on the date of grant 
and recognizes such expense&#13;in its consolidated financial statements over 
the requisite service period. The Company uses the Black-Scholes pricing model 
to&#13;determine the fair value of stock-based compensation awards on the date 
of grant. The Black-Scholes pricing model requires management&#13;to make 
assumptions regarding option lives, expected volatility, and risk free interest 
rates.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times 
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Income&#13;Taxes&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&l
t;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company recognizes 
income taxes on an accrual basis based on tax positions taken, or expected to be
taken, in tax returns. A tax&#13;position is defined as a position in a 
previously filed tax return or a position expected to be taken in future tax 
filing that&#13;is reflected in measuring current or deferred income tax assets 
and liabilities. Tax positions are recognized only when it is&#13;more likely 
than not (i.e., likelihood of greater than 50%), based on technical merits, that
the position would be sustained upon&#13;examination by taxing authorities. Tax 
positions that meet the more likely than not threshold are measured using a 
probability-weighted&#13;approach as the largest amount of tax benefit that is 
greater than 50% likely of being realized upon settlement. Income taxes&#13;are 
accounted for using an asset and liability approach that requires the 
recognition of deferred tax assets and liabilities for&#13;the expected future 
tax consequences of events that have been recognized in our financial statements
or tax returns. A valuation&#13;allowance is established to reduce deferred tax 
assets if all, or some portion, of such assets will more than likely not be 
realized.&#13;No provision for income taxes was recorded during the periods 
presented because the Company had a net taxable loss. Should they&#13;occur, our
policy is to classify interest and penalties related to tax positions as 
interest expense. Since our inception, no&#13;such interest or penalties have 
been incurred.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Discontinued&#13;Operations&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&
#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;assets and financial
results of the Company&amp;#146;s oil and gas and mineral assets are being 
reported as discontinued operations&#13;as a result of the sale of the oil and 
gas properties in February 2013 and the sale of the Company&amp;#146;s 
subsidiary which controlled&#13;various mineral leases and claims in December 
2013. Certain amounts reported in the prior periods presented have been 
reclassified&#13;to conform to the current period financial statement 
presentation. These reclassifications have no effect on previously 
reported&#13;net income (loss). See &amp;#147;Note 3. Discontinued 
Operations&amp;#148; for a summary of the amounts reclassified for the 
periods&#13;presented herein.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font:
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Earnings&#13;(Loss)
Per Share&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company presents 
both basic and diluted earnings per share (&amp;#147;EPS&amp;#148;) amounts. 
Basic EPS is calculated by dividing net&#13;income (loss) by the weighted 
average number of common shares outstanding during the period presented. Diluted
EPS amounts are&#13;based upon the weighted average number of common and common 
equivalent shares outstanding during the period presented. 
Potentially&#13;dilutive shares of common stock consisted of warrants to 
purchase shares of common stock (8,200,000 shares for 2013 and nil 
shares&#13;for 2012) and options to purchase shares of common stock (80,000 
shares for 2013 and nil shares for 2012). During the periods&#13;presented, 
potentially dilutive shares of common stock were not included in the computation
of dilutive loss per share as to do&#13;so would be anti-
dilutive.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Comprehensive&#13;Income 
(Loss)&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times 
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Comprehensive&#13;loss
 is comprised of net loss,and a reclassification on disposal of subsidiary for 
the periods presented.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Related&#13;Party 
Transactions&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;related party is 
generally defined as (i) any person who holds 10% or more of the 
Company&amp;#146;s securities and their immediate&#13;families; (ii) the 
Company&amp;#146;s management; (iii) someone who directly or indirectly 
controls, is controlled by or is under&#13;common control with the Company; or
(iv) anyone who can significantly influence the financial and operating 
decisions of the Company.&#13;A transaction is considered to be a related party 
transaction when there is a transfer of resources or obligations between 
related&#13;parties. See &amp;#147;Note 7. Related Party Transactions,&amp;#148;
for further discussion.&lt;/font&gt;&lt;/p&gt;</us-
gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock 
contextRef="From2014-01-01to2014-06-30">&lt;p style="margin: 
0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify"&gt;On August 1, 2013, the Company engaged
Vector&#13;to assist the Company with identifying subject matter experts in the 
medical device and biotechnology industries and to assist&#13;the Company with 
its ongoing research, development and eventual commercialization of its 
Regeneration Technology (collectively,&#13;the &amp;#147;Services&amp;#148;). In
consideration of the Services, the Company will pay Vector a monthly consulting 
fee of $5,000.&#13;The consulting agreement with Vector continues until December
31, 2014, unless earlier terminated by either party upon 5 days 
prior&#13;written notice.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;In connection with the 
Company&amp;#146;s anticipated&#13;Section 510(k) submission of its proprietary 
Cell Deposition Device to the Food and Drug Administration, the Company has 
engaged&#13;StemCell System GmbH (&amp;#147;StemCell Systems&amp;#148;) to 
provide it with prototypes and related documents. The Company received&#13;a 
purchase order from StemCell Systems in the amount of $130,000, for which 
$65,000 was paid in the three months ended June 30,&#13;2014. The remaining 
payments are due prior to December 31, 2014, the exact timing of which is 
dependent on when the work is performed.&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent:
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;See also &amp;#147;Note 6. 
Related Party Transactions.&amp;#148;&lt;/p&gt;</us-
gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock 
contextRef="From2013-01-01to2013-12-31">&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;On&#13;June 27, 2012, the Company entered into
an At-Will Executive Services Agreement (the &amp;#147;Bien Services 
Agreement&amp;#148;) with&#13;Ms. Janet Bien, pursuant to which Ms. Bien was to 
serve as the Company&amp;#146;s Chief Financial Officer. Pursuant to the Bien 
Services&#13;Agreement, Ms. Bien was to provide the Company with services 
consistent with that of a Chief Financial Officer on a part-time&#13;basis, for 
which she was to be paid a monthly fee of $2,400 and was to be reimbursed for 
any business related expenses. The Bien&#13;Services Agreement was terminable by
either the Company or Ms. Bien upon written notice with or without cause. The 
Bien Services&#13;Agreement was terminated effective as of September 30, 
2013.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times 
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;February 15, 2013, 
the Company entered into an agreement with Kenneth Kirkland, Ph.D. (the 
&amp;#147;Kirkland AB Agreement&amp;#148;)&#13;pursuant to which Dr. Kirkland 
will serve as a member of the Company&amp;#146;s Advisory Board. The Kirkland AB
Agreement provides&#13;for a monthly fee of $2,000 and may be terminated by 
either party with a five day notice. The Kirkland AB Agreement was 
terminated&#13;effective as of June 30, 
2013.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;August 1, 2013, the 
Company engaged Vector to assist the Company with identifying subject matter 
experts in the medical device&#13;and biotechnology industries and to assist the
Company with its ongoing research, development and eventual commercialization 
of&#13;its Regeneration Technology (collectively, the 
&amp;#147;Services&amp;#148;). In consideration of the Services, the Company 
will pay&#13;Vector a monthly consulting fee of Five Thousand Dollars ($5,000). 
The consulting agreement with Vector continues until December&#13;31, 2014, 
unless earlier terminated by either party upon five (5) days prior written 
notice.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;October 1, 2013, the 
Company entered into an At-Will Executive Services Agreement (the 
&amp;#147;Rosen Services Agreement&amp;#148;)&#13;with Ms. Rhonda Rosen, 
pursuant to which Ms. Rosen is to serve as the Company&amp;#146;s Chief 
Financial Officer. Pursuant to the&#13;Rosen Services Agreement, Ms. Rosen was 
to provide the Company with services consistent with that of a Chief Financial 
Officer&#13;on a part-time basis, for which is to be paid a monthly fee of 
$2,400 and reimbursed for any business related 
expenses.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;December 1, 
2013, we appointed Mr. Bold as our President &amp;#38; CEO and entered into the 
Consulting Agreement with Mr. Bold. Pursuant&#13;to the terms of the Consulting 
Agreement, Mr. Bold is expected to serve on a part-time basis and will receive 
an annual fee of&#13;$50,000, payable in 12 equal installments, which is 
prorated for any partial months during the term of the Consulting 
Agreement.&#13;In addition to Mr. Bold&amp;#146;s fee, he was issued Option 
Shares to purchase up to 40,000 shares of our common stock at a price&#13;of 
$0.75 per share the closing price of our common stock as quoted on the OTCQB on 
November 29, 2013. The Options Shares may be&#13;exercised on a 
&amp;#147;cashless basis&amp;#148; using the formula contained therein and, 
subject to Mr. Bold&amp;#146;s continued service&#13;as our President and Chief 
Executive Officer, vest as follows: (a) 20,000 Options Shares vest on December 
1, 2014; and (b) 20,000&#13;Options Shares vest on December 1, 
2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; 
text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;See also &amp;#147;Note 7. Related 
Party&#13;Transactions&amp;#148;.&lt;/font&gt;&lt;/p&gt;</us-
gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2014-
01-01to2014-06-30">&lt;p style="margin: 0pt; text-align: 
justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;As&#13;compensation for their service on the Board, Dr. 
Kirkland and Mr. Sierchio will receive an annual retainer of $6,000, 
payable&#13;in equal yearly installments in arrears and prorated for any partial
years of service. Additionally, subject to their entering&#13;into a non-
statutory stock option agreement with us, Dr. Kirkland and Mr. Sierchio were 
each issued incentive stock options to&#13;purchase up to 20,000 shares of the 
Company&amp;#146;s common stock at an exercise price of $0.65 per share, the 
closing price of&#13;the Company&amp;#146;s common stock as quoted on the OTC 
Markets Group Inc. QB tier (the &amp;#147;OTCQB&amp;#148;) on July 31, 2013, 
pursuant&#13;to the Incentive Plan. Subject to their continued service as a 
member of the Board, 10,000 of the option shares vest immediately&#13;and 10,000
of the option shares vest on the first anniversary of date of 
grant.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;September 30, 
2013, Ms. Rosen resigned as President and Chief Executive Officer and the 
Company entered into an At-Will Executive&#13;Services Agreement (the 
&amp;#147;Rosen Services Agreement&amp;#148;), pursuant to which Ms. Rosen will 
serve as the Company&amp;#146;s&#13;Chief Financial Officer. Pursuant to the 
Rosen Services Agreement, Ms. Rosen will provide the Company with services 
consistent&#13;with that of a Chief Financial Officer on a part-time basis, for 
which she will be paid a monthly fee of $2,400 and will be reimbursed&#13;for 
any business related expenses. The Rosen Services Agreement is terminable by 
either the Company or Ms. Rosen upon advance&#13;written 
notice.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;November 29, 2013, 
the Company entered into a subscription agreement with Kalen Capital Corporation
(the &amp;#147;Investor&amp;#148;),&#13;a private Alberta corporation wholly 
owned by Mr. Harmel S. Rayat and a majority shareholder of the 
Company&amp;#146;s, pursuant&#13;to which the Investor purchased 3,500,000 Units
at a purchase price of $0.43 per Unit, for an aggregate purchase amount of 
$1,505,000.&#13;Each Unit consists of: (a) one share of common stock; (b) one 
Series B Warrant exercisable for one share of Common Stock at an&#13;exercise 
price of $0.43 per share if exercised within the first eighteen months or $0.46 
per share if exercised after the first&#13;eighteen months and prior to 
expiration on November 29, 2018; and (c) one Series C Warrant exercisable for 
one share of common&#13;stock at an exercise price of $0.43 per share if 
exercised within the first eighteen months or $0.49 per share if exercised 
after&#13;the first eighteen months and prior to expiration on November 29, 
2018. Each of the Series B Warrant and Series C Warrant contains&#13;a provision
allowing the holder to exercise the respective warrant on a cashless basis as 
further set forth therein. The Unit&#13;price of $0.43 represents a 30% discount
to the 20 day average closing price of the Common Stock as quoted on the OTCQB 
as of&#13;October 31, 2013, the last trading date prior to us entering into a 
non-binding term sheet with the Investor regarding the purchase&#13;of the 
Units.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 1, 2013, the
Company appointed Mr. Bold as its President &amp;#38; CEO and entered into the 
Consulting Agreement with Mr.&#13;Bold. Pursuant to the terms of the Consulting 
Agreement, Mr. Bold is expected to serve on a part-time basis and will receive 
an&#13;annual fee of $50,000, payable in 12 equal installments, which is 
prorated for any partial months during the term of the Consulting&#13;Agreement.
In addition to Mr. Bold&amp;#146;s fee, he was issued Option Shares to purchase 
up to 40,000 shares of the Company&amp;#146;s&#13;common stock at a price of 
$0.75 per share the closing price of the Company&amp;#146;s common stock as 
quoted on the OTCQB on November&#13;29, 2013. The Options Shares may be 
exercised on a cashless basis using the formula contained therein and, subject 
to Mr. Bold&amp;#146;s&#13;continued service as the Company&amp;#146;s President
and Chief Executive Officer, vest as follows, 20,000 Options Shares on: 
(a)&#13;December 1, 2014; and (b) December 1, 
2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 31, 2013, 
the Company completed the sale of 100% of the issued and outstanding shares of 
Fostung Resources to Duke for&#13;a promissory note in the amount of $80,000, 
which amount approximated the fair value of the leases and mining claims 
controlled&#13;by Fostung Resources, as concluded by an independent third-party 
geological consultant. Principal and interest at 4.0% are payable&#13;on 
December 31, 2015. Mr. Herdev S. Rayat, the majority shareholder of Duke, is the
brother of Mr. Harmel S. Rayat, the Company&amp;#146;s&#13;majority 
shareholder.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;April 1, 2014, the 
Company appointed Ms. Patsy Trisler as its Vice President &amp;#150; Clinical 
&amp;#38; Regulatory Affairs and entered&#13;into the Trisler Consulting 
Agreement with Ms. Trisler. Pursuant to the terms of the Trisler Consulting 
Agreement, Ms. Trisler&#13;will receive a monthly fee of $5,000, which covers 
her services for up to 40 hours in any given month and will pay her an 
hourly&#13;fee of $125 for every hour in excess of forty, prorated for any 
partial hour. The Consulting Agreement may be terminated at any&#13;time by 
either Ms. Trisler or the Company. In addition to Ms. Trisler&amp;#146;s fee, 
she was issued Option Shares to purchase up&#13;to 50,000 shares of the 
Company&amp;#146;s common stock at a price of $1.05 per share, the closing price
of the Company&amp;#146;s common&#13;stock as quoted on the OTCQB on March 31, 
2014. The Options Shares may be exercised on a &amp;#147;cashless 
basis&amp;#148; using the&#13;formula contained therein and, subject to Ms. 
Trisler&amp;#146;s continued service as the Company&amp;#146;s Vice President 
&amp;#150;&#13;Clinical &amp;#38; Regulatory Affairs, vest as follows, 10,000 
Options Shares on: (a) April 1, 2015; (b) April 1, 2016; (c) April&#13;1, 2017; 
(d) April 1, 2018; and (e) April 1, 2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;On&#13;April 20, 2014, the Company appointed Andrew Danielson as its 
Director of Business Development at an annual salary of $60,000.&#13;In addition
Mr. Danielson was issued Option Shares to purchase 5,000 shares of the 
Company&amp;#146;s common stock at a price of&#13;$1.05 per share, the closing 
price of the Company&amp;#146;s common stock as quoted on the OTCQB on April 17,
2014. The Options Shares&#13;may be exercised on a &amp;#147;cashless 
basis&amp;#148; using the formula contained therein and, subject to Mr. 
Danielson&amp;#146;s continued&#13;service with the Company. The Options Shares 
vest on April 20, 2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;/font&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;the three months 
ended June 30, 2014, directors&amp;#146; and management fees, consulting fees 
and reimbursement of expenses paid&#13;to officers and directors of the Company 
were $3,000 (2013: $0). For the&amp;#160;six months
 ended June 30, 2014, directors&amp;#146;&#13;and management fees, consulting 
fees and reimbursement of expenses paid to officers and directors of the Company
was $6,000 (2013:&#13;$0). Legal fees paid to one of the Company&amp;#146;s 
directors in the three months ended June 30, 2014 were $27,820 (2013: 
$38,974).&#13;Legal fees paid to one of the Company&amp;#146;s directors in 
the&amp;#160;six months ended June 30, 2014 were $82,185 (2013: 
$62,439).&#13;Amounts included in accounts payable and accrued expenses, and due
to related parties, at June 30, 2014 were $36,080 (2013: 
$4,800).&lt;/font&gt;&lt;/p&gt;</us-
gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2013-
01-01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;Effective&#13;as of June 19, 2012, Mr. Joseph Sierchio, a 
member of the Company&amp;#146;s Board, was appointed as its Acting Interim 
President&#13;and Chief Executive Officer; and effective as of June 27, 2012, 
Ms. Janet Bien was appointed as the Company&amp;#146;s Chief 
Financial&#13;Officer.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;June 20, 2013, Mr. 
Joseph Sierchio, resigned as the Acting Interim President and Chief Executive 
Officer and remains a director;&#13;Ms. Rhonda B. Rosen was appointed to serve 
as the President and Chief Executive Officer and a member of the Board and 
entered&#13;into an employment agreement for a two year term (the 
&amp;#147;Rosen Employment Agreement&amp;#148;), subject to the earlier 
termination&#13;provisions contained therein. Pursuant to the terms of the Rosen
Employment Agreement, Ms. Rosen was paid an annual salary of&#13;$120,000. In 
addition to Ms. Rosen&amp;#146;s salary, she was eligible to receive a cash 
bonus to be determined by our Board, in&#13;their sole discretion. The Rosen 
Employment Agreement also provides Ms. Rosen with a monthly stipend of no more 
than $1,500 to&#13;cover medical insurance premiums until such time as the 
Company can make available an alternative medical insurance 
plan.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;July 29, 2013, the 
Board appointed Dr. Kenneth Kirkland to serve as a member of the Board effective
August 1, 2013. Prior to this&#13;appointment, Dr. Kirkland resigned from the 
Company&amp;#146;s Advisory Board. See &amp;#147;Note 6. 
Commitments&amp;#148;.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;compensation for 
their service on the Board, Dr. Kirkland and Mr. Sierchio will receive an annual
retainer of $6,000, payable&#13;in equal yearly installments in arrears and 
prorated for any partial years of service. Additionally, subject to their 
entering&#13;into a non-statutory stock option agreement with us, Dr. Kirkland 
and Mr. Sierchio were each issued incentive stock options to&#13;purchase up to 
20,000 shares of our common stock at an exercise price of $0.65 per share, the 
closing price of the Company&amp;#146;s&#13;common stock as quoted on the OTC 
Markets Group Inc. QB tier (the &amp;#147;OTCQB&amp;#148;) on July 31, 2013, 
pursuant to the Incentive&#13;Plan. Subject to their continued service as a 
member of the Board, 10,000 of the option shares vest immediately and 10,000 
of&#13;the option shares vest on the first anniversary of date of 
grant.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;September 30, 
2013, Ms. Bien resigned as the Company&amp;#146;s Chief Financial Officer. 
Effective September 30, 2013, Ms. Rosen&#13;resigned as President and Chief 
Executive Officer, the Rosen Employment Agreement was terminated and the Company
entered into&#13;an At-Will Executive Services Agreement (the &amp;#147;Rosen 
Services Agreement&amp;#148;), pursuant to which Ms. Rosen will serve as&#13;the
Company&amp;#146;s Chief Financial Officer. Pursuant to the Rosen Services 
Agreement, Ms. Rosen will provide the Company with&#13;services consistent with
that of a Chief Financial Officer on a part-time basis, for which she will be 
paid a monthly fee of $2,400&#13;and will be reimbursed for any business related
expenses. The Rosen Services Agreement is terminable by either the Company 
or&#13;Ms. Rosen upon advance written notice. The incentive stock options to 
purchase up to 350,000 shares of the Company&amp;#146;s common&#13;stock at an 
exercise price of $0.72 per share, previously issued to Ms. Rosen, were 
forfeited effective September 30, 2013.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;September 30, 
2013, Mr. Sierchio resumed the position of Acting Interim President and Chief 
Executive Officer.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;November 29, 2013, we
entered into a subscription agreement with the Investor, a private Alberta 
corporation wholly owned by Mr.&#13;Harmel Rayat and a majority shareholder of 
ours, pursuant to which the Investor purchased 3,500,000 Units at a purchase 
price&#13;of $0.43 per Unit, for an aggregate purchase amount of $1,505,000. 
Each Unit consists of: (a) one share of Common Stock; (b) one&#13;Series B 
Warrant exercisable for one share of Common Stock at an exercise price of $0.43 
per share if exercised within the first&#13;eighteen months or $0.46 per share 
if exercised after the first eighteen months and prior to expiration on November
29, 2018;&#13;and (c) one Series C Warrant exercisable for one share of Common 
Stock at an exercise price of $0.43 per share if exercised within&#13;the first 
eighteen months or $0.49 per share if exercised after the first eighteen months 
and prior to expiration on November&#13;29, 2018. Each of the Series B Warrant 
and Series C Warrant contains a provision allowing the holder to exercise the 
respective&#13;warrant on a cashless basis as further set forth therein. The 
Unit price of $0.43 represents a 30% discount to the 20 day average&#13;closing 
price of the Common Stock as quoted on the OTCQB as of October 31, 2013, the 
last trading date prior to us entering into&#13;a non-binding term sheet with 
the Investor regarding the purchase of the 
Units.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 1, 2013, we 
appointed Mr. Bold as our President &amp;#38; CEO and entered into the 
Consulting Agreement with Mr. Bold.&#13;Pursuant to the terms of the Consulting 
Agreement, Mr. Bold is expected to serve on a part-time basis and will receive 
an annual&#13;fee of $50,000, payable in 12 equal installments, which is 
prorated for any partial months during the term of the Consulting 
Agreement.&#13;In addition to Mr. Bold&amp;#146;s fee, he was issued Option 
Shares to purchase up to 40,000 shares of our common stock at a price&#13;of 
$0.75 per share the closing price of our common stock as quoted on the OTCQB on 
November 29, 2013. The Options Shares may be&#13;exercised on a 
&amp;#147;cashless basis&amp;#148; using the formula contained therein and, 
subject to Mr. Bold&amp;#146;s continued service&#13;as our President and Chief 
Executive Officer, vest as follows: (a) 20,000 Options Shares vest on December 
1, 2014; and (b) 20,000&#13;Options Shares vest on December 1, 
2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 31, 2013, we
completed the sale of 100% of the issued and outstanding shares of Fostung 
Resources to Duke for a promissory&#13;note in the amount of $80,000, which
amount approximated the fair value of the leases and mining claims controlled by
Fostung&#13;Resources, as concluded by an independent third-party geological 
consultant. Principal and interest at 4.0% are payable on December&#13;31, 2015.
Mr. Herdev S. Rayat, the majority shareholder of Duke, is the brother of Mr. 
Harmel S. Rayat, our majority shareholder.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font
 style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; 
text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;For the year ended December 31,&#13;2013, management fees, consulting 
fees and reimbursement of expenses paid to officers and directors of the Company
were $49,097&#13;(2012: $43,298). Legal fees paid to one of our directors in 
2013 were $165,591 (2012: $72,503). Amounts included in accounts payable&#13;and
due to related parties at December 31, 2013 were $44,219 (2012: $9,638). The 
total expense recognized during 2013 for legal&#13;fees was $197,609 (including 
unpaid amounts of $32,018 as of December 31, 2013).&lt;/font&gt;&lt;/p&gt;</us-
gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2014-01-
01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;The interim consolidated financial 
statements&#13;included herein have been prepared by the Company, without audit,
in accordance with the rules and regulations of the Securities&#13;and Exchange 
Commission (&amp;#147;SEC&amp;#148;) pursuant to Part 210 of Regulation S-X. 
Certain information and footnote disclosures&#13;normally included in financial 
statements prepared in accordance with accounting principles generally accepted 
in the United States&#13;of America (&amp;#147;GAAP&amp;#148;) have been 
condensed or omitted pursuant to such SEC rules and regulations, although the 
Company&#13;believes that the disclosures included are adequate to make the 
information presented not misleading.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt
Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;In management&amp;#146;s
opinion, the unaudited&#13;consolidated financial statements contained herein 
reflect all adjustments, consisting solely of normal recurring items, 
which&#13;are necessary for the fair presentation of the Company&amp;#146;s 
financial position, results of operations, and cash flows on a 
basis&#13;consistent with that of the Company&amp;#146;s prior audited 
consolidated financial statements. The Company has evaluated 
information&#13;about subsequent events that became available to us through the 
date the financial statements were issued. This information relates&#13;to 
events, transactions or changes in circumstances that would require us to adjust
the amounts reported in the financial statements&#13;or to disclose information 
about those events, transactions or changes in circumstances. However, the 
results of operations for&#13;interim periods may not be indicative of results 
to be expected for the full fiscal year. Therefore, these financial 
statements&#13;should be read in conjunction with the Company&amp;#146;s audited
financial statements, including the notes thereto for the year 
ended&#13;December 31, 2013, which may be found under the Company&amp;#146;s 
profile on EDGAR.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2013-01-
01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;As&#13;the Company is devoting substantially all of its efforts to 
establishing a new business, and while planned principal operations&#13;have 
commenced, there has been no revenue generated from sales, license fees or 
royalties, and as such, the Company is considered&#13;a development stage 
company. Accordingly, the Company&amp;#146;s consolidated financial statements 
are presented in accordance with&#13;authoritative accounting guidance related 
to a development stage enterprise.&lt;/font&gt;&lt;/p&gt;</us-
gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2014-01-01to2014-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;These consolidated financial statements have&#13;been
prepared in accordance with US GAAP and include the accounts of the Company and 
its wholly owned subsidiary, RenovaCare Sciences.&#13;All significant 
intercompany transactions and balances have been eliminated. RenovaCare Sciences
was incorporated under the laws&#13;of the State of Nevada on June 12, 
2013.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2013-01-01to2013-12-
31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;These&#13;consolidated financial statements have been prepared in 
accordance with US GAAP and include the accounts of the Company and 
its&#13;wholly owned subsidiary, RenovaCare Sciences. All significant 
intercompany transactions and balances have been eliminated. 
RenovaCare&#13;Sciences was incorporated under the laws of the State of Nevada 
on June 12, 2013.&lt;/font&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <rcar:AccountingStandardsCodificationPolicyTextBlock contextRef="From2014-
01-01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"&gt;Any reference in these notes to 
applicable&#13;accounting guidance is meant to refer to the authoritative non-
governmental US GAAP as found in the Financial Accounting 
Standards&#13;Board&amp;#146;s Accounting Standards 
Codification.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times,
Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="background-color: white"&gt;In June&#13;2014, the 
Financial Accounting Standards Board (&amp;#147;FASB&amp;#148;) issued 
Accounting Standards Update (&amp;#147;ASU&amp;#148;) 2014-10,&#13;Development 
Stage Entities (Topic 915): Elimination of Certain Financial Reporting 
Requirements. ASU 2014-10 eliminates the distinction&#13;of a development stage 
entity and certain related disclosure requirements, including the elimination of
inception-to-date information&#13;on the statements of operations, cash flows 
and stockholders&amp;#146; equity. The amendments in ASU 2014-10 will be 
effective prospectively&#13;for annual reporting periods beginning after 
December 15, 2014, and interim periods within those annual periods, however 
early&#13;adoption is permitted. The Company adopted ASU 2014-10 during the 
quarter ended June 30, 2014, thereby no longer presenting or&#13;disclosing any 
information required by Topic 915.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="background-color: white"&gt;In May&#13;2014, the FASB issued ASU 2014-09,
Revenue from Contracts with Customers (Topic 606), which supersedes the revenue 
recognition&#13;requirements in Accounting Standards Codification 
(&amp;#147;ASC&amp;#148;) 605, Revenue Recognition. The new revenue recognition 
standard&#13;requires entities to recognize revenue in a way that depicts the 
transfer of promised goods or services to customers in an amount&#13;that 
reflects the consideration to which the entity expects to be entitled to in 
exchange for those goods or services. ASU 2014-09&#13;is effective for interim 
and annual reporting periods beginning after December 15, 2016 and is to be 
applied retrospectively. The&#13;Company does not currently have any revenue. As
such, ASU 2014-09 will not have any effect on the Company&amp;#146;s results of 
operations&#13;and financial position. If the Company begins generating revenue 
prior to the effective date of ASU 2014-09, it will evaluate the&#13;effect that
ASU 2014-09 will have on its results of operations and financial 
position.&lt;/font&gt;&lt;/p&gt;</rcar:AccountingStandardsCodificationPolicyText
Block>
    <rcar:AccountingStandardsCodificationPolicyTextBlock contextRef="From2013-
01-01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;Any&#13;reference in these notes to applicable accounting 
guidance is meant to refer to the authoritative non-governmental US GAAP 
as&#13;found in the Financial Accounting Standards Board&amp;#146;s Accounting 
Standards 
Codification.&lt;/font&gt;&lt;/p&gt;</rcar:AccountingStandardsCodificationPolicy
TextBlock>
<us-gaap:UseOfEstimates contextRef="From2014-01-01to2014-06-30">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;The preparation of consolidated financial statements&#13;in 
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates&#13;and assumptions that affect 
the reported amounts of assets and liabilities and the reported amounts of 
revenues and expenses during&#13;the reporting period. Actual results, as 
determined by future events, may differ from these estimates.&lt;/p&gt;</us-
gaap:UseOfEstimates>
    <us-gaap:UseOfEstimates contextRef="From2013-01-01to2013-12-31">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;preparation of consolidated financial statements in conformity
with accounting principles generally accepted in the United States&#13;of 
America requires management to make estimates and assumptions that affect the 
reported amounts of assets and liabilities and&#13;the reported amounts of 
revenues and expenses during the reporting period. Actual results, as determined
by future events, may&#13;differ from these 
estimates.&lt;/font&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2014-01-
01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;The Company considers all highly liquid 
instruments&#13;purchased with an original maturity of three months or less to 
be cash equivalents. Cash and cash equivalents may at times exceed&#13;federally
insured limits.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2013-01-
01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;Company considers all highly liquid instruments purchased with
an original maturity of three months or less to be cash equivalents.&#13;Cash 
and cash equivalents may at times exceed federally insured 
limits.&lt;/font&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:PolicyLoansReceivablePolicy contextRef="From2014-01-01to2014-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;The note receivable from Duke Mountain Resources,&#13;Inc. 
(&amp;#147;Duke&amp;#148;) is unsecured, bears interest at 4.0% and principal 
and interest are due on December 31, 2015. The Company&amp;#146;s&#13;credit 
risk assessment is limited due to the related party nature of the 
arrangement.&lt;/p&gt;</us-gaap:PolicyLoansReceivablePolicy>
    <us-gaap:PolicyLoansReceivablePolicy contextRef="From2013-01-01to2013-12-
31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;note receivable from Duke Mountain is unsecured, bears 
interest at 4.0%, and principal and interest are due on December 31, 
2015.&#13;The Company&amp;#146;s credit risk assessment is limited due to the 
related party nature of the arrangement.&lt;/font&gt;&lt;/p&gt;</us-
gaap:PolicyLoansReceivablePolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2014-01-
01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;The carrying amounts for cash and 
cash&#13;equivalents and payables approximate fair value based on observable 
quoted prices for active markets &amp;#150; Level 1 inputs.&#13;The carrying 
amount of the note receivable from Duke approximates fair value based on similar
market inputs for interest&#13;rates for a specific creditor -  Level 2 
inputs.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2013-01-
01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify; text-indent: 0pt"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;The&#13;carrying amounts for cash and cash 
equivalents, and payables approximate fair value based on observable quoted 
prices for inactive&#13;markets &amp;#150; Level 1 inputs. The carrying amount 
of the note receivable from Duke Mountain approximates fair value based 
on&#13;observable market inputs for interest rates &amp;#150; Level 2 
inputs.&lt;/font&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
<us-gaap:InProcessResearchAndDevelopmentPolicy contextRef="From2014-01-
01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;The Company intends to outsource its research&#13;and
development efforts and expense related costs as incurred, including the cost of
manufacturing product for testing, licensing&#13;fees and costs associated with 
planning and conducting clinical trials. The value ascribed to patents and other
intellectual property&#13;acquired will be capitalized as it relates to 
particular research and development projects that may have alternative future 
uses.&lt;/p&gt;</us-gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:InProcessResearchAndDevelopmentPolicy contextRef="From2013-01-
01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;Company intends to outsource its research and development 
efforts and expense related costs as incurred, including the cost 
of&#13;manufacturing product for testing, licensing fees and costs associated 
with planning and conducting clinical trials. The value&#13;ascribed to patents 
and other intellectual property acquired will be capitalized as it relates to 
particular research and development&#13;projects that may have alternative 
future uses.&lt;/font&gt;&lt;/p&gt;</us-
gaap:InProcessResearchAndDevelopmentPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2014-01-
01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;The intangible asset consists primarily of&#13;Cell 
Deposition Device technology that the Company acquired during 2013 and is 
recorded at cost. At the time of acquisition the&#13;technology had not reached 
technological feasibility. The amount capitalized is accounted for as an 
indefinite-lived intangible&#13;asset, subject to impairment testing until 
completion or abandonment. Upon successful completion, a determination will be 
made&#13;as to the then useful life of the intangible asset, generally 
determined by the period in which substantially all of the cash flows&#13;are 
expected to be generated, and begin amortization. The Company tests the 
intangible asset for impairment at least annually or&#13;more frequently if 
impairment indicators exist after performing a qualitative analysis. Management 
has multiple criteria that it&#13;considers when performing the qualitative 
analysis. The results of this review are then weighed and prioritized. If the 
totality&#13;of the relevant events and circumstances indicate that it is not 
more likely than not that the fair value of the intangible asset&#13;is less 
than its carrying amount, additional impairment tests are not 
necessary.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;The Company assessed the following qualitative&#13;factors that 
could affect any change in the fair value of the intangible asset: analysis of 
the technology&amp;#146;s current phase,&#13;additional testing necessary to 
bring the technology to market, development of competing products, changes in 
projections caused&#13;by delays, changes in regulations, changes in the market 
for the technology and changes in cost projections to bring the 
technology&#13;to market. Based on a qualitative assessment, management 
concluded that a positive assertion can be made from the qualitative 
assessment&#13;that it is not more likely than not that the fair value of the 
intangible asset is less than its carrying amount.&lt;/p&gt;</us-
gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2013-01-
01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;intangible asset consists primarily of Cell Deposition Device 
technology that the Company acquired during 2013 and is recorded&#13;at cost. At
the time of acquisition, the technology had not reached technological 
feasibility. The amount capitalized is accounted&#13;for as an indefinite-lived 
intangible asset, subject to impairment testing until completion or abandonment.
Upon successful completion,&#13;a determination will be made as to the then 
useful life of the intangible asset, generally determined by the period in which
substantially&#13;all of the cash flows are expected to be generated, and begin 
amortization. The Company tests the intangible asset for impairment&#13;at least
annually or more frequently if impairment indicators exist after performing a 
qualitative analysis. Management has multiple&#13;criteria that it considers 
when performing the qualitative analysis. The results of this review are then 
weighed and prioritized.&#13;If the totality of the relevant events and 
circumstances indicate that it is not more likely than not that the fair value 
of the&#13;intangible asset is less than its carrying amount, additional 
impairment tests are not necessary.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company assessed the
following qualitative factors that could affect any change in the fair value of 
the intangible asset: analysis&#13;of the technology&amp;#146;s current phase, 
additional testing necessary to bring the technology to market, development of 
competing&#13;products, changes in projections caused by delays, changes in 
regulations, changes in the market for the technology and changes&#13;in cost 
projections to bring the technology to market. Based on a qualitative 
assessment, management concluded that a positive&#13;assertion can be made from 
the qualitative assessment that it is not more likely than not that the fair 
value of the intangible&#13;asset is less than its carrying 
amount.&lt;/font&gt;&lt;/p&gt;</us-
gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <rcar:StockOptionsPolicyTextBlock contextRef="From2014-01-01to2014-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;The Company measures all stock-based compensation&#13;awards 
using a fair value method on the date of grant and recognizes such expense in 
its consolidated financial statements over&#13;the requisite service period. The
Company uses the Black-Scholes pricing model to determine the fair value of 
stock-based compensation&#13;awards on the date of grant. The Black-Scholes 
pricing model requires management to make assumptions regarding option lives, 
expected&#13;volatility, and risk free interest 
rates.&lt;/p&gt;</rcar:StockOptionsPolicyTextBlock>
    <rcar:StockOptionsPolicyTextBlock contextRef="From2013-01-01to2013-12-
31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;Company measures all stock-based compensation awards using a 
fair value method on the date of grant and recognizes such expense&#13;in its 
consolidated financial statements over the requisite service period. The Company
uses the Black-Scholes pricing model to&#13;determine the fair value of stock-
based compensation awards on the date of grant. The Black-Scholes pricing model 
requires management&#13;to make assumptions regarding option lives, expected 
volatility, and risk free interest 
rates.&lt;/font&gt;&lt;/p&gt;</rcar:StockOptionsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2014-01-01to2014-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;The Company recognizes income taxes on an accrual&#13;basis 
based on tax positions taken, or expected to be taken, in tax returns. A tax 
position is defined as a position in a previously&#13;filed tax return or a 
position expected to be taken in future tax filing that is reflected in 
measuring current or deferred income&#13;tax assets and liabilities. Tax 
positions are recognized only when it is more likely than not (i.e., likelihood 
of greater than&#13;50%), based on technical merits, that the position would be 
sustained upon examination by taxing authorities. Tax positions that&#13;meet 
the more likely than not threshold are measured using a probability-weighted 
approach as the largest amount of tax benefit&#13;that is greater than 50% 
likely of being realized upon settlement. Income taxes are accounted for using 
an asset and liability&#13;approach that requires the recognition of deferred 
tax assets and liabilities for the expected future tax consequences of 
events&#13;that have been recognized in the Company&amp;#146;s financial 
statements or tax returns. A valuation allowance is established to 
reduce&#13;deferred tax assets if all, or some portion, of such assets will more
than likely not be realized. Should they occur, the 
Company&amp;#146;s&#13;policy is to classify interest and penalties related to
tax positions as interest expense. Since the Company&amp;#146;s 
inception,&#13;no such interest or penalties have been incurred. The Company did
not record an income tax provision during the periods presented&#13;due to net 
taxable losses.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2013-01-01to2013-12-
31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;Company recognizes income taxes on an accrual basis based on 
tax positions taken, or expected to be taken, in tax returns. A tax&#13;position
is defined as a position in a previously filed tax return or a position expected
to be taken in future tax filing that&#13;is reflected in measuring current or 
deferred income tax assets and liabilities. Tax positions are recognized only 
when it is&#13;more likely than not (i.e., likelihood of greater than 50%), 
based on technical merits, that the position would be sustained 
upon&#13;examination by taxing authorities. Tax positions that meet the more 
likely than not threshold are measured using a probability-weighted&#13;approach
as the largest amount of tax benefit that is greater than 50% likely of being 
realized upon settlement. Income taxes&#13;are accounted for using an asset and 
liability approach that requires the recognition of deferred tax assets and 
liabilities for&#13;the expected future tax consequences of events that have 
been recognized in our financial statements or tax returns. A 
valuation&#13;allowance is established to reduce deferred tax assets if all, or 
some portion, of such assets will more than likely not be realized.&#13;No 
provision for income taxes was recorded during the periods presented because the
Company had a net taxable loss. Should they&#13;occur, our policy is to classify
interest and penalties related to tax positions as interest expense. Since our 
inception, no&#13;such interest or penalties have been 
incurred.&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock contextRef="From2014-01-
01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;The results of the Company&amp;#146;s oil and&#13;gas
and mineral assets are being reported as discontinued operations as a result of 
the sale of the oil and gas properties in February&#13;2013 and the sale of the 
Company&amp;#146;s subsidiary which controlled various mineral leases and claims
in December 2013. Certain&#13;amounts reported in the prior periods presented 
have been reclassified to conform to the current period financial statement 
presentation.&#13;These reclassifications have no effect on previously reported 
net income (loss).&lt;/p&gt;</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock contextRef="From2013-01-
01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The&#13;assets and financial results of the Company&amp;#146;s oil and
gas and mineral assets are being reported as discontinued operations&#13;as a 
result of the sale of the oil and gas properties in February 2013 and the sale 
of the Company&amp;#146;s subsidiary which controlled&#13;various mineral leases
and claims in December 2013. Certain amounts reported in the prior periods 
presented have been reclassified&#13;to conform to the current period financial 
statement presentation. These reclassifications have no effect on previously 
reported&#13;net income (loss). See &amp;#147;Note 3. Discontinued 
Operations&amp;#148; for a summary of the amounts reclassified for the 
periods&#13;presented herein.&lt;/font&gt;&lt;/p&gt;</us-
gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2014-01-01to2014-
06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;The Company presents both basic and diluted&#13;earnings per 
share (&amp;#147;EPS&amp;#148;) amounts. Basic EPS is calculated by dividing net
income (loss) by the weighted average number&#13;of common shares outstanding 
during the period presented. Diluted EPS amounts are based upon the weighted 
average number of common&#13;and common equivalent shares outstanding during the
period presented. Potentially dilutive shares of common stock consisted 
of&#13;warrants to purchase shares of common stock (8,200,000 shares as of June 
30, 2014 and December 31, 2013) and options to purchase&#13;shares of common 
stock (135,000 shares as of June 30, 2014 and 80,000 as of December 31, 2013). 
During the periods presented, potentially&#13;dilutive shares of common stock
were not included in the computation of dilutive loss per share as to do so 
would be anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2013-01-01to2013-
12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify; text-indent: 0pt"&gt;&lt;font style="font: 10pt Times New Roman,
Times, Serif"&gt;&lt;/font&gt;The&#13;Company presents both basic and diluted 
earnings per share (&amp;#147;EPS&amp;#148;) amounts. Basic EPS is calculated by
dividing net&#13;income (loss) by the weighted average number of common shares 
outstanding during the period presented. Diluted EPS amounts are&#13;based upon 
the weighted average number of common and common equivalent shares outstanding 
during the period presented. Potentially&#13;dilutive shares of common stock 
consisted of warrants to purchase shares of common stock (8,200,000 shares for 
2013 and nil shares&#13;for 2012) and options to purchase shares of common stock
(80,000 shares for 2013 and nil shares for 2012). During the 
periods&#13;presented, potentially dilutive shares of common stock were not 
included in the computation of dilutive loss per share as to do&#13;so would be 
anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <rcar:RelatedPartyTransactionsPolicyTextBlock contextRef="From2014-01-
01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;A related party is generally defined as (i)&#13;any 
person who holds 10% or more of the Company&amp;#146;s securities and their 
immediate families; (ii) the Company&amp;#146;s management;&#13;(iii) someone 
who directly or indirectly controls, is controlled by or is under common control
with the Company; or (iv) anyone&#13;who can significantly influence the 
financial and operating decisions of the Company. A transaction is considered to
be a related&#13;party transaction when there is a transfer of resources or 
obligations between related parties. See &amp;#147;Note 6. Related 
Party&#13;Transactions,&amp;#148; for further 
discussion.&lt;/p&gt;</rcar:RelatedPartyTransactionsPolicyTextBlock>
    <rcar:RelatedPartyTransactionsPolicyTextBlock contextRef="From2013-01-
01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;A&#13;related party is generally defined as (i) any person who holds 
10% or more of the Company&amp;#146;s securities and their 
immediate&#13;families; (ii) the Company&amp;#146;s management; (iii) someone 
who directly or indirectly controls, is controlled by or is under&#13;common 
control with the Company; or (iv) anyone who can significantly influence the 
financial and operating decisions of the Company.&#13;A transaction is 
considered to be a related party transaction when there is a transfer of 
resources or obligations between related&#13;parties. See &amp;#147;Note 7. 
Related Party Transactions,&amp;#148; for further 
discussion.&lt;/font&gt;&lt;/p&gt;</rcar:RelatedPartyTransactionsPolicyTextBlock
>
    <us-gaap:SponsorFees contextRef="From2014-01-01to2014-06-30" unitRef="USD" 
decimals="0">195333</us-gaap:SponsorFees>
    <us-gaap:SponsorFees contextRef="From2014-04-01to2014-06-30" unitRef="USD" 
decimals="0">68500</us-gaap:SponsorFees>
    <rcar:CommonStockConsistedOfWarrantsToPurchaseShares contextRef="AsOf2013-
12-31" unitRef="shares" 
decimals="INF">8200000</rcar:CommonStockConsistedOfWarrantsToPurchaseShares>
    <rcar:CommonStockConsistedOfWarrantsToPurchaseShares contextRef="AsOf2014-
06-30" unitRef="shares" 
decimals="INF">8200000</rcar:CommonStockConsistedOfWarrantsToPurchaseShares>
    <rcar:OptionsToPurchaseSharesOfCommonStock contextRef="AsOf2013-12-31" 
unitRef="shares" 
decimals="INF">80000</rcar:OptionsToPurchaseSharesOfCommonStock>
    <rcar:OptionsToPurchaseSharesOfCommonStock contextRef="AsOf2014-06-30" 
unitRef="shares" 
decimals="INF">135000</rcar:OptionsToPurchaseSharesOfCommonStock>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber contextRef="AsOf2013-12-31" unitRef="shares" 
decimals="INF">80000</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber contextRef="AsOf2014-06-30" unitRef="shares" 
decimals="INF">135000</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber contextRef="AsOf2012-12-31" unitRef="shares" 
xsi:nil="true" />
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod contextRef="From2014-01-01to2014-06-30" 
unitRef="shares" decimals="INF">55000</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod contextRef="From2013-01-01to2013-12-31" 
unitRef="shares" decimals="INF">430000</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod>
    
<rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIn
strumentsExercisable contextRef="From2014-01-01to2014-06-30" unitRef="shares" 
decimals="INF">20000</rcar:ShareBasedCompensationArrangementByShareBasedPaymentA
wardNonOptionEquityInstrumentsExercisable>
    
<rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIn
strumentsExercisable contextRef="From2013-01-01to2013-12-31" unitRef="shares" 
decimals="INF">20000</rcar:ShareBasedCompensationArrangementByShareBasedPaymentA
wardNonOptionEquityInstrumentsExercisable>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2013-
12-31" unitRef="USD_per_Share" decimals="INF">0.70</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2014-
06-30" unitRef="USD_per_Share" decimals="INF">0.84</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2012-
12-31" unitRef="USD_per_Share" xsi:nil="true" />
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue 
contextRef="From2014-01-01to2014-06-30" unitRef="USD_per_Share" 
decimals="INF">1.05</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue 
contextRef="From2013-01-01to2013-12-31" unitRef="USD_per_Share" 
decimals="INF">0.72</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue 
contextRef="From2014-01-01to2014-06-30" unitRef="USD_per_Share" 
decimals="INF">0.70</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue 
contextRef="From2013-01-01to2013-12-31" unitRef="USD_per_Share" 
decimals="INF">0.65</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    
<rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstruments
OtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1 
contextRef="From2014-01-01to2014-06-
30">P9Y1M17D</rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardEqui
tyInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
1>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms 
contextRef="From2014-01-01to2014-06-30">P9Y4M17D</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms 
contextRef="From2013-01-01to2013-12-31">P9Y9M</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1 contextRef="From2014-01-01to2014-06-
30">P9Y1M17D</us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1>
    <us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1 contextRef="From2013-01-01to2013-12-
31">P9Y6M</us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1>
    
<rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstruments
OtherThanOptionsGrantedWeightedAverageRemainingContractualTerms 
contextRef="From2014-01-01to2014-06-
30">P9Y9M</rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityI
nstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms>
    
<rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstruments
OtherThanOptionsGrantedWeightedAverageRemainingContractualTerms 
contextRef="From2013-01-01to2013-12-
31">P9Y6M18D</rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardEqui
tyInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms>
    <us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2013-12-31" 
unitRef="USD" decimals="0">23200</us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding>
    <us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2014-06-30" 
unitRef="USD" decimals="0">14850</us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding>
    <us-
gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2012-12-31" 
unitRef="USD" xsi:nil="true" />
    
<rcar:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstruments
OtherThanOptionsAggregateIntrinsicValueExercisable contextRef="From2014-01-
01to2014-06-30" unitRef="USD" 
decimals="0">5000</rcar:SharebasedCompensationArrangementBySharebasedPaymentAwar
dEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable>
    
<rcar:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstruments
OtherThanOptionsAggregateIntrinsicValueExercisable contextRef="From2013-01-
01to2013-12-31" unitRef="USD" 
decimals="0">6800</rcar:SharebasedCompensationArrangementBySharebasedPaymentAwar
dEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable>
    
<rcar:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstruments
OtherThanOptionsAggregateIntrinsicValueGranted contextRef="From2014-01-01to2014-
06-30" unitRef="USD" 
decimals="0">0</rcar:SharebasedCompensationArrangementBySharebasedPaymentAwardEq
uityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2014-01-
01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;On July 12, 2013, the Company, together with&#13;its 
wholly owned subsidiary, RenovaCare Sciences, entered into an asset purchase 
agreement with Dr. J&amp;#246;rg Gerlach, MD, PhD,&#13;pursuant to which 
RenovaCare Sciences purchased all of Dr. Gerlach&amp;#146;s rights, title and 
interest in the Cell Deposition Device.&#13;The Company plans to further the 
development of the Cell Deposition Device, if commercially viable, bring the 
product to market.&#13;Pursuant to the terms of the Asset Purchase Agreement, 
upon the closing of the transaction, the Company paid Dr. Gerlach 
$100,002&#13;and issued to Dr. Gerlach a Series A Stock Purchase Warrant (the 
&amp;#147;Series A Warrant&amp;#148;) entitling him to purchase 
1,200,000&#13;shares (each a &amp;#147;Warrant Share&amp;#148;) of the 
Company&amp;#146;s common stock, subject to vesting milestones through July 
11,&#13;2019, at an exercise price of $0.35 per share. Acquisition related costs
amounted to $52,852 and were capitalized together with&#13;the cash payment. 
Additional costs capitalized during 2013, and which related to a wound cap 
technology, amounted to $10,000. No&#13;additional costs were capitalized during
2014. At June 30, 2014, intangible assets amounted to 
$162,854.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;The Series A Warrant was issued
in exchange&#13;for services to be rendered in the future by Dr. Gerlach. An 
additional agreed upon cash sum amounting to $300,000 will be paid&#13;to Dr. 
Gerlach upon the Company attaining certain milestones related to the 
Regeneration Technology. The value of the Series A&#13;Warrant will be 
recognized as consulting expenses to the Company over the vesting term of the 
underlying warrant, subject to Dr.&#13;Gerlach providing ongoing consulting 
services to the Company with respect to the Regeneration Technology. As such, 
the measurement&#13;date for accounting purposes will be the date on which 
performance by Dr. Gerlach is completed. The fair value of each 
Warrant&#13;Share is estimated at the end of each reporting period during which 
Dr. Gerlach renders services using the Black-Scholes option&#13;pricing model. 
The fair value of each Warrant Share was approximately $0.79 as of June 30, 
2014. Assumptions required for the Black-Scholes&#13;model are as 
follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent:
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: 
#CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-
size: 10pt"&gt;Weighted average risk-free interest 
rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;1.62%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-
align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected life in 
years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font-size: 10pt"&gt;5.00 
Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Weighted Avg Expected 
Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;90.9%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-
align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected dividend 
yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Consulting 
expense associated with the Series&#13;A Warrant amounted to $68,500 and 
$195,333 during the three and six months ended June 30, 2014.&lt;/p&gt;</us-
gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2013-01-
01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;On July&#13;12, 2013, the Company, together with its wholly owned 
subsidiary, RenovaCare Sciences, entered into an asset purchase 
agreement&#13;with Dr. J&amp;#246;rg Gerlach, MD, PhD, pursuant to which 
RenovaCare Sciences purchased all of Dr. Gerlach&amp;#146;s rights, 
title&#13;and interest in the Cell Deposition Device. The Company plans to 
further the development of the Cell Deposition Device, if 
commercially&#13;viable, bring the product to market. Pursuant to the terms of 
the Asset Purchase Agreement, upon the closing of the transaction,&#13;the 
Company paid Dr. Gerlach $100,002 and issued to Dr. Gerlach a Series A Stock 
Purchase Warrant (the &amp;#147;Series A Warrant&amp;#148;)&#13;entitling him to
purchase 1,200,000 shares (each a &amp;#147;Warrant Share&amp;#148;) of the 
Company&amp;#146;s common stock, subject to&#13;vesting milestones through July 
11, 2019, at an exercise price of $0.35 per share. Acquisition related costs 
amounted to $52,852&#13;and were capitalized together with the cash payment. 
Additional costs capitalized during 2013, and which related to a wound 
cap&#13;technology, amounted to $10,000. At December 31, 2013, intangible assets
amounted to $162,854.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The Series&#13;A Warrant was
issued in exchange for services to be rendered in the future by Dr. Gerlach. An 
additional agreed upon cash sum&#13;amounting to $300,000 will be paid to Dr. 
Gerlach upon the Company attaining certain milestones related to the 
Regeneration Technology.&#13;The value of the Series A Warrant will be 
recognized as consulting expenses to the Company over the vesting term of the 
underlying&#13;warrant, subject to Dr. Gerlach providing ongoing consulting 
services to the Company with respect to the Regeneration Technology.&#13;As 
such, the measurement date for accounting purposes will be the date on which 
performance by Dr. Gerlach is completed. The fair&#13;value of each Warrant 
Share is estimated at the end of each reporting period during which Dr. Gerlach
renders services using the&#13;Black-Scholes option pricing model. The fair 
value of each Warrant Share was approximately $0.87 as of December 31, 2013. 
Assumptions&#13;required for the Black-Scholes model are as 
follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table 
cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif;
width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td 
style="width: 75%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 25%; 
border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted 
average risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;1.75%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-
align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Expected life in 
years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.5 
Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;Weighted Avg Expected 
Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;102.0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-
align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Expected dividend 
yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$0&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; 
text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Consulting expense associated with the Series A Warrant&#13;amounted 
to $237,971 during 2013.&lt;/font&gt;&lt;/p&gt;</us-
gaap:IntangibleAssetsDisclosureTextBlock>
    <rcar:CommonStockOptionsTextBlock contextRef="From2014-01-01to2014-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Approval&#13;of the 2013 Long-Term Incentive 
Plan&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New
Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;June 20, 2013, the 
Board of Directors (the &amp;#147;Board&amp;#148;) adopted, subject to receiving
shareholder approval, the 2013 Long-Term&#13;Incentive Plan (the 
&amp;#147;Incentive Plan&amp;#148;). The Incentive Plan provides for the 
issuance of stock options of up to 20,000,000&#13;shares (subject to adjustment)
of the Company&amp;#146;s common stock to officers, directors, key employees and
consultants of the&#13;Company. Options granted to employees under the Incentive
Plan, including directors and officers who are employees, may be 
incentive&#13;stock options or non-qualified stock options; options granted to 
others under the Incentive Plan are limited to non-qualified&#13;stock options. 
On November 15, 2013, shareholders owning a majority of the Company&amp;#146;s 
issued and outstanding shares approved&#13;the Incentive 
Plan.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Incentive Plan is 
administered by the Board or a committee designated by the Board. Subject to the
provisions of the Incentive&#13;Plan, the Board has the authority to determine 
the officers, employees and consultants to whom options will be granted, the 
number&#13;of shares covered by each option, vesting rights and the terms and 
conditions of each option that is granted to them; however,&#13;no person may be
granted in any of the Company&amp;#146;s fiscal year, options to purchase more 
than 2,000,000 shares under the Incentive&#13;Plan, and the aggregate fair 
market value (determined at the time the option is granted) of the shares with 
respect to which incentive&#13;stock options are exercisable for the first time 
by an optionee during any calendar year cannot exceed $100,000. Options 
granted&#13;pursuant to the Incentive Plan are exercisable no later than ten 
years after the date of grant.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;exercise price per 
share of common stock for options granted under the Incentive Plan will be the 
fair market value of the Company&amp;#146;s&#13;common stock on the date of 
grant, using the closing price of the Company&amp;#146;s common stock on the 
last trading day prior to&#13;the date of grant, except for incentive stock 
options granted to a holder of ten percent or more of the Company&amp;#146;s 
common&#13;stock, for whom the exercise price per share will not be less than 
110% of the fair market value. No option can be granted under&#13;the Incentive 
Plan after June 20, 2023.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent:
0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2014, 
there were 19,865,000 shares available for 
grant.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Stock&#13;Option 
Activity&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times
New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;August 1, 2013, the 
Company granted to each of Messrs. Kirkland and Sierchio 20,000 stock options. 
The exercise price per share&#13;is $0.65; 10,000 options vested on the grant 
date and, subject to continued service as a member of the Company&amp;#146;s 
Board, the&#13;remaining 10,000 options will vest on August 1, 2014 and may be 
exercised on a &amp;#147;cashless basis&amp;#148; using the formula 
contained&#13;therein.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;December 1, 
2013, the Company appointed Mr. Bold as its President &amp;#38; CEO and entered 
into an at-will consulting agreement (the&#13;&amp;#147;Consulting 
Agreement&amp;#148;) with Mr. Bold. Pursuant to the terms of the Consulting 
Agreement, Mr. Bold was issued a stock&#13;option to purchase up to 40,000 
shares of the Company&amp;#146;s common stock (the &amp;#147;Option 
Shares&amp;#148;) at a price of $0.75&#13;per share the closing price of the 
Company&amp;#146;s common stock as quoted on the OTCQB on November 29, 2013. The
Options Shares&#13;may be exercised on a &amp;#147;cashless basis&amp;#148; 
using the formula contained therein and, subject to Mr. Bold&amp;#146;s 
continued&#13;service as the Company&amp;#146;s President and Chief Executive 
Officer, the Options Shares vest as follows, 20,000 on: (a) December&#13;1, 
2014; and (b) December 1, 2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;April 1, 2014, the 
Company appointed Ms. Patsy Trisler as its Vice President &amp;#150; Clinical 
&amp;#38; Regulatory Affairs and entered&#13;into an at-will consulting 
agreement (the &amp;#147;Trisler Consulting Agreement&amp;#148;) with Ms. 
Trisler. Pursuant to the terms of&#13;the Trisler Consulting Agreement, Ms. 
Trisler was issued Option Shares to purchase up to 50,000 shares of the 
Company&amp;#146;s common&#13;stock at a price of $1.05 per share, the closing 
price of the Company&amp;#146;s common stock as quoted on the OTCQB on April 1, 
2014.&#13;The Options Shares may be exercised on a &amp;#147;cashless 
basis&amp;#148; using the formula contained therein and, subject to Ms. 
Trisler&amp;#146;s&#13;continued service as the Company&amp;#146;s Vice 
President &amp;#150; Clinical &amp;#38; Regulatory Affairs, the Options Shares 
vest as follows,&#13;10,000 on: (a) April 1, 2015; (b) April 1, 2016; (c) April 
1, 2017; (d) April 1, 2018; and (e) April 1, 
2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;April 20, 2014, the 
Company appointed Andrew Danielson as its Director of Business Development and 
issued Mr. Danielson Option&#13;Shares to purchase 5,000 shares of the 
Company&amp;#146;s common stock at a price of $1.05 per share, the closing price
of the Company&amp;#146;s&#13;common stock as quoted on the OTCQB on April 17, 
2014. The Options Shares may be exercised on a &amp;#147;cashless 
basis&amp;#148; using&#13;the formula contained therein and, subject to Mr. 
Danielson&amp;#146;s continued service with the Company. The Options Shares 
vest&#13;on April 20, 2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following table 
summarizes stock option activity for the period ended June 30, 
2014.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table
 cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, 
Serif; width: 100%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: 
bottom; padding-bottom: 1.5pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;br /&gt;&#13;    &amp;#160;&lt;br /&gt;&#13;    
&amp;#160;&lt;br /&gt;&#13;    &amp;#160;&lt;br /&gt;&#13;    
&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 
1.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;br /&gt;&#13;    &amp;#160;&lt;br /&gt;&#13;    
&amp;#160;&lt;br /&gt;&#13;    &amp;#160;&lt;br 
/&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" id="ffc" 
style="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt 
solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;br /&gt;&#13;    
&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;/td&gt;&#13;    &lt;td 
colspan="2" style="vertical-align: bottom; text-align: center; border-bottom:
Black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;br /&gt;&#13;    
&lt;b&gt;Average&lt;/b&gt;&lt;br /&gt;&#13;    &lt;b&gt;Exercise 
Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center; padding-bottom: 1.5pt"&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center; padding-bottom: 1.5pt"&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt 
solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;br /&gt;&#13;    
&lt;b&gt;Average&lt;/b&gt;&lt;br /&gt;&#13;    
&lt;b&gt;Remaining&lt;/b&gt;&lt;br /&gt;&#13;    
&lt;b&gt;Contractual&lt;/b&gt;&lt;br /&gt;&#13;    &lt;b&gt;Life 
(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center; padding-bottom: 1.5pt"&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center; padding-bottom: 1.5pt"&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt 
solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;br /&gt;&#13;    
&lt;b&gt;Intrinsic&lt;/b&gt;&lt;br /&gt;&#13;    
&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-
bottom: 1.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;br /&gt;&#13;    &amp;#160;&lt;br /&gt;&#13;    
&amp;#160;&lt;br /&gt;&#13;    &amp;#160;&lt;br /&gt;&#13;    
&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;tr style="background-
color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance
January&#13;    1, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%;
text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times
New Roman, Times, Serif"&gt;80,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times
New Roman, Times, Serif"&gt;9.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; width: 9%; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: white"&gt;&#13;    &lt;td style="vertical-align:
bottom; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;Options&#13;    
granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; 
padding-bottom: 1.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: right; border-bottom: Black 1.5pt solid"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;55,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; border-bottom: Black 1.5pt 
solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: right; border-bottom: Black 1.5pt solid"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;1.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify; padding-bottom: 1.5pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: right; border-bottom: Black 1.5pt solid"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; border-bottom: Black 1.5pt solid"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: right; border-bottom: Black 1.5pt 
solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 1.5pt"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;Balance&#13;    June 30, 
2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; padding-
bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: right; border-bottom: Black 2.5pt double"&gt;&lt;font
style="font: 10pt Times New Roman, Times, 
Serif"&gt;135,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;font 
style="font:
 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13; 
&lt;td style="vertical-align: bottom; border-bottom: Black 2.5pt 
double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: right; border-bottom: Black 2.5pt double"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;0.84&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify; padding-bottom: 2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: right; border-bottom: Black 2.5pt double"&gt;&lt;font
style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; border-bottom: Black 2.5pt double"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: right; border-bottom: Black 2.5pt 
double"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;14,850&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 2.5pt"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;Exercisable&#13;    at June 30, 
2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align:
bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;9.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align:
bottom; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;5,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&
lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;fair value of each 
stock option is estimated at the date of grant using the Black-Scholes option 
pricing model. The weighted-average&#13;fair value of stock options granted 
during 2013 was approximately $0.49 to $0.57 per share. The weighted average 
fair value of&#13;stock options granted during 2014 was $1.05 per share. 
Assumptions regarding volatility, expected term, dividend yield and risk-
free&#13;interest rate are required for the Black-Scholes model. The volatility 
assumption is based on the Company&amp;#146;s historical experience.&#13;The 
risk-free interest rate is based on a U.S. treasury note with a maturity similar
to the option award&amp;#146;s expected life.&#13;The expected life represents 
the average period of time that options granted are expected to be outstanding. 
The assumptions for&#13;volatility, expected life, dividend yield and risk-free 
interest rate are presented in the table 
below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: 
#CCEEFF"&gt;&#13;    &lt;td style="width: 82%; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted average risk-
free&#13;    interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
18%; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;1.43 &amp;#150; 1.62%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;Expected life in years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;4.50 &amp;#150; 5.50&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;Weighted Avg. Expected Volatility&lt;/font&gt;&lt;/td&gt;&#13; 
&lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman,
Times, Serif"&gt;99.5%&amp;#160;&amp;#150; 
105.3%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Expected dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the three and six
months ended June 30, 2014, stock-based compensation expense of $12,573 and 
$19,355, respectively, was recognized&#13;as general and administrative 
expenses. There were 20,000 stock options vested and 115,000 unvested, as of 
June 30, 2014. As of&#13;June 30, 2014, the Company had $55,387 of total 
unrecognized compensation cost related to unvested stock options, which is 
expected&#13;to be recognized by April 1, 
2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; 
text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;The Company issues new shares when options are 
exercised.&lt;/font&gt;&lt;/p&gt;</rcar:CommonStockOptionsTextBlock>
    <rcar:CommonStockOptionsTextBlock contextRef="From2013-01-01to2013-12-
31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;i&gt;Approval&#13;of the 2013 Long-Term Incentive 
Plan&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On June&#13;20, 2013, the 
Board of Directors (the &amp;#147;Board&amp;#148;) adopted, subject to receiving
shareholder approval, the 2013 Long-Term&#13;Incentive Plan (the 
&amp;#147;Incentive Plan&amp;#148;). The Incentive Plan provides for the 
issuance of stock options of up to 20,000,000&#13;shares (subject to adjustment)
of the Company&amp;#146;s common stock to officers, directors, key employees and
consultants of the&#13;Company. Options granted to employees under the Incentive
Plan, including directors and officers who are employees, may be 
incentive&#13;stock options or non-qualified stock options; options granted to 
others under the Incentive Plan are limited to non-qualified&#13;stock 
options.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The Incentive&#13;Plan is 
administered by the Board or a committee designated by the Board. Subject to the
provisions of the Incentive Plan, the&#13;Board has the authority to determine 
the officers, employees and consultants to whom options will be granted, the 
number of shares&#13;covered by each option, vesting rights and the terms and 
conditions of each option that is granted to them; however, no person&#13;may be
granted in any of the Company&amp;#146;s fiscal year, options to purchase more 
than 2,000,000 shares under the Incentive Plan,&#13;and the aggregate fair 
market value (determined at the time the option is granted) of the shares with 
respect to which incentive&#13;stock options are exercisable for the first time 
by an optionee during any calendar year cannot exceed $100,000. Options 
granted&#13;pursuant to the Incentive Plan are exercisable no later than ten 
years after the date of grant.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The exercise&#13;price per 
share of common stock for options granted under the Incentive Plan will be the 
fair market value of the Company&amp;#146;s&#13;common stock on the date of 
grant, using the closing price of the Company&amp;#146;s common stock on the 
last trading day prior to&#13;the date of grant, except for incentive stock 
options granted to a holder of ten percent or more of the Company&amp;#146;s 
common&#13;stock, for whom the exercise price per share will not be less than 
110% of the fair market value. No option can be granted under&#13;the Incentive 
Plan after June 20, 2023.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;As of December&#13;31, 2013,
there were 19,920,000 shares available for 
grant.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Stock&#13;Option 
Activity&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On August&#13;1, 2013, the 
Company granted to Messrs. Kirkland and Sierchio (20,000 stock options each) for
stock options granted on August&#13;1, 2013. The exercise price per share is 
$0.65; 10,000 options vested on the grant date and, subject to continued service
as a&#13;member of our Board, the remaining 10,000 options will vest on August 
1, 2014. The Options Shares may be exercised on a 
&amp;#147;cashless&#13;basis&amp;#148; using the formula contained 
therein.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;December 1, 
2013, we appointed Mr. Bold as our President &amp;#38; CEO and entered into an 
at-will consulting agreement (the &amp;#147;Consulting&#13;Agreement&amp;#148;) 
with Mr. Bold. Pursuant to the terms of the Consulting Agreement, Mr. Bold is 
expected to serve on a part-time&#13;basis and will receive an annual fee of 
$50,000, payable in 12 equal installments, which is prorated for any partial 
months during&#13;the term of the Consulting Agreement. In addition to Mr. 
Bold&amp;#146;s fee, he was issued a stock option to purchase up to 
40,000&#13;shares of our common stock (the &amp;#147;Option Shares&amp;#148;) at
a price of $0.75 per share the closing price of our common stock&#13;as quoted 
on the OTCQB on November 29, 2013. The Options Shares may be exercised on a 
&amp;#147;cashless basis&amp;#148; using the formula&#13;contained therein and, 
subject to Mr. Bold&amp;#146;s continued service as our President and Chief 
Executive Officer, vest as follows:&#13;(a) 20,000 Options Shares vest on 
December 1, 2014; and (b) 20,000 Options Shares vest on December 1, 
2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following table 
summarizes stock option activity for the year ended December 31, 
2013.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&lt;/font&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td 
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-
bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: Black 1pt solid"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Options 
Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-
bottom: 1pt"&gt;&lt;font style="font: 10pt Times
 New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;Weighted&#13;Average Exercise 
Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-
bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;Weighted&#13;Average Remaining Contractual Life 
(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-
bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times,
Serif"&gt;&lt;b&gt;Aggregate&#13;Intrinsic 
Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="width: 53%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Balance January 1, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width:
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width:
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options 
granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;430,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0.72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align:
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options 
forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
(350,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font
 style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0.72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance 
December 31, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;80,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: 
black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: 
black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;23,200&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Exercisable at December 31, 2013&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;6,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&
lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The fair&#13;value of each
stock option is estimated at the date of grant using the Black-Scholes option 
pricing model. The estimated weighted-average&#13;fair value of stock options 
granted during 2013 was approximately $0.49 to $0.57 per share. Assumptions 
regarding volatility,&#13;expected term, dividend yield and risk-free interest 
rate are required for the Black-Scholes model. The volatility assumption&#13;is 
based on the Company&amp;#146;s historical experience. The risk-free interest 
rate is based on a U.S. treasury note with a maturity&#13;similar to the option 
award&amp;#146;s expected life. The expected life represents the average period 
of time that options granted&#13;are expected to be outstanding. The assumptions
for volatility, expected life, dividend yield and risk-free interest rate 
are&#13;presented in the table below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td 
style="width: 75%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 25%; 
border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted 
average risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;1.43 &amp;#150; 1.49%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected 
life in years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.0 
&amp;#150; 5.5 Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted 
Avg Expected Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-
align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;99.5% - 103.4%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected 
dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$0&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New
 Roman, Times, Serif"&gt;During the&#13;year ended December 31, 2013, stock-
based compensation expense of $15,440, was recognized as general and 
administrative expenses.&#13;There were 20,000 stock options vested and 60,000 
unvested, as of December 31, 2013. There was no stock compensation expense 
recognized&#13;in 2012. As of December 31, 2013, the Company had $27,317 of 
total unrecognized compensation cost related to unvested stock 
options,&#13;which is expected to be recognized by December 31, 
2015.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The Company&#13;issues new 
shares when options are 
exercised.&lt;/font&gt;&lt;/p&gt;</rcar:CommonStockOptionsTextBlock>
    <us-
gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock contextRef="From2014-01-01to2014-06-30">&lt;p
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;Assumptions required for the Black-Scholes&#13;model are as 
follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: 
#CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-
size: 10pt"&gt;Weighted average risk-free interest 
rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;1.62%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-
align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected life in 
years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font-size: 10pt"&gt;5.00 
Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Weighted Avg Expected 
Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;90.9%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-
align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected dividend 
yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-
gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock>
    <us-
gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock contextRef="From2014-01-01to2014-06-30_us-
gaap_StockOptionMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"&gt;The assumptions for volatility, expected 
life,&#13;dividend yield and risk-free interest rate are presented in the table 
below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif;
margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: 
#CCEEFF"&gt;&#13;    &lt;td style="width: 82%; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;Weighted average risk-free interest 
rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: 
center"&gt;&lt;font style="font-size: 10pt"&gt;1.43 &amp;#150; 
1.62%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected life in 
years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font-size: 10pt"&gt;4.50 &amp;#150; 
5.50&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Weighted Avg. Expected 
Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font-size: 10pt"&gt;99.5%&amp;#160;&amp;#150; 
105.3%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Expected dividend 
yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-
gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock>
    <us-
gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock contextRef="From2013-01-01to2013-12-31">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Assumptions&#13;required for the Black-Scholes model are as 
follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table 
cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif;
width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td 
style="width: 75%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 25%; 
border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted 
average risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;1.75%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-
align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Expected life in 
years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.5 
Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;Weighted Avg Expected 
Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;102.0%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-
align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Expected dividend 
yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$0&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-
gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock>
    <us-
gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock contextRef="From2013-01-01to2013-12-31_us-
gaap_StockOptionMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;The&#13;assumptions for volatility, expected life, dividend 
yield and risk-free interest rate are presented in the table 
below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td 
style="width: 75%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 25%; 
border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted 
average risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;1.43 &amp;#150; 1.49%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected 
life in years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.0 
&amp;#150; 5.5 Years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted 
Avg Expected Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-
align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;99.5% - 103.4%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected 
dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$0&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-
gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock 
contextRef="From2014-01-01to2014-06-30">&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes 
stock option&#13;activity for the period ended June 30, 
2014.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr&gt;&#13;    &lt;td style="vertical-align: bottom; padding-
bottom: 1.5pt"&gt;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 
1.5pt"&gt;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br
/&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
colspan="2" id="ffc" style="vertical-align: bottom; text-align: center; border-
bottom: Black 1.5pt solid"&gt;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font-size: 
10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: center; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br
/&gt;&#13;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; 
padding-bottom: 1.5pt"&gt;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-
align: bottom; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;font
style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br 
/&gt;&#13;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font-size: 10pt"&gt;&lt;b&gt;Exercise 
Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; 
padding-bottom: 1.5pt"&gt;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-
align: bottom; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;font
style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br 
/&gt;&#13;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br 
/&gt;&#13;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font-size: 10pt"&gt;&lt;b&gt;Life 
(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
center; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; 
padding-bottom: 1.5pt"&gt;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="vertical-
align: bottom; text-align: center; border-bottom: Black 1.5pt
solid"&gt;&amp;#160;&lt;br /&gt;&#13;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;br 
/&gt;&#13;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;br /&gt;&#13;&amp;#160;&lt;br 
/&gt;&#13;&amp;#160;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;tr style="background-
color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance January 1, 
2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; width: 9%; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;80,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%"&gt;&lt;font style="font-size: 
10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom;
width: 9%; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    
&lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;9.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;
&lt;td style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color:
white"&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify; 
padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Options 
granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; 
padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 
1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right; border-bottom: Black 1.5pt solid"&gt;&lt;font style="font-
size: 10pt"&gt;55,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 
1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; 
padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; border-bottom: Black 1.5pt solid"&gt;
$&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: right; 
border-bottom: Black 1.5pt solid"&gt;&lt;font style="font-size: 
10pt"&gt;1.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 
1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; 
padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 
1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right; border-bottom: Black 1.5pt solid"&gt;&lt;font style="font-
size: 10pt"&gt;9.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 
1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; 
padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; border-bottom: Black 1.5pt solid"&gt;&lt;font style="font-size: 
10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom;
text-align: right; border-bottom: Black 1.5pt solid"&gt;&lt;font style="font-
size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom:
1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: 
#CCEEFF"&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: justify; 
padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Balance June 30, 
2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; padding-
bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 
2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right; border-bottom: Black 2.5pt double"&gt;&lt;font style="font-
size: 10pt"&gt;135,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 
2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; 
padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 
10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom;
text-align: right; border-bottom: Black 2.5pt double"&gt;&lt;font style="font-
size: 10pt"&gt;0.84&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 
2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify; 
padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 
2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right; border-bottom: Black 2.5pt double"&gt;&lt;font style="font-
size: 10pt"&gt;9.38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify; padding-bottom: 
2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;
    &lt;td style="text-align: justify; padding-bottom: 
2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 10pt"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: right; border-bottom: Black 2.5pt double"&gt;&lt;font style="font-size: 
10pt"&gt;14,850&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify; padding-bottom: 
2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: 
white"&gt;&#13;    &lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Exercisable at June 30, 
2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom"&gt;&lt;font style="font-size: 10pt"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: right"&gt;&lt;font style="font-size: 
10pt"&gt;0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;9.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom"&gt;&lt;font style="font-size: 10pt"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: right"&gt;&lt;font style="font-size: 
10pt"&gt;5,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-
gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock 
contextRef="From2013-01-01to2013-12-31">&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt
Times New Roman, Times, Serif"&gt;The following&#13;table summarizes stock 
option activity for the year ended December 31, 
2013.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td 
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-
bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: Black 1pt solid"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Options 
Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-
bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;Weighted&#13;Average Exercise 
Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-
bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;Weighted&#13;Average Remaining Contractual Life 
(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-
bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;Aggregate&#13;Intrinsic 
Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt; &lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="width: 53%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Balance January 1, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width:
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width:
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 9%; text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options 
granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td
 style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;430,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0.72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.55&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options 
forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
(350,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0.72&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance 
December 31, 2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;80,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: 
black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;0.70&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: 
black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;23,200&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Exercisable at December 31, 2013&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;20,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;9.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;6,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&
lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;</us-
gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2014-01-
01to2014-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;The Company has no items of other 
comprehensive&#13;income in any period presented. Therefore, net loss equals 
comprehensive loss.&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="From2013-01-
01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Comprehensive&#13;loss is comprised of net loss,and a reclassification
on disposal of subsidiary for the periods presented.&lt;/font&gt;&lt;/p&gt;</us-
gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <rcar:PurcheseOrderRecevied contextRef="From2014-01-01to2014-06-30" 
unitRef="USD" decimals="0">130000</rcar:PurcheseOrderRecevied>
    <rcar:PurcheseOrderAmountReceived contextRef="From2014-04-01to2014-06-30" 
unitRef="USD" decimals="0">65000</rcar:PurcheseOrderAmountReceived>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation 
contextRef="AsOf2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation 
contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">543877</us-
gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities 
contextRef="AsOf2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities 
contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">12932</us-
gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities>
    <rcar:LongtermLiabilitiesOfDiscontinuedOperations contextRef="AsOf2013-12-
31" unitRef="USD" xsi:nil="true" />
    <rcar:LongtermLiabilitiesOfDiscontinuedOperations contextRef="AsOf2012-12-
31" unitRef="USD" 
decimals="0">57532</rcar:LongtermLiabilitiesOfDiscontinuedOperations>
    <us-gaap:Liabilities contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">55441</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2012-12-31" unitRef="USD" 
decimals="0">98075</us-gaap:Liabilities>
    <rcar:AccumulatedDeficitSinceDevelopmentStage contextRef="AsOf2013-12-31" 
unitRef="USD" decimals="0">-
1068310</rcar:AccumulatedDeficitSinceDevelopmentStage>
    <rcar:AccumulatedDeficitSinceDevelopmentStage contextRef="AsOf2012-12-31" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax 
contextRef="AsOf2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax 
contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">-4104</us-
gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:GainOrLossOnSaleOfStockInSubsidiary contextRef="From2013-01-
01to2013-12-31" unitRef="USD" decimals="0">-453581</us-
gaap:GainOrLossOnSaleOfStockInSubsidiary>
    <us-gaap:GainOrLossOnSaleOfStockInSubsidiary contextRef="From2013-02-
20to2013-12-31" unitRef="USD" decimals="0">-453581</us-
gaap:GainOrLossOnSaleOfStockInSubsidiary>
    <us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations 
contextRef="From2014-01-01to2014-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations 
contextRef="From2013-01-01to2013-06-30" unitRef="USD" decimals="0">49338</us-
gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations>
    <us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations 
contextRef="From2013-01-01to2013-12-31" unitRef="USD" decimals="0">-404243</us-
gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations>
    <us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations 
contextRef="From2014-04-01to2014-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations 
contextRef="From2013-04-01to2013-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations 
contextRef="From2012-01-01to2012-12-31" unitRef="USD" decimals="0">-14420</us-
gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations>
    <us-gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations 
contextRef="From2013-02-20to2013-12-31" unitRef="USD" decimals="0">-453581</us-
gaap:GainLossOnDispositionOfRealEstateDiscontinuedOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2013-
01-01to2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2012-
01-01to2012-12-31" unitRef="USD" decimals="0">-14420</us-
gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2013-
02-20to2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2013-01-01to2013-12-31"
unitRef="USD" decimals="0">-1028684</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2012-01-01to2012-12-31"
unitRef="USD" decimals="0">-243959</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2013-02-20to2013-12-31"
unitRef="USD" decimals="0">-1064206</us-gaap:ComprehensiveIncomeNetOfTax>
    <rcar:ImpairmentAndDepreciation contextRef="From2013-01-01to2013-12-31" 
unitRef="USD" xsi:nil="true" />
    <rcar:ImpairmentAndDepreciation contextRef="From2012-01-01to2012-12-31" 
unitRef="USD" decimals="0">1527</rcar:ImpairmentAndDepreciation>
    <rcar:ImpairmentAndDepreciation contextRef="From2013-02-20to2013-12-31" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:ResultsOfOperationsAccretionOfAssetRetirementObligations 
contextRef="From2013-01-01to2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ResultsOfOperationsAccretionOfAssetRetirementObligations 
contextRef="From2012-01-01to2012-12-31" unitRef="USD" decimals="0">2216</us-
gaap:ResultsOfOperationsAccretionOfAssetRetirementObligations>
    <us-gaap:ResultsOfOperationsAccretionOfAssetRetirementObligations 
contextRef="From2013-02-20to2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostsIncurredAcquisitionOfOilAndGasProperties contextRef="From2013-
01-01to2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostsIncurredAcquisitionOfOilAndGasProperties contextRef="From2012-
01-01to2012-12-31" unitRef="USD" decimals="0">-6962</us-
gaap:CostsIncurredAcquisitionOfOilAndGasProperties>
    <us-gaap:CostsIncurredAcquisitionOfOilAndGasProperties contextRef="From2013-
02-20to2013-12-31" unitRef="USD" xsi:nil="true" />
    <rcar:AcquisitionOfIntellectualProperty contextRef="From2013-01-01to2013-12-
31" unitRef="USD" decimals="0">162854</rcar:AcquisitionOfIntellectualProperty>
    <rcar:AcquisitionOfIntellectualProperty contextRef="From2012-01-01to2012-12-
31" unitRef="USD" xsi:nil="true" />
    <rcar:AcquisitionOfIntellectualProperty contextRef="From2013-02-20to2013-12-
31" unitRef="USD" decimals="0">162854</rcar:AcquisitionOfIntellectualProperty>
    <rcar:SaleOfCommonStockAndWarrants contextRef="From2013-01-01to2013-12-31" 
unitRef="USD" decimals="0">1505000</rcar:SaleOfCommonStockAndWarrants>
    <rcar:SaleOfCommonStockAndWarrants contextRef="From2012-01-01to2012-12-31" 
unitRef="USD" xsi:nil="true" />
    <rcar:SaleOfCommonStockAndWarrants contextRef="From2013-02-20to2013-12-31" 
unitRef="USD" decimals="0">1505000</rcar:SaleOfCommonStockAndWarrants>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2013-01-
01to2013-12-31" unitRef="USD" decimals="0">1505000</us-
gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2012-01-
01to2012-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2013-02-
20to2013-12-31" unitRef="USD" decimals="0">1505000</us-
gaap:NetCashProvidedByUsedInFinancingActivities>
    
<rcar:NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfSubsidiary 
contextRef="From2013-01-01to2013-12-31" unitRef="USD" 
decimals="0">80000</rcar:NoncashInvestingAndFinancingActivitiesNoteReceivedOnDis
posalOfSubsidiary>
    
<rcar:NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfSubsidiary 
contextRef="From2012-01-01to2012-12-31" unitRef="USD" xsi:nil="true" />
    
<rcar:NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfSubsidiary 
contextRef="From2013-02-20to2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2013-
01-01to2013-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;On February&#13;18, 2013, we completed the sale of our working 
interest in the Onnie Ray #1, Haile #1, Pearce #1 and Stahl #1 oil wells. We 
entered&#13;into an Assignment Agreement with Leexus Oil LLC, the wells 
operator, whereby the Company assigned its right, title and interest&#13;in the 
oil, gas and mineral leases and the oil and gas wells. Consideration for the 
assignment was the assumption of all outstanding&#13;liabilities and assumption 
of all future payments for any and all work performed on the 
wells.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On February&#13;19, 2013, we
completed the sale of our working interest in the Cooke #6 well. We entered into
an Assignment Agreement with Millennium&#13;Petro-Physics, the well operator, 
whereby we assigned the right, title and interest in the oil, gas and mineral 
leases and the&#13;oil and gas wells. Consideration for the assignment was 
$3,000 cash.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The carrying&#13;amount of 
the oil and gas properties was $24,127 on the date of disposal. The related 
asset retirement obligation amounted to&#13;$57,532 and liabilities assumed 
amounted to $12,932. Including the $3,000 cash received, the Company recognized 
a gain of $49,338&#13;in the year ended December 31, 2013, as a result of the 
disposal.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font:
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;On December&#13;31, 2013, we
entered into a stock purchase agreement with Duke, pursuant to which we sold to 
Duke 100% of the issued and outstanding&#13;shares of Fostung Resources, a 
wholly owned subsidiary of ours, for a promissory note in the amount of $80,000,
which amount approximated&#13;the fair value of the leases and mining claims 
controlled by Fostung Resources, as concluded by an independent third-party 
geological&#13;consultant. Principal and interest at 4.0% are payable on 
December 31, 2015. Including the $80,000 of consideration received,&#13;the 
Company recognized a loss on the disposal of the subsidiary of 
$453,581.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The 
Company&amp;#146;s&#13;revenue reported in discontinued operations for the years
ended December 31, 2013 and December 31, 2012 were $nil and 
$16,549,&#13;respectively. The Company&amp;#146;s net loss reported in 
discontinued operations for the years ended December 31, 2013 and 
December&#13;31, 2012 was $(404,243) and $(14,420), respectively. The Company 
has not recognized any revenue nor incurred expenses with respect&#13;to its 
previously owned oil and gas and mineral assets since their respective sales, 
and will not recognize any continuing cash&#13;flows with respect to these 
properties in the future.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;Assets and&#13;liabilities 
of discontinued operations in the accompanying balance sheets consist of the 
following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table 
cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif;
width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#13;    
31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;Assets:&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="width: 89%; padding-left: 9pt"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;Oil and Gas Properties, net&lt;/font&gt;&lt;/td&gt;&#13;
&lt;td style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align:
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;24,127&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td 
style="padding-left: 9pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Mining properties&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-
align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;519,750&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="padding-left: 9pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: 
black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;544,677&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times,
 Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td 
style="padding-left: 9pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-
align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
(12,932&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align:
bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 
9pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Asset 
retirement obligation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(57,532&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align:
bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
(70,464&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-
gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2013-01-01to2013-12-
31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;There is&#13;no current or 
deferred tax expense for 2013 and 2012, due to the Company&amp;#146;s loss 
position. Realization of the future tax&#13;benefits related to the deferred tax
assets is dependent on many factors, including the Company&amp;#146;s ability to
generate taxable&#13;income within the net operating loss carryforward period. 
Management has considered these factors in reaching its conclusion as&#13;to the
valuation allowance for financial reporting purposes and has recorded a full 
valuation allowance against the deferred tax&#13;asset. The income tax effect, 
utilizing a 34% income tax rate, of temporary differences comprising the 
deferred tax assets and&#13;deferred tax liabilities is a result of the 
following at December 31:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;Deferred tax 
assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="width: 78%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Net operating loss carryforwards&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align:
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;2,027,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;1,852,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;86,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;106,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;2,113,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;1,958,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Valuation
allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(2,113,000&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(1,958,000&lt;/font&gt;&lt;/td&gt;&#13;
    &lt;td nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align:
bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;Net deferred tax 
assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: 
black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: 
black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&
lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The 2013&#13;increase in the
valuation allowance was $155,000 (2012: 
$81,000).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;The Company&#13;has 
available net operating loss carryforwards of approximately $5,961,000 for tax
purposes to offset future taxable income which&#13;expires commencing 2014 
through to the year 2033. Pursuant to the Tax Reform Act of 1986, annual 
utilization of the Company&amp;#146;s&#13;net operating loss carryforwards may 
be limited if a cumulative change in ownership of more than 50% is deemed to 
occur within&#13;any three-year period. The tax years 2010 through 2013 remain 
open to examination by federal agencies and other jurisdictions&#13;in which it 
operates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;A reconciliation&#13;between
the statutory federal income tax rate (34%) and the effective rate of income tax
expense for the years ended December&#13;31 
follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table 
cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif;
width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="width: 78%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Statutory federal income tax rate&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align:
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align:
bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;Valuation 
allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
%)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
%)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; 
background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p
 style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2014-01-01to2014-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;There&#13;were no subsequent events to disclose as of the issue date 
of this report.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2013-01-01to2013-12-
31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;There&#13;were no subsequent events to disclose as of the issue date 
of this report.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <rcar:AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock 
contextRef="From2013-01-01to2013-12-31">&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;Assets&#13;and liabilities of discontinued 
operations in the accompanying balance sheets consist of the 
following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table 
cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif;
width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;December&#13;    
31, 2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;Assets:&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="width: 89%; padding-left: 9pt"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;Oil and Gas Properties, net&lt;/font&gt;&lt;/td&gt;&#13;
&lt;td style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align:
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;24,127&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td 
style="padding-left: 9pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Mining properties&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-
align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;519,750&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="padding-left: 9pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: 
black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;544,677&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td 
style="padding-left: 9pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-
align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
(12,932&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align:
bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 
9pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Asset 
retirement obligation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(57,532&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align:
bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
(70,464&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</rcar:AssetsAn
dLiabilitiesOfDiscontinuedOperationsTablesTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock 
contextRef="From2013-01-01to2013-12-31">&lt;p style="margin: 
0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" 
style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr 
style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;Deferred tax 
assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align:
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="width: 78%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Net operating loss carryforwards&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align:
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;2,027,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;1,852,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;86,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;106,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;2,113,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;1,958,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: white"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Valuation
allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(2,113,000&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(1,958,000&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align:
bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;Net deferred tax 
assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: 
black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font style="font:
10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&
#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-
gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock 
contextRef="From2013-01-01to2013-12-31">&lt;p style="margin: 
0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New 
Roman, Times, Serif"&gt;A&#13;reconciliation between the statutory federal 
income tax rate (34%) and the effective rate of income tax expense for the 
years&#13;ended December 31 follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 
100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    
&lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2013&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&lt;b&gt;2012&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td 
style="width: 78%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;Statutory federal income tax rate&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="width: 1%; text-align: right"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align:
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 
1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 8%; 
text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" 
style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align:
bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 
10pt Times New Roman, Times, Serif"&gt;Valuation
allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
right"&gt;&lt;font style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
%)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times,
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
nowrap="nowrap"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;
%)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; 
background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt 
Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times 
New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-
bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, 
Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, 
Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap"&gt;&lt;font 
style="font: 10pt Times New Roman, Times, Serif"&gt;
%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p 
style="margin: 0pt"&gt;&lt;/p&gt;</us-
gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2013-
12-31" unitRef="USD" decimals="0">2027000</us-
gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2012-
12-31" unitRef="USD" decimals="0">1852000</us-
gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts 
contextRef="AsOf2013-12-31" unitRef="USD" decimals="0">86000</us-
gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts 
contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">106000</us-
gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2013-12-31" unitRef="USD" 
decimals="0">2113000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2012-12-31" unitRef="USD" 
decimals="0">1958000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2013-12-31" 
unitRef="USD" decimals="0">-2113000</us-
gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2012-12-31" 
unitRef="USD" decimals="0">-1958000</us-
gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2013-12-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2012-12-31" unitRef="USD"
xsi:nil="true" />
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
contextRef="From2013-01-01to2013-12-31" unitRef="Pure" decimals="INF">0.34</us-
gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
contextRef="From2012-01-01to2012-12-31" unitRef="Pure" decimals="INF">0.34</us-
gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-
gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance contextRef="From2013-01-01to2013-12-31" unitRef="Pure" decimals="INF">-
0.34</us-
gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance>
    <us-
gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance contextRef="From2012-01-01to2012-12-31" unitRef="Pure" decimals="INF">-
0.34</us-
gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2013-01-
01to2013-12-31" unitRef="Pure" decimals="INF">0.00</us-
gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2012-01-
01to2012-12-31" unitRef="Pure" decimals="INF">0.00</us-
gaap:EffectiveIncomeTaxRateContinuingOperations>
    <rcar:IncreaseInValuationAllowance contextRef="From2013-01-01to2013-12-31" 
unitRef="USD" decimals="0">155000</rcar:IncreaseInValuationAllowance>
    <rcar:IncreaseInValuationAllowance contextRef="From2012-01-01to2012-12-31" 
unitRef="USD" decimals="0">81000</rcar:IncreaseInValuationAllowance>
    <us-gaap:OilAndGasPropertyFullCostMethodNet contextRef="AsOf2012-12-
31_custom_OilAndGasPropertiesNetMember" unitRef="USD" decimals="0">24127</us-
gaap:OilAndGasPropertyFullCostMethodNet>
    <us-gaap:OilAndGasPropertyFullCostMethodNet contextRef="AsOf2012-12-
31_custom_UnprovenPropertiesMember_custom_MiningPropertiesMember" unitRef="USD" 
decimals="0">519750</us-gaap:OilAndGasPropertyFullCostMethodNet>
    <us-gaap:OilAndGasPropertyFullCostMethodNet contextRef="AsOf2012-12-
31_custom_DepreciationAndImpairmentMember_us-gaap_OtherCurrentAssetsMember" 
unitRef="USD" decimals="0">800</us-gaap:OilAndGasPropertyFullCostMethodNet>
    <us-gaap:OilAndGasPropertyFullCostMethodNet contextRef="AsOf2013-12-31_us-
gaap_AssetsMember" unitRef="USD" decimals="0">544677</us-
gaap:OilAndGasPropertyFullCostMethodNet>
    <us-gaap:AssetRetirementObligation contextRef="AsOf2013-12-31" unitRef="USD"
decimals="0">57532</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation contextRef="AsOf2012-12-
31_custom_TotalLiabilitiesMember" unitRef="USD" decimals="0">-70464</us-
gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation contextRef="AsOf2012-12-31_us-
gaap_AccountsPayableMember" unitRef="USD" decimals="0">-12932</us-
gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation contextRef="AsOf2012-12-
31_custom_AssetRetirementObligationMember" unitRef="USD" decimals="0">-
57532</us-gaap:AssetRetirementObligation>
    <rcar:CarryingAmountOfOilAndGasProperties contextRef="AsOf2013-12-31" 
unitRef="USD" decimals="0">24127</rcar:CarryingAmountOfOilAndGasProperties>
    <us-gaap:OilAndGasReclamationLiabilityNoncurrent contextRef="AsOf2013-12-31"
unitRef="USD" decimals="0">12932</us-
gaap:OilAndGasReclamationLiabilityNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash 
contextRef="AsOf2013-12-31" unitRef="USD" decimals="0">3000</us-
gaap:DisposalGroupIncludingDiscontinuedOperationCash>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss 
contextRef="From2013-01-01to2013-12-31" unitRef="USD" decimals="0">49338</us-
gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
contextRef="From2013-01-01to2013-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue 
contextRef="From2012-01-01to2012-12-31" unitRef="USD" decimals="0">16549</us-
gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss 
contextRef="From2013-01-01to2013-12-31" unitRef="USD" decimals="0">-404243</us-
gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss 
contextRef="From2012-01-01to2012-12-31" unitRef="USD" decimals="0">-14420</us-
gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod contextRef="From2013-01-01to2013-12-31" 
unitRef="shares" decimals="INF">-350000</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod>
    <us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue 
contextRef="From2013-01-01to2013-12-31" unitRef="USD_per_Share" 
decimals="INF">0.72</us-
gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    
<rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstruments
OtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms 
contextRef="From2013-01-01to2013-12-
31">P9Y6M</rcar:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityI
nstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms>
    <rcar:StockOptionsGranted contextRef="From2013-01-01to2013-12-31" 
unitRef="USD_per_Share" decimals="INF">0.49</rcar:StockOptionsGranted>
    <us-gaap:OtherNonoperatingExpense contextRef="From2013-01-01to2013-12-
31_custom_LegalFeeMember" unitRef="USD" decimals="0">197609</us-
gaap:OtherNonoperatingExpense>
    <rcar:ExpenseRecognizedUnpaidAmounts contextRef="From2013-01-01to2013-12-
31_custom_LegalFeeMember" unitRef="USD" 
decimals="0">32018</rcar:ExpenseRecognizedUnpaidAmounts>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>rcar-20140630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.0a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: rcar_S%2D1.xfr; Date: 
2014%2D09%2D05T15:06:51 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 
+Kwpo7xRiXgen8uIanEsOaeGecP9zZF3OZkxvm13bblqnyAnPBaxOiDwDPxGURUC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xmlns:xbrldt="http://xbrl.org/2005/xbrldt" 
xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-
gaap/2013-01-31" xmlns:us-roles="http://fasb.org/us-roles/2013-01-31" 
xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-
types="http://fasb.org/us-types/2013-01-31" 
xmlns:rcar="http://janusresourcesinc.com/20140630" 
elementFormDefault="qualified" 
targetNamespace="http://janusresourcesinc.com/20140630">
    <annotation>
      <appinfo>
<link:roleType
roleURI="http://janusresourcesinc.com/role/DocumentAndEntityInformation" 
id="DocumentAndEntityInformation">
<link:definition>00000001 - Document - Document and Entity
Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/ConsolidatedBalanceSheets" 
id="ConsolidatedBalanceSheets">
<link:definition>00000002 - Statement - CONSOLIDATED BALANCE
SHEETS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/ConsolidatedBalanceSheetsParenthetica
l" id="ConsolidatedBalanceSheetsParenthetical">
<link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS
(Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfOperations" 
id="ConsolidatedStatementsOfOperations">
<link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF
OPERATIONS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementComprehensiveLos
s" id="ConsolidatedStatementComprehensiveLoss">
<link:definition>00000005 - Statement - CONSOLIDATED STATEMENT
COMPREHENSIVE LOSS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfStockholdersE
quity" id="ConsolidatedStatementsOfStockholdersEquity">
<link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF
STOCKHOLDERS' EQUITY</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfCashFlows" 
id="ConsolidatedStatementsOfCashFlows">
<link:definition>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH
FLOWS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOpe
rations" id="OrganizationNatureAndContinuanceOfOperations">
<link:definition>00000008 - Disclosure - Organization, Nature and
Continuance of Operations</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPolicies" 
id="SignificantAccountingPolicies">
<link:definition>00000009 - Disclosure - Significant Accounting
Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperations" 
id="DiscontinuedOperations">
<link:definition>00000010 - Disclosure - Discontinued
Operations</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualProperty" id="IntangibleAssets-IntellectualProperty">
<link:definition>00000011 - Disclosure - Intangible Assets -
Intellectual Property</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/CommonStockOptions" 
id="CommonStockOptions">
<link:definition>00000012 - Disclosure - Common Stock
Options</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://janusresourcesinc.com/role/Commitments"
id="Commitments">
<link:definition>00000013 - Disclosure - Commitments</link:definition>
  <link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/RelatedPartyTransactions" 
id="RelatedPartyTransactions">
<link:definition>00000014 - Disclosure - Related Party
Transactions</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
id="IncomeTaxes">
<link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://janusresourcesinc.com/role/IncomeTaxes"
<link:definition>00000015 - Disclosure - Income Taxes</link:definition>
  <link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/SubsequentEvents" 
id="SubsequentEvents">
<link:definition>00000016 - Disclosure - Subsequent
Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPoliciesPolicies
" id="SignificantAccountingPoliciesPolicies">
<link:definition>00000017 - Disclosure - Significant Accounting Policies
(Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/NotesToFinancialStatementsPropertyPla
ntAndEquipmentDisclosureTextBlockTables" 
id="NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables
">
<link:definition>00000018 - Disclosure - Discontinued Oil and Gas
Operations (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertTables" id="IntangibleAssets-IntellectualPropertTables">
<link:definition>00000019 - Disclosure - Intangible Assets -
Intellectual Propert (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsTables" 
id="CommonStockOptionsTables">
<link:definition>00000020 - Disclosure - Common Stock Options
(Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/IncomeTaxesTables" 
id="IncomeTaxesTables">
<link:definition>00000021 - Disclosure - Income Taxes
(Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOpe
rationsDetailsNarrative" 
id="OrganizationNatureAndContinuanceOfOperationsDetailsNarrative">
<link:definition>00000022 - Disclosure - Organization Nature and
Continuance of Operations (Details Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPoliciesDetailsN
arrative" id="SignificantAccountingPoliciesDetailsNarrative">
<link:definition>00000023 - Disclosure - Significant Accounting Policies
(Details Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperationsDetails" 
id="DiscontinuedOperationsDetails">
<link:definition>00000024 - Disclosure - Discontinued Operations
(Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperationsDetailsNarrativ
e" id="DiscontinuedOperationsDetailsNarrative">
<link:definition>00000025 - Disclosure - Discontinued Operations
(Details Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetails" id="IntangibleAssets-IntellectualPropertDetails">
<link:definition>00000026 - Disclosure - Intangible Assets -
Intellectual Propert (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetailsNarrative" id="IntangibleAssets-
IntellectualPropertDetailsNarrative">
<link:definition>00000027 - Disclosure - Intangible Assets -
Intellectual Propert (Details Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetails" 
id="CommonStockOptionsDetails">
<link:definition>00000028 - Disclosure - Common Stock Options
(Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetails1" 
id="CommonStockOptionsDetails1">
<link:definition>00000029 - Disclosure - Common Stock Options (Details
1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetailsNarrative" 
id="CommonStockOptionsDetailsNarrative">
<link:definition>00000030 - Disclosure - Common Stock Options (Details
Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/CommitmentsDetailsNarrative" 
id="CommitmentsDetailsNarrative">
<link:definition>00000031 - Disclosure - Commitments (Details
Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/RelatedPartyTransactionsDetailsNarrat
ive" id="RelatedPartyTransactionsDetailsNarrative">
<link:definition>00000032 - Disclosure - Related Party Transactions
(Details Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetails" 
id="IncomeTaxesDetails">
<link:definition>00000033 - Disclosure - Income Taxes
(Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetails1" 
id="IncomeTaxesDetails1">
<link:definition>00000034 - Disclosure - Income Taxes (Details
1)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetailsNarrative" 
id="IncomeTaxesDetailsNarrative">
<link:definition>00000035 - Disclosure - Income Taxes (Details
Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="rcar-20140630_pre.xml"
xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" 
xlink:title="Presentation Links" />
<link:linkbaseRef xlink:type="simple" xlink:href="rcar-20140630_lab.xml"
xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" 
xlink:title="Label Links" />
<link:linkbaseRef xlink:type="simple" xlink:href="rcar-20140630_cal.xml"
xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" 
xlink:title="Calculation Links" />
<link:linkbaseRef xlink:type="simple" xlink:href="rcar-20140630_def.xml"
xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" 
xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" 
schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" 
schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2013-01-31" 
schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2013-01-31" 
schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-
31.xsd" />
    <import namespace="http://fasb.org/us-types/2013-01-31" 
schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-
31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" 
schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" 
schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <element id="rcar_FeeMember" name="FeeMember" nillable="true" 
xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_LegalFeeMember" name="LegalFeeMember" nillable="true" 
xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_AdvisoryFeesMember" name="AdvisoryFeesMember" 
nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_AccumulatedDeficitMember" name="AccumulatedDeficitMember" 
nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_AccumulatedOtherComprehensiveLossMember" 
name="AccumulatedOtherComprehensiveLossMember" nillable="true" 
xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_OilAndGasPropertiesNetMember" 
name="OilAndGasPropertiesNetMember" nillable="true" xbrli:periodType="duration" 
type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_TotalLiabilitiesMember" name="TotalLiabilitiesMember" 
nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_MiningPropertiesMember" name="MiningPropertiesMember" 
nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_AssetRetirementObligationMember" 
name="AssetRetirementObligationMember" nillable="true" 
xbrli:periodType="duration" type="nonnum:domainItemType"
substitutionGroup="xbrli:item" />
    <element id="rcar_OptionGrantedMember" name="OptionGrantedMember" 
nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_OptionCancelledMember" name="OptionCancelledMember" 
nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_OptionExercisedMember" name="OptionExercisedMember" 
nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_EmployeesAndDirectorsMember" 
name="EmployeesAndDirectorsMember" nillable="true" xbrli:periodType="duration" 
type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_TwoDirectorsMember" name="TwoDirectorsMember" 
nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_EmployeeMember" name="EmployeeMember" nillable="true" 
xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_DocumentAndEntityInformationAbstract" 
name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_ConsolidatedBalanceSheetsAbstract" 
name="ConsolidatedBalanceSheetsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_LongtermLiabilitiesOfDiscontinuedOperations" 
name="LongtermLiabilitiesOfDiscontinuedOperations" nillable="true" 
xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_AccumulatedDeficitSinceDevelopmentStage" 
name="AccumulatedDeficitSinceDevelopmentStage" nillable="true" 
xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_ConsolidatedBalanceSheetsParentheticalAbstract" 
name="ConsolidatedBalanceSheetsParentheticalAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_ConsolidatedStatementsOfOperationsAbstract" 
name="ConsolidatedStatementsOfOperationsAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss" 
name="ConsolidatedStatementsOfComprehensiveIncomeLoss" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_ConsolidatedStatementsOfStockholdersEquityAbstract" 
name="ConsolidatedStatementsOfStockholdersEquityAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_StockBasedCompensation" name="StockBasedCompensation" 
nillable="true" xbrli:periodType="duration" xbrli:balance="credit" 
type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_StockBasedCompensationOptions" 
name="StockBasedCompensationOptions" nillable="true" xbrli:periodType="duration"
xbrli:balance="credit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_IssuanceOfUnits" name="IssuanceOfUnits" nillable="true" 
xbrli:periodType="duration" type="xbrli:sharesItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_CommonUnitIssuance" name="CommonUnitIssuance" 
nillable="true" xbrli:periodType="duration" xbrli:balance="credit" 
type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
<element id="rcar_ConsolidatedStatementsOfCashFlowsAbstract" 
name="ConsolidatedStatementsOfCashFlowsAbstract" abstract="true" nillable="true"
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_StockBasedConsultingExpense" 
name="StockBasedConsultingExpense" nillable="true" xbrli:periodType="duration" 
xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_ImpairmentAndDepreciation" 
name="ImpairmentAndDepreciation" nillable="true" xbrli:periodType="duration" 
xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_AcquisitionOfIntellectualProperty" 
name="AcquisitionOfIntellectualProperty" nillable="true" 
xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType"
substitutionGroup="xbrli:item" />
    <element id="rcar_SaleOfCommonStockAndWarrants" 
name="SaleOfCommonStockAndWarrants" nillable="true" xbrli:periodType="duration" 
xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfSubsidiar
y" 
name="NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfSubsidiary" 
nillable="true" xbrli:periodType="duration" xbrli:balance="debit" 
type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_NotesToFinancialStatementsAbstract" 
name="NotesToFinancialStatementsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_DiscontinuedOperationsAbstract" 
name="DiscontinuedOperationsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_CommonStockOptionsTextBlock" 
name="CommonStockOptionsTextBlock" nillable="true" xbrli:periodType="duration" 
type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_IncomeTaxesAbstract" name="IncomeTaxesAbstract" 
abstract="true" nillable="true" xbrli:periodType="duration" 
type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_SubsequentEventAbstract" name="SubsequentEventAbstract" 
abstract="true" nillable="true" xbrli:periodType="duration" 
type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_SignificantAccountingPoliciesPoliciesAbstract" 
name="SignificantAccountingPoliciesPoliciesAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_AccountingStandardsCodificationPolicyTextBlock" 
name="AccountingStandardsCodificationPolicyTextBlock" nillable="true" 
xbrli:periodType="duration" type="nonnum:textBlockItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_StockOptionsPolicyTextBlock" 
name="StockOptionsPolicyTextBlock" nillable="true" xbrli:periodType="duration" 
type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_RelatedPartyTransactionsPolicyTextBlock" 
name="RelatedPartyTransactionsPolicyTextBlock" nillable="true" 
xbrli:periodType="duration" type="nonnum:textBlockItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_OilAndGasPropertiesAbstract" 
name="OilAndGasPropertiesAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock"
name="AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock" 
nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_IntangibleAssetsIntellectualPropertTablesAbstract" 
name="IntangibleAssetsIntellectualPropertTablesAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_CommonStockOptionsTablesAbstract" 
name="CommonStockOptionsTablesAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_IncomeTaxesTablesAbstract" 
name="IncomeTaxesTablesAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAbstract" 
name="OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAbstract" 
abstract="true" nillable="true" xbrli:periodType="duration" 
type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract" 
name="SignificantAccountingPoliciesDetailsNarrativeAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_CommonStockConsistedOfWarrantsToPurchaseShares" 
name="CommonStockConsistedOfWarrantsToPurchaseShares" nillable="true" 
xbrli:periodType="instant" type="xbrli:sharesItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_OptionsToPurchaseSharesOfCommonStock" 
name="OptionsToPurchaseSharesOfCommonStock" nillable="true" 
xbrli:periodType="instant" type="xbrli:sharesItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_DiscontinuedOperationsDetailsAbstract" 
name="DiscontinuedOperationsDetailsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_DiscontinuedOperationsDetailsNarrativeAbstract" 
name="DiscontinuedOperationsDetailsNarrativeAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_CarryingAmountOfOilAndGasProperties" 
name="CarryingAmountOfOilAndGasProperties" nillable="true" 
xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_IntangibleAssetsIntellectualPropertDetailsAbstract" 
name="IntangibleAssetsIntellectualPropertDetailsAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract" 
name="IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract" 
abstract="true" nillable="true" xbrli:periodType="duration" 
type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_CommonStockOptionsDetailsAbstract" 
name="CommonStockOptionsDetailsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_OptionsOutstandingAbstract" 
name="OptionsOutstandingAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquit
yInstrumentsExercisable"
name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIn
strumentsExercisable" nillable="true" xbrli:periodType="duration" 
type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_WeightedAverageRemainingContractedTerm" 
name="WeightedAverageRemainingContractedTerm" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrume
ntsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1" 
name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstruments
OtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1" 
nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrume
ntsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms" 
name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstruments
OtherThanOptionsGrantedWeightedAverageRemainingContractualTerms" nillable="true"
xbrli:periodType="duration" type="xbrli:durationItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrume
ntsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms" 
name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstruments
OtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms" 
nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrume
ntsOtherThanOptionsAggregateIntrinsicValueGranted" 
name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstruments
OtherThanOptionsAggregateIntrinsicValueGranted" nillable="true" 
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element 
id="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrume
ntsOtherThanOptionsAggregateIntrinsicValueExercisable" 
name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstruments
OtherThanOptionsAggregateIntrinsicValueExercisable" nillable="true" 
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_CommonStockOptionsDetails1Abstract" 
name="CommonStockOptionsDetails1Abstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_CommonStockOptionsDetailsNarrativeAbstract" 
name="CommonStockOptionsDetailsNarrativeAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_SharesAvailable" name="SharesAvailable" nillable="true" 
xbrli:periodType="instant" type="xbrli:sharesItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_StockbasedCompensationAdministrativeExpense" 
name="StockbasedCompensationAdministrativeExpense" nillable="true" 
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_UnrecognizedCompensationCost" 
name="UnrecognizedCompensationCost" nillable="true" xbrli:periodType="instant" 
xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_StockOptionsUnvested" name="StockOptionsUnvested" 
nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" 
substitutionGroup="xbrli:item" />
<element id="rcar_StockOptionsGranted" name="StockOptionsGranted" 
nillable="true" xbrli:periodType="duration" type="num:perShareItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_CommitmentsDetailsNarrativeAbstract" 
name="CommitmentsDetailsNarrativeAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_PurcheseOrderRecevied" name="PurcheseOrderRecevied" 
nillable="true" xbrli:periodType="duration" xbrli:balance="debit" 
type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="rcar_PurcheseOrderAmountReceived" 
name="PurcheseOrderAmountReceived" nillable="true" xbrli:periodType="duration" 
xbrli:balance="credit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_RelatedPartyTransactionsDetailsNarrativeAbstract" 
name="RelatedPartyTransactionsDetailsNarrativeAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_ExpenseRecognizedUnpaidAmounts" 
name="ExpenseRecognizedUnpaidAmounts" nillable="true" 
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_IncomeTaxesDetailsAbstract" 
name="IncomeTaxesDetailsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_IncomeTaxesDetails1Abstract" 
name="IncomeTaxesDetails1Abstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="rcar_IncreaseInValuationAllowance" 
name="IncreaseInValuationAllowance" nillable="true" xbrli:periodType="duration" 
xbrli:balance="credit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>rcar-20140630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.0a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: rcar_S%2D1.xfr; Date: 
2014%2D09%2D05T15:06:51 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase 
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DocumentAndEntityInformation" 
xlink:href="rcar-20140630.xsd#DocumentAndEntityInformation" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedBalanceSheets" 
xlink:href="rcar-20140630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
<link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedBalanceSheetsParenthetica
l" xlink:href="rcar-20140630.xsd#ConsolidatedBalanceSheetsParenthetical" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfOperations" 
xlink:href="rcar-20140630.xsd#ConsolidatedStatementsOfOperations" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementComprehensiveLos
s" xlink:href="rcar-20140630.xsd#ConsolidatedStatementComprehensiveLoss" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfStockholdersE
quity" xlink:href="rcar-20140630.xsd#ConsolidatedStatementsOfStockholdersEquity"
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfCashFlows" 
xlink:href="rcar-20140630.xsd#ConsolidatedStatementsOfCashFlows" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOpe
rations" xlink:href="rcar-
20140630.xsd#OrganizationNatureAndContinuanceOfOperations" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPolicies" 
xlink:href="rcar-20140630.xsd#SignificantAccountingPolicies" xlink:type="simple"
/>
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperations" 
xlink:href="rcar-20140630.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualProperty" xlink:href="rcar-20140630.xsd#IntangibleAssets-
IntellectualProperty" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/CommonStockOptions"
xlink:href="rcar-20140630.xsd#CommonStockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/Commitments" 
xlink:href="rcar-20140630.xsd#Commitments" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/RelatedPartyTransactions" 
xlink:href="rcar-20140630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IncomeTaxes" 
xlink:href="rcar-20140630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/SubsequentEvents" 
xlink:href="rcar-20140630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPoliciesPolicies
" xlink:href="rcar-20140630.xsd#SignificantAccountingPoliciesPolicies" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/NotesToFinancialStatementsPropertyPla
ntAndEquipmentDisclosureTextBlockTables" xlink:href="rcar-
20140630.xsd#NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBl
ockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertTables" xlink:href="rcar-20140630.xsd#IntangibleAssets-
IntellectualPropertTables" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsTables" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IncomeTaxesTables" 
xlink:href="rcar-20140630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef
roleURI="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOpe
rationsDetailsNarrative" xlink:href="rcar-
20140630.xsd#OrganizationNatureAndContinuanceOfOperationsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPoliciesDetailsN
arrative" xlink:href="rcar-
20140630.xsd#SignificantAccountingPoliciesDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperationsDetails" 
xlink:href="rcar-20140630.xsd#DiscontinuedOperationsDetails" xlink:type="simple"
/>
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperationsDetailsNarrativ
e" xlink:href="rcar-20140630.xsd#DiscontinuedOperationsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetails" xlink:href="rcar-20140630.xsd#IntangibleAssets-
IntellectualPropertDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetailsNarrative" xlink:href="rcar-
20140630.xsd#IntangibleAssets-IntellectualPropertDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetails" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsDetails" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetails1" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsDetails1" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetailsNarrative" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommitmentsDetailsNarrative" 
xlink:href="rcar-20140630.xsd#CommitmentsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/RelatedPartyTransactionsDetailsNarrat
ive" xlink:href="rcar-20140630.xsd#RelatedPartyTransactionsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetails"
xlink:href="rcar-20140630.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetails1" 
xlink:href="rcar-20140630.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetailsNarrative" 
xlink:href="rcar-20140630.xsd#IncomeTaxesDetailsNarrative" 
xlink:type="simple" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DocumentAndEntityInformation" 
xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedBalanceSheets" 
xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" 
xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-
gaapCashAndCashEquivalentsAtCarryingValue" />
<link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-
gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseCurrent" 
xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-
gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" 
xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:calculationArc order="300" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-
gaapOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-
gaapAssets" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndNotesReceivableNet" 
xlink:label="loc_us-gaapAccountsAndNotesReceivableNet" />
      <link:calculationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssets" xlink:to="loc_us-
gaapAccountsAndNotesReceivableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" 
xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:calculationArc order="300" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" 
xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-
gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-
gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-
gaapAccountsPayableRelatedPartiesCurrent" />
      <link:calculationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-
gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-
gaapLiabilities" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent"
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_LongtermLiabilitiesOfDiscontinuedOperations" 
xlink:label="loc_rcarLongtermLiabilitiesOfDiscontinuedOperations" />
      <link:calculationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilities" 
xlink:to="loc_rcarLongtermLiabilitiesOfDiscontinuedOperations" xlink:type="arc" 
weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" 
xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-
gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" 
xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-
gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" 
xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="300" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-
gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-
gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="400" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-
gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" 
xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-
gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-
gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedBalanceSheetsParenthet
ical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS 
(Parenthetical)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementsOfOperations
" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" 
xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" 
xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-
gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-
gaapIncomeLossFromContinuingOperations" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-
gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-
gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:calculationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-
gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementComprehensive
Loss" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENT COMPREHENSIVE 
LOSS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" 
xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-
gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax" xlink:label="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustme
ntNetOfTax" />
      <link:calculationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustme
ntNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementsOfStockholde
rsEquity" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF 
STOCKHOLDERS' EQUITY" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementsOfCashFlows"
xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" 
xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockBasedConsultingExpense" 
xlink:label="loc_rcarStockBasedConsultingExpense" />
      <link:calculationArc order="300" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_rcarStockBasedConsultingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" 
xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:calculationArc order="400" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" weight="-1"
/>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-
gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="500" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" 
weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" 
xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="600" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" 
weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" 
xlink:label="loc_us-
gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="700" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment" xlink:label="loc_us-
gaapProceedsFromSaleOfOilAndGasPropertyAndEquipment" />
      <link:calculationArc order="100"
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" 
xlink:to="loc_us-gaapProceedsFromSaleOfOilAndGasPropertyAndEquipment" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SaleOfCommonStockAndWarrants" 
xlink:label="loc_rcarSaleOfCommonStockAndWarrants" />
      <link:calculationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" 
xlink:to="loc_rcarSaleOfCommonStockAndWarrants" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOf
Operations" xlink:title="00000008 - Disclosure - Organization, Nature and 
Continuance of Operations" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SignificantAccountingPolicies" 
xlink:title="00000009 - Disclosure - Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DiscontinuedOperations" 
xlink:title="00000010 - Disclosure - Discontinued Operations" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualProperty" xlink:title="00000011 - Disclosure - Intangible Assets - 
Intellectual Property" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptions" 
xlink:title="00000012 - Disclosure - Common Stock Options" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/Commitments" xlink:title="00000013
- Disclosure - Commitments" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/RelatedPartyTransactions" 
xlink:title="00000014 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxes" xlink:title="00000015
- Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SubsequentEvents" 
xlink:title="00000016 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SignificantAccountingPoliciesPolic
ies" xlink:title="00000017 - Disclosure - Significant Accounting Policies 
(Policies)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/NotesToFinancialStatementsProperty
PlantAndEquipmentDisclosureTextBlockTables" xlink:title="00000018 - Disclosure -
Discontinued Oil and Gas Operations (Tables)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertTables" xlink:title="00000019 - Disclosure - Intangible 
Assets - Intellectual Propert (Tables)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsTables" 
xlink:title="00000020 - Disclosure - Common Stock Options (Tables)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesTables" 
xlink:title="00000021 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended"
xlink:role="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOf
OperationsDetailsNarrative" xlink:title="00000022 - Disclosure - Organization 
Nature and Continuance of Operations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SignificantAccountingPoliciesDetai
lsNarrative" xlink:title="00000023 - Disclosure - Significant Accounting 
Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DiscontinuedOperationsDetails" 
xlink:title="00000024 - Disclosure - Discontinued Operations (Details)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DiscontinuedOperationsDetailsNarra
tive" xlink:title="00000025 - Disclosure - Discontinued Operations (Details 
Narrative)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetails" xlink:title="00000026 - Disclosure - Intangible 
Assets - Intellectual Propert (Details)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetailsNarrative" xlink:title="00000027 - Disclosure - 
Intangible Assets - Intellectual Propert (Details Narrative)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsDetails" 
xlink:title="00000028 - Disclosure - Common Stock Options (Details)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsDetails1" 
xlink:title="00000029 - Disclosure - Common Stock Options (Details 1)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsDetailsNarrative
" xlink:title="00000030 - Disclosure - Common Stock Options (Details Narrative)"
/>
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommitmentsDetailsNarrative" 
xlink:title="00000031 - Disclosure - Commitments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/RelatedPartyTransactionsDetailsNar
rative" xlink:title="00000032 - Disclosure - Related Party Transactions (Details
Narrative)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesDetails" 
xlink:title="00000033 - Disclosure - Income Taxes (Details)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesDetails1" 
xlink:title="00000034 - Disclosure - Income Taxes (Details 1)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesDetailsNarrative" 
xlink:title="00000035 - Disclosure - Income Taxes (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>rcar-20140630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.0a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: rcar_S%2D1.xfr; Date: 
2014%2D09%2D05T15:06:51 -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrldt="http://xbrl.org/2005/xbrldt" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase 
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DocumentAndEntityInformation" 
xlink:href="rcar-20140630.xsd#DocumentAndEntityInformation" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedBalanceSheets" 
xlink:href="rcar-20140630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedBalanceSheetsParenthetica
l" xlink:href="rcar-20140630.xsd#ConsolidatedBalanceSheetsParenthetical" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfOperations" 
xlink:href="rcar-20140630.xsd#ConsolidatedStatementsOfOperations" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementComprehensiveLos
s" xlink:href="rcar-20140630.xsd#ConsolidatedStatementComprehensiveLoss" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfStockholdersE
quity" xlink:href="rcar-20140630.xsd#ConsolidatedStatementsOfStockholdersEquity"
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfCashFlows" 
xlink:href="rcar-20140630.xsd#ConsolidatedStatementsOfCashFlows" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOpe
rations" xlink:href="rcar-
20140630.xsd#OrganizationNatureAndContinuanceOfOperations" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPolicies" 
xlink:href="rcar-20140630.xsd#SignificantAccountingPolicies" xlink:type="simple"
/>
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperations" 
xlink:href="rcar-20140630.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualProperty" xlink:href="rcar-20140630.xsd#IntangibleAssets-
IntellectualProperty" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/CommonStockOptions"
xlink:href="rcar-20140630.xsd#CommonStockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/Commitments" 
xlink:href="rcar-20140630.xsd#Commitments" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/RelatedPartyTransactions" 
xlink:href="rcar-20140630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IncomeTaxes" 
xlink:href="rcar-20140630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/SubsequentEvents" 
xlink:href="rcar-20140630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPoliciesPolicies
" xlink:href="rcar-20140630.xsd#SignificantAccountingPoliciesPolicies"
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/NotesToFinancialStatementsPropertyPla
ntAndEquipmentDisclosureTextBlockTables" xlink:href="rcar-
20140630.xsd#NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBl
ockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertTables" xlink:href="rcar-20140630.xsd#IntangibleAssets-
IntellectualPropertTables" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsTables" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IncomeTaxesTables" 
xlink:href="rcar-20140630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOpe
rationsDetailsNarrative" xlink:href="rcar-
20140630.xsd#OrganizationNatureAndContinuanceOfOperationsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPoliciesDetailsN
arrative" xlink:href="rcar-
20140630.xsd#SignificantAccountingPoliciesDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperationsDetails" 
xlink:href="rcar-20140630.xsd#DiscontinuedOperationsDetails" xlink:type="simple"
/>
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperationsDetailsNarrativ
e" xlink:href="rcar-20140630.xsd#DiscontinuedOperationsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetails" xlink:href="rcar-20140630.xsd#IntangibleAssets-
IntellectualPropertDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetailsNarrative" xlink:href="rcar-
20140630.xsd#IntangibleAssets-IntellectualPropertDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetails" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsDetails" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetails1" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsDetails1" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetailsNarrative" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommitmentsDetailsNarrative" 
xlink:href="rcar-20140630.xsd#CommitmentsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/RelatedPartyTransactionsDetailsNarrat
ive" xlink:href="rcar-20140630.xsd#RelatedPartyTransactionsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetails"
xlink:href="rcar-20140630.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetails1" 
xlink:href="rcar-20140630.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetailsNarrative"
xlink:href="rcar-20140630.xsd#IncomeTaxesDetailsNarrative" 
xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" 
arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" 
arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" 
arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" 
arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" 
arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" 
arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DocumentAndEntityInformation" 
xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedBalanceSheets" 
xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedBalanceSheetsParenthet
ical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS 
(Parenthetical)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementsOfOperations
" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementComprehensive
Loss" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENT COMPREHENSIVE 
LOSS" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementsOfStockholde
rsEquity" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF 
STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" 
xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" 
xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" 
xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" 
xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" 
xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" 
xbrldt:contextElement="segment" xlink:from="loc_us-
gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" 
xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-
gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" 
xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-
gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" 
xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-
gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-
gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-
gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-
gaapSharesIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapSharesIssued_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapStockholdersEquity_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockBasedCompensation" 
xlink:label="loc_rcarStockBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_rcarStockBasedCompensation_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockBasedCompensationOptions" 
xlink:label="loc_rcarStockBasedCompensationOptions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_rcarStockBasedCompensationOptions_60" xlink:type="arc" 
order="6" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IssuanceOfUnits" xlink:label="loc_rcarIssuanceOfUnits_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_rcarIssuanceOfUnits_60" xlink:type="arc" order="7" />
<link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonUnitIssuance" 
xlink:label="loc_rcarCommonUnitIssuance_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_rcarCommonUnitIssuance_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax" xlink:label="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustme
ntNetOfTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustme
ntNetOfTax_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapNetIncomeLoss_60" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementsOfCashFlows"
xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOf
Operations" xlink:title="00000008 - Disclosure - Organization, Nature and 
Continuance of Operations" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SignificantAccountingPolicies" 
xlink:title="00000009 - Disclosure - Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DiscontinuedOperations" 
xlink:title="00000010 - Disclosure - Discontinued Operations" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualProperty" xlink:title="00000011 - Disclosure - Intangible Assets - 
Intellectual Property" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptions" 
xlink:title="00000012 - Disclosure - Common Stock Options" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/Commitments" xlink:title="00000013
- Disclosure - Commitments" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/RelatedPartyTransactions" 
xlink:title="00000014 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxes" xlink:title="00000015
- Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SubsequentEvents" 
xlink:title="00000016 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SignificantAccountingPoliciesPolic
ies" xlink:title="00000017 - Disclosure - Significant Accounting Policies 
(Policies)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/NotesToFinancialStatementsProperty
PlantAndEquipmentDisclosureTextBlockTables" xlink:title="00000018 - Disclosure -
Discontinued Oil and Gas Operations (Tables)" />
    <link:definitionLink xlink:type="extended"
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertTables" xlink:title="00000019 - Disclosure - Intangible 
Assets - Intellectual Propert (Tables)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsTables" 
xlink:title="00000020 - Disclosure - Common Stock Options (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" 
xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" 
xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:type="arc" 
order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPPlanDomain" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" 
xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" 
xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" xlink:type="arc" 
order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPPlanDomain_10" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" 
xbrldt:contextElement="segment" xlink:from="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="loc_us-
gaapEmployeeStockOwnershipPlanESOPPlanDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockOptionMember" 
xlink:label="loc_us-gaapStockOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" 
xlink:to="loc_us-gaapStockOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" 
xlink:label="loc_us-
gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock_50" 
xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock" xlink:label="loc_us-
gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuatio
nTechniquesTableTextBlock_50" />
<link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuatio
nTechniquesTableTextBlock_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesTables" 
xlink:title="00000021 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOf
OperationsDetailsNarrative" xlink:title="00000022 - Disclosure - Organization 
Nature and Continuance of Operations (Details Narrative)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SignificantAccountingPoliciesDetai
lsNarrative" xlink:title="00000023 - Disclosure - Significant Accounting 
Policies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DiscontinuedOperationsDetails" 
xlink:title="00000024 - Disclosure - Discontinued Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" 
xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" 
xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-
gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-
gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" 
xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-
gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-
gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" 
xbrldt:contextElement="segment" xlink:from="loc_us-
gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-
gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OilAndGasPropertiesNetMember" 
xlink:label="loc_rcarOilAndGasPropertiesNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" 
xlink:to="loc_rcarOilAndGasPropertiesNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_MiningPropertiesMember" 
xlink:label="loc_rcarMiningPropertiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" 
xlink:to="loc_rcarMiningPropertiesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherCurrentAssetsMember" 
xlink:label="loc_us-gaapOtherCurrentAssetsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" 
xlink:to="loc_us-gaapOtherCurrentAssetsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsMember" xlink:label="loc_us-
gaapAssetsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" 
xlink:to="loc_us-gaapAssetsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" 
xlink:label="loc_us-gaapFairValueByLiabilityClassAxis" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapFairValueByLiabilityClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliation
ByLiabilityClassDomain" xlink:label="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" 
xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliation
ByLiabilityClassDomain" xlink:label="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain_10" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" 
xbrldt:contextElement="segment" xlink:from="loc_us-
gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableMember" 
xlink:label="loc_us-gaapAccountsPayableMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" xlink:to="loc_us-gaapAccountsPayableMember_40" 
xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AssetRetirementObligationMember" 
xlink:label="loc_rcarAssetRetirementObligationMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" xlink:to="loc_rcarAssetRetirementObligationMember_50" 
xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_TotalLiabilitiesMember" 
xlink:label="loc_rcarTotalLiabilitiesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" xlink:to="loc_rcarTotalLiabilitiesMember_60" 
xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OilAndGasPropertyFullCostMethodNet" xlink:label="loc_us-
gaapOilAndGasPropertyFullCostMethodNet_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapOilAndGasPropertyFullCostMethodNet_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetRetirementObligation" 
xlink:label="loc_us-gaapAssetRetirementObligation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapAssetRetirementObligation_80" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DiscontinuedOperationsDetailsNarra
tive" xlink:title="00000025 - Disclosure - Discontinued Operations (Details 
Narrative)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetails" xlink:title="00000026 - Disclosure - Intangible 
Assets - Intellectual Propert (Details)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetailsNarrative" xlink:title="00000027 - Disclosure - 
Intangible Assets - Intellectual Propert (Details Narrative)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsDetails" 
xlink:title="00000028 - Disclosure - Common Stock Options (Details)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsDetails1" 
xlink:title="00000029 - Disclosure - Common Stock Options (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" 
xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" 
xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:type="arc" 
order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPPlanDomain" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" 
xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" 
xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" xlink:type="arc" 
order="20" />
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPPlanDomain_10" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" 
xbrldt:contextElement="segment" xlink:from="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="loc_us-
gaapEmployeeStockOwnershipPlanESOPPlanDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockOptionMember" 
xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" 
xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-
gaapRangeAxis" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" 
xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-
gaapRangeMember" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" 
xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" 
xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-
gaapRangeMember_10" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" 
xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" 
xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" 
xlink:label="loc_us-gaapMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-
gaapMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" 
xlink:label="loc_us-gaapMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-
gaapMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-
gaapFairValueAssumptionsRiskFreeInterestRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssumptionsRiskFreeInterestRate_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" 
xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssumptionsExpectedTerm_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-
gaapFairValueAssumptionsWeightedAverageVolatilityRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssumptionsWeightedAverageVolatilityRate_70" xlink:type="arc" 
order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-
gaapFairValueAssumptionsExpectedDividendRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssumptionsExpectedDividendRate_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsDetailsNarrative
" xlink:title="00000030 - Disclosure - Common Stock Options (Details Narrative)"
/>
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommitmentsDetailsNarrative" 
xlink:title="00000031 - Disclosure - Commitments (Details Narrative)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/RelatedPartyTransactionsDetailsNar
rative" xlink:title="00000032 - Disclosure - Related Party Transactions (Details
Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" 
xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" 
xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-
gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" 
xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" 
xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" 
xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" 
xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" 
xbrldt:contextElement="segment" xlink:from="loc_us-
gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-
gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OfficerMember" 
xlink:label="loc_us-gaapOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-
gaapOfficerMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DirectorMember" 
xlink:label="loc_us-gaapDirectorMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-
gaapDirectorMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" 
xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-
gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" 
xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-
gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20"
/>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-
gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" 
xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" 
xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" 
xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_FeeMember" xlink:label="loc_rcarFeeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" 
xlink:to="loc_rcarFeeMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_LegalFeeMember" xlink:label="loc_rcarLegalFeeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" 
xlink:to="loc_rcarLegalFeeMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" 
xlink:label="loc_us-
gaapRelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapRelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_170" 
xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-
gaapAccountsPayableRelatedPartiesCurrentAndNoncurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapAccountsPayableRelatedPartiesCurrentAndNoncurrent_170" xlink:type="arc" 
order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingExpense" 
xlink:label="loc_us-gaapOtherNonoperatingExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapOtherNonoperatingExpense_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ExpenseRecognizedUnpaidAmounts" 
xlink:label="loc_rcarExpenseRecognizedUnpaidAmounts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_rcarExpenseRecognizedUnpaidAmounts_170" xlink:type="arc" order="3"
/>
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesDetails" 
xlink:title="00000033 - Disclosure - Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesDetails1" 
xlink:title="00000034 - Disclosure - Income Taxes (Details 1)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesDetailsNarrative" 
xlink:title="00000035 - Disclosure - Income Taxes (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>rcar-20140630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.0a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: rcar_S%2D1.xfr; Date: 
2014%2D09%2D05T15:06:51 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase 
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedPeriodEndLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedPeriodStartLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedTotalLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"
roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedTerseLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:labelLink xlink:type="extended" 
xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OfficerMember" xlink:label="us-
gaap_OfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OfficerMember" xlink:to="us-gaap_OfficerMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OfficerMember_lbl" xml:lang="en-US">Officer and directors 
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" 
xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related 
Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_FeeMember" xlink:label="rcar_FeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_FeeMember" xlink:to="rcar_FeeMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_FeeMember_lbl" xml:lang="en-US">Management Fee 
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" 
xlink:label="us-gaap_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-
gaap_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual 
[Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-
gaap_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DirectorMember" xlink:to="us-gaap_DirectorMember_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DirectorMember_lbl" xml:lang="en-US">Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_LegalFeeMember" xlink:label="rcar_LegalFeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_LegalFeeMember" xlink:to="rcar_LegalFeeMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_LegalFeeMember_lbl" xml:lang="en-US">Legal Fee 
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AdvisoryFeesMember" xlink:label="rcar_AdvisoryFeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AdvisoryFeesMember" 
xlink:to="rcar_AdvisoryFeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource"
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_AdvisoryFeesMember_lbl" xml:lang="en-US">Advisory 
Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" 
xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-
gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" 
xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-
gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components 
[Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" 
xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-
gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In 
Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AccumulatedDeficitMember" 
xlink:label="rcar_AccumulatedDeficitMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AccumulatedDeficitMember" 
xlink:to="rcar_AccumulatedDeficitMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_AccumulatedDeficitMember_lbl" xml:lang="en-US">Accumulated 
deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AccumulatedOtherComprehensiveLossMember" 
xlink:label="rcar_AccumulatedOtherComprehensiveLossMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AccumulatedOtherComprehensiveLossMember" 
xlink:to="rcar_AccumulatedOtherComprehensiveLossMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_AccumulatedOtherComprehensiveLossMember_lbl" xml:lang="en-
US">Accumulated other comprehensive (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OilAndGasPropertiesNetMember" 
xlink:label="rcar_OilAndGasPropertiesNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OilAndGasPropertiesNetMember" 
xlink:to="rcar_OilAndGasPropertiesNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_OilAndGasPropertiesNetMember_lbl" xml:lang="en-US">Oil And Gas
Properties, Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-
gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-
gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant 
and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_TotalLiabilitiesMember" 
xlink:label="rcar_TotalLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_TotalLiabilitiesMember" 
xlink:to="rcar_TotalLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_TotalLiabilitiesMember_lbl" xml:lang="en-US">Total Liabilities
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" 
xlink:label="us-gaap_FairValueByLiabilityClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-
gaap_FairValueByLiabilityClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US">Liability Class 
[Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_MiningPropertiesMember" 
xlink:label="rcar_MiningPropertiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_MiningPropertiesMember" 
xlink:to="rcar_MiningPropertiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_MiningPropertiesMember_lbl" xml:lang="en-US">Mining Properties
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherCurrentAssetsMember" 
xlink:label="us-gaap_OtherCurrentAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OtherCurrentAssetsMember" xlink:to="us-
gaap_OtherCurrentAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OtherCurrentAssetsMember_lbl" xml:lang="en-US">Other current assets 
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableMember" 
xlink:label="us-gaap_AccountsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-
gaap_AccountsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts payable 
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AssetRetirementObligationMember" 
xlink:label="rcar_AssetRetirementObligationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AssetRetirementObligationMember"
xlink:to="rcar_AssetRetirementObligationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_AssetRetirementObligationMember_lbl" xml:lang="en-US">Asset 
retirement obligation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OptionGrantedMember" xlink:label="rcar_OptionGrantedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OptionGrantedMember" 
xlink:to="rcar_OptionGrantedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_OptionGrantedMember_lbl" xml:lang="en-US">Option Granted 
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-
gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OptionCancelledMember" 
xlink:label="rcar_OptionCancelledMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OptionCancelledMember" 
xlink:to="rcar_OptionCancelledMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_OptionCancelledMember_lbl" xml:lang="en-US">Option Cancelled 
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OptionExercisedMember" 
xlink:label="rcar_OptionExercisedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OptionExercisedMember" 
xlink:to="rcar_OptionExercisedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_OptionExercisedMember_lbl" xml:lang="en-US">Option Exercised 
[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsMember" xlink:label="us-
gaap_AssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsMember" xlink:to="us-gaap_AssetsMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AssetsMember_lbl" xml:lang="en-US">Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-
gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_WarrantMember_lbl" xml:lang="en-US">Warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" 
xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-
gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right 
[Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockOptionMember" 
xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-
gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StockOptionMember_lbl" xml:lang="en-US">Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:label="us-
gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" 
xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_lbl" xml:lang="en-
US">Employee Stock Ownership Plan (ESOP) Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDefe
rredCompensationAxis" xlink:label="us-
gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDefe
rredCompensationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDefe
rredCompensationAxis" xlink:to="us-
gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDefe
rredCompensationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDefe
rredCompensationAxis_lbl" xml:lang="en-US">Type of Deferred Compensation 
[Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_EmployeesAndDirectorsMember" 
xlink:label="rcar_EmployeesAndDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_EmployeesAndDirectorsMember" 
xlink:to="rcar_EmployeesAndDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_EmployeesAndDirectorsMember_lbl" xml:lang="en-US">Employees 
and Directors</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-
gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_MinimumMember_lbl" xml:lang="en-US">Minimum</link:label>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-
gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-
gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_MaximumMember_lbl" xml:lang="en-US">Maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_TwoDirectorsMember" xlink:label="rcar_TwoDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_TwoDirectorsMember" 
xlink:to="rcar_TwoDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_TwoDirectorsMember_lbl" xml:lang="en-US">Two 
Directors</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_EmployeeMember" xlink:label="rcar_EmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_EmployeeMember" xlink:to="rcar_EmployeeMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_EmployeeMember_lbl" xml:lang="en-US">Employee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" 
xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-
gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated 
Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-
gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" 
xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated
other comprehensive (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_DocumentAndEntityInformationAbstract" 
xlink:label="rcar_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_DocumentAndEntityInformationAbstract" 
xlink:to="rcar_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource"
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-
US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityRegistrantName" 
xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant 
Name</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityCentralIndexKey" 
xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central 
Index Key</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" 
xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_DocumentPeriodEndDate" 
xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End
Date</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" 
xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_CurrentFiscalYearEndDate" 
xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_CurrentFiscalYearEndDate" 
xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal 
Year End Date</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityWellKnownSeasonedIssuer" 
xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityWellKnownSeasonedIssuer" 
xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Is Entity a
Well-known Seasoned Issuer?</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityVoluntaryFilers" 
xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Is Entity a 
Voluntary Filer?</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityCurrentReportingStatus" 
xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityCurrentReportingStatus" 
xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Is Entity's 
Reporting Status Current?</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityFilerCategory" 
xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer 
Category</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedBalanceSheetsAbstract" 
xlink:label="rcar_ConsolidatedBalanceSheetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_ConsolidatedBalanceSheetsAbstract" 
xlink:to="rcar_ConsolidatedBalanceSheetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ConsolidatedBalanceSheetsAbstract_lbl" xml:lang="en-
US">Consolidated Balance Sheets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-
gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" 
xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-
gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-
gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-
gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash 
equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseCurrent" 
xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-
gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" 
xlink:label="us-gaap_OtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-
gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other 
receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-
gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndNotesReceivableNet" 
xlink:label="us-gaap_AccountsAndNotesReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccountsAndNotesReceivableNet" xlink:to="us-
gaap_AccountsAndNotesReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccountsAndNotesReceivableNet_lbl" xml:lang="en-US">Note receivable from 
Duke Mountain</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:label="us-
gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" 
xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_lbl" xml:lang="en-
US">Long-term assets of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" 
xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-
gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible 
assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="us-
gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-
gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" 
xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc"
/>
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES 
AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" 
xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-
gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current 
liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-
gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" 
xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts 
payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="us-
gaap_AccountsPayableRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="us-
gaap_AccountsPayableRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccountsPayableRelatedPartiesCurrent_lbl" xml:lang="en-US">Accrued expenses
- related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" 
xlink:label="us-
gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" 
xlink:to="us-
gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_lbl" 
xml:lang="en-US">Current liabilities of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" 
xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-
gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current 
liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_LongtermLiabilitiesOfDiscontinuedOperations" 
xlink:label="rcar_LongtermLiabilitiesOfDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_LongtermLiabilitiesOfDiscontinuedOperations" 
xlink:to="rcar_LongtermLiabilitiesOfDiscontinuedOperations_lbl" xlink:type="arc"
/>
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_LongtermLiabilitiesOfDiscontinuedOperations_lbl" xml:lang="en-
US">Long-term liabilities of discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="us-
gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" 
xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-
gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' 
EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" 
xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-
gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock: $0.0001 par 
value: Authorized: 10,000,000 shares Issued and outstanding: nil</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-
gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-
gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock: $0.00001 par value: 
Authorized: 500,000,000 Issued and outstanding: 66,575,122 shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" 
xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-
gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in 
capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-
gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-
gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated 
deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AccumulatedDeficitSinceDevelopmentStage" 
xlink:label="rcar_AccumulatedDeficitSinceDevelopmentStage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AccumulatedDeficitSinceDevelopmentStage" 
xlink:to="rcar_AccumulatedDeficitSinceDevelopmentStage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_AccumulatedDeficitSinceDevelopmentStage_lbl" xml:lang="en-
US">Accumulated deficit since development stage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" 
xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-
US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-
gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders'
equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" 
xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-
gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities 
and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedBalanceSheetsParentheticalAbstract" 
xlink:label="rcar_ConsolidatedBalanceSheetsParentheticalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_ConsolidatedBalanceSheetsParentheticalAbstract" 
xlink:to="rcar_ConsolidatedBalanceSheetsParentheticalAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ConsolidatedBalanceSheetsParentheticalAbstract_lbl" 
xml:lang="en-US">Consolidated Balance Sheets Parenthetical</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-
gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-
gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred 
stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" 
xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-
gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, 
Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" 
xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-
gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares 
Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" 
xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-
gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, 
shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-
gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-
gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par
value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" 
xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-
gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, 
Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" 
xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-
gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares 
Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" 
xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-
gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares 
outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedStatementsOfOperationsAbstract" 
xlink:label="rcar_ConsolidatedStatementsOfOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_ConsolidatedStatementsOfOperationsAbstract" 
xlink:to="rcar_ConsolidatedStatementsOfOperationsAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ConsolidatedStatementsOfOperationsAbstract_lbl" xml:lang="en-
US">Consolidated Statements Of Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="us-
gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_Revenues_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpensesAbstract" 
xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-
gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" 
xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-
gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and 
administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" 
xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-
gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating 
expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromContinuingOperations" xlink:label="us-
gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-
gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Net loss from 
continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-
gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" 
xlink:to="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xml:lang="en-
US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" 
xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xml:lang="en-US">Income/
(loss) from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" 
xlink:label="us-gaap_GainLossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-
gaap_GainLossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Gain on disposal of oil
and gas properties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:label="us-
gaap_GainOrLossOnSaleOfStockInSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:to="us-
gaap_GainOrLossOnSaleOfStockInSubsidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_GainOrLossOnSaleOfStockInSubsidiary_lbl" xml:lang="en-US">Loss on disposal 
of subsidiary (Fostung)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations" xlink:label="us-
gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations" xlink:to="us-
gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations_lbl" xml:lang="en-
US">Gain (Loss) on discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-
gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" 
xlink:label="us-gaap_EarningsPerShareDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_EarningsPerShareDilutedAbstract" xlink:to="us-
gaap_EarningsPerShareDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EarningsPerShareDilutedAbstract_lbl" xml:lang="en-US">Earnings per share - 
basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="us-
gaap_IncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" 
xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xml:lang="en-
US">Loss per common share continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" 
xml:lang="en-US">Income (loss) per common share discontinued 
operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" 
xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-
gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per common 
share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-
gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" 
xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-
US">Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss" 
xlink:label="rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss" 
xlink:to="rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss_lbl" 
xml:lang="en-US">Consolidated Statement Comprehensive Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:label="us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:to="us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl"
xml:lang="en-US">Other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax" xlink:label="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax" xlink:to="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax_lbl" xml:lang="en-US">Reclassification adjustment on disposal of 
subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" 
xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-
gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Total comprehensive 
loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-
gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-
gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line 
Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-
gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_SharesIssued_lbl" xml:lang="en-US">Beginning Balance, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-
gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning Balance, 
Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockBasedCompensation" 
xlink:label="rcar_StockBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockBasedCompensation" 
xlink:to="rcar_StockBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_StockBasedCompensation_lbl" xml:lang="en-US">Stock based 
compensation - Series A Warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockBasedCompensationOptions" 
xlink:label="rcar_StockBasedCompensationOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockBasedCompensationOptions" 
xlink:to="rcar_StockBasedCompensationOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_StockBasedCompensationOptions_lbl" xml:lang="en-US">Stock 
based compensation - options</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IssuanceOfUnits" xlink:label="rcar_IssuanceOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IssuanceOfUnits" xlink:to="rcar_IssuanceOfUnits_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_IssuanceOfUnits_lbl" xml:lang="en-US">Issuance of 
Units</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonUnitIssuance" xlink:label="rcar_CommonUnitIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CommonUnitIssuance" 
xlink:to="rcar_CommonUnitIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_CommonUnitIssuance_lbl" xml:lang="en-US">Issuance of Units, 
Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_SharesIssued_2_lbl" xml:lang="en-US">Ending Balance, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-
gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending Balance, 
Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedStatementsOfCashFlowsAbstract" 
xlink:label="rcar_ConsolidatedStatementsOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_ConsolidatedStatementsOfCashFlowsAbstract" 
xlink:to="rcar_ConsolidatedStatementsOfCashFlowsAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource"
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ConsolidatedStatementsOfCashFlowsAbstract_lbl" xml:lang="en-
US">Consolidated Statements Of Cash Flows</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" 
xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-
US">Cash flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract" xlink:label="us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract" xlink:to="us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash 
flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" 
xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-
gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation 
expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockBasedConsultingExpense" 
xlink:label="rcar_StockBasedConsultingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockBasedConsultingExpense" 
xlink:to="rcar_StockBasedConsultingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_StockBasedConsultingExpense_lbl" xml:lang="en-US">Stock based 
consulting expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ImpairmentAndDepreciation" 
xlink:label="rcar_ImpairmentAndDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_ImpairmentAndDepreciation" 
xlink:to="rcar_ImpairmentAndDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ImpairmentAndDepreciation_lbl" xml:lang="en-US">Impairment and
depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ResultsOfOperationsAccretionOfAssetRetirementObligations" xlink:label="us-
gaap_ResultsOfOperationsAccretionOfAssetRetirementObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ResultsOfOperationsAccretionOfAssetRetirementObligations" xlink:to="us-
gaap_ResultsOfOperationsAccretionOfAssetRetirementObligations_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ResultsOfOperationsAccretionOfAssetRetirementObligations_lbl" xml:lang="en-
US">Accretion of asset retirement obligation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-
gaap_GainLossOnDispositionOfAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-
gaap_GainLossOnDispositionOfAssets_2_lbl" xml:lang="en-US">Gain on disposal of 
oil and gas properties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:to="us-
gaap_GainOrLossOnSaleOfStockInSubsidiary_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-
gaap_GainOrLossOnSaleOfStockInSubsidiary_2_lbl" xml:lang="en-US">Loss on 
disposal of subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in
operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-
gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-
gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-
gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Decrease 
(increase) in receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" 
xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-
gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-
gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Decrease (increase) 
in prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-
US">(Decrease) increase in accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash 
flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" 
xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-
US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CostsIncurredAcquisitionOfOilAndGasProperties" xlink:label="us-
gaap_CostsIncurredAcquisitionOfOilAndGasProperties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CostsIncurredAcquisitionOfOilAndGasProperties" 
xlink:to="us-gaap_CostsIncurredAcquisitionOfOilAndGasProperties_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CostsIncurredAcquisitionOfOilAndGasProperties_lbl" xml:lang="en-
US">Acquisition of oil and gas properties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment" xlink:label="us-
gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment" 
xlink:to="us-gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment_lbl" xml:lang="en-
US">Proceeds from disposal of oil and gas properties</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AcquisitionOfIntellectualProperty" 
xlink:label="rcar_AcquisitionOfIntellectualProperty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AcquisitionOfIntellectualProperty" 
xlink:to="rcar_AcquisitionOfIntellectualProperty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2009/role/negatedLabel" 
xlink:label="rcar_AcquisitionOfIntellectualProperty_lbl" xml:lang="en-
US">Acquisition of intellectual property</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash 
flows from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" 
xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-
US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SaleOfCommonStockAndWarrants" 
xlink:label="rcar_SaleOfCommonStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_SaleOfCommonStockAndWarrants" 
xlink:to="rcar_SaleOfCommonStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_SaleOfCommonStockAndWarrants_lbl" xml:lang="en-US">Sale of 
common stock and warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash 
flows from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" 
xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Change 
in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-
gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash
equivalents, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-
gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and cash
equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-
gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" 
xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental 
disclosure of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOf
Subsidiary" 
xlink:label="rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOf
Subsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfS
ubsidiary" 
xlink:to="rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfSub
sidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOf
Subsidiary_lbl" xml:lang="en-US">Non-cash investing and financing activities - 
Note received on disposal of subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_NotesToFinancialStatementsAbstract" 
xlink:label="rcar_NotesToFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_NotesToFinancialStatementsAbstract" 
xlink:to="rcar_NotesToFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_NotesToFinancialStatementsAbstract_lbl" xml:lang="en-US">Notes
to Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NatureOfOperations" 
xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-
gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NatureOfOperations_lbl" xml:lang="en-US">Note 1. Organization, Nature and 
Continuance of Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" 
xlink:label="us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" 
xml:lang="en-US">Note 2. Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_DiscontinuedOperationsAbstract" 
xlink:label="rcar_DiscontinuedOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_DiscontinuedOperationsAbstract" 
xlink:to="rcar_DiscontinuedOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_DiscontinuedOperationsAbstract_lbl" xml:lang="en-
US">Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" 
xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Note 3. 
Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-
gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-
gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Note 4. 
Intangible Assets - Intellectual Property</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockOptionsTextBlock" 
xlink:label="rcar_CommonStockOptionsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CommonStockOptionsTextBlock" 
xlink:to="rcar_CommonStockOptionsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_CommonStockOptionsTextBlock_lbl" xml:lang="en-US">Note 5. 
Common Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" 
xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Note 
6. Commitments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-
gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" 
xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Note 7. 
Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncomeTaxesAbstract" xlink:label="rcar_IncomeTaxesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IncomeTaxesAbstract" 
xlink:to="rcar_IncomeTaxesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_IncomeTaxesAbstract_lbl" xml:lang="en-US">Income 
Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" 
xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-
gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Note 8. Income 
Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SubsequentEventAbstract" 
xlink:label="rcar_SubsequentEventAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_SubsequentEventAbstract" 
xlink:to="rcar_SubsequentEventAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_SubsequentEventAbstract_lbl" xml:lang="en-US">Subsequent 
Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsTextBlock" 
xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-
gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Note 9. Subsequent 
Events</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SignificantAccountingPoliciesPoliciesAbstract" 
xlink:label="rcar_SignificantAccountingPoliciesPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_SignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="rcar_SignificantAccountingPoliciesPoliciesAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_SignificantAccountingPoliciesPoliciesAbstract_lbl" 
xml:lang="en-US">Significant Accounting Policies Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-
gaap_BasisOfAccountingPolicyPolicyTextBlock" />
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-
gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of 
Presentation and Principles of Accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" 
xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-
gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of 
Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AccountingStandardsCodificationPolicyTextBlock" 
xlink:label="rcar_AccountingStandardsCodificationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AccountingStandardsCodificationPolicyTextBlock" 
xlink:to="rcar_AccountingStandardsCodificationPolicyTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_AccountingStandardsCodificationPolicyTextBlock_lbl" 
xml:lang="en-US">Applicable Accounting Guidance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-
gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_UseOfEstimates_lbl" xml:lang="en-US">Accounting Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-
gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-
gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash 
Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PolicyLoansReceivablePolicy" 
xlink:label="us-gaap_PolicyLoansReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PolicyLoansReceivablePolicy" xlink:to="us-
gaap_PolicyLoansReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PolicyLoansReceivablePolicy_lbl" xml:lang="en-US">Note Receivable from Duke
Mountain</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-
gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-
gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of 
Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="us-
gaap_InProcessResearchAndDevelopmentPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_InProcessResearchAndDevelopmentPolicy" xlink:to="us-
gaap_InProcessResearchAndDevelopmentPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_InProcessResearchAndDevelopmentPolicy_lbl" xml:lang="en-US">Research and 
Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-
gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" 
xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Intangible
Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockOptionsPolicyTextBlock" 
xlink:label="rcar_StockOptionsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockOptionsPolicyTextBlock" 
xlink:to="rcar_StockOptionsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" 
xlink:label="rcar_StockOptionsPolicyTextBlock_lbl" xml:lang="en-US">Stock 
Options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" 
xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-
gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DiscontinuedOperationsPolicyTextBlock" xlink:label="us-
gaap_DiscontinuedOperationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="us-
gaap_DiscontinuedOperationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_DiscontinuedOperationsPolicyTextBlock_lbl" xml:lang="en-US">Discontinued 
Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" 
xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-
gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings (Loss) Per 
Share</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_RelatedPartyTransactionsPolicyTextBlock" 
xlink:label="rcar_RelatedPartyTransactionsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_RelatedPartyTransactionsPolicyTextBlock" 
xlink:to="rcar_RelatedPartyTransactionsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_RelatedPartyTransactionsPolicyTextBlock_lbl" xml:lang="en-
US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-
gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" 
xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="arc"
/>
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xml:lang="en-
US">Comprehensive Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OilAndGasPropertiesAbstract" 
xlink:label="rcar_OilAndGasPropertiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OilAndGasPropertiesAbstract" 
xlink:to="rcar_OilAndGasPropertiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_OilAndGasPropertiesAbstract_lbl" xml:lang="en-US">Discontinued
Oil And Gas Operations Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock" 
xlink:label="rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock" /
>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock" 
xlink:to="rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock_lb
l" xml:lang="en-US">Assets and liabilities of discontinued 
operations</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IntangibleAssetsIntellectualPropertTablesAbstract" 
xlink:label="rcar_IntangibleAssetsIntellectualPropertTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IntangibleAssetsIntellectualPropertTablesAbstract" 
xlink:to="rcar_IntangibleAssetsIntellectualPropertTablesAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_IntangibleAssetsIntellectualPropertTablesAbstract_lbl" 
xml:lang="en-US">Intangible Assets - Intellectual Propert Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock" xlink:label="us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock" xlink:to="us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock_lbl" xml:lang="en-US">Assumptions required for the 
Black-Scholes model</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" 
xlink:label="us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl" 
xml:lang="en-US">Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncomeTaxesTablesAbstract" 
xlink:label="rcar_IncomeTaxesTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IncomeTaxesTablesAbstract" 
xlink:to="rcar_IncomeTaxesTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_IncomeTaxesTablesAbstract_lbl" xml:lang="en-US">Income Taxes 
Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-
gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-
gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-
US">Schedule of deferred tax assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" 
xlink:label="us-
gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-
gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"
xml:lang="en-US">Reconciliation of the statutory federal income tax expense 
(benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAb
stract" 
xlink:label="rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAb
stract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAbs
tract" 
xlink:to="rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAbstr
act_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAb
stract_lbl" xml:lang="en-US">Organization Nature And Continuance Of Operations 
Details Narrative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-
gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-
gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated 
deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract" 
xlink:label="rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract" 
xlink:to="rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract_lbl" 
xml:lang="en-US">Significant Accounting Policies Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockConsistedOfWarrantsToPurchaseShares" 
xlink:label="rcar_CommonStockConsistedOfWarrantsToPurchaseShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CommonStockConsistedOfWarrantsToPurchaseShares" 
xlink:to="rcar_CommonStockConsistedOfWarrantsToPurchaseShares_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_CommonStockConsistedOfWarrantsToPurchaseShares_lbl" 
xml:lang="en-US">Common stock consisted of warrants to purchase 
shares</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OptionsToPurchaseSharesOfCommonStock" 
xlink:label="rcar_OptionsToPurchaseSharesOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OptionsToPurchaseSharesOfCommonStock" 
xlink:to="rcar_OptionsToPurchaseSharesOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_OptionsToPurchaseSharesOfCommonStock_lbl" xml:lang="en-
US">Options to purchase shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OilAndGasPropertyFullCostMethodNet" xlink:label="us-
gaap_OilAndGasPropertyFullCostMethodNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OilAndGasPropertyFullCostMethodNet" xlink:to="us-
gaap_OilAndGasPropertyFullCostMethodNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OilAndGasPropertyFullCostMethodNet_lbl" xml:lang="en-
US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetRetirementObligation" 
xlink:label="us-gaap_AssetRetirementObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetRetirementObligation" xlink:to="us-
gaap_AssetRetirementObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AssetRetirementObligation_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_DiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:label="rcar_DiscontinuedOperationsDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_DiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:to="rcar_DiscontinuedOperationsDetailsNarrativeAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_DiscontinuedOperationsDetailsNarrativeAbstract_lbl" 
xml:lang="en-US">Discontinued Operations Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CarryingAmountOfOilAndGasProperties" 
xlink:label="rcar_CarryingAmountOfOilAndGasProperties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CarryingAmountOfOilAndGasProperties" 
xlink:to="rcar_CarryingAmountOfOilAndGasProperties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_CarryingAmountOfOilAndGasProperties_lbl" xml:lang="en-
US">Carrying amount of the oil and gas properties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetRetirementObligation" xlink:to="us-
gaap_AssetRetirementObligation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_AssetRetirementObligation_2_lbl" xml:lang="en-US">Asset retirement 
obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OilAndGasReclamationLiabilityNoncurrent" xlink:label="us-
gaap_OilAndGasReclamationLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OilAndGasReclamationLiabilityNoncurrent" 
xlink:to="us-gaap_OilAndGasReclamationLiabilityNoncurrent_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OilAndGasReclamationLiabilityNoncurrent_lbl" xml:lang="en-US">Asset 
retirement obligation, liabilities assumed</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:label="us-
gaap_DisposalGroupIncludingDiscontinuedOperationCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" 
xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DisposalGroupIncludingDiscontinuedOperationCash_lbl" xml:lang="en-US">Cash 
received</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" 
xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"
/>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="us-
gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" 
xml:lang="en-US">Recognized gain</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="us-
gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" 
xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xml:lang="en-
US">Revenue reported in discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" 
xlink:label="us-
gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" 
xlink:to="us-
gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" 
xml:lang="en-US">Net loss reported</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IntangibleAssetsIntellectualPropertDetailsAbstract" 
xlink:label="rcar_IntangibleAssetsIntellectualPropertDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IntangibleAssetsIntellectualPropertDetailsAbstract" 
xlink:to="rcar_IntangibleAssetsIntellectualPropertDetailsAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_IntangibleAssetsIntellectualPropertDetailsAbstract_lbl" 
xml:lang="en-US">Intangible Assets - Intellectual Propert Details</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-
gaap_FairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_FairValueAssumptionsRiskFreeInterestRate" 
xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc"
/>
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Weighted 
average risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" 
xlink:label="us-gaap_FairValueAssumptionsExpectedTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="us-
gaap_FairValueAssumptionsExpectedTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_FairValueAssumptionsExpectedTerm_lbl" xml:lang="en-US">Expected life in 
years</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_FairValueAssumptionsWeightedAverageVolatilityRate" 
xlink:to="us-gaap_FairValueAssumptionsWeightedAverageVolatilityRate_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-
US">Weighted Avg Expected Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="us-
gaap_FairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_FairValueAssumptionsExpectedDividendRate" 
xlink:to="us-gaap_FairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc"
/>
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_FairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected 
dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract" 
xlink:label="rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract" /
>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract" 
xlink:to="rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract_lb
l" xml:lang="en-US">Intangible Assets - Intellectual Propert Details 
Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" 
xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-
gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible 
assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharePrice" xlink:label="us-
gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SharePrice_lbl" xml:lang="en-US">Fair value of Warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SponsorFees" xlink:label="us-
gaap_SponsorFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SponsorFees" xlink:to="us-gaap_SponsorFees_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SponsorFees_lbl" xml:lang="en-US">Consulting expense associated with the 
Series A Warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockOptionsDetailsAbstract" 
xlink:label="rcar_CommonStockOptionsDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CommonStockOptionsDetailsAbstract" 
xlink:to="rcar_CommonStockOptionsDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_CommonStockOptionsDetailsAbstract_lbl" xml:lang="en-US">Common
Stock Options Details</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OptionsOutstandingAbstract" 
xlink:label="rcar_OptionsOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OptionsOutstandingAbstract" 
xlink:to="rcar_OptionsOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_OptionsOutstandingAbstract_lbl" xml:lang="en-US">Options 
Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber_lbl" xml:lang="en-US">Options outstanding - beginning 
balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Options 
forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber_2_lbl" xml:lang="en-US">Options oustanding - ending 
balance</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOp
tionEquityInstrumentsExercisable" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOp
tionEquityInstrumentsExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOpt
ionEquityInstrumentsExercisable" 
xlink:to="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptio
nEquityInstrumentsExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOp
tionEquityInstrumentsExercisable_lbl" xml:lang="en-US">Options 
exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" 
xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" 
xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource"
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" 
xml:lang="en-US">Weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-
US">Options outstanding - beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" 
xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-
US">Options forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-
US">Options outstanding - ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" 
xml:lang="en-US">Options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_WeightedAverageRemainingContractedTerm" 
xlink:label="rcar_WeightedAverageRemainingContractedTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_WeightedAverageRemainingContractedTerm" 
xlink:to="rcar_WeightedAverageRemainingContractedTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_WeightedAverageRemainingContractedTerm_lbl" xml:lang="en-
US">Weighted average remaining contracted term</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1
" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1
" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquity
InstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1"
xlink:to="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityIn
strumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1_lb
l" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1
_lbl" xml:lang="en-US">Warrants outstanding - beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquity
InstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms" 
xlink:to="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityIn
strumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms_lbl"
xml:lang="en-US">Options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms" /
>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquity
InstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms" 
xlink:to="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityIn
strumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms_lb
l" xml:lang="en-US">Options forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms" 
xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms" 
xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" 
xml:lang="en-US">Warrants outstanding - ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1" xlink:label="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1" xlink:to="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Warrants 
exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedIntrinsicValueRollForward" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedIntrinsicValueRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedIntrinsicValueRollForward" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedIntrinsicValueRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedIntrinsicValueRollForward_lbl" xml:lang="en-
US">Aggregate intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Options 
outstanding - beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" 
xlink:label="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquity
InstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" 
xlink:to="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityIn
strumentsOtherThanOptionsAggregateIntrinsicValueGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" 
xlink:label="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_lbl" xml:lang="en-
US">Options granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xml:lang="en-
US">Options outstanding - ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable" 
xlink:label="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquity
InstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable" 
xlink:to="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityIn
strumentsOtherThanOptionsAggregateIntrinsicValueExercisable_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" 
xlink:label="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_lbl" 
xml:lang="en-US">Options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockOptionsDetailsNarrativeAbstract" 
xlink:label="rcar_CommonStockOptionsDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CommonStockOptionsDetailsNarrativeAbstract" 
xlink:to="rcar_CommonStockOptionsDetailsNarrativeAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_CommonStockOptionsDetailsNarrativeAbstract_lbl" xml:lang="en-
US">Common Stock Options Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SharesAvailable" xlink:label="rcar_SharesAvailable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_SharesAvailable" xlink:to="rcar_SharesAvailable_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_SharesAvailable_lbl" xml:lang="en-US">Shares 
available</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockbasedCompensationAdministrativeExpense" 
xlink:label="rcar_StockbasedCompensationAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockbasedCompensationAdministrativeExpense" 
xlink:to="rcar_StockbasedCompensationAdministrativeExpense_lbl" xlink:type="arc"
/>
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_StockbasedCompensationAdministrativeExpense_lbl" xml:lang="en-
US">Stock-based compensation administrative expense</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_UnrecognizedCompensationCost" 
xlink:label="rcar_UnrecognizedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_UnrecognizedCompensationCost" 
xlink:to="rcar_UnrecognizedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_UnrecognizedCompensationCost_lbl" xml:lang="en-
US">Unrecognized compensation cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares" xlink:label="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares" xlink:to="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares_lbl" xlink:type="arc" />
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares_lbl" xml:lang="en-US">Stock options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockOptionsUnvested" 
xlink:label="rcar_StockOptionsUnvested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockOptionsUnvested" 
xlink:to="rcar_StockOptionsUnvested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_StockOptionsUnvested_lbl" xml:lang="en-US">Stock options 
unvested</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockOptionsGranted" xlink:label="rcar_StockOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockOptionsGranted" 
xlink:to="rcar_StockOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_StockOptionsGranted_lbl" xml:lang="en-US">Stock options 
granted</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommitmentsDetailsNarrativeAbstract" 
xlink:label="rcar_CommitmentsDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CommitmentsDetailsNarrativeAbstract" 
xlink:to="rcar_CommitmentsDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_CommitmentsDetailsNarrativeAbstract_lbl" xml:lang="en-
US">Commitments Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_PurcheseOrderRecevied" 
xlink:label="rcar_PurcheseOrderRecevied" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_PurcheseOrderRecevied" 
xlink:to="rcar_PurcheseOrderRecevied_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_PurcheseOrderRecevied_lbl" xml:lang="en-US">Purchese order 
recevied</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_PurcheseOrderAmountReceived" 
xlink:label="rcar_PurcheseOrderAmountReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_PurcheseOrderAmountReceived" 
xlink:to="rcar_PurcheseOrderAmountReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_PurcheseOrderAmountReceived_lbl" xml:lang="en-US">Purchese 
order amount received</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" 
xlink:label="us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" 
xlink:to="us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" 
xlink:type="arc" />
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" 
xml:lang="en-US">Fees paid or due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="us-
gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" 
xlink:to="us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-
US">Accounts payable - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingExpense" 
xlink:label="us-gaap_OtherNonoperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-
gaap_OtherNonoperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Expense 
recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ExpenseRecognizedUnpaidAmounts" 
xlink:label="rcar_ExpenseRecognizedUnpaidAmounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_ExpenseRecognizedUnpaidAmounts" 
xlink:to="rcar_ExpenseRecognizedUnpaidAmounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ExpenseRecognizedUnpaidAmounts_lbl" xml:lang="en-US">Expense 
recognized unpaid amounts</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncomeTaxesDetailsAbstract" 
xlink:label="rcar_IncomeTaxesDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IncomeTaxesDetailsAbstract" 
xlink:to="rcar_IncomeTaxesDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_IncomeTaxesDetailsAbstract_lbl" xml:lang="en-US">Income Taxes 
Details</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" 
xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-
gaap_DeferredTaxAssetsGrossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DeferredTaxAssetsGrossAbstract_lbl" xml:lang="en-US">Deferred tax 
assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-
gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" 
xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" 
xlink:type="arc" />
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net 
operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" 
xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts"
/>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:to="us-
gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_lbl" 
xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" 
xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-
gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred tax assets 
gross</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-
gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-
gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation 
allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" 
xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-
gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncomeTaxesDetails1Abstract" 
xlink:label="rcar_IncomeTaxesDetails1Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IncomeTaxesDetails1Abstract" 
xlink:to="rcar_IncomeTaxesDetails1Abstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_IncomeTaxesDetails1Abstract_lbl" xml:lang="en-US">Income Taxes
Details 1</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" 
xlink:label="us-
gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" 
xlink:to="us-
gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" 
xml:lang="en-US">Statutory federal income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance" xlink:label="us-
gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance" xlink:to="us-
gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-
gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" 
xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Income tax
provision (benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IncomeTaxesDetails1Abstract" 
xlink:to="rcar_IncomeTaxesDetails1Abstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" 
xlink:label="rcar_IncomeTaxesDetails1Abstract_2_lbl" xml:lang="en-US">Income 
Taxes Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncreaseInValuationAllowance" 
xlink:label="rcar_IncreaseInValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IncreaseInValuationAllowance" 
xlink:to="rcar_IncreaseInValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_IncreaseInValuationAllowance_lbl" xml:lang="en-US">Increase in
the valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AccountingStandardsCodificationPolicyTextBlock" 
xlink:to="rcar_AccountingStandardsCodificationPolicyTextBlock_doc" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_AccountingStandardsCodificationPolicyTextBlock_doc" 
xml:lang="en-US">Accounting Standards Codification Policy [Text 
Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AccumulatedDeficitMember" 
xlink:to="rcar_AccumulatedDeficitMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_AccumulatedDeficitMember_doc" xml:lang="en-US">Custom 
Element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AccumulatedOtherComprehensiveLossMember" 
xlink:to="rcar_AccumulatedOtherComprehensiveLossMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_AccumulatedOtherComprehensiveLossMember_doc" xml:lang="en-
US">Custom Element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AdvisoryFeesMember" 
xlink:to="rcar_AdvisoryFeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_AdvisoryFeesMember_doc" xml:lang="en-US">Depreciation and 
Impairment Losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AssetRetirementObligationMember" 
xlink:to="rcar_AssetRetirementObligationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_AssetRetirementObligationMember_doc" xml:lang="en-US">Asset 
retirement obligation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CommonStockOptionsTextBlock" 
xlink:to="rcar_CommonStockOptionsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_CommonStockOptionsTextBlock_doc" xml:lang="en-US">Common stock
options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_FeeMember" xlink:to="rcar_FeeMember_doc" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_FeeMember_doc" xml:lang="en-US">Custom Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_LegalFeeMember" xlink:to="rcar_LegalFeeMember_doc" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_LegalFeeMember_doc" xml:lang="en-US">Custom 
Element.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OilAndGasPropertiesNetMember" 
xlink:to="rcar_OilAndGasPropertiesNetMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_OilAndGasPropertiesNetMember_doc" xml:lang="en-US">Oil and gas
properties net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OptionCancelledMember" 
xlink:to="rcar_OptionCancelledMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_OptionCancelledMember_doc" xml:lang="en-US">Option 
cancelled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OptionExercisedMember" 
xlink:to="rcar_OptionExercisedMember_doc" xlink:type="arc" />
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_OptionExercisedMember_doc" xml:lang="en-US">Option 
exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_OptionGrantedMember" 
xlink:to="rcar_OptionGrantedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_OptionGrantedMember_doc" xml:lang="en-US">Option 
granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_RelatedPartyTransactionsPolicyTextBlock" 
xlink:to="rcar_RelatedPartyTransactionsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_RelatedPartyTransactionsPolicyTextBlock_doc" xml:lang="en-
US">Related Party Transactions Policy [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_SharesAvailable" xlink:to="rcar_SharesAvailable_doc" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_SharesAvailable_doc" xml:lang="en-US">Shares 
available.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockBasedCompensation" 
xlink:to="rcar_StockBasedCompensation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_StockBasedCompensation_doc" xml:lang="en-US">Custom 
Element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockOptionsPolicyTextBlock" 
xlink:to="rcar_StockOptionsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_StockOptionsPolicyTextBlock_doc" xml:lang="en-US">Stock 
options policy.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockbasedCompensationAdministrativeExpense" 
xlink:to="rcar_StockbasedCompensationAdministrativeExpense_doc" xlink:type="arc"
/>
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_StockbasedCompensationAdministrativeExpense_doc" xml:lang="en-
US">Stock based compensation administrative expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_TotalLiabilitiesMember" 
xlink:to="rcar_TotalLiabilitiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_TotalLiabilitiesMember_doc" xml:lang="en-US">Total 
liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_UnrecognizedCompensationCost" 
xlink:to="rcar_UnrecognizedCompensationCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_UnrecognizedCompensationCost_doc" xml:lang="en-
US">Unrecognized compensation cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockBasedCompensationOptions" 
xlink:to="rcar_StockBasedCompensationOptions_doc" xlink:type="arc" />
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_StockBasedCompensationOptions_doc" xml:lang="en-US">Stock 
based compensation - options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CommonUnitIssuance" 
xlink:to="rcar_CommonUnitIssuance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_CommonUnitIssuance_doc" xml:lang="en-US">Issuance of Units, 
Value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockBasedConsultingExpense" 
xlink:to="rcar_StockBasedConsultingExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_StockBasedConsultingExpense_doc" xml:lang="en-US">Stock based 
consulting expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOpt
ionEquityInstrumentsExercisable" 
xlink:to="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptio
nEquityInstrumentsExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOp
tionEquityInstrumentsExercisable_doc" xml:lang="en-US">warrants 
exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_WeightedAverageRemainingContractedTerm" 
xlink:to="rcar_WeightedAverageRemainingContractedTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_WeightedAverageRemainingContractedTerm_doc" xml:lang="en-
US">Weighted average remaining contracted term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_LongtermLiabilitiesOfDiscontinuedOperations" 
xlink:to="rcar_LongtermLiabilitiesOfDiscontinuedOperations_doc" xlink:type="arc"
/>
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_LongtermLiabilitiesOfDiscontinuedOperations_doc" xml:lang="en-
US">Custom Element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AccumulatedDeficitSinceDevelopmentStage" 
xlink:to="rcar_AccumulatedDeficitSinceDevelopmentStage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_AccumulatedDeficitSinceDevelopmentStage_doc" xml:lang="en-
US">Custom Element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_ImpairmentAndDepreciation" 
xlink:to="rcar_ImpairmentAndDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_ImpairmentAndDepreciation_doc" xml:lang="en-US">Custom 
Element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AcquisitionOfIntellectualProperty" 
xlink:to="rcar_AcquisitionOfIntellectualProperty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_AcquisitionOfIntellectualProperty_doc" xml:lang="en-
US">Acquisition of intellectual property.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_SaleOfCommonStockAndWarrants" 
xlink:to="rcar_SaleOfCommonStockAndWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_SaleOfCommonStockAndWarrants_doc" xml:lang="en-US">Sale of 
common stock and warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock" 
xlink:to="rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock_doc" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock_do
c" xml:lang="en-US">Assets and liabilities of discontinued 
operations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_IncreaseInValuationAllowance" 
xlink:to="rcar_IncreaseInValuationAllowance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_IncreaseInValuationAllowance_doc" xml:lang="en-US">Increase in
the valuation allowance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_CarryingAmountOfOilAndGasProperties" 
xlink:to="rcar_CarryingAmountOfOilAndGasProperties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_CarryingAmountOfOilAndGasProperties_doc" xml:lang="en-
US">Carrying amount of the oil and gas properties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockOptionsGranted" 
xlink:to="rcar_StockOptionsGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_StockOptionsGranted_doc" xml:lang="en-US">Stock options 
granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_ExpenseRecognizedUnpaidAmounts" 
xlink:to="rcar_ExpenseRecognizedUnpaidAmounts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="rcar_ExpenseRecognizedUnpaidAmounts_doc" xml:lang="en-US">Expense 
recognized unpaid amounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" 
xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccumulatedOtherComprehensiveIncomeMember_2_lbl" xml:lang="en-
US">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource"
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-
gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, 
Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default 
Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-
gaap_RetainedEarningsAccumulatedDeficit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_RetainedEarningsAccumulatedDeficit_3_lbl" xml:lang="en-US">Retained 
Earnings (Accumulated Deficit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-
gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity 
Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-
gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and 
Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-
gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-
gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income 
(Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_3_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SharesIssued_3_lbl" xml:lang="en-US">Shares, Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-
gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase 
(Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-
gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase 
(Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash
Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_AcquisitionOfIntellectualProperty" 
xlink:to="rcar_AcquisitionOfIntellectualProperty_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_AcquisitionOfIntellectualProperty_3_lbl" xml:lang="en-
US">AcquisitionOfIntellectualProperty</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash
Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash
Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="rcar_StockOptionsPolicyTextBlock" 
xlink:to="rcar_StockOptionsPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_StockOptionsPolicyTextBlock_3_lbl" xml:lang="en-
US">StockOptionsPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-
gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy
Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="us-
gaap_DiscontinuedOperationsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DiscontinuedOperationsPolicyTextBlock_2_lbl" xml:lang="en-US">Discontinued 
Operations, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-
gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-Lived
Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation 
Arrangement by Share-based Payment Award, Non-Option Equity Instruments, 
Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-
US">Share-based Compensation Arrangement by Share-based Payment Award, Equity 
Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair 
Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" 
xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment 
Award, Equity Instruments Other than Options, Grants in Period, Weighted Average
Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-
US">Share-based Compensation Arrangement by Share-based Payment Award, Equity 
Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair 
Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2_lbl" 
xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment 
Award, Equity Instruments Other than Options, Vested in Period, Weighted Average
Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquity
InstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms" 
xlink:to="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityIn
strumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms_2_lb
l" xml:lang="en-
US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsGrantedWeightedAverageRemainingContractualTerms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquity
InstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms" 
xlink:to="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityIn
strumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms_2_lbl
" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms_2_
lbl" xml:lang="en-
US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsForfeitedWeightedAverageRemainingContractualTerms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xml:lang="en-US">Share-
based Compensation Arrangement by Share-based Payment Award, Equity Instruments 
Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquity
InstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" 
xlink:to="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityIn
strumentsOtherThanOptionsAggregateIntrinsicValueGranted_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted_2_lbl" xml:lang="en-
US">SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOt
herThanOptionsAggregateIntrinsicValueGranted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" 
xlink:from="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquity
InstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable" 
xlink:to="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityIn
strumentsOtherThanOptionsAggregateIntrinsicValueExercisable_2_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_2_lbl" 
xml:lang="en-
US">SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOt
herThanOptionsAggregateIntrinsicValueExercisable</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>rcar-20140630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.0a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: rcar_S%2D1.xfr; Date: 
2014%2D09%2D05T15:06:51 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase 
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DocumentAndEntityInformation" 
xlink:href="rcar-20140630.xsd#DocumentAndEntityInformation" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedBalanceSheets" 
xlink:href="rcar-20140630.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedBalanceSheetsParenthetica
l" xlink:href="rcar-20140630.xsd#ConsolidatedBalanceSheetsParenthetical" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfOperations" 
xlink:href="rcar-20140630.xsd#ConsolidatedStatementsOfOperations" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementComprehensiveLos
s" xlink:href="rcar-20140630.xsd#ConsolidatedStatementComprehensiveLoss" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfStockholdersE
quity" xlink:href="rcar-20140630.xsd#ConsolidatedStatementsOfStockholdersEquity"
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/ConsolidatedStatementsOfCashFlows" 
xlink:href="rcar-20140630.xsd#ConsolidatedStatementsOfCashFlows" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOpe
rations" xlink:href="rcar-
20140630.xsd#OrganizationNatureAndContinuanceOfOperations" 
xlink:type="simple" />
<link:roleRef 
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPolicies" 
xlink:href="rcar-20140630.xsd#SignificantAccountingPolicies" xlink:type="simple"
/>
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperations" 
xlink:href="rcar-20140630.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualProperty" xlink:href="rcar-20140630.xsd#IntangibleAssets-
IntellectualProperty" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/CommonStockOptions"
xlink:href="rcar-20140630.xsd#CommonStockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/Commitments" 
xlink:href="rcar-20140630.xsd#Commitments" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/RelatedPartyTransactions" 
xlink:href="rcar-20140630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IncomeTaxes" 
xlink:href="rcar-20140630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/SubsequentEvents" 
xlink:href="rcar-20140630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPoliciesPolicies
" xlink:href="rcar-20140630.xsd#SignificantAccountingPoliciesPolicies" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/NotesToFinancialStatementsPropertyPla
ntAndEquipmentDisclosureTextBlockTables" xlink:href="rcar-
20140630.xsd#NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBl
ockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertTables" xlink:href="rcar-20140630.xsd#IntangibleAssets-
IntellectualPropertTables" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsTables" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IncomeTaxesTables" 
xlink:href="rcar-20140630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOpe
rationsDetailsNarrative" xlink:href="rcar-
20140630.xsd#OrganizationNatureAndContinuanceOfOperationsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/SignificantAccountingPoliciesDetailsN
arrative" xlink:href="rcar-
20140630.xsd#SignificantAccountingPoliciesDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperationsDetails" 
xlink:href="rcar-20140630.xsd#DiscontinuedOperationsDetails" xlink:type="simple"
/>
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/DiscontinuedOperationsDetailsNarrativ
e" xlink:href="rcar-20140630.xsd#DiscontinuedOperationsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetails" xlink:href="rcar-20140630.xsd#IntangibleAssets-
IntellectualPropertDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetailsNarrative" xlink:href="rcar-
20140630.xsd#IntangibleAssets-IntellectualPropertDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetails" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsDetails" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetails1" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsDetails1" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommonStockOptionsDetailsNarrative" 
xlink:href="rcar-20140630.xsd#CommonStockOptionsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/CommitmentsDetailsNarrative" 
xlink:href="rcar-20140630.xsd#CommitmentsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/RelatedPartyTransactionsDetailsNarrat
ive" xlink:href="rcar-20140630.xsd#RelatedPartyTransactionsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetails"
xlink:href="rcar-20140630.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetails1" 
xlink:href="rcar-20140630.xsd#IncomeTaxesDetails1" xlink:type="simple" />
    <link:roleRef 
roleURI="http://janusresourcesinc.com/role/IncomeTaxesDetailsNarrative" 
xlink:href="rcar-20140630.xsd#IncomeTaxesDetailsNarrative" 
xlink:type="simple" />
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DocumentAndEntityInformation" 
xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_DocumentAndEntityInformationAbstract" 
xlink:label="loc_rcarDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" 
xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" 
xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40"
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_CurrentFiscalYearEndDate" 
xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityWellKnownSeasonedIssuer" 
xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityCurrentReportingStatus" 
xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-
31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedBalanceSheets" 
xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedBalanceSheetsAbstract" 
xlink:label="loc_rcarConsolidatedBalanceSheetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" 
xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedBalanceSheetsAbstract" xlink:to="loc_us-
gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" 
xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-
gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-
gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-
gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseCurrent" 
xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-
gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" 
xlink:label="loc_us-gaapOtherReceivablesNetCurrent" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-
gaapOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" 
xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-
gaapAssetsCurrent" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndNotesReceivableNet" 
xlink:label="loc_us-gaapAccountsAndNotesReceivableNet" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-
gaapAccountsAndNotesReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:label="loc_us-
gaapAssetsOfDisposalGroupIncludingDiscontinuedOperation" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-
gaapAssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" 
xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-
gaapOtherIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-
gaapAssets" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-
gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedBalanceSheetsAbstract" xlink:to="loc_us-
gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" 
xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="110" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-
gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-
gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-
gaapAccountsPayableRelatedPartiesCurrent" />
      <link:presentationArc order="130" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-
gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" 
xlink:label="loc_us-
gaapDisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" />
      <link:presentationArc order="140" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-
gaapDisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" 
xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="150" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-
gaapLiabilitiesCurrent" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_LongtermLiabilitiesOfDiscontinuedOperations" 
xlink:label="loc_rcarLongtermLiabilitiesOfDiscontinuedOperations" />
      <link:presentationArc order="160" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_rcarLongtermLiabilitiesOfDiscontinuedOperations" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-
gaapLiabilities" />
      <link:presentationArc order="170" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapLiabilities" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" 
xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="180" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedBalanceSheetsAbstract" xlink:to="loc_us-
gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" 
xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="190" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" 
xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" 
xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="210" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-
gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="220" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AccumulatedDeficitSinceDevelopmentStage" 
xlink:label="loc_rcarAccumulatedDeficitSinceDevelopmentStage" />
      <link:presentationArc order="230" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" 
xlink:to="loc_rcarAccumulatedDeficitSinceDevelopmentStage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-
gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="240" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="250" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapStockholdersEquity" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" 
xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="260" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended"
xlink:role="http://janusresourcesinc.com/role/ConsolidatedBalanceSheetsParenthet
ical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS 
(Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedBalanceSheetsParentheticalAbstract" 
xlink:label="loc_rcarConsolidatedBalanceSheetsParentheticalAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" 
xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedBalanceSheetsParentheticalAbstract" 
xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-
gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" 
xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" 
xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" 
xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-
gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" 
xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" 
xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockSharesIssued" xlink:type="arc" />
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" 
xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementsOfOperations
" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedStatementsOfOperationsAbstract" 
xlink:label="loc_rcarConsolidatedStatementsOfOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-
gaapRevenues" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfOperationsAbstract" 
xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpensesAbstract" 
xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfOperationsAbstract" 
xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" 
xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-
gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" 
xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-
gaapOperatingExpenses" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-
gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfOperationsAbstract" 
xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-
gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfOperationsAbstract" 
xlink:to="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-
gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
<link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" 
xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" 
xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" 
xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:label="loc_us-
gaapGainOrLossOnSaleOfStockInSubsidiary" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" 
xlink:to="loc_us-gaapGainOrLossOnSaleOfStockInSubsidiary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations" 
xlink:label="loc_us-gaapGainLossOnDispositionOfRealEstateDiscontinuedOperations"
/>
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" 
xlink:to="loc_us-gaapGainLossOnDispositionOfRealEstateDiscontinuedOperations" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfOperationsAbstract" 
xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" 
xlink:label="loc_us-gaapEarningsPerShareDilutedAbstract" />
      <link:presentationArc order="110" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfOperationsAbstract" 
xlink:to="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-
gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-
gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" 
xlink:label="loc_us-
gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:presentationArc order="130" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-
gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" 
xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="140" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-
gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-
gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="150" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfOperationsAbstract" 
xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" 
xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementComprehensive
Loss" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENT COMPREHENSIVE 
LOSS">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss" 
xlink:label="loc_rcarConsolidatedStatementsOfComprehensiveIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfComprehensiveIncomeLoss" 
xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:label="loc_us-
gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfComprehensiveIncomeLoss" 
xlink:to="loc_us-
gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax" xlink:label="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustme
ntNetOfTax" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:to="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustme
ntNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" 
xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfComprehensiveIncomeLoss" 
xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended"
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementsOfStockholde
rsEquity" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF 
STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedStatementsOfStockholdersEquityAbstract" 
xlink:label="loc_rcarConsolidatedStatementsOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfStockholdersEquityAbstract" 
xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" 
order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" 
xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" 
xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" 
xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" 
xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" 
xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-
gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-
gaapSharesIssued" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"
/>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapStockholdersEquity" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockBasedCompensation" 
xlink:label="loc_rcarStockBasedCompensation" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_rcarStockBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockBasedCompensationOptions" 
xlink:label="loc_rcarStockBasedCompensationOptions" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_rcarStockBasedCompensationOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IssuanceOfUnits" xlink:label="loc_rcarIssuanceOfUnits" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rcarIssuanceOfUnits" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonUnitIssuance" 
xlink:label="loc_rcarCommonUnitIssuance" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_rcarCommonUnitIssuance"
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax" xlink:label="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustme
ntNetOfTax" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustme
ntNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-
gaapSharesIssued_2" />
<link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_2" 
xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="130" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapStockholdersEquity_2" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/ConsolidatedStatementsOfCashFlows"
xlink:title="00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ConsolidatedStatementsOfCashFlowsAbstract" 
xlink:label="loc_rcarConsolidatedStatementsOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-
gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" 
xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract" xlink:label="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" 
xlink:to="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" 
xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockBasedConsultingExpense" 
xlink:label="loc_rcarStockBasedConsultingExpense" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:to="loc_rcarStockBasedConsultingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ImpairmentAndDepreciation" 
xlink:label="loc_rcarImpairmentAndDepreciation" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:to="loc_rcarImpairmentAndDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ResultsOfOperationsAccretionOfAssetRetirementObligations" 
xlink:label="loc_us-
gaapResultsOfOperationsAccretionOfAssetRetirementObligations" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:to="loc_us-
gaapResultsOfOperationsAccretionOfAssetRetirementObligations" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" 
xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:label="loc_us-
gaapGainOrLossOnSaleOfStockInSubsidiary" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:to="loc_us-gaapGainOrLossOnSaleOfStockInSubsidiary" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-
gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" 
xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-
gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" 
xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="110" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" 
xlink:label="loc_us-
gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="130" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" 
xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-
gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="140" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CostsIncurredAcquisitionOfOilAndGasProperties" xlink:label="loc_us-
gaapCostsIncurredAcquisitionOfOilAndGasProperties" />
      <link:presentationArc order="150" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" 
xlink:to="loc_us-gaapCostsIncurredAcquisitionOfOilAndGasProperties" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment" xlink:label="loc_us-
gaapProceedsFromSaleOfOilAndGasPropertyAndEquipment" />
      <link:presentationArc order="160" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" 
xlink:to="loc_us-gaapProceedsFromSaleOfOilAndGasPropertyAndEquipment" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AcquisitionOfIntellectualProperty" 
xlink:label="loc_rcarAcquisitionOfIntellectualProperty" />
      <link:presentationArc order="170" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" 
xlink:to="loc_rcarAcquisitionOfIntellectualProperty" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="180" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" 
xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-
gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="190" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SaleOfCommonStockAndWarrants" 
xlink:label="loc_rcarSaleOfCommonStockAndWarrants" />
      <link:presentationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" 
xlink:to="loc_rcarSaleOfCommonStockAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="210" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" 
xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-
gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="220" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-
gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="230" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-
gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="240" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-
gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="250" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarConsolidatedStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOf
Subsidiary" 
xlink:label="loc_rcarNoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposa
lOfSubsidiary" />
      <link:presentationArc order="260" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract"
xlink:to="loc_rcarNoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOf
Subsidiary" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOf
Operations" xlink:title="00000008 - Disclosure - Organization, Nature and 
Continuance of Operations">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_NotesToFinancialStatementsAbstract" 
xlink:label="loc_rcarNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NatureOfOperations" 
xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SignificantAccountingPolicies" 
xlink:title="00000009 - Disclosure - Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_NotesToFinancialStatementsAbstract" 
xlink:label="loc_rcarNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" 
xlink:label="loc_us-
gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" 
xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DiscontinuedOperations" 
xlink:title="00000010 - Disclosure - Discontinued Operations">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_DiscontinuedOperationsAbstract" 
xlink:label="loc_rcarDiscontinuedOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-
gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDiscontinuedOperationsAbstract" xlink:to="loc_us-
gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualProperty" xlink:title="00000011 - Disclosure - Intangible Assets - 
Intellectual Property">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_NotesToFinancialStatementsAbstract" 
xlink:label="loc_rcarNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-
gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptions" 
xlink:title="00000012 - Disclosure - Common Stock Options">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_NotesToFinancialStatementsAbstract" 
xlink:label="loc_rcarNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockOptionsTextBlock" 
xlink:label="loc_rcarCommonStockOptionsTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarNotesToFinancialStatementsAbstract" 
xlink:to="loc_rcarCommonStockOptionsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/Commitments" xlink:title="00000013
- Disclosure - Commitments">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_NotesToFinancialStatementsAbstract" 
xlink:label="loc_rcarNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-
gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/RelatedPartyTransactions" 
xlink:title="00000014 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_NotesToFinancialStatementsAbstract" 
xlink:label="loc_rcarNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-
gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxes" xlink:title="00000015
- Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncomeTaxesAbstract" xlink:label="loc_rcarIncomeTaxesAbstract"
/>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" 
xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesAbstract" xlink:to="loc_us-
gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SubsequentEvents" 
xlink:title="00000016 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SubsequentEventAbstract" 
xlink:label="loc_rcarSubsequentEventAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsTextBlock" 
xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSubsequentEventAbstract" xlink:to="loc_us-
gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SignificantAccountingPoliciesPolic
ies" xlink:title="00000017 - Disclosure - Significant Accounting Policies 
(Policies)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SignificantAccountingPoliciesPoliciesAbstract" 
xlink:label="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-
gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" 
xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AccountingStandardsCodificationPolicyTextBlock" 
xlink:label="loc_rcarAccountingStandardsCodificationPolicyTextBlock" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_rcarAccountingStandardsCodificationPolicyTextBlock" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" 
xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-
gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PolicyLoansReceivablePolicy" 
xlink:label="loc_us-gaapPolicyLoansReceivablePolicy" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapPolicyLoansReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-
gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_InProcessResearchAndDevelopmentPolicy" xlink:label="loc_us-
gaapInProcessResearchAndDevelopmentPolicy" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapInProcessResearchAndDevelopmentPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-
gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockOptionsPolicyTextBlock" 
xlink:label="loc_rcarStockOptionsPolicyTextBlock" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_rcarStockOptionsPolicyTextBlock" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" 
xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DiscontinuedOperationsPolicyTextBlock" xlink:label="loc_us-
gaapDiscontinuedOperationsPolicyTextBlock" />
      <link:presentationArc order="110" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapDiscontinuedOperationsPolicyTextBlock" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" 
xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_RelatedPartyTransactionsPolicyTextBlock" 
xlink:label="loc_rcarRelatedPartyTransactionsPolicyTextBlock" />
      <link:presentationArc order="130" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_rcarRelatedPartyTransactionsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="loc_us-
gaapComprehensiveIncomePolicyPolicyTextBlock" />
      <link:presentationArc order="140" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapComprehensiveIncomePolicyPolicyTextBlock" 
xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/NotesToFinancialStatementsProperty
PlantAndEquipmentDisclosureTextBlockTables" xlink:title="00000018 - Disclosure -
Discontinued Oil and Gas Operations (Tables)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OilAndGasPropertiesAbstract" 
xlink:label="loc_rcarOilAndGasPropertiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock" 
xlink:label="loc_rcarAssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock
" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarOilAndGasPropertiesAbstract" 
xlink:to="loc_rcarAssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock" 
xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertTables" xlink:title="00000019 - Disclosure - Intangible 
Assets - Intellectual Propert (Tables)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IntangibleAssetsIntellectualPropertTablesAbstract" 
xlink:label="loc_rcarIntangibleAssetsIntellectualPropertTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock" xlink:label="loc_us-
gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuatio
nTechniquesTableTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIntangibleAssetsIntellectualPropertTablesAbstract" 
xlink:to="loc_us-
gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuatio
nTechniquesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsTables" 
xlink:title="00000020 - Disclosure - Common Stock Options (Tables)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockOptionsTablesAbstract" 
xlink:label="loc_rcarCommonStockOptionsTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsTablesAbstract" xlink:to="loc_us-
gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems"
order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPPlanDomain" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" 
xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockOptionMember" 
xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" 
xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" 
xlink:label="loc_us-
gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock" xlink:label="loc_us-
gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuatio
nTechniquesTableTextBlock" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuatio
nTechniquesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesTables" 
xlink:title="00000021 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncomeTaxesTablesAbstract" 
xlink:label="loc_rcarIncomeTaxesTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" 
xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"
/>
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesTablesAbstract" xlink:to="loc_us-
gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"
xlink:label="loc_us-
gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesTablesAbstract" xlink:to="loc_us-
gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" 
xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOf
OperationsDetailsNarrative" xlink:title="00000022 - Disclosure - Organization 
Nature and Continuance of Operations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAb
stract" 
xlink:label="loc_rcarOrganizationNatureAndContinuanceOfOperationsDetailsNarrativ
eAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-
gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarOrganizationNatureAndContinuanceOfOperationsDetailsNarrative
Abstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/SignificantAccountingPoliciesDetai
lsNarrative" xlink:title="00000023 - Disclosure - Significant Accounting 
Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract" 
xlink:label="loc_rcarSignificantAccountingPoliciesDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockConsistedOfWarrantsToPurchaseShares" 
xlink:label="loc_rcarCommonStockConsistedOfWarrantsToPurchaseShares" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesDetailsNarrativeAbstract" 
xlink:to="loc_rcarCommonStockConsistedOfWarrantsToPurchaseShares" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OptionsToPurchaseSharesOfCommonStock" 
xlink:label="loc_rcarOptionsToPurchaseSharesOfCommonStock" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarSignificantAccountingPoliciesDetailsNarrativeAbstract" 
xlink:to="loc_rcarOptionsToPurchaseSharesOfCommonStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DiscontinuedOperationsDetails" 
xlink:title="00000024 - Disclosure - Discontinued Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_DiscontinuedOperationsDetailsAbstract" 
xlink:label="loc_rcarDiscontinuedOperationsDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDiscontinuedOperationsDetailsAbstract" xlink:to="loc_us-
gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" 
order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-
gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-
gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-
gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OilAndGasPropertiesNetMember" 
xlink:label="loc_rcarOilAndGasPropertiesNetMember" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" 
xlink:to="loc_rcarOilAndGasPropertiesNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_MiningPropertiesMember" 
xlink:label="loc_rcarMiningPropertiesMember" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" 
xlink:to="loc_rcarMiningPropertiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherCurrentAssetsMember" 
xlink:label="loc_us-gaapOtherCurrentAssetsMember" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-
gaapOtherCurrentAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsMember" xlink:label="loc_us-
gaapAssetsMember" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-
gaapAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis" 
xlink:label="loc_us-gaapFairValueByLiabilityClassAxis" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapFairValueByLiabilityClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliation
ByLiabilityClassDomain" xlink:label="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" />
      <link:presentationArc xlink:type="arc"
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableMember" 
xlink:label="loc_us-gaapAccountsPayableMember" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" xlink:to="loc_us-gaapAccountsPayableMember" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_AssetRetirementObligationMember" 
xlink:label="loc_rcarAssetRetirementObligationMember" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" xlink:to="loc_rcarAssetRetirementObligationMember" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_TotalLiabilitiesMember" 
xlink:label="loc_rcarTotalLiabilitiesMember" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationB
yLiabilityClassDomain" xlink:to="loc_rcarTotalLiabilitiesMember" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OilAndGasPropertyFullCostMethodNet" xlink:label="loc_us-
gaapOilAndGasPropertyFullCostMethodNet" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapOilAndGasPropertyFullCostMethodNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetRetirementObligation" 
xlink:label="loc_us-gaapAssetRetirementObligation" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapAssetRetirementObligation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/DiscontinuedOperationsDetailsNarra
tive" xlink:title="00000025 - Disclosure - Discontinued Operations (Details 
Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_DiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:label="loc_rcarDiscontinuedOperationsDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CarryingAmountOfOilAndGasProperties" 
xlink:label="loc_rcarCarryingAmountOfOilAndGasProperties" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:to="loc_rcarCarryingAmountOfOilAndGasProperties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetRetirementObligation" 
xlink:label="loc_us-gaapAssetRetirementObligation" />
<link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapAssetRetirementObligation" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_OilAndGasReclamationLiabilityNoncurrent" xlink:label="loc_us-
gaapOilAndGasReclamationLiabilityNoncurrent" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapOilAndGasReclamationLiabilityNoncurrent" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:label="loc_us-
gaapDisposalGroupIncludingDiscontinuedOperationCash" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCash" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" 
xlink:label="loc_us-
gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss"
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-
gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" 
xlink:label="loc_us-
gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarDiscontinuedOperationsDetailsNarrativeAbstract" 
xlink:to="loc_us-
gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" 
xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetails" xlink:title="00000026 - Disclosure - Intangible 
Assets - Intellectual Propert (Details)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IntangibleAssetsIntellectualPropertDetailsAbstract" 
xlink:label="loc_rcarIntangibleAssetsIntellectualPropertDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-
gaapFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIntangibleAssetsIntellectualPropertDetailsAbstract" 
xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" 
xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIntangibleAssetsIntellectualPropertDetailsAbstract" 
xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-
gaapFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIntangibleAssetsIntellectualPropertDetailsAbstract" 
xlink:to="loc_us-gaapFairValueAssumptionsWeightedAverageVolatilityRate" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-
gaapFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIntangibleAssetsIntellectualPropertDetailsAbstract" 
xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate" 
xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetailsNarrative" xlink:title="00000027 - Disclosure - 
Intangible Assets - Intellectual Propert (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract" 
xlink:label="loc_rcarIntangibleAssetsIntellectualPropertDetailsNarrativeAbstract
" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" 
xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIntangibleAssetsIntellectualPropertDetailsNarrativeAbstract"
xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-
gaapSharePrice" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIntangibleAssetsIntellectualPropertDetailsNarrativeAbstract"
xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SponsorFees" xlink:label="loc_us-
gaapSponsorFees" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIntangibleAssetsIntellectualPropertDetailsNarrativeAbstract"
xlink:to="loc_us-gaapSponsorFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended"
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsDetails" 
xlink:title="00000028 - Disclosure - Common Stock Options (Details)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockOptionsDetailsAbstract" 
xlink:label="loc_rcarCommonStockOptionsDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_OptionsOutstandingAbstract" 
xlink:label="loc_rcarOptionsOutstandingAbstract" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsAbstract" 
xlink:to="loc_rcarOptionsOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber" xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInst
rumentsOutstandingNumber" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarOptionsOutstandingAbstract" xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInst
rumentsOutstandingNumber" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod" xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsGrantsInPeriod" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarOptionsOutstandingAbstract" xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod" xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarOptionsOutstandingAbstract" xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsForfeitedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber" xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInst
rumentsOutstandingNumber_2" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarOptionsOutstandingAbstract" xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInst
rumentsOutstandingNumber_2" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOp
tionEquityInstrumentsExercisable" 
xlink:label="loc_rcarShareBasedCompensationArrangementByShareBasedPaymentAwardNo
nOptionEquityInstrumentsExercisable" />
      <link:presentationArc order="60"
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarOptionsOutstandingAbstract" 
xlink:to="loc_rcarShareBasedCompensationArrangementByShareBasedPaymentAwardNonOp
tionEquityInstrumentsExercisable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" 
xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsAbstract" xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" 
xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" 
xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" 
xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue" 
xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="110" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" 
xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" 
xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" 
xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="130" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" 
xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_WeightedAverageRemainingContractedTerm" 
xlink:label="loc_rcarWeightedAverageRemainingContractedTerm" />
      <link:presentationArc order="150" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsAbstract" 
xlink:to="loc_rcarWeightedAverageRemainingContractedTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1
" 
xlink:label="loc_rcarShareBasedCompensationArrangementByShareBasedPaymentAwardEq
uityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTer
ms1" />
      <link:presentationArc order="160" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarWeightedAverageRemainingContractedTerm" 
xlink:to="loc_rcarShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1
" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms" 
xlink:label="loc_rcarShareBasedCompensationArrangementByShareBasedPaymentAwardEq
uityInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms" 
/>
      <link:presentationArc order="170" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarWeightedAverageRemainingContractedTerm" 
xlink:to="loc_rcarShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms" 
xlink:label="loc_rcarShareBasedCompensationArrangementByShareBasedPaymentAwardEq
uityInstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms
" />
      <link:presentationArc order="180" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarWeightedAverageRemainingContractedTerm" 
xlink:to="loc_rcarShareBasedCompensationArrangementByShareBasedPaymentAwardEquit
yInstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms" 
xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="190" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarWeightedAverageRemainingContractedTerm" xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsOutstandingWeightedAverageRemainingContractualTerms" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1" xlink:label="loc_us-
gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableW
eightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarWeightedAverageRemainingContractedTerm" xlink:to="loc_us-
gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableW
eightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedIntrinsicValueRollForward" xlink:label="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedIntrinsicValueRollForward" />
      <link:presentationArc order="220" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsAbstract" xlink:to="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedIntrinsicValueRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-
gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOt
herThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="230" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedIntrinsicValueRollForward" xlink:to="loc_us-
gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOt
herThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" 
xlink:label="loc_rcarSharebasedCompensationArrangementBySharebasedPaymentAwardEq
uityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" />
      <link:presentationArc order="240" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedIntrinsicValueRollForward" 
xlink:to="loc_rcarSharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-
gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOt
herThanOptionsAggregateIntrinsicValueOutstanding_2" />
      <link:presentationArc order="250" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedIntrinsicValueRollForward" xlink:to="loc_us-
gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOt
herThanOptionsAggregateIntrinsicValueOutstanding_2" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable" 
xlink:label="loc_rcarSharebasedCompensationArrangementBySharebasedPaymentAwardEq
uityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable" />
      <link:presentationArc order="260" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOt
herThanOptionsNonvestedIntrinsicValueRollForward" 
xlink:to="loc_rcarSharebasedCompensationArrangementBySharebasedPaymentAwardEquit
yInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable" xlink:type="arc"
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsDetails1" 
xlink:title="00000029 - Disclosure - Common Stock Options (Details 1)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockOptionsDetails1Abstract" 
xlink:label="loc_rcarCommonStockOptionsDetails1Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetails1Abstract" xlink:to="loc_us-
gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" 
order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:label="loc_us-
gaapEmployeeStockOwnershipPlanESOPPlanDomain" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" 
xlink:to="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockOptionMember" 
xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEmployeeStockOwnershipPlanESOPPlanDomain" 
xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-
gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" 
order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-
gaapRangeMember" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" 
xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" 
xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-
gaapFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" 
xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssumptionsExpectedTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-
gaapFairValueAssumptionsWeightedAverageVolatilityRate" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-
gaapFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommonStockOptionsDetailsNarrative
" xlink:title="00000030 - Disclosure - Common Stock Options (Details 
Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommonStockOptionsDetailsNarrativeAbstract" 
xlink:label="loc_rcarCommonStockOptionsDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_SharesAvailable" xlink:label="loc_rcarSharesAvailable" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsNarrativeAbstract" 
xlink:to="loc_rcarSharesAvailable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockbasedCompensationAdministrativeExpense" 
xlink:label="loc_rcarStockbasedCompensationAdministrativeExpense" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsNarrativeAbstract" 
xlink:to="loc_rcarStockbasedCompensationAdministrativeExpense" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_UnrecognizedCompensationCost" 
xlink:label="loc_rcarUnrecognizedCompensationCost" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsNarrativeAbstract" 
xlink:to="loc_rcarUnrecognizedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares" xlink:label="loc_us-
gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumber
OfShares" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsNarrativeAbstract" 
xlink:to="loc_us-
gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumber
OfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockOptionsUnvested" 
xlink:label="loc_rcarStockOptionsUnvested" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsNarrativeAbstract" 
xlink:to="loc_rcarStockOptionsUnvested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_StockOptionsGranted" xlink:label="loc_rcarStockOptionsGranted"
/>
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommonStockOptionsDetailsNarrativeAbstract"
xlink:to="loc_rcarStockOptionsGranted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/CommitmentsDetailsNarrative" 
xlink:title="00000031 - Disclosure - Commitments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_CommitmentsDetailsNarrativeAbstract" 
xlink:label="loc_rcarCommitmentsDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_PurcheseOrderRecevied" 
xlink:label="loc_rcarPurcheseOrderRecevied" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommitmentsDetailsNarrativeAbstract" 
xlink:to="loc_rcarPurcheseOrderRecevied" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_PurcheseOrderAmountReceived" 
xlink:label="loc_rcarPurcheseOrderAmountReceived" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarCommitmentsDetailsNarrativeAbstract" 
xlink:to="loc_rcarPurcheseOrderAmountReceived" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/RelatedPartyTransactionsDetailsNar
rative" xlink:title="00000032 - Disclosure - Related Party Transactions (Details
Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_RelatedPartyTransactionsDetailsNarrativeAbstract" 
xlink:label="loc_rcarRelatedPartyTransactionsDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarRelatedPartyTransactionsDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" 
order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-
gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RelatedPartyDomain" 
xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" 
xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OfficerMember" 
xlink:label="loc_us-gaapOfficerMember" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapOfficerMember" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DirectorMember" 
xlink:label="loc_us-gaapDirectorMember" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapDirectorMember" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" 
xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-
gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-
gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_FeeMember" xlink:label="loc_rcarFeeMember" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" 
xlink:to="loc_rcarFeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_LegalFeeMember" xlink:label="loc_rcarLegalFeeMember" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" 
xlink:to="loc_rcarLegalFeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" 
xlink:label="loc_us-
gaapRelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapRelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-
gaapAccountsPayableRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapAccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingExpense" 
xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapOtherNonoperatingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_ExpenseRecognizedUnpaidAmounts" 
xlink:label="loc_rcarExpenseRecognizedUnpaidAmounts" />
<link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_rcarExpenseRecognizedUnpaidAmounts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesDetails" 
xlink:title="00000033 - Disclosure - Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncomeTaxesDetailsAbstract" 
xlink:label="loc_rcarIncomeTaxesDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" 
xlink:label="loc_us-gaapDeferredTaxAssetsGrossAbstract" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesDetailsAbstract" xlink:to="loc_us-
gaapDeferredTaxAssetsGrossAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-
gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:to="loc_us-
gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" 
xlink:label="loc_us-
gaapDeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:to="loc_us-
gaapDeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:type="arc"
/>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" 
xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapDeferredTaxAssetsGrossAbstract" xlink:to="loc_us-
gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-
gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesDetailsAbstract" xlink:to="loc_us-
gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" 
xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesDetailsAbstract" xlink:to="loc_us-
gaapDeferredTaxAssetsNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesDetails1" 
xlink:title="00000034 - Disclosure - Income Taxes (Details 1)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncomeTaxesDetails1Abstract"
xlink:label="loc_rcarIncomeTaxesDetails1Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" 
xlink:label="loc_us-
gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesDetails1Abstract" xlink:to="loc_us-
gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance" xlink:label="loc_us-
gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowa
nce" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesDetails1Abstract" xlink:to="loc_us-
gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowa
nce" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2013/elts/us-gaap-2013-01-31.xsd#us-
gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-
gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesDetails1Abstract" xlink:to="loc_us-
gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://janusresourcesinc.com/role/IncomeTaxesDetailsNarrative" 
xlink:title="00000035 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncomeTaxesDetails1Abstract" 
xlink:label="loc_rcarIncomeTaxesDetails1Abstract" />
      <link:loc xlink:type="locator" xlink:href="rcar-
20140630.xsd#rcar_IncreaseInValuationAllowance" 
xlink:label="loc_rcarIncreaseInValuationAllowance" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_rcarIncomeTaxesDetails1Abstract" 
xlink:to="loc_rcarIncreaseInValuationAllowance" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img001.jpg
<TEXT>
begin 644 img001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!/`9$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]Y?'=PUKX
M1O9%@N;DH@8QV]X+20C(R1*64)@9).X<`T6WB?[+>K;:L=/TRXO+R2WTV(WJ
MN^H(J[PRJ0IW[0Q*#=@*3DU7^*6A2>)_AWK.GPZ5I6MRW=J\:6&IN4M+LD<)
M(0K$*?\`=-8.G>)K;4?$NI+<VEQ:#PQK%O:B?6-,\BUC\ZTB51ILQ1?-4O*J
M%\M\[2QY&`HZ:<%*&OG^EOQ\OF>;B*\Z=9\JTM'7IO*]]MDNC=F]4EJ^]HKR
MZ'XFZK\*/AYKVJZ_X>U2R\,>!H+\S7$UZ^K:MJMM:QQM#<Q1QJS2&51-E78.
M"J\'<=O9^!?B1I/Q$T+2[W3[@JVK:9;ZQ%9W*&"]BMIUW1M+`V)(\\@A@,,K
M#J#6=2C*&^WW_D=-#%TZT4XZ7Z--/[FD_P`#>HHHK(Z0HKBOC/\`M#^#OV?]
M%^V^*M;M=.WJ6AML^9<W./\`GG$N6;GC.,#N17P#^UE_P5>\4?$^UN=&\!PW
M'A+1904>^+C^TKE?9AQ"/]PEO]L=*]'!97B,4_<6G=['S^<\38#+4U6G>?\`
M*M7_`,#YGN?_``4A_P""HVD?LK>';[PUX/EM=;^(L\9B"KB2VT,D?ZR;LT@Z
MK%^+8&`WL?[`_BG5O&_[&?PWU?7=0N]5UC4-#@GN[RZD,DUQ(0<LS'DDU^(N
MO:&UY+))(6D=V+,[')8GJ2?6OVV_X)^P?9?V*OAI'_=T*`?I7KYQEU+"82$8
M:MO5]]/R/DN$L_Q>:YO5JUG:"A[L5LO>7WOS_(]AHHHKY<_30KX^_P""ZOQJ
M\6?L_?\`!./Q5XG\%:_J7AGQ!::AIL<-_82^5/$KW<:.`WH5)!^M?8-?"W_!
MQO\`\HJ/&7_84TK_`-+8J[\JBI8VE&2NN9?F>9G4I1R^M*+LU&7Y'Q_^RE^R
MM^WQ^U[^SWX9^)'A[]IFVL-&\56[W-K;ZCKU^EU$JRO&0X2U=0<H>C'@BO06
M_P""8O\`P42"\?M2Z$3VSXAU(?\`ME7UY_P1`_Y14_!O_L%3_P#I9<5]65ZF
M,SFK3Q$Z<80LFU\*Z,\;`9#0JX6G5G.=Y13?ORZI'XN_%#XA?\%&_P#@EWIS
M^+_%6M:;\5_`NFD/J4N$U:TA3/WI6\N&]B7'\8P@_B/2OT:_X)I_\%%?"_\`
MP4C^`*^+=$MVTC6M,E%EKVBRRB233+G;N&&P-\3C)1\#.&!`96`^@-5TJVUW
M2[FRO;>&[L[R)H)X)D#QS1L"K(RG@J02"#U!K\6?^#?FV_X4O_P5U_:$^&VB
M22'PM8VFKP)&&+*18:Q%;VSD]\1S2#/^W3YJ6/PE6I*"C4IV=XJR:ZW0N6ME
MF.HTHU)3I5;JTG=IVT:?;R/VNHKRS]K#]M/X:?L1^`%\1_$GQ/9^'[.=FCM(
M"&FN]0D`R4@A0%Y",C)`VKD%B!S7PQ>?\'5/P+@\0&"+P3\4Y].#[3=BSL59
MA_>$9NNGU8'V%>5ALLQ>(CST:;:[GMXO.,%A9<F(J*+[=3].J*\5_8U_X*#?
M"G]O3PI/J7PX\30ZG/8JIO\`2[A#;:CIV>GFPMSM)X#KN0G(#$@UK_MB?MA>
M#_V&_@Q-X\\<MJ::#!=PV3&PMOM$WF2DA/ER..#DYKG>&K*K[%Q?-M;J=2Q=
M!T?K"FN3>]]+'J=%?*WQ9_X+,_`;X*?L^^%/B'KWB2[AM/'%@-2T31HK7S=9
MO822N[[.#^[7*L-\C*F01NSQ7S=I/_!U/\"KW7Q!<^"OBE9V#/M%V;.R=D']
MYHQ<YQZX)/L:ZZ63XVJG*%-M(X:^>Y?1DHU*L4WY]S].J*\\_9D_:K\`_MB?
M"^#QA\.O$5IXBT29S#(\09)K24`%HIHF`>.0`@[6`R"",@@GOKZ^ATRRFN;F
M6*WM[=&EEEE<(D2*,EF)X``!))KSYPE"3A-6:Z'ITZD*D5.#NGU1+17Y^_M&
M?\')7[/'P+\67&BZ/)XG^(MU:.8Y;KP]:Q'3U8<$">:2,2>S1AU/9JU_V5?^
M#AW]GK]ISQ=:^'[F_P!=^'NL7KB*V'B>WB@M+F0]%6XBDDC4GMYICR>!DXSZ
M#R?&JG[5TG;T_3<\Q9]ESJ^Q5:/-Z_KL?==%<7^T)\=='_9J^"GB'Q[K\&IW
M.A^&+7[;?+IUO]HN%A#`,ZID9"@[FYX56/:N8_8P_;7\"?MZ?"&3QK\/KN]N
M=(@OY=,G2\M_(N+>>-48JZ9.,K(C#GD,*XE0J.G[9+W4[7\ST'B*2JJ@Y+F:
MO;K8];HHKQO]MG]NWX?_`/!/_P"&-CXL^(=W?P:=J>H)IEK%8VWVBXGF9'DX
M3(^4+&Q+9P.!U(J:5*=2:A35V^A5:M"E!U*KM%;MGLE%<9I?QZ\-7'P(L?B1
MJ=Z/#/A2\TB'6WN=;*V7V*VEC613/N.(VVL,@G()QUKX5^+W_!SY^SW\/O$,
MVGZ#IOCSQND+E?MVGZ=%;6<F.ZFXECE/XQ@>]=.&R_$XAN-&#=MSDQ6:83#1
M4J]11OMY_(_1VBOA3]ES_@X@_9W_`&E_%]IX?N+_`%_X?ZO?R"&V'B:UB@M+
MB0G`47$4DD:9[&4H,\=<9^UO&_B^T\`^"M7UZ^;%CHMC-?W##M'%&TC'\E-1
MB,'7H3Y*T&F^YIA<?AL3!U*$U)+>W3U/@#_@L-_P6GN_V0/%EM\)/A'IT7B;
MXP:L(DE;R#=QZ&9L>2@A7F:ZD#*4C/`#(6#;@I^;/#'_``0X_:O_`&X=-3Q1
M\<_C?>>&[S4AYZ:5>7$^JSV8;G:UO')';0?[D;$#N`<BH/\`@W3^$TG[7_[:
M7Q:_:*\;Q)J6L:5=%[!IAO6+4+]Y9)94ST,4*>6HZ!9Q@<#'[75]#B\4LKDL
M+A4N=)<TFKN[ULK[(^7P."><Q>-QLG[-M\D$VE9.UW;=L_$WQK_P2%_;$_X)
MR:9)XQ^"7Q@U'QI;:0IN+C2-/FG@N+A%Y/\`Q+YFDM[D``_)N+G^%6-?:7_!
M'#_@KW9_\%&O"%_X=\36=IH'Q5\+0"74;*#*V^J6^X(;J!6)9<.0LD9)VEE(
M)#87[@K\</VIOV;O%O['O_!P/X"^(OPW\&>)[GPIXUO+#4-=GTC29Y["T^VS
M266H"1XT**2H:X8,>&D#<<8BEBHYG3G2Q*7M$FXRT5[='ZEU\'+**E.OA&W2
M;490;;2O]I=58_8^BJ?B'Q%8>$="O-4U6]M--TS3H7N+J[NIEA@MHD!9G=V(
M55`!)).`!7Y]_'+_`(.9OV=_A1XDGTO0X?&?CY[=RC7FC6$<5B2.#MDN)(V;
MV*H5/4$C%>%A<#B,2[4(.7H?1XS,<-A$GB9J-^Y^B%%?`'[.O_!R/^SK\=/%
M5KHNJS>*/AY=WCB**X\16<2V#.3@`SPR2",?[4@11W(K[[M;J.^MHYH9$FAF
M4/'(C!E=2,@@C@@CO2Q.#KX>7+7@X^H\'F&&Q4>;#S4DNQ)17A/AO_@I3\&O
M%7[2GB'X26WBX)XX\*QW,VJVES87%O;V:6ZAYG:Y=!#M53DG?C%?-7Q]_P"#
MES]GCX.^*KG1]$3Q=\09;5S&][H=E$NGEAP0LL\L9<>C(C*>H8CFM:668NK+
MEA3;=K[='L95LWP5&//4JQ2O;?JMU\NI^A=%?('_``3\_P""U'PM_P""BGQ`
MN/"?A31O'.C>(K2T>^D@U32U:#RE(!;SX'D1!E@!YFS)(`R2`>D_;@_X*Z_!
M+]@*_P#[+\9^(+G4/%!C$H\/Z)`+S450C(:0%ECBR,$>:Z%@<@$4GEV)5;ZN
MX/G[%1S7!NA]951<G>^G_#GTW17YG>"/^#IKX"^(?$4=IJWA;XE>'[.5PHOI
M;&UN(HA_>D6.<N!_N*Y]J_07X)_'3PA^T?\`#FP\6^!O$&F^)O#NI`F"]LI-
MR$C[R,#AD=>C(P#*>"!1BLNQ.&5Z\&DQ8/-<)BVUAZBDU]_W'64445Q'H&)\
M1YS:^"-1D6RTK472+<EMJ5P+>UF8$;1)(5<*,XYVGG%9EQ;W\.OW$UM'%=7&
MG"/&J7TR;/(FNS)=6HCA"D-%!''L9EYW199B)"=+XF>'[OQ5\/M9TZPO8--O
M[NSDCMKR;3UOTM)2IV2FW8@2[6P=A/.,5Y[?^*(=/U?2+I;;3(M8\3Q7]YHL
M$0;3-:N0+"%WQ:S@1376]`&\]HU11'D\-751C*4+1\_R_*R?RO?H>9BIT:=;
MGK2M>R5[6OS65NM^:44O-I1LV[S?#_4[73[&UU31;S6/%WAK3_#TFNV4UQ:7
M=[JE^;R:2=!!=RD1R#RT9!;_`.LC'D;MBLFZ/Q+X5TWPWK$/BG7;*REEN5>]
MU;Q-//'HU_HNFVDK7UM;2O#M>:WBD.UXV?807,@<,P.DOB.TU+PI:R:O?Q6\
M%ULT`ZS<:Q%:2ZLDMNNZ2W>U?:D[7),8"E&#1.4P-F?./B#XIN+KQ#;1PZ#9
M:-J%AK3:=J%_JGAF74O^$BLFT^1YDMI$<NN]8(5,LI*MY(C(9F11V4XSFK_U
M^&NC=_6UU8\G$U:5&JES--O;Y)NZ::LXQY5?9<W))2.H_9C_`&@6\0^'?"'A
M_P`3>*]#\9>+_$&CR:[%K/A[3I(-'U.T,S&)XB6<+^Z:,8+G)4GC<!7D_P#P
M4`_X**W'P2\03>"/!9@/B)(U;4-1D42+IN]0RQQJ>&EVD,2V0H(X))VT_!_Q
M>CT"X\"6VG^)+"._E\3:?HNK0:3`6L(%CE%L;1+61\62@M%&WEJ")"H*Y;CX
M._:=\4/KG[4'Q(G:0R%?%>JV^XG./*O)8L?ALQ^%?4Y!D-#%8R3J*ZBF[=&[
MVOLM.R_X8_)O$CQ"S#*<G@\.W%U)J/-I>,>3FY;\TGSWWEIUM_,5_$WBO4O'
M&MW&IZO?W>IZA=MOEN;F4RR2'W8\UESVP<54L]0S5Z*42#BOLZ^"Y-$C\9RK
MB%5_>E*[9E7VF[J_93]A>/R?V0/AVOIHL`_2OR"2T:\E6.-&D>0A551DL3T`
M'K7[0?LX^!+CX8_`3P?H%V-MYI6DV\%PO]V41@N/P8D?A7PG%=HTH1>]_P!#
M]]\+)NKB:U2.RBE][_X#.UHHHKX@_:PKX6_X.-_^45'C+_L*:5_Z6Q5]TU\+
M?\'&_P#RBH\9?]A32O\`TMBKT<H_WZC_`(E^9Y6>_P#(NK_X)?D8?_!'[]O/
MX)?"K_@FS\*?#_B;XM_#CP_KNF:;-'=Z?J/B&UMKFU8W<[`/&[AE.T@\CH17
MTF__``4W_9T12?\`A>GPFX]/%5D?_:E?FI_P3H_X-Y_@O^UW^Q5X!^(_B3Q/
M\3[+7/%5E+<W<&F:C8QVD;+<2Q@1K)9NX&$'5SSFO;/^(5?]GO\`Z'+XR_\`
M@VTW_P"0*]?&T,J>(J.=65^9WTZW/"R_$9RL+25.C!QY8V][I96.I_;I_P"#
MAWX,?`/X>ZE:?#77+?XE^/;B%HM.ATV-WTVTE8866>X(".BGG9$69L`'8#N'
M%_\`!`K]A_7OV3/A/X]^/OQ<2YTCQ)XYM'N_*OT*W5CIB%KF:XG7&5>9P'*$
M9"Q(3RQ`^/\`]@[X<:'_`,$NO^"Y,OPP^(.C:3K6CZA>-H^@:OJUE%-+:&X*
MRZ;?1.RX25_DA=DP%,L@_@K]A_\`@I[J=QI'_!.CXX36I83?\(1JR97JJM:2
M*Q_[Y)K3&PIX6,<%A5[M7E;F^JOHEV,LNJUL;.>88QKFH<R4$M(NVK?=L_+#
M]A?]GV^_X+Z_MT^.?C-\7&U!_AAX1N4M--T-9VC2526:WT]64@K''&/,F9"&
M=Y001O)'ZZ:;^Q)\&](\'CP_;_"CX<QZ)Y?E&R_X1RT,+KC'S*8_F)[DY)[U
M^,W_``1M^-'[9'PO_92U"T_9_P#@]\/_`!MX*NO$5S<W.IZO<(ER;[R;=)(R
M#J-N=JQI#C]WWZGM]8_\-9_\%._^C</A%_X&1_\`RYK7-\-7G7]G3JQC"&D5
MSI6MY=S+(L7AZ>&56K1G.I/64O9MWOYVV_`^>?\`@JS^QQ/_`,$9/VEO`?[1
M7P'\[0O#E_JALM0T82NUI:W!4R-;<DDVMS$DH*$G8T9VD90)],?\%\OBMIGQ
MU_X(Q:3XTT5F;2?%E]H>KVF[[RQ3J9%#?[0#8([$&O#_`-M_P]_P4/\`V^_@
M+<_#SQG^SU\/;'1[F\@OOM&D:C;17<,D+94JTNJR(,Y(.4/#'I6Q_P`%$OA#
MXL^`?_!N%X%\'>.-/?2O%/A_4-/M;ZS:>.<VY%U<%%WQLR'$93[K$5O&TI86
M5:<958SMI)-N.ZO;L<L[PAC(T*<H490<K.+BE+9VOWW/.O\`@@-_P2B\._M=
M>&+CXS?&"UE\5:'IEP-$\,Z+?R,]K<"W10TTJY^>),B-(ON923<I`%?K5XI_
M8,^"7C3PG)H>I?"/X<3Z5)'Y7D+X=M(A$N,?(R(&C([%"".Q%>8_\$3?#-OX
M4_X)9?!NVMD")/H\EZ^!U>>YFF<_]].:^IZ\'.,QKU<9-J32BVEKM8^FR'*L
M/1P%-<B;DDVVKW;5S\9_V`O!,W_!,C_@OSXE^!F@7EV_@#X@V,K65M/*7"1B
MS;4+9FSRSPF.>`,>2'8G[U=S_P`'%G[5GB_Q=X^^'W[+7P[GECU?XD/;S:R(
M9"C7B7%P;>TLV8?=C:1'>0=U6//RE@:/QN_Y6J?AG_V`Q_Z9[^N4^-B#Q-_P
M=9^$[74OFMK`V1M@_0;-#:=,?]MB3]:]^*C/%4\745Y*CS^LE=7/FIN5/!U<
M%2=HRK^S7E%V;2_'[S[D_8>_X(T_!3]C?X8Z?I\O@_P]XT\6&!3JGB'6].CO
M)[J<CY_)64,((L\*B8X`W%FRQYC_`(*._P#!$7X4?MA?"359/"GA3P]X&^(]
MI;O-I&JZ19QV,5U,!E8;J.,!)(WP%+D%TX(.`5;[;HKY59GBE6^L<[YO7^M/
M(^SED^"EA_JWLUR6MM_6OGN?EW_P;W_M8:C^U+^SCX__`&?OB@)M4U#P%;-I
MBQWQ+37.D3B2WDM),\GR&5H\GHDL:C[E>0_\$*/%^H?L%?\`!3;XM_LR>);E
MQ;ZO/,-+:7CS[JSW20R*.PGLG:3W\N,8JU_P2/0>&_\`@X9_:4T[3OEL)?\`
MA)A)&OW$QK5LV,=MK<#ZXJ3_`(.(_AIJO[)G[9GP>_:>\)0^7<K>06FH,ORI
M)?63"6#S#W\ZW\R(C^Y;D=Z^JE"G/&5<&M%7BI+RE:Z_4^*A4JPP%''MWEAY
MN+?>%[/\+'[*5^./_!3V[?\`X*9_\%KOA=^SY9.UUX0^'CK+X@"',>YE6[O\
MD<?\>\<$(S]V1F'?%?IWXQ_:X\*^%?V.;OXV"X$_A*'PQ_PE$#;@K7$+0":*
M,>CN65`/[S`5^=G_``;3?!C5?BCXE^+W[2GBY3<:]XWU6;2[*Y=<%R\HNKZ1
M<_PM*T"@CIY+BO%RF+PU.MC9;P7*O\3T_!'T.=26*JT,OAJIOFE_@CK^+L6O
M^#@W1?B7^TI\>/@M\`/!VD>(HO!NO3VMWJ]_8Z;-+I\<UQ=FT@,[HNP);JDD
MA4D`"0,>BD?;W[-?_!,#X%_LK^!;/1?#GPY\,7,UO$J3ZKJFG0WVI7S`?,\L
M\BEN3D[5P@S\J@<5X7_P5A_X+5V7[!GBRP^'/@;PZOCOXM:Q'')'8/O:UTP2
MG$(E2/\`>2RR'&V%"I(()894-\\Z9KG_``56^-UBFJ6L6@^`;*_'F16LUKHU
MN\2GL8YEFG3Z/AA75&CBJN"IPYHTH:[RMS>=MSDEB,'1Q]6HH2K5';X8WY$E
MM?9>9ZC_`,%WO^"8GPGU[]BCQA\2O#G@[0O"?C;P3#%J,=[H]FEDM_#YR)-%
M<)&`DF48E6(WAD7#;2P,7[%7[1NM?&G_`(-R_'&JZQ=S7FL^%_`OB;0#=2,6
MDE2VM+A;<D]25A:)<GD[,]Z^8OVX/V7_`-O_`$S]E'QQK_Q9^+.B7G@;3M.,
MVLZ7#J2![R'>HV".&U5&^8KP6`]Z]N_X(^>%I?'/_!OG\6=%MT+W&K67BNSB
M4#EGDL"BX_$BNN=+DR^"G453EJ*S3O;RNSAIUN?-)NG2=+FI2NFDKN^CLON-
MC_@U-TY(OV)OB!=@#S)_&\L+'U"6%F1_Z&?SK]0Z_*C_`(-0O&%O>_LM_$_0
M%<&ZTWQ5%J$B9Y5+BTCC0_B;9_RK]5Z\/B!-9C5OW_1'T/##3RNC;M^K"BBO
M,?BM^V;\+?@;\4M%\$^+?&^AZ#XL\1+"^F:7=2D7%Z)IFAB**`<[I$91[@UY
M4*<YNT%=^1[=2K"FN:HTEYGP?_P<EZ_\3OB%X,^&WPA^'VB>)=0TSQG?27>O
MS:;8SS0E8WA2VAF>-2!'YDCR,&[PH>U?5'[(/_!)CX(?L@?#?3=(TWP+X;U[
M6X8$6_U_6-.BO;^_FP-[[Y`WE*3TCCPH&.">3P7_``5F_P""Q6@_\$W;+3/#
MNE:,/&'Q-\10?:+#2#*8[>R@+%%GN"N6(9U8)&GS/L;YEP"?E?0_B)_P5/\`
MVB],37-)TK0OAWIFH@206T]AI5H\:GD?N;OSKE/^V@#5])2HXJK@:=-2C2AK
MJY6YG^>A\E6KX.CF52JXRK5+)6C'FY%VOMKN?1O_``6!_P""6OPB^,/[&OQ"
M\5:=X*\.^&?&O@S0KO7]/U;1[&.RFE-K$T[0S",*)4=$9/G!VE@01BJ'_!MI
M\>-7^-/_``3>M[#6;F6[E\`Z_=>&[265MSFU6*"XB4D]D%R8U'98U'0"OE;]
MH[]E?_@HS=_L^^.M8\?_`!?T%?"FF^'M0O-;L8]2BB:[LH[:1[B();V@5BT8
M=<;@#GJ.M>V?\&J7_)A_CG_L?;G_`--VGUMB*+CE4XRJJIRR5K-NWWG/A,0I
MYU"<*,J7-"5[I+FMULC\V_VZ?ACXF^.W_!:;XE^`/"=U/:ZKX\\9-H64D9(V
MBE>/?YNWDQ+MWL/1/:OW&_9)_P""1_P+_9&^'%CHVG>`_#GB/5HXE%]KVN:;
M#?7^H2X^9]TBMY2D](X\*.."<D_G/^R1X3MO$O\`P=$^/KBX0.VB:CK=_`",
M@2?9#"#^`F8_7%?MA4\08ZK&%'#P=ER1;MU?](KA?+J,IU\54BG+VDDK]$GT
M];GR7^WQ\0O`G_!*G]D#XC_$_P`!^"O"/AKQ5J\5OI]K_9NE06@U&_=FCMFF
M$:J)!%YDDI!ZJC#/-?(W_!$K_@D?X=^-?PZ3]H;X[V'_``L#Q3X]N9=3TNQU
MP?:;=(3(W^F7$;96>69@S*'!0(5.-S?+U_\`P=6ZG<V_[#?@6UCW"VN?'$+3
M$="5L+W:#_WTQ_"N/_9J_:4_X*+>%?V=/`.F>#?V>_A1?^$-/\.:?;:'=2W<
M8DNK%+:-8)&_XFZ?,T81C\J\D_*.E5A*=7^S>>E-1E4EJW*SLNB;)QM6C_:W
MLZU-RA3BFHQBY+FEJVTC]#?BQ_P3^^"?QM\#S^'O$7PM\$76FS1F)?)TB&VG
MMAC&89HE62)AV*,#7Y4?LQ?VY_P0Z_X+*0?!V35[Z_\`A'\6)K:*R^UOUCNG
M:*SN6QA1-#<*T#N``R;F('RA?H#_`(:S_P""G?\`T;A\(O\`P,C_`/ES7S?^
MV'^RG^W;_P`%`?CA\/O%OCKX'>%_#U[X(F2.WN-`U:RAS%]H24M()=1F9MA4
MD;<?>;@YJ\MH2IJ='$UH.G).ZYT[/HUKO<C-L1"HX8C"4*BJP::?LY*ZZIZ;
M6/W(HHHKX\^["N5\3?#--;NKJ2&[N83JLC"\E-S/Y]M$;9H?]"=9!]E<L(V+
M(.</D;F##JJ*J,Y1^%F=2C"I;G5[.Z]3YY\>V5YX;U3Q'K$WA#4+_6M5U"&/
M2M'U353=:1Y5A(1'?6_RO!8R.DS2$$*[M&N<L*\6^*&M:5H?C/\`M'3M9U/2
M[M=6UG47LM-N+NUTC57,,4$[:D_ER*)(P`T>&1=ZY4'#5]RZWHEGXET:ZT[4
M;2VO]/OX7M[FVN8EEAN(G!5D=&!#*02"",$&OSA_X*I:AKO[.'BZ"&SDU<>'
M=:M)=5MM1ANH)+D3Q7*.^F+;-&<QM&V!+]X*=N2WS'W<KJ*M-4;:^OEM^'KO
MY6^,XCPM3"Q>,C*\=$U9;W>NB3UO9WNMK):\WSIXA_;!NO&/[5/P*T#0/$FC
M^(_!/BSXA>%VT:>!9FU".SMM1A%Q]JED.7+W<:;<`<0L#R*\H\:^,_MG[8GQ
MV\.7+XN],^(&O7=NI_CMY=3N#D>NV0L#_O+6#^SIIEYXK_X*%?![6+VTM[56
M\<:')9Q1P>5]GA^VP'8%QA0&SP/QYS7)?\%'X=3^%O[9GQ$\<:/Q<:;X[UF.
MY4_<FAEOIOE?_9SQ]7!'(K]"RFI'"XY+O'7[S\:XSR%9UPY.A!KF4TX=DU&U
MO2UUY'K$<IA:O6?V??V5_B!^T;,#X7T"YN+!6V2:C<?N+.,CK^\;AB.ZKN;V
MK0_X(^_"'PW_`,%!O&-QK=VQ?PWX5CBFU73B^V9[ARWEV[8YV'8[%AU"XX+<
M?L7HVC6GAW2K>QL+6WLK*TC$4%O!&(XH4'`55'``]!5<4\64\'/ZMAHJ4[7;
M>RO^;/AO"?P;QN:4WF&;SE1HJ32BOCDXNS=W=*-]+V;=G:RLW\M?LD_\$P=+
M^"7B"S\2>+-0A\1:_9,);6WAC*V5E(.C_-\TK`\J2%`/.W(!'U=117Y/C,=6
MQ53VM=W9_7^39'@LJPZPN!ARQ^]M]VWJV%%%%<AZP5\+?\'&_P#RBH\9?]A3
M2O\`TMBK[IKY]_X*>_L::E^WQ^Q_KGPTTK6K+P_>ZM=V=RE[=PM+%&()TE(*
MKSR%Q^-=N6U8T\73J3=DI)O[SS\VHSK8*K2IJ\G%I>MCE?\`@B!_RBI^#?\`
MV"I__2RXKZLKQ_\`8%_9IO?V._V0/`_PUU'4[76;WPI9R6TM[;1M'%<%IY)<
MJK<CAP.?2O8*C&SC/$5)QV<F_P`33+J<J>$I4YJS48I^J2/RK_X.=OV,9O&G
MP=\-_'3P[#)'KOP^F33M8F@RLIT^67,,V1SF&X88QT%RQ_AKZM_8<^/6F_\`
M!5#_`()DV]SJLZ&\\6:!=^%/%*H!F"],#6]R=O0;U<3*.RRI7T3\4?AKH_QD
M^&^O>$_$-HM]H?B2PFTV_MV_Y:PRH4<`]C@G!Z@X(Z5^>?\`P3U_X(F_$_\`
MX)]_MD6&OZ-\99-3^#MO<WES=^'!/=VDFJM)9S00&XME)MI'C:2-MY/_`"R!
M"J<`>K2Q5*M@/8U9\LZ;O%]UV^_]#Q:V#K8?,OK%&'-3K)*:[/;F^[?YGB/_
M``;V?M'/^QC^T-\2?V6_B9+'H&M3ZX]QHXN7V13:E&HAG@5CP3-%'`\1Z.(S
MC)=0?V8KXL_X*C?\$6_!/_!1:6+Q/9Z@_@CXF6$*Q0Z[;P>;%?HGW([J,%2^
MWHLBL'4?W@`H^2+7_@F=_P`%'/"=B/#.F?M!V4NAH/)BO#XMO=T<?0?O'MC<
M+@=E)QCBML3#"YA+ZRJJIS?Q*7?NGYG/A)XW*X?5'1=6"^&4;7MV:\NY]%_\
M%D?^"Q.J?L'>(/"'@;X6V7AGQ;\4-?NU>\TO4+>>\6QM67;$AC@EC<3S2,FP
M;C\J-E?F0U@?\'!%SXAO/^".EA+XNBT^#Q7+J&B/K,5@K+:17I4F=8@S.PC$
MFX+EF.`,D]:U_P#@FQ_P0=T3]DOXFK\4/B?XE?XG_%(2FZM[F57:RTRX;[TZ
MF4F2XGZXEDQMSD(&`:O>/^"J/[$&I_\`!0?]DVZ^'6D:[8>';RXU2UOQ>7D+
MS1!868E=JG.3FIA7P5#$T(47=0=Y3MO_`,!%U,-F&)PF(G75G.-HPOMIU?=D
M/_!';_E&%\%?^Q;A_P#0GKZ5KRS]B/\`9]N_V4_V3O`GPZO]1M]6O/".EII\
MMY;QM'%<,I)W*IY`Y[UZG7B8R<9UYSCLV_S/H<#3E3PU.$]U%)_<?DE\;O\`
ME:H^&?\`V`Q_Z9[^N7_X+N^'=8_8K_X*;?!G]IO3M.GO-!,EG!J/E#[]S9R-
MYD!;HIFLWVIGKY4A[5]D^/O^"8.N>,/^"OGA3]I2/Q3I4.B^'K#[')HK6TAN
MIC]BN;;(DSM`S.&Z=%-?2G[1G[.GA#]J[X/ZOX%\<Z1#K/AW6H]DT+G:\3CE
M)8W'*2(<%6'(/MD5[W]JTJ5:A->]%4U&2^^Z/FWDU:M0Q--^[)U7.#]+6?YH
MO_!3XU>&/VB/A=HWC+P=J]KK?AW7K=;FTNH&R&!ZJPZJZG*LAPRL""`16'^U
M9^U'X2_8Y^!FN>/O&FH16.DZ-`S)$7`FU"?!\NVA4_>ED(P!]2<*"1^7&J?\
M$%?VE_V0O%^HR_LV?'9[+PUJ$ID-C>:I<Z5<^B^;'$CV\[*./,(0^BCI5OP-
M_P`&^_QQ_:F^(VG:Y^U)\;+C7M)TYMR:=I^J7.I73ID;HDDG1(K4-CDQH^?0
M'D9++<`I>T>(7L^UGS>EOU-GFV9N'LEA6JFU[KD];]NMB?\`X-H_A)K_`,4_
MC#\:OVC?$5JT!\8W<VF6<I!VW<UQ=?;;XKGJJN+=<]"2PZJ:^[O^"L'[)_\`
MPV;^P7X^\'6]M]HUR.R.K:&`N7^WVO[V)%]#)M:+/I,:]J^$OPF\.?`GX;:/
MX0\):3:Z'X<T"V6UL;&V7"0H.>IY9B269B2S,Q))))KHJXL9F<JN-^MTU:S5
MEV2V._`91"CE_P!2JN]T^9]W+?\`X!_,[?\`_!277/'G_!)?PU^S-9K?W7B`
M^+#`?+4L;G20RW%M;9[N;V4@#LL"#N*_H)_85_9GM?V/?V1?`7PYMUC\WPWI
M4<5])']V>\?,MU(/9IWD8>Q%?$OPT_X-YK+P!_P4S3XS'Q-I$W@2R\23>)K'
MPTMDXG@F;=+#'OSLV17#*PX^[&H[YK],Z]'/LPP]:,:6$^%MSE_B?^1Y7#65
MXJA.=;&_$DH1_P`,?\_T/Q3^&<VF>$?^#IKQ(?B#Y,=Q>WTXT*6^QY?GRZ;'
M]BVEN,F$[$_VRH'S8K]K*^+_`/@JK_P1K\*_\%(4L/$=GJ[^"_B5HD`M[/6H
MH/-AO(58LD-P@*L0K$[9%(9-QX886OD_3/\`@G!_P4@\+62^&K#]H327T6,>
M3'>R>)KN1TCZ#]X]H;@8'H>.QIUUA\?"G/VJA*,5%J5^G5>O8,,\5EE2K3]@
MZD9R<E*-NO1KR[GJG_!RG^W!H/PF_9$N?A#8ZA;S^-/B)+;_`&BSB<&73]-B
MF69YI`/N^8\:1J#]X-(1]PUT'_!LXD5[_P`$Q1"X25#XHU*.1&&005AR"/H?
MUK-_8]_X-XO"?P_G\1^)OC=XHO?B[X]\5Z?=6%S=3M)]GL/M,+0RS(\I:2:X
MV,=LTF-N00@8!JE_X)H?\$:?B?\`\$[_`-J-]4@^,3Z[\)5%W(/#L<UW:_;)
MY8O+CFFM0QMS(H"Y?)/R#&.,:5:N!67RP5&I[R?-=I^\^R_#<RHT<Q>9PS"O
M2]V2Y;)J\%?=]^KT/C?]E_XCR_\`!!#_`(*W>,?!?C6.[M/A5XW/D17^QG1;
M!Y6DL+\`<OY.7AD`R1NFP"5`/[H^%?%>F>.?#EEK&BZC9:MI.I0K<6E[9SK/
M;W,;#*NCJ2K*?4&O(?VY_P#@GU\-_P#@H1\,5\.>/]+D>:R+2:7J]DPBU#2)
M&`!:*0@C!P-R,&1L#(RJD?FFW_!!K]K#]D[4[F#X#_']8_#DTI<6O]L7VAR,
M3W>W02P,1_>W9/H,XK*K/"YDHU*M3V=5*SOM*W6_1FM"GC<IE*E1I>UHMMJS
M]Z-^EGNC]??B7\3?#WP;\#:EXF\5:SI^@:!I$)GO+^]F$4,"#U)[GH`.22``
M2<5^*_[->K:A_P`%HO\`@NK%\4[&PNXOAI\+9[:^MIIXR/*M;)F:Q1L\"2>Z
MW3;.H4R]=G/7:5_P;]?M*?M6>)K*?]H?X]->:):2"06T6JWFN7*#N(TG$<$)
M(R-R[L9^Z>E?J-^R)^QUX!_8>^#]KX*^'NCC3-+A;SKF>5O,N]2G(`:>XDP"
M\AP.P```4*H`"53"Y?2G[&?M*LE:ZVBGOZLJ5+&9I6I^WI^RHP?-9OWI-;:=
M%_7I^4G[3DVF^$O^#I;PK?\`Q#\F/PQ<SZ9+I+WN!`K'2/*M6!;@`:BN0>@8
M$]J_:RODW_@J3_P26\&_\%,_!NGO?7TOA?QQX?C>/2=?@@$VV-CN-O/'E?-A
M+?,`&#(Q)4X9E;XNT/\`X)G?\%%OA3IZ>%_#7[0.D7'AV!1!;7$OB*Z<P1#A
M0#-:M+&`,?*A(7H*=3ZOCZ-+]ZH2A%1:E>VG5/S%1^M9;B*R5%U(5).2<;7U
MZ-/MT/I+_@X&_;CT']F?]A[Q'X)CU"W?QO\`$^R?1K#3D<&:.RE.RZN77JL?
ME;XP3U>08SAL>:?\&J,JG]A/QTF1O7QY<,1W`.GV&/Y'\JV/V+_^#?:P\&_$
MZ?XD?M#>,I_C/X[N58B"YDFFL()&4KYDDLQ\VY=0?D+!%3KM)"E:'[%/_!#;
MXD?L(_MFZ?XD\(?&>YD^$,6HR7M]X=-Q=VLVIIY4B11W$,9^SSM&77YVQG;D
M*O0;.I@(X&I@J=3WM)<UG:3[+_@F"I9E/,J>85:7NZQY4U>*?5_\#:QXO^Q+
M_P`K._Q8_P!_6O\`T7%7[-U\,_`7_@DQK_P@_P""L'C']HJX\7:/>:/XF:_,
M6CQVLBW,'VA4`W.3M.-O.!WK[FKR\YQ%.M4IND[VA%?-'KY!A*V'I58UE9N<
MFO1['QW_`,%V?V4]0_:S_P""='BK3]%M9+[Q!X1GB\4:=;1KN>X:V#K,B@<E
MC;RS[0.6;:.]<7_P;Z?MWZ-^T[^Q5H/@6ZU"!/'7POLTT>[L7D`EN+"/Y+6Y
MC7JR"/9$Q'1X^<!US]\5^9'[;_\`P;WOXN^,TWQ2_9S\;GX3>-9YVNY;$33V
MEB)VR6EMY[?,MMN).4"NAW'`0<'7!8BA5PSP.)ERZWC+>SZI^3,LQPV)H8M9
MCA(\^G+*.S:W37FC]-R<5^<>L?\`!9'QK\8_^"M&A?`?X*:;X)\3^!K:YA@\
M2:Y<VMS<RQK$6DU"2WFCN$B"1QXB1F1@9AU8,HKP[5?^"5G_``4%^.FGMX7\
M<?'^PM/"MP/)O67Q'=R?:83PRE(H$:8$?PR,`>YK[M_X)H_\$J?`/_!-/P-=
M0Z#)-X@\7ZU&J:QXCO(ECGNE4Y$,2`D0P!N=@))."S-A<7[#!82G*4YJK-JR
M2O9>;?EV,_K.88ZK"%.G*C!.\G*UW;[*7GW/J"BBBO`/I@J*]OH=-LY;BXEB
M@@@0R22R,%2-1R22>`!ZU\Z_M*_\%"[3X/7EYI'ACPCXE\7Z]:NT,C)830V%
MO(I((:4IE\'L@(/]X5\"?M%?'/XU_M-7+KXCM/$BZ7NW1Z59:=/!91^GR`9<
MCL7+$>M?691PCBL9:I5:IP[O?Y+_`#L?C_&?C-E&2.6'PD)8FNM.6"?*G_>G
M:W_@/,^Z1]D_M2?\%;_"GPUCN=)\`B#Q=KHRAO<G^S;5O7<,&8^R87_;[5^:
M_P"T)\4/%/QU\13:IK]YJ.MW^L,;:XNEN5A:PA*M\T8X"JIP`J#@MD#K4D/P
MF\5Q/_R+/B#K_P!`Z;_XFM[PO\`O'/C+4H['3O!_B6[NI3A4339>/<G;@#W.
M`*^\IY'@<NI_N7KUDVK_`/`]#\1H>(6><18I?7H-1O[L%%J*?335M^;N^PW_
M`()[_!V;QS^W#\,;.(33KH^J1:G))(Q=E2T4S[F;W,8&>Y8>M6_^"B_P*BL/
MVK_BCH>J0$VFNZE/?=,;DN_WX93Z@R<'L5]J_17_`()N_L$2_LNZ;>>)O$P@
M?QGK4`M_)C8.NEV^0QBW#AG9@I8C@;5`)Y)7_@H]^P=<?M-:=:>)O"ZP#QAI
M$!MVMY&$:ZI;@E@FX\+(I+;2<`[B"1P1\A'.:+S/67N6Y;]+WO?TZ?B?NV(X
M>QJX?YH0?M4^;EZVM:UN_6V_3<_(7]@*V\9?L3WFIZAI6IOI>KKJ;-;W5O(&
M6\M@B!?,3D%20V4<=1TZ&OUB_98_X*X^$OBBMMI'CL0>$-?;""[+'^S+MO7>
M>83[/\H_O]J_/#Q=\"/'7A/59;'4?!WB:TNHCAHWTR;\P=N"/<<&LJ'X0^*B
M<GPSX@S_`-@Z;_XFOM\1D&`S&E>NUS=))J__``4?SI_Q$_B'(\>W@H-QO[T)
M1?*_U3\U;SNM#]X+.\BU"TCG@ECG@F4/')&P9'4\@@C@@U)7X]_L[_'?XU_L
MS7")X=L_$DFE!MSZ3?:=//92=SA"`4)[E"I/K7WQ^S3_`,%"+/XR7EEI'B7P
MEXE\'Z_=NL,?FV$TUC<2,0`%E"93)[.`!_>-?G>;\(XK!7J4FJD.ZW^:_P`K
MG]!\%^,V49XXX?%0EAJ[TY9I\K?]V=DO_`N5]DSZ,HHHKY,_8`HHK@?VE+W6
M;#X5S2:,VJ1?Z;:+J$NF1E[Z&P-P@NG@`!;S!#O(V@L!DJ-P%:T*7M:D:=[7
M=CDQ^+6%PU3$M-\B;LMW97.^HKP'Q]JEO;?LN>)YO`^K>-KQ4U&U$=Q?76I&
MY13<6PE$,\@-R8MA?+(6QF0`\8#)/$MWH_[+USJ&FWNLM<VWB'3FN98;[5+^
M9(?[0L_/"O=*+@IY!;<JKMP7ZY:O0CE<I)--ZRY=5;MOKIN?.5.+*=.<H2BG
MRTG5O&5TTN;2+M:7P[Z;K0^@:*\G^+?Q;AG\->#]?T>[U8:0OB:"/4)(+.Y1
MS;B*8.'CV!RF[9G*XSBO2O#?B.T\6Z)!J-B\DEI<@M&SPO$Q`)'*N`PY!ZBN
M*KAJE."G);W7HUT]3W,)FN'Q%>>'IR3<4FM4[IJ_,O+I?:Y>HKYH^'(\:)^T
M%9SWA\1V>D7GBC7$:]N=9N[JTN[>)[A8+/[$R^5;Y!1XY00"L!`.7"F[\)=8
MU"Y_:=UZ+5[W63LUR]2QAFU75Q'Y(C^0+;[?L1CQNP2W7D#(%>A/*7'FM*]H
M\VFO5KOY>OD?.8?C&-7V:=)QYZGL_>;7V8ROK'6ZE9*UF]I-:GT517S%J>N?
M$G0?&UQMDUW4O#FM_$.VMD9-XFT6*.]AW`]VLIH=P/\`"K+CD2<:=_K&H#]L
M35K?4;W68],34-/73XO[5U>"`@VT)(2&!3:R*92=WFD#);=Q1_9#U]]/W6]-
M=K:=._X7U5A?ZZ0]U.C*+<XP][1>\IM.]G=6AI;K))V::7T517SE\>+CXBZ9
M\3]7T?PQ/K+6LJQ>,K:X5W:+;:0LDNEAL_*)IX[4[.A6>;CK5G6O$7C+6O@%
M9BQM_%<GB'XE:O)=)%:S""\T/3'<R;8WE=4@=;1$099<32Y`)R*E94W"$^=6
ME;Y75[OTUOZ&DN,(QK5Z/U>=Z7-T^)I\J4>[DW&W^+R9]"45X/>_$WQ(O[/O
MA+4=9BUK2M=T?Q#86'B)8HG:5EAN52X<B+=OBD0;SL+*5?&37K%E\4=$O](T
MB^CNI?LVNW?V&R9[69&EFQ(=I5E#)_JGY8`<#GD9Y:V!J4U??5K35:>?GNO(
M];`Y_A<3+EOROEC.TM':7D]4T]'V;MN=!17G?[4T&M7GP;GM_#VH:EI.JW>J
MZ3;1WM@"9[5)-2M4E<`=0(V<L#\I7=GC-<G\,?B?XNT2'XFZIXMTC4S?>'A;
MI!8VX>2WOY4MN6LQS\D[[2!U4OAN5-71P$JM!UHR6]K==XK_`-N_`RQG$-/"
MX]8&K3E9QYN>WNK2HVGYI4]NM]+V9[A17A7[-\'C#4-+\0^#OB%%XIMKRYCB
MU2"^EOPDSK,`+B*&XM96\M8[A7*+O#+%*BXPM4O"^A^(O#O['%YJ%M>>,KSQ
M+-B[F^T:A=W=[MBN_F6)9'9U)A4_(F-WH2:UEEJC-PYTWS12:U3YNM[].IQT
M>*)U*,<0L/)+DJ3:E=3BZ;2<7&V[;7+JKK7M?Z"HKY[\=>.M<\;^!OC!K7AJ
MX\1MI_\`95I;Z%(B7-JYN4CD,QMU8*X.7C!=1R5(R2O%SX3^)/$GPR\/_$F[
MU:QUV231)(AINA7&IW.M32/Y.5:*[F4-(D[LJA>1&4;.TY`;RJ:IN7,N;33K
MKR_ES6VMH[M:74>+J,L1&ER/D:D^?5JT74UT5FFJ;:UNU)-)KF:]XHKP+X&:
MSXZT+X>>,O#OBV#Q&NO6>GMJFGWM[+'-+<>="WF)')"\BCR[E)=B;MRQR0C'
M`-6]7^*EQXN_8VUZ30[S77\4:3X77SI%MKF&\2[-N>59E5FDWJW*Y.?J*4LK
MFJG(I)JZ5UJM=G?L71XLHSPZK3IRA+DG/DEI*\+\T;/6^E_378]RHKRCXN?$
M&7Q9\'=2\5^![[4I-2\&L^I16WV:XA35#%&6DM)(F56D62-BHP#M<HPY7%=7
M\.X)/`GA[1=&UG5;_6-=U)9;B:ZECE=9YO\`62X."L,8+81"0`H"C.*YIX24
M:?.][M6L[Z*[^5K?TCTZ.<4ZN)=""O#E4E.ZY7S/EBD[ZMM-6\EK=I'64445
MR'L!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`5%/90W4T,DL,4CV
M[F2)F0$Q,5*DJ>QVL1D=B1WJ6B@32>C"BBB@84444`%%%%`!1110`4444`%%
A%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0`=?[]DX`$``+H6```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,F-UNVC`8AL\G[1XBGT[$
MV-FZMB+T8#^'&]+8!;CQ!XE(;,MV.[C[.8&B"E$J5*2^)T00^WL?K.B1\D[N
MUEV;/9(/C34E$_F8960JJQNS+-G?^<_1-<M"5$:KUAHJV88"NYM^_#"9;QR%
M+.TVH61UC.Z6\U#5U*F06T<FW5E8WZF8OOHE=ZI:J25Q.1Y?\<J:2":.8C^#
M32??::$>VIC]6*>?MR2>VL"R;]N%?5;)E'-M4ZF82/FCT0<IHUU"GG8.:T+=
MN/`I83!^-*&_\W+`;M_O=#2^T93-E(^_5)<P^+KE_ZQ?W5N[RD\/.4)I%XNF
M(FVKARZ=0!Z<)Z5#312[-A^N>:<:\\1](G]8'/AP$1<&Z?_?,/A,#@G"48!P
M?`;A^`+"<07"\16$XQJ$XP:$0XQ10%",*E"4*E"<*E"D*E"L*E"T*E"\*E#$
M*E#,*E',*E',*E',*E',*E',*E',*E',*E',*E',*E',6J"8M4`Q:X%BU@+%
MK`6*68OW,FM,S2#QX?/MC^DPYI5J*L1-2^'"KY/;H:\EU\J3_A-]ZE`O#O!\
M]BF.U##.O'4A=:V>SC^%IS*UWSUR:1#YV-"^3CU62^X34T][?N!!+TI]$ZQ)
M'\GF0_,\_0\``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?
M<F5L<R\N<F5L<R"B!`(HH``"````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````````````",DL].PS`,QN](
MO$/D^^IN2`BAI;M,2+LA5![`).X?M8VC)$#W]H0#@DICV]'VY\\_6][NYFE4
M'QQB+T[#NBA!L3-B>]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBR
MBXL:NI3\(V(T'4\4"_'L<J61,%'*86C1DQFH9=R4Y3V&OQY0+3S5P6H(!WL'
MJC[Z//FRMS1-;W@OYGUBETZ,0)X3.\MVY4-F"ZG/VZB:0LM)@Q7SG-,1R?LB
M8P.>)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%
M#U1?````__\#`%!+`P04``8`"````"$`Z,')Y]\!``"K%0``&@`(`7AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS(*($`2B@``$`````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````O)C+3L,P$$7W2/Q#Y#UU9P;*0Z1L$!);'A]@)6Y3
MT2:1;1[]>ZP*4BK!91/-)I(=U;FZ,[TGD^N;C\VZ>/,AKKJV-#29FL*W55>O
MVF5IGI_N3BY,$9-K:[?N6E^:K8_F9GY\=/W@UR[E'\5FU<<BG]+&TC0I]5?6
MQJKQ&Q<G7>_;?&?1A8U+>1F6MG?5BUMZR]/IS(:?9YCYP9G%?5V:<%^3F.)I
MV^='_W]XMUBL*G_;5:\;WZ9?GF'?N_`2&^]3/M2%I4^E&;:BW=TAF63-QOXA
M)_NA*^<"R>&9LAR>03FD+8>0'#E5EB.G2,ZYLIIS)(9860TQE*-M#D%W^$S9
M'3Y#[HAV"`H,01DU!&/C@J\?4\C,B=GVKUP^V$;F:#<R[F/M0"8<R)GGJKCB
M*2S5I;:<2R1'FU805MJ-`_N&U*V!WK`VR!F"7+0C1V#FR*CLC&F[SB_Y^QS>
MK='?2)N5$)6DK8:@'-8F-T-R\ZCD'D:G?;<,6U_3%,/Q148-O92G3K^7LEO:
MW16&"VDSDB`C29N1!!DIVB006"QM$$`.:%<*%HJTK2'H#6LSDB$C>51&#BFW
M3YMAZSOXX'PIVIDC,'-$&YH"H:D-*<RH7&/-[X\#O^W!)];Y)P```/__`P!0
M2P,$%``&``@````A`'`G#X*!`P``10L```\```!X;"]W;W)K8F]O:RYX;6R4
MEE%OFS`0Q]\G[3L@WC<"I-U:-9VRA*V1NB0:K'VT7'`2JV!GMFG:??H=I"4'
MSE#V1`SQG[O__>[PU9?G(G>>F-)<BI'K?QRX#A.IS+A8C]Q?R;</GUU'&RHR
MFDO!1NX+T^Z7Z_?OKG92/3Y(^>B`@-`C=V/,]M+S=+IA!=4?Y98)>+*2JJ`&
MEFKMZ:UB--,;QDR1>\%@<.X5E`MWKW"I3M&0JQ5/V52F9<&$V8LHEE,#X>L-
MWVKW^FK%<W:WS\BAV^V<%A#W<^XZ.=4FRKAAV<@]@Z7<L=8-56Z_ECR'IQ?A
M('2]ZR;)I7(RMJ)E;A)([TT=_`J&07!>_;.RXHZSG3YLJI;.\ST7F=Q5?P5K
M7YI5"`'LZD?W/#,;>#X8#)I[-XRO-^;M)LA[2+]V$-Y37QU1I_?F"(%*D4@8
M;E[(3.S=YQ)*6+D^@\Q\UU&7''ZH6>97@6.5R6(>+VYGTW$23<G7\>UX/HE(
M?!-%28PD`B01_(<$65*D$B*5VNM_!A(G$,^/:)[$9/&-+)814ADBE6%O+(T*
MF2Q^+']&-T@%?&],.3M-I8XE3A9(Y1RIU$R<F-%DC-W]A%0^=6-9J#45_$^-
M.YE34RI65WPBH>3024V90QS,YZY,S->"0R-18<@X3659[5Z3I<QYRAF6P=%<
M=&6F7*?UBTN6D<66J7T;XOTP/1IG_4%78"9@LJSY0\[(6&MF-#!K6)ZSU)04
M&O:0S@76L;F512$%B8U,'R&0>AB@W4/HO$,4-K*PFYMJGFB\J=4I%J$_JZ$#
M:2^I@E9+%!6:IM:+<:OX%I\S&+0%(PE]AJ%Z2':(6\.W>(S+!\U^EQ`NB9ZZ
M0>-^\"T(^^L."3>&#W%+^!:'[<KSO(;P.]5["K`.YM"W0.P'H!40)M&W4)P<
M(0",!;):SF(<81YWQA^NQY'-F,'`8K"_-7$J`:8"%ITH^HL$>YLB!1@46'2$
MVD5JVI-,F:$<=]<9[H_`PK1?IY49IB:PR.VO=BLSC,W^`UMG_?JUZQ<"5PX6
M86P"B^.CV.S]P=P$+6XLBOM42,N?%D*G0?P:#9FCK$)<,%AT"E_%\SK07HNM
MX6.AJO'\U)KN$%LS%T.+Z'^/N$H5AX.!#BV@6VUEFQMBBF'12>;8[I:I(9YY
ML#AE_U$W,+QP/`,=K^8(CEHIS5,X`U:7ZA!5.^Z]G8"O_P(``/__`P!02P,$
M%``&``@````A`-=^\O'5!0``6AP``!@```!X;"]W;W)K<VAE971S+W-H965T
M-"YX;6R4F=F.JS@0AN]'FG=`W'?`K$F4Y*@)VY'.2*/1+-<T<1+4(41`;V\_
M90R)[1";OLEB?R[;O\OE`J]^?)8G[1W735&=USJ:F;J&SWFU*\Z'M?[/W_'3
M7->:-COOLE-UQFO]"S?ZC\WOOZT^JOJU.6+<:F#AW*SU8]M>EH;1Y$=<9LVL
MNN`SU.RKNLQ:^%L?C.92XVS7-2I/AF6:GE%FQ5FG%I;U%!O5?E_D.*SRMQ*?
M6VJDQJ>LA?$WQ^+2#-;*?(JY,JM?WRY/>55>P,1+<2K:K\ZHKI7Y\N?A7-79
MRPGF_8F<+!]L=W_NS)=%7E=-M6]G8,Z@`[V?\\)8&&!IL]H5,`,BNU;C_5I_
M1LL4+71CL^H$^K?`'PWS6VN.U4=2%[M?Q1F#VK!.9`5>JNJ5H#]WI`@:&W>M
MXVX%_JRU'=YG;Z?VK^HCQ<7AV,)RNS`C,K'E[BO$30Z*@IF9Y1)+>76"`<"G
M5A;$-4"1[+/[_BAV[7&MV][,]4T;`:Z]X*:-"V)2U_*WIJW*_RB$>E/4B-4;
M@1:]$01%$QM[?6/X'AI[,\=R_?EWAN#W5L"O!RO6S)J[R/74$S&H*)W&8=9F
MFU5=?6C@N##MYI*1;8"68'D0ETIQE?N1VB`S,?),K*QUF!\(V8"+O&\\M#+>
M857S'@E&$(M'M@-"UI"8#8>"FUG!:C000Y.8%L#G;20VWTTRM&$0AT?2`2%^
M"4)=U8(U9]4:=\%!%`(348:Q!;2`'9NHP#WAN?S0PGM$,!+=$Z*1^!ZQ!`D2
M-9*.(+?1<KK9O&[$RVP(!'+]2"/@V*7T>#$"BC@,(DQCJR1")1$IB5A))$HB
ME1&<F##=Z4Y(X+4.*W7;#[X@(D58$6V31[9J)%0CD1J)U4BB1E(IPFD)\7RZ
ME@06''+."Q50!/J_RBTZI)((E42D)&(ED2B)5$9P(D+<GRXB@06'7`@B4F3>
MG2.V;7MS(<)M66!NVZZP"B%;[YD(SGJ^AX@%D.-8HL/'+.`AQ[>$,28<`*>P
M<XM\W=F5LH!E+5S[9H$3#X[UZ>(1F!?/%[9J0!&)>"PP)AY;/RH>"XR*QP*C
MXG'`F'@L(!./Y/A,]B(_3P@LB">D$P%%J'A/HZ['$6/R<<"H?APQ*B!'C"K(
M$V,2<H1,P\5W-"0P'P)]87,&%)&%0"41*HE(2<1*(E$2J8S@=C&";(;UQ&D9
M3M=*<$DA5`4](]-3C81J)%(C\0@B1LYD`I/V3+_/R!:X13%>5I*(,QM\HJPT
M?6>3'E\XA@-$&596<2K;"4PX@8EZAD[76=BV<%[%$XPD*B.IW`@O*\G<&5GE
M<9,\Z8J!4SCM@IYAY104WZJ14(U$:B3ND=Z['!?R`R'.)VHDE7;$JTDR]^EJ
MTCR?<T[QL0;=/PO<.Z>:"2?8B7I&XIRT(ZF</&(ZEB.$L93KYDFVY<&'OJ$F
MH84(*C[?(,KX73XY?JKSR-BQSA.CYSJ/+)SY0C@:8YY`IC>WT2WR=7EC(C*V
MY<^%>)'R#(B]<!]DE^1%V3?4I"D_K.;U\<47^@XZBVM=NM-E3P[]FQTE$JD[
MBM5(HD92*<+O=)+4,SM]XG%$'P6X'7];KDZ/`%%F07W4G)E"Q-KV`'5BP6="
M5>M(UCKN*R4KFJ@Z2!]TP*M'LOKOJT>?!5CUYL+\`T2947&VLLI05AG)*N.^
M4JH:'=;#14T?=,"K1A)Y1C7%64W3?DXMP94"1)F'P]KVP*B<H:IU)&L=]Y52
MU<3A"5$T?=`!KQK)W*>K1O-\3C6AUP"N.,A)0X]!SW-]%UD"L^49VQQA0IX9
MM1/QS*B=N&>D2G)#MAT3(4<(/.3FAIF6V!75E%[-T&N#$M<'O,6G4Z/EU1NY
M=G$@9EU+KU="SQ9Y[RV4!V@)+_GORT.TA#?Y]^4)N5HBY<;5$-SL7+(#_B.K
M#\6YT4YX#T,P9SZ<)S6]&Z)_VNK276Z\5"W<Z70_CW"'A^%:P9P!O*^J=OA#
M.KC>"F[^!P``__\#`%!+`P04``8`"````"$`E,LV7TL#``!A"@``&0```'AL
M+W=O<FMS:&5E=',O<VAE970S,"YX;6R45EUOFS`4?9^T_X#\7CX")"$*J9J@
M;I,V:9KV\>R`"58!(]MIVG^_:YP03%J2OH2`CP_GG'N-O;Q_J4KKF7!!61TC
MSW:11>J49;3>Q>C/[\>[.;*$Q'6&2U:3&+T2@>Y7GS\M#XP_B8(0:0%#+6)4
M2-DL'$>D!:FPL%E#:AC)&:^PA%N^<T3#"<[:257I3%QWZE28UD@S+/@M'"S/
M:4H2ENXK4DM-PDF))>@7!6W$B:U*;Z&K,'_:-W<IJQJ@V-*2RM>6%%E5NOBV
MJQG'VQ)\OW@!3D_<[<T%?453S@3+I0UTCA9ZZ3ER(@>85LN,@@,5N\5)'J,'
M;Y%$R%DMVWS^4G(0O?^6*-CA"Z?9=UH3"!O*I`JP9>Q)0;]EZA%,=BYF/[8%
M^,FMC.1X7\I?[/"5T%TAH=HA&%*^%MEK0D0*@0*-/0D54\I*$`"_5D559T`@
M^*6]'F@FBQCY4SN<N;X'<&M+A'RDBA)9Z5Y(5OW3(.](I4DF1Q(?U!_'0SN8
MA+/Y1UB"(PM<3RS3FUD<[:N-*<$2KY:<'2QH/5`N&JP:V5L`\RD?[:9+[+W`
M("E%\J!88C1%%F0AH,C/*S\*ELXS5"8]8M8:`[\=9CHQ(9M+B&<BDDO$]/P>
M!SQUQB#TOK&W"W[2K\!*OVH`96BM'_3%#K5>121O(-[1"HW1UZJ*X$.KCVM6
MDP#7R]./0C.NM<9`7;O,SPI:HYNKB&0,820.K^F[&%>OP#&"B#IE?C0=J->8
M>=M/7C2?AJ[KFI#-=4AB0B+X_O98#`.PHOL&;BN#FC0T,C-5KC5FIHW`NO?-
M\8TQ'OGAH(R),1X&P3D%0S^LO[[^\0(H\%#WW-2UUABM.PS]^<#7YLIXTA^?
MS'SO/-_0/?N(;@4>ZHX&NC4&"M\UU[#M-4*WEMD1[;)(QA@,[>J<T/M^CF>N
MP*;VH->+^LNC,6/:->*X++S+19&,41CBHX^(5^"A^,'G>:TQ8^*O(N`TH-X3
MM8O%M8-S;;5TO=7K/:PB?$<VI"R%E;*]VL8]F-8][4X8#Y/VD-`-P`[?X!WY
M@?F.UL(J20Y377L&ZXSK,X*^D:QI=\@MD["WMW\+.,H1V"%<&\`Y8_)THTXA
MW>%P]1\``/__`P!02P,$%``&``@````A`-:W01O0`P``R0T``!D```!X;"]W
M;W)K<VAE971S+W-H965T,CDN>&ULE%==CZLV$'VOU/^`>%_`$,@2);G:L-WV
M2JU45?UX=L!)K`6,;&>S^^\[QH1@L\LE>2`!C@_'9X:9R?K;>U4Z;X0+RNJ-
MB[S`=4B=LX+6QXW[S]\O#X^N(R2N"URRFFS<#R+<;]N??UI?&'\5)T*D`PRU
MV+@G*9N5[XO\1"HL/-:0&NX<&*^PA%-^]$7#"2[:157IAT&0^!6FM:L95GP.
M!SL<:$Z>67ZN2"TU"2<EEJ!?G&@CKFQ5/H>NPOSUW#SDK&J`8D]+*C]:4M>I
M\M7W8\TXWI>P[W>TP/F5NST9T5<TYTRP@_2`SM="QWM._=0'INVZH+`#9;O#
MR6'C/J%5AA+7WZY;@_ZEY"(&OQUQ8I=?.2U^IS4!MR%.*@)[QEX5]'NA+L%B
M?[3ZI8W`G]PIR`&?2_D7N_Q&Z/$D(=PQ[$AM;%5\/!.1@Z-`XX6Q8LI9"0+@
MZ%14I08X@M_;[PLMY&GC1HD7+X,(`=S9$R%?J*)TG?PL)*O^TR#446F2L".!
M[XX$)5[X&*,XN8,EZEC@^\:R"./EXPPMOMY7:],SEGB[YNSB0.Z!<M%@E<EH
M!<R?^P*&*.R3`F_<Q'5@RP*"^;:-TF#MOT$`\@ZSTQ@X]AAD(K(Q(EGT$!]T
M]>+`L/GB%%B)4T%4:G?ZPE!)V#^F162?(+Y0`M8,E:@TBB`9I^U2BS8N/*2W
M(D2V71J3H-9-Y"4H-3Z_/-B:K07+.!A^PN$"P\N%N8-IY0IL*[?"N-,8./:[
MBY)'R^#/,&F/,?3!ZS1T>%J?`MOZHIY7AU]C.F<#+PW2H5&!!<\,.'2$F^^&
M3$C^^3(5V)9Y2S`M4V.N,LT]9%_<-!0M[U&DP*8BE,3F0W<:,PRLI3F;0AC:
M5!N=75T4V-06(NO).XWYPJTO;AJ*TGL4*;"I*$KMUT!CIMR:0AC:$%24H5WS
MJDR[RE09CLI,!^KKS"(:%@I=#:<QIE)5PV<'%NF*;Q9"V\<.-#0R2F\O82=1
M,QF@0=$Q-:KJ/E^C[@6F1JM&[)`&7=//2U/KW<FF$*8ZJZ-,USLT;B51.E*G
M04-SK-<GZW@^AYCZ`#-T;V8NJE4_S$4-ZG/QQST/62L6Z3![3=UW]1$U"H[T
MCC)3@T##H-/=NEB7F=,@4^-=303&X['&4>R-3@'M*PZ-.<(L\6KD5IQ]"(+H
MEBE:JIZH]:A8$7XD&2E+X>3LK*9E-:[T5_M)_BEL9_'^!@S2#3Z2/S`_TEHX
M)3G`TL!;@E5<C^+Z1+*F'43W3,((W?X\P5\F`D-<X`'XP)B\GJAA_W+]$[;]
M'P``__\#`%!+`P04``8`"````"$`$<@HA:@$``#1$@``&0```'AL+W=O<FMS
M:&5E=',O<VAE970R."YX;6R4F&V/HCH4Q]]O<K\#X?V(4!4TZF9D,G<WV4UN
M;N[#:\2J9(`:BN/,M]_3'H0^B(O[PAWMG]-?_Z?M*5U^_2ARYYU6/&/ERO5'
M8]>A9<IV67E8N?_^\_H4N0ZODW*7Y*RD*_>3<O?K^H\ORPNKWOB1TMJ!""5?
MN<>Z/BT\CZ='6B1\Q$ZTA)8]JXJDAJ_5P>.GBB8[^5"1>\%X//.*)"M=C+"H
MAL1@^WV6TA>6G@M:UABDHGE2`S\_9B=^C5:D0\(52?5V/CVEK#A!B&V69_6G
M#.HZ1;KX?BA9E6QS&/>'/TG2:VSYQ0I?9&G%.-O7(PCG(:@]YKDW]R#2>KG+
M8`3"=J>B^Y7[["_B8.IZZZ4TZ+^,7KCRM\./[/)GE>U^9"4%MR%/(@-;QMZ$
M]/M._`0/>];3KS(#?U7.CNZ3<U[_S2[?:'8XUI#N*8Q(#&RQ^WRA/`5'(<P(
M,5*6`P!\.D4FI@8XDGS(_R_9KCZN7#(;3<,Q\4'N;"FO7S,1TG72,Z]9\3^*
M?`'5!@F:(`3HL3T@HTDP#:,!43PDD@-\2>IDO:S8Q8%9`WWR4R+FH+^`R+='
M!!1"^RS$*W?F.@#+(0WO:Q).EMX[6)<VF@UJX+/5^+HBMA6S+H@'7"T<#'DX
MG!`+..&9H-W@#RI)8)#<4/20@#7#28084JQ8$,S&>M<;U$P43=>SQ(_O*327
M((C*)B8G@2E^/Y7BH94+!K1I(N'48$1-)!,=C>&?WAYC.WQV,3J)A@BS7$6\
MCR;$.EHP,=%0@VC3J8VFMD^(QJZ!P5P>#B;$!MALIGNR08WJB9E75"#Z$Q'L
M/::%C[`)L<Y&0I,--=BS+WO6X6-5H"=<,TV4M<%[AA";8*'>[P8U"`:E33$$
MET)_N\8U?X1+B/5%2L+(X$+-O63>4VAL/JQ(U;1AJU0^9;IGKH5&-)?K=#PR
MS(V;9G44I&?&^6)K'IQ9J=;A[(7:B!`.CD@&?*RU`WRW1>OVB:UZ.!EN[.KN
M%E@KU4>1ZHNY5!M)ZVP?G-BJA\/AQJ["D7!NS#P?1=>>(XM,;^]RKKL&@WL`
M3*CU?)*PBXQ%U4?1%<QHCHWF69=N'<PH"`-7`^[J,/2NX$3=5&X`470WK?<D
M.J=1'P9RVH6"1,8I:./;E8)$W03#C>^&J)L).NE#U<*WR\6-I8LBU4D2$7VB
MQDTD7=3'^%#A\.W*<6,1HTCMONN\\="6D*AO7CY40GS<_;65')E%MQ&IA"2R
MEHU=1U2KM4P'1B6Y?YB2:F-11V:=:T0ZHSD7;XIZ?`P>*B12;=3BR-P1&Y'*
M:&;ZKD3W4.S]RHX];%T'6#&T?%N'YD84RFH<$#C.&"NF$:@#Z:O'@=CE%<S?
MI!IK@HIG+VH9<N5.\+!@HF$$%:WS6#<0-`^0";4Q":V2%Z"H.9Y.HJEEG"K0
MG=79C.+R&]>P&*BNV55/O*;#`#"I-UXWM/89')U;8Y$,;Q;PQ;N@U8'&-,^Y
MD[*SN#7P(1GMK^V-QG,@[R3:!KA0."4'^C.I#EG)G9SNX5$X,0%:A5<2^*5F
M)_E:OV4U7"7(/X]P=43AE7@\`O&>L?KZ15QZM)=1ZU\```#__P,`4$L#!!0`
M!@`(````(0!ZX.?ZZP(``!0(```9````>&PO=V]R:W-H965T<R]S:&5E=#(W
M+GAM;)15VXZ;,!!]K]1_L/R^7`,D4<AJ$[1MI5:JJEZ>'3#!6L#(=C:[?]\Q
M#BR0;9*^`,9G#F?.C(?5_4M5HF<J).-UC%W+P8C6*<]8O8_QKY^/=W.,I")U
M1DI>TQB_4HGOUQ\_K(Y</,F"4H6`H98Q+I1JEK8MTX)61%J\H37LY%Q41,%2
M[&W9"$JR-J@J;<]Q0KLBK,:&82ENX>!YSE*:\/10T5H9$D%+HD"_+%@C.[8J
MO86N(N+IT-REO&J`8L=*IEY;4HRJ=/EE7W-!=B7D_>+.2-IQMXLS^HJE@DN>
M*POH;"/T/.>%O;"!:;W*&&2@;4>"YC%^<)=)B.WUJO7G-Z-'.7A&LN#'3X)E
M7UE-P6PHDR[`CO,G#?V2Z5<0;)]%/[8%^"Y01G-R*-4/?OQ,V;Y04.T`$M)Y
M+;/7A,H4#`4:RPLT4\I+$`!75#'=&6`(>6GO1Y:I(L9^:`61X[L`1SLJU2/3
ME!BE!ZEX]<>`W!.5(?%.)#ZH/^T'ULP+HOG_L,Q.+'#O6#S+FP=N$%[78IN\
M6IL2HLAZ)?@10>N!<MD0W<CN$I@[?TPVO6/_,@R<TB0/FB7&(4;@A80B/Z_]
MR%G9SU"9](39&`Q<>TSHC2';<X@[1B0=0M<<,NC3`(N':;Q?WDZM!FNUNMQ:
M_L:\&$J;*KN*2-Y!S'KQ(ZW0!D.MVG(?&ONR9AT$N(%[?C0Q9V,P4,7>X3<%
M;:+;JXCD$F*4!7QFF,5E]1H<8["H5^9/I&T,)&J;QPVAKR>`[35`<@$P4@X'
M]W;E&CQ1'DV:8V,PBU:Z8T6+ONS&],O;R7A['O71(]%PMH:B;VL:'305[_?\
MIO<-QO@>S@-G<FRWPWUW$?C^A`"FM_X(F-_7]JUR)@4SG<W8J:C8TRTM2XE2
M?M"3UP7?^K?]3^'!:^=ZOP%#N2%[^HV(/:LE*FD.H6`VN"?,6#<+Q9MVJ.VX
M@G'</A;P]Z5PS!T+P#GGJEOH(=+_S]=_`0``__\#`%!+`P04``8`"````"$`
M6PX@I>H"```H"```&0```'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6R455UO
MFS`4?9^T_V#YO7PFD$0A59.N6Z5-FJ9]/#O&@%7`R'::]M_O&@<*I*U2'@";
M<T_./??F>GW]5)7HD4G%19U@W_$P8C45*:_S!/_Y?7>UP$AI4J>D%#5+\#-3
M^'KS^=/Z*.2#*AC3"!AJE>!"ZV;ENHH6K"+*$0VKX4LF9$4T+&7NJD8RDK9!
M5>D&GA>Y%>$UM@PK>0F'R#).V:V@AXK5VI)(5A(-^E7!&]6Q5?02NHK(AT-S
M1475`,6>EUP_MZ08571UG]="DGT)>3_Y,T([[G9Q1E]Q*H42F7:`SK5"SW->
MNDL7F#;KE$,&QG8D69;@&W^UB[&[6;?^_.7LJ`;O2!7B^%7R]#NO&9@-93(%
MV`OQ8*#WJ=F"8/<L^JXMP$^)4I:10ZE_B>,WQO-"0[7GD)#):Y4^WS)%P5"@
M<8*Y8:*B!`%P1Q4WG0&&D*?V>>2I+A(<1LX\]D(?X&C/E+[CAA(C>E!:5/\L
MR#]169+@1`+/$XD_=V;!/%Y\A"4\L<"S8XDN9G%M7JU-MT23S5J*(X+6`^6J
M(::1_14P=_[8;'K'WC(,G#(D-X8EP1%&X(6"(C]NPBA:NX]0&7K";"T&[CW&
M'R-VYXAHUD-<$-RK!B>'JE^O9B?.@(TX4UVC=FLWADJ"_F=:Q.X5Q!M*P+.A
M$N-?"%WZOB(3!+B!%6$4CR5L+68VP+PHL"+?0XS<`I*/:S1!"08C^G(%OC?1
M:#&1WU;<=R)_.;J^7$U]G03$<V]X!<.`40;P7QMF\+Z[!CQ5/FFUK<6`G#Z[
M,%J,L]N]AEGVF)$^Z/S+]1GP5%_8\]H6M9B3LYZS])9#H[P)?#>"PVGVXOM(
M9OP1F08\E3EIP:W%=#+'.<!8-P1G'ZTB.['M**J8S-F.E:5"5!S,-#8=U>_V
M!\5-T,[Z_@,,ZH;D[`>1.:\5*ED&H9X30^&D'?5VH473#KJ]T#"BV]<"3F0&
ML\!S`)P)H;N%.4SZ,W[S'P``__\#`%!+`P04``8`"````"$`@*#:K#D#``"C
M"0``&0```'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6R4EEUOFS`4AN\G[3\@
MWY=O2!.%5$VJ;I,V:9KV<>V`"58!(]MIVG^_8TY"@'09O4F"_?KE.>?8/EG>
MO52E]<RDXJ).B&>[Q&)U*C)>[Q+RZ^?CS2VQE*9U1DM1LX2\,D7N5A\_+`]"
M/JF",6V!0ZT24FC=+!Q'I06KJ+)%PVJ8R86LJ(9'N7-4(QG-VD55Z?BN&SL5
MY35!AX6<XB'RG*?L0:3[BM4:320KJ09^5?!&G=RJ=(I=1>73OKE)1=6`Q9:7
M7+^VIL2JTL6772TDW980]XL7TO3DW3Y<V%<\E4*)7-M@YR#H9<QS9^Z`TVJ9
M<8C`I-V2+$_(O;?8>"YQ5LLV0;\Y.ZC>;TL5XO!)\NPKKQED&^ID*K`5XLE(
MOV1F"!8[%ZL?VPI\EU;&<KHO]0]Q^,SXKM!0[@@B,H$MLM<'IE+(*-C8?F2<
M4E$"`'Q:%3=;`S)"7]KO`\]TD9`@MJ.9&W@@M[9,Z4=N+(F5[I46U1\4>4<K
M-/&/)@'0'^=]V[^-O"C^OXN#1&V`#U33U5**@P6[!MZI&FKVH+<`YU-DR-'%
M^J]0(49C<F]<$A(3"Z)04)_G51#=+IUGR&EZU*PO-7$XE&Q.$E,+X.L@(?0^
MY-MI/[$8L6$Q93!P:QP`[P[.'[_X#4G4L0U0($=]%).O`/;3=22S"'0]@B":
M=_Y(B9JPIQE#7E,,&,'D_8QF44(@$5V6@M@=,:)FUA;8#SU_-IS?X#Q\=A[G
M&`:$L.O[A->S9\1#,M\-AF]>H^:V)8MF4>`/YS<X/X$,]G"?;%I]S:(A81![
M0X(U:I#0\^<7A#@_@7`V)+R>.R,>DXURLT8-D@6N.RKZ!J<G@)ENU[M*KH,9
M\1AL7%34(%@X#X+1C;+!^0ED\R'9M**:16/"\W;&0XN:/D$P3A]*CG6/H_!\
M[@<G`MK7.[+7JL=PYQL+X8XB/*XWH1OZX2C#IFF:((\2+PS],S[B84_$EE$Q
MN6,;5I;*2L7>]#L?#EPWVO7B>]]<OJ/QM>G19MSI)J!%-G3'OE&YX[6R2I:#
MI6O/X+!*;++XH$73-JJMT-`<VY\%_!EB<+F[-HAS(?3IP;R@^WNU^@L``/__
M`P!02P,$%``&``@````A`*8#G%!>`P``]@H``!D```!X;"]W;W)K<VAE971S
M+W-H965T,C0N>&ULE)9=CZ(P%(;O-]G_0+@?H,B'&G4SXW>RFVPV^W%=H6HS
M0$E;QYE_OZ<44)`)>D.E?7CI><_AV,FW]S0QW@@7E&53$UF.:9`L8C'-#E/S
MS^_5T]`TA,19C!.6D:GY083Y;?;UR^3,^*LX$B(-4,C$U#Q*F8]M6T1'DF)A
ML9QDL+)G/,42;OG!%CDG."X>2A/;=9S`3C'-3*TPYO=HL/V>1F3!HE-*,JE%
M.$FPA/V+(\U%I99&]\BEF+^>\J>(I3E([&A"Y4<A:AII--X>,L;Q+H&XWY&'
MHTJ[N+F13VG$F6![:8&<K3=Z&_/('MF@-)O$%")0MAN<[*?F,QIO/=.>30I_
M_E)R%E>_#7%DYS6G\7>:$3`;TJ02L&/L5:';6$W!P_;-TZLB`3^Y$9,]/B7R
M%SMO"#T<)63;AX!47./X8T%$!(:"C.7Z2BEB"6P`KD9*566`(?B]&,\TEL>I
M.0@L/W0&"'!C1X1<425I&M%)2);^TQ`JI;2(6XK`6(H@UW*'/O*#!U0&I0J,
MI8K[^%:\4@3&*A[?&OJ^%PS#^P,"LG`%QFHKGN6Y?CA\Q):@5('QLI<0.:/!
M`UL)2Q$8JZV$%O*<1YR%;[T(!\9*8W1W<H$L'H:Q?!@%=WMAZW(KJG>!)9Y-
M.#L;T!&@H$2.57]!8U"NRE8765W(G]4Q%+`2>58J4Q/\A1(5\.V]S0;>:&*_
MP0<3E<S++>-Z362N$;C6,J[?1!;]R+(?6?4CZWYDTX]L.Y!+T#;DH$X$?+/7
MB>CN&Y7?"E9^JSZB$O#2GICK"7A];>7`=UI>=C&HR2R[&+?)K+J809-9=S$7
M)XH@-EU,*__;+B:HW]5P%/K7_8XJ>&J"^I5?8:VK3=8,=+2::44P[R46O<2R
MEUAI(BR^,]=#;FN?Z^MU'XW"=N(WU\#0:97%]GK5][P@O.@W_`4C[O=7P4U_
MT:C=(32CX_)#?]"JL_GU^A-R1VU@T0`Z%)8-('2\H)7`E0;@^EF*U[W$II>`
M<X@RH_LMVF)]SM"=.B7\0.8D2801L9,Z0[B0^GJV/MX\NZH?M.9?T!B:@SJY
MU`MP[,CQ@?S`_$`S821D#Y*.I?X+N3ZXZ!O)\N+_8<<D'#B*GT<X7Q+H-XX%
M\)XQ6=VH%]0GUME_````__\#`%!+`P04``8`"````"$`R\02(H\"``!S!@``
M&0```'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6R,E5UOVR`4AN\G[3\@[FOL
MQ$[:*$[5)LI6:9.F:1_7!&,;U1@+R$?__0[0H*3IJN3",?#R\IQS`,_O#[)#
M.ZZ-4'V)LR3%B/=,5:)O2OS[U_KF%B-C:5_13O6\Q"_<X/O%YT_SO=+/IN7<
M(G#H38E;:X<9(8:U7%*3J('W,%(K+:F%IFZ(&32GE9\D.S)*TPF15/0X.,ST
M-1ZJK@7C*\6VDO<VF&C>40O\IA6#.;I)=HV=I/IY.]PP)0>PV(A.V!=OBI%D
MLZ>F5YIN.HC[D.64';U]X\)>"J:54;5-P(X$T,N8[\@=`:?%O!(0@4L[TKPN
M\4,V6Q:8+.8^/W\$WYN3=V1:M?^B1?5-]!R2#65R!=@H]>RD3Y7K@LGD8O;:
M%^"'1A6OZ;:S/]7^*Q=-:Z':!03DXII5+RMN&"04;)*1QV"J`P!X(BG<SH"$
MT(/_WXO*MB4>3Y)BFHXSD*,--W8MG"5&;&NLDG^#*'-0T63T:C(&^M?Q(LE'
MQ?3V"A<2B'R`*VKI8J[5'L&F@37-0-T6S&;@?(PL<,18_Q<JX#F3!^=2X@E&
M$(6!\NP6>3J:DQWDE+UJ'H,&GE$S>2-97DJR:$(`.%)#+DZIWZ_#$<Z)'9Q+
MIJ-]#!VG)&]!/E*<@4#*K@=Q8BC]20;R=!P##&Q!DY]JSA7+CQ1G;&!R/9L3
MEQCBCM7)T_Q\Y<>@^8@M**9^!V3C%'[1X@P-=OWU:$[\%JV(OB%M01,6GA2G
MZ_IQN!R<Q_OH@2P<_G`V)-<-7_*N,XBIK3O8&804>^.=\S#RUT8<@#,_T(9_
MI[H1O4$=KV%JFDQA=1UNC="P:O`G;Z,LG';_VL+ESF%SI@F(:Z7LL>'NI?BY
M6/P#``#__P,`4$L#!!0`!@`(````(0`/'T\24`0``'41```9````>&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;)2878^C-A2&[ROU/R#N-V`@)$1)5D/XZ$JM
M5%6[[34A3H(&<(29R<R_[S$&@LW63F]F$OLY+_;K@^V3[=>/JC3><4,+4N],
MM+!-`]<Y.17U96?^^)Y\69L&;;/ZE)6DQCOS$U/SZ_[77[9WTKS2*\:M`0HU
MW9G7MKUM+(OF5UQE=$%NN(:>,VFJK(6OS<6BMP9GIRZH*BW'MGVKRHK:Y`J;
MYAD-<CX7.8Y(_E;ANN4B#2ZS%L9/K\6-#FI5_HQ<E36O;[<O.:EN('$LRJ+]
M[$1-H\HWWRXU:;)C"?/^0%Z6#]K=EYE\5>0-H>3<+D#.X@.=SSFP`@N4]MM3
M`3-@MAL-/N_,%[1)D6-:^VUGT-\%OM/)9X->R3UMBM/O18W!;5@GM@)'0EX9
M^NW$FB#8FD4GW0K\V1@G?,[>RO8O<O\-%Y=K"\N]A!FQB6U.GQ&F.3@*,@MG
MR91R4L(`X*]1%2PUP)'LH_M_+T[M=6>Z_F*YLET$N''$M$T*)FD:^1MM2?4/
MAU`OQ46<7@0B>A&8\K/!?A^\F@0OG/42+7W]$"P^G<Z=*&NS_;8A=P-2#@9,
M;QE+8+0!Y<$6/HG1J/_R"0QB(B],96?"",$""HO[OO=L?VN]PX+D/1/.&=\1
MD<.`,/N9;C0T/'21&!(/Q!"2#`V/$-\38](!8?D"-HQ>P%I,O?AY:@Q39C";
M\O#@D#>`]NB!/+TYX2_%H45S1!*)YX0LDLP11[;@)\AC*((I[O\QA<$[$\1'
M#SQ[)4XQY,RJRQ+7M]>VV'_@_=Y40R0BC4*L54BF"I[GH$!\0CKM#WQW/78+
MUL`8G\\7!LO6/'2[=`\YHYCZ04M$6B+6$HF62%6$X!%L=<][Q&#9(VEI0L[`
M\Q\I-JY.Y^)!2T1:(M82"2?671JC8.7;TD!3E81@$6R;SUO$8,DB)+U!(6=4
M%FF)2$O$6B+A!+?(=6PDI7NJ4A`<@H-IZA`[I%RX`:@W:!8D.R6='B%G5$YI
MB4A+Q%HBT1*IBA"\8A?6R8&N]HC!LD?2@1-RIE]%VY:2[<"[O>X]D/JB::@_
M"XT5H<DTU`OL0#I%4J'?=8)';@EN!*(;SV4."Y)=<<5-)N2,*G.T1*0E8BV1
M:(E410A>(7BEGD^=CI9=DG.GAU0VZ9&H1W@*KAVT?EQ5NAT_%@#?\5QI+T[T
M#TF5B.@3NS].7K'GD@KQ6Z=P-T+2M2SL(:5?7$>!1'J56(\D>B15(J)G[,(Y
M\4R]+;&J:/8&SG*+0_PBZ:S6CK3[''J5_J:Y#E:2VU$/**R,]4@B/`;YRV4@
MG3*LKF73X0-9.4O[L9EPDWC5RNNR"C<7?,!E28V<O+&*E.VM8^M8+;]TQ;+4
M'J(-%%%0DDCM$=I`I31O3UC5S=JM,0"*WEMVP7]DS:6HJ5'B,PS!7JS@.M/P
MLIE_:<FMJQZ/I(5RM_MXA9\W,)1M]@+@,R'M\(4]8/S!9/\O````__\#`%!+
M`P04``8`"````"$`>14DB*8"``!P!P``&0```'AL+W=O<FMS:&5E=',O<VAE
M970S,RYX;6R4E5UOFS`4AN\G[3]8OB]@`H%$(563JENE59JF?5P[8()5P,AV
MFO;?[]A.6YQT77J3Q.'AY3G'UF%Q^=BUZ(%)Q45?8!)$&+&^%!7OMP7^]?/F
M(L=(:=I7M!4]*_`34_AR^?G38B_DO6H8TP@2>E7@1NMA'H:J;%A'52`&UL.5
M6LB.:EC*;:@&R6AE;^K:,(ZB:=A1WF.7,)?G9(BZYB6[%N6N8[UV(9*U5(._
M:OB@GM.Z\IRXCLK[W7!1BFZ`B`UON7ZRH1AUY?QVVPM)-RW4_4@26CYGV\5)
M?,=+*92H=0!QH1,]K7D6SD)(6BXJ#A68MB/)Z@)?D?DZP^%R8?OSF[.]&OU&
MJA'[+Y)7WWC/H-FP368#-D+<&_2V,G_!S>')W3=V`[Y+5+&:[EK]0^R_,KYM
M-.QV"@69NN;5TS53)3048H(X-4FE:$$`/E''S<F`AM!'^[WGE6X*/(F")$ZS
MG`"/-DSI&VXR,2IW2HONCZ/((<NEQ(>4">@?KL=!G*<DG?X_)71*ML)KJNER
M(<4>P:F!9ZJ!FC-(YI#\=DE0BV&O#&QO`5D%V_"P3$BZ"!^@=^6!69TR<>(C
MZS>0UY00Q%[LH.;S[0P,K<7HQ6X2Y?ZC5XY)1LRQW'N$YP8/.M_-P`6&[)';
M[,C-,9GM:QS%611%/K$>$R1/80J\$IX;%'B^FX&/W,AKKMWYE6-RZY9/Q\^U
MU]?CZR3R`$\,COOY8@;VQ1(R]5NR<HP3BPF9G*J-"3)+\S'AN4T_XF9@WVU"
MR)&;8YS;Q=MR'O*N7?81.P/[=@G)CNP<`QLW.I(^`C/5Q/P#<;US0].-E(%N
MV1V56]XKU+(:<J,@@_9+-S+=0HO!CI"-T##I[,\&WFP,YDL4`%P+H9\79BB_
MO"N7?P$``/__`P!02P,$%``&``@````A`+/E"T>1!0``$A<``!@```!X;"]W
M;W)K<VAE971S+W-H965T,BYX;6R46-N.HS@0?5]I_P'QW@&#S25*>C0!]>Y(
M.])JM9=GFI`.ZA`BH&]_OV7*'>PB3<C+=#(^KIRJ4ZX#7GU[KP[6:]&T97U<
MVVSAVE9QS.MM>7Q:V__\_7`7V5;;9<=M=JB/Q=K^*%K[V_VOOZS>ZN:YW1=%
M9T&$8[NV]UUW6CI.F^^+*FL7]:DXPLJN;JJL@Z_-D].>FB+;]INJ@^.Y;N!4
M67FT,<*RF1.CWNW*O$CK_*4JCAT&:8I#U@'_=E^>VL]H53XG7)4USR^GN[RN
M3A#BL3R4W4<?U+:J?/GCZ5@WV>,!\GYG/,L_8_=?1N&K,F_JMMYU"PCG(-%Q
MSK$3.Q#I?K4M(0-9=JLI=FO[.UNF7F`[]ZN^0/^6Q5NK?;;:??WV6U-N_RB/
M!50;=)(*/-;ULX3^V,K_@LW.:/=#K\"?C;4M=MG+H?NK?ON]*)_V'<@M(".9
MV'+[D19M#A6%,`M/R$AY?0`"\*]5E;(UH"+9>__WK=QV^[7M!PL1NCX#N/58
MM-U#*4/:5O[2=G7U'X*8"H5!/!4$_JH@##[.W.RKS5S;O/`BP41PG8*#Z?35
M2;,NNU\U]9L%+0>$VU,F&Y@M(;(LBP_%O5P6J(?<\UUNZK<"N@4M7^\]?^6\
M0OES!=E<@)B(Y`*"FY#T`D2<(0YD<$X#RJBG,4U?@B%-VQKH!^>P?88;A$!!
MSA#"+;F*2*<0!GE@,I^\!*]MB'UFYH6$/$+"7AC&@LB-B3J)@1!N%'&"2'6$
M8+Z(OR@\E&@^=PDFW"/"'2$1-A7W?9);HJ\SSW?-[:F^',+!."\;!8<3.Y^T
M!!/2\3DL=@M"D#0+7$(JP66@=I9LQ/L3(L]2I`4P:`>WT)9@D[;/"&V$*-HL
MYBZEE1@(P5PWI'VB(X3'8C$(9G`/;^$NP83[H"26'"'('0JFE:Q?3ZZLI[C^
MA28&<_D$</.$E)M(!J1R&X3H#.B(&2.H0"E"L`R"^U'X1?EC,XGI^2C!A#RA
MMD'(9\>#"Q%`<@V0(D!/7TO.$("!'^D*3)/OT83],+NP>11&T>=^``/0/!N)
M"0F%%],QFYH0-Q"1/T0Q,Y!&IO70E0S0]F`"#_."^A-#C%Z^X;?Q!%R'I),0
M,P-I9EH&,Y\3T`)ULZ(#?2.?@*#;4(N0>QXYZ8D!8&P$2$U`&&LSRLQ!>IJ6
MPQ45T`$-[M2L&&+4\8/I1R9LH@`3,J63$),_A-'YS]1`[B+G@?H70\P$S>0"
M1#NO?<>E"J..E1?[@Y1F(M+MY@N!WJ@+P8G#;N23_+F)F!=P1J9M8B"$X)Q(
ME1H`[L(P/4\$D[QT/(W\3!70)XTD"(,-0\RD"F/(6`7$J*8,Q9<J2`O4$KER
M'-`PC00&>=58'9OJ:"@A1)&[)(,.B",W'&:W*8-TOOGLT2?UD:KIJ]B/[7;$
M_BHD95,0,P/I@%H&LI$X]/$5'=`W#1T(S0V;]%;E#M<QZ70<(QF/>/2\9/I=
MYFSB@]XHB\+P_HT@"(@1)M/+J;FL/0&;[&_R9P^]UY"`T-HH#/9YR'WACYY0
M38CGN0$C!RHU((('GN<//V1F`&ST9IIN(D^B2=V'!T=5=\1@!G?`37#M'1";
M2,51&"$\/XQ'.1AQ.(_A+6)H6#,)8M#S1JLW-FI.C5IAID:K@JA<F!M$/B,V
MDUX(HXU?,Q=IJ>1T7[]8\>0N(@PU:X69S`7#Z!"-9Z]=JL*H?#G[4I2;S%K>
M1)$$!*GB1F'PEQE4F8?$"A,3$L0ACX;&5_QURX^#,!1#H4PEI!_>K@2Z*#3O
M^2%<$)8;N*^4R:J+EHNO$2;DXFN$";GX&H&WFGAO=\J>BI]9\U0>6^M0[("=
MNPBA%@W>:>*7KC[U]W./=0=WD?W'/=P]%W!YYRX`O*OK[O.+O#4]WV;?_P\`
M`/__`P!02P,$%``&``@````A`$A)X\P9`P``XPH``!@```!X;"]W;W)K<VAE
M971S+W-H965T,RYX;6R4EDN/VC`4A?>5^A\B[R</(.$A8#203ENIE:JJC[5)
M'&)-$D>V9YCY][V.0P8;&@(+DN#/1^=<7QPO[U_+PGDA7%!6K5#@^L@A5<)2
M6NU7Z/>OQ[L9<H3$58H+5I$5>B,"W:\_?E@>&'\2.2'2`85*K%`N9;WP/)'D
MI,3"936I8"1CO,02'OG>$S4G.&TFE84W\OW(*S&MD%98\"$:+,MH0F*6/)>D
MDEJ$DP)+\"]R6HNC6ID,D2LQ?WJN[Q)6UB"QHP65;XTH<LID\75?,8YW!>1^
M#28X.6HW#V?R)4TX$RR3+LAYVNAYYKDW]T!IO4PI)%!E=SC)5N@A6,2!C[SU
MLBG0'TH.XN3>$3D[?.8T_48K`M6&=5(KL&/L2:%?4_433/;.9C\V*_"#.RG)
M\',A?[+#%T+WN83E#B&1"K9(WV(B$J@HR+BC4"DEK``#\.V45+4&5`2_-M<#
M366^0N/(#:?^.`#<V1$A'ZF21$[R+"0K_VHH:*6TR*@5@6LK$L#MP,GC=O+D
M9+([FH5!&%VWX.DX375B+/%ZR=G!@98#PZ+&JH&#!2BKLHRAN)?+`O50<Q[4
MI&8JT`+6\F4=CI;>"Y0_:9'-.6(1VPO$Q!2)+R!AAWB0H(L!93R-T6]?P1`3
M.9W]R;B3;1)N-`(%>4=,8GN5B/L(PSPX&6Y>P2L$VIVST#:OD7FS,,&G.ZNJ
MV_[A^+_#AF<HS7#/"K8\6Z8V&IEIS[[^6!6_CL2]B.$?_K3#_2O8\O_>A[IA
M-#)I_/N6\9ZQ^/*8836ZQ:J"+:N1:6>CD<M6>\;BRV.&U>DM5A5L69U:5C72
M=K+;ML7Q`JUMK<+V1CX>SALQU:'@9-/LWVT4;,6<63$UHIL_/,8SF>T`)CYE
MX'RA/YV.$6%^2P0%6Q'FG:SN?XWH"%$43L-@9&_XUY'80,:^J6+XA[/"#6O0
MT&:"R/J7;EJF-\(`1IUB5+5:G<LA]#%%OXAKO"??,=_32C@%R6!;]]TI;`M<
M'U+T@V1U\\+=,0F'B^8VA\,D@;>Q[P*<,2:/#^H8U!U/U_\```#__P,`4$L#
M!!0`!@`(````(0"4!%ASB$D``.XI`0`4````>&PO<VAA<F5D4W1R:6YG<RYX
M;6SLG>ER',>UY[]/Q+Q#A2YU!44`$%8NDNP;(`A*M$D"EX"D\<="=P%HL]$%
M]\+%G_P.\^E&S$3X*>8!/&_B)YG?_YS,JJRE`5`6)<N#""]$5U7FR9-G7S*_
M_H]WE^/L33&=C<K);S[97-_X)"LF@W(XFIS_YI/O3IZN/?PDF\WSR3`?EY/B
M-Y^\+V:?_,=O__M_^WHVFV=\.YG]YI.+^?SJRR^^F`TNBLM\MEY>%1.>G)73
MRWS.G]/S+V97TR(?SBZ*8GXY_F)K8^/^%Y?Y:/))-B@7DSGS;CW<_21;3$9_
M6A3[_M/.ULXGO_UZ-OKMU_/?/BD'B\MB,L^`(SN8S$?S]]FSB4\`W%]_,?_M
MUU_H57_]?O:BG,PO9KPZ+(;MI[];3-:S[8W5;&MC<Z?]L)II[U8S?=;^/@#W
MJC@?S>;3')!?YI=%^ZW/7A63\DT^R*?%*@L9K+=?",/LL^9I/N:58?$N^WWQ
MOOW>9QL;&YL;F_<?;#QL/ZI6<O+^J@O`\=KFT@^.BNFH%)Z'V9-\WOEVCYT8
MVFX\'>?G[5$^.\O'L\XW^XOIE+5D3T>S`>OY0Y%/EX[_V=K:YM;:=@>^9]I/
MV_H\^Z$8C]=>3\JWD^RXR&=0YC![-ILMBNE_=`!Z6;9_2D?ZOAPO)O-\^A[8
MQCV?5^]^-LM>%5?E=`YG9,?S?+Z896%9W3G_4,S:DP;8;99L'[R>E]/N?AY?
MYF/`2*;:+R^O\DGGS?W#E\>'SY\]V3LY>)(]WGN^]W+_(#O^]N#@Y#A;^>[X
M27;O\S8$3XH!A+]IA+]]W<.M]L.X??EL5LP[*]O/9Q?&F0/]H_C38O0F'[/;
MG1>/IL55/AIFQ3LDQ*R+HL/Y!4N?%H."$4['W1<^^]M?__;7-G`GY1R2&@0*
MZP?Q93DODH&SLVEYF3U9O"Z0%-K^44>&/"\GYVOS8GJ9^8A9>98-H5X$RVBR
M@-R0<M-\CO3I+/,9`T[.1RP@?-L/<3^D$=7C47XZ&H_FHRX6]@8F-6?95?Y>
M:#+<YX/!5&!=_YV]$M&?K8&2,90X9"3HNCM3#S`?@(?FQEP#6(WKY*4/GBCY
MMHWPXY/#_=]_>_C\R<&KX\^R@__\[MG)']KO0)QG!5)JB+HK!Z^_S.YMK$NZ
M"C<9!+THOLSV%O.+<CKZ<S'\,MO<6.6Q_IO-+A#D,Q=`0]N-<C$WI8FL^#*;
MC,;MR6#JRW+2G&GY5+L^C\UE4JYGDOOW5W<?[*YN;FT%<-I3[@V'4%,Y@5?$
MA&NC23;(KT;P3N?-`=IVX80Q+,Y&@]'\%J]DL]%D4&3#XDTQ+J],/X""\XXJ
M@'JKT4MC^`$2;EI<(!)&;XIL7,XZ'.649/MR48Z'6"N?F9R9=\2BOYF0@FW'
M;;Z\5J`>L<%8%,5\A/KZ?)F`;9'0:DTZ;?QUWJPIZ\97&]1VV[<3@FQ_DM+B
M-2`W7UL.;_.]:X'M??4Z2%.==WR"ZGMQ\!)]=_@T.SPZ>+5W\HP7EFW.]K5&
MX>;&]8^WKGV<FI3;7?Q.9N5X-#1!*\.A$'/,LL.S['"I#GD%&Z%FVF,=+-&<
MWQ03M-'8-<'P<C0QZW,N?HK2OCV4<TK08I@TR]Y[6<R-)UUG!OTG&VBY`GQR
M6STY*"^++U;$\9_[\+?4L-^@L#/D)Z]?E3/6C7(N1[[\\QS%.!5P?1KM.7.U
MOYPM3F>CX4@VX,K3<C9?3,X[MI/-N**O/P^?W\82B+AKX_X@GTY`(8!B[QB+
MH(M/\]EH8#LX'(T7:.7V5P:[O@!MICVD=OC#+)+K=P0?`U1G`=6=,6Z)]EX`
MVE#^4(S.+V13Y'B5R/^H'3^8K[/]PQ='KPZ^/7AY_.S[@^SYX?%2WM['"NNR
M6(9\212+H&\#ZQ8GN$G>&_>\]ZH8C+'71BA#L_FR?/C'Q6QN6JY%AS4UM2=S
MCKMYLH8F:HJY/D-FF<!C]:*28UDS;5`28^!(QL"S"2[)C<;`DYN-@3Z-[E37
M!L&PT?[Q,7[S1*R1/<['.?;$:K9W*0L]R^=9ZK]T7)2>+X_=++OI2T.0N`^:
MU>9@A_@>K^%;3K&*L[WLAWPJ9[X-[C6?EE?]O@%.JM8EB?7=9-3UD63?-5Y8
MS;Z7\=F>6J*ECZ+QVF^!OHZ2:G_6C[L;/ZLW*U6)G2C+\MFN_>P:QMC?._XV
M>_K\\(?E,D+.Z=FX?#MS55-KOGR`HNSWM"HNGV7S,L,S+2<#P@39)"I%?M6_
MS?.]8?`OVUNXE'J"*K[^_<EL,;98Q)*WGQ$V&$U-0BEJ-BP0<8.1479[8$SR
M*:8MP@*J-+>4I<Y'4S-4LO)T/#KO_<[TP:W%W_X%7C'<)-6-!F)$V#PXUX(P
M,=H[J(+U"2#.T&`X&?:OSS7.-:&")5^`A&M#$"OQ.XT?YF0BO&M)H7Z7^SK+
MZ3:$T=X.BZ<DQ#2:O"EFCJV*4CL8VAL0=YF9AW=[:^AH6@Z*8A@XXL.MJ=:D
MH\F<N%PQF"_D9+H-UO'0)+C:6.E;X4U8.1M-D)-&0\NQ<DP@2NA`KE?^MIE8
M;UV@=PR"/NCZ9NI`9\0MFK2UB9[M']=$PVR;^UY<S4XK-0CL\`KAV,Z$RX)N
MJ\3OB4XM^^YX<74U-L9FCV3W8>XL,".%I"@A64856^\0VLMRLF9O)IO&A'U(
MPJA]60?>4*^WEA6'T_-\,OJS29U50NAS@2A<8>G!"96&/'1!TA.$T\0FM)\Z
MG;#:VO=J(].@W%S/_O%I/;"_CV'N@?U5],9Y86&.MZ/Y18;&S]X2PQB_SPA>
M*]B4.!^\EOW]+_\+P^V*B._?__*_/U_-SDA]$"H5ZO0XK]E\%?$W(Y`^N%AM
M1%U`TVHV.LL"B1?\)?(OIDC_<<"IMCM?S,MQ>5XN9MG*@N`-PIB`!4[39/[W
MO_P7,Q)<'\#/>#SZ/P)"4X$PQ4X49B^PJP;Y!%K-`!`"**?993%4@,1V*D=F
M6<`DRZ&X8#?/UK,35A%6"(CRU8HW(X``(U!4.7[#6+"1%HM@'9<>9+4AT]@2
M"SC%V,SP=<WS3=^MW3_[K-\S[.1<#B?9[Q9`L;GE$7*VK@;U`_9Q-:N)(#L>
M@,\!^-HOIU?KV0K;V_/4MSK/7A9O\F'.=DU)-!CQ"ZUL'6!YM@.$_2Z?L&6I
MZ+6QQ??$JPU[6"7LC&ORJP44(M69GT\+U^A&B4^FZ]GO_N__F9YGWS!^+BIZ
M\60U.[K@?_A&5NA<1L_;B]'@HG=)<61<O;&YX!HR#&84-)4G.`-UHWF(4DM#
M0+4V<)[-T>3N0UW"(N50Y/C>"&GV&A(8X=,%"4#^,']O)(H,8%VE+!F6*O'J
ML4:1G_9K6IQ;+"2:,Q>+2U!AXQDQ9RMZ2UP&3>-2$#]PI?D$,AP482?(=9YG
MAB:]G4SXW;&1%+/AYD[$+V!]9K_YOWNHO46V1E6]D[/BBO1S[;D%4'UT^\H%
M`[,1AQQIOL"',V`QWU1;-L+1EZ@,$AEV!.,E5,#;;T<L&HZ="G&B%3;X;#%E
M\&F4(8;%>3&XF/AV:*AAH4P(G`8UN#`3D4:9`J!OR%:PQ3#><#&HY$)8>#'L
M\-I)S5D9Q`D\`_#(0!A=2N0,S:JNS43YY(`O6.H?:WT5HM1(ESWDUAE\#*@Q
MQ=O@8Z/+N66,L.FJ0'080!MP[_[Z)E)E/,8>;DJK80D(DY+E>:X)<`.M":$6
MKW,0#<LA+E,(Q;8JBZ(Q@N6>PBI07#<N*I+$V4):<#U[D4\(JYAA?UJ,1TP<
MJ"`A$5NFX4<HLW_4E@B^KOG6<&9-2>&MQ.QL@VA$4KR#$I1#B!1E=H-%#BKB
MFBW.E#1@0[7V2W+^J22M00M$Z-'0^<6T7)Q?R,DO+D\AQY"HW/$]\,5K;Y-5
M9OD9T-2?**'O4.#MR`I"B*"UB$$IOR45*O7K>;7W@FVV&,`5L[.%]/$T'R$E
M0T[$=ZFS6F.7F@C9O@YIU^+]S@+X)[<`&K8(R@:"@3[ZS051S]/B=+I0F'CS
MH7'MYB.W%.R/ZOO$HG/=*4DPQ>1#JKW)L>47L\IJ&<NI=1&@H#U*ASCCZ-+,
MO38G;*]G!V=G>%>*ZE>@;'DARW9#RB'B!Y2=8-"ENL>TB>3V%=9EAV[OS)]_
M5O,G6\WN[)^W,FJBV8,2P/OXU5D]L%B'J5<S5M:TW+TL0$9XO^&>EJU@F`=-
M[-K&/`P5MBQW*?K,>V`P^85^LZJ8S8V-3Z.R':FN"JM;:J\N:ZC2.F=9R)G5
MH&3/YT/W=3J/(EBIBT.!H)Q]YEA0Y^9F_#@G3HNV/U1MUJA<)3TQD6LD*/*E
M'C0?8.ABU\@;P)NER@?HJ;.2V59$0RKWC`(OWWOH11S!R0D/\%>GY;L1Q8N`
M)'/CC$"JEX!$G"R5VXFL/Z6DS+.)-6:PN&9(X,E@O!@R.*_@G(Q8M<P5,Y@N
M1M/AFLP5&9>RP,VAYA.%>^&`CMP^^5BF=#+P+:SFW?7=:#5KC2"W0^IWUK2E
MA)R3H*LI`8X?94U#XV[3_VM:T,>)-TMJ0H%W649'9'CQ*KHA6['VUGKV@9\]
M)MUN='JD,!IBQB(&DB]'4_RU$5%2>UQ#T(X:BD$LH#&Z%$\C0$.11^UY8W+%
M<@_&=*9GXPL<DPORX]AI!4$$Y23D\R(.((L8'4,S$#%$Y!*IHW2+F)[G(:9#
MRP]6T8GI0I`*<&(?*MM236(45,<%SJKEMNR-@W>H%+(PFD.B43D?Q:2.#_8E
MF1N!'VJ>YMD6A3'P\JMJY.QX[7^L9_M45Z@&(PD4V_AG93DW45M'EN4R4P@N
M#ZM"`5_VXJC"1,]20PI&E'!5;Y`[X!J<Y\65)#;?"HO*KO*7!7U](XFC(4QM
MO=_L[1W9@NM=8`>1P(IDHCO0&W-]G0;"<!8O,A"5]2(<R3[6;N'")GO(!K<]
M]!0S%4+8?DH*<-$A%W.:<TI3-4Z*8+`C0@4L!2'8/K30$'QT5,*S24;0*P0)
M3':75W@7Y<2=A,7$"(IQ;J9:WM!&\VX@6ZHDE>&QD%]=!('*U5A4'6E_X(2"
M'8%N?.LA3(5,](@]N>1E=XRTZ@G^_FPFIRI&\$S;AK4Z4S)0@E-;4$T^,8!G
MX7!TI.UU';M0C*,1VX#B<ZNU,44LD*5W`S=A5?9,!KW)GA`7W@9I33VG\!9A
MW;&V5L3),K$LQ'CYJ9A;[B(;+R`40P)^,VZC!_<F'XTMMH9IAN,8PR3"ARK*
M##$U,A)Y\Q8Q0SQ+MIL`LM!B/;<7_C)>&6:%-*APF"D7;N(##5/G:P>C*;$R
M!K=0ML'WMES@+P<%9)`1<[9TN8'DII0">RJ9MX4O!U6AVS(FHYHT[SB"L0C-
M.'IN#^AZ]FWYEH^F3O9P3Y<\C.JB$/=,&]YY;@:C`J789I:Z0%9#&'$(H.69
M\KX#K:VB7.)("#9K<7A/9L8(`88A6&P@L(;>K9HA-T`F0ZI+ACG%3']<3&PO
M(FE6>L'H/Q)CWWC2%-(UXC?1B02R*`>"`/`(K`#$\1@"?\=2BPPJ1`#5&2HX
M-<Y#^L8`P50^4T4$]'SPY)N]5QUAU-2F^Y6>A,QZ%*HB<-4K0FV5O4M(NQ;:
M5U%U]BB,[XXSB7GC_R!HG31C+K_)Z?X>[+<D/=>;UB'@S):GCJC14HBQ-%E*
M<BA&7A/MCX(@]"/AL(Z:55N0LH=UXD@Y,L`/*2%0TG62M,FFYT2C(8?$?E@4
M/&:S.ONRYUDYA>UK$R?[9H$-`Y>WMV9O0H!4!?+*9HE"F9.]"J0%Z]>C)8KZ
M/(RFN/IE@?<B/K=A]`^!31)2%?6ROF"Q";GE\Q*.G2@HG(^S:@\)FQL1^LST
MZECRGS<2V$$!;6K3X2Q[7/)_1IZ]C_=I;XN5?!V\/`N(4S#9!<=M)C.KXNG>
M\6.S*H++W#OY=U<FMV5U[1U_9Z]KJC7Z"6#$NGB>U6"G'6#[JHXU6SE!AP^R
M1YN[GW^9'02:D19ARZ,U5@/ZJNI4>N69'@NR0ZW'WUG;&[-E%>&9;)#X17F[
MR&',OM`A>Z+..U.HP0",#22U5</^6F[)9FR+HCAG`)SYL-GX8VU>KAE:4OW(
MXD0B">,#5ZK9JP20F[\S53J&_@`V/W0(N#8F&NI-:Y9A2]$04V)%%5M%I,TD
MV:%(K!C)RWQ"R8'R:+'_*VJ*NE"CE8K8W/7^0C<_V@I&UH91LM1:&#P,N9I=
MN-+*D,\R:X=>22@6XA6W2YL6AKV"8$A7-<3J#^(?HQ(-'&5]-S4V+?`[)B7I
M*1R#J;P169GZFI6'?=5?!(UA?-`1S)>PS^:V5,39QTXOT"()-\$DP2ZI(=X@
MDAY*WCWS@I[`'AE('*ML8I]B6PJ8IQ4?W-^X3W&$FY&S!8C!<'<EQRY9*H[_
M'Y2D1<W42FE2TJN7,U.Q8/R\=^Q>T?T-=C."]ZH>UK=A4KSMG1.Z-7'$0V,(
MS,#(S"8%#;H_5ZE#@45D"UR9?45(:*3EBP/,,D/VBM<]IL5NGY<EDHXMFA53
M9:[-EJ-6).!)H_$?#W79B,%R]R&E9$<$V]P2!1Y'I68+7.[6C8TJ6T>@*X/!
MJPQ=1#_2K0F1<0>>1-IL/!+YUARFKR)/2)K\:/ZZSZ<83!%*TT(`B:&3\G"3
M77K2N&90B+X#[0#Z3,E!:B(JIF(-)BI0>:Z]];XO*1;GI'91-!4;(LN@K4V:
MZ+JL9\\:'@XV%V70LYA=%O-%HG97)"C/&J$F.YDJ@1;1*[<&\R1Z'T9+`6*C
MB.1M?]/P@-A5&NR#%M`Q%^JPS0%J1:'43MSF!%J[,ONM\O)N-OV@/5Z2$)(F
M,MF0UW/]8X&!BD]KYUGD?BE?G)H57X5M(04ABTLO\'9NS4UY&()=24"$T05B
M6ZP2QY544N5J0XGC^CX)&^X?B1?5,)LE8KVMC*!9+[P,&V>AYJIPPZ1T2*)'
M/TK6/8:0!(O5)``*?%RMM"/*]V/)H?WC`*&&6XM@Z-W9P`L>%D#0L!!(\8**
M()3:F#Y_^H"A\?ET889"E>T8ADW%L*%\"#-OS`90^*#M!I/XOT614<NI]GZD
M"*&OR/RM*@>*02J`VX_,P\/75ZT,<NF=BF"S,S0(/52`!UP+Q>-D97&`09NX
M7RK@B!H(7<J.O&N;B47JR`WM]#5?,>;R7(Z$W`(:()"BBKY3K`.9,BAV-BQC
M+3OK&Y\:104F`'$F&ZM7<"J&"W/4VO[>;D-`FMU,Z3/1CFPZFKTVZIW-M$T"
MPI`"<C16D$/1"/2T!;X,,/IF8=VH<<++53J(?*J\BG4WZ.W:>GU6TT4;]\(D
MQR9,O1C,M)M<@Q`/UX([>ZT?0Z<T1'A5Y7;2M(YW?\B:)A@SM>;S[$\+=HQ/
M"1I"))K#&@6@OGSZFC9XBLC^9_9<%GNVR4Y<D1MS/+;@BYA83@`)4$Q4)YLJ
MJ&80HLHO?>8PF8%440":/$))MIA*?QR<S'<1R&M0MR*H;<Q"?-`4(4[A*W5$
M]DEB7<OB@F&"+0(U*$%HI691A=1#II4(*"&B0@W9!FN,Y00C,)A.*22<`RL%
M:_L0>D$X14HOSM@2MW395BL]TSZ!"=FOJ]`J9656VGI6@!TCCS!\54)H.N2*
M@B@KO_!7)AI*:G<P)FZJBM;YE.+9L+\*YD'8L\%T=`K`+#LM`_0.*.&D4PKO
MU;N2+-'I"-5&EOS4DN$X0X,A4^PT&EC=+4S>CTF6_4=<%=Y71EP2W6V9,8(!
M1I13':3^`OW1X<!G>-GAJ(*]WK,=Q&^L);YDBLQENG8)WH`D1XA,]J._H)+-
MJ$H)#4:T3,QPU/@(>@TO8=NEEI4$EE-%IUB7MAS]AL#F8RMP9+ZD%-I_KR>Z
M((H&NX%,ZEJU1?&1[>4913<C.USAO3-LL)+3S4#0!;N"SXWW13Z@0I6"RBRL
MC<&M5%@3-Y1J+$ZU(R*+4=V"$T@2$3ZG3U7QH7'HN$&LG$)UI84\UK/OKI!"
M=5U:\BH*O2K$=(LI4M$EJ0-Q3!#'(&FBFFS*VN"`LTH4=V&MLR=-0T%H=G^4
M!59>UJD\FCE\(+<49<X>Z$43N%XWF"/WJZ@HT)SB%G@UKG26>,LL6YE&D+:7
M]S=TC[&NB+F'ZK0+"48A"V7AT7WFG(L&$9"$6M''.%QH*VGRL_23$,PMT9S%
M.\(=H7Z0E3(V03A5P.,M<^J&<PXYE/%[,@2-FDO%\SD=8:X$(0(64D`T`#'P
MP+[1KU(84:F]>FBMJ7_P$Y[`X#$X36A`U/]FA%\IA/(A>Z"N6C&#E)G2$?BU
M5$Q4GH.5M%8VDL8;8_;7.063:XTH?D"&QG?0F54\8R@<CUXK]L&CB?U8<6ZB
MG<+VMZG*;`2SRO2Q/(F6/H00ZJ,HD@T5B\!DK%A@5'FACLP2NJ)U*7G$?^!P
M?CRCQJY\JVU,\2P5H1VW)9!,)M`>K'4Y<"$="I7;"+7N7;*Z+]D!)XI(_I5L
MH6'COUBLUP9G5ZJY;RPUBH!J9>+7TRI,4X^CWUW3-QL[`$F"`[G!$H.^FY%X
MJ_,T01L04!/6$0%F]@]1*>^;+TZK?&[S=R$A&!FF2/DS@<N(J)[-%'$ZY8WK
M6:>MUS*L"G6DF^3[*!-S57H]UC?#32%I;KM'18]5ZZ/4]`$B!%D9>E!,!D8W
M9LG83@-PZ<]%ZAW:/5:(DF,?+,G6ML!2PB9:+A\$?E!^05^MN35H%!`[E'-Z
M?(;X!:%[)V%.;ZB(@8D8'CA7$[/)D!`<^S,S6%X[>)@2]\:R-^9@%*4WGC&O
MF1X*`K4>B`J:HRG797W8ZX]I-7F]=CP@3LLO,JY%S9<E1"JZK_10#S_>A`:(
M0?3;6*Q#<=VDUWG]4%GEY\,R(%O`AH"L#`"XI])W]"ZA-E`>[UW5F>^$+C)5
MYFZ:&>D=HGCFAS.<Y._Z@R11V"5[AFVL\QSF^D2;C*3%7*$XF>X.JVNI7`=>
M"5PCH3`GEC%9E::LP!;3:B1[(#G(!\3/%E-JV^E\3[\7WYC](T4$:58#BVQ4
M;E=U<BDEB%"NAM*,R>M]DVN,8*KJ.T80KHWOF38$+QF4UYPY]#A*6X8'L,(Z
M1VK<F)203D%I)G$7:**!%*F<"K>4?TS0?*:]75+T*L25T7JQ+@<#/3FZ(!0K
M=4"#%2Z,V(+]V-WXE`AUO0\R0<W\5!F*=45)[XI@8Q@P\YPZNS%;8&I9U<5"
MYF#Q+K<4H<0=L7K0H[7'U!G9H?:*#&M5XT7O`A1((>\L;<CR@[@AN1@;`:?E
M:6B46#/;0ZZ9^:E8U&9K`KCU5LB,J@HJM7.G6'QGH"YN71LKCC1S&4XIA%)L
M4WV)C&^+Y80Y`LU2!1@W*9D+SJ9-'H"%]N2[-+89"_4*U21@#8Z*RX7PL-FF
M/MBVBG($O0W5(1ES`?1I1;D)J<KF,XM3<0+&\_B:SUNGJA,*$Y<Q5N!K,QOJ
MH'":[H*4`"GA1J\C$1V@%\JW5@@&=V`Y42,RXGQ-F$X95OQ7'<45.")9%P8Q
M7YH$F$F"7,D05V$0<)LB".LWU\((QX@YV(,RS"#/N&'4W'GE`JMA/^FG"J46
MZ<JN5+:')8[P*=7=H%-4%&*+D2L9M`4VE64Y8Q"`5P5TY`SV(PEV:0_`N"K^
ME(QNHU(_FH)=Q9#T156S(2?JR>J]X1,+-;BV"-`3&XU>)-EWJ%_NWR"(7=E?
M;^BW9R>"[RHPW&>RGM90J16B9#HC@@59(8_WLG6TP)/TT*1#1C(?KS?PTG`6
MFG24-J](["$WK#TVDC4\%)E.6R^F1J:G4]<)5CW*V6QY)M':Y;"ERI],YP(=
M@&Q["'4GW2G!H1=VTF]3"OF1#3.A4X;IGA!5M9XQQ0_JXL08@*_"ZX'OS'_J
MV:N:'N!5)]21,U1(.8B"M9"H=7R[^VI4I`M%`;:'1E5$UNM1_1"AF<=J(-(Z
MC<1WL1NZ`EO$$RC/C]+IT,Y!/$\JG%!UA!(ZUNDWUYF8`<29]U'+;!B8"`VG
M3RG_W#ZD2D4+!T?'5K00L&LF/5_RLWB<6)DB5B(L--60<U7,9.HL(=:ZUKH%
M>U(%#Y.%[23B"%:K3KE"KB:M!QV.B^B60_S$#\\R@"(%2'6X)C85HSV\>6+S
M=AP&)7`]UU&U/=P6G"."R#%H8IA52&[F)Q,EBS2_P(('U".:,1':]TUL5JT@
M2SY<>;C*F<KI692P+J,WDOVVN16KQ'-@/[>?PVE%(O`;Y]K<WKW-3-Y:(1D"
M(-UIV2@/W/;*37I4/@!O5NHHW027>(UUX'1(B+"\,:&@J/`O$2P!X!LA&%GX
M$&5!'CR6XBG4M1:_Z'#<*PO34BMNG1HG2>EDF^7VX'MGB"M[%R9)PVXH?A?"
M*R-MQ7N!-4.K4(5&)<@8[VYSXU.9SZ:,683PU9">S0IO'I-4&=&;S8EV.&5G
MF(Z4(,^^XN@<9FA_73O;]@)OS-!PG*=L``SI$1\HCL;\BA>%OZ!3-33B_(CC
M_0_9^W"\7E2B:@AR`P.'%SROE\S_E5Y>&;VQ9<<9Y<TGY70*X4W."+='15_;
M26+/H*NP(8=D/*2-C=J22<R%J7<G`&RE#P#,KF/.2,>E.Y04PKH?P'@($-:E
M(PLHDL6L$CDAXD-;/0NI3TE"H!;SMRKL3X<U*_T89Q`1^E*IP/LJ]_-INT2T
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M9+Q+1";M1/\2B<B[?(U,DR0!A47YKY*OZ5JMTD8RNV458]JHS%R9M&`N$^B[
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M<?Q?>59&3-(,.7O`GU\)3UI:+4:I5T4HBOQ'Q@P7NRBAG]PJE.2FE[)MAU_O
M4CZ>$[I+^6`C)2F?!S]5RN>E8NK+U5';OCE,*C(V'\;3S3GS#T&I/@1EPE!6
ML3Y#YM7;<LH1W)S7$^MT@DH_I$V&YC?Z3/Z-BT2_Y7":POYUI/84_=/<NN-Y
M?C'6'[*2WM((,UOGRM;,,@5,QJ!V0/D>":USZWO(]IJ'DS\OBG<+KDCC\^?/
M]SVL:N.$Q$U)H1$E>M:Z+M"C=L2*8T1-@8-IQX_S;??T\;`8H%O-SC&-4P,N
M.=I/(Z=V7EC)?LC<>%XYB@6?VKKD9&V;]J_*1^706,M$4C:05"0:``P0BDWC
MVZ'&C.8U#1MZT`@YF.BB+EB;I'PQ()#NC<6^#N6U-/#H'Z*!_;*D(_;?[MO.
M?N#&OJ`AN8"&%I?9D9JTUXXNZ+`8D$83P@1ZSPY#J=7&ZK5?=&/O;5OU@[I>
M.H+_!.!:21_MI6!.Z2@IEA*IW-O:X=[.!W'_8OUR5$/K=DQQ3,*!"/*LE`1V
MK^<)UJ:XN<SN[3Y8W=W>,EII4)JHC%?<,@WO<DC,HVV.T'O6.#<H6:GT)`F\
MD!ZMV(U?/?8E57JNO!"KO;?S:'5[^R%<;@N__IPA,1^#IR5FU;I[2+A31X(8
M:,N56QR?^O&/0"69IPH*M4IU[OD`1XA82%ZB0V73_X*GE,9#%/.Q46"E1BAY
M]D9EI:7#]<687.U]I2.Y18O!D`5W,7'NXO<6A&E%"4PB-HS$%=DRL>^,='>W
M5W<?;O8R=M`QYOW'BH#4XV5H0*-T0:?E)O4%44&($2A>Z#]QR[#4QL(6Q`V>
M[LD3D,R_M\DEOW"7&*8ZH,;%0PI<-'%YK?;'/PIT$EXK.QL[JUL[V^Z;W%OA
MU*2=K0U*WY<"&4I/),5J\6&1=#^XA4,#%=ZQBEPKN+:C#ZQ/-XPI`2<-?U57
M2SJ7I5(V5>HF-2G$4-1(=$")5`V>&3ZPHSZPNN<)I605;/Q,FYAOK"RBI-VQ
M#1(#$SE+I'L0@:['.T2UUQL'%V4NVZPPGHHT+/D@>,*18KB*7+1@Y5@ZTS#2
M=]43U[G'R6?O_'P8:.T;]O:H*NJEE+KHW'YXKRV@7_@1]C4"VB\<@B'JPD*+
MG&]*^YWGM[_XO/WIBNNQ]L^=RUQMZ>QPCPYM?[OB:K3S\X.-U9W[G7L-G]7=
MP&%SUY!C22=XP&CW4C09]#L2>E4[\8<-@(G_\2XO^G5=+128I+\=O2$MK2[,
M:C]CF9VI"!WI$&XPAQ?U4_]8E#]ZE;)?K86J]VMPZ/JINCKA!3N6`('E93#K
MV1&Z/UZNI,&IGO(*//WAI,DK`_6/UF[1JC?'Z!7=V";&#[`EU8IN1$=?R.XY
M3*YD0GU8C;#;A.&(.N!*7\GQ5\.5I]ZJ6$'R@U^85UV?5+T7'EA-.%X*SI:`
MN^!,9,:NBHDWVP7**VK-Q_JA'#(.?:RJ:!LGHMVE7*ATJV_P:S39Q[L1*7.E
M&I`Z4OE>?I>,<P1^*C$UM":V!]6EQ3MME\EI3H<0%N]MK&_OUN7`*KFCWCM<
M"Q7M[G`LA74Z10M[:_7AKF/3]'1Z?D#SUC?;-IV>$UPYIJA;H'WD]..0H%$D
M,&@ENX,K@@)>,2[M.$2^2AIT>3F%CQ,%-S8VUKF#+^VX]NDZ`-=S(H;VYLW2
M<1W!40FF/*BMQE3WA8N=CHH[@5[;E&+)J$!^\&KC*+'00FH\>:JR0142@^Z&
M(E6=<4*T@$L]6HU/N^<L-).9LL;A"8@198*]>]NA6#X>H&"LTF*%JE,@\E,^
M5^6;AAB$PP\3DDOV1IO]*KV%[*2J!W/IX^>'!!KO8J>ZHJLVCERMZ]`!9@_M
M3X8CS17AJSIR(T=(L$0I81798SLUYZUS<H.)$G1Z&E$%ISBDYZ6MEX!'F#S=
MH'3R'E-H.1+VTI+84#EC@1-S?<TKJLM0$2&T@2F'&1"C:=U'CD=3A!"(=<,U
M:2.&?RW(Y=AOUJB8%&H(('V"(`G7/X063>A0F+2WW:H67CR!$QO`_`2]%)-.
MOBPVGM#G#8M:0+,C.704$Z4>:%SKAKXEM`H@),68*"'$V8-'H>^BT0`"HU0A
M)B7K$'+BK>B?-$'RCFP5UC*!6Y&SCK'X0_NN=_4\KW5[GMOFTT$\.=F.)X&Y
MS3=JO[6[OK&1_4%>4_M)->_>F_.L&NS[J@&[_7[UBC4D:3/?CXIQ]T[5FLX#
MDRGN%.\:-!+7WG58MB%U[S]<W05N]]<>[1(*V8X4HH_]`#,]G8W>L=-VD)G$
MW+`I<CNB],["0P>A#/!M[BP\+SV[L_#N+#RS\+#7VK$C+,=;VFS]Y8T=(2=%
M<V>UW5EM[F3>66WT>MDI`]C+/Y'5]O!!L-HZO/S36VZZKJO7M%)RL^EH_`@;
M:&O[P>JC!YO1[K&V_+9-AMNB(AT/,QSVGXCT4F$Q<@&W>7?OBE@+KE7T>*R.
MYCDNS-J)_"#2"8I.T.)VQ%F/;6#,N*+IM7F;IETCH/&>6.>K3A&+MT>'&P:X
M,BF<OMYPISPI(5/>"F]4T$O<T\QT('0.NA:^:IXFV`J.N%_0_#WX;#A)T9B7
MI#9_".BM#C]0J[5Z+@@:E%HKRB-MY5XA&Q+/+JSO]OD\8C0XFIUPC`8K=>4O
MG<N<6!9QM9J]YE20@@J#\GU]^F:\Q\X`D4$<1EV/IV)QB@ZMUQYBJ3\V_]5B
M<<V52\O%NTZJF<WXCA!9([/\F&HP'3%F]YKP::")%HJF="U.UNR`LC,=`=%X
M3-^R4VL*J77/QL9G+:L)IAVR$T_.!5W7#`\B)H1LWOB)%N$>`;1Y0DG@[JV?
M5LI*_JBS`*N"PW2/@K:6KY&>GF`#!:=11UAVH>WX'B?=!:D;>DC1J^Y/DA>)
MWZV!`LLHKSF`P76+E@ZB455&/!2B>HWBF)K>]*L8N-G%W<2B,XY/H?Y<?1/;
M5YF^?7I8I`#"UTN)D(](TQ(F"5L:@PR!"'W&^DR*@+N!8BV^:`L)^->K68R\
M^,7W1H:"$0P1X=4^D$?B6.78IYY\RUH(-8#4A/KY]/*K>!V$'69#P&&&S`SD
M&U_%'5*.*I@F*04D=Q%QPD]8(DNNPK+U"3];;6&PG..T$$/].44[YW[(``FU
MT.;IT:V5ZB`W2@/F]KJ=VZKO')!DL96$">AM!Y,\LK*,6XVW/:AKY^M$$7@V
MFN(KVJP0)Y%?GU?TZ"=/6&)/)YAS:8Q%(,CM32;D_L*!X"%>3@3UL,7PX*\1
MPF^2J3%["#,;1+20CT%3.!B,\T`\WA&.'Q5*8LV';6DO^[7"UE""2P1MNS@-
MLG`II>7'K8X4LFPO&S$U"XPU-K&'HAI3,6<'>!(5EIW0@YBID(5DD7;]F-)G
MWVC42;-K4[O9#KQP((;=O@;5]LREG;J:F]9;1AX1!PR0VXD:8$X+8Q=`HA2`
M^I26G:Z10N@%&R8N!,K2':ERR$2P_7QZG0>W:>=X>#ZI@VH+T@>^"`=:1KB7
M[IW?.&,1/C=;MK8[E+-G:K81!321ACJT#`!ID8?WF\>YO(D7SHF0^NGQ.#G%
M4K<.<,K/O)/21(OM+<X7;*8G8%!AR?:G<L[%X%GV@E,;IK/U[/>CZ6ML-`0'
M_ST>L4D7HVBN-%6QVT)+-P)Q2C#T_NY7G*%B=D[D"\EIQ'>@7UNDLR`S-@RY
MD/?GW1##E86><UQ>/*0H69+91::<?*73XC+D"UJS&WT(!`'0P-&.+3F(][@L
M@],29<IF&$'IL*:9F@YJ7F.W.)586M<:]($8T'31:(<F#JJ+CBH_HW>',%>)
M_@M/+[C)[K$=%4@(@!J#(Z)P7!X#Y_Q[?GGU5;9_<&B`\XNI1;Z"V=!*\S5;
M*S!%G\*2,Q;KCY;T?OVP*@*U)*!I@3CU#6G3OD%6:[B3V`4M&D:]@=D`M%*&
M;A;O-$SBFT1@7,6A:0@_=$L[@U]`ME&RJ\HQ/DARC,8*'R8>(;QP(T$@V\.3
M_?]\+!*JC,6M4-?I;.$@S0),T6CXB:A*^]W@E+A1P3N(=5`)V[19I:8B\?G^
MQ:@X(Y;/:4;FI1VZ0^&LU%J*\0[X"&D)Y7>=O2=?9BOYYW4LS.EZYRNCSI73
MSI/=#G,<PI%L&E<Z6-9XIRFT$I9`3AWE\]G[[(2<QUC>G?/&]]KP>FDZVF(_
M7B+@W$)N$$;E3.KWV=Z9-(&;AC^*>>+D??2?,!'`AC=OX*/KQH.?ZG'2)&Z#
M]F6&MSAJ]X,XJL4WF^L;"=_X=OQ4C-/8Z5^$:6J$WIYO?@R%W8Z-HIX*;)2B
M!QTJ_DE_NL]/@^9/#_AIV/SI86"^HOGSH^6<%V(P2UEO;S*<<L[3DYQ.A/$,
M^1<X+P9I9-T]EF+$G$`4U,4\$C/!)Y:TJ@=83L`-T^@F7?#S4^X#%U*_".FF
M&%Q"O%7&--C\O7!6AI")W;#Y7<%\@L5=%3-REJKN+?5F2SMZH:'4[9X>!46B
M*Q@2]7AZ6#,-:[A+AN[J=0*$=>-&^U%,1K=_W_,3+=L_H^*\_NA(MD'[Z:MH
M-+8?(.%QBNR&K_:CY[KC8\6BN=U2Q^BCMS]ZQG#<<S4:M!]\K]MMVC\^SC'(
M46R_X\X=M;<&[=A^+>KIX+NT'U>C+`BU;G/?*3'03@UEP(]M,!S5V*WV@$84
MC3L;S)=H$$-?.4?#W4Z,Z&8)1.DVG6RX5E5&/#QT+0^GEII#YY$/I$0Z?QW1
MJ2NLMDU[6CC8#_CRJHV=1U*>>"R[#])J-"TR3IC]N`EW;,)[35W:3BJ<A^/M
MWU1E%,GA]@IA*;;+>:YPD9=/F%6UI.+#8B"W*3%QF5#/J6S#PN_64X2H/C^]
M%3K@DA1,*#M07;4:%"U"GS[8,I#2X?+LN_7C=>(,=L^"7?<-EG75*-Y=O&\N
M7KO%KLAX#?1@ERZ8Q-/$=@&XREA\[L9/U-A<X2IAV8589:"6((ZD3[B`CK&A
M<Q^\IA:/:H7Q`8!80A+$]<EJ5'G@O\9BLG."[8-W+H"-M`RU%BYP3RF,?=NI
M`MI<W]FV&\8VU^]O?=KFT9WUW0U[2LIIH_TPRLZ,0I[UVU3R/'JTOOOIW_XJ
MLWIS8W=]NS/=D_I4V=N6VN#'++M@(Y8!L57W*"[??;!M1'^/N,GV+I?"UDT$
M.IU1;F;5-T#XHCKIU3Z*X7(=[$T:*@PM"U".NL=C@B/3%"`A6B'S99-\`$D;
M#ECU'ZGX[$9XQ-@R@AJBL^G(Z%RZ>RQ@FYRCR+#49=N+20(\@2^=LNY--G;3
M2U+B&*=O2CJU9(XHZI7$C9SAE)N,2R@V-2*[=J#$7;`7W%KCF%+,O1@:UF5(
MD5>2R"\G/[=I"U?.,!!,BA!_"@F*NYR>1R(#IH,!EX21V;@Z?U)EUNYR>G4.
M^4-R>FW:=`:MXF_Q,&YCTB@+D#&/HCSP\\+S6\1F%<"X7=CU^G#K2IPZB9;!
MUQ3M?VYF=5-$Q6`UWEAS]J@5&S7WZ+^0O$!4?.P(K;K9_\&HK"_BT#V#CQ-/
MZSD:^;HXK3JB>\.S6NW1KRT\VU(8BAEB[>#8TR\QG:]Y"D\A;].C%E+V"@NP
MH-PG/LE8QR]+E=WS:!,=OJ&[%`-F<TMGP?".+ARF#=^ZZ1-M1=Y9-S.%BQY)
MI6I:[CF,Y;G!<I<-*#O8-*9IJ2JL746NU<)5-2/(G&_$18%Q->/+?R@>K2U&
M.]<9OY\T!MT9'0/CUQUW;K+$M;'F5F#9H\E!$+;8/X8M*AG>B35_T'<_<<!#
M]?3+6HV[AE(0;(<WQSBPT_W<I>NC&(E9[Z]780U,NRJ.D=TJ<`%#A4B%7Q7=
M5J554*$1FMANO[;6_B'N)S&BLX)3\#O=`"O;+DK:'\8)JYV/VKO]8BN2<>/[
MLGR;@82?)YI!)C)TN\0PP\\2UV@VH]Q%'^ZB#RHEDD_W8Z,/.X\ZX0!ZB&+P
MH;_>U0(*V1K1A.WUG<[G233A.I%ZVPC"[NH.Z>6?(4YPWU-NT4^/88*."*J"
M#VAYJI3<J&^X_C$"DKCP6%0$;CDNYCHOIO+A+=2P]6!U>_,7"#6T%]Q5LSC`
M5"F:1=B6WR]5?<PU+=>\<H.W54S.N=-JF'U/F)!J&LQ!0G8ZG4&F),->J03-
M^-[**;@8SVJ&0U4D<4@5C6D'ID000R1.%_MPRY;N25&J6?;,Z0A(JUO6.4^=
MJAOKXM;#ZR9EU-CCJ3@E1WA=$"ILI<SL.D-9S]`%=U<.,(S#U=TRA%4/LJ3;
ME?0@!^"P=,)=\?(2VKV/0S>D\M-F+@^H`&']?N%=-*[C6\VXE=G^6/81HP1K
MU4%'_%R#A+KURA-0J,Q]M^1I78%BB`];PPMV<HM*>.>D_]N$0S9R,;':&[#$
M?4IL)I[`J"IJQ8(@BF>.PWMOU=]5\9J.*.&R[NPM-;JJ.)MPM0UAZC:EX3,`
M`!=#VY64!E="(1:<T754NKI&;LIQ>'%W<V/E-3<V+4XOR6OJ+L*P(3@TS%O,
ME:KI/[M`9*$IGNKJ4I')D^GBG*YTK^CUK6BB7@6WD9Z/N33(QCU^3R'59?;-
MY>FWF2Z':SWP2ABFLLK>(5=XS)W<^9N8X_LK*M8U>0PM#LL!AU,1+O==BQP2
MG#T`K4L+=)0QAS5S=A(M!`UH*D[QMDSAY-XFV285NUOHPJ.4]T+=FWPQ:Z0+
M_.518R,K+;B;,0S'<<7BKM#2ST+07+J$QG><1??0D%#.;:X#),`(5-LA#E70
M=%@0<;6R*G;2+J#5ZW;(&ZXO0D`U7CV!3ATQR(5+)8KN%E=+K<-W;?I#C'FH
MU!/*6\V=;U>F[,W7?E`O-O9M*-:)S%J?5U$U,#PF,:..60FK6?V\69Q"6I%#
MS?1JW\E<*CNQ8;15X'5F\0']NY:BQB->0_04KN26)P16J"'JUKPL`<HK7-*I
M(MTF,SD!"P9;D22+:N`IA@M\JV0.I_V%BJ8.-+V!C90P.<C'+`16>@HUY=Q"
M6HNY*-NV5G="DW%`"J]2[7=Y2F5R$LB(EV%5'-;(.CA6NYOCT[M\4YZ=F'V0
M;RD>$&O5SMAA"4TAY^B0[$,TDKJBN)ISQ9VQE^`_G5=RSJ_%5+*$S0:GQ]3Z
M>N5E2!YO]X3-H.7J^M&Z>R(%O$W/+8WP>\XG+$@$QC+4U>SH8OW)>D71\?=L
M[W&+GM.R<.=JG090O6_*JR+>ZZI(]X;T0:A`S`*7CK-JF'3:*%@]_]=')LH6
M2<2&HM)KM):1;\[Y]^!;===!5YFXZY_<2*]6@^WM2O-/W=)D]JD9*FX+G3O3
MZ1<SG9Z*!D[@VIF9!EAQ.KINY9XE'T,'VB]@4AEIKNQ^_@&6%51VB.U]BJW@
M`;KM-IG!$8B:6++\0;KM%>>2W*S<7EW0])-G]O(R]>8CH>5_$O6V#"[7;_XT
MJ(U?0L'Y,F^CVSY(H[6-FH^;/W&%4OD<50+`U5Z,^G=-#PE@4V;+!DC*UD%4
MFDAWU5'^_Y$7\?!L3+;!%JVBXDZ9?C=Q,9>_\$$%^-TQ[I(?5F\2@^7'GHC^
MZ,F/CDOSX+JCTW$F.B[U2P5OKOVJ+2_V_,K:JN@E%(_2V1B,?5GNXMJ036[8
M=M*38OJJ76E)EI)#)VD*0AO)*[WO/FF2J?0TI4*-A#32;*6B/YS;Q0/WF)';
M_2E+?6OR)0!-E*XZ&DU!F*3%F[6P.+.&Y8JZ"K369-U\M+`.A33-G[4,Y<5L
MU<YAJXS#+A)4V&1)C%!WO:Q)K\O?L?R@NBG=Y:6%S+K5*BJ]7G*TW_V/T#Z0
MO<BGKW7:ZC<<-'A%AFJPGM&+,U=<J,K&JCW'W%S(QLZIB7FBIA&@=37[1Z&B
M1E\TFQ3#4]?VH06ZC%7\7N!36G(OED\9XU:7@T-CVK(;/PAT[PVUI-NQ#J>S
M<,M-HY2VPX6U#N[Z;JDUHHH%.[<?1^^H*E\0<$OZ@@SPA"2<C#^&(=?<+7?K
MY/<&,TJ!D,JG2P#ZL(#$K2PV3?5+V&L6D`B'[]T<C@@O?I#I9C[F,ARHGC"X
MK3<&(WP,BT;DPS=6LMZ,2G0H]+"G?^XZ%T$"=#:8CIRM6A+Q]^HFS_;SJY'J
M*?=+3BX,4>TH%9Y9X68YE6`@*R/[Y(W27GMC7)2YVC?K;QKGQQ.#D7[Y-B<$
M.,Z.H3_J6R3U+#H43X&P*LEPW`@:ID6/?:3LXD=R@5!-M+&&&<>@A[-!OILH
MQ*^IJL<-JXK:7]5SZ36/8B&(\]AU4'^2!F,9VSQ)*GZI)[-/+7Y/'$VJR\LN
M.,FUO\/=.Y'T^-C/JGV<Q0,<"^^MJ(X!:(RA-`Z2[-@*VJY1&&%!ADJ=\!L&
M1;8H0A*BQ"X+_?A#MCR$BT$AY6P[]^OR_>8`WK(ME/=_K]VLPL>8_J.8$^D2
M:>RKH@,K0<7^[5"A3`ZH<.7^45'QZ.=`1:"C0/`=JA!6PX\U?J11L<2@;)>I
MECZA-JQ\*UM(6Q38"-,D4H#]C'8*9^\3KISJK!J/Z#:;LQ6QC(=*Z\(.C$E"
MB@QK+=DF[\0Q;4Y*&@9R.F0^]9/@%\P!&`)J:\-B<[$-9%DG9$+H_1Z,!U1C
M:*2V3#3'N'D"`]*IHLF%4B((XY:]>*H[G(4VG%N8EH/HW0W6:%'B$8*.-1[Z
M.8H:&<+ZV\1,GW2NLBB]\9O^*LA;-ZEKYOTZ<WCGQ?_$U8T?[,7[AEQCY3<X
MYI^RI;XE"&YQ1(.T>,,SB^&CX.AX:OK_L7=NNVTD1QA^%5YX8060$E&B;#(!
M`BC6.LC")UC:Y"+(A0X4S4`6#5&RUXN\2.[V6?;)\OU5W3TSW3,<2K9A8R-@
M+[QB3Q^JNZNJJ_ZJ:NC^.9W64IH]09&Q)DRZBP^\W]I!BHO/$DB?;FZ3O42O
M+D*HI?@8.>J_BSQA=0(K&,?3Q?+Z!K[S>KK$=",'(VSRX(;J5'J\&V>79UR>
M%+P9N)_]`5_31;RL3,0"AQ]JD7G@)V`1352>_E*K$B:7.7.@CN`<RY[DRI5@
M#Y82JYB@(7%HHYQEW@1U">Z97+]H&%=G6P(@?QS,IHN+Q<S0'GPB>`/2!I,B
M[%=0@`O3_GBV(U3`E"#'URRM8XKD%`?Z^Z1(NLJ;LHEE>J1(2J8U][B>X+L7
MU@'ZMVBD#=W9SF];IVV,OAX6U!G\K9?7%\R[H*U=E0,A6'>91&C58^!=U9>_
M?V.+IKTHP5JBO]?TY7A,+?W8$B!Y,DVY_R\F,$%UP0UL)B/P13.>ZT%#M0-C
M(PE#H^\Y?6J,)2".--S9L]L#[(=KHQ_5D1(M$4[/GDN3P8[4:8#2%Q&^T6(>
M+_V0IG^2ODVAD+QR@J=9&QUIPUW6Q@3&44+LJZ9VX%@)W)0/Y.,(/*1/$'VS
M.2JP-/%$"AR4T@Q'K"NSQG[>?$&E,,K(*P[G1:YD]S`,FC.&L#^V!W_7WRNA
MM%8:E!;Q%$Q3V8*C>*ISC"^?H.+77\I,R5@/?!+(48MF;["_6HS._IV35NB-
MSW\6XT*%SF!V>^`(S^9=$#NNLEJL=?H]G-38?<TKM9[^U0PG]Y5W/4C>@70,
MVDS]Z=G^..%I&K;V_RC!Q=/`Y?KP9XKE!A"'N09TW7]U6\%V7`(SM:Q:\#ZT
MNJ`M2"W1'ZQ1,LA9.QAYA`(YQ`C%*<9[6O,T2%3&HMKF)>F\""9!@L/=/V+S
M`!,0YO_K+ZOK&GSUZ2,3W/$RJ,_^&8]3BR$+8$"1`PL39*I)'CO`%6&"-MFW
M8:&('Q#H,:_W..CNF`S)(^AV]Y'[2!T&'N]L#L=[:6`J]8QV)PR\;P5\I"8$
M993UJ+(<U@81X:-GX)!]\?3T2C4-XX%!A^6O@CI"I0C=E,8ZU]E#G->!/Z,P
MBUV<7>-J^:/-\3:G)O?!5?X"-U!83ZK=),"Y>\9_`'3Q[DURM#%@?SH^L<+*
M4B"M@"4J<2$7A/`B[!F4HUW'[>#)C%J!3NQOG"4"LT(TFA;2&#P_45VPQ9PX
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MH(`,0"HBIRO1?L@KCM+$1-IC7XJ!K+^\OP,?T1'.?._IUALDOD8!.Q<YH+1>
ME;X9X=*&I=B_1T8H>;"2MG^+R`C=5XQI:WET[M$0XN7AO?/MH2$,&)^N<I.5
MV47NTA4&E>;TF9$6SN=6L'K)+8F[$`PEW;#&?NZ!&5\X4N2W`LPPRQ9O$42;
MI++[IA<&LS`U)3D,W<H9@O/C56YYJ*W+$A_O5#YJV36)JP3X+OP=F>BDX]64
M+"RP@K2A:GK.@%J(2GGM"A6BYXYBO4GP07@`D7!^DRA_:34CI"7=19DOYH$J
M4^2,ULJRN[H2ZJ(K'EV[>H/=$<BR#HH%^<:[DOU/-1<<A56?0O(G?W/0%>PF
MR1M_#UW1$_F3H"MU<AHJJ0/V^>DHGGOHBMQ+]]`5GE^?#;KRZ7F[7+5J<:Q9
M^%X$#O2X)9^T0%[<FF1E'N[C3N[C3NKF+=G@;HE/T9MT+<M?X?3[JDFWT(Q:
M4"O<6I3)>["*5='Z;8%5=$[7`JA$]]SJ-$!?P1,WFFQN3QZ;>V<'5]QH=W-G
M,E[I5]*:HT7?4"+RX@4WS9"L&'N38>KN,4F/MW=OXRUJ]PM)52MN5AAS--K<
M&4[2D)/-1[M:P!$O#$],'!Q/B.'3Q>R2?/_R/AD&U68NP_]%Y;^3/8($S8\W
M'VW3J7NWY.BYN73K>G![\9AZL$O5N^$X9!<HIE>ZIUX(1#:6#1Y^`%+H^*=I
M49N>:?-"1(1BT#Z](61+`&$(/CV?\C^\Z(Y_BIXTP]G8$F0TX1^XN`+Y7,Q7
M?OB+!>B;^!#$\3)M).%1Z_.;ZQL&5O<GT\OIN5Q<T3EGYF.9^6MS(!.1(IB8
M:`4^PS3&"08+1(82_,OUXIKYA(Y/YA<JL4#7,X93,)K&-J<A-!=Y:G!YI?=8
M$":`Q9V=L,6<`I[^R-8!H@;TC@MN<?9[XJJ2)UOY9N3'5F8@?P@O!<2SB0F1
M1"S<*6A\XM98!0UQ8CJ&VZP%FJ[R\7O^:L-UF]M`9^4\)0@!;@V:29WPNH2Z
MP56NH7760,CA_82R!-ZT=78\DW_LVLQ=)6W]!`=:V*Y;X2T2"9%@:/ZS1@7C
M/?I.#EB12TU$1BHUXG7&Q47L"`BLLSF?<8J$;I04(KN]/M4"RS'=U=_X^\7<
MMPKGK#;[F)4)21A=VU5-C>8-+;*\'Y2'IVCS8O4V%W?E):NXRMV<*D"1;5O>
M9`.7]M`@",4OP\W)WEAQE?DOFEN#,'X!\F9'T-6N)+NBX@`)--IV`)S5D$==
M63;DV1<''@_UOR7S4,]/0LXOG;#*(=5S.\R/6,.D8IHB$\/DD8UC/$1')YU@
M;B1(#GNY)9;0N):6I-VB2_Q(X4VR`A?,?\2Y(J1QAB_-XPU,W.UL[^Z6+XHC
M!GT]Y4*]E55*YVDX&3\2.,"P2G[*?2-UH*O5FR&[=\T!U1:+YA*(@^/R1C7N
MS#YX2DW%F6T.M7"G5\LW\W>:0N5"W-OF9HFY`8R!ZT*44]AQ9$KB<@;<V+(5
M1OZC/1(Q/8H6@FPG@MBA\)I^8F4@B148<FQF;_D4<)R>3^%5QQ>$/XFB@9DX
M6/;?R*LE/DRO_0K["EF?(EN<+@LKW;[Q(#KB!EM>L)/I]8>I!F:2E1\J#IIQ
MD<$&K(4J=,$:7SD8C5-#J5K[*%_%'-6YK]YS7]6D(D?-4./%M3],X<(=D\DO
M69%GD<D6;8I:-D3%+@F0ED#]'DCK=<%.7D@\3RQ\=G5#MAE1::9<93VL^K5<
M=R9`Y.M&3L740R*+V8,)OV$0.]"<+A<@Q=8=`L"8GP/<9JK[#JD1SWZUN""'
M&^=B(_ZK7&//E_'#G%JL"%<W$M7$2E!QM)_FZ]<IL']`/N(-"5)$9NJ/`>;#
M_[S#6>_%:.IH]U1^90'IK]X;&PG9H!%$$DD:`Z%LCO00%"VPYS,H21$]3MD[
ML@J[*,SFYT2<.C+?4[Q9_^;`-A!_;5(,5-7Y2;.*!5I"U5H?S*:44/$Z[F&6
M`P5N:5L&<';*,#/SK3#1G3C13Z>K&.#G(BR*RA<B[7/!O-!>ZAO?3N/:SO>2
MN=KYE02M2T'N'\F7'2OCK-*4G"EU/I8Z5(%-:::P;.?3<M*HJ@ZY\/1*N)(0
M0FV22#'5TK(H!&TI=:1?BHMZP"U/<.:7Y'W4WOT5X?S2E56A?3:.="R7Q54M
MOMTOO_5/\T-%YF.IWAJKKIW!5,1UTGR"PLP<\@[`K"']#-@3^MKB37(]M6R;
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M[^<H)9Q0_F63H=488)AXYW8$%:="#?_SN:5I_%<^@C$K.,8U#,-@F(L3`(I^
M1KJ^.;+:5,]JK]BNEN+?D0<'!FB(9+W\NKYY[L%[5?/.EO96318=&(A8>%>W
MMM"^GW/J]-%_C8O1U47_T6OJCE$W6P21.(/YHB!*ID#2?.(KMG6S(>&@FE`-
M^?=/CI=O.!4&3RU^%',*1C^96_)O7TME!XKNFCAB"$UA32FJ<V'Z0OPV[WMM
M*;D1;\B=>P@=Y-\_W//'6-??!X]"ZHF\P:VGOL;A6KO/WM/VM-+E86[_$+^_
MO,Z7`#./&;VCM.'\+,CLJ]RPYN[4J^P0TR$:_GYW-VVZ0=RP3@D3@$>UFHL\
M%DZFLSGICWC*G7A!U'S.D?D"($)#.U/++5`U]H^>3VJY2_)>4SF5F/8A):2P
M1UC>O)K$]=JS*(9P2X<6@""RRK.RH@#SRT<+NX>1BH=>M>A>4CV<!#O#T(_P
M@/H`RIB>]Y_:33J.>FH0[\(`D_[*GF+#?*B.I:S>OS3\*,RO:R&I]Q4[O9\2
MY\Q3U1L9'J?Y5-LUWGCQAJ5N8EEOXLGXST!R[^U-L9D/1V%3NDATF/=SC-&@
M[&?U]/H5O-;OX^K2YSE1#K,R><7OFOR66P]0A##BA?J6[:4Y\\]_7%D?,V_M
ME%H$/B*H<2GXFFUBM8[5/7745A;%0AV+011':_#T^F>]]'U%CH4WO+SQ9V'H
M-(G]?EZN*FL6DBITRW<LNO"65Y;RX`A)L)31PU[>Q8S65T&WF)YW'"+3<JIZ
MW-U3<N=W*7'?4WCCDM4R\Z"!Y'V4+3(O8_Y!R$AO+Z'*!1LG,.!>'B<'V*JI
M\5L(%N+QVN)Q_7CK@?O)<1##3A/!F&__9\TW;MC1SGUL\3(-9E>8;O(%E0WS
M%JT##TK6V&@73]PP[^U)\C>T.(+RQJ%+<\M<+<CE+@=!YU.Y,8%;W%V^Z_-0
M51/[PW)Y_>?_`0``__\#`%!+`P04``8`"````"$`E=C81K`+``"$:```#0``
M`'AL+W-T>6QE<RYX;6S47?N/XL@1_CU2_@?+FT1W4F8`8P:8&^:TL./<2IO)
MZ7:B1,I%D0$SXUL_.&-V9R[*_YZJ]JL:8[L-#3U[Z';`T%5???7HA]OVS??/
MOJ=]=J*-&P83O7?9U34G6(1+-WB<Z']_L"Y&NK:)[6!I>V'@3/079Z-_?_O[
MW]ULXA?/^?CD.+$&(H+-1'^*X_5UI[-9/#F^O;D,UTX`WZS"R+=C^!@]=C;K
MR+&7&VSD>QVCV[WJ^+8;Z(F$:W\A(L2WHT_;]<4B]-=V[,Y=SXU?F"Q=\Q?7
M[Q^#,++G'D!][IGV(I/-/I3$^^XB"C?A*KX$<9UPM7(73AGEN#/N@*3;FV#K
M6WZ\T1;A-H@GNI$?TI)OWB\G^I6N)2;/PB6`^-.OVS#^[@_)GS=_?O.F^Y]O
MO_O73\[RWS]_4_[NYV_U3J:&R`0?U,N\[-:*A:\3R9W4@MN;51@00PR@"=FZ
M_A2$7P(+OX-@`//P9[<WF]^TS[8'1WH(;Q%Z8:3%X&6PCQT);-])?C&S/7<>
MN?BSE>V[WDMRV,`#+##2W_DNN`D/=A(-Y]4S1S2932.$P=G4QR/4)A],LO%@
MO4WV+WMLXG0-FG4=PQ^GBUE1;Y<T7>6X*'%XC*[<5T1/]#B?Z)8%-:37[2*M
MU&$G4C:>=4'?V91=#<YF6=_J6T.IEG&Q6/8;*NQ;,JEL4&B]';X[&YWRE559
MEY;A<V4`)IQ<%EU(W9K\'EKX.D><G+E#.XW'F%2NZ+/4*VKC@^L[&^W>^:+]
M%/IV@,323HW]FNN3.?_(%Y^Y?HQ(I`+G,D8F<$;/!GAS/2\?"_8'.%J"([<W
M,"R-G2BPX(.6OG]X6<-8*8`1-)K927[7\.O'R'[I&6S$(-9@$WKN$E$\SM@(
M+>TA9U=WUNR.Z27(1%%4"+6LV?`$0N^FXYE\I+,QBZZ.1/,-"UZ2D;X=X$NR
M4`O^FTGC-*V1IBR0N3PM=G%&U;T<CL?C4>]J-!J-S7[/-!G)\S2BW6#I/#LX
MR9)&4QG!`!",^Z/QE0%`NN:(J3HK@CX`&`X&HT%O;)CP/RO*IT<@F].!KMJK
M!($BKQ($BKS*!O4R2E^:*;"^H3A7"0)%7B4(%'EU*+D"#Y5[E2!0Y%6"0)%7
MV5*4Q%R%=4/%N4H0*/(J0:#(J](&GVD%'BOW*D&@R*L$P;F]FDVK9G=W%EN8
M*(_,I(V/4UTXB&^OB\T:89XZ#Z,EG.#)SEKT3)@C)L=N;SQG%<.,-'(?G_!O
M'*[AWWD8QW`ZY/9FZ=J/86![\+:3M<C^UK2$$T9P;FBBQT_NXA,HXZ;U"3>)
MBE-IR*N>B;,)<VAVA^;`N$HF;))4^\[2W?IEZW+=>^,2:$1NFPTG'`:YDC0<
MBC6Q#GHA=9]@"^9JYFG!!A`364@(MI!A8[$^+&HC:2%F(VD@:"-I(6HCI,Z^
MY,J87(9;.%>YZV#+&G6[R5*<J)YZ@03XGHC9#X*T*?/9V&0/HXUMVMH*]:64
M&U,#7VQTO,?2AA9E.QL:[+&RH86HC7S<9-[EA.=+%UB>]R#9X9O[^6$P0%'2
MD.`A%3XM3WB&(#E'(%SM>&M+:G8LD:5'U`K"+4`[LE/<Z3?:V9+VPM"I+QS/
M^XC=[#]7><\.BV6W-\\KLG$`=G/@F77<EX!O844Z?9OTXLD'L*FJ$>P+J&BD
MV>NU]W*_]>=.9+$M'DP%.VJ!GN+3E`T_BL]O/?<Q\!VVW*<G8GZ,PMA9Q&P+
M"ENIK\+3K\#32P6)X#E&OUFA'W@2YN,8_;"<M-<?P(M2_1!<POIEQ@-NMDF#
M&EQ`@[H.CTP$L&B0(0`GJ$"`FX-2#B`\52"`R5B&``*T0`!P:J+BF#SHD6H&
M,5"H!/VG4@DU)K.24WE"*ZO*+^BOL=+BRN]1-)-Z"X%>T`P?:@`<I;*JQ*HJ
M,<3MD&D%!?"AA@(+>ETY75ZOJN8K(X047<!0,`)EH(X1>5%):B[H+`#4,S*5
M.`XA08&E2#4$@*,$`G%$3U'_VZ,8%/7`-!H4=<$4`M<'GS$GJ">X'E(1!L"C
M)"N*<4*/ZS'.2`.!H*I"DF@P5)5(BD%5C2Q<8:@JD02"J@I)/:&J1%(,JFHD
M<86J$DD@`"-**B3UA*H223&HJI&%*_JJ2B2!H*I"$D_T3UPB.W39-%E$)>NG
M<(*P>BD4')1-_W=]];QJ7$CM54V:0%;6/)D])3-'\`6;2Y&I-%Z.96=KI]I3
M&+F_P203+\M:P&*J$^EX&5_L+NB1+Y&]?G">82J:G$UZ7AUE8`.F0C^LF.M:
M&^72^3D"BX"G&XAHM)Q-ZAL7YG<B@U_<;HR01A!H9XI!.OV2PA.S1C5-N`:F
M&@-TDLHQT'!!/.F:,QSFQA!'5[-?MIO87;VTK!^M$=6<]3J^`!Q1?7HP&'E=
MW.+T[74APGFU5$2M:B51WM^=3]5%O\560!OK-BV=N(6!3P0-KX'`M>7F#IVR
M=&J@;.<$CQ02K%,WWC@UO$:?DL+>`LO^7MB"'@)]DH[AVGM:!8$U)9`C9'?"
M_FJ#_,1`C_71">`='.3U6%YID->#WI^#HD'.57(\J2,>Y=/TS%*6_I63MD9O
M84^;#<DKNYD3@:/]CM1(A[N&*"&SJKYS450&US[VA?W_M5%\"%XZM37`\WO'
M:>40%F']()ZSQ9%#<P]2\OCYC13E>(JUKB@)T],&C?#87WK1DT(\C>"C)Y:G
M'D2+`\3\:>XHX$=\O(@DV0&SE&-3K,]5Y!+J_?UZPQ*<7,>?&*`P@;@VL&]\
M4(_O%;F]18_`NUVXN%''"_-*UAE;S'Q4\RHVP"GE4WO8!Y$O=PQ9LH(/#[YJ
M'817O/H"EN8L+`]QI"/^&AAN'&M4!3$_'RM-(;Z2(&ZP0DI(-%)<%:_G`$?+
M\0'Q6ME?--2#RM$HQ2/</1`"*P$UY?M!->D0A+0#`^!SMCB17O;##P?YZ#L9
M9130J8?0AQ!6Z=)#8ZQ-0E8J[T%VUKE+.)[:H*&N$HN=FN6UTYMV;#*_OG-M
M[1W08AYT0/VMQ"-M,8+Z4!0@G?YB;18Z%;U_Q%!9]?:E#=L^!!N&R.67_,67
M^?8B#>^X"'>([OY1N]#>+K`LY4,8C+KYUO7@UBQ8EG'KUP+.>8?^-#F8GMNK
MDY6O!!G8AQ-9,!%L*RNO,P9N!R2R8`&ZK2Q0G]2L/EA+9,&5J:UEP1;-5!9N
MUBQPF3!9:XL+FJ2R>.X'@MR;^_S(MC47N-!D$5Q45N%'G,$366!R6UF%'\%Q
M5!:8W%96X4=`2&29H*2MK,*/X`4J"\*MK:S<CR;V3@5?`T'NK_;ZD8]5W(,H
M@HO**OS(QVI?,%:IK,*/?*RBR6UQ%7X$J80O$[YH*ZOP(U\G3,$Z06TL_,AS
M/Q#D?K>B\A%O"$9\(J7P';PC'.%0582C1$KA-3[*^X)1GD@I_,7'MRD8WXF4
MPE,@CUADPA?B%N4^ZO/LFH+L3NUE5G7Y@,%^1@0&/$M@L?7@&0\A/B&"[;'%
MLW7$(+RB0DC2D[/XI,W@E@FY(#X?L!L5$73WO/;LP([#Z$7#?;6Y.-[I`T%Q
M?PG#G"->@@$?10#]`,_3@$=U:,!+PA`?P[BOLXV8/!=X>O`BNS9BH'6"AH\_
M'$RV$0.M$S%\4<7QDXB8]\%ZFWN(KZ78=8N(^.`&GYPE'SD\PP:`%)%T[VSC
MR,[CCT\I0Y"8>[S11BZ#+Q')':ZSNX*DX\][N*]&1B*>F"6Y@V-H$>!_V\:$
M1FQ%A.`43T3(@QO#78ZR).9$("PA$2'L=<]%[%0401G_L*,`LX5+W9T8K;"H
MN'(`1O_+Y^*F*XSW&)\XPV['DL\'@*BEL[*W7OR0?SG1B_=_9?</@V!*?_6C
M^SF,F8B)7KS_@#=F@RR&:3:4FP\;N-D7_-6VD3O1_WLW'8[?W5G&Q:@['5V8
M?6=P,1Y,WUT,S-GTW3MKW#6ZL_\!9?AXGFMXOLL1C[]AC^F!:P=ZYO7&@X?D
M1*FQ*?B/Q;&)3CXD\-G=F``V;`C,C.AL\L<'W?X?``#__P,`4$L#!!0`!@`(
M````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_;
M-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7
M`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA
M0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD
M$4&P/I:;N.V%2B6;E8KT81C+RSPA,<Q-N(BP@E<15,8"'P'=B%76JM5F)<(T
M]E",(R![>S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G;
M`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG
M6NO76U=V<OH&P-0RKM?K=7NUG)X!8-\'3:TL19KU_D:MD]$L@.SC,NUNM5&M
MN_@"_?4EF5N=3J?12F6Q1`W(/M:7\!O59GU[S<$;D,4WEO#USG:WVW3P!F3Q
MS25\_TJK67?Q!A0R&D^7T-JA_7Y*/8=,.-LMA6\`?*.:PA<HB(8\NC2+"8_5
MJEB+\'TN^@#00(85C9&:)V2"?8CB+HY&@F+-`&\27)BQ0[Y<&M*\D/0%353;
M^S#!D!$+>J^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;G
MUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M
M@4=%^)!&1*);Y`@=\`AT,X9Q)2<C<;X5PQ!39P4.@78)Z9X*'>"M.69EN`YQ
MC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#<N9B5L0=
M8'Q8QKN+8\>UO5D"53,+2L?VW9`X8NXS'"L<D)@HI.?XE)`2[>Y1ZMAUC_J"
M2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$
M'Q+FF/$ZGBD<E9$<XH@5#7X3J[!,R,%<^$5<3RKP=$`81[TQD;)LS6T!^A:<
M?@-#O2IU^QZ;1RY2*#HMHWD3<UY$[O!I-\114H8=T#@L8C^04PA1C/:Y*H/O
M<3=#]#OX`<<KW7V7$L?=IQ>".S1P1%H$B)Z9B1)?7B?<B=_!G$TP,54&2KI3
MJ2,:_UW99A3JMN7PKFRWO6W8Q,J29_=$L5Z%^P^6Z!T\B_<)9,7R%O6N0K^K
MT-Y;7Z%7Y?+%U^5%*88JK1L2VVN;SCM:V7A/*&,#-6?DIC2]MX0-:-R'0;W.
M'#I)?A!+0GC4F0P,'%P@L%F#!%<?414.0IQ`WU[S-)%`IJ0#B1(NX;QHADMI
M:SST_LJ>-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?7
M85;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&Q
MMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q<J2(EH/&PSZ['B*U0K<6IKL&W`[
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MX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0U
MG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO
M]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_
M7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'`
MB\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?<DV'D@72#LX
M@L;)#MI@TJ2L:=/625LMVZPON-/-^9XPMI;L+/X^I['SYLQEY^3B11H[M;!C
M:SNVTM3@V9,I"D.3["!C'&.^E!4_9O'1?7#T#GPVF#$E33#!IRJ!H8<>F#R`
MY+<<S=*MOP```/__`P!02P,$%``&``@````A`-]P,5M_`@``X`4``!D```!X
M;"]W;W)K<VAE971S+W-H965T,S4N>&ULC)1=;]HP%(;O)^T_6+YOG(2$4D2H
M"E6W2ILT3?NX-LY)8C6.(]N4]M_O.(8(2K=Q`[']YO%[OK*X?5$M>09CI>X*
MFD0Q)=`)7<JN+NC/'P]7,TJLXUW)6]U!05_!TMOEQP^+G39/M@%P!`F=+6CC
M7#]GS(H&%+>1[J'#DTH;Q1TN3<UL;X"7PTNJ96D<3YGBLJ.!,#>7,'1520'W
M6FP5="Y`#+3<H7_;R-X>:$I<@E/</&W[*Z%5CXB-;*5[':"4*#%_K#MM^*;%
MN%^2C(L#>UB<X9441EM=N0AQ+!@]C_F&W3`D+1>EQ`A\VHF!JJ!WR7R=4;9<
M#/GY)6%GCYZ);?3NDY'E%]D!)AO+Y`NPT?K)2Q]+OX4OL[.W'X8"?#.DA(IO
M6_==[SZ#K!N'U<XQ(!_7O'R]!RLPH8B)TMR3A&[1`/X2)7UG8$+XR_"_DZ5K
M"CJ91OEU/$E03C9@W8/T2$K$UCJM?@=1LD<%2+J'3-#]_CR-TEF>Y-/_4UAP
M-`1XSQU?+HS>$6P:O-/VW+=@,D?R(;+@8XSU;Z%BC!YRYRD%G5*"45@LS_,R
M2],%>\:<BKUF=:Z99J>2]4'B:X'^1I,8^K')]]-^\.+%WHLO@S>W"AO('LVE
M;R]^1Y*/WDZL8(XNM^+%6.NCF[/D9N0&=T&3'6M.%>M_*4Z\(>1R;UY<4`Q\
MS$J63DYO7@7-]5#0),_C.#X5X,QY2!#,DN/S8"Q,5&@X!::&-;2M)4)O_;2D
M"!YWQT&^2WWIWNRO<,"'<6#C`0Y8SVOXRDTM.TM:J!`91]<X42:,:%@XW0]M
MOM$.1VMX;/!+"M@:<83B2FMW6/C&&[_-RS\```#__P,`4$L#!!0`!@`(````
M(0`W)F_7K`(```P'```9````>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;(R5
M76^;,!2&[R?M/UB^+P8"+(U"JB95MTJK-$W[N':,`:L8(]MIVG^_8QQ02-HN
M-PFV7UX_YQS[L+QYD0UZYMH(U>8X"D*,>,M4(=HJQ[]_W5_-,3*6M@5M5,MS
M_,H-OEE]_K3<*_UD:LXM`H?6Y+BVMEL08EC-)36!ZG@+*Z72DEH8ZHJ83G-:
M]"_)AL1AF!%)18N]PT)?XJ'*4C!^I]A.\M9Z$\T;:H'?U*(S@YMDE]A)JI]V
MW153L@.+K6B$?>U-,9)L\5"U2M-M`W&_1`EE@W<_.+.7@FEE5&D#L",>]#SF
M:W)-P&FU+`1$X-*.-"]S?!LM-ADFJV6?GS^"[\W1,S*UVG_5HO@N6@[)AC*Y
M`FR5>G+2A\)-P<OD[.W[O@`_-"IX27>-_:GVW[BH:@O53B$@%]>B>+WCAD%"
MP2:(4^?$5`,`\(ND<"<#$D)?^O^]*&R=XUD8S-,TR>9?P&;+C;T7SA,CMC-6
MR;]>%1V\O$M\<)D!_F$]#N)Y&J49[/H?%^*1^@COJ*6KI59[!*<&]C0==6<P
M6H#S$)KG&(-]+U8(TIG<.I<<9QA!%`;J\[Q*HOF2/$-2V4&S/M=DR52R&22N
M&,`W0D+HQY!OYWU@<6+'XNK@X-9^`KQ'N/ATXS<DZ<@V08$<78[BQ%#LHYV3
MZ'KT]71>DQQKIHK-1XH)&YA<SN;$.8;`QZS,SDKF-5G45S0,9J=I>W]]P@6G
M\W(N)YYR)7$XS<C::PY<5V^`?2"8D,&)O9S,B4_)HA,RKQDR-EV$%N4,SA8]
MD>\^_FY*KBN^X4UC$%,[UUEB*,$X.S:]V]B=\I/Y-33#OG.0<0&:44<K_DAU
M)5J#&EZ"91BXYJ-]._,#J[J^(VR5A2[4/];PU>%PB\(`Q*52=ABX.SI^QU;_
M````__\#`%!+`P04``8`"````"$`O(*.,Q\#``"_"0``&````'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;)26VVZC,!"&[U?:=T"^;\#DU$0A5;M5=ROM2JL]
M7CM@@E7`K.TT[=MWS"0&IZV6W"0<?O[/,QYF6%T]567PR)46LDX('44DX'4J
M,U%O$_+[U]W%)0FT877&2EGSA#QS3:[6'S^L]E(]Z()S$X!#K1-2&-,LPU"G
M!:^8'LF&UW`GEZIB!D[5-M2-XBQK'ZK*,(ZB65@Q41-T6*HA'C+/1<IO9;JK
M>&W01/&2&5B_+D2CCVY5.L2N8NIAUURDLFK`8B-*89Y;4Q)4Z?)^6TO%-B7$
M_40G+#UZMR>O["N1*JEE;D9@%^)"7\>\"!<A.*U7F8`(;-H#Q?.$7-/E#1V3
M<+UJ$_1'\+WN'0>ZD/O/2F1?1<TAV[!/AFU^\I*GAF>P<R2P.[*1\L$^>@^7
M(H#H5F`A^M\1<QU;2N@P_>,C\J[=MN\JR'C.=J7Y(?=?N-@6!DA32(/-QC)[
MON4ZA6T`UBB>6M=4EF`!OT$E;#U!&MD3KDYDIDC(>#::SJ,Q!7FPX=K<"6M)
M@G2GC:S^HH@>K-`D/IC`_Q[OQX--0EQ0&^LM,VR]4G(?0*4!4C?,UBU=@O';
M`4$D5GMMQ0F90<H3HB&KC^MH%3Y"WM*#X@85\.L4U"E"0#HNL(9SK=AR;6+M
M0F[P0A\3OXT9GX.Q8MB9WN+'SA6YJ)CT%!.G\,(#R?#PK#@A$)-+VM2Y(A<5
M?>[,*3PN5--PKA7[W+ES12XJ^MQ+I_"X4!/#N5;L<Q?.%;FHZ'-I5VD>>'X.
MV(I],.W*$\DHF;;%/:&7\3M8.PT&OS96?(+MRA6Q*/$"[FK/"WAQ#MF*3\A=
MP2(9)1ZYJSZ/3*'7]H.V37`,U_[3,^Q3)VOHBA?7T#HGQ%M$5XK^(FR'&9QY
MBOVH_VK1KH(/<-0,@MN^,QR.7<J#GQ8Z14T?_E[)P5`\!XZMJ@^/3VN]=?33
M'G>%B6G'\8@CH^)JRS_QLM1!*G=VW%%X3]Q5-[\/@]7=@$G8L"W_QM16U#HH
M>0Z/1J,Y=!>%LQ1/C&S:@;21!F9@>UC`AQ*'CA^-0)Q+:8XG=G*[3Z_U"P``
M`/__`P!02P,$%``&``@````A`%!;W,5:`@``\P4``!D```!X;"]W;W)K<VAE
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M*WDIF%9&%38".1*,7M?\2!X)*&637$`%+G:D>9'BYW@\ZV.237P^OP7?FK,Y
M,I7:?M$B_R8:#F'#-KD-6"JU<M"7W+T",KEB+_P&?-<HYP5=U_:'VG[EHJPL
M['8"!;FZQOE^S@V#0$$FZB9.B:D:#,`32>$Z`P*A.S]N16ZK%/<&43+L]&*`
MHR4W=B&<)$9L;:R2?P(H/D@%D>Y!!,:#2`S3&\F]`QG&$SGJCI(X&?S?`@GE
M^'3FU-)LHM460<>!8=-2U[_Q&)1=+#T(]_U8(`_'>78D3P6T@:W<9+U^,B$;
MR)\=,--K3/<2,7L'T3]!"/@[F820[C?I2%`,1F<F!R=]7\@T8/IGF'\./&+V
M$>+"(WSH?H^.E&+XQIG'X1N/`3/R,8_@TH#?)6+V$>+"(Q1ZOT='>NMQ=.E@
M&C#!8]Q+KBV>`T87)02#X=R&SFQIR5^I+D5C4,T+B*83#>&0Z7!JP\*JUG?@
M4EDX;7Y:P>7*H3T[$8`+I>QQX>Z%TW6=_04``/__`P!02P,$%``&``@````A
M`!^GL!-;!P``0QX``!D```!X;"]W;W)K<VAE971S+W-H965T,C$N>&ULK%G;
M;J-($'U?:?_!\OO8-!C?E'@4&S"@76FUFMU])C:.46QC`4EF_GZKZ2[Z4H[C
M:.8EQ(?J4UV'ZNJBN?OZ_7CHO>95792G^SX;./U>?MJ4V^+T=-__YUOT9=KO
MU4UVVF:'\I3?]W_D=?_KXO??[M[*ZKG>YWG3`X93?=_?-\UY/AS6FWU^S.I!
M><Y/<&=75L>L@9_5T[`^5WFV;0<=#T/7<<;#8U:<^H)A7MW"4>YVQ28/RLW+
M,3\U@J3*#UD#\Z_WQ;E&MN/F%KIC5CV_G+]LRN,9*!Z+0]'\:$G[O>-FGCR=
MRBI[/$#<W]DHVR!W^X/0'XM-5=;EKAD`W5!,E,8\&\Z&P+2XVQ80`9>]5^6[
M^_X#FZ>NTQ\N[EJ!_BWRMUK[OU?OR[=U56S_*$XYJ`W/B3^!Q[)\YJ;)ED,P
M>$A&1^T3^*OJ;?-=]G)H_B[?XKQXVC?PN'V(B`<VW_X(\GH#B@+-P/4YTZ8\
MP`3@;^]8\-0`1;+O[?6MV#;[^[XW'O@3QV-@WGO,ZR8J.&6_MWFIF_+XGS!B
MDDJ0N)($KA=(K@STY$"XRH','XQ<?S)MW5\9.9(CX8HNKTX1@FGCA"MZ&@W8
MR!GS,*_X&<MQ<)7C_($[]9G_T<")'`A7='AC:+`TVZG"]:;09M(>KNCIIM`8
M))MX]CSKQ'.]'MQ0)$^;BT'69(N[JGSKP0*']*C/&2\7;,YI,0N%L%U>OI>6
MD(^<Y8'3W/=!:LBX&M;2Z\+S9G?#5\C_C;194IOQR#19H0G/=LX;V$!H`Y$-
MK&T@MH'$!E(-&((NG3BP*GZ%.)R&BX-1+1%0:KFV$FB"8P(;"&T@LH&U#<0V
MD-A`J@&&$K#,?X42G`;JE)XF(\?,@:6T@?+0Y9(M3F?2J4.0D"`10=8$B0F2
M$"35$4,DF/*O$(G3P'*$1]$)X(V8I9(P\JZIU)ET*A$D)$A$D#5!8H(D!$EU
MQ%`)JO8%E083P)M]L7E>EF+7NK`/>E!91+WA)*U&&-M2(F*GY+5C19!`(#YK
M"Y3K,,\4->SN(VLD.<2FR5G7A#7N1O&R!ZRNR9IT]Y$UU5D-;:"`7M7F6WEN
M2_8%;6`W1'$XBRF.1,"O2BEG:LYS)8S\65>G`H&,VSZFU3TD2"2I-84(3TQ&
M)01)=1Y#$]B&#4VNQ\ZMS=@E`GNR%KNU-ZVDT43%?F$8FXU-R4)I-),)Y4X<
MQRIGD3`1C62KX9KXBF_QE1B^V-2'=MWRE>J^#`WY.P/=Y3^YYCB)*:U`7"B(
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M45FK44)6!;/;3;12CRM`2']<='N05IX1\-@W-Y$(N?3,%5-UE<<8K:YZ3&[R
MF"+7A?SFS2U1W5<[!<K^P5H7/3+WT^66-[)R:\FZ3EI9$>T[&UPJ@1J&4$BA
MB$)K"L442BB4&I"9I;S-M?5R?9ZEGWV#%@TS2(91+9GLH8VVC4W,]%DI*QP8
M4"BD4$2A-85B"B442@W(5`AF;RCT0>9P<VN7$)"GE%GQ<S*PTJ"`0B&%(@JM
M*113**%0:D!FS+R9M;,"SL<^]X[#9$NLXEXBI$K%BD*!A-Y_SU$&F#(1TFA]
M/$+*6:P&OO.NHPR0.46:EMF4B?>KUV2ZL=B(MM=8.1)24U\Q`>FO-Q+2WV\H
M%$D(-B\,:4VY8CHPH5!J<)E:\$Y4U^*#9<+-K64B(7V#\)C]DL>DE=Y!=`,Q
MP%!9M4=Y5E&.Y&UH-E7A]ICU3K56),@;(Z3:WP2A2=O[>Y:K]"-7IHB\5]5%
M%*>9GUUWLBG6UYUL@F$S4OL9(]V9M%(#`R8@_5T'(2AABLNUWIHB:<7/N#4K
MR^,:K93'&.GU[DQ.PN2R/*;(95HICX;2_-%3I7^F.VL9S8Q&2&7+"B$M?24T
M4E8A0N)]R0HTDG?Y14E+LE=:P8KMLA=IE:<$H8N>^.<CODKYY:(G(:GX0B1.
MY8]Y]92O\L.A[FW*%_[U!Q;`XJZ#Q:>I@$WFH9B9=0?JT)P7'IBS=0<^9SVT
M:6+A2_C,U98V&W?A\]<%GJ4WAQ/0"_RC^8,HP3;1:`Z'@1<&,`]FU)XMV2/@
M#N^YZ)C`G\,A'<5C?P[';!0/QG,XLJ)X/)[#$13%8>L$82_=@:T/A+UT!]HT
MF.VE")?,ASOMO(9=B/`)[YP]Y7]FU5-QJGN'?`</V6E+5"4^`HH?C3SJ>RP;
M^'@'>0#?9N!C;0YGD`YO+W=EV>`/"&38??Y=_`\``/__`P!02P,$%``&``@`
M```A`)EV+$`B!0``"1(``!D```!X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
MK%A;;ZLX$'Y?:?\#XKV`(5>4Y*A<NGNDL])J=7;WF1(G00TX`MJT_WYG\`5L
M:)6NFH?2?(P_SS<S]MC9?'LMS]8+K9N"55N;.)YMT2IG^Z(Z;NV_?S[<K6RK
M:;-JGYU91;?V&VWL;[M??]E<6?W4G"AM+6"HFJU]:MM+Z+I-?J)EUCCL0BMX
M<V!UF;7PM3ZZS:6FV;X;5)Y=W_,6;ID5E<T9POH6#G8X%#E-6/Y<TJKE)#4]
M9RWXWYR*2R/9ROP6NC*KGYXO=SDK+T#Q6)R+]JTCM:TR#[\?*U9GCV?0_4IF
M62ZYNR\C^K+(:]:P0^L`G<L='6M>NVL7F':;?0$*,.Q630];^YZ$*9G;[F[3
M!>B?@EZ;P?]6<V+7W^IB_Z.H*$0;\H09>&3L"4V_[Q&"P>YH]$.7@3]K:T\/
MV?.Y_8M=?Z?%\=1"NN>@"(6%^[>$-CE$%&@<OW,C9V=P`/Y:98&E`1')7KOG
MM=BWIZT=+)SYT@L(F%N/M&D?"J2TK?RY:5GY+S<BZ)0B\04)/"4)<9;$6P=+
M(/E@8"`&PE,,7-TT;B;&P?-S$X([G5QXBH%+9S6?SQ:K:4]='JXN^DG69KM-
MS:X6E#0$I+EDN$!("&0R[%RK2L1[>8#8(<D]LFSMA6U!B!LHGI>=[RTV[@LD
M/!<VT=B&Z!:QM,"4(&TB@9YV,=/'I-($:PLD*5V0PB_0A2RH2WH42:#WR-<=
MBJ6%'))(8##$%"%-3!%03E\@`EE@.0R20P+#ZTC80!VJ#!I.QLI$*5/(NX-2
M96)*@YF^0!JR0.5"_)3;OK?4,Q)QH^`C;<I$:5-(SVP$)%4FIC981Z:VP(/%
M\<E%A32=..E4Q)$`'@.Y*UUNK(SDL$0A@V'$6)ZI,C+5@.-#-=,;LMP(T%CW
MF2/@LW0G'B')"$F'B+:NE[HWN%_YBZ73[WHW[UG(I+O*$2.\:R.\RDCJ210R
M#*]1A*DR,L.+!YC!!OQQ>-%8]YDCP_".D$0@ODI!.D2T\*YU;W@[Z*+;GHK\
M*6(0;]AR)[P,8-OGS0`Y="<Y$D!2^[HEGA%88;3LV@=Q%F2M?=([8\]*Q#Q]
M9:4<F1'1@4B@IM!$$CB=#&-NJOS)+N^IA,.$E-FQZ#H%%$!X!T)';0ZGAPT9
MO!U8F>HDO<YE!"V5,\JH+>?>\.,/HZ;'`!OGS75'>)N%C596?20@(ZE]Q+M:
MB*45]\]SUMYZZ)]GV"?"WH>^,8B-$<%4LNH1[#="72EVU]N5\EZL*>60D56C
M&\38A""K,Z\K/B-/B7A+]&P:ZE-A%<AL>GU1Z)*PK=XNB3=A39+HR_W:B<D(
M2@1D),,0G@JKF6\(USW&9CGP&)=<L,*C_&>[(N%M5U,C.C&0#8IFKA:_*$5E
M)6LX$5Q!7]:I!ND2L$,:$ORY\S\4()&Q<7`(SBC2MQ@O/[A+]%`B(7@ST&DT
M*+RE=0.[W'(%_-;%S_TEK8\TIN=S8^7L&6]4D-_=1L'\N@=SR?N>^686PLD'
MW#1Q&-!-:>*+$+KYA/TRA*8X@:]":$\3.(&)(3OC-_>S\!Y$CU]$LS">&A#-
M0S@E3=@O0CB<3.#+,)YR-5J%\92K$0E"7$\33"`BGA010<`QY^,Q</.^[PK4
M"&Q$8,"$?8(W]0D\\D.XG(SY$S],I_`(1$QI2((0CO7`XRJ'X")^R8[TCZP^
M%E5CG>D!RLKKC@TUO\KS+ZUHK(^LA2MXUV-/\),+A;N>APOIP%@KO^`$ZD><
MW7\```#__P,`4$L#!!0`!@`(````(0!)O;*/A08``-4:```9````>&PO=V]R
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M1!ORA!EXK*HG%/VT1PB4/4N;\0S\53O[_)`^G]N_J]??\^)X:B'=$V"$Q);[
MKW'>9!!1,#,*)V@IJ\[@`/QUR@)+`R*2?N'7UV+?GM9NY(\F,S\*0-QYS)N6
M%6C2=;+GIJW*_X10($T)(Z$T`E=E9-H;N:$8246X*D6(P`V%L52`JU28WI0'
M#IP>7*5\&-SE&9CEBG"5BI-1,/:G&!7;/T]$E2<I3MMTLZJK5P<J'^+67%/L
MHV`)IE1VA(4N7]]*%^0)C3R@E;4+^I")!FKL91-,%ROO!>HBDS);6V8ZIB([
M)8)5@'9C$TA,@&F`!Y0Z7I#I=^"%5I"7<FBK@)YH:))0(DHG-H'$!)@&$!)0
M=>]``JU`U]Q,CI2!JNTR:/+J1#IB%I)8"-,1P@T>]0[<T`J4+@2P\SN8SVA9
M;850=(M<)]*1LY#$0IB.$'+0@R:Y"53J&[L*K7!RRJFM0"*X:'3GE.ZN$U)J
ML84D%L)TA'"!KM:Y#*_;:B%`8>JR0,!EY<W.0F(+22R$Z0CQ;T;]PQ4LFN,L
M>6NXT1#U72!&N(UU;=<)*8*QA206PG2$T,%]C[8@WPXW"E.7!:*'VT)B"TDL
MA.D(\6]!_?OQ<*,AZKM`:+@7OE'=G5`7;@M)+(3I"*$3P#B_/]Y<FCHM(3WB
M-A3;4&)#C$#439QS6EE@V*?1:/;V*@_$Q(0E4P5P*R$C\($1^%Y**<8VE-@0
M(Q!EA8-/8W6[V'&5-RI&0B3X0DJ#8ELJL2%&(.HF#C'-S9\(OAB'\"@5PVT@
M)R1DLE_3%Z$9_$Y**<:]HH(2&V($HJQP>FFLOA-\,>N(YW+\:4M[8$&Q#24V
MQ`A$W<3!=+^;*&TTJ(",ZH[,`'=2*IHQOJ6`+:V2$AMB!**>X\BZWW,QX$B`
MY<SKJV476%!L0XD-,0)1-W$4:6YB=0<3OK2TIR)[VE8(#+X!1+#5ER\`8IX1
M[R6DEX<%Q8&`HH"_-8R#<&;L.Y->0F6&20@6%H`H&9Q;-\A\KJ[?(@,[AHZ-
MF'Z$C82@)K0V-7S=!9V4\C664!1U+9_8$%.*`XQP=&F,OM.F8M`1SR4$E:-Y
M/C'K7TK-.C?C0$+`25.<4L5$22UX`D/,()5@4B(4YP3D)>U-PQ<,F+TMH1#*
M4W/1<&"GI/H^BA6D945!8TYD$BQF$V/OP90(+VE2=^B!GJ4?:B)NA"Y>"J+)
M,W?\2DI+GH3$R0[OT41!,TYP[EOLQ,X`2)I=%1ISFK.#`Q2(.JX0JJGN7RZX
M08.IF-MAGY&=E()+UTT*NEV32DK4Y&0\GLZ,FF!*9""5`]->7P\5V]N-"#RL
M8I40]=U\G5"*<XUTIZCBD"BI/N-,0D/I>].D#^U)+R$LH*[-X!B5]OE.2>GI
M$K;0M4XQ6)A+2*_82X6^L?]D2DI?@4._WRC1?L39K:V:/]:/:,2H4@GI_1CZ
MYF8"7SY1L<].+"'2CT(JA`G8!2?TC9'"E"(L?IK4MVCC]L"D_5.-B@:-$`@(
M<JJJ<0>L4(HTJH1HL5N9%U(1)6?,)CR>YN8A7C="($Z@Q>%FF=?'?)>?SXV3
M5<]XN@QML5EUL#CZAKWW$C?(P,.Z,X8[X\$[$[C#5PU+9PIW^%FA>6>VA/?]
M@:?,E_">/8`OEO#".H`'/CR!+\_F$P(XQ1?;(>M."'=X2QIW8.NUQ,V5_1S8
ML\"=(<_@8\'#D*TM/G[`TA8>/B@/@1^*^\,8[`^&$/(QF`[(QF`R(!?<CM>Q
MAH\*U_28_YG6Q^+2..?\`&7A\WUN+3Y+B!^MW"(^5BU\3H#:AU-Q^'R4PWDT
M?'APG4-5M>H'Q,[K/DAM_@<``/__`P!02P,$%``&``@````A`,S:AM3C!P``
MQ2@``!@```!X;"]W;W)K<VAE971S+W-H965T.2YX;6R<FMMNXS80AN\+]!T$
MW6]LG1TCR2+)8ML%6J`H>KA6;#D6UK8,2=GLOGV'Y%"<H2B;ZDT<3X:<X<^9
MCXRMNX_?CX?@6]5V=7.Z#Z.;91A4ITVSK4^O]^'??WW^L`J#KB]/V_+0G*K[
M\$?5A1\??O[I[KUIOW;[JNH#F.'4W8?[OC^O%XMNLZ^.97?3G*L3_&77M,>R
MA[?MZZ([MU6YE8..AT6\7.:+8UF?0C7#NO69H]GMZDWUJ=F\':M3KR9IJT/9
M0_[=OCYW>K;CQF>Z8]E^?3M_V#3',TSQ4A_J_H><-`R.F_67UU/3EB\'6/?W
M*"TW>F[Y9C3]L=ZT3=?L^AN8;J$2':_Y=G&[@)D>[K8UK$#('K35[CY\C-;/
M110N'NZD0/_4U7M'?@^Z??/^2UMO?ZM/%:@-^R1VX*5IO@K7+UMA@L&+T>C/
M<@?^:(-MM2O?#OV?S?NO5?VZ[V&[,UB16-AZ^^-3U6U`49CF)L[$3)OF``G`
MS^!8B](`1<KO\O6]WO;[^S#);K)BF43@'KQ47?^Y%E.&P>:MZYOCO\I)KFB8
M),9)$L@>)\E])UFHA.3Z/I5]^7#7-N\!%`V$[,ZE*,%H#1.[%P0K$;Z/POD^
MS,,`<NU@%[X]1&ETM_@&RFW0YTGYP$_CPSV>QQYY.K@L(*\A.5BQ?W+"620G
MU!?9/BD#S20>PDB/9X?'1"8@C7\FPAEVF$J06*&?E$]*?$QDE=PE#Z823.*?
MFW"&O8:5F_U)[>24TZ7D+GFPY*"\:7*B<>)<-,F54A/C9)[#=J*%R9HFUHY>
M<6*I01W3U"Z7OG#F^:`E&0KN&2T*);2."QY)BK!,;XJK*HB!/"I:@&!D_^S2
M<3D5Q2`54T$<4=X`$,X\'[3(-:NZI186Z99'$BHD6>&A@AC(HZ*%JY`-"U2)
MH!,OF'QP8KE%,)6_#-*;9Z1-1`AFXM$$`HGH\CB)X$2XUA41LC,>BNY)FZ:6
MJ;307ERQB9(0=*#I7>X,Z6V)@6"E8E`3%T.`[G^)(09:@=$TM4P4`[W@A331
M:J(R!.I(>E?$4&`$309N16BB8E`3%T,`C$03E9&G'H6!X*-QT32U2M0"O;AB
MMQ-:S$)F-&:F-E$M)JD9.;#II<68FG(J*)6I5:(6.)`IEIG#D>_4+'!&8W)J
M$]5BDIV1`YYQEGG`4XZTNL2%SVPY[#FJX?0R!RY3(P9E:=U>[A+IS7/2)J(&
M,_%H#GXFR]Q#C7@,4&UBM9%9U]IG[<5KPQR\/+]9`(T1C:1WM8FJ,0G0&'*B
MVOLR0XZS=D%,!2:^2M,!JC+T0*Z8.7ZY%K/X&8_YJ4WDHJ5-4AX>S<'/*%YY
M7#C%E=0Z3;2)K]-T`*KAXFPV<<^(9Q%4>EL[1'&)"5`35\-!T*+P$6.,T-@)
M1],`F`MZ,<F*B:,UGH50Z6V)@;RDI3&)T-B!4)_C1(ZSXCK1:!H`M4`OWDP3
M6B2@&&WBRP"5WCPG;2+(8"96&(D#H-$R]@"H'&E%1J;R=9H&4&KH@;PR)BX:
MR2R`2F\K)Z0EJ0SM-89&(JAG7;J\VD0.M`*+N<#$EIF9BS:*@5Y,LMR<P'RS
M9A$T&1-4FVAIH)=##!=!4]CB*Q4YQF?B!*.I?Y0"O9A@N3E^N12S\)D@&,G!
MJDVT+B;QF3CPZ=DE8W[*R4:%8>H?U7!1-C<',%=C%C\3)"-5@\(2$Z`F'LW!
M3[__WQ,$(8WL8B-I`$P&O5AMK";:)`4OVL67ZU5Z\];5)E(;VC1N$]$1-)JX
M=,51<?T_-3G0"HP`9<LD+:#$T`.YESF`V6:ELP`JO:V<Z'43$Z`F'LT"Z!7I
M$7ZD'%(G#TW98P).+W/L\IQF43,=4U.;:#E,4C-U4-.O.>1(2WLG$NU[IQ[(
MZF$U`<YT%CBEMY43I21N!S5Q[1W@]&N.,3=3-+%EDB\,,!<G-\VQR].;Q<UT
MS$UM(@<J,_%H#FZFR]L;4.]*GXRQF3JQ:3H`Q7!BTW032R\#82G(+N<DO7EE
M:!/I$VT:8S-S8#/*$H^+IQQI179RT[YXZH$`#_-I7VX.7J[&+&YF2$1",FTB
MI<%,/)H`FG7QC+V^&,@0A32RDXZF!51MZ(&LG5:&+3R_60S-Q@S5)EH;DPS-
M'`SU:A0YT"H-)T+MNZ<>R$JCF$!H-@NATMO*B?(2=X.:N/0NA'I]X)>-&:I-
M;)VD!3`9%VE7$Q>,;!9#I;>E!F*5E@::'-AP,#3*X=OO:PS-Q@S5)M8!A;E4
MHA@NTA:&M&RS\ED,E=Y<#&TB8FC36(S<P5!QQ;Y,;CG*BHK\9&5!RE\IH0<R
MO5932LSB9S[FIS81?C(3UUT@S^:G5Y/D8J2E!IK8.@MS:J(:Z`4OYC0I)OB9
MS^*G]+9RHK#$!*B)J^'@9U3<>GS<ER,MR6FB35/KQ&1<F%V9$YCG-PN@.:*1
MYD1IB0DH4RJ^;N/!'/ST%&/,S]Q%QL*0$7-17HY<9K$R1PK2A5,P8C!E<@2S
M4'F%"F,^YE?(A_&5USA^,8N%TIO7O#81%J+)$<R!PBSRN$W"PV)V_VL3[W]3
MRVK=Z$5240^-J8>JCE7[6CU7AT,7;)HW\4!8#(])#=;A8;5'N;FV/5T_JH?8
M%L-?X"&R<_E:_5ZVK_6I"P[5#N9<R@6VZC$T]:9OSJ`B/$K6]/#XF/QU#X\+
M5O`<U%*<DKNFZ?4;T2K#`X@/_P$``/__`P!02P,$%``&``@````A`"F,\-@9
M`P``3@D``!@```!X;"]W;W)K<VAE971S+W-H965T."YX;6R,5LMNVS`0O!?H
M/Q"\QY3\C`W;@>T@;8`6*(H^SK1$640D42#I./G[+DF)$?VJ+X:T'L[.#LE=
MS1_>R@*],JFXJ!8X[D48L2H1*:]V"_S[U]/=/49*TRJEA:C8`K\SA1^6GS_-
M#T*^J)PQC8"A4@N<:UW/"%%)SDJJ>J)F%?R3"5E2#:]R1U0M&4WMHK(@_2@:
MDY+R"CN&F;R%0V093]BC2/8EJ[0CD:R@&O2KG->J92N36^A**E_V]5TBRAHH
MMKS@^MV28E0FL^==)23=%E#W6SRD2<MM7T[H2YY(H42F>T!'G-#3FJ=D2H!I
M.4\Y5&!L1Y)E"[R*9YLXQF0YMP;]X>R@.L](Y>+P1?+T&Z\8N`W[9'9@*\2+
M@3ZG)@2+R<GJ)[L#/R1*64;WA?XI#E\9W^4:MGL$%9G"9NG[(U,).`HTO?[(
M,"6B``'PBTINC@8X0M\6>`")>:IS>!KW1I-H$`,<;9G23]Q08I3LE1;E7P>R
M%1''9:4]4DV7<RD."/8;T*JFYO3$,R!N-3D&K_*22%!G2%:&98''&$%^!<Z^
M+N-!/">OX$;28-8.`[\?F!"Q.46,AQY"0+!7W0]5GW>P%6?`1IQQU*A=NT!7
M2=^GL8C-&<0%)>!9U[_K2@S8[M^'!8.CU&N'&79L^LCLQ%U#!"X!R>W:#!@.
M`53>$3<(?5D[T#5QUQ"!.#BR77'FX/7C2>_B?6AWTZRS.OUV-A&XCQWEQZ:=
M!4U\>8$T.,==:=?WU(!#/4W$-@.W8]U(D&D29K(FC.__;X)9%R9M(J$)(U^?
MTW$6=.]!@30S=3J-X;H)!ASJ:2(=$[J1(-,TS&1-&-@>>*$UMD?!+`RS-I'0
MA;$OT+EP%C3UH$!;#%2WVV#1H:(F-/3=9]."W+#H=C48/D&RF^^$77B4US73
M;MZFO0;F#*.CNMWT<B.B9'+'-JPH%$K$WDRF/O1V'_53<]4WU1W'A[.5FZ;$
M_P/3K*8[]IW*':\4*E@&G%%O`I=3NGGH7K2HH1J8:4+#'+./.7RW,&C>D;D<
MF1"Z?8',Q'\)+?\!``#__P,`4$L#!!0`!@`(````(0`N/;?W2`<``.HA```8
M````>&PO=V]R:W-H965T<R]S:&5E=#<N>&ULG)I=;Z,X%(;O5]K_$.4^"3;?
M5=/1$&!WI%UIM=J/:YJ0!DT2(J#3F7^_Q]B`SR'%=&_:!AX??%X?VV]P'S]]
MOYP7W_*J+LKK=LG6UG*17_?EH;B^;)=__Y6N@N6B;K+K(3N7UWR[_)'7RT]/
M/__T^%967^M3GC<+B'"MM\M3T]P>-IMZ?\HO6;TN;_D5[AS+ZI(U\+%ZV=2W
M*L\.;:/+><,MR]M<LN*ZE!$>JCDQRN.QV.=QN7^]Y-=&!JGR<]9`_^M3<:N[
M:)?]G'"7K/KZ>EOMR\L-0CP7YZ+YT09=+B[[AR\OU[+*GL^0]W?F9/LN=OMA
M%/Y2[*NR+H_-&L)M9$?'.8>;<`.1GAX/!60@9%]4^7&[_,P>4AXN-T^/K4#_
M%/E;K?V]J$_EVR]5<?BMN.:@-HR3&('GLOPJT"\'<0D:;T:MTW8$_J@6A_R8
MO9Z;/\NW7_/BY=3`<+N0D4CLX?`CSNL]*`IAUMP5D?;E&3H`/Q>70I0&*))]
M;W^_%8?FM%W:WMKU+9L!OGC.ZR8M1,CE8O]:-^7E7PDQ%4H&X2J(#;U7]^'2
MS,:.:@R_N\;>VN&N'WRD"]#9-@]OB,+7/'"9ZYD3V4A16HWCK,F>'JOR;0&%
M"VG7MTQ,`_8`D3MQI12]W.^I#3*+()]%E.T2VH.0-93(MR=FN8^;;S"L>\5$
M=QA,[#I"C*$(&\L+\+,/Z]FX3=*UT1`'(VF'B"*#K/O480#UU._74Y>A@$6&
M7=\B>4'O&\?/W8T)CV@2CQ%.>I^8D?0.,CP(I0SE.S]E`<-DT=1GEH=SC"0#
MA=V/$.G_SDC$1B(Q$ND4@12`KLY70,#;)<C;9^?[1`")^&W-KSR+P;J"B1TB
M0B<(29W$"`")`YM9.$9"$)O[08"1%"'<L4,W[`FD`*PCN@)BQCOO+J==^8M&
MM!:H%)*!?O1JT5HP$K&12(Q$.D4@)6"]TI687@`$C&N!660,(LD$<@$,;7>8
MA>UZMI/WG?9^P(?QD:L=:NTZ#BT"P_VTBS[H;P\A4.+^1Q(7,$V<=#V23)>X
M:]MT$DA`KPVM;S)]/0:W_=!G??VV0&("TLF'(`&$-]1VO>F1%S`1@$[02#)Z
M?K3VC40\)JA&B1E)):*&PN7#)$4"A%@`L0C8X,RFA1"-J!!DD"+)3`EA).(Q
M,1+"C*02D4)PSH:="PG!(&N]%.8IT;;"4OADP"/%Z%+0-':*D9U<.:%MDR4E
MGA$E,49)IZ-@081=FCTWF#17^A;)&-G@(@7I2A"Q=F8D5HC4RG%M-R"UEQB)
M=/(Q6`9AJC099M:%M&+@1OH]D#&R%D9,0I-R&)'8'"4Q(^DD@@41%DL39'JI
M8-*001J:$&30(P6IZF>>-6Q7<K]4@-HPZ>T8M;<#:U0/G2L47T@"VCQ%S9GM
MLZ%_.',8*3WSF:4@6N$E@C%B""(F(:4`!^,WK-=*`IWPX:L>WA1C%,$.Z!,2
M=-^S;=(^1?=7Z`%8!.&JM.&?*8+T8K@,AI6X33$27^9!*2F";X4^Z>,.`6"0
M:9(Q`KC%7?*(!`$L8-8PU&T?4@2L;)NY0RUB'83+^K@.TIMA'<A01TPW>"O;
ML7RM$ZH:$,*XX]#OBS&)8MN.0QZ4$,0)@Y!L.RE&N.?S=V>'<%V:((9U07HT
MO$"2AT=L;.3(>.W,2&Q&$C.23B*X,H3SFB^$]&FX(JBM9F._-Q+"B,1WHE`C
MDLQ@4L6HQ<H+M;4("R&<ER;$S*5"^C4D"!\FH5HJS+YOQW3C9UMTV8_5?5A7
M^ZUI+,=TC'0Z!E*#$X,Y/3]:FNP:G.QKD8+T#&A9F)%8(?WN"Z\2293$C*1W
M'J2IB97XD+/D=YPE)SM#I"!=">WI<LU4C,SS3CV@^ROFW=-!]J63R@U'4J4X
MRON3@T.!ZY/#4`Z")N]=./63;4AXB:,5-!G(G1F)S4AB1M))!%?#A_PDO^,G
MZ=87*6A2B,X2#I.?:!6K*'*PP0>XHR4D,2/IG;YHE8F5@`Y_H"0$35<(ZBNY
MA":5,"*QBC*IA(PR@:1W^O*N$L1D&B;''7/)B?.+Q-%(;R[OFRJ,,'`ZM+)B
MA##+"KR0[-4)0L+0Y0ZQ-2DB5MQWF#_T%E?$_S*9_([)U-[_R!U40?V`!8%#
MUI,=0EQFNR$IKQ@3EL4<,HD23-R)D2+"#WQ?>]^'Q2`&<YZ=X-)#8CM!1B12
MD!*#>8$5CL20<21BAYQIW6P5C7$0UQHKFIB1%"%$="P'L9DSY9`V$?EN^@(Z
MXD8ON3,CL1E)S$@ZB6!!A%<C=M-\H`$GUJ-E5%N6U&21T.0R:D1B]2@]"GU2
MHAAYC@2O*JAK%2?LHK_O!)&"R"-T>;Q[R:N7?)>?S_5B7[Z*XW$;CAWZJ_W1
M_6<NCC3)]8@]P&'L^'H"1_WM]4W?`$[:;]E+_GM6O137>G'.C_`H:^W#LEO)
MLWKYH2EO[6'S<]G`&7O[YPG^IR*'8UYK#?"Q+)ON@SBH[?]+X^D_````__\#
M`%!+`P04``8`"````"$`6GV]=^<$``"R%```&````'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;)R876_J.!"&[U?:_Q#E'A+GDR#@Z$"2W2/M2JO5?ER'8"`J
MB5&2EO;?[S@34MO0&+87#32/QYYWQN.I%]_>RY/Q1NNF8-72)%/;-&B5LUU1
M'9;FWW^EDYEI-&U6[;(3J^C2_*"-^6WU\T^+"ZM?FB.EK0$6JF9I'MOV/+>L
M)C_2,FNF[$PK>+-G=9FU\+4^6,VYIMFN&U2>+,>V`ZO,BLI$"_/Z$1MLOR]R
M&K/\M:15BT9J>LI:6']S+,[-U5J9/V*NS.J7U_,D9^493&R+4]%^=$9-H\SG
M/PX5J[/M"?Q^)UZ67VUW7V[,ET5>LX;MVRF8LW"AMSY'5F2!I=5B5X`'7':C
MIONE^9W,4Q*8UFK1"?1/02^-\-EHCNSR2UWL?BLJ"FI#G'@$MHR]</3'CO\)
M!ELWH],N`G_4QH[NL]=3^R>[_$J+P[&%</O@$7=LOON(:9.#HF!FZOC<4LY.
ML`#X;90%3PU0)'OOGI=BUQZ7IAM,_=!V">#&EC9M6G"3II&_-BTK_T6(]*;0
MB-,;@6=OA'A39^83/WC"BMM;@6=OQ?$>7@*0G1_PO"XAFA+/?F8!X'!G`YZ]
MC?^A1=`;@>=U(?:C@EH8G"[6<=9FJT7-+@9L()"_.6=\.Y(Y&.9!=B%5[@<9
MHLO'?.>#NJ%`-Y"9;ZO9;&&]03+E/;*^@T0RLKE%(EM&XCL(D9'D#N+(2'H'
M<0?$`B$&-2#-GE>##UJ:\'M0(_(&\YU@:T3"3JK`55S8B&]]+W`<-Y#'QR(Q
M\;R(V+8R12(C1'V?BN^C(`S]SW!($L`>>5X"/DB1P)==6",RZR6P0Y\X2IPV
MB,`^&X14G(RU1*(ETC%"4@(6\KP2?)"BA!+,-2*BFZZ2]QM$4"S'#:-029E8
M;R/1(^G(-)(24+9$)<:+`X<5!4(E%Q"!V8=`WRB`""I`?,]3%(KU)A(]DGX]
MB^0_%,;'_>>PXK]:'!%!YUS?YC^R0ALD1(74K:`E$BV1CA&2`.$S`G!8$>"S
MUF`]1,3KBH&K5(H-OKR&WO:B0"'BZ_"O\R?1(ZDR#X_#$`7)>][1/GU&\D&R
M"C.U$"`B!OEF&^B16(\DB*"BWNW1\.5K285(5F&\"'!8]AZ.K$%=3`)D1MW7
M(S$BZ-N$V*X3JKU(HK>2CEJ19"#0'3V?#=TH51"EJ*]["+=%$"CILNE?HZNA
MX]@!44[06$(FOL_/#H5)AEF^WCVI9(<$4>@)R2O+P9LK87.,IP7!5@QZD:'R
M$UM9X+J'T,\@\.^U"CTC)H]:(/5(HD?24416@G=8@A(/MM+8EXF*1$K@UP29
M$6<W/8*:D<AWW<\.M]MML=Y(HD?2L7ED-7B;):BAR0MLRB05U*:!C#5NG8^;
M'KFJX/KJP:&WD>B1=&0:60.(V!,:<%HM$6K-)`B-IH(6B7LKJ-,DL`G\5RX7
MYT0_43IJ11:"]UE",CRX-;`[$Y,"ZKN\SC6_D0#5^G^M;FNF^#KT7-]5CZ%8
MLC"!FNI[D9(W2<^(LJM'=2K9(2X<LT+7+LO!^RY!#LW>P"Y-ED$I=FNX".(R
MC-?,L7:O+Q):).EG$J50%L-OI?AB[B.H!-XZX4W$.3O0W[/Z4%2-<:)[.!GL
M:0AQJ_'.";^T[-S=.&Q9"W=%W<<CW`U2N(Z`2Q#3V#/67K_P6ZWAMG'U'P``
M`/__`P!02P,$%``&``@````A`!JW'0<8`P``]@@``!@```!X;"]W;W)K<VAE
M971S+W-H965T-2YX;6R45MN.FS`0?:_4?[#\OES#)5'(:C=HVTJM5%6]/#M@
M@K6`D>UL=O^^8YP0(-LD?0%LCH_/G!D\+.]?ZPJ]4"$9;Q+L6@Y&M,EXSIIM
M@G_]?+J+,9**-#FI>$,3_$8EOE]]_+#<<_$L2TH5`H9&)KA4JEW8MLQ*6A-I
M\98V\*;@HB8*AF)KRU90DG>+ZLKV'">T:\(:;!@6XA8.7A0LHRG/=C5ME"$1
MM"(*],N2M?+(5F>WT-5$/._:NXS7+5!L6,746T>*49TMOFP;+LBF@KA?W1G)
MCMS=X(R^9IG@DA?*`CK;"#V/>6[/;6!:+7,&$6C;D:!%@A_<11IA>[7L_/G-
MZ%X.GI$L^?Z38/E7UE`P&]*D$[#A_%E#O^1Z"A;;9ZN?N@1\%RBG!=E5Z@??
M?Z9L6RK(=@`!Z;@6^5M*90:&`HWE!9HIXQ4(@"NJF:X,,(2\=O<]RU698#^T
M@LCQ78"C#97JB6E*C+*=5+S^8T#N@<J0>`<2N!](W-":>4$4_P^+?V"9G5@\
MRXL#-PBO:[%-7)U-*5%DM11\CZ#T0+ELB2YD=P',1W],-+UC_S(,G-(D#YHE
MP2%&X(6$)+^L8G]IOT!BL@/DT4#@VD/""61]SA+.QBSI$:)S#A'T88"UPS#>
M3^]1K09KM3K=6OZCF1AJ\R8;KZ]#TG<@02]_I!92.52K3?>AM"^KUHL`-S`P
MGHA\-!!(8^_Q!+&^BD@O(49!P#;#("Z+U^`$@T.]LBCJO3%),)"HJYX[UPEC
MWW7&D/4$XGM1'(\AZ0CBS?QY,.\1(_GP^=XN7X,GWI]2:^0;"&S?1SCU_BHB
MO808B8<O;2C^M@+2B\8YB,/>&Q.$@<1=#F:N,XW@\NO4O!Y:X)\R.-(?C?5?
MKAT-GNB>UHZ!G&IGYCF3T-83B!>'T\\'^I#>Z,#R;NV8/F,.T)J*+5W3JI(H
MXSO=0SSPK9_MV]N#IP^:R?P:VE[7).S^!;2=EFSI-R*VK)&HH@50.E8$12%,
MXS(#Q=ONV-YP!0VG>RSA_X+"0>98`"XX5\>!/B;[/Y;57P```/__`P!02P,$
M%``&``@````A`.'?HLMD`@``L`4``!D```!X;"]W;W)K<VAE971S+W-H965T
M,C(N>&ULC%1=;]HP%'V?M/]@^;UQ0A(HB%"U16R5-FF:]O%L'(=8Q'%DFZ]_
MOVN;KT+7\D)L./=PSKGW9ORPE0U:<VV$:@N<1#%&O&6J%.VBP+]_S>[N,3*6
MMB5M5,L+O.,&/TP^?QIOE%Z:FG.+@*$U!:ZM[4:$&%9S24VD.M["+Y72DEJX
MZ@4QG>:T]$6R(;TX[A-)18L#PTC?PJ&J2C`^56PE>6L#B>8-M:#?U*(S!S;)
M;J&35"]7W1U3L@.*N6B$W7E2C"0;O2Q:I>F\`=_;)*/LP.TO5_12,*V,JFP$
M="0(O?8\)$,"3)-Q*<"!BQUI7A7X,1E-4TPF8Y_/'\$WYNR,3*TV7[0HOXF6
M0]C0)M>`N5)+!WTIW5=03*ZJ9[X!/S0J>457C?VI-E^Y6-06NIV#(>=K5.ZF
MW#`(%&BB7NZ8F&I``'PB*=QD0"!TZY\;4=JZP&D_R@=QF@`<S;FQ,^$H,6(K
M8Y7\&T#)GBJ0]/8D\-R3)'"\L3C=%V=GQ5'O/D_R_L<22+#CTYE22R=CK38(
M)@X$FXZZ^4U&P.QBR?X;"^3A:AY=D2\%M(%6KB=IEH[)&O)G>\S3-:;W&O'\
M!B)[#9F^`<F/$`(6CCX@QTL?*0S)V^T]^'!%T$B,SGQ<2'@*&(CFB+E`/'^(
MF+Z'>.4"I)R[>%^]`Q<8N$_*!L=P?*.>`F3@6]2'2<V&I_@\XOD<D>>]=#"\
M:!,LI?N;P)%EPR2.3P$$\6'IPEAU=,&_4[T0K4$-KT!:'`U@H'18N7"QJO/C
M,U<65L4?:W@S<IBM.`)PI90]7-Q2']^UDW\```#__P,`4$L#!!0`!@`(````
M(0`08[8N*QL``#.7```9````>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;*R=
M67,;M]*&[[^J[S^H='\D<=/"LGUJN._[?J?(M*V*9;HD)4[^_6EPI@?+`\M2
M*KF(Z`>-'@#]`I@9$."[__[U\/7DS_WCT_WAV_O3PMG%Z<G^V]WAX_VWS^]/
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MJ";=\N7I^8=WQQ9:W>]_/#F?3YZ^''ZT'^\_#NZ_[:6Y)5`F!+\=#K\;T^Y'
M@R3S.7*WCB&8/)Y\W'^Z_>/K\^SPH[.___SE6>)=D2J9FE4__MW8/]U)DXJ;
MLV+%>+H[?)4"R/]/'NZ--J1);O\Z_OUQ__'YR_O3XLWIR6_[I^?6O7%U>G+W
MQ]/SX6&=)A8R%VGF8I:Y)*5.TTN79Y6KBU)!KO52QG*64?[J5:_/BM>50N7R
M%SG%[[&\\E=S2LU>D_,RRWEE<[[RFM)9CM>4O]DU*V=7A8N;TM7+M92&/.:3
MOUF^0NE5&0LB@S0JTL):S5<6MB#!2//:J+SVLAH6(Z"W7E:;MR`?WM1*!0E(
M6F`;F<+5JV14T,B8#V\ML$:G:/K<F]1;U$YC/FC6B[-"^>)7ZBUJCS$?M,"E
M5]6UJ'$U'[*LE5==4Z-:M+VM]+K2:F<S?3*[Y/6K+JEB*%HQ%&[.RL7*U?6O
MAH:BRL&,0V]JW)+V&O,ARUDHOZIQ2QK1DHW+Z]JHI&$Q'[*+7KZFC4H:%O-!
M2WM]=EVIE"^O?S&PE#0PYL-KVN@\'?6/DTCC]OGVP[O'PX\3F9JEWD_?;\U$
M7Z@:9SI]I(-^/J'\;#Z1B<1X28R;]Z<2;)DRGF06_/-#L7CQ[OQ/F;CN,IL:
M;0J^15TMS"QEW#9"T`Q!*P3M$'1"T`U!+P3]$`Q",`S!*`3C$$Q",`W!+`1S
M!;95+\M^DRW41)ML&8)5"-8AV(1@&X)=")(\X'K=)`]O3A#.!/%,$-`$$4T0
MT@0Q3=R@GHNT<WU+=_XW]&W<&'UKY6H*;&B*?F3J:J%9&B%HAJ`5@G8(.B'H
MAJ`7@GX(!B$8AF`4@G$()B&8AF`6@KD"I\5",:N)-MDR!*L0K$.P"<$V!+L0
M)`E('EXM28)P)HAG@H`FB&B"D":(:>(&U1.SS##_AIB-F_>G\O]\L"Z4`O76
M,AN9FG*C(%KUW$0;J0'2!&F!M$$Z(%V0'D@?9``R!!F!C$$F(%.0&<@\)S]M
MPD5NHDVX!%F!K$$V(%N0'4B2$-FX:XD2QCEAH!-&.F&H$\8Z8;`3+]I>!Q`Y
M_AL=P+B1&Q[I]KFXB\7@9J26&IF;L]PH[`&YB396`Z0)T@)I@W1`NB`]D#[(
M`&0(,@(9@TQ`IB`SD'E.?MJ$B]Q$FW`)L@)9@VQ`MB`[D"0ALG'7$B5U6C'0
M"2.=,-0)8YTPV/+&*!VBR\=7/^[]C-RB>ST@_II';\N-]5'H6I=:2BKRN)RK
MNE@,!O]Z;J39&B!-D!9(&Z0#T@7I@?1!!B!#D!'(&&0",@69@<QS\D(C+G(C
M;<0ER`ID#;(!V8+L0)*$R,9>2Y0PT@E#G3#6"8.=,-H)PYUX\?;&=GEX?(.R
MC;6O[)3(,ZS6K@[2`&F"M$#:(!V0+D@/I`\R`!F"C$#&(!.0*<@,9`ZR`%F"
MK$#6(!N0+<@.)$F(:D0,:\*X)@QLPL@F#&W"V"9><#W-RJLJ3[/F[4FQ<B9]
M[XWO3XPC7\XI$3F[8TPI>,;,C53S#9`F2`ND#=(!Z8+T0/H@`Y`AR`AD##(!
MF8+,0.8Y<1JQ4O$;<9$;:2,N058@:Y`-R!9D!Y(D1#6B.A%#G3#6"8.=,-H)
MPYUX\?9$+_<.GNA?O@4QUKZR4^(.U"`-D"9("Z0-T@'I@O1`^B`#D"'("&0,
M,@&9@LQ`YB`+D"7("F0-L@'9@NQ`DH2H1E0G8EP3!C9A9!.&-F%L$R^XGF9E
M*<'3[#\>J(TC7\XI"0;J\$DQ-](QI@'2!&F!M$$Z(%V0'D@?9``R!!F!C$$F
M(%.0&<@\)\Y`70P:<9$;:2,N058@:Y`-R!9D!Y(D1#6B.A%#G3#6"8.=,-H)
MPYUX\?9$;U:1/=6_/%(?S7UM9\@=JXD:1$VB%E&;J$/4)>H1]8D&1$.B$=&8
M:$(T)9H1S8D61$NB%=&::$.T)=H1R0J.48>\!K8/3+*&0U:/L$C$926'>2,Q
ME]4<VD6B+BLZKIVO:[,<%2Y:_J/;[D*ZL"5O`G5(J64H&,^#>\:ZM=*,#:(F
M48NH3=0AZA+UB/I$`Z(AT8AH3#0AFA+-B.86N0-\T*H+:Z6MNB1:$:V)-D1;
MHAV1=(Q4%'['((MH0!8X:1=1@2QRTBZB`UGHI)VO!+]CF(4LMV/\8L!/U[T\
M]:?(J7O=O";WQXD&49.H1=0FZA!UB7I$?:(!T9!H1#0FFA!-B69$<Z(%T9)H
M1;0FVA!MB79$HFL$4@9\LDC`1=>TBX1<=$V[2-!%U[3SP^[KVBQ4O4'7Z;J6
M7$.'D9KY4EPJ8G?\N?3?!-2ME69L$#6)6D1MH@Y1EZA'U"<:$`V)1D1CH@G1
ME&A&-+?(:=5*T*H+:Z6MNB1:$:V)-D1;HAV1J#]7@)9"U$\6T8"HGW81%8CZ
M:1?1@:B?=KX2?/6;Q:`WJ#]=._+4GRTGV5N]>@&H0=0D:A&UB3I$7:(>49]H
M0#0D&A&-B29$4Z(9T9QH0;0D6A&MB39$6Z(=D>@:@11=DT4"+KJF723DHFO:
M18(NNJ:='W9?UV:)Z@VZ3E>T/%VG*%C-O`I']=Q*>W[#?+]9I@/)J*A)U")J
M$W6(ND0]HC[1@&A(-"(:$TV(ID0SHKE%SJA>#%IU8:VT"9=$*Z(UT89H2[0C
M$O4CD*)^LGJ$140@#[',&Y&!/,32+B($>8AU[7SUFY6M-Z@_70CSU(^UL;KY
M[GUXKP[4I%6+J$W4(>H2]8CZ1`.B(=&(:$PT(9H2S8CF1`NB)=&*:$VT(=H2
M[8A$UXB:Z)HL$G`9U6D7";F,ZK2+!%U&==KY8?=U;5:JWJ#K=&'+TW6^UN6.
M/]?AJ)Y;Z?C3,!M)?/4WB5I$;:(.49>H1]0G&A`-B49$8Z()T91H1C2WR&G5
M"D9U-.'29M2&7A&MB39$6Z(=D:@?I1#UD]4C+"("&=69-R(#&=5I%Q&"C.JN
MG:]^L^;U!O6G2V2>^K%J5C>;FWQ=-XB:1"VB-E&'J$O4(^H3#8B&1".B,=&$
M:$HT(YH3+8B61"NB-=&&:$NT(Q)=(Y"B:[)(P&54IUTDY#*JTRX2=!G5:>>'
MW=>U6=9R=?V/%U`+Z0*9)_E\S<P9FHHWX8"?6^DXU,A\.6\KFT0MHC91AZA+
MU"/J$PV(AD0CHC'1A&A*-".:6^2T:B681A?62EMU2;0B6A-MB+9$.R+I&(BM
M=`RR>H1%1"`#/O-&9"`#/NTB0I`!W[7S.H;9/.IUC)=?N1_-_376##DBKA,U
MB)I$+:(V48>H2]0CZA,-B(9$(Z(QT81H2C0CFA,MB)9$*Z(UT89H2[0CDHU%
M[AIFNE.R%F&1@,OV(N:-A%RV&-$N$G399D0[/^R^KLW"T[\RX!?3)2QWP,^0
M2-X9FDK!?M&ZM=*AJ4'4)&H1M8DZ1%VB'E&?:$`T)!H1C8DF1%.B&='<(J=5
M*\$TNK!6VJI+HA71FFA#M"7:$4G'X+IF+<(B&I".P;P1%4C'H%U$!](Q:.<K
MP>\89N7*[1B_&/#3A2Y/_5C[JIO3`(([?*(F48NH3=0AZA+UB/I$`Z(AT8AH
M3#0AFA+-B.9$"Z(ET8IH3;0AVA+MB$37"&12B[!(P$77S!L)N>B:=I&@BZYI
MYX?=U[59DW)U_8_O\(OIZI8G^7S!RQF:2L&.NWJ6T;D3:A`UB5I$;:(.49>H
M1]0G&A`-B49$8Z()T91H1C179->Y%T1+HA71.D,5N\5]0ZNM6MDK[HBD%Z3A
M=IQ)+\@D8+/*GNK,3NY,[&ZTRV`WFG2,W$RG+-EJS4OD,G`NH3JH.$R%X#)5
M0EIDOV.812VW8_QBP$_7P#SU8UFL;HYB"0=\H":M6D1MH@Y1EZA'U"<:$`V)
M1D1CH@G1E&A&-%=DP[@@6A*MB-89<M2YH=56K>P5=T0B]31JCC.1>A9)FU6D
MGMD=#_-*GP0:$:8A=_WE,7?\:=!=#6O47:9AC^G:+$V]0=?I2I:GZQ0%M_%!
M]ZV;LX-"J0,U:=4B:A-UB+I$/:(^T8!H2#0B&A--B*9$,Z*Y(AOM!=&2:$6T
MSI"CI@VMMFKE#\/![+RS5ODHG"BSLX:H/PNN+;^H/V453_UDJ@*GO'*[0W^J
M`_'G3AS![CBY`^(E5!RQ#F'6N=[0(=)E,:]#8*6L7@1J$#6)6D1MH@Y1EZA'
MU"<:$`V)1D1CH@G1E&A&-%=DU;,@6F:H(H.J<^,0O$!862M5[%J1%>R&[K=J
M9>6Z(Y*Q/XVMJ]8:O8GZ,SOK3NYIR%0%KK]<!K8]Y`@9YE4AN#U,E1"3NEG`
M<J5N;O8+<JBA=)CG+_=WO]<.!D1/_2K)\5[I!&9.:I.1W>L!V<J8+6X]LY*#
MU30*C0SYW;<4=-^FM=*,+4765YNHH\@;'4K!E\V[UDK=]Q19]WVB@:(7W0^M
ME;H?*;+NQT0319[[<C`:3ZV5NI]ER&GH.=&":*F^[-<#5T1K16[70;2W:G65
M1WM')%TGS>E*O98QI_S2=3([ZTZZ#EFN%5LXF3A0.NDZS)O+Q;E&+HZC/_]Q
MP*R;N5WG%X\#Z3*;UT>RE3<K@WH1J)&AH(\$6^*:UDIET%)DW;>).HH\E96"
MK^YVK96Z[RFR[OM$`T4ONA]:*W4_4F3=CXDFBCSWY>#.<VJMU/TL0X[&YADR
MZZ'.7!(T]$*MK$B6BNR7"%>*1&6.KV#D66=6\D)>R[6Q&15M%;GE*MP$$=JI
MU8M7E/Z6"LRYI-RHI4R^S*#7E/Z6,5LGZ6^YW0N5DB=R7D*UZ%Y"Q>BU-^HE
M]VZONJHJ-*V8WU'-FMT;.FJZQ.=UU&S5SVJQ;LXD-0\S%C4RY,R\3:*6(INQ
M3=11Y.FZ%'Q)IVNM-'`]1=9]GVB@R'<?+`D/K96Z'RFR[L=$$T6>^W(PK4^M
ME;J?9<AIU7F&S&L>VY/*04]:J)4MUU)1*5?U2E'Y>#!IN70A__E?+EBKB9T"
M-XJL[ZTBMU"0[DZMBL?+79Q=!>.2],941?)XHDT@O3%C]G+2&S-FZR*],;<S
MIZS>G%4JICKY?X%6I%OR6BI&:=S\^JI&EZD<Y45R;J?B2\ON=3ASZNX;.MS1
MW+][S)"C@SI1(T-NAR-J*;)E;Q-U%-FAN$O44V1]]8D&BCSYEX+UMZ&UTC8=
M*;+NQT031;:H4Z)9AIPFG&?(&W"+E\%$LE`K.QLL%=G)8*7(GVX"T:TS*[/B
M;#OO1=`--M:7ML16D8S]>49V,+6Z^FD'LP50UTG-YLJ9JDN:)F<J+YFSL@[F
M#Q5RTJ'1N9SS8P,A1QVFS'6D<G.9ZLV=$%5PD2G,G$KM]:A_])AV]!)TM&S)
MTRJNGEDYPFEDJ)*>^6\.9&X2M1197VVBCB+KJTO44V1]]8D&BJ02N4J*Y6!(
M'UHKC>U(D74_)IHHLD6=$LTRY+37/$/^G'493*\+M;*%6"JR,EPINCFJ\-J,
M[[X.UVIA)Y&-(NMZJ^@7/2K3PX7V*/]:<E)H:N#-6,KLU>2LT,S.UD0."_6<
MW\A+AL"[JLKUKK)RYQ[5E;DUS`./X4%.%,T*D;9=L20_21)<4;47F\7,JJE[
MVQCVN<7A^\]>C8@[?3<BN@C?C62H)&]O\M(7R\&#1MU:J6P;ZLLV:E/13^71
MHI\V44?]O-BB7;7*!UR_.7MTW"<:J!=;C:$B'6L+QWNS_&8FZ#HC.AT33=3I
MBW6:JE4F$G:P&5W/-9/KNG@93/$+M7*GTDP.MNXKM?II`=:9A3/1;#23=;U5
MY)8)G6*G5AK"R[`3)KQ:4K.Y5(S2Q5$5Z>(9TSB&SE6O3E5DSLPSY<Y5HMZ]
M"BHC/3S+FK;=I0R/OB+E".'4(C:IFI7CESKXJ]Y]FE]["-Y]9JCD!J(8/K+4
MK976ND'4S%#9O&S]\\/Q'M^O88N9VD0=]>.^*$=[=M7*#%]_?I!?BPKBUZ/G
M/M&`:.A[YM@_8IXQT43=N$,GJC%5J[0:@21F=#M79&>P!=&2:$6T)MH0;8EV
M1#+=INH2$:M(I"^2Y6)R['(U.4SEY/K+!>38Y0IRF$K(S:N"29G_$&C6N</>
M]9.S>8XK#3J=OG[9P1S)'7:]%`53:_"(4\\RBI6V:H.HF:%R.I852N;Y.NQ[
M^>7449N..NK('0\@VJY:I4/9Q=EU<$/0H^<^T8!HZ'N^.2L=[R)_/KFB4F,Z
MG:C3%RLU5:NL#<O7E:`)9W0]5V36H/)?D;D*,BZLE;;]DFA%M";:$&V)=D32
M0;/&LC??TD')<LDY=KGF'*:B<[[Z)O,C_>4R<_*JSMR\JJJ4^1W4K(F''=1=
M^M,.^?*ZAOG21]@)4Q3,?\&[@7J64:PT?@VB9H;D&S)F1I(;>/;!_&KJITT_
M'?4C8V>NJ4@?3'W)LX:YFKRQ\_M[CX[[1`.BH5X^=7QS]JO[6]1I3*<3=?IB
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M-N9!J%/D=6F@AIE?_8[?)&H1M8DZ1%VB'E&?:$`T)!H1C8DF1%.B&=$\0_XK
MV(*-V/&+2PO-*$MCMD\YRW1^7,T"FMO5?Q'7=+W-&ZI39,86>[E0;/52:N6+
MK1R\6YIG5H%P[2B553#FZ\I:>14LF[6+UU?P:.X+-T.F69T*!JU>5RLIF[4*
M'PSFF540P>"A:)%9E;,[MOQ^S:^8>0_\AHJEKXW=R,D\<.QK7N0JJ%AJY4>N
M$BQWS=67O9=8$"V)5D1KH@W1EFA')+^!E%72%BRI15@]PAH1UHRP5H2U(ZP3
M85V/^0$V+_G>$.#LK:&M:$T$=`RPK]Q`;?7,2D1W?#[(U7;L;'/UX<W05X&/
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M1/VTBZA`U$^[B`Y$_;3SE>"KW[S$>8/ZTW<^GOI3Y(WJ0(TR4).H1=0FZA!U
MB7I$?:(!T9!H1#0FFA!-B69$<T7'7YM,'R"(ED0KHC71AFA+M",276=1LP43
M79/5(RR/N),W#[G#\I@[+`^ZP_*H.RP/^Y'YNC9OY]Z@Z_1EGJ?K%(FN7QA_
MZN7<2@>;!E&3J$74)NH0=8EZ1'VB`=&0:$0T)IH038EF1'-%-HH+HB71BFA-
MM"':$NV(1.I9(&W!1.ID><`=NSSB#LM#[K`\Y@[+@^ZP/.H.R\-^9*G4SY^^
M[/?/C=OGVP_O'O:/G_?U_=>O3R=WAS^^R?-]0;YZX?"3Q_VG]Z<RJU;EQVV/
M3O(LFE0Q2<<'$R1=FJ3CLFV85"I)DBR-B_R19*XEBVBQ)'.M=,H(<Y4+YEK'
M[_XAJ6B2CD^/2#+%D!N_R+4*5Y*4?N$SS%6X-DG'E3`DW9BDFYC#XH4DI5]L
M"7,53>'E/)M(,8JF\.FWZ<)<!9-+?FDDDJM@<J7#$G*9*LM)]K%<IN7E,/!8
MDFGY](T[')HHRV&SS"4W,U5SCQ9+J4A*3#32>R0EYFU^U&#$V=R4+>9K;DH6
M=65B>_PN5E@9$]EH8$U<HV$MF+#*CQY%*EF42J9?50PN(]M-)256LEI)4N2-
M8\1;Z4I28H6NE:XE)59J>9:2QHS%6LYEK9KC9B/7$76;TSEC*3>2$FL$.1Q-
MZA-O@X*DQ#0JY^M(2JQ7RF\YR76B>437YK=;8F63FD95+:?J2TI4A`6)3U33
M<F:SI$2C(%EB4JM)AJB]-'.TE:61HVTL31QM89'9+*HR&1U,CY8=DFR51$:(
M>&N)LXC]_#BB1!)J)E81/C^.3I&$FH0CIKOY<=R/9$BD=T>[?<V,(;$,<EQ-
M];@C-5)O.;:F*GMSHFTBQ]=4C[M1(_GD?)JJ[+V)YI-S:JK'W:F1?')>357V
MOL5J+)M7I6KFD(]H/AF[S'D'T309OLP&\6B:C&!F!RS3Y$B@JMGTRQ0Y&:BZ
MB:9L)<6<",0\6RF\.4`EEE*1E%C)91^^I,3*+=N,)256-MD%+8*):E+*9C9$
MLP1R:E+5[(MFBAR>5#6G)<52RI(2JX\<S2$IL?K(L062$JN/;,&6E%@)C`#-
MV4\L@1PS(RFQ$LA&\ZK9Z\`\LM^\:K8\,$6VG5?-IO)8RK6DQ,88V?`G*;%1
M1C8K5<WNI(BW4D%28B60W?=5LP&$>603?M7L`V&*[,6OFIWVL91K28F56G9!
M2DJLU+*#JVKV9T6\2:G-AA*FR"[SJMFKP!39:UXU.Q:8(OVM&A]G9=>KI,1*
M+7OQ)"56:ME35#5[B"+7D5*;G0Y,D1&M6HNFR([[JMG%P3RR[[X:']%DA["D
MQ$HMNQ4E)59JV695-3NI(M>14IL=(9)RGM_N/'UX]_WV\WYX^_CY_MO3R=?]
M)WG$D"]JR=/QX_UGLT4C_<=SMCGCM\/S\^%!GD).3[[L;S_N9>_2A?E9]D^'
MP[/^PUS@Q^'Q]^-CS(?_"0```/__`P!02P,$%``&``@````A`,]TY&`^!```
MR0\``!D```!X;"]W;W)K<VAE971S+W-H965T,30N>&ULE%==;Z,X%'U?:?\#
MXGT``_D@2C)J4W5WI!UIM=J=>:;@)*B`$29-^^_W7MN`#31A7M)R<WSON<?7
MAWC[];W(K3=:\XR5.YLXGFW1,F%I5IYV]G__/G]9VQ9OXC*-<U;2G?U!N?UU
M__MOVRNK7_F9TL:"#"7?V>>FJ3:NRY,S+6+NL(J6\,V1U47<P&-]<GE5TS@5
MBXK<]3UOZ19Q5MHRPZ:>DX,=CUE"GUAR*6C9R"0US>,&^/-S5O$V6Y',25?$
M]>NE^I*PHH(4+UF>-1\BJ6T5R>;;J61U_))#W^\DC),VMW@8I2^RI&:<'1L'
MTKF2Z+CGR(U<R+3?IAET@+);-3WN[`>R.?B![>ZW0J`?&;UR[7^+G]GUCSI+
M_\I*"FK#/N$.O##VBM!O*89@L3M:_2QVX._:2NDQON3-/^SZ)\U.YP:V>P$=
M86.;]..)\@04A32.O\!,"<N!`'Q:18:C`8K$[^+O-4N;\\X.B+->+,+E>@5I
M7BAOGC/,:5O)A3>L^"E11.6267R5)0#Z*LO26:R\@$#1.TE<R4@T^!0W\7Y;
MLZL%4P,E>17C#)(-))[N"%I![`."=_;2MH`KAVUXVY-5L'7?0+I$81XE!CY[
MC(DXC!'+L(.XP*LC!QW/)X=@)(?R(]M'&="9^%T9@3A,(#YA`M+,9X)@V&)=
M@F!0^E%B0@W35Y;D;B$,E2#)?&X(AKV&SKO]\==+4Y='";I%[A;"(`>3J9/#
MD^,O%@Z._>U9PX6":+>?*@*G5Z.^,JD?ID!1WY_!#099YW:;#X)-/BHBK$-N
MF1XQ*JW,2D*%-4&SN*,"+C2KJHBIPGJ@PA0HZJ4RN.%+:K8#(-CDHR*:"GK$
MJ!29E5"%T(L<4.VV]+C.+*HBI@C10(0I4-0K95`CD&J^"@)M,FI#F@Y&R*R&
M%JAI/G\>B#)/O[>Y-F2($7D#,:91O60F/S1&C=_M[4$S&>Q/&]+54"@1,JNA
MTVG54(V`1,[=PT&D14*QSB/:D"D&&8JA%NJHP.LE,^FAUVGT[H@AG='@I$*Z
M&'K(K(8&IE438H3WI<!E@XE4(;U)/QJ\AP[X,P87ZJC`ZP4SR:'!:>3N2*'L
M4-^>SB$U#X\&/R$.I$/!OIH$)HPT]-8S7B=D[*1M2&_=CX:OX2E4X/4RFOQ^
MR4S)V$W;D#XKG_HIF3!4?]9K1:P<C,ND72Z&)V<"%7C]!AIJ^*#L_'$1:).3
M"H7=^3ZTH+&+^!.>2I;P`_G>VT4L'-25+JO75;ZKSTK@];-B]OU+]NF/[5.%
M]/J?NB?<>PR1T3#F]3UV3Y$+7LJ:WI-.V4^%[%M>G.2]HJ#UB1YHGG,K81>\
M%/EP4^BBW87M0=C",!YN'H`$'OON&[A(5?&)?H_K4U9R*Z='R.F)(U_+JYA\
M:%@%G<-%B#5P@Q+_GN'*3.$JX.$4'!EKV@<LT%W"]_\#``#__P,`4$L#!!0`
M!@`(````(0#+.7F&4!,``#%@```9````>&PO=V]R:W-H965T<R]S:&5E=#(P
M+GAM;*R<R7(;.1*&[Q,Q[Z#0O27N2X7M"7#?]_TF2[3-:$ETB+3=_?:3*""Q
M_1`M=70?6O17B020F=@+]>%_?ST]7OW<OYP.Q^>/U]F;S/75_OG^^'!X_OKQ
M>KEH_5&YOCJ=[YX?[AZ/S_N/UW_O3]?_^_3?_WSX=7SY\_1MOS]?D8;GT\?K
M;^?S]^3V]G3_;?]T=[HY?M\_TY,OQY>GNS/]\^7K[>G[R_[N(4WT]'B;RV1*
MMT]WA^=KI2%Y>8N.XY<OA_M]XWC_XVG_?%9*7O:/=V<J_^G;X?N)M3W=OT7=
MT]W+GS^^_W%_?/I.*CX?'@_GOU.EUU=/]TGWZ_/QY>[S(]7[KVSA[IYUI_\`
M]4^'^Y?CZ?CE?$/J;E5!L<[5V^HM:?KTX>%`-9!FOWK9?_EX+;*)Z.9SU[>?
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MFMQ-MI`I25=>*'>VS`GIATY8<DQ_*2G7.6LKG7^_[W,4]ZG)Y0]=`O+^NTV0
MXW"6/[2>JHW$"Q7)F1BV05Q^D_=R[#WY@\MN4[ZU"7'@2E]I+96W."_'7I<_
M./NJ8[I+E6;OY1SO9=Z2:YX=)G]PK@5;ZPN9YME>\H=.6KS)58K9XN\"-5_0
M82)_<*ZEBW6]5?U=VGTV[LYWGSZ\'']=T:!$`7+Z?B>'N&R2)YMSQZE*;KK2
MUWI2ZD*E%B'5?+PFTU,G>:+^_^>G?+[\X?8G==GW6J:&,EE?HLX2LG^6:ALA
M:(:@%8)V"#HAZ(:@%X)^"`8A&(9@%()Q""8AF(9@%H(Y`VO54L$WV8)%V&3+
M$*Q"L`[!)@3;$.Q"((S#.5]AW&L(N%.`/P4X5(!'!;A4@$^%Z]1;"FT3W]2-
M_1OQ+=7(^.;*U1A8U^1\S]19@I,T0M`,02L$[1!T0M`-02\$_1`,0C`,P2@$
MXQ!,0C`-P2P$<P:.Q<)@9A$VV3($JQ"L0[`)P38$NQ`(`<2XETLBP)T"_"G`
MH0(\*L"E`GPJ7*=ZP4PCQ;\1S%(-]?=4:]-;YW)A;ZV$Y`ACA`)WU8T(6ZD!
MI`FD!:0-I`.D"Z0'I`]D`&0(9`1D#&0"9`ID!F1NR*LF7!@1-N$2R`K(&L@&
MR!;(#H@0B&J(T,\"'2W0TP)=+=#7`IU-2\4T0BGXR"Q>"Z!P]%I`?'W'LQ(I
MG08Z6[>FB)SHF*C.Y<.>VPAQL@:0)I`6D#:0#I`ND!Z0/I`!D"&0$9`QD`F0
M*9`9D+DACA&+57_X6Q@A-N(2R`K(&L@&R!;(#H@0B*SON42BCE+H:H&^%NAL
M@=X6Z&[A^=N+;`K)=T2VE/8C6Q&*;*Y='4@#2!-("T@;2`=(%T@/2!_(`,@0
MR`C(&,@$R!3(#,A<DW17*EUN+(`L@:R`K(%L@&R![(`(@:B&B-UJBRW8KPYB
MQSJ(/>L@=JV#V+<.8N>FR(M96N^](V:EM!^SBJA]P=0#=2`-18JTOG9Z[+S?
MV32-$`=_2Q-;C3:0CDGEJB[ZJKM&B%7W0%$?R,"DNJ!Z:(18]0@4C8%,@$R!
MS!1Q##L'L@"R!+("LE:D:%="&Y#9:AEK^QT0(4"1J($FH>/!]WXI&*^%C1$V
MI."(L.44.B0<HPB,"<%!80LO.`1275[\TS[A.^)?2OOQKXA3HCJ0AB*^!?+!
M3+QIA-@`+4UL-=I`.B:5&Z2E(/Z-$*ON@:(^D(%)=4'UT`BQZA$H&@.9F%2.
MZD*PDS0U0JQZIHACZSF0!9`ED!60M2)NDP"9K9:Q[M@!$0(4B1IH$CI$*""X
M:L+&B$$<$6[\HRZ,"<%!84LJNFZYO/B7QV?NYN'EV;B4]N-?$<<G=2`-19SJ
M-H&T-+%E;@/IF%1.V(1;E%TCQ(;L@:(^D(%)Y:JN^.UH:(18]0@4C8%,3"I'
M=2'H_Z9&B%7/%'$,.P>R`+($L@*R5L0-=I#9:AEOR"X%+71GA+C00H!N40/E
M0H>($Q`"8T1PD+CQC[HX3/R2!I,+84/'%)4#!8<$.D%X1Y.0TGZ34,3Q7!U(
M0Q''`DT@+4V<)@&D`ZFZ0'J0J@]D8%(Y09H/UH-#(\1&'(&B,9")2>6H+@0.
MFAHA5CU3Q+'B',@"R%+KH46AG6J6,GX[7ADASFRMB0VU#:C>:AG;:>^`"`&*
M1`TT"1T/CO<%!H3@B+"%$CHD'*.(-A8"@T)P5&"P9ZGA>-&N3H]NY$'U^=OA
M_L_:D2Q)AP>1@2%/IT3Z[$AJ\5M!JIC.X&WXUA$U-"JJ4WAY8-1$U&)D=;41
M=1A975U$/4965Q_1@!%5W`92(0BDH97B2!HQLNK'B":,;%&GB&8:.2:<(UH@
M6K(NNY.P0K1F9`-L@[JV+%4VDY4=(CI,4A'@C"ITG*284W[!,5"TZNA(2:=U
MF(D"6S@Z5D)])@Z<M"80'&8B(=("Y,F8.P4*6\#B^/VU%D!'W*8)J`,VVI+G
M6*AE%<K3HL@)HF#B7[=2G+"A4;9B=#495=.3V4J&_O-[M1;J:2/JL!X:24V9
MLM5PQ<!2Y32WS$UPLM!#Q7U$`]9BJS%DI!17;[)Y61/S7S#C&J'2,:()*[U8
MIRE+*0O2VUVA!6>H>LZ)7-4Y/,'5OK<!M[0)V:LK1C07-Z;/E8+-BK66HM='
M..'&)F2T9>26"]RX8ZF+.5+;5<5WLJ2V"U6BMJN9]2>U72-WH5)T1HQ9<,#2
M.SM<+3HG-EE8=5`O.CQ^4ZY=+U=OV2-/SBXV^K<->^K4T6OS"N5=Q^0*@9/K
M:?8T.%I+-A`U-2K(<?;GIV(1(K:%B=J(.JS'G16!4;LL);NTGY_H3<N@T#W4
MW$<T0#3T-=-;3('F$:89(YJP&K<[A6I,64I5(^@D9ZAVKI%\Y\DVR]!C"Y:R
MW?N24=[$[XI1(;5A(>W<_&YZS2)V;-XPLKJWC-Q"05UW+)7C;CI85E+35N%(
MXY1I8S5F-CMJVEK.UH6:MF9*>_4F#4#356>",8':..;%`4K&-?ESA+J,0Y3>
M73-R')"J['[KE8>+,&33ZY'D0CEGY1'['1-8=5Q)5>#\:_(51IK3!J-W,%+6
MK10G;"!J:E10PUXV'VO*)CM6U$9%'5;D=B\0%UV64D-=YJ82S#EZJ+F/:(!H
MZ&NNWN33F8@)"AB_H5)C5#IAI1<K-64I;<-"I0B-&W*;ZT0TDW(:=REPXH*E
M[$BT9&1[Z!4C?S0-FL%:2\G7/VUWD@D:YL;J8F]O&;E%!=?N6,K,S`+-U.25
M%?S17#%WJ.7(=2:9U.2-G!P#J,G[G1>U<53>XD365#2.:T4.X]AU"\&1J@KK
MMW%YL/OOMG%U5.RU<86"T3IP:3UKI-A9#41-C7*J[X_,+UN8J(VHPWK(@B:`
M(`ZZ+&6Z?M]3/53<1S1`-/05_WZ&#K89H]()*[U8IRE+*0MB'SE#S7-.XVK.
ME8)^:,%2MGM?,K(1NF+TZAIKS1)V.-TPLJJWC'[3DK7E,CQX^QZDAJP$_+%;
M,YL;C=V:V9I00_:4XY2+6C)JYP!U1V&.T-S%RM",7*O3JZL\Q7]0'Q.RJ?'\
MMB[/R*&M%^TF%`_HD4TH=PFNCMJ]!JZ0>@U)G4_+.R5R7$_?3$I1`U$340M1
M&U$'41=1#U$?T0#1$-$(T1C1!-$4T0S17*-@"`WVAA<LY0ZAVATV+E<L]>H:
M?*TEG-%KPXFLZBVCBT&Y8RD>*\.U-C4Q540G-UKYZF+;[*B)056HB1FYU\9*
M5,XQY(Z!'$2>@:'#IQ:F\U.V*]'$"QJ8FZ'?P.2Y/#8PODOS]CL"ZGQ?SO3-
MV)3/![.$FKRUHUJ8E0IFH'4K8\=4DXQ1$Z5:B-J(.HBZB'J(^H@&B(:(1HC&
MB":(IHAFB.86O6K3A95A`RX1K1"M$6T0;1'M$%&;`C=2FT(6B0!J4R@7B0':
M"4:Y2!10FT$Y/P[\5B)/R=U6\IOA1HH'AQX*T2M\UDOY?+#<J%/K3]N'G44T
M$#41M1"U$740=1'U$/41#1`-$8T0C1%-$$T1S1#-+;I@U865LM$/AEZAU!K1
M!M$6T0X113]D2=&/+!(#%/TH%XD"BGZ4B\0!13_*^9'@1S\-IN^)?BD>1+]"
M%/WL@;H<U.108%$#41-1"U$;40=1%U$/41_1`-$0T0C1&-$$T131#-&<D9W?
M+Q`M$:T0K1%M$&T1[1!17&M'VH)17",S#G?DC,<=9ESN,.-SAQFG.\QXW6'&
M[2GSXUJ>D+N]>GB^][:M?G7.[JTM],D^C3%F,I3+!K.RNKQ.+%N`WK:Z*66K
MWG_-/X(=G+E.0?,];D8+C0K9=*V8RV3M^Q->76DB>[FN;UM(I6K\MJV1OU.2
M#=X(JK,4U=DQ25A!5D_AXT@%AENP+C9<66X(V/]RKN%\(\C#(=?AEX?QG#Y+
MLM%4T\C?^G5LKA:2+,7+BVJF:HM'OZR/4OFYEO</&D(3+EBK;T*[H>%756ZY
MOZ.J:H?>#6):ZZ?AZ?LBG*UKJ8+>J_`7'G/]5'8'CC^#ZB\X)_:GLR?JUTEN
M';ZC3E(\B%6%G!5^71I=MD)GT8^HB:B%J(VH@ZB+J(>HCVB`:(AHA&B,:()H
MBFB&:*Z1_..X-`B+A98JZ$U($Q:^/^7.D.O/?W@_G396I0O=I6<V7-'7M!#Y
MV98[*'7=RG#_VD#41-1"U$;40=1%U$/41S1`-$0T0C1&-$$T131#-+?H59LN
MK`S;=(EHA6B-:(-HBVB'B"X!JQ!Q6KEP(H)+1A>!42X2`G09&.4B04`7@E$N
M$@9T*=B5\QN)W+KY-QJ)WB1R6PENT-">J>X-7_5HW<JPW1J(FHA:B-J(.HBZ
MB'J(^H@&B(:(1HC&B":(IHAFB.86O6K3A95AFRX1K1"M$6T0;1'M$%$K,=[G
M4E`K01:)`+HPCW*1&*!+\R@7B0*Z.(]R?ASXK41NY[BMY#<S.[7[XTUW](80
M96O&M7S>SJ[TS,Y(L84:.4!-1"U$;40=1%U$/41]1`-$0T0C1&-$$T131#-$
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M,;DKY(;L;SRG-I'<T*1+'WJ)P8-]'5$#41-1"U$;40>1_%QI4(@>HCZB`:(A
MHA&B,:()HBFB&:*Y1D'`!K&QT%*O[,&HKZVJSP4^[5^^[NO[Q\?3U?WQA_R2
M:D6^)&VP^LXK3>;H0Z\T"R&_P:.R?)2^&!$^RLI'=.`4296MR$?I6R!!*EJ<
M)W+'(9*(GJ3K97Q$ZY=$4*WQ":UB2%W:0T-&)7H2JQ.-D?0D5NY:/I=(MV`^
MM-:3A8MFE*4BJ)W[H`CS/*5)7X,.'\B:1FT@<XEE0D?LB:"PP)+103ME'ZTG
M.4B>K<;25.A)W#UYLDTL'WH=@<H6S8B^M2`?I==7@IK*3PC'[%G+4@$B)9O+
M3P[''M3(,S%%\QPEB#T09/RH5VI4PU@%:Q28,9_4R+U1EPBJM;P$A_:ECV(D
M=%86?52G1_+Z6R15DQ[)6W"11RUZ)"_#11ZUZ1%]_R+VA!HH?1D@]H3:)UV0
MCCVITI-J]$DV0X^B95B7$GFU$-5M2HF\8(@/MJ6$/B\2X>6$OK$0X96$[IY'
M>#6A.[D13H65EQ;QR4PVE]B#>2F1=RTQQ:*4R!N7^&!92NA;*Q%>3NB#$Q%>
M2>AN?H17$[J@'.%4"7F+$Y^,2HF\=HH/QJ5$7C[%!Y-2,HV5=5).IK&R3BK)
M-%;62369QLI*]UL3>:$5<^Z5$GD#%Q_T2XF\AXL/!J6$OK(3X>6$OCX2X96$
M/M00X=6$+K!'.)557N3%)]3,XJV,&IF\=XHI.J6$OC03X>6$OL`1X96$/D,0
MX=6$;FQ'.)4UWK52'Q/O8JB'D7=N45>CE-`7=B*\G-"71R*\DM`7&2*\FM!-
M]0BGLNK^Z]:,`_2]]N]W7_?#NY>OA^?3U>/^"\U"Z'HI;<>]J"^^JW^<]97;
MS\<S?:F=U@3T56/Z-/^>[H=GY"V?+\?CF?]!6=^:C_U_^K\`````__\#`%!+
M`P04``8`"````"$`Q#6;CEH$``!!#@``&0```'AL+W=O<FMS:&5E=',O<VAE
M970Q.2YX;6RL5]N.HS@0?1]I_P'QWMS)!249=8#>'6E&&JUF=Y\)<1+4@"/L
M=+K_?LKX$FSHJ%O:/+2;RJGC.E5V45E]?6UJZP5UI,+MVO8=S[906^)]U1[7
M]C^_GAX6MD5HT>Z+&K=H;;\A8G_=_/%E=<7=,SDA1"U@:,G:/E%Z3ER7E"?4
M%,3!9]3"-P?<-06%Q^[HDG.'BGWOU-1NX'DSMRFJUN8,2?<1#GPX5"7*<'EI
M4$LY28?J@D+\Y%2=B61KRH_0-47W?#D_E+@Y`\6NJBOZUI/:5E,FWXXM[HI=
M#;I?_:@H)7?_,*)OJK+#!!^H`W0N#W2L>>DN76#:K/85*&!IMSIT6-N/?I+[
MONUN5GV"_JW0E0S^M\@)7__LJOWWJD60;:@3J\`.XV<&_;9G)G!V1]Y/?05^
M=M8>'8I+3?_&U[]0=3Q1*'<,BIBP9/^6(5)"1H'&"6+&5.(:`H"_5E.QHP$9
M*5[[]5KMZ6EMAS,GGGNA#W!KAPA]JABE;9470G'S'P?UBA1)($A@E22^,_>]
M93@'DCN.H7"$53@N/N07"3]8/[<AA-/+A54XSIU%'$>SQ72D+D]7G_VLH,5F
MU>&K!4<:$D+.!;L@?@)D,NU<JRK$>W6``C"21\:RMF>V!2DF<'A>-F$8KMP7
M*'@I,-LQQM<1J42PZC+:3!INM+-(]\DEA)TMD*1T00G_!UV,A>F2$6VEX191
MH`>42H1TR:1AX&**D!!3!!PG4T0(-VOZ3LA:,"<X_5HMC`VW`@/'3A7,@*0*
MHH0HR[M.N8*82F`G4PF[W9\\9HP%#BJD2X4=AK%>@"T'A?>T*8C2IBPW9B,A
MN8*8VD"'J2V(G<^K8SR].AG5EEM"6`9Z9[K>5(&D6Z8L=]QR!3+EP"T>RKE_
MV!A8CYE;(&893CJR9,(2*$P^M&CW>*Y'P_N3PYH</57E\Q9#9J`'3$090A_B
MW8EQZ$%R2PB[JL0&OF<D5H#F?3_SG9F_U#[Y@W'U,['/37K.+9'?4P2>?^N)
MFD@VQ(R:\$WD+WQ^3R2\W*1*1J*KY)80EH%*L^D*T%(#F<H$M\YDY"L73#)?
M\]@;?H)AOC3UL/50_40I!RH96%?)+48M;XGNCT`J0#PVSUEZRV%LG@'/.#R`
M=O9^YG+!"<L`M%"'2-/H0]O^N,@>K:L4)J.81H]*!2KR^@-G%"B3M'H9#>VY
MW$G6T;L=!ET2>_4.3NW]NL'L:!9.F*!3JU8Q-F7"9-3"$,Y&4T8?!89P'C&?
M.OG<TZ#NB%)4U\0J\85-E/`BVJR468R[4?((G!"8\<4V2M(^8-,>)]"))_"S
M!!K@A-WWDW1RARQ*X%TS]LCB!)KVA'V60/L<VV%B?^P[K!DIVW@"G[$)?\*^
M#1(8:L;\69#D4_9MF,#P,($/$Y@/P.ZJ@&"`/Q=']*/HCE5+K!H=H!Q>W_@Z
M_A.`/U#1`'>8PN@.%8-!%7ZJ(9@1/?:B/6!,Y0/;0/WXV_P&``#__P,`4$L#
M!!0`!@`(````(0#U*DNSA@,``&$+```9````>&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;(Q6VX[:,!!]K]1_B/*^A(0[(JR`U;:56JFJ>GDVB4.L3>+(-LON
MWW?&#L$&%O(2R.1XYLRQ?>S%XUM9>*]42,:KV`][?=^C5<)35NUB_\_OYX>I
M[TE%JI04O**Q_TZE_[C\_&EQX.)%YI0J#S)4,O9SI>IY$,@DIR61/5[3"KYD
M7)1$P:O8!;(6E*1Z4%D$4;\_#DK"*M]DF(LN.7B6L80^\61?TDJ9)((61`%_
MF;-:'K.529=T)1$O^_HAX64-*;:L8.I=)_6],IE_VU5<D&T!?;^%0Y(<<^N7
MB_0E2P27/%,]2!<8HI<]SX)9`)F6BY1!!RB[)V@6^ZMPO@E'?K!<:('^,GJ0
MUG]/YOSP1;#T.ZLHJ`WSA#.PY?P%H=]2#,'@X&+TLYZ!G\)+:4;VA?K%#U\I
MV^4*IGL$'6%C\_3]B<H$%(4TO4C32'@!!.#IE0R7!BA"WO3O@:4JC_T(EL:6
M2O7,,)7O)7NI>/G/?`R13#LX:@8/@+7Y/ACW1I/^((1:=Y($AHCNZXDHLEP(
M?O!@L4!)61-<>N$<$E]O!$@@=H7@V!_['G"5H/[K,IJ,%L$K*)8TF+7!P+/%
MA"YB<XD8#UM(`+Q:<M!Q=W((1G(H&;)=FX#-)&K+:,3F"N(#)B!-=R8(CGUX
MGB08G)5>&\S0PIPJ&W*W$(Y*D*0[-P3#7$/G+;EH,G9U61O0+7*W$`XY6)DV
M.=PP43CI?;AGCDL-QVF>[70V$=BS%O.)RWQS#33MMR"'&JQCF]KMI8]@ET\3
MT89A9LR..)4F;B7M&I,96L2=#8<#W:I-Q%5AVC9HB%P#34_;T.&&1U-G`T"P
MRZ>)6"K8$:?2S*VD59C!0KPM/(YR2S815X+9F0370-/3)G2(A9"JNP8:[3)J
M0L/6>S9'D#E.;$\+T?XLP;4,8S#R>T+H@6=UC97:=1MS=<29#EIQW+[1_RPJ
MMR<"/>-L)IJ07;\!7>D;_<PJIIU@&G;8!*%Q0BC6>D$3L@LW(+?QDZ>ZC:-]
M65SN-&[,SJE_]+\CHTW8@*XTCIYD%=.-C[OTW9B9W;<)V7TW(+?OTZ%L^C87
M&G/PEU3LZ(86A?02OL?+2@1'>1MM+U(K7?<\/IROS`4K:+_`!:<F._J#B!VK
MI%?0#'+V>Q-@)LP5R;PH7L/RA9L*5W#%T7]SN,I2.*O[N/PSSM7Q!70-VLOQ
M\C\```#__P,`4$L#!!0`!@`(````(0`<4:-4-P4``(`2```9````>&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;*Q86V^K1A!^K]3_@'@_YFYL9/LH-M`>J96J
MZK1])GAMHP!K`8F3?]\9=A?OQ7&3MB\A?)Z9G6_GMLOJZVM36R^DZRO:KFUO
MYMH6:4NZK]KCVO[C>_YE85O]4+3[HJ8M6=MOI+>_;G[\876AW5-_(F2PP$+;
MK^W3,)P3Q^G+$VF*?D;/I(5?#K1KB@%>NZ/3GSM2[$>EIG9\UYT[35&U-K.0
M=!^Q00^'JB0I+9\;T@[,2$?J8@#_^U-U[H6UIOR(N:;HGI[/7TK:G,'$8U57
MP]MHU+::,OEV;&E7/-;`^]4+BU+8'E\,\TU5=K2GAV$&YASFJ,EYZ2P=L+19
M[2M@@-MN=>2PMA^\)/?FMK-9C1OT9T4NO?2_U9_HY:>NVO]2M01V&^*$$7BD
M]`E%O^T1`F7'T,['"/S667MR*)[KX7=Z^9E4Q],`X8Z`$1)+]F\IZ4O843`S
M\R.T5-(:'("_5E-A:L".%*_C\U+MA]/:#N:S*'8##\2M1](/>84F;:M\[@?:
M_,6$/&Z*&?&Y$7C>,')',>"*\.2*WF(6>^XRB&'U.XHA5X2G6/%#>F!UI`M/
ML6`P"_TH7HQ\[ZPXYYKPG%;T0G>.VV2J.6R;QZBEQ5!L5AV]6%`*L)']N<#"
M\A(P)<+%+$P!?"]^$#@T\H!6UC;H0VAZ2+J731"X*^<%$J7D,EM39AZJ(CLA
M@FF!=E,=R'0@EP`'*$V\(/3_`R^T@KR$0UL!7(GZ.@DA(G12'<AT()<`A02D
MH4XB@(J\74LB%J@$5:/$PE,W>LME(%NG@.DT)I&)AX%D!I++B$(%EM*I8%OX
M9)ZA%<A4V*_)[R#P-7),*+A';A*9R!E(9B"YC"CD@(A.SH]FGZ>'=D9ZPJTM
M0P)X3(2]9:`2WDU"0BTUD,Q`<AE1V$`9RVSN9QL*JRXS)/"GHMD92&H@F8'D
M,J+X%ZO^L98UPP8]G*KR:4MAJZ`MW/`[@-;$&A;:4-WF")M)V'QV!I(R)/#&
M#A=Z?JP5338)B$CDW,@XGQ06>.`Q&N^5Q7=Z?H\%='A!`XVH-#B"FR%:L;?4
MW-Q-0L+-E"%!,`4M,Y"<:YE4EBJ5&QLON8S"JLL<@7A++D=:CG.A>'(PY0AX
M):G-5;6,"RW'B/D8,E4@9P(^.]3(`\2#1BL'Z#ZK45JEQ2$?4E%R4%M_)Z2N
MY9(*2`J&@,*11^0MXT@;K[D0&1-8R30/9^2=5/M0P8Q&-()L]L)I4B:X4#=X
M)Q2ER''(O\[53$#Q2'#A&NS86K?BA,-39P='1G`*NX&HHX^W!IPN6H9RR+]&
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MF_A#F#RP[P;Z`F$"!V-381LE<,2\@<\3.-H![DR&X/Y_+H[DUZ([5FUOU>0`
MF^*.7:UC7Q#8R\#/1(]T@)L_[!O<5^%+#X'#FHL-_T#I(%YP@>G;T>9O````
M__\#`%!+`P04``8`"````"$`6A5(6(4"``!T!@``&0```'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6R,E5UOFS`4AN\G[3]8OB\&\M$5A51IJFZ5-FF:]G'M
MF`-8Q1C93M/^^QW;#4N;KLT-P>;URW.^R.+R077D'HR5NB]IEJ240"]T)?NF
MI+]^WIQ]HL0ZWE>\TSV4]!$LO5Q^_+#8:7-G6P!'T*&W)6V=&PK&K&A!<9OH
M`7I\4FNCN,.E:9@=#/`J'%(=R]-TSA27/8T.A3G%0]>U%'"MQ59![Z*)@8X[
MY+>M'.S>38E3[!0W=]OA3&@UH,5&=M(]!E-*E"ANFUX;ONDP[H=LRL7>.RR.
M[)441EM=NP3M6`0]COF"73!T6BXJB1'XM!,#=4E76;&>4;9<A/S\EK"S!_?$
MMGKWV<CJJ^P!DXUE\@78:'WGI;>5W\+#[.CT32C`=T,JJ/FV<S_T[@O(IG58
M[1D&Y.,JJL=KL`(3BC9)'C"$[A``KT1)WQF8$/X0?G>R<FU)\UF23=,YJLD&
MK+N1WI$2L;5.JS]1DWFFT2-_\I@@?'P^F2>S\W22O6_"(D\([YH[OEP8O2/8
M,OA*.W#?@%F!QJ_'@Q!>N_+BDLXI05:+-;A?3O)\P>XQ<>))<Q4U>!TUV7/%
M^E@QGXX2AEPC'$9\.IP7>SB?,D][%3<.25ZPKE]1_(<$4W,ZB1>7%*]C"H[3
M%#73`\V_-P?\]5N*9UE"D]/9O!AKC9$?P$W&],?,1=%;<&\IGL%A>Q_"^;G)
MYWY&WFDU?RYPCN5\VL'1/2!_F;1W1!$M3GD<`P6F@35TG25";_T$Y]C8X^[X
M<5GEOK%>[D^+59AV-C[`H1]X`]^X:61O20<U6J;).8*9^-F("Z>','P;[7#>
MPVV+7W?`QDT3%-=:N_T"7\S&_XOE7P```/__`P!02P,$%``&``@````A``\N
MNYU'"```MB0``!D```!X;"]W;W)K<VAE971S+W-H965T,34N>&ULK)K;;MLX
M$(;O%]AW,'S?6)1\%.(4M77&+K!8='>O%5M.A-B6(2E-^_8[%#GB81S'27M3
M-9^&/S7#(3FB=?OY^V$_^%;435D=ET-VXPP'Q7%3;<OCPW+XS]?HTWPX:-K\
MN,WWU;%8#G\4S?#SW>^_W;Y4]5/S6!3M`!2.S7+XV+8G?S1J-H_%(6]NJE-Q
MA#N[JC[D+?Q9/XR:4UWDVZ[183]R'6<Z.N3E<2@4_/H:C6JW*S=%4&V>#\6Q
M%2)UL<];>/[FL3PUJ';87"-WR.NGY].G374X@<1]N2_;'YWH<'#8^.G#L:KS
M^SWX_9V-\PUJ=W\0^4.YJ:NFVK4W(#<2#TI]7HP6(U"ZN]V6X`$/^Z`N=LOA
M%^9G[G0XNKOM`O1O6;PTVO\'S6/U$M?E]H_R6$"T89SX"-Q7U1,W3;<<0>,1
M:1UU(_!7/=@6N_QYW_Y=O21%^?#8PG!/P"/NF+_]$13-!B(*,C?NA"MMJCT\
M`/P[.)0\-2`B^??N^E)NV\?ET'5NV-B9@O7@OFC:J.2*P\'FN6FKPW_"ADDE
MH>%*#;A*#6]Z,YDY'N,B%QIZLB%<L:%[,V/.PIM=;CB6#>$J&U[7(:AVWL(5
M.U3>7GC0J6P'5]F.L3Y*%]K-9#NX8G_7.0C3LWM0N+[+P85L!U?L\"H'&22>
MR`.>@7*0+[DX$GG4I660M_G=;5V]#&"N0ZHTIYRO',SGJIB0(DI]BKZ6H9":
M7.4+EUD.(=Z0?0U,JV]W;#J['7V#J;"1-BMJ,QV;)FLTX8G/=0,;A#:(;!#;
M(+%!:H-,`R.(2Q\<F"&_(CA<A@<'O5HA4-%R[4B@";8);!#:(+)!;(/$!JD-
M,@T8D8`I_RLBP6660_CW0II(&U@K>B,[.+U)'QU"0D(B0F)"$D)20C*=&$&"
M1_X50>(R,!UA*/H`>,[4G"DK8>1=BE)OTD>)D)"0B)"8D(20E)!,)T:48#$G
M4?+F?+N3>\_5BPY7Z@*%#JX$\>"BA<Y:A]:]$38+"`D)B0B)"4D(20G)=&+$
M!19/(R[G2P)<<+FUZ;L@GMLO,VM"`D)"0B)"8D(20E)",IT8CL+N:C@JMIP;
M7D.TC^7F:57!X,&2?"8`'FPM8L/A(J;_DHBJB6\>:T("02:LVZ%<AWGFK`K[
M^Y@:D=00%117C8EJTK?B^QZHNJ9JVM]'U4Q7-6+#ZWRZ':O8?*U.K\4&)A`&
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MNLHJ02NEE2)25AFB,QG":T+=YX]-+U%90C?H]XI)9"Q>C)E+S!JMU+`&$HFS
M#+%T(X+-1YNJUF85H14L&+V5ZUA6,>TQP8;ZK!-/[YH]6IMNA@U?Z]',+EY7
MDDC#<0(\+B\><(.\OI)@HE(UHBZ0M:C9;R&RH99'`2)]N.BF(:T\P^'IQ!S4
M"+7TS)7/I1(D0:N+/:97]9BAUIG\YE4KB?KDO74)/^FRY[I`>MDJK3044!12
M%%$44Y10E%*4&<C,0%[8ZK%X8WT3=;"17K(TYCG;5V/,&O\UZZUP-0@H"BF*
M*(HI2BA**<H,9(:!U[#O"(,L>57JKIA`VCBO*0HH"BF**(HI2BA**<H,9/H,
ML\SPF2_S'WMW95S**J4$,M]>F55QKF5#L%)IT3=$%%*KB**8HH2BE*+,0&:(
M>`GZCK201:V>%@(9:4%0P`@**8HHBBE**$HIR@QD^`Q%T'M\[LS-H9?(&GK[
MX$)9X3@'%(44113%%"44I11E!C+#8)?)EQ=&EY;#$NE#3U%`44A11%%,44)1
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MK7`_\\(%[Z0DZA*I;%FCE9Z^PFJLK$)I-19'%9:CD;S[5O;*SE5/"<JJGE)$
M9WOBWPQPGU[M2814?!8@?G\]%/5#L2[V^V:PJ9[Y3_Z0<W>W/1;?(ZS8PN>5
M!\PK^X[KP*<*W:DBN<,_8N@6,>M.X'I^"-U0-5C5?+Z,T3OP1<27+NDLK15T
M<JZ/E0N=G]%9>3[\<G9&?PSZ70K;'8Q]^!&)-EA-?/@1Y0R?^O";`^7!S(=S
M?<J3F0\G\Y0'<Q].N2E/YCZ<6E,.FS`$]9S+L(E"4,_=63%P0NQ9MM<,W("W
M+MH/O"_!G7-/O&)SN-,]VZB7@Z]&3OE#\6=>/Y3'9K`O=I!B3O?&7HOO3L0?
MK?Q%X;YJX8,1V$GA&P#X/JB`GSH<?JJRJZH6_X"'&O5?'-W]#P``__\#`%!+
M`P04``8`"````"$`#"\1MR@&```('0``&0```'AL+W=O<FMS:&5E=',O<VAE
M970Q-RYX;6R46=N.HS@0?5]I_P'Q/@$;"$F49-3):'9'VI%6J[T\T\1)4`>(
M@+[,WV_YPJ6,QY"75F(?EX^/RZ><]O;S1WYSWEA59V6Q<\G"=QU6I.4I*RX[
M]Y^_OWY:N4[=),4IN94%V[D_6.U^WO_ZR_:]K%[J*V.-`Q&*>N=>F^:^\;PZ
MO;(\J1?EG170<RZK/&G@:W7QZGO%DI,8E-\\ZOM++T^RPI41-M6<&.7YG*7L
M2YF^YJQH9)"*W9(&^-?7[%ZWT?)T3K@\J5Y>[Y_2,K]#B.?LEC4_1%#7R=/-
MMTM15LGS#=;]0<(D;6.++Z/P>99695V>FP6$\R31\9K7WMJ#2/OM*8,5<-F=
MBIUW[A/9'$/B>ONM$.C?C+W7@\].?2W??ZNRTQ]9P4!MV">^`\]E^<*AWTZ\
M"09[H]%?Q0[\63DG=DY>;\U?Y?OO++M<&]CN"%;$%[8Y_?C"ZA04A3`+&O%(
M:7D#`O#7R3.>&J!(\K%S`Y@X.S57^+1<1+$?$(`[SZQNOF8\I.NDKW53YO])
MD%B1)V,):E^2)MEOJ_+=@?T&='U/>/:0#00V<P$2'/O$P3MWZ3HP30T"ONT#
M&FV]-UATJC`'B8&_'89@Q'&,6(8=Q`->'3GZ"#D.YN2X<)SM038,F=!N&H$X
M&A`_80+2S)>)@\4V=1($=(FG/DA,.)"IGUF2LR&02A!D/C<.AKV&E7?D2!AH
MY"3(1LZ&0.0@,X?D>,Y3/US$/\W[-M?X0$&TVT_5`N=N0%U7S02*XVY]B!LD
M\I";/?<Y&/-1+>+0RRV3+:%P@6$>QW@B+D(0Q3-$X`/QI*H%BZ"=P:,$C7GP
M2C+[L'/P*%/T-)8@6Z;8$&@WUIB<<$<2+283A8_#&JD6K%&?`W*O)D"(&H%0
M\X43Z)%RJRX'Q?P'A;))9X5@@MQ3!SO+Q5N&T]H1Y<6T=\VV":NWQNR/4RC,
MCOOL@)W]H'%OTC:T;1H<-=4TSG&B6;5PG"B:<=C$2)Q);1,2(_)U,5JKYM5_
M>.X)M\GY"Y>F"BOK+$\$`$IBF3)O59-AX=SZ!I,)E_&7<Q:N3',XL<E'HU$E
MER@#EX>LE73>.G#V2"O6!X6R'IC6@/LX?7W`.V.P9$)7_.(U=0<:>S(QF7*D
M%=7C%`KS>\BJB<FKHW[IRG%L5JR2RP;!!`UV/<MQQG9-3%8<Z35M"H78T8<,
M6Z!UPX[T4J=0MORS0C!!@V''\8STHV/';INP2>GUSHB*^ZJ$Z3WDV+1S[/[<
MD:@/+=-/H:SZR4!F""9H<'GBTQEF1Z59#UVV;1H*&-"1@&H@1O6KQ/Q@#4,S
MMI<\RM%Z`BZU,G-0*+,Z\OQ:(9@@MVZM6A#X]3OA?MP?M>+<-@UU(4N]5$RA
M,+F'R@<UE8^E7CX4RJK>[/)!#>5CWHU>C,27C+8)"ZB7#R-JU><(%O"A\D&[
M\M%=/-JFP8T+->'9#+6`DGCZ^DG'Q:!MPF)HI>PXA4+T`H@U3'7[613HT5G4
MJM%!H6S99(5@@H9B0*)@AID%XVK0-F$!M6)VG$)A?@]5@\!4#9::FQX4RBK@
M[&H0&*I!Z*\7<)XG-GM<#$0LV'^L7V_STFB-J%7O.5@_6.4#"<C1HP34?H`=
M`HFRZF>#8(*&8C#OOS3!N!ZT34C`N#<J):`:B%"KWO0POX?J06"J![%6D`X*
M915P=CT(#/6`SOK1*4;B>M`V(6GB/K>4@*8?':O>*+&`#]6#H*L'@_M<W.^-
M('!0**N`,I`9@@D:2@B)US,NQ,&XAK1-6,!>&B6@&HA0J]XH$;\04/./L$#K
M1SC6:XA"F=61'*T03-!00R(RHX3P.Y]VHVN;ALH$5',@_E0B!@Y19-4O4M*3
MKR'RR2%GU84=V>U6.VGYRE\ZX#?]?MLUJV>8(-P\@8G`7634LX2>V-BS@IZU
MJ2?T-T]`U1"-0@_\*C+U4.@)C#W`#:ZRIC'`#:XEAIX`YH%Z:^J!>:"2&'H(
M!#.UP_3&]</RC7,3F!O>F$PS`%_XEX2I!X+!KVWH\;H-@'>H>W)AWY/JDA6U
M<V-GV#U?I%<E7[+DEZ:\PZ[":U39P`N4^'B%%T<&[S$^OP^>R[)IO_`)NC?,
M_?\```#__P,`4$L#!!0`!@`(````(0`C-E,5-`$``$`"```1``@!9&]C4')O
M<',O8V]R92YX;6P@H@0!**```0``````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````"4D4%/PR`8AN\F_H>&>PMT:I2T+%&SDTM,G)GQAO!M(Q9*`.WV[V5=
M5V?TXI&\+P_/]U%-MZ;)/L$'W=H:T8*@#*QLE;;K&CTO9ODURD(45HFFM5"C
M'00TY>=GE71,MAX>?>O`1PTA2R0;F'0UVL3H&,9!;L"(4*2&3>&J]4;$=/1K
M[(1\%VO`)2%7V$`42D2!]\#<C40T()4<D>[#-SU`20P-&+`Q8%I0_-V-X$WX
M\T*?G#2-CCN79AIT3]E*'L*QO0UZ+'9=5W237B/Y4_PR?WCJ1\VUW>]*`N+[
M_30BQ'E:Y4J#NMWQ[9MOLA`V%?Z=54KV=DQZ$!%4EMYC![MCLIS<W2]FB)>$
M7N3D)B>7BY(P2EA)7BM\;`WW^0@T@\"_B/2$>`3PWOOGG_,O````__\#`%!+
M`P04``8`"````"$`C>,H]^T"``!X"0``$``(`61O8U!R;W!S+V%P<"YX;6P@
MH@0!**```0``````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````````````````"<5M]OVC`0
M?I^T_P'EO0TMW315(14+Z4!J"6K2[M%RG0.L!CNS'03]ZW=)"B2;R<3>;-^O
M[[Z[L^W=;==9;P-*<RF&SM5EW^F!8#+E8CETGI/[BV].3QLJ4II)`4-G!]JY
M\S]_\N9*YJ`,!]U#%T(/G94Q^:WK:K:"-=67*!8H64BUI@:W:NG*Q8(S&$M6
MK$$8][K?_^K"UH!((;W(#PZ=VN/MQOROTU2R$I]^278Y`O:]49YGG%&#6?J/
MG"FIY<+TPBV#S'.;0@_1Q<`*Q<W.[WMN<^O%C&80H&-_03,-GGL\\"9`2]+F
ME"OM>QMSNP%FI.II_HZT73N]5ZJAA#-T-E1Q*@S"*M7J3;7.<FV4_U.J-[T"
M,-IS4:$^K)9-W>::W_B#+Y4&KMJ:I8<:"0K:&!-N,M#18DZ5L4`>?&EBKE#4
MB&M`^RH2[`T2"H-\D:FHJ\UE$_DAAR":Q='#=#Q*PC'Y/GH8S8*0Q),P3.)S
M]<F<_MLD3C#28SA+8A+=DV@>GF%"@NAQ_A1.SC"IHL1)=*Y),+*G'ZDE%?R]
M:EHRHZ904)$=2&1;6*/$?"DXSAAV%QDQ)HM2<TGF$IN?8[\>2E%VWD<=N6:5
MPP)2$N%(5_%:K7?0G0J\"9;\-0,RTAH;%"MN(,NPTPN*@W10/+H/Y'HM!8F-
M9&_HOAQ`N^]2D9OR7K#+GR"C!B&6W;HCB:)"4W;:W10OL360A&[![B\N7C7\
M*C`>"3<GHW83>F5->=QBE&=5T7Y07;-K->DFUA[&QBSFB\6Q)]QDI$NON^WL
M6+IINK;FW*;IT'AD#(9R>S-UF]BA=5-KA]9M,["F8RU'G8N]'ET&Q)Y+I\GL
M)*R/L?I@5N-=HLHIW]@OA-.#5CJP!FFU5E?.-L43N5I5K<A;3]P?C]H#%V_Z
M.4_D&"^/_:O=/O3B%560XGNVEQ\/O`D^V"HKG00KO/H@W>O\+2C_&"_U1\J_
MNKGL#_KX?6B<>>[QR^3_!@``__\#`%!+`0(M`!0`!@`(````(0`=?[]DX`$`
M`+H6```3``````````````````````!;0V]N=&5N=%]4>7!E<UTN>&UL4$L!
M`BT`%``&``@````A`+55,"/U````3`(```L`````````````````&00``%]R
M96QS+RYR96QS4$L!`BT`%``&``@````A`.C!R>??`0``JQ4``!H`````````
M````````/P<``'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!`BT`%``&
M``@````A`'`G#X*!`P``10L```\`````````````````7@H``'AL+W=O<FMB
M;V]K+GAM;%!+`0(M`!0`!@`(````(0#7?O+QU04``%H<```8````````````
M``````P.``!X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"+0`4``8`"```
M`"$`E,LV7TL#``!A"@``&0`````````````````7%```>&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+`0(M`!0`!@`(````(0#6MT$;T`,``,D-```9````
M`````````````)D7``!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L!`BT`
M%``&``@````A`!'(*(6H!```T1(``!D`````````````````H!L``'AL+W=O
M<FMS:&5E=',O<VAE970R."YX;6Q02P$"+0`4``8`"````"$`>N#G^NL"```4
M"```&0````````````````!_(```>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM
M;%!+`0(M`!0`!@`(````(0!;#B"EZ@(``"@(```9`````````````````*$C
M``!X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L!`BT`%``&``@````A`("@
MVJPY`P``HPD``!D`````````````````PB8``'AL+W=O<FMS:&5E=',O<VAE
M970R-2YX;6Q02P$"+0`4``8`"````"$`I@.<4%X#``#V"@``&0``````````
M```````R*@``>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+`0(M`!0`!@`(
M````(0#+Q!(BCP(``',&```9`````````````````,<M``!X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L!`BT`%``&``@````A``\?3Q)0!```=1$``!D`
M````````````````C3```'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M+0`4``8`"````"$`>14DB*8"``!P!P``&0`````````````````4-0``>&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+`0(M`!0`!@`(````(0"SY0M'D04`
M`!(7```8`````````````````/$W``!X;"]W;W)K<VAE971S+W-H965T,BYX
M;6Q02P$"+0`4``8`"````"$`2$GCS!D#``#C"@``&`````````````````"X
M/0``>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!`BT`%``&``@````A`)0$
M6'.(20``[BD!`!0`````````````````!T$``'AL+W-H87)E9%-T<FEN9W,N
M>&UL4$L!`BT`%``&``@````A`)78V$:P"P``A&@```T`````````````````
MP8H``'AL+W-T>6QE<RYX;6Q02P$"+0`4``8`"````"$`^V*E;90&``"G&P``
M$P````````````````"<E@``>&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`
M!@`(````(0#?<#%;?P(``.`%```9`````````````````&&=``!X;"]W;W)K
M<VAE971S+W-H965T,S4N>&UL4$L!`BT`%``&``@````A`#<F;]>L`@``#`<`
M`!D`````````````````%Z```'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"+0`4``8`"````"$`O(*.,Q\#``"_"0``&`````````````````#ZH@``
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!`BT`%``&``@````A`%!;W,5:
M`@``\P4``!D`````````````````3Z8``'AL+W=O<FMS:&5E=',O<VAE970R
M,RYX;6Q02P$"+0`4``8`"````"$`'Z>P$UL'``!#'@``&0``````````````
M``#@J```>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+`0(M`!0`!@`(````
M(0"9=BQ`(@4```D2```9`````````````````'*P``!X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L!`BT`%``&``@````A`$F]LH^%!@``U1H``!D`````
M````````````R[4``'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"+0`4
M``8`"````"$`S-J&U.,'``#%*```&`````````````````"'O```>&PO=V]R
M:W-H965T<R]S:&5E=#DN>&UL4$L!`BT`%``&``@````A`"F,\-@9`P``3@D`
M`!@`````````````````H,0``'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+
M`0(M`!0`!@`(````(0`N/;?W2`<``.HA```8`````````````````._'``!X
M;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"+0`4``8`"````"$`6GV]=^<$
M``"R%```&`````````````````!MSP``>&PO=V]R:W-H965T<R]S:&5E=#8N
M>&UL4$L!`BT`%``&``@````A`!JW'0<8`P``]@@``!@`````````````````
MBM0``'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+`0(M`!0`!@`(````(0#A
MWZ++9`(``+`%```9`````````````````-C7``!X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L!`BT`%``&``@````A`!!CMBXK&P``,Y<``!D`````````
M````````<]H``'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"+0`4``8`
M"````"$`SW3D8#X$``#)#P``&0````````````````#5]0``>&PO=V]R:W-H
M965T<R]S:&5E=#$T+GAM;%!+`0(M`!0`!@`(````(0#+.7F&4!,``#%@```9
M`````````````````$KZ``!X;"]W;W)K<VAE971S+W-H965T,C`N>&UL4$L!
M`BT`%``&``@````A`,0UFXY:!```00X``!D`````````````````T0T!`'AL
M+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"+0`4``8`"````"$`]2I+LX8#
M``!A"P``&0````````````````!B$@$`>&PO=V]R:W-H965T<R]S:&5E=#$S
M+GAM;%!+`0(M`!0`!@`(````(0`<4:-4-P4``(`2```9````````````````
M`!\6`0!X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L!`BT`%``&``@````A
M`%H52%B%`@``=`8``!D`````````````````C1L!`'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"+0`4``8`"````"$`#RZ[G4<(``"V)```&0``````
M``````````!)'@$`>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+`0(M`!0`
M!@`(````(0`,+Q&W*`8```@=```9`````````````````,<F`0!X;"]W;W)K
M<VAE971S+W-H965T,3<N>&UL4$L!`BT`%``&``@````A`",V4Q4T`0``0`(`
M`!$`````````````````)BT!`&1O8U!R;W!S+V-O<F4N>&UL4$L!`BT`%``&
M``@````A`(WC*/?M`@``>`D``!``````````````````D2\!`&1O8U!R;W!S
>+V%P<"YX;6Q02P4&`````"P`+`#F"P``M#,!````
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0E1GAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Income Taxes (Details) (USD 
$)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax 
assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss
carryforwards</a></td>
        <td class="nump">$ 2,027,000<span></span></td>
        <td class="nump">$ 1,852,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts', 
window );">Other</a></td>
        <td class="nump">86,000<span></span></td>
        <td class="nump">106,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DeferredTaxAssetsGross', window );">Deferred tax assets gross</a></td>
        <td class="nump">2,113,000<span></span></td>
        <td class="nump">1,958,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation 
allowance</a></td>
        <td class="num">(2,113,000)<span></span></td>
        <td class="num">(1,958,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DeferredTaxAssetsNet', window );">Deferred tax asset</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred 
tax asset attributable to deductible temporary differences and 
carryforwards.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
<p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-
109319<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Deferred Tax 
Asset<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6510090<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsGrossAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
</tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount after allocation of valuation allowances of deferred 
tax asset attributable to deductible temporary differences and 
carryforwards.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),
(c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-
109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
</div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DeferredTaxAssetsOperatingLossCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred 
tax asset attributable to deductible operating loss carryforwards.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-
109319<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-
109319<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-
109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DeferredTaxAssetsOperatingLossCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
</div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of deferred tax assets for which it is more likely 
than not that a tax benefit will not be realized.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-
109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
<tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable 
temporary differences from other capitalized costs not separately disclosed.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-
109319<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-
109319<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (d)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-
109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */
/* DefRef Styles */
..report table.authRefData{
background-color: #def;
border: 2px solid #2F4497;
font-size: 1em;
position: absolute;
}
..report table.authRefData a {
display: block;
font-weight: bold;
}
..report table.authRefData p {
margin-top: 0px;
}
..report table.authRefData .hide {
background-color: #2F4497;
padding: 1px 3px 0px 0px;
text-align: right;
}
..report table.authRefData .hide a:hover {
background-color: #2F4497;
}
..report table.authRefData .body {
height: 150px;
overflow: auto;
width: 400px;
}
..report table.authRefData table{
font-size: 1em;
}
/* Report Styles */
..pl a, .pl a:visited {
color: black;
text-decoration: none;
}
/* table */
..report {
background-color: white;
border: 2px solid #acf;
clear: both;
color: black;
font: normal 8pt Helvetica, Arial, san-serif;
margin-bottom: 2em;
}
..report hr {
border: 1px solid #acf;
}
/* Top labels */
..report th {
background-color: #acf;
color: black;
font-weight: bold;
text-align: center;
}
..report th.void {
background-color: transparent;
color: #000000;
font: bold 10pt Helvetica, Arial, san-serif;
text-align: left;
}
..report .pl {
text-align: left;
vertical-align: top;
white-space: normal;
width: 200px;
word-wrap: break-word;
}
..report td.pl a.a {
cursor: pointer;
display: block;
width: 200px;
overflow: hidden;
}
..report td.pl div.a {
width: 200px;
}
..report td.pl a:hover {
background-color: #ffc;
}
/* Header rows... */
..report tr.rh {
background-color: #acf;
color: black;
font-weight: bold;
}
/* Calendars... */
..report .rc {
background-color: #f0f0f0;
}
/* Even rows... */
..report .re, .report .reu {
background-color: #def;
}
..report .reu td {
border-bottom: 1px solid black;
}
/* Odd rows... */
..report .ro, .report .rou {
background-color: white;
}
..report .rou td {
border-bottom: 1px solid black;
}
..report .rou table td, .report .reu table td {
border-bottom: 0px solid black;
}
/* styles for footnote marker */
..report .fn {
white-space: nowrap;
}
/* styles for numeric types */
..report .num, .report .nump {
text-align: right;
white-space: nowrap;
..report .nump {
padding-left: 2em;
}
..report .nump {
padding: 0px 0.4em 0px 2em;
}
/* styles for text types */
..report .text {
text-align: left;
white-space: normal;
..report .text .big {
margin-bottom: 1em;
width: 17em;
}
..report .text .more {
display: none;
}
..report .text .note {
font-style: italic;
font-weight: bold;
}
}
}
..report .text .small {
width: 10em;
}
..report sup {
font-style: italic;
}
..report .outerFootnotes {
font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001477932-14-004914-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-14-004914-xbrl.zip
M4$L#!!0````(`"^!)45%"F>!$X8``+'W!0`1`!P`<F-A<BTR,#$T,#8S,"YX
M;6Q55`D``WD8"E1Y&`I4=7@+``$$)0X```0Y`0``[%U9<]M(DG[?B/T/6,U.
M1T^$*.'D(=F>D"7+H6[;4DAV]_23H@04R1J#`!<')<ZOWZP"00(@"1:``@E*
M](,LX:C\,O/+K+OP[I\O(UN:8,\GKO/^2#F1CR3LF*Y%G,'[HQ\/K8N'RYN;
M(^F?'_[[OR3X]^Y_6BWIFF#;.I.N7+-UX_3=<^D;&N$SZ3-VL(<"USN7_D!V
M2*^X__IX_P7^C,H_D_03&4FM%D=A?V#'<KT?]S?SPH9!,#X[/7U^?CYQW`EZ
M=KV?_HGI\A7WX(:>B>=E>2;R'A_^KEXI)R]]P'N%`KBJRHH.U^0>_6%\5XPS
MN7UF*)P2`A2$_ER"_"+/_D6OOWMY\FQR1G]*8'+'/WOQR?NCA%+/VHGK#4Y5
M659.__7URX,YQ"/4(HX?(,?$1_%;-G%^KGI/Z?5ZI^QN_.C2DU1X+$,[I;>?
MD+\HF0+,>7X)"=RU@OD+R8>-T^AFZE&R\M%V]"B)'[5PYCD?FR<#=W(*-^!Y
M16O)2DM3XL<]W%\+N7T*=^,'B>_JJM+)TR]Z(GXA]%L#A,;S%_K(?V(/SVZL
M``-W/-?&_LIWV)T5+SFNXX2CU;BLP#L-IF-\"@^UX"GL$7/^WN:7TB\`!GIY
M-3IV9Y5](5#F+_P;.:'O89_%DD\<$\)O1%_2Y;8F'\5!0HEUYC/ZWN.^Q#AY
M-F2>HL6UXA=.7GSK:':;RG]_Y)/1V`:"G<9%14%CNDZ`7P*)6.^/KCUW1`N@
M,&4E<*/?VZV%_/EKV`E(,)U?G5\G%KW3)]B3&$J<LF/,M\N;WX\^0/@JLM+N
MR-UWI]F7%^).5\J;21N##UQK&04$DQ?0O/-AH4Y<TN+>TFN0%A,O4;T7XJW4
M*_'U%(#XXLRDZ^U\&?W^>.$_WO8?-:5UA4WJ.67/S!QEK8#:2VDI*E![+F)V
M1XR]+OS;/@L?)F-_C:35::1%\.J9X'V<954@6Y^8V/N*1T_8>S1#/W!'C]<8
M1Q=V9M=%V.+!""<,,K]E`9B7L4U,$D18)8O`DU&[:J;=V3VV(42M.PCOZ7</
M.3XR`WC`_SA-WKEX(?[1A_B=E$7>G:Z451+.=Q+8^+9_XUAD0JP0V9%DFJ7/
MYC;?+'*>MC*V$9,8]68EQAF'M02'M0.'#QQ>SV&M#(>U'7/XBGC8A+Y<FL1?
M\`#9;YK):;MLC\IIRQ_XO*KQM9\=@43C*U-QU=+XTA(])VTO#98E8_&>TY:2
M:\+.K%$]3ZZ7[FCD.@^!:_Y\'9F4#GYA^OZG_PL!-^@W=AWXTT\GSR6]=YW'
MRE`GU3^J)8^I![HT@RZ)U*QN;_#@X/<&^7T;XR%Y5<6%91':*$7V'2+6C7.)
MQB1`]IOB0ZX-#E4(3Q5RH%'#:+3CJN7`A^;RH=8J)Y,?9N,ZM\2^<*S/R+_S
M7"@W(-C_AH/7P8:92M,[&ZP(6E)2C&EY'Z??IV.<&&/)L\(KSP\9/GQW(1"^
M$/1$;$+-\#J8<(V(QY9G?)S&NDTO;>3["0ZLUOQM>?^',_;<"78689`>!?Y*
M'.(,LG?WG1W\>6*U_F^+(U=X[&&3(%J!@K%N1F,(+JK5C"KSN;!@B+W+T//@
MUH7OX^`ML64^_;7&"&^$,O-&IVFZ(33#[M`4/=FO9!)I0Z4R;VRNTOV-^'^6
M,ACS[W%`/-8XOWVRR8#ECS=!!%9S;##!*^?#4B?TK=8'#:D#MK36*[M0<^Y_
M-L)[.WX]*>#3:&R[4XPCQ9X=[/E#,J:4^/1P>W=%?--V_=##_D?&DS0IEJRQ
MTY'-YJU(+4.H^1W:9!^%HP/-RM"L"+9[Y`PRV2YE^P.I!9(:O1Q(O2M2)VU_
M(#7OM.:K7$>X/^OV&C99R;$?X+`.];`.=7WB:]C>@/2XQYXMJ]SR8$`VT`^+
MG7:_V&D;ZX_SFKJ'50D-6Y70\(;FFE1RH%'#:+33+0[I,>=['"#B8.L3\N@D
M[BL9?>8DQ6KE#YV2HO74@43-(E%C:Z;L#/B!.#LGSH[G/`\,:!(#MK'4]E!Y
M-)D!NVZ/7IAF.`K9*%^T2@P,Y^$A->\$WSBF.WHE@YR\_19>>QQ:K9Q+[@[T
MV@=Z[7HIUH$G>\>3731>#CS9/Y[LJ(FS9]-?#:_?UT^5[[.=FS>%N_YHK'VV
M<V./;-I/VZ8JX=U.F1[.&CR<-=CHD?#UQXX=.'S@L,#&UVY7::_D\&&9XHZ(
MW*Q5BJ\D(Q_8?&!S8W.SFF#S?JZ_3=E9+6-G=0L#$.!+M:7*KVB@AZK3H(&>
M1<<8W-G;,]NF.\94@9U-K!XV%S=W<W%CAU<+$>JPN;@)^S`;L[GXE9!ZUMB/
M:7#8<MP<JC=FR_%>4OTPRMB0[NQ>]V3KY_"*GNP26U>3^L#A-\;A)H\2\!W]
ML&:?_UMD\F%'_W[EY,,)%0<^[T5^#AT2D=D?(NC,+'%QA!'MY7R8@60/Q07&
M]])B:(EK9/QXN%HK8/:%[3-XIDKYCZ#ZXP.%N22)T6&%>>GKW^CGL.GGZ9<Y
M5P!B%N:J4A-"K[#CCHBS2>QFTV?EKBHXOI^R`H=-[\(5IDQ#&\.O_#ZS,#G[
MQ,+F'@^('T#&"+ZA$99F_+RGWP+/^Y+W/6@W01#-^%BZ<<R3=Z?KBEP6>0D!
MZR$;<@-^^1U/N64F\^G:TI+BKEPSI!F#GN_)+>6AI43%)]]>5>H=B^]/4?1S
M%Y^<.UY;6E+<!=RUZ!/7-AIPB^DCV\>1A%0!R9)GYUU?$]]$]E\8>45U:<6)
M,*^T9?__B6W[=\=]=AZ`IZZ#K1O?#Z$:X17[S4WZ?TUIRV+_<.W0@00_O28V
M]OR2XC*EK&!W9(=[/':]@#@#NDX]Y)?V%\TOFTI;ELK07(*Y!Z[''U$/(V3#
M>]*\>(DNCT?.-`DA570L>7&J+NYC@&BQT39H9-QZ;&&^Q0Y:!E*S:B`%*/,A
M=HGF)78C77-(%C8)X//?']U\NX;H/Z'Q_^ZTF&1Q>&.C[0M>M0'V98_X%V$P
M=#WR'VSQ\6#6"LH"5.3HWSJ(66'5H2V[O#'0EKV[16@LPU9SY@8\D81J6+B]
MMP4LW.X2AN4V#.A\OD63>HV.2H@1@$J4R\2B$N6\'%2),^9JKT.329Y#KB"H
MI:K/W4`M57.*@RJTTC3DI?R?(ZHB*N[PW2HJ[O!5Q:(24$NVVT;'4%0U!]#J
M&J$`&&ZG;0,,MZ_:FBP(C*B*DL,\?!6`V)IRN[!$^B\'UIK1[D\O8^SXV*==
MWN0@^)\D&"9?6=,_7GO$]8:%":EZ(JDI]+"U5#JIB'L+9EBQK5:$&5Z-#;CF
MDG()T>UU]'VR1N6SW_.LH7:ZZEYQH\).WSP[M/<O393=+/IJTD35S89YANBJ
M2M?8)V-4W:N6&QRJKO7VUQB%%CGFV4'OR;W./MFAPD*Y7#MH:J^[3W:HO-@J
MSQI*VS!ZRCZ9H_):G3QS=%1#UH1;@ZU;F8T`3!"QZ1=BJTUF]'IJ--2PJNBB
M8ODG*GK=ML$IEO;$GI"/+3HG"-:*OB1MC8C#9O<#,L$S,_+.-^;2N*<91@R+
M7[1(R*N.R,J%;.BZO%O(JTZ;RH6L&AVM(N0?#H2H.W#H(%CRS4O7#[@'J9?Z
M`9K2F>'**[\2$!X#&8;6+0R$6?)CUI)BHL+0M)3#EL241)+71EG^TD\&XXM/
MSAQBOS\*O!`?2:<U8,C_1$@NE[1.KZ/48;/R7\9IGH_7''*]`T=S'UBY-6Q;
MH%>T+XU[65"AFG.=L&JPMITP2D*I$(?9ZKP>.]:51'9.@MHR2EDF;#&Q%(-8
M`PVC"/P!Q=)I+^28O"U<_AA.#V/'9%L6+!A7E8"6]5Y[:T`%\%^`M6HA?6E<
MF_R3Z(NN]T_<E[]&Q&.+*"[@@5$4!/?$_WGM85`MP-"5#>X+K%]>8&/KZU<L
MZU#:B0E*7O$UPRY\W`6'FKJVEVJFCCK8`V_F!\A:V!VC<;!?(PGK.X6#1_E>
M/<K_B<E@")7!Q01[:(#_<*%J(#;=I",R4?;D#?!S86Q+#_&D[?4VA.;>Z%V$
MK\J);&R(U>WK72*W@AYJ<MJ]L8J\">+N+/T"#32]9FO0<703"OB.O1'W[JP[
MXZ]\6,E2:T)1_'"U._VO]M>]P)T^*0NLO6W<*[_)T@P<)?R^;;;6>&I:51^`
M90+\!7K<%K37D#,@3S9]%P?^-UQZC@RZ+UTCF:ARI53'Q#7V7`D3FWZ^\X@I
M:'-+-[$Z9E%V,:G%]ZET>CQ2(R.4]GW'4'MJ0KVH.'XA7,[4M7:WJY<7LG+C
M3%:(W#:ZVF8AINF&]&->CO7-#;!_CTU,)G210H4(ZJ8W=^3*J`R(Q^);!;3&
M.^L&_M+^F>U#+\U?0Y'ECI;U^JS4PB*YV*ST=%F318GDX;:A*CUC*4C72+SS
M\!@1:[;"HJI]52V]^7"YZ-+R>8RMZIK6J0L`C^D[1G)PCTO^%X*>:".>X*KL
M-@Q=3ZS`6RZXG&B^!3UM7='$R^:QN2X;>B'1<<JZ0U.:IQ(+[:H;@L:>LIQ*
M\T1M@`>)%:Y`4K3$,451U.2>IP(2!8/E,6E';PA8KG9%IY>J7\J#33P!K[&>
MQ-"U+>SYT9=&A;7A-@D2`:Q4NV\;P$JU%8L"$^B\=J^C=]N)EKX@X5P.TA19
M[RCBA6=77Q=;`]#6:H!4;5E"NUV#BY8^V5YZ18*AMU55JP&BN$43'565VXI:
MFQ5SA??:G8[1JRW(FD0J<4N_.KIF:,EN9%V\YUO@DL+6TO4>]/ST^AE?!IQA
MT,6<-7`]Z]PRX"`(#3TY35-;.BN[9"CC:64;;A:^OJEBU-8%)\N8A*`KW*?'
MY)9MR2RS?K,L,>AXFCK+M-\6.I[Z:3F=%4>W)M&7=>=2?;VF_`HP^/J*F4I(
M/`RN$;AL`XL31J)!P"9ZRGHCU53(%EI&*(_MA0OEL72J\;]):/HTM*(6WI0K
M.4M?8TI!I9<<76>U1HV3A.O*KX*CS,1@'3BJF'PQ6T)++SZJ)U8(GT63Z75]
M^=60\(1^MQP0N!.UB+ZXOI"-3ZVVK'22F[U3$@J+7W&$1;[XGMY--J-$2A>T
MO4J(]$(]TUJ1E.E&*;*F=KI=46[*6VI4JI=7(X6WU',J@VK;/BNT2;ZE:5J[
M*S*RL\>)Y8OO:IHA3/E5G]W.E4X/VTF.P556?NEKU!M\W^YJBLPIG_,\2:Y,
MRGU28=[QDIQ'?U8"M'2B8Q5`189&*P%BF[SBK5VW?;K12VA%N`:<9LB)<U8R
M\E>VE58D1DJ]:]?#9.!$C1LS>9C,A6.QO^S9`1K_#OV`?F\#F'O;_XY>ME[=
M-T,-H>V&9JA4;8MGLW01,^R;'O6M1[-&V>\-6X.C*=$HZA=J>.S"=:R:7#Z!
MR?/HIZ7IBQ^GBT?NT)1>NGA&GC4[`>`/[$/T?@MIE-[VHTJW>,<Z[S3T3)4N
M&.ORP0JSAW\X$_:X,&44)7GJV0I)99:JL96WCEEM19BNJTJBM5U8;BW`>7I)
M6EONKEB[O%O@?(L,M*Y`W'F;0Z[8=_X<2^RI!!NV+*X27C/H]?MNFJ].F4WY
MC4.\:P=<(G\(44+_HY/G$V1CNC4AN$2>-X66\O*TR67T^^.%_WC;?]24UA4V
MH;Y6-LQV=CN=Y$(X+KG5P1;:Z2!WN\EET=N%R+<SHMV5>SN#R#6/JVA&<A'`
MMOW,4?WU5&673(36K=++MZ$,=-`K(OP,_5W:Z+UUKH@_=GW6H[_MK]@#QC^)
MLZF34%AFT9D;O:<EFP"Y\@2#XV@0;A,<Q]!X'=[:-!XN7*:`KFL9/3?U0#?)
M3'0ZH4Q:91(GA%"]'=-/6HLZ0')I$FJS6#%`"\^X0CY+;73;#5".60RV^L'8
M/M#*4UU;M&BE2;%MX2P^?:;VC.37*K9HT&(3;6U%[ZB5@,[N.(/X-'T1R2B;
MBY:$E$)1---D$TT=*#C6V&6RB!@417-$-D4(LT6A!)")?S$@BD9W-KB%F:)0
MZ&8C=R.*S]B!)VRZ";*NSS=DPW:#2`$(JX;TMA$6#_?Z$59-!5NQ894T43_`
MJBED*R:LE%X*(KS'$^R$I1L#FS?&K"^>(R6(*[Y4AVZ#<:KVQ3>@K]KMSBM>
M0`][`_JJG>EXT4;\">Z/R"<FL/J*V&&IN<;\@Z%:]%C7111MD"X`[$;V;_B$
M^>ZP%COGBQI6W2;8C8'9,!;DAWF#6+`Q9^1A+0TTW=&](KX9]76QM>CJQBLV
MH$A6&BM7=(9(F[LTK%KU$Y=4]D&_XHE(:;J"59+7GCA04+YKIGZ"<F1-RJT:
M)H379YFWEJR9&W4<>&I1J*XTV0Q]!*;%72DDL`W7#(7JRGN[TJ>6/%="F<Q1
M[^D%J[=AX`?(L:!`EB&%K4]=WD)3"(=P)?+S&?=.J28ID:746B5T64E]CF6W
M2N0GKOVA4TZRVA,ZY6>H>I58^AJ@XX=V8LI'Q!3.VN_09F15P51AA+:Z.([!
M^77?=A5H@@H#I25-4&CTOZ@)8EK'(R]U?`.;?=HT7U!Y.$7G$;MJ]KS_VL#P
MK#9F'PNM"XZ`0?U"NA=B:BG=H7WH87CH"D?_WSCQ!I#%&29"2-O.-+$W2A6%
MM/"BNFXSD'(L6=H9TL*KP!2MH^@[LVJQA6!:-].[%0`U?0"_B(!2-47NY,%,
MBQ0!L7`DI3]"L'V(/*O^-&W+$(O&SDZ,6#1B%$,D1)[#ZD7$4$?N=7)MRP.D
M/G4*K^B2V_E^:)(Z'.V9;FH+>M/4*5P':IIB<-77.W-/L8Z1K!IMT>K0T_*0
M/[SS7+JWTOHX_>'3+Z?-5W1>F`&9"(O_EJ;+'2-]MA*G>+'`BV_\4'5=U9L&
MG"<(]%ZWU]T]\.+[&-H=56F&Q0M6SIJFZQT1P%=OF+S#'G&M;/C7$IY%`(@&
M7R)$E52(-@<\QY$0/4/5N\W`7CQ2.[K2:3<#?.$Q'%GNMGL],>#71/H-.^)%
M1&7*<1)F!0!%(TY+G<_#+[M.U#Q#(T8O=3+TKH`7CK-VKZWN'G;Q`S4S)W&7
M!PZOF!A;;&;]`0+SMG]+Z+:`S\B'6U"?!E/XBX;M>)0]GT=<D`E`42W2"@*H
M'?]F#C0-OX!I!3%6K+JEX!L*0H_*WK0I>XGT'WZQ@_.QY`=3&[\_ZL-+9Y(B
MCP/I.QE!X'_#S]*].T+.<73A6'J`*K!_+HV0-R#.F22?2U1,"]ED`'_2D^9(
M?WKTRR`XO\>..T&7R,/'$E29)\=2X`XP/=!.>B;!4*+GKCX/7=N>_O(W13MW
MGQUL27[XY!.+(&\J_0J/2K^@T?C\;XK>.:>S*<B9QA>ZY_\XEOJN&=+-C*XC
MT8>1"7:.#D0XECSL8^29PV/@X`3;;F1_Y%C'$NE+SXB>&!=@^,MT1R/LF014
M^`\S7@2G+Z$P<&UWX(:^]&OH0TJ2D#2&)Z"<&$7['(0_.Y*);=O_!_LOM)%'
MT7AH3%-G,$3@=>1(3U@"K!9@]J01MHB);(I&0I#NAC@@IH3&8QLN,_^=,!#?
M0:F9WH#8E\8>GA#`8T\EXDQ<>P+ED4AW_#*VW<CYK-BDTJ#+DPL6'Q&V@RKU
M[#AB*85*7W-)A&J`?(9@<?N$,N5T3#W+[D0_:F//S,)M^7R[<F\=Z;<0[*NH
MQQ(-R&-FW9D3,A1F4!8TEK(4/I86,2`]F$`<$]!=NM[X1/IUP>P5#Z58CD"A
M";(0,-4;QWX#&@%K0>A/!\0R)$"0WY`#;+U8Q$$D[5@"&F"/L25PP<$2HL>%
M2.,0`H0VH='`P^STQ"@TK[P3Z;<(@PH<]P;29Y"%:#!]O3J6[H;P`]ZE9Q@'
M8!+0GYC#A+(,SESA6`IPW;8I&6GQLP*3@>31!2G@K(`$-F8L)`RUSV0@*8#6
M-CO'$N(G&+H6#<XIBR?_)T0!\=WHP,MCR1][B!XE%)F%!IGONQ#A=/\'GN=B
M^B9UKH<';&LALQ?`&X9`G:A,%M=+F0@N2E<X/GL%?IT0$Z==9KN0+I@M66*:
MBV>(?CPP[?K1`9XTI]#.!;L6_9Y.!1)-`YEX9J1<B0/L,,\)B!+$#]!@%MT)
M*L],`WF'4)FS1.4#'M('R=2O$#H13N(@A^9'FE-=<"8\_4Q`]A.U'9B3$@L\
MU`\]%AHSJ$Q:@,VA$SDJRDK@4)J&@#(LCB(8B1P,@">$S2E"ZK%"<YX\9Z5B
MZXTDHF3NA^@!2YO@>Y;YV0F0EN1`!+OQ\!%#8[N^'R?R^`;8SQ]*?=M]!A.R
M+X$!HRY\2J+?0G"$)K-$IZ<273(L`Y=^"`LMCFF.RZ%,^]_VB0+UBFT#`1E1
M&8X8M^4"&L<%'T9G5@+Z6:A1YLQV65*TC$[Q5@#*)::D--.G#^V76"':MMFD
M7Y27HQCHA[1I=")]10Z*#H@%,MD$A,\HOT9K5BH5Q'[!\S$`Z0G9].1V\.4B
M>JP%B"6T\QSDLN``;V//`8/&D01^,&<?&XN#R@_[5!$<)=<1QODH9S$X8DDD
M&'IN.(`4#G2A*_HD38G\NVA11":99Y&9KU`?@"U>HZ]$@"P\QBP72]"R&4!<
M(B^@+2Y:\443"E,*TP]-4,?OAS2$/43HP,Q,+V:16'$&(U:>98V%-UG#9QYE
MB;[B4ONV7`MX58>EQA8P+9D66+3P;/.9F2R_";W4]JBE^1QS>6,36JJS^<Q0
M<#2AI?J;SYDV<K8)G6A=I]%`4\5BWEO],/7(-7[R0NK(_V_O6YO;1I($_TI%
MGQUA1U`</D0]W+L;(<MVKV?;+9_EGKG]-`&1H(1I$&`#H&3UK[]\5!4*($`"
M)$@"%")VMBT)0&5E96;E._L7]$3_DA52^D&_'Q\X@<**&%)^`%0!VWNT`MRQ
MAMU%AR7#B3T44'RZEC.C%=,B8]@5'Z=3&_TP=@S.H)>A&,/QC*V9+6]S$WFD
M?2"!X&/,W,@&BCWV>(]OPXPI):"!.[AA6BULVZR2+=78-9)8UMHV8A]V#0%3
MR+81N[-KI&!;9=N(V+@1NS9L")PRQHW8C6%CP+'*N'FR#8VL>G.&H"ABTHA-
MS)D&2I2CD8E+]UX':2DI6>#[_OB/?,&R^,,67S#MQ@+R_*;HBAV?IDS$!S.=
M.P2)(02SA!!`11<__((6[/=ZKQ7/.#Q9BQ20N'A'<#D0/O3)#Z,%_$8#)WZ-
M)@G8Y!,$B7XJ!:PIIOW@WO*<OV!54.%M%CFN]42KW0`F0//HB&NPNT"\DZS*
MU57A!5@M[)#DLI!59K`?7RHU8$#:BNNM&2(97WAUT>OT>J",,&[D'T"^!/X/
M9T;BB.P_RPE`"\+^U1)3N2J0H3;=/8M,;'3P,H+GQNYBPH\!-SL>FTADKSTX
MP>0$320T=5%*D)8ZYK(5.,T7Q^Z[AFNMGX1IR/25B,)^DN^;N$1&W9%RB2"Y
MH&(@)0R!$FO7)NA[<Y40#(EMBOV[2C00.1!OXRJ!APOX1<RC..6CV+=?A)%@
M^D;$.K_(,M>5<9)@*6=X,_V*MCW(9SDJZC96DF3J*)#*5]]%M(;?`;3W+EY]
MAP\H;B>^X&4'_T%(4"$^$Q5$>5\#8"=G[C*UQ?@@A#L:]4V4WPH!*4'>Z$TI
MAS,95,Z,[EF@W`D)FEC1!W4HDG+`47<W2!@;>/?!>K1!D-@8";6!A?E63]C%
MJ.&!3B6LQ<2).LCP(/G]8(*R+8X#DL&U<*64!M-KX4J))@7*K0URVM%NHH\_
M0)/T[FD=U':0`@UE[/;CM:%Z)91!'`HE!OT>?OB;7D?<GOP_]O%>VP&IH8Z'
MAG1,VU/?CTB7FCCA&.Z+14!7#CSB\G7)B($W,S&G\;.,`/I9,@I[Q#07\26&
M"\`S]CR*76XX^11^NHTH_(3<!C83B"$3"[]<77TUT1"?%IST!*M:0$8&`M3%
M"+]E8@GD+A\,8#+[8-"2Q9.]?TBYLM)WGHDOC29T!5@3N&+(VH2[Q_K#9DW<
M0/N<Y8M20N!ZAZ,&!11U\Q>G"=9H!PV%^S,;K#.MH"4<Z7.P9M!P1")<>"2M
MN-_A&I&(-SN-DU4R,;"GKCV.R*UEZ>F188>^Y82:S>&[MDO6&TL1U+U!>T5-
M$Y:>A=HV`U;Q;-2"T-A3WBFRS.;F!9S4O,R]Q7`KIQ!%*,"DTE=YK"IU8F64
M54R4?Z",`NAJ!]IP)Q[/7Q<$&5JD15&YG+6#%HF-YJ?%DL^0R'=XIZ`1##($
MX4$E/Y)2A]WIPGJT')>\1R!@%K$22T*)O5QV)B`<#(#3E'X!5'#)=1:O']"$
M05(U>64@G'B$:(ABE2\HL@_&3@#&#KH5QDHR/OD+=Z*4;(+.E]2"8+%WEXQR
MM,GF?F"(_DPR1++PE:RU,W`%LAI^7Q98/I/_]I_@Q:`C_:)$.2)!-4272H^8
M4Z)W"`S]3$;9'<(S(<?E(UD(ZA,`\1U%CV@T74S;H.W#+D.T_9]M*]"$`:SE
M8T(</!3FX"%\(,22-](BE`'=_7OAT59CMVL&M2HZS?IL1]Y<BG?Q$Z@,A!1L
ML]'@D+`CO`+=&9/EB)#B:,0+`#CUT4B)O3^9'.1/'2!@`/WCAU^NOK6W7GOK
M;6JYQ,:9$OK76B)CG*#QYDSS:>P[RC7IRUZG=V287AFFQ>^W`JT`&3<CY5MF
M*W"9ZY*_QJ/(N`R'%X]?=L45R&PS8D27@8Q<)Z\;7$,YMXQM@.$P@XU&>-_F
M)4-B'@)L0[K1,WWG9"PBFO`'&1[U/<[64J';5HP>7AQ=<2P3U#,"-W86B5\6
M#E%P*Y$.OX,KF>L*FA?H.2A66`D-M?[CJZ@T*MJQ)T/<RU-$I_[,EFX%^@S^
M@V30`G32P(E8+?1\[^3>!RW30_D&LDZ++I9&K"U)%?B3EH@&W=QBV,X*0/%\
M[\-_3#TJ\ZEK?T+""J52*Q$.L8.?X1X8_W$?X-&>C'W7#]ZABAS9IKU.DCO.
ML2UR](FX[-7M>],))D.]F2__/B>[T'C[ZO9W\V5RU?=['954H7,O;BE1ZR-\
MD%R4;[[[<V<L+ONCM^_$1WFQ22-=.1CCC7PC`\^A\'(<=($K]?9WM6)\.X;*
MJ08OC!,%-QF98S8"Q+?Z6"[+ENO$<,LE0CV&I<.)(DG@X8\V#10_B?P30I9A
M:3(DS*&F:9IT+QBN!4K&P]0`T#3@'@]CEJ5`6/3,H24PYKV)<D`GL*("6;;.
MM`.+*9SSOV5I%$7%/6]!'A:%:&6BWME`VQ3&3D6J^B.5V*U3C@S+%G4K$D5H
M4\N/R[]UQ`-;RYQCPY;\Q">DH2R<8[Y+%+%7P5"\\!&D2V-WDT6@CN'/A14@
M?&Q9+J>>!_8=VMH"DXML[1C"MV7&ISQNSGQZ3ODR9-H.?$+3[48"\;+I\K`.
M&SA2,?[%>C:E.$AE+8H5R?<NT;:@:#T'MK'S=P!F`S.<N`98_1G("25?SWIG
M;Y53)5P`9X7V1`I(&?5'IZH/1HD63XFP-DJ3=9I!\C9(A)7.>J,8X&_Q0LS9
M'B`K`PH1RF5,<$*6U`XK5/+IO^)=H&4'QL\S^PXG-FP^XGV2985*%4A9SOP!
MC-[[**0P_=$.,/&/OCK6V,.O>3+G1[JSX*O2;\V?)4_O1&4_ZAPJNA'X3F&O
MG?;A>92?.>&4"OBC#,^Q6PREY!),7?/@.0X9&H+<="A2_M.F(OR,);B"E+15
M&UVOD7E5+#N?,W)*R%C%O\ESH5(@#)5US+WPK81OZN=Y6ZI4(,/1%SM5^1)-
M9G0L._"[XG/2<"<LJ(`AX4?1#GOAI<X=XW<B3>0$]SD1`4\P*,>[\1Z3W])6
M:9LR=R/;.YRSB:.3=8W6QE/V>3(H_1&^CWF!X1%8Y<><R\'.0*VO%TGIP(=0
M&T2IGLI'$.5S$90YHO(1]`T7QUUUP-]61*6R\1>S.0L,$C26$CIV'`-303$T
M>+!:@5]UC2Z!\'.<4I+Q6B(?T%83G0U=.WW%@)0?1WSWD&RC-%:=N$YJLTQ^
M4]&UF?4LE>XI7LVDR[#31.^XB;+OV$3<M<JE1$K`'X31K:KY(N&HY9S2>Y2B
M&E*^Q8-S_P`"RG7@'%$\A5&PD/E7NMR(11PFX#L`*;#U#%,_4?A1]""P;3$#
MB!Y(607!IQ3'5'ZN#(U?YZ3O<O3;XLJ9$!5B&R6P/9$R%&!;H,V-[I6HE08U
MX)+?_,B6]0JZ,SM)[D1Y2O,YZ*C%`F5H!JL.L$1]$1J-"]`.QLBI'9`!%AG/
MLOH0>/NTVWO-]7FL)LF*:O4(WRV@%TP6=E:)\"BW1&(,"X(M%CCA'Z3FA"'I
M30`/R0MTWW+Y`NLK[-'ENAG/,O/PJ<J<M:Y6QAR>Y3Y9#KMC_Z%JJN(HP.?X
MMFH^/QZUD!D#5W$-L;0JT%>55\>C"GBIG7AHEMB9U75WI)J@S7:'_C&277\N
M?&+K@#QX%,8@UXW,8@W^0.M'XG<$>_X5PS^B#^)GOE#E5RE0E5C(%Y,&?&$F
M@"$((.PRP0#(^@%<,/;8H70,^`-4D8A>-O2G2K$&OUN">J"@;BIM')&0^B:;
MEVC3R`QT7OMA*Y]JNJFT;83,Z$W(?L&J9M)ZE).63GBI68L]!8Z-$JX1K5Z,
M\>0%)V!1:6@Z5(P/*`<V`+B8@KABKXJJWJ=H`#>H[8`F,X;OXY^GMO3&J"5T
M2P2RU>:N)?W[](B'G^+"8\>C^N`H@/M3"CR25DRYX3AP[C@D8?92X/)(Q(V+
M\0X*W<IFH]S$)[`G.K`LBPVI3ANW'IF9WZAP.6/JN9.'4>F3\_\M(RN@-*)=
MR($!E^H6.=K!#B1L*-2*P,-+A<]@*GCWCDY.(T]C\P7$44L]1Y^9[&,CJU6H
M#@6`<+C8)J?OH]&7)%VM'4L%Z236C:0<*ICW@XDL4<-N6R#"NN**/X"^'_)4
M&ZUW4DU0'JP)A0H#VQH_H+!2?R+)-K6MT.%J:)4*0VJ<*98`".FPEU"0TA6J
MW@I3![WS)Z[#_;J2..I@7N^_R<GN"P=VZP3LH&<A+3`*X%+_*=>672N$=0=;
M]RE+KRM^GZ-*J(NTC4=5AR+E*+=D`0;+U9DU01"4"0O_\U#XX2=<9ZK-UV5X
MXRA$T@./3[.['J,2*B7@#H/M$76287"XU1#=5D8:4F`4H;"S3W4/F'#^#T57
M$?D@\+E'6S)[!_$59D+,6K'&K"(3;*,1R9@VTB7HTWZ`>CB7,Z&#<&H>B*R?
M\0-T)3KX*L6Z8<<4N:'V<'_"MU0VI>59[C-0?Z(?`993S7#^ZUS*-;@@,<!N
M,<D[D>%-?<(3,3XODY`R%OB>K`F*'H@K'AU@640L'>T3CDN6#58H'@V\\!=V
M[T$H9"2;VD)H-RSI'?:C%9=VT>V?**222+$U^`X'[`F5KO,'EM?!GSSZI>;J
MI9XFV=(#?2WD_,4/H-*4,J6`,"838FG@TQ3K,$GAJKIPK[W5#WY!:'%.#C75
MX<9W00;@L9K4C:HK\AHW4*2*,AF,I)@#Y[:H<KRE'CEI6GJGN44%1Y.70,+S
MQ\DF8H[!B@2-*9D<UX*BJ-)12_,"\Z5UWDGW!T/Q;!N%YJ268TYF7/XGE55N
M`FI1U\@[%+:N]9Q\,%$+;OP>@>'E=5%<JNF7?%CR'=L-YK)K]]45[Y4[(B7V
MM*^T8\:;XYY#'%>6&2B/RE`(L7$DSC/F[F)T.:F@;<[WMY0Y!HUH&-;+G%:(
M'%YUIFGJ!.D-YRHT7X,^:K-`2?T9:%S4@P)U0$HZ/V&?YMB<:&X]40*HZKAK
M\"UWEE0I?"I[[AZ;^,K6&#)IDS,"E?M$"3F'6P6L2<;!^A>I_+#%8*MT29V+
M8JJ=U'\8'W_O6K"?V_&#CSYF]!@C_#,?Q#9(3<Y%T9T6EP72.G1D;9HA6;5P
M1N8/)^;([!\SWP<N$UB)\M4Y4Q[M%3A/K98_4@M/U`]9(Z?0V!2#]4F7<RLB
M#R]&/GM`1$SYWZT?;<I@33>5EI"&!'/H!$6$IT=:%E46!^@KY4X@.AP$C^A\
M7I!%P->PE!^D[6GY!X=?".QH$6`+VRO\D751Y8]Q0FJMY['#U1+Q'SQJ;JF;
MD&-CA(GQ.<'=+]7C60!0=R;VM.)[\`76,JU(Y9_+)'C.;>0K@US-4BOWL:'M
MU`ZXVEKA*"<3$21D`CE68,<X1N3!)LC,)BV2W>996N0;IVMW._QKY\''2PAE
ML&U%=%G`4Z/>Z[<=XTQ092;_$>9@4KL/I8AJ]#RI-ADAD!/WKUG,98V$_</2
M#AMTK5@_Z#:4Y9H9.V._MIJTD*,*@XS&,B]"@[R,)_JB!?7_3K;].R%G@7)F
M43S20L=Z*,N\@WO*OHCCF0#*G>T!S2BE/%S"C@('F]';G!POO6<+<F#94>1R
MDH3X;)"^3N#0#C8R:230JE^V>>S/0@,LBRKD'<B7>EP%`I!H2LHG(=VP/WHP
M^Z3$)(PJ!;F,9(='LPU.7%IO4)V36X*0VU;&8%CVA@NN#"`%`:UG5>8+YV+=
MN4[XP%P'6UN,[<QM.E-\DP1%B-BFA%ML2X3*R().FYXC=R'1$YTDGZ)*])%-
M7N@<N^*6&[_`YN"8Q\"PN2-9YMB=\5E6A(Q=6`K$J9'7@SXJ&RQN.@`5_4)'
M99*;E?TJ7Y/Z'@""-9)Y:^OZR0Y6Z]%6]1?\P%@W/CP5;DMU/'64WQC]SS)4
M:\JD.8Z&I+YX1FJSJIG1G=54'A%V>(6W*!F`FZ&VBM3AM8T/3JAZU4ZDR:D'
MXS1>_3AJG2KA$,^4!.;L$ME-FV:,J(L@L/55I6H80BK:5@21J*]"38G7-)W:
MH>5JAU/.K!3',X>3R+@6%7`;[V:`;_0?7S<VA4`Q^H;+AN&.E^@+/.SJROB\
MQF=<R;8LPQ(7'<MSAT6VK&Q19B?%?92#E8-%&;=>HJT>25W*@E!?EO,7>%40
MXG%MGZ&<:M!1L#JQ/?0&A>O;YLK68^19O:F/5H!Y)GRQO_D53TI\!>J\Q3$`
M1[1/8RN-ORO31JSDW9"'3J&Q.N:<',==T)P7><;(_SS?P4P`__CUULS_EH*(
MP@WP'?@K:HU@6(UEXWJ,C#B/SH3C,BH;DG0PYG05FE8VC0"A$6!G#F]!@H]C
M,C.T0>2L"6/\Q)+B%LN\KO@@-X1`*8&I^F6Q)4BF3;'%.;.*_FETH"\+TE<?
MLZSB:#OA',,F\1P-M=E(-D6G=J)DT,J!:)Q8I0:%Y+SXYJ(SZ-$`"_6$M3R2
MT4A?3/5A?"L;^^MHT]KU^L/1FM7HDSQ48]78@K=P<"O4\0X8&!J'8AW^J$4I
M&@%F]VG.Q)O-%W%;6/4=OHB!+`WBYQR,"=@B?NP3P)R)$_56<R^KQ@LW+;&_
ML15*L'ZE,H_O1D>]]FJJY::NI"5@5N<X82*#2?LYWSAO*;4`>YB@=^[!%^@L
M"V&MUSH[:(4VGNR.#T\YF'6$8QXM6=4VM6:."P_\#&O!8CD?BD,U]!P\B/X9
MG^9S87MA4(,CSE?"Y!OYDU3]L7=4>@X0/AARET;..&+Y)1]:ZL?[,[[PQGDD
M9*A5,2IO=):DXLFI2SZO5#_DY+R6B3TF!TC:"E->+*,II5#-K2=VH%W&5JJR
MRGR>_+;4=XGR[Q)M6.+!:-A<_PZH2EH,=W;TQ%9*S,V40XP>U5O;'":'Q8CB
M#!MA,@3+3-^)%15R2NJ!:V`B+F@@0BNX7VH3)ZYN!VH/[`?,L0<50KJUV:I)
M71C[ARW7?#S8@'`PY*GK/C6N(48:F_@S-7MJG_2\K/_&FT*?@>I5C@X`TKEP
MV(4;)C]+?^FFL)&:3+3-W*%=SS!JTDAH37PO=H91X\7J5:B#8;K&"</%CSY=
M^(E\;S56%A-O5%D33FM0,2J..V*3MCN,Y]EAR(DE3P_8<)]JCFRSL#LUDYZ\
M?S2I%-20B>S!2)*$')&>K_MOZ51R3BE$OVJHJI]LKGV"ZSOPGSGRTY&]<&1?
ML=1>8R5%I]?G38LFVJ6<&O<Y-Q:V/B4)C<38U9HSOBG9RC>K"[`11\MI5&H'
M@.RP-3=K("';40&UWT$[*L`[KE$!#HW`A9^[(\=KR7YM>\)V?$`#=M".#ZCY
M`36?Q&*)<+P-2QM_2&UWTK8[:<LJ;7?2HSJIMA5IK8ZC^02E6?_%M")M_)&5
MZ#M:I)EH9T4W4;&RDRA!T783?0DTI\7$R^DFVO@SVZQU:*=9O4.UJ%O71)2M
ML!A:V2XDOX]HVR^TACMP7U*_T,8?5]L<M&T.VC)0VQSTB$^H69U`.VTKT+85
M:-L*M&T%VACY>CPW1-L*M&T%VK8";87(=H;`,;8";?SIM'T_7VC?S\93[A'L
MP#W>#J"-/YRVW6?;[K-M]_GRVGWZBZ!0;T]A]/54'K*]]_84Z;Z>!,EOOM'.
MDL/#AL#"2A_E?%W=[/+.)C,VX=)%KZNUU/\RT4^4377N*8K8K*J!J,AK'HJ+
M)#J%$@3ENH4V]9IJ_D6KM:#C;M_9^'-2"I$ABV,YN=\&GA*.=!-/<9@&G@1-
MJHFGV'\#3V4TR@(0<9`&GIS=J9MXRK9^F>UZAMB4SSA>@]N3K7HL0/YLAIA7
M>94:7T;[4N4QE>A2]3,*97`+.&W=60VD_+%W#6W\2;4M0ML6H3()5E^0'ERF
M_'N=)P%_&Y3O#'I19`VAOY_5_C,IV7?;`E3DM/]D`Z-M`5J_';A9[=PX66)%
M2[<F[K3Q9[5\1,1MCFSZYH0LQE1'N`Z5%2\IIJB(@IDP]T/+99^)5M13*J'9
M>ZZA*&O^H6L&/?H>O8T_JK8A;]N0=ZN&O.>[:<B[FUZ?@-R9$Y&K'[YQ36X)
M('5\!]T4<`,M`GME=\]3H[LG_/OL9-A+=??4'#N/?MJ_,+CQQ-7B'GXA9'?]
M9+M$V[L'UIF(?]B8P:>\27C5ALFL;B)Z!]MOP9=E(TG*A)Y9$8:5T#L?1'%&
MFSVA:-N$\\4I*=CQC>0TX$0`*M#,KQ;5H9WDPNAE].Y]=A5RI4@R6X\*;C#2
M@P%9ZCD9('?)]&/5Y/*;+3.5\7??8VC>C'VJ90&=Q'WN:!ABTK[E3!/#2_46
MXV*:__0JU"]-/MQ)8=!UL4Y1XAKXC_H6L"A"AZ:LY,&OO*)1"G'!LO&$=1_8
M[,$CS,B/*8]:*'/0T\7/IQWX`R7+`>Y`HF(942#[PZ'(LQWB0Y899/&.Q,1Z
M#MD=27`\@:R.J&UG!)OK[HV,LWJ_95VV>V,I/G;/ED(U=1N8%Q,:B%BDKN3F
MK7QGU.^]^>,MLM#,(:FGZ!-]UL`3$2JR>:47[.']A$%O*B0,%O?B:@)G"=S#
M=-A)!>]"Q>8,1&3/Z-NWSR'\4_PRN_MOTWF3^KM)\F3M8Y!Q@F5PLK@L\",_
M>IY+1E:WS\0?<V5U,BN+:V)U9U;M.L#`I&RSDUY?B90XO/VJ/R2/0H?N$/;,
MOSKCZ2,8Z)Q;CK;Q$QU";`^M?S63A&!`WE!)^3/+H3(Y8-*XKRN6_;-/'C:?
MP58<AK;&U#J$DK2F$B1*VYC;1+?"N'[%DQ_\@7^5]0+*-'F1S(0:A.6&?JF^
M_MV8)K,TA'*W>O4Z09,Z?M]P'@/QQ."<B'J05A$BFY-[\)(&=2(Z^2=>91]_
M@/Y._C)UWXDK?3>]25Z?[QT@_>7'3-&B^R1_`9'Q=PL=`/A6!V5$N)#-#9FQ
M\`GZXA.[YC`-U%;9,!EB^/K!L<V^#S=34!3MH"N^&I^F5%$33%:X%:B=I565
M(%Q25D*U3^6857<UI:!@@5L>1)RACY?P"1;#*2>T$YJ2+D0)8JDV1R3K8E5"
MZ0^#SBD.6<)>W?K1P'9F=[!C&3=#>%5;;RVV53<UF<$*VY47U]()TW=9A\"$
MD%B',/$!RVBTD5:15"(8+;@S^*^_B+B"(EX[YRS,M0EH"DYRP0'N_A9[V[&8
M[JD.M8TWS)N_`REJ="2^/\JV2)+B)J7O_H\-FA?^UPG^<(&^.^+K0_=#-RUP
MU)_%U?M,<<-F[))D^0!"0;]*"KN6+<!CM@KWY,B9J\FC$_JP,VJ.RF2<"8B2
M'7%@)8N#>Y*#L=X=TS7S%7;ND2:FR`*@M2L5?04`20[B%,<4%YFCV_;7XKEE
MFQRV*6[%BQU8\*RO%[;B,Q;>WH+GL'!A*U[LS((G0`I8\9^0F;[#Q1:2H0;`
M83^S-VS<OY4-A#:U[`F(C:U[$A5O1F\-(U]D&?@-Y)>CX?@;.'^\<')8?GNM
M_)L?KE/+V?.#Y(AZW+<'WYM8@M[+4\SYHTZEBCE!D0=MQUAV=ZHYYS<GU'.Q
MI)H[A;7R4KIX4^FX^9SX4>E$!*3V_FB.?+*QN,%W*-WP"Q#N>RKG""D['2,4
M=-]*EAM>_"RN/][P16>R+Y.IO@>NDO>`^FS,%<I-S_7>P<R(%2U_I!/#A24*
M1@D0<V<630NM_DI_'2GBU'U#TC*!\&HDW7"R^QZJ#OT!#W&C;KZ6Z\ZX1Y_F
M#V!-.>A)DCW%DK`NAUUT1F84;FW5SF0[#$]7_>.FU&9-,0,@=X2TFITPY+Q3
M>N&6,X;,)*;%''\\3:0LX;R[19#,*N+"^$#I1LC>O>[YR,@;HA0CUP]E%_:Q
MG?V=4#4BE&EF-]^O_^][_.$W_U$F#E]*)9PT!EE'K6!GZT`6*:'*I"O]8T&/
MS5M(/:#3-6)P7+;#C1V"V<*U2-W@VJ>(TV<%&5E&WYLL#,<)O5+"JF3M)!]0
MEVZ2K_$U)>5K1SQ274@H6TR$[\0;ZRULF\XAM6=ZU&SQ*M6@GVF%-W?J/5E0
M4.3=T8N3LKN&*\^SFPX0<Y#+3`/1]+D^&+R=JU?"06"8$.PB]KL:RPVA-3E<
M,%$'+Q.NG$"7XTM!1EZ03M*G@O]#`7(+1LKXP?'S;IG`)BE$WI979XE;1F8'
MRVOF&2V>Y\1M0V6Q04#-H[F#4LZ5\TR/8/H8`]X55[I_#!J0AM#C#=*MK=K!
ML.9-0W6PJF(1H>>'9;JLTT\9=(MP+3(P-0,[FZEK"@O</,YM-3X<JKX%J4MK
MD+ZT<M3NI7L,2X/YZH@O*KC-SHS;K)-YG:6C]?FK9-QRXHOLL?M+X,,&/GOC
MKH";+T+[-66IT)UH1@MH!!F<^U"K8O,,Y>BS1M]70#@@.GV@2_=6EJ=/TG&?
ML:LJC?B(0^-2T:E+JGL:'._:ER0ZID[`#<X`V""492_)GA*'N9_R`X:M91!;
M!LL1!],J1?WG7N;,%5*&='U:86L_+TI3WN)?;=<G?>+9G,^%)$5C;H7,>G*\
ME3#J8[=%V9C;LE%/\3;9AW%]M$T^&-OWL8M_?;PM#Q?D6"@8:^-OD)//FCS2
MD+^\[)U6F-1$F$B'WY+!M\KE1SGOX\#)5#7^!RN/Q#6W/84/\(!/?#`E$#Y[
M>`OY@2D`5&Y.X#SB!73EWF')JA@;7TG,,@5R1"WFOZU@9KOB%D@0%#66;\`J
MUK]]FM9#EQZF!Z\*H2U?X\R#?)DSJ,9LH&%G).N7<(!9*&URI129JLSID%09
M?*PC]4#`V3VV5H(MZE?,'"/XMI&%]Q&U,GP];I3K3]E&Q91?MOA3E4<_DRF*
M?\:C!AIX+_[)Y5E*W^+A`)AQ:W[CFK]Q&^MG"?,^:V/\KC,5L0\`"<$QM0LN
M7P.ZB.<EX0?.\C[`/5/U^PQ#ZANZ0RG-#?\Q=U0<9=E]<2&M\W$")=?%4,)H
MY0JL=6KK]BBY7(D2K?1F?Z,,2KJ"Z"J..B6I!#^UA"?IH0DUFZJF'Y9JS8G?
MDIQ&($@<<;^5<"ZCO+)2D.^_I(>(W#`R-5LVY>4D1ZJGIJL*64$6Y24P']BZ
M=-0"9>@U5_,OXOM^T*,0M:JA7'*02<%@,$"V@XR"U(DXR3`1*'&Q8W`46%QO
M25RN#F41:DM.&%;<G</%F>1WA%O?CN+D3BU\XF9L5&0D!8=R`482,X?RV;<7
M[,H+=MF!;]ZOV9Y\O%>J\^03&$EOOMBW)U\:IX8W7QS$DY],ZJ)@_#X\^2N,
MEAP'ORCJW-_4$Y+T]W->\GJ?OTCY^U,RO"+?OD1,AI\D9[>;N?L[.:Y^WR,E
M*XM]#7=_39SYK?@M)GZ'F?)7#D.PDZUY^CTL)I1=H)GEJ6+.Z*80\_8G/XP6
M\)MONIH-D_9Q[I;J&D<*$U9=H+>6QG0MEQ=<2&'(HD[^P9C7)5NA+S6I-MK_
MS+B20'8!2K4-`H-I"5`:21PWWKY[5@,I5`$!:*[!Y(13>.YM/?)"Y@]1T]FO
M.3,1>6XB53.8/O3,&8ELRMG!Q'[4IAP?4YXEA^BE(DI\Z"[@Z4#P^PR;L+-*
M^&9]O^7C.O+Q%5QXKDA4P&3H4"$0I!6%6+GAA*X=*&7J'WA]I#4J&EMWK>91
MQ5K6-^Z:C\QZ-46."TVE*X[#(`QJG14*&/K9^*DU^M>J;W7,[TA/HZE@+;D'
M1Z8X&6,?ZU"P:24=?=1!4VHK8+DM`HYA`3[OX8O2LHQ5.2PB?"`O,3TLPPUJ
MM?Y@1!^T89UG>@`_AA.-0]H>&G//G7SU#=]015L9B%S.1B93G&%@Q5.[)PT\
M"3_AK5S6]@R4IA6^L+C&I]Q&HTU#88;&U^_VU@;`5G_7]%?DJGU?:.R9RN0L
MH>^5R>]07NBB>F#V:911`W/9G,,#15@]0TGLKU(2A2F81NQ],W]U]C-YG^A7
M!`7_^AQ^/4D^J7Q5=O+7E\=Z'QW7S33HK;Z:KKQ)`-_Z8'F.[6+G"GDS?:#>
M$#YI+^]5I,8<U,E.1VDZ@X(JX[2OSGJQH]B4:Z@"Q:L4$F&C;>469^9M+[O6
MFJN2,<[SY994Z[:5727M5XWP3,G%(EE*KW3M=J;P56'Z!&TU.%TL`?>!JGZW
MVL$GHP'XBO)N*0(FDJG#F!QD596>=X3C4SNI^@U5S2[#N&HBE(K74B18*1L^
M^S1"V2%1KI?B,$[N>34D_GZ#UN\[\0JK0#ZQ9A0?1>C\*+LCG6]2P:Y$\1V!
M<.#D++DAECVXJ5_M>_8N&M_T5@F=>)'UA?N$!XG/P7GG8A`C='C1N3P_?<NB
M>&L@BIZ)A.5BT.E?C#0L9X/.Z?!2PG(E>TN:/0AE"_U0>UTI9(I#)8S,`![I
M@ET(J*5\W-O'H;]%F9`,X50N8JR<=BZPX&AM-F6)?,B*4RF;5#*?3/TQBB7[
MEZI^'N^AO_NA/7_0R7V=(A6D,M4,&2M65Z1V<L5#FS]3Y&H6J]::]W-<K2SN
M,JL[XX+_9-'],@#%"G@X'"<S?1I[01Z+,LQ''.>C9=&DF9J&9YQ'9&NSU;A[
M"@9]E1!E%!EE8^_-*JV8NM)U8L77S$S4S/8/8:[`;.[ZSZS':V\&UUY'3SXE
M`W.@*C-G[F/\=G;67#)9>*D04PT,T>'Z<%F=7>.3R@<D70+':6K+EHJT#3C2
MDNF"H6\DFO31N[$/Q@9:I5&==!LICQ=-![[SO84J@$M.&T8?E!1MCJ=T-TP8
M]^%#F"`0V/&0X/QM<CF!JIU/Y`=2_;ORNP$;H=><^HCZQO@4RNGIJ>1I<L3I
M,F>@W45`@USF0,K.8J;J;6FB"/FUDF*0.OSQK+9'RW'E_9V829_Q;4Q#;JI8
M.2+!"$22S+&3HD,+)<K33[6:2$BJ;-D3W[+)<GV*S7#R"0Y\YBN;%V/^3=0%
M:*&LAZH6:#:1T8KQK"N,^ICU936U/[_F4V!;0-.H`IK,JL^-JV6*IY[LK5I&
M*1JZ4H:`V7.UC$A4RFC?3@.K95H15[0RALS,M/51ID6$7B:CW9>A#Q,0I0MP
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M;2NWMI5;*UYW5NGU9.^\P$N8Q5T$Q_X+O$1<W$40'*C`RV0+@F-?!5XH)6I4
MR76\[15EVBCGK7!.HLEU;$00Y^TW)Y3R#T\O.[W+<X(!<Q`'F(,X[`PN+U:F
MAB+M)%(P:4PT?[%_-NJ,+OM"?>Y\`-;W$#Y7)+%2FY;9:93(0$L22^WDM#/H
M7^IE+SMGPPO9NCWRL;F.Q!.J5_Z]Y_R%LZ]8\:&OH%AR<<=*VPHY;;9_>=XY
MZ\&'&6Y\?N&QNUIN"`75<-`!&U!:,DL@[C:C4\Y93$U3?.;_OV5?S$K9FUWC
M['E$T@8`)ZR7ZM@!QI=MSH+@R+.D%:D7/8"]"9H76.E@G@)1L'PVR+JC)]18
M<%911Q%9,&%GO3("@X6K^8FJF<Q)GK=ZWJFFQX\_0%/U[MF>E:/@S%%L'Z_-
M,*[I^<(3%8,^15B_Z;7$[<G_ZXIK=+XY>+N@*LA_P-6FOA_1C3C1IQ_*:Q(>
M<RD+(&:B+.S%^,E`@*4I!75DO*@0&?'D6/@[^I?U:#8TA>&G6_QZJ#3OJQF<
MX]@RL?#+U=57$PWQ:<%I3Y#Y)C2T=(81DTD"2Y2\!5C,/I@.9FO!J=XG!_@A
M)'>VZ]B/J%Y@/`K_:N`L1A.-AY^@E1218*%\,%)D#-3K"=0TA'Z&577D=]C?
MU+=#CTN,;R#3TO#GH$.I:84+CSA+YFRN96/#N)$\'-A3G/V!?BXX$@1`VJO2
M(TMZI.]BN@'E!2+%H]!>!.SIP5&#4B-D]H2C]6PLFC6GBI-..#=&SZZ(K<5P
MJU`)Y=O"S<MFZ%P.'9$I_I1#.45[B6T^-O`4-K)BI#GKLB=+HG.]1$P.:*1I
MD:CT6LRIFHP9*7<H`S$D`#2/\-#`%LDE=_;8FIGID.Q,BQX"S6+D:6/G:,:9
M/O%D8C0!$"@G3+`17]JA*KKAE3OF@&/RSK)`)?5A[`3CQ0RMB+'BY"=_X:(,
M^',!>H;@=%6F%L-&P'#OW`\,495[D[#+4,J&)-LSKD"^P._+`@N*M?^$!=P=
MY9==IAK=TD+=?6KB_8PG0&%(&_V58TY&]:?Z,YRBJ_U'FK87P#I3V(K,["+"
M`+;R93Y3N`(/X0,AEJ+H%J$-Z.[?"Z_`C%1)IUF?[HA8.\+7\?(*V9L!>Y@N
M:<"YMB?9>;(2<0I'/.'IWOD<Y$\=-J(^?OCEZELW2[4JIA]5IU4UJ43F:BG7
MA*>A/OJ1G#R%A([.0M0+@.Q\GG]K3S&00!0*ABT($2=\H-%(((J?=#8&RTLX
M5)<SJO$6F&O3..80@H&T!1HG!8PUZ3#UD)@C%<)#:P"X$PP#.51*Y=VB?P*6
M@G,A_9Y4=W3O^\^@-3BJ,`N^@TI&LM0X,9A=Q@_,45>PM7MVAU#1Z14I4K!/
M-;4J,U%CW8U(UK]6-9;U,X9C`0()E%"6"8;&=K]P^%%E&U'P=QEH\G8#LL/<
M'K+;<LBUWBF<82VMC=`N<!Q(=U*5-.V*#+WY]UN!*J[TZ9!FR9>1LF)3)C8]
MA]>E&5%'EG(F#M5J?+,]_]&Z1H*X'3LV72A<A(C)8+`C!RQYU)#IYI!DF+R;
M:-2;Y?+-&2O<H!7+E+=NUBKLEO=4V-\VQ:QK/6DEGZRA2.9K_@;JQL3B'%4L
MHAN824%+XQ[R:6-;.FJ2?"4B+*@I9QBWU1$AQXG+$*+8$1%R%D5!0A2EB'"5
MC"M"D<'8"M[%4O`6W=I6,`FO_0DAH9Z"[HK&M4_A"D,B844XU#J8C_YR`#EV
MKV7<)7`/SFQIBM.G5*@S>0UA:/T>J[$\I%B@7DV,H=36I!H>)X/&V!0:G00&
MI9\GZF0RGA0FYE^(&9Z6-W?6^(_[`+%[,O9=/WB'"E5D*Y,=V4#YD&4CE=78
MEQ50AM_FT]5MH@I!!G<R7_Y]3J:A\?;5[>_FRT3S_5Y'JOBQ6G)+:LE'^""Y
M<M]\]^?.6%SV1V_?B8]24D@[7?G%XHU\(SO/H8`2F832(H;%U8JQN`F5'PA>
M&&N3F'*5,_4DC("082^759I5[$E2AFBFL6,G@<?D7PI_GD3^"2$K;9S+H+,A
M^E->!L/#@'!1T)JC,V9S#`0IDJU0P)[W)KHFR,2*2IJ.\WK!:%+90ZHC&>4%
MR'(DA6AEI=[90+$40^.4J3B(.U*-+G20RS!N==X:FM7RX_)O'?'`1C,5W\H9
M+!-918+Y"IB1'47V).GQH$>0+HW=&:D+?RZL@,;C9K7B(&/B#LUMX?I@R6O?
M$+XMS7-YW+13M`T2+@TZ?O(V:[K=*%)V^9)DTQ<Y@M<032!JM'Q1Y]B[1`V$
M;3NRZ'`\6`#*!5.1N`8(_!E&M*30..N=O57.@G`!Y!+:$\GURD:441[-<R8#
M$XNLNVV2(B[AWC_KC6*`O\4+,;FB`9P!A0CE,B8X(8L?AR]J'9G2[Z/^!RK2
M,_O$)C9L/N)]DOXUY?@NQ](!H_<^<IYO-"R$KXXU]BBQ1+K.I-D/7Y7^6/YL
M<LAR(G%7"DKV1FG?%/[292N4FQ=RF(1=/LCZ2S!US8-GOUAH2"=\4\D2+AW<
M4"Z=L5A2D)(69*-+,3+E'YT90:'$S,0'O*%;#CW.L#_WF55:B]0L.A?8@O(F
M&'MA48MOZN=Y6RK+*,-;D.DPU%&G9<=T5WQ.JO>$!16\B7AH-]/./"YD-J6_
MJKY+<)\3,?#*H8SO<'H3;X`(96FKM$T4V5'.1D3.)G*5]0T4\(IU]R89EU<R
M!E9,^<]T(FVO^$L%HK#R+S95_"NF%V47_A[:-]./<"(STAP/;\[A'<(.`*U2
M%@V6XX.HM*"<WC[2*XPHK[ZOC!P5%4:U%?*TW++@@I^IFC<4'982(W8<L3'2
M)^!Y+)C&5UW'NG-<OA)5L6;6*U+*R2[#*@6&U4'MTDY?&NC!C?@V(6E%J5[)
M#BC3183ZOHH#82@"2`D90_5X"(T=9_J^DA15GMZ:)(+4Y5F68$75Q)I.2RA$
ML*):8DW177&"%941JS1DUA#L*C_9:NJ]!LL4Y_?"?SX"@A]Q?%D4UL\G9MJ-
M2J<-*8#UX-QCA;'K`/@3RI@/%K$,C8O2F"2!F@,'%L-D>2M:4+(DN22-GH>4
M.!8J/9-L=SO&35<@LN+$`>-/)%TP:X6VBXV_U11">R)IGCH2V4AI,UV.DG9L
M%CF2RLZQB<*I)"&('1`!PU&&$,1J(ECIZMZ$(OC/O_I@5GZC`A34&?F7->%G
MRH@+-&PLWRBE_`M*6?3<Q4G<LDYEW#7M>'PXZ>@4"Q##8\1N!\[-(B,YG:SM
MF4'K9#XW"%_,5,T>T/$]T^3C8!`L"#97X(1_T'T2AJH;`9VQK1-@^6*(DV"?
MA6>1S)=Q$2K\NY>E.1FDL.)4MR2`)@J"`A14A"0Z&],$09%-%V)W-+%*5I0@
MD$^6$_P#JRQNIMK$^QR+S5K)"K`+@V?R#4D-#-U*8U/^LGO#D,%TIIR&'IHU
M)F9YR9TE*[W\.W1G$1')2C*J-N-U+/:TS&0?*&-PRJ\8?A!]H);Y0MT*&>"J
MD\RG5P.^,!/`$&C&M0()A%PP=J[9LI`\X`]020XZQ=!JEI0(OSL1$N*!ACB#
MA`K1167$M#^YDQ[F,(^JDT3KZ=/4#SH5$B<@.RX<7T^B8B/RU.)T'9VRV1;#
MFT^N@DEU"=(D::X2=1O1Z6?O:^!C<C&H%C8.@`'%RHAJUDKHZ:PV`,:;D"Z*
MQ7FD$2DG+>TA+K,QPJ$JI<^P3_4U,_:Q4P:G:J!7?)*.@>(#2!8`_&(*!,9F
M+9S]9#'FYKV13:G=*D]/N6ET79-:(O3'#JU)NC=E#7)$CC*D\7-<SB?'TD0!
MG*(D4R8M"[N@W'%(8FY%6K9S.1SBQL5X!\4C`_151S(".98Q/A4Q'?-4;JH4
MHM;>*K.9OPRV^GB!(E9A5:0Q"I__MXRL6#R/B0,#1N=9:<$OPAQ?4B'RJXQF
MFZC3%2;ZI>.I@N"E%"U.]*)R@I=EWZ6)7E1.\-(36)[H5TGMC3C@%]^?X*[@
MV<]P$7G4"?N*''?U]%4Y&DKV+\;MB>#JAF\XKFX+?@U'"::%[NH%R,`^!Y$]
M?O"P&/DY+H72F1/JI,V"1QD=Q:!S0"52$9%D5USQR]2:`OV=^+)<2X4%C<4>
M+"Z7"K";*Q*@^A-1Z]2V0H=\I#I1A30(D]2P]P6[?E6+BE"57$\=]/&>N$`U
M$P-'DN0!3XDN"0[LU@G8U<N,)UN#RWIV<D[#Y^]@Z[['LXQ_QUY^X6*,%#9=
MF(]V*%W(:`NO^61F372S!=42Y`'[`H8V?L)UIMH62Y]KQ_!G)WVY^#0[?M&_
MK7(;,M+O2?KH!"%=`F5V&;DS<N19=Z0P,2(?F/@O*TY64!2"^`HS(68E+,8L
MD`E6UT<R,._J_HC4OGT:<+T1>JVFYFNRP`7KA>T?#KY.07O8,<4`J'0`>YCH
MC'?/<I^!`[KB2^S`QV*`&19$PQ&!E>)@EH#%Y"Z'W,<NOB<\$>/S,D4H8X'O
MR<(=[/N-WGH'6%JV%('SP/90LN$!!=:!'_["!"49CJ<28T=J$O*00'C:CU9<
M>T42/5'I))%BJRT@*U#I(:+2=?[`&CAJB(^_U%R]W.X@?68JJX(]DO@!O`A3
M6GQ']W#!SC%)UN$B!5Q55]:]D.S+1,(9>6%4DPE?]>4RJ(A56(OKX.F`QE1>
M)4-(Y'3FA!A5G[;V[-YIRE1/Q,(VX2[B[!0Q1T]U1^;0Z?-4\B\NC$2Q8+3Y
MB2\+7QI=G81R1$&\V=R.#)4&,Q/C.CAYT?.$#`MDGYZ9/`&MX3GY<**8U_A]
M]*!M/E4E9L!&'&-4WJ'.92Z;LR=5><@?[HKWEN[/DY``VLF6:+T0M_[@:*!,
M6Y$O!'03X$@)>1'$O?^SOQTG6E7'WV(=;V?:$L65HFK5J29:%<7T,;$C78RY
M>;T^UDDS3+7*6)P;O$XA$SM7QG1Q7IY")O:JC#$X60J9V*,RINAD22$3>U;&
M9%`KJ9")?2MC'/-+*F1BW\I8MOC8B3*V]R9-.Q]OW-#64VE?U'K%4>Q*:30-
MD"**H]B5TJB<04441[$CI3%.BRRF.(KJE4;MJBBM.%9G%,;NDH**XRI_7'DM
MDI)TJ0&P;`M93Q><8MX97*;4/`BO=RJ].N%HE3D+BE'Z1*G*W-#3,H]@9D</
MONXNFAAX(WL;R4H/+B/0[F=''LK:]$G,Q3;2#5DCM/6X'Y5!:.X+W:T$SGO7
M@CW=CA]\#"9B:!#AG_G`@=0C16E"&715!!U9FV9(5BV\*E_3S-",FS;+>C%4
M1>&LE<9%D#SZ*#;P^F>%BW(JIIBME8PF)LRD=62Z#3DWT00JQ0^B<EY0LKLX
M/XC*>8&S:3?@!U$U+\0NC9+\(,KQ0FZ110'&B",V@`K[N_6CWG+>H#N'(!:1
M]</FGEX>3_>6S2"Y/[=.KX#'="D34!&<"(`">DC*Z)-_</B%P(X6@8?%;XGW
MN=O.U)$SKRSC#]0C7,_N85O<H5([_3G!K735*UD`4(-`CK?A>_`%5GNLB!T.
M5/O'.?7,Z!1LE"HB?'Z"14'<B@)QQ'0('\K.@@?:3B#'"A+]-GT/=!>R!5FM
MR51IWCA=N]OA7SL/OC]ASK$MGM=@\64SZKU^VS'.!'4X<G)@_C]U\%*:D4;/
MD^I\%0)%<$LZFN1D_["T1P%M?^L'R3!9`)6Q*_PTASQPL`!IH]FZ&7#7`S6G
M#VPE1B=:1((^>L>(>SYYXND3$\Z7P3D2<M":"S1-685QX@V`<F=[0#.F:S%,
M8$@`=A0X\,J=S76!TL5#FX;3BUS.$12?3?*G3HF)<)P$V).FK'GDT@^B@);U
MI%)ZL3B."V!Q])^BIGP2TBI]W/8L)E^\",BG,>;R)#;F8SS$O4<,JG-RJR^S
MKY(@S;!<%*EG<ZC".=WXBCD.MK603=BSMNE,\6T2%"%BFXH]T(6'U\B"3IR>
M(Y]6/`I9GJ)L$Z?.L"MNN8\;;`R.>`P,F]>0BNTP3OG@8MBQ"TN!1#1R5M&1
M8GO<+LML+)44=9:1"BMO:1PYA>C(0;#NA="1^;>\5?T5'`.DUXT/3R5=)"_M
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M,10%#;I']0<D*-X@3[_-5`L+D7=E/-%$A=&XJ^)C*\QIH@HN4TF:VW&:J(C+
MV#6].:?E-CTOQV7*E;@EIXFMN(S-P25.`S(RIZK_A@5&@`"3;T3,.,90-5G!
MMIC-$/.J$%+CRY`QRKT@T:6Z5RB4\5S,M;?@1NS_T0HPM3_\:@<T&*V>EZ'2
M</0`T#L_>B"#;BPG"KD+=8*VW)$Q@<\HM_[X]=:LMI;'0:%5^!;\E?IO6RY6
M%40R"NP\.A..0:=H0Z7EQ*XR'CTJO(6>G<7Q9YKS)P>1&;/)EE2\F%.0PFA3
M!)0B&Q(U9"V1^K]B<:$7UI55$HZXB*\T2%]]+./@U&_".<V3UP/6$@,-U>")
MB2H2D!-ADV,6<UY^<]$9]!*S%WF,4:*%(AW]\F`C+C)9'F_/FF?.>OWAJ,AJ
M//PM?Z:2^+!":>^`RJSQ)[NBK,8A#;5`.\*<K<.E/K/Y(AXBHK^#9&D0/N>?
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MXSPBXSS[LJDXKHHY:\8<`&I(-'7)F\@I$=I48(Y3C4@G]IA<;VEKCQSZ,>4D
MA["H;JWJ[)BCZ/S,=\@C'CWP'"IXVFR'&^B1LSAL[@X(0UHF=W;TQ-908JID
MIM5QAB,+^#$B=78L&/3>25D?TT6`\)`INJ`!@<O9105YIRI^:Y+7X$IV,BW(
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M8;0/NHGMIM_8X*H`__N$MRXX*DT%+Q%)@UQ"^A$Z[\!<_<^?X'OV3^)OE4&\
M#"A>H=\?++F1\!>26Y^]K^PJ*'W?Y1SSJ*)3+@E_G?"6I<BOQ=OIL"(9LB'B
M.&V\>O[X^,,.0%>EG(NJ:&Q@7'>[!?G`V-F(DO:/G=W3+(#S:*/&]4_I+KUB
M;RG1\@?0]76WP&+W.*C,_P)CZE\$SA(&>]WSO7!B\5TU!=.9QLE*3%^<MIC>
M!-/+*D4*TW71+,KMKJBIO8*F^MW>:/_W:(T(JP+\K[YXUDK/P8O&_S^(JP]&
M__NZO4INLU'XWX[^S_8B?S;$_W9ZX5JH#'LX!=(W>V8Y&+A4\R(7EOO=#F9A
MOW#T\>OE__:_],\_;*O=[F07^R/P#:`K@^)31G$M]]$X)&=&]0#)EU^:A.&[
M]<#=I8&3(!CV8D$0-I$'!X2VI@C+([RS-.$=!EL[%N!T_RV95I6(1^3<>D'?
M')SF$V7_8O>W^H9HW9I;U@)V=7^/G4$B^S-`X'BA,^;)%T9R7U&W5BH2/!@.
MEKS*!]I"W=%9**1_>C%JT5D(G9D.JGRW5,SZ^]S#5M&)9?(8I3SO!]I*K7&Z
MUK1>RF5I<6K+FZL*&CT8,N4>ECMQ)-L28JV6ZV,G@3IE)]]XXN\+]UGT!US/
MDNC?`C_X]S:EJ&'6'U<:8/'[@T\-?I\P$S(N->R(;[;G/UK7@%UQ.W:HT+\C
M;"KZIC[-?MR(0.?!6X!4+NRCS,(/05?\G?/D!J=G/P?WXA<[<*WQ0T=\^=`1
M7Q\^=-2(W'`A1\9SB6/&XL8,5=DE&3\O/VCF4`:H.6'O"2?"9J;F)$75MR>S
MQ_;2*$6:G$,I\"JYCSJO);N3YG^O@PT(,.$2^9,23A\=Y-*.T2A43?:)NX02
M$%\-A$343Q1U5;D:D:!0J4GB2N&\$Q=L('%2`S?9M35.+TS0A)A;SL1$HWC5
MI[*(@2XZ<\)PP1F9YF,6426<R97@U"L-C<PU$V]PF3B?4C\N_VX6R0#H<%((
M[H,S2Y15]%65AEG[]<9F".*/JS5)%)A?SD_8-<LD$CW&'V7#VIGCPK]\CSIH
M!/[B_D'R5K^CRN0O.SBYQ,*.+R2!;9Z)AZN^ZG6'H[B0`N=NQQ-O4@.A9K+!
M!RS^:C3H7(P&1+-4NV&V45]FWTAU"9^SY(-EXLZ[_'7S`T9W>.[;QZQFM(6P
ML,*#A@7.C1:VG22,?3J1KOC-3T^(X"67`(_7/:7.\XFRO,Y2X^$42OIGB)/3
M_<T*R>](?<#Y(6G^H58CDC<=I$!N3ZS+E62G2C4\.K"]B93;G++-C5SNGDVN
MAL/QS-[-),QE%1B16;B8R;,A\06',Y1%5*IK/LH350QNR@LMF)3@L:*([5DQ
MEI7H!L.9C4K@G6^V;':/S/-=DZ4YH$\RNL(2@:`Q)6$S>M%8G&V.G>8!`MGR
M1/?Z5S#J!J!*)J`45DM12KU+;8YEX5E"C,#F"0B%`&H:PSTUO7M?6B,*`/.P
M3`#H#@61-Y<?78F,*^YURO)=MCE"H<"%=%0R1'-DQ^K\0,K"A66'&D&1;BNJ
MYA/(]OK4>2=)*YRP3Z,45$^U9!M3$M)*V",())QE_QX:WDGCP:B]D#?1;W`Q
M/X''J6M2>#`\)@!,TF&,/&Z.%"TU0N5Z/5E&9_1$70<U7R?$:,;(4;@"0+B?
M7V:5&.,AF&U4Y50.U1X@`9;LNH6]62VNM..F[N&[)@BZB`TG4'O"N84H1:V=
M?IZC`)$_EX;WR9E$#_AH[_5/\:*X7J`^]HC--,:6J_9RYT>1/_M9W`%N[P.\
MO4[&P!'!._%_KJ\_?OST*?X0:O3TL8GZ6)FRHY,01`=O@Y[Y9[HF%KO@GBQW
MP5TN`HDF*T"2*+A\G3RR,2G>A8'K=\\&KW-7IG\&6R,8>#*R=X7>CZKG&$U;
M@?OA&>>FET3F%A@<=>%:^]^5:U:$QGW1Z=7CO=!8_8=NX;P_E%[VNI='0I14
MLX_WUK-CNY/]H;!7"G]_(S&=^%6=+I'=:,O72XK=TD#<6%64E8CJQD\8'F<7
MG1'V"H%3?M6_''6&PZ'9O0#[2K)W(71^@$;A10\AJC+P=E(IR.YXM]:?5)$+
MJDD%N])_18=2Q(<E=N>_XDKU@CXLL4/_5>R(*>;#2K0WKMA_Q=W&"OBPQ`[]
M5]KSL=:')?;CO^*N5>M]6&(?_BL^HO4^++%+_Y6FV=4^++%+_Q63R3H?UE6T
MW`6JN$>J\4/&FK^#[WE7>;9_3.S2-V:T+5WE'TO+HIWXQG0H(],_)O;E&S,;
MQZ7]8V)OOC$FC1S_F-B7;TSVZLSW-.W#-T9`9/G'1&6^L8OSO/YZ"?^8;,ZR
MRD<F\OUCNQ15>Y>K=?.FK3*?Y4?/1Z]WBZ8B3K+!Z/7/`'(`M'["D,,.D(!$
MOSL""&C`5RD_6JD6@G?X#Z1K`OANJ;/@?GU%6V]I1P[-76"_WP7Z.Y@G:6OP
M]^W;+`S8J#LZN,^S.CK>N\.S./WV!MURKKR:$O"^_*"%(7O5.Z"#]'`&V:[-
MK%).5<-+$EM$TG8>#,\[E^=]TY8O,A^DL+<TW05+=7*J49;>UGJ'@_^X0K7[
M44Z3E'87]9;]%8RH$RP-P(%"Z)9ZM,57U_((L4ZVDM(.>C^DTYN@HYC!H&<Z
MO=_[5D#6WP=J](BCW5->27HBT6]Z`M8<=@DV3&UXUP8QC;8T&FW8UA)L,DO2
M3R>#<@B@)/6D5T[15@P"6XZIE]G"-P8QHF>&+&<U\%9W589?+.8(]H`\)TO)
M?\;&K`D>`MKP13VE^)8_G8))',`93!1:.^(/^UG88+'[S[::G,$2CQI*\\?-
M+N%=(04+S]]EX19_@)OC1DN(Z,A&S-0=4Q\J=<V44%'#331X]<=P)OPSNB`<
M]2G&1Q)K@?!\[X2FOM-(BL2??];/&=#ZZ(?-!Y6`<)V9(Q]/?'X9`D"()W[S
M']G@[X\4'1LD%V*,AH>NS:Q_XT"WYQ7')GUWA!NCAD.2`5.O&CRR!'S>E=**
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M-]N%2Y;PEBFI8Z3=JJ"]CB(7T<CD1UT+N2FP6#6RGN4`,AG0SE@6N0B0*T=P
MROTF6=>0?Y:0:B]"!=P!J!W;/%9W36=W8P:3#+;CDB3L*3Z3=V2$=3E"U+7#
MD#FS3^WDI]EG@2452H1ASW5#)L<-W+.$`3&Y84`,<FWJEL$/,XD@5+=^JO8E
MH@[VE";1O^Q<G"6'6#U:CJLOG59PU^]<M3>&?$T$*5_FXFH,_*F<S:W7I78G
M)[TN5XM[^*+H9^0:)BQ[TJZGX@L(\@!LW?]Q@C]<5%;Q?[<.7`$/CO)8B)1=
M_'W%+4$P@+;Z"MNQ_2PX*TG?7]QX4]V0!`[?@K!JPL,3#[*4`7\>!3RSU9"N
MG+N-3*".]FT$JL=(&A"ZRQYIU#-0MHDRGJHG#0BU2P+9S&_#!!FZ`W&:FCEB
M,]8=,)5BX5JT%1H*KRZ[5;,S6]XY".]\I"FLRES261Z93&3-Y[Y#;/0EZ`+!
MN91@A'F[7^&*P]A1)`EE"/1P_?&&"&HI2S<Z(1HT\H+B2O,WBGYC@C/"%3J[
MU'23DAFH`%J3K9KUK4Z\&R//S&+6YZM>FN*&5<QNS=.$.5Q024XY7^4=0SDX
M8<+]&P$09A+G^8BM2:V6;JRGPS;_7/B&/+KY?OU_W^,/VNLWN%1I/BCSE%4K
MH40P=B$GA)012T)1G5!R1U)0LCX?"\L<#,0TBE1Y_>#84_'QASWF87DW[!AB
M@D]NEZ5EG+3449>##XSXQGJK<Z,XUYUEZ<^TRIN[^*^2IT:M`*R5`%3*`S"0
MJR["7+$'*L!7*PIQ>)03NAAY8?GW#R2]M!#LCP#F:Q=N8?2PQ8+QFWV/`T/]
MX%E<3=%P#$TYR6I$45EI,)P"J9B\1&6&7\@7F=I&7?7ICODM4X(F!%N&\!R5
M$IZ&-R\E&+'[=JR%=78A%1/$$:?CIL3$?B5BC/1E/T^&!IF#@"T)MY"X9+&8
M%)DF1D%91CEI_NH,?C5._NH<?C5)_NI""ED[^>O+5L+65\(.>JM%[)4W">!;
M'RS/L5T,:$@)J\+FR,SOD6&0D3X8U4]&?1!J"_$';N*6`1FR:+2!!E>=`%KV
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MD*0#L"0=*(7\]0$,S)6`Y>%4`UQ?V-(=]2BQ=GMP+[A$H6(TUNW<:PO8'@CR
M52/H$`<JME1XO%38,+%XV95M$5IRK-V1OQRA.#BRR[FDDKRV%VH)%7EG?EWE
M?5,0JBJ8S8WC74-<.5\>#?#$MONPZ$>C"AF[$>AO!)"E,+Q[*JGJDCH(B6.*
M0$O@-0.RT1BN%7E?8F[R"T)^(X#,[2W5BNJ5OI?C).22UD:U+OGEC0^JV;CT
MU&L($\E%NV#JBN`^S)W5!.!7\3G!+R;^XLZU*]#)AGNW.PY]`(T`LM2]52U)
M[/OBJA;Z7O>BK,QKJ;D.,J_1P.^/OB^[PXN7A/U&`-E*ZTW5C]/.Q>A(M8^2
MQD:5H8WM]_<Q;L6EP;&BJDV+&K)L\Z"L8V2Q7EBL%S2K)E34\B:H52I/O<ZR
M7M`T`V=[I+L*<W;JA<-Z0?,")=J.O6:'4E`/.U]W5_MM6(7Q\HRR1&5QUE"U
M1"M1HY5&T;EH3[(BZ41.2LH`)+L3J3'U(GMVVNDE3<F`4SXWIV^:B^KQ3(D%
M"81UBY[2HJGF`XFA;`++8P)JPOJH!^9T:.8'S7O!-B^=U-07:J.@9T41((EY
M4=2LN,B@-]YGO"Z.&)&`X3'>66'<XB"CW\*#`_L/J/\(PAO0U-VX\TK.-*O$
MERWQ>_>V*Z*`Q@,^8_]6V84`>]9'"VH0'CHSQ[4"U?E&5;`_&:,8$!S;'/(4
M@Y'X-8[T`TAL:B&.?:_ET<KJ=^P!X5!K:R#<]+%R"VAU+C3)TFB4S[BTC),%
MQ!,0F>>*P*P^5[%\IA+T>'(FEZ??V:[_M/LI??65EG4;YU=R`%<JO?EBL*N$
MU_R!<QJB;0;/*7Q=I."O;@C=Z=#L?M3OG@T.-]-KI[IN;0?6G79'/?,,1MT5
M_M&*CJ``Z^R67:X>0;S7<[#=Y65W]-H0EP9W]$;=X;&S1^W&X94;,MC:,X>S
M9SZ0EDX0DBKU@#H7:F"A\P/48R]Z"+.Z(778TCAA%1:G3MM>:)%&J@;U4;^Q
M06=T/J3OO>I?=H:C44>-07$>P?;HD&403P$G..`W/$_;I1?5K!Z<K_UHZ\G@
MI&FJ)O99+;!5'VO\1K_/S=,6'O^R(T=%)SL\@46B3)KE?OFZ`=R#!9N!C0PO
MSDE3]B,`=.$9H\P3Z!C[J$;$T],5"$E@.VHD3*S`\YGXJ3'I=\]M`\&E7>W!
MZ-?'3XW[0N'!XVJXSX/M9<WML2?Y(R;7S8O<9J[DT)@K.3SI#TZ&_7:N9!WW
MWOC+X\8C"4H@MC,DVQF2#9TAV53V:[X`2?`;`7J("8U"3V<D$`XUH5'HZ8P$
MQB$F-`H]G9%`./"$1CX7M@G:"8W'/*&QE871S^;`)C[I=AIC.XVQ@=,86V;&
MR8MD_)C3=H;FH"IC^N+EH%?/Z8OM.1K^B=I.6FQ/B?P0/!Z0@%PW5?'+RFF*
M;S)]R:A%OR6.S+Y=_"P(5@]A%+L:P,BJNQ["Z"\"8^*BV&3:XE83/`B<#>8(
M=9M/E\W?P;J9BT]VSJA%I+I*1RT:E!7/]B*H=CUJT8C)X.O(:C83^]P*HA.T
M]&(:I\W13MAW:=/F/&\!=O'4YJ@8CQ/KP.O/=-&#7=T?"!M=5/#O,+)<%T$P
M@T+SP`_(QX$B".49+NW`\S)$-TF%\=!?OF)W7=`>!28%J6F165,+`=R.P`S`
MI5&3VI^0,V;2]'I*"5357$FQ9J9D>BT54=QFB&2%X]*D/;75$$E3V"?9;.6T
MR-2LLW<$"@XXDQ=>UF@TV&>*YXUID:7>:Z<BU2!G>=.I2.2DXBP`?:S*G&GN
MN2;@3AYR`[(K5V4;+?7NV7$QK>J^+]H%UBV@SW<G\JC<E(>6*NJRP"&H(F-\
M2G;+LNH:EAT:$TTZ3S<Y)4QL-?[+\Y\":_Z?/_%_?VHE0NT7:.^)=H%Z4$7I
M>V(W92^'QDY%9ZS$NIXN1QXL68BT[?"_5LPW;8%6S+<+U(,J,L1\\:F)%9H(
M*P6D'IHIC&F88KLQEZW0;-H"K=!L%Z@'5;2Z\2YTXWA<+A=SR%FX8L,AMZV`
M;]H">V-E_GDOM?DRT#,:5C`%+S7U5Z5CE+S+<@;+5=1[:_OQAH>'(=W"HR+4
MG&PIN6J$H2,FGK)][78[4K*EF2;0S+8PM,3S@HFG%3B;'TY%>EQN'Y^M]Y`N
MY2MWU'6@^,/QV`YV?SHLU4@]1>-'A8K]$T)90;>;7N>#]O!?NA2X[(X*#P,]
M.!6\A!7K1.F'./&*U)@5[JC*%)FI'TQMIU5E#K[[-\/10769MX='0:O"U$^4
M'?'AUVGWEZLZ#]>-"E["BG6B]`:K,+OSQ*C@V5(E6Q,/.#OIX$X.@1Q4.05R
MA\#MQ(%YT7IXFD!6936I`U%3F>%X+2VU(JJ@\G;>'/_32R6JA@BHP;`SJ/5U
M5Y%BN$O?EC%/&7N/'(.&>%1RHMSTXU9B'IW'ZZR]+E^\$&B4Q^NHJ*`&(N"L
M<U'K"R!#R:EXNM5NM]&,UDW?9>-D@G'/0WCC#^Y]'._5NH&Y!$&)H;D9PU6W
M')A+$&P\-%=4.3"70-EH:*ZH<F`N@;'!T-SL0<B;#,PE"`X[-'?O0JM)W=KD
M1\]'-4BO'HQ>+]5XLP>CWQWMN(C1E>5_VM*^TZ`WU)^0/VEXJPG#^YDJ?'IY
MN+&I%7AR:CHY>-1-#PX6_[L2M":1^=7C?9T'!(L3>'S8/3T&NJ[=R-]7I09@
MMT;1CB;YZBEFJWKV%IW>.^J<GO;2,WI%P?F\!$6)&;UGO<P1O<L-A]7@7_B[
MY\OO9>XA-5<8;@%X?R#'_&9A96G,[^"\,^Q7.>:7`%D:]2NRQORFX6L[:!_6
MX:"L6+9P]SD$>!&>W%O6_-TGRPFH!\95&-I1>.5-?G6L.[QB'3O\0J:P/;GQ
MOMGC18"R`![XS4>*Y1_?8W-Z?)\H]KL]?O"</V$;WU$4KYPH?&I,%(9_GYT,
M>[N<*)ST<ZSR1]!AD$^"<&YVM]\7<>5/PFY<2_$-.UN4X;B3$,0;;V.7%E).
M:>P:72<-7+][-CB<KE@%>O=M!J77!VNG=W#[IE(ZW;N)DX;DLM<]H&%>*5'N
MRX9)`]`KA;_85/F/O^WU)J[S]?\O"=2_#,7E"ZFKNU0,RKG)Z01+AC_6N\E;
MG6(?LEHU8!J\+J?1[U>_Z*<;1)56,-).UU;AV$ZTGW9':?]J*;]4S56/[H%U
M#_2B&C+(H-S>J#L\$M)MU9)FJ"5#0RT9GO0')\/^+I6/K1Q(ADN#3K!(FD6F
M2Z.-TK=1^C9*_W*C]$!_![MEMP:_QE'Y-@R_%_KM#;KEU)R:$O#1A-];Y5$K
MCX?Q:6UUZFJR[\YR1PLXQ%J-M-5(6XWTY6JD;=YHFS=ZM`IKFS?:*JZ9BNOM
M^,&>+%S[9GH#6E%PBUE@[S&=\MK("KP:1X#NZ+EV&5940$=N14H9):4'-$AX
MT_D+/FWF++)^*3>BW96R\(GS2_^^\&PQ[%&6XFEW%WI@\Z.D*[@J3SXL#:A"
M32IC@\FI2;O]TVKYT""(S<EMS@0.>3K^:=V!%)^'&>N\A:,_6HV56:`K--FU
M8[+RO[W-$/G<2Z")I-KP760,'CPLU>IQK;L@6SG^=2??WG;F]G'0TW'LHN6*
MJKZM!RWOY.O&\.:=?'^[@=#'P0O'L8N]</0*&$OQHQY;NPN:UF-P=_+U#4?K
M-D3OYY_S_#,;9?05H<*R&6C98UU/2QY&SJ"\!#`E!$C>1E/SW:K[8KEY=FD<
MENOZ7'2/U:#R,"=3`&EE&WOM]`3+=%I^">=7%\ZZ[)9N@'K4Y](TOBK7/'57
M)UCR)EZ;\5WB'EZI^!9`8'4C/(L`5`'!'GA)(L\*K>K1J$("WB%NZG+2A1#_
MJIYGW>_V"K?Z;4^ZN3Q=9@+"BSKGRC!<E0ZR2RJHE5`_J*]@&=Q!*1U%NQ#,
MD/PN-)7!_J7:[I9<1<^TZKIA(DO7UW#ONLIFV#D`XJO#\KY%VT9`]KH791GP
M9=#!L?'\97=XT1YTR_#]T\Y%\0D5^Z"$`_I<"F,M-7JI8OUEET)K=]+I,*Z]
M*K:X.S0=7E8<(I!1[S.I*UM4&+&H]P$TB"EV;!<5NP7IG\N%!%OD].^X/*!)
MK4X2M05THBOK"\12;<&JSM6[[X&\/0*.N.1TR9>VPC55!;Y4?H]H%UBW0&[.
MU^YK@%NJJ.T"AZ"*C)S-[$C!VCA!8S#1I/-TDW5&8JN:H-2(Q58BU'Z!]IYH
M%Z@'592^)W;4/^0X[@XEUG7)$<(L2X3$MD5NK9AOV@*MF&\7J`=59(CYXJ5:
M%9H(*P6DKG<41FVBV*Z.L!6:35N@%9KM`O6@BE8WWH5N'%?H(M"ZHE9L6/W:
M"OBF+;`W5N:?]S);1`9Z1L,*VH!F5R"7#:+G%(>M#A3O_HI=7[^W-QC2<X,J
M0LW)EI*K1A@Z8N(IFX2Q4?5G2S-'13/;PM`2SPLFGE;@;'XX%>EQN^OL6UU5
M^J$H_G`\MH/=GPY+Y6*G:/RH4+%_0B@KZ':PZ5[W?-`>_DN7`I?=4>&R]H-3
MP4M8L4Z4?H@3KTB-V>4TB)MX?M'4=EI5YN"[?S,<'527>7MX%+0J3/U$V1$?
M?IUV?[EJ<GK=J.`EK%@G2F^P"K,[3XP*GBT5K37Q@+.3#NYD6X1!@;X(=0!N
M)P[,<BV&#RX;7RI9E=6D#D1-9;H$M+34BJB"REOQMHHM4;4":A68@V%G4.OK
MKB+%<)>^K51WHV/0$(]*3I1KH-1*S*/S>)VUU^6+%P*-\G@=%1740`2<=2YJ
M?0%D*#EQ"ZNZ-#Y:`I[:'>VDP1:^$=@/\)+S:'_VQO[,_NJ[SOB9_W_=AFTC
MN);W+!ZL$*A'.)$]"X4_%3[B`6`T-D.'Z=".A.,)?$M.VX9G0BSLF70%?#.P
MIWY@=X1G1\+UPU#8?RXL-TQ^C/[2S3J+H@BL$O%-:F-VO70FA&1'(M@!JL4#
M5-CO6-Y$6"*PQZX5ALX4;`[J;@;_-W'"N1]:+CX>+NY"9^)@;45RE'IHG.Y:
M/BI[=L'8"MY]703`?J%]@U;D-[!`'AU[4I0]Q,)S^*'?;S_\)";VV)D!L6%K
MLO_J#T%W[OW'W_)7R8?C:@8F6(3/P4[RH#DM`\W9*`>8Y%)ILKX*0SL*;Z8?
MY&']`K;A'%#K+K"6"WZ+H#G>PI[<P('QV9K07L&[!E6G(/P1.N\\QX6;*UC8
M/XF_[6CU0?;J"?R,3H<7Y^<Q+6VP=!KZ$J^2W+]>!`%0^J^.=>>X3N38886H
MW`TP13#;'UP.!S%BMP<DP3:_^MY]9`<SX^]T:,M?JP*;52Q9B!K/1XBSLLNE
M#WTS4DI",CH][<>GEW$,!1<KLNW+B][Y:.5BA)&K\7@Q6[@67`H?;+A2G.@6
M%`/[@_UHN_Y\!M1R&V'W@@VW?-+OG5T,^TI:%ERM*@AS\+165,8K,MLLWX6_
MPGW\FQW=3+];/ZH4TMNO7(0V3D[[O5-#/I=;-0WT+Y;CW03XQ(UW:Z'J?8O-
M5S][M[$F4E!36PWT:#BZ,/BGP+K5@3HX&?3V#BJ_P%+>(2D^_69;[L<P@K,J
M("6+:UOK"+-":)+GOE[;.KT<#B^2J-P`DKUMJ`AU]$X'I\,Z;ZF`1KQ?BCE=
M0S%[A&9@''<A8=L_/1WTZGS:E8BW"K847S4(6/8[F5=?<49<1R?;@K`M<919
M?P?H6T<&Z]"7H3EL>6!I;7)P<79QNM)-D8>>DK"5/DD0Z9>CRWV`5II?00D'
M*CLK!1OIWI]G<\L)4,>^\D#[AG?&SK)K8'OV*[]8V>/ICP;GT@C)76>KK6_+
M.M_L<.&BER1F5M#+`YM%*;E0OL$/@8T@W=RYSOU6&LD^P2E[5H-!WZ#532'9
M,8*W%Y5A%`+KH4MF<C7^<^&H:_/&<8'D?K'"KX$_Q]P2>U>'O#4,I87DV>79
MP!1#)=;?!0(W/43IF##6_`R?=UV;FCK*92NQ>OMG@XO1J7:?K%EQ>_@*G.A.
MD%+J0ML"*6Q]P_TW\SVRP8%2_FD%V-F@$N.N/^H9T8%5JVT%UK;'M`$:RIU0
M:30HM@8]Y-H*'^#P'IV)/7G__'MH3SY[GQS/\G!TC8S=;BX4L^$LOWRU@&]Q
MH)5A;K,3WAQS1!N_^=X87OOL/=IAA(]YDXQ7?O,C6\75E)5IN3?3:EV,%T:4
ML2JX]K;9;47"C@]B6WU)2?.OKD4J^4>0^N3]1T/7]<-%<#SSS6X\\<F^"[`_
M(J4%]"\XA[<CGFS*#7#MR)Y0:!^0;U.6QR(03W[P!_:7=K`S*QPBYG;@,S>>
MY]CBF_4L_D^_(_[;<N`5_-=7VPK&^$^!F06WD?7@X@^^X\(ZKAMVQ3]M06U>
M92MK^+`/SPI0EF'#B'QQ=1_8I#&+)R=Z$+_:]H]%*$`#$[_^>MVAY>E;PB>M
MVP]@#YA8<O=,?U-)*Q9]$?;DP/U#^5;PKA-A+C.`IC8D@:`W`<J.N+=">F#F
M>/!U5[BV%=K\*_D,_1L?DSNZ!HT>Q),,<*L$"2O>T!,\*W^UF/'X.$"OY;J`
MXGB*#25K&$$Z2LU8>F.ZB(`LQ=QZQD]3WP%*MJ&GX>]X8)B<`;^?8:Z'%^-K
M]U/H=D2[)4?3U7`'2]QWN17W7?O^'\!D9W2N)DN)]>STQ0%E%KAW,2-(OMI1
MX)]\?7@.G7$8,U<&;SW9,4OA8[DL)8JS$X&P*4N]&F+ZN\`;IB7M@^T`\P3A
MK@^>E0RS*&,)23@M+^>Q[4SG-SCM]`?G2D9-K(@(7R6>4;J@"&P*(N/9VY$(
MM#=%^-J=(GA%)$N?('@U.N^,A@-:-R%149KBM^+GQ:O^H',Y''2%SG4A8`S:
MPNPXTDTZB>L%?NO?>\Y?^#W8G4,2^M7I96<XO#`OE55S03L"N0,^A6XDA3&]
M_Z921/-I&L2U.BL",SZOI[2H%3P5=HXY>R#9A)64MA\6?]@=_&NX`!T3">[I
MP1D_X'="WR4*Q$<$#CQ5!.``F2)5`?6F]8,0<X\I!?>3'T8+(-9O=@@WQ1CA
MM^#;ONL^"_\)9;21M,G7"3Q"V@+RX0P6\>$O'NC>2E['C/N*B\4[$ECY!VL.
M+_X`TT:-(<&7II83B$?L1*_`-R3\C(>3C%W+F;&%&`"``!M<)UD;H&>0#?D1
MN,<<8)PY<@\B[\$))B=S"ST^][;O^O=8(D>0P&O(0H#B+@Z+`@-C;KG)2\F*
MQ&D7D&RQ]D1%;;ZWQ).C)4G`N,#=C1.WDA8+&A>9HH'R;Y6(,W)JZ:Y/'-&K
MT]&P,[KHMXQ_T,M,GJ+<S.G9SR%!'-B/MK?`"VGN!Q'Q/YZG#HA*C4DU`].R
M/\P3_D2>Z=\.0#(`@;[RY+7YJG_6&<&E(D$(YS::S;;[S+?C,JQQ8OUN`#7E
MX8"O\3>GO=/.X'3XEB%^TS_MG`YZ;SLB%UY94!`E.(48AW'L`5B.=,,+^P<6
M6:#.@`)5?I-YSB?;;@ZO.?XBU)+/U#E,W9-TB%"$F.N'VP;)%8-(BC<*(7CA
M"73D)'P$GD0AB310#`B&J>L_)4%#F1YA_K:I[T@1R]9;R^`'VP'GC>,A+]G;
MK'IFLHFZ(,=CIE^D@#O9-R=\L&UV<(=.J)4X/4K^W<XQM?=C;<+H]P:6$^YB
MW!)W6^AWL=G"+@<NN7)44>*60$C534&[N,LNMZMSM>)!:(^%5(;DJ"'A'6#U
M9E#&=G.1+G",@1K)Y=I3V,UE%0.Y;J1J]`NH1G$J`Y5CEJQF;@=0['=*$CO+
M-N21'6"G!KT/U:=VP"=?V',1:_`E::$.+'$X)MS![D?]R\YYK3M=[.^.V,6]
MP!7]7,PI#>7#'WJUC=`,-;C&H.VH^><+X)S=]<BMDR!LFP-6<)F<GG;.SC=5
MIAK$$KOL#FB4?]=6(7GAG-]<PCV$SG\U'F.<,U3AP0:>^-X%^"X&N'!&QJ%H
M/']^2Z,5_*O\_)G#'WFKYU?%.YSY=+2\TZKXK8I?D!/.>YW3L]-&<$+<$C,N
M?2E3FY!=M?_=^E%9'8,.-AM744,B_M1S4CB<Q./YVL?E!V)B3VU*,8FL'RK-
MA%)B=-8+ABX[8K*P95)'5L(-)=NH#A5=@1TJG+\LE;,?9WW@*@3$G>W94RI*
MD+FM\ML)<&2NBA.*.`$.OCC#/)2I-8Y\3.=S$IEJ&;"QA?:,*]S;F`03$1A$
M;O\G;MB)Z2LRQP'3AV3F`WR6]D;9O8"6)RN8R+Z/7?'%\JQ[UB0>K%"GQG%N
M.**18<34B<"VQ@^4QAZI!+^0TG9#E<6#"V,.(6/-PM0)RJW`LYARP9#ERH0F
M<LLO`D"X3#+$Y3%/)YA0OMUTX;J9'[,P23>,EE#-2<N(;LY1DC@AFIA.[7'4
M$8L(T/@7KFR)X>EK\Q%$:8<.VIX!>)C*-W'@-:"QL:V[;JHCRCIBE8N2^)N9
MF.(LYPCK]))47_XVVZ3--GDYV29Z!D7=$TO:L\LZNS8IJ`RH'Y:OCJ(90K4R
M53)(L19P'5PLU`H;[2D=+O?K_**"])S?5NOQ98/[;;;7GK.].KW!^1;3G0Z3
M\-723AUHI]^Y&`T:1SL5B=G=>8@I1:J)=WD;*\G.B3IKI^>U)%6MY.W5G:9V
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MG0(=@<9S_Z#RUZG3\:`W'';%5Z/A+?X)I\Y]L[$GO;@:4Q9S__+B#)LM>@O+
ME?G5EIDSG].%<RT*9M:SN+.%Z\P<ZGT)&!%R%#$V>1P_6-X],0&VB@S"!V>.
M*\Y\W#_\38QZKSGIWIYQ9KX_'F,G=LJ0YU1Q#^<,!+9]0AM6"?%X=(A?;J4)
M^.EI_%`Y06#/J$GTW/;PL_8/:^9XO.6[9S&U)]RB\AX1+#/;?6K*\>]%X(03
M9TRM""4OR\:\CD*&O8?F_BU_1C]?4:4!G)#+@_MD/4?T9-LL5G$TZ2+"SLKJ
M1%.U`N+-\/3U6SU.@BL,D#(#V?[<+#\P2E+RNK02!,.^K`C(2@EM.AFT!0`U
M<<'6,HF\+0!H[MFU!0`OQT!O$\K;4VK4*6W`]C5(^[]=IW^6I,KCS]W>%H8=
M)7$/-VU=L`,4O6Z)IB6:ZHBF(LFZNP!;F\E0$]!V$WO>F$NVYXDVAZ&EH]W2
MT>[5UA=N(NTQTKQ#X';"$0=+YBFKH+:$U!+2]DIK.F4A.\22WSHM;O:VJF%;
MNKG;[>(NM/]<V%[T\1$G@*_L['9J=':#?Y^=#'NUG5!/C=H(?S0"T?-I/"9O
M5=BT5PR<3AA%.`TZ,3!5SP^.'APU_#`O*!IC/A>;6Z%]?4.]%NVKT1Z,K>#=
M%>4U7GD3H]7XS?2#,:3O1L_H^XZ\>#RGPEN7^0;)*=;MG,(V<-P&'[<+/K9S
M"JN@A*MV3F'S*:.=4W@0R^IHNP^U<PIS$=_.*:S+Q;"[W;=S"MLYA6U,95-H
MVSF%1R,(:^T0;T@-7SNGL`*F:.<4UI[SFTNX[9S"P]![.Z>PG5/8`#IO]?P<
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MB*QCJR0"+CF71^QW)@]!D)S+(]J9/&UB[`M-KFP38YM[=FUB[,M17-M$R_:4
M&G5*%;E'VID\-<]I;,>KK(6EG<G3$DV%1%.19&UG\A2#I8W)I&(RM9RETM)1
M2T=5T-'NU=87;B+M,0+3CE+9D8+:$E)+2-LKK;L(Y96/P:7C>4O!P!M5'?NK
M'X;79FUL(GQW%=Y,C9"=6'@._^'WVP\_B8D]=F:6&V*LY;\&O<%YK]>+X2^Q
M9L7@#@J`V[\8#78`KA%A5;_]R`$[JJ"[MN9.!&SQESVY]L-H8V1?G.7!7A*`
MW6ZET$'T]K`7/M%?`JH$WY"^^_WA:H*ASV\.1"%D78XNJ@!"&[-7RI;=%"TG
MZ_&RO%A%\!7!V,EZE&T`'V:A%4?8C]!YYSDNJ!C!POY)_&W3S^?L=]WGBUP?
M5]$G=@UK7W'BX:(Y'3%D7Q>!;1[%Y]\^_?1?O>[P-#Z("N#:TU8'QE:7#Z&^
M6[U^L+Q[>*`L?VU^PB?E]UT"R`/@8(.CKP,.KGWJ?P?:2]P`KS(F-J5I\>6K
M!7PCEMP.<.HX"$\'MA7"6U7P4,8-/QK1;;5VL:V@6HV]#'VS7PXHA>0;Q[WR
M)K]8H1RA]/QIX;JHK'VQHP=_LOJ>^]=X$8*%^:_T1T`=A!>_4);;:I7MM#\X
MCT]\/3`[`?]W;Q[XC[870\^@J[_S!)WT7U=N;-2_/!_U#KZS#_8\`+"8!+S)
MY]G<<@+LF2PW*!?[%VOK/#*%Q5J!/5[T#K!!R:$:\L+0CDY/S\ZWHC5:ZIMN
M.WVCNTYOJIF/SD?#00Q1[O>W`B1%$=]],,@,LZT`YD[.>Z=GI_N"4Q^L;&'_
ME3O8%X&S/[C<.SYSWRT"<%D"(.E.C@Z01U<SQ,_--$/X;FQ!LS@NNDPN1X/J
MY%HS`EV1VO-OH$S)F4P;0I<ZWH*K+9ER3CCW0\L%,WPQAYO276`R<F9#XFLK
M?-@4V)3%76[1+6`F[P(<T=2)?DV[,394>$XOA\.+C?:2`F:+;7W#,=.+3?6W
MM>9])8"45=GZ9Z/3RXWP*H'88AO:=<JZ=56D<G+:.QV<#C?:5`9(N]]@V3,[
MZ9^>#C9C[`+[NWVP`OL]:.Z3:W^&;E16W((`;4^\$MX_QX_`Q8B_ND*']\<_
M%R#T/GLA$#C^,B2%[CO8K#=SLI`^^<'4=B)[\MG[:@>./RE_VB&N'"[;TD,T
MAPR4['$3>\<?&*WA/VV,EMF3JT<XSWO[%_AX]`$,TT^@6J.]M9F0^A=0Q[\(
MN`RK^'RP1_06VF-"(]G#B:<`^F;/+#+*T!L06.-H8;G?[6!66(C]U]?+_SW[
M(E6=&L&?Q&ODC_^07Z(CL#=@VW6TA5=0WFI+"AYN#U0KW;E7!GL*0J5TYE_M
M>\O]9!?1Z<&,/NL9EV0>!`F\R=^A`^_>P^`3&/B6,V%-MBB);`#L$-Z^D-A<
M#0.`^Q]_^W$7N,X[_/_PX_\'4$L#!!0````(`"^!)45DHSP0:`H``/]R```5
M`!P`<F-A<BTR,#$T,#8S,%]C86PN>&UL550)``-Y&`I4>1@*5'5X"P`!!"4.
M```$.0$``.U=;7/B.!+^?E7W'W1L7>U<U1$@))E+=G);!,@,M0SD`C.[]VE*
ML05HQ\BL9>?E?OU*M@'+;Y(=L)RJFP\)..I6=S^M5NO%/1]^?EY;X!$Y%-OD
MNM$Y:3<`(H9M8K*\;GR9-7NS_FC4`-2%Q(263=!U@]B-G__]U[\`]N_#WYI-
M<(N195Z!@6TT1V1A_P0F<(VNP$=$D`-=V_D)?(66QY_8O]W<C]G7H+LK<';2
MAJ#95&#V%1'3=K[<CW;,5JZ[N6JUGIZ>3HC]")]LYSL],6PU=C/;<PRTX^48
MT/DV^_OIH'/RO&#R#J#+GIZV.V?L6?N2_SB?=\ZOVA=7YQW%'ESH>G370_NY
M'?X+R#]8F'R_XC\>($6`@4#HU3/%UXV(7D_=$]M9MD[;[4[KM\_CF;%":]C$
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M-Q8;O'/(`HY4SV/TI2$&JRE;G-/1H[&:X#*ZXT495<-F$&C,V`;(A=BB$^CP
M!X_HD!E<%N\J(UE1_4HQJR3C"SLOE_C%B*L46-GTQ;AH")^*")1@I4\9971>
MP_/H\X,B,E+"J@3ME):T4[6HR@ZBSN%X*Z0R,DM(*UI!%96\*)_CY3[*43&+
MXNBB24=;#LG1A2L0@*6D><(:T#(\RY]3Q^R[0,$6*(B8R-SRX:(>ZMR$/>;,
MPJ.N#FB"+57T(R0F"%@`@<?Q=9"?B0@*G#*I=ZL_]KD_G<RFX]&@-Q\.P$UO
MW)OTAV#V:3B<S[;'4EOIV1)0D-CBYV*V(^(>"NP??BT@??!/P#S:7$*X:3%_
MZ+:0Y=+M$^XAW6:[$QZ$_1`^_A9,T7W/X0<DVPXL^(`LO]MO8;M8LY8^@?DF
M-E](L%]\!?T(+1Z3>VZ?N?@+R\#],]-L113)XPI&_*GG&,!V3.1<-SKM]K8G
MZ!B"'R7/)<,6+>JM`Y]M8N8;6_J%8Z_S+!Y:URZC3!09)D4#/"&\7+E,?JU(
MWCEH`[$Y?-X@0I'4!3.:JR%UJAFI7%UKA\S472'G'AF(N13??9@@5PI/'HT:
M1EW-&,FUKAU0@5JRL%V?<)9A^71T:F?L8)>'LHCK[_+N785Y2@X&^61UB5]9
MT*@H73NH_*$<WX?(12F;HB[!*R]JY:A:.VS&&#Y@"[L8R=/.M+8UB`!W\(6/
M`#8FV!/'0V81G0HQT1^XLU7+B!0%C%,[WXSI$-DZ*8%L!K7^@%\6TEQSU`[+
MB)9*`:9F@RT#DDH&4W)+R;_D/+;)TD7..B+#=)%_?2AB<<ZB$(=:#90X'(6U
MJ>DHR;[5F!PL:6WU[A\L$!L"IB^79-\GM;'^`9]SJ32Q@9"E;.U\*G*^(]N-
M2[34/^B5(<E2LW9X]$P3<[VA=0>Q.2)]N,'N_AY\2B*31:!_+:2,CD3IVH%T
MST]J"#*'T"&8+"G+O;RUYR=<`[3`!LY)/%5HU:`[JP-TZJ:H'8J15(`M@(I,
MKG)*_;.5JG8Q/&5O3LCPTYKX%5&T;'+^H177<\R^ZSO03']=2CC=[*J?;H)W
M`K]_5'U6*WF52E#K+$^MV9S]^CR<,)6FMV!Z-[SOS4>L@<;CVU`?L@Q/EG*6
MNBE--0;*X`5?B^\2F6M,,'6#"PJA<-EJ2`GUA\E,4&+A0M$&M9OD)L@-KIA$
MW^=+(A5KIE'@O1BW#*OP#C+#)W>_(B16H=7O<JF0Q-Q-W0JU\SA1]/0M%F:"
MZ6(.GU6AE''1GX44!U7-,K5/1A3>'A9F[7.E69L]_GQW/_PTG,Q&7X=@/)WI
MG+D%U0(4Y1Z<2_3F9X3JPZ8""+'QECXFZQ8O_4/A%.7\.&$[3$82+%",Z)5@
MEHCXWT((S-\]ZM]XEOOEL?K3'X.+>\AQ;?]V8G=^R00A?E^HK[IF\VG_ET_3
M\6!X/_L1#/_S933_K\X%9;*F@J#9>W7-^KW9)W`[GOZJ<U;B=]Z81G>._8B9
ME6Y>OE!DCLAN1=-CSOHH.5,MPN/_<U:9K+`@1&]R"INMH(-N(-.-QU(62(5W
M!5(.)S/:ZY]"7@U8OBF.?^[OA_&P?T(]*[*UD7'.GTNA_Q"I/")2Y6HZFCY"
M3/APGQ*V1-S8U#\:FRYD]X<E9/K/E%X]MI0,DP)G4_N&B(.8"PY0\'M$MG>U
M]A=T<S="%*C5T#VO,[I%S/060!9?(RD"<)Q2#=R+MP5NNGG>`K`JEV?+C.=\
M?FI.\/YM.4$14]9NGLZPQX@\(OK*]5<J#ZW7]VP#(=/?MYY!B]>#P?PL["/<
ME4J*5DG*N]I7D%%MUW`Y,">N`Y8RWEOQ][!\UJO\/97'09=%OMTCMP"9Q7_E
M+]J3U)3:7SKDDM36+W/@$!9&"@:IY?YEJ6*CPC[?OWB)@ET=-_8ERO*?(&#J
MURZ(L`7V`J0=(Q]/4;6JI()FEW'-(CS`G@G8<ZF@FD3^'?NH_)UV7/XH<<7F
M+U:X5%"C$U=CSPL$S()G.W9@SZ^*W?',&J>"%J=Q+0)"X%."'6DU`L<+H`J2
M=M,DW5$<7T!I'51!VK.XM"$Y\.F!R*`*/T^62A7D/4]Z,Z<`(4D%@3"K=*H@
MYD4B]NW(P)9.<]#.#=Z=]P6#-WBW_53)+<VC%$L5#)"8E\7HCRU_3F99<V0F
M`.\"CI68H$0)54'!Q/2L.B]4JJ6TWFI4I]/$E)TV2U2,4E8]5D'PE$EZ']8J
M%?@@Q5<%W1)3=[0+I007O`M[`KNN*K%%N4*M@O*);$`:1_6HJE;255`MD3ID
MY,<[E?0K(@$KD5S(-*H8I#)57P4%$VF)>LRO$L-7U8$5%$ZD,845KAAB>?E8
M0;]$EI(^X54)GD)964&%1!Z2JP+HZ%4BW]^ZB@F(/M^25:(5M$ED)1$.NI0H
M7)16T"B1BV0O=_4%^<PBMH(JB<Q"3!FKC=?9M6T%F1,I0ZK,%8UQE6*W@O2Y
M>P_9[A)N3?,?_#\69$_^!%!+`P04````"``O@25%Z:U_S>X-``"RM0``%0`<
M`')C87(M,C`Q-#`V,S!?9&5F+GAM;%54"0`#>1@*5'D8"E1U>`L``00E#@``
M!#D!``#M76USV[@1_MZ9_@=6-YVF,U4D^2T77]P;V98OFMJ6*RG)]9,')B$)
M%PI0"-(O]^L+4*)$B@0!RB2!9)0/CEZPBV=W@06PBZ4^_/H\=ZU'Z%%$\%FC
M\[;=L""VB8/P]*SQ:=3LCB[Z_89%?8`=X!(,SQJ8-'[]]U__8K%_'_[6;%I7
M"+K.J75)[&8?3\@OUBV8PU/K-XBA!WSB_6)]!F[`/R&_GP^OV=ME=Z?6T=LV
ML)I-!6:?(7:(]VG87S.;^?[BM-5Z>GIZB\DC>"+>5_K6)FKL1B3P;+CFY=G`
MNQ_]_>"R\_9YPO!>`I]]>M#N'+'/VN_YG^-QY_BT?7)ZW%'LP0=^0-<]M)_;
MJW]+\@\NPE]/^9\'0*'%C(#IZ3-%9XV87$^';XDW;1VTVYW6[S?7(WL&YZ")
M,#>&#1L1%>>21==Y__Y]*_PV:IIJ^?S@N5$?AZT(SIHS^];QUP3QQL>MY9?Q
MIBB'=0PT1:<TE.2:V,`/AYT4D25LP=\UHV9-_E&S<]`\9(:D3B.R4ZALC[AP
M""<6_Y\-I'6O?P`<4`_2<$A0A&TVBN8MWJK%C!K,(?:[V.EA'_DOW,+>/$3-
M)`G9SCPX.6OP$=3D`Z9]<MCF??^D0NN_+-A\HFB^<)EF6J^%>T$P)2YRV.AU
MSH'+]3V:0>A3&58I85U`[X#'5#:#/K*!NS/J3"X5BL#G.N2VIH/)8,&='K-Q
M(:7G<Z@#^@69+SPX@YBB1WA-Z&[PA5QJTO[()_;7&7$=ML+TO@5LUNUJ!3&G
MFD2Y`'1VY9*GG<=1BD')P`?>%&#T9SA4;]EBYT'FZA@8'^&`S\4B<V$77B6+
M,T)3C";,8S"7;=LDX'U/[YAB;02E^)6(2P9\B:B]U!!TU#6=3U4RQ#YFB_X4
M/;BP2RESS&R'Y$/7A;8?`/?.(ZQ_^0PMQ*3TR3F?$QSZ@L%"T:N+*"J`AOQP
MKJM@VFI:,I@A=+G[80NO_S+V`*;`5M*6C*[T\<A>PC%XEL_HC*9E.YS@@<)O
M`;-*[U'%BJ+V=?K!4OQAQ7[QEOB0CLD5PFSE0,#=K(F1L[ASP7)?SM;U!?^&
M.T674+;LC.&S?^ZRR3L&S.%(Y:RB+PT^6$W8XIPJ]\9JP&5TU7D95<4*"#3N
MV"ZA#Y!+;X''/WB$9>[@1+SK]&1%Y=N)62T[OE7GNVW\MHCK!*RL^F)<-+A/
M10OLP$J?,,K6>0W/RM<'1<M(">L"VMD9::=NJ,H#1)U#=2>D73!+2&LZ015%
M7I1/=7L?9:\HHJ@<FG2VY9!4#JZ``Y:2YH$%GAWAS6H<[UN0A(ER03S[<AQ"
MFC$6GAT\P*:#YCP8S%,>JX[B"EES0=AOL::M59M6)H/J<:\[:SID#E!!T&GJ
M&A"'/37G</X`O8)PDZ358P6N6PQA2%`]+DS\;E%H$4VM8Q).0.#Z.P_*B#R)
MF7V,,.)KQ#5[F\`-GWV('>A$R#G#LM*F[&/.;)44[UA-*Z**OP38L98LK`2/
MRD609T03^`\8Z'7LA[V^&-R.!M?]R^ZX=VF==Z^[MQ<]:_2QUQN/=(+/3HPF
M)#E4E\1ZD^#WSYHED^1,$U(=Y4DU&K/_;GJW3*+!E36XZPV[XSYKH$L><1(U
M(=.QDDSLXYN[8>]C[W;4_]RSK@<C;7+E9U43LIVHVVLT'ES\Y^/@^K(W'/W#
MZOWW4W_\O^CB1R2A2^R$6"Z_>4*\3(\<>M()H`^A.PUH<PK`@KGFSF$+NCZ-
M/N%[L,-FN[.Z:O+3ZN/[-6JF2]AG+]?6<\$#=,.^[U>-L]JV#(`>!B$58*_:
M;4/>C*>N%X%?+4>*:_YR#3SE41\V`GMNV!M;1^&4OXB033PRE^ISI3N2*T%<
MP0Q(PR(>&Z%GC4Y[@\4E%#IG#=\+,D368:7E_.'.@F`^N[K/2&6L99.5:L/,
MW;O,9DE3".R5)W.&^;0::@OKY>I,(#*0H'FIADF?4&16R54X41%`9)R#]G=O
MG?M.A@QE&2C:K;_6%[[6@J&0(B,>ZC5B++1XLSK&B@R8:GI?NNV2YVF!7?)G
M"9%C-M/9=1TGU!MP[P!R^O@"+)`/7)E5<LDJF%ZEFT@N@-!>>@TVY*%"#)T>
M\##"4RJS5';[^RPO;IB)<I`+UR;-D\FV@WD0QO$'['3M)0Z$RW"O=&*ILKC/
M<N&&6;"8,,*U2J]11S/`SLI]2H/-<3ICFQYK=7^BQS3JQZAML,+YI/G$)`HZ
M9!V3MMN:;X5LR,)IL*,MTHFG9=44[_T<L+,QGY5L2B:BO#$%\];9C<W5L`2S
M2,7'=:AXZW:QDJ97--^CPN/017H_*5?OW+$MKZY]8HH1:7JKE=FZS0(KTN:[
M<K6Y/,SP;B,0`H6F&YJM4P%>D5I_UKH6BO9//,UP13R(IO@B\#R([?CMD2YV
MPG=N.!6[SA\!#2_'W$)_,!F#9_%Z6DU_Y@Z(ZL46C:OW6L<5@[B14#P<$LV,
MMV(:;5ZB8)U4:VT)PKKYJBOAEBX"3.39WJGGV2ZZHX_6U?7@2QWYPYWJ`1.2
M_<RO$:Q++=B;.,M_64NFX?V"&%N+3*PXX\KE5*L;3`CV?ENP&`]KP\3:<*G^
MOD=^36$<?J>]#3].7*_RBQ46)J3H;$NQX64MF2T_6[.S-OQJ2+X+2Q`30AQL
M"[$DM$)*:TU:"][M\L0$T,,LH&N*RO%)BQ038(^VP:[(K9#>2C*H88RGRQ@3
M<(_3(YE36"N2ZCV@J*HQ@?(DY?369%9$I]=9YSKMSKN"3MMZ$[VJXU95)56,
M"?E3JW'2ZR,W7(E_`S2V`EAOEASKT,`.I8T)^5*+LNIZ4*>0TC+(N$@'J84Z
M:W78P#?@0DQJ.[^_<;6_<57&59'YPB4O$"YGSA.&'IVA!7>)O='@;C-'Z'GH
M)_/O8>W$S.S;6:_0CVG7&/)%X?]++PHI<]!SL^LUQBIB]K2NS+L"5INQ3;XH
M5O^`,/E&66QW)+MBD6JJ[;Y2T8F8D3].R2'TSYIO4=@SZ`0N#P#R$'MX`R&5
M*^RRX_4C8H=UOFBMSR<YEMR=Z?VQX3'LU\HF&@=ZI^D50%[X9-7EX8J=3*\1
M>$`N4SJD-Q!PA^4,\!#:@>>Q@S5K<$NP%[UE"D"4TX?2CZ$]P^A;L'KZBL*`
MJ:5[XX=6?5I0V"QJR;J(']R3.$IG1(LW,;8Z(P"E/*0G(5HJAASO0BG+8KU9
M]62MNZI#%;L]SR<A>RHL+0WJ:9%4[<$_"<E2,6Q!DF8MT3[^LX___+#Q'V$0
M_/QES/K.C_<H$9L=WRD@OVGQ'"%T#EQVNE<BUA/%*6(216.F-6)<P*9J:YH<
MIJG4XM5$9`0700?(92A^`U%RD>V,;J$OC+9PFCP2375\1>8149>D;#<JL,$-
MXJ50&PRYVL]NK"O:M:/B<X0P--2UO$,:WA+UER=L64121*&K2F\'4ZE((ER=
M-%?M*=DH(8VFVKO=[9)"+UPT]-IB'9HZ?XEB4B\7+J"2AV1(R,S>IBO);%IM
MWAIT?N@PC!5^PN2!0N^1ZZ"/%X'/OB;89E1A-&);;-F&L(:N]1P.U`:"8/!4
M;0?C#A4_\@@T^4!CY"@U.36]BBC3._#"95)X`D"Z^?V1GAU'?>XE]>0`@1)$
M1CXJ^:05[IB&T$=>."\&#RZ:@MSK!9Q,0J4K-5B[&55U(;+F<<G6'!,?N`GA
M<XR8W5A7U9L6V^6H0&2R$\VG[JT`S<M5X+H7A/HWT)\1YQ;Z8I<KI[W_V?"<
MOJ(((N-I7B%%GD)R',\B,=Y2^<@5XHA:;DP4_"V71%8Z5:HDRTK7FV??Y>==
M$O*EBIS4BTC6:7BCQ)38,U4455C>>@TL_Y68A'BIFJ?L`IH:3:?PXS$)"5)5
M3;D26)W]+9#]+9`?]A;(O@IH7P6TKP+:5P'MJX#V54"YU3,_2!&0L8^:'K(S
M@N329:R)V8MF2A;3\K,A0.FSH>.-]"QH:45F*#HIAW$K45%=F[R>%+"'R0L!
MOS4V#^8RHR2:Z;H8ES7$B02FT,/K]3HWX%E)[?%FNBZY*:@]!5/H@`RYC-.E
M-)@OPSM#1+]>>1#R.!S;_OE#MJHIW&B0<+A_9WATO9`@9NZ3LD3H/2^@[4-G
M#+UY,2O&*;]+ZZ4$,'/#E07]"T33&8/>?80>F,+/A#\@EF=?BT_&7%;?I5WE
M$@GW%L89.AJCE^@1.1`[Q>V;Q>&[-*M0$)$UC[0_@5?Y9^[C299#Q>>L:<MX
MK9ZSJ29,JM(]QD&3#**G=ZH)E*IO%S_-,U,^`[)*J=FW3XCM$V*E_()8]L0Z
M?XE_(PG4%>!A>"2OL#9,.R_$<<I2'EEM-07^BNM=;#C#4U6OLY#1X<+RK6AR
M6'$PF2`;>M)ZSG@S37FEG.E!\L&:Z>4ND<?.%42J^V0[;<%%5>UGP!4Z,;T&
M&//]]6#2QPX_V07`S=\A")J;O1G(E=&TB%,*[!?DS\*!QSWP#"W&I(?9J4BZ
MY!1FI&?'D&\<B2'5=&/<SD&7C4W><U0X#FI]GLH5%">->8/U]YIV$+O.(2(0
MH6PO*E#K-9P"5Z;;9"-=NX02-)PAB*%)2L%1@<>+,87TBBDG?H)8JV)%4C@6
MH<KXOF-ZF+T4`46CPJC:Z!AL!&GT')GP\;/V\HUX&!1F9;[A=Q3)S`-<^&@@
M!I4LZ[WP=#5^<X[1`@KS#9>/O*:%<-4G+P&>8O0G=#[A!4!.=QZ.*<'"F$]D
ML.95P2LDE74_DCJO.NTP]?#BY#.I:RTHW$:<78YVF'HJ<29D7H:F`[0DD9C[
M.WOBU.AJ#/$_#X!"]LG_`5!+`P04````"``O@25%UT'G\CPT```($0,`%0`<
M`')C87(M,C`Q-#`V,S!?;&%B+GAM;%54"0`#>1@*5'D8"E1U>`L``00E#@``
M!#D!``#M??MSW#B2YN\7<?\#SGL7XXZP_.C77GNG=T+6PZ<8M4LKR=V[T3'1
M09&H$LX464.R9&G^^@7`1Y'$F\4"TO),Q+3MJDS4!^!#(I$`$G_^R\-=BNYQ
M49(\^_G9FY>OGR&<Q7E"LM7/SSY>'1Q>'9V=/4-E%65)E.89_OE9EC_[R[__
MS_^!Z/_^_+\.#M`IP6GR%AWG\<%9MLS_#7V([O!;]!YGN(BJO/@W]&N4;M@G
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M5NR`?73PYMN#[VCOE,FSMO%Y"Q9YBB_Q$O%JOJT>UY2?);E;IPP4_^RVP$LY
MF+0H7C']5QE>T0Y/V`_]Q'[HS8_LA_ZE^?@\NL'I,\0D*?^4]?II4%:C],HW
MV`M<D#PYR::A'FL'@D_'3E'M4(&^OO<J7.=5E$X"W]?T#OL#GM;B6SW_+4VG
M$3RMI7N:0]@I^_"<_FT`'#]4=/[!20N=E:4Q</RGN-UMRNY*S^-!N2DSEGDA
M;1%>Y#(J;WBYF_)@%45K6OZ;[U[AM"K;3P[8)P>OWS36\5^:C_]8+)<DQL4O
M^.X&=S_`:_?S,X7,JS%:)GU8M)"C(C;4NY%X%>=T4EA7!VG=PK7ZLLCOE#_=
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M+.23,W*`?;(,)<"P1`IK3(_CV;T8Q01Q3MWS5#M+C"6\315R:-U\,?PZ>/>J
M,8W[E@O-.FDH^O8PN2=E7CS2GRK5_2N3\M;':HA=/XLB,/I:B6O<WZT@Z_(2
MAG4_RN_N\NRJRN-/6@,OD?-IXY4P^V9>$`I.#Q.R,4%J.<0%8?"#A=*Y;WOR
M]PVI'BG`=9[1?Y8:/]*@XY,W5O#['-(J@.&3#<HQMVI1M)4%Y64>)@EA:^<H
MO8A(<I8=16M21:G6)AET?/+,"GZ?9UH%,#RS02E.<JT.8DH'9QEJU/;EW,3Q
MYF[#`RG'>$EB4FE<'*6L/T?'`'?K[B@$@[/#!IW`BJTX2FKY_=-A4=WB@AF\
M`M_BK"3W^#PO=0ZPK6H(LMA41L8=G1XX*EF`U3$K9^HH[NNCYRDMX9L]D6U!
MTL,L>1^5%T6^QD5%</D!:^R/7MX;K6Q@=US2"<,@D`5"8:.(I(CJ(*J$MEHO
M$-4#%L%MT#U>4/P5A<S\N#7S_=X]7M/?UOCA5IH^O22'JO1])0NUX#QTQSIF
M9*OY`G%=OH79:;]`3'N_.T3U$0@2W9"4L,&@MF(J26_V2P^ULUQRL>!<,6,3
M]@B8,.I)`[-1IQ$I^&&[=X\MR,>C-"IU40*#CD^[9`6_;Y&T"L'YY8)2"$FW
M@HA+[M?B_$(RDJVVTZ_:XJ@DO5D</=3.XLC%@C/"C$W8U.;"/=<(F,6I%PJ;
MHJ"3XV%9XDI.'K.XUX-7!M"#,U@*V>!<L@0H.-SUTJR61Q%7`,8INI+,-UE5
M7D2/T4TJWP@UR'J-.>K@#F*-,D$P/-*ADZSUN2Q:U\)[WS=E-+W$%2EXM'UQ
MDY(5/V&OB2&95/S%CNS`;V-&>OG@A'$`*?"&::&B4T-YI[=O"BW6[%?>%W1)
MAQ--8$@FYB\>I`:Y#0.),C`HH08FS$%<$C6BP&8?MNIGUY=T`9V!B-?(C03<
M($33^SXX*S2@A*`+_1>_-+;?A4Y-O"-V7RM-S69`$/1L"!1`1Z9@)!6\VXW0
M%.:@$_8S%9P\X"(FI9D%@J!G%BB`CE@PDH+$`CDT!0LZ86#3@L7B-MR"UK2(
M!;EPM5BL'D)<GOX6%<QQT5)A)..3"U)X?3(,!,"P089J3(=&!@8->%QVL6PP
M+8I+LKJM-$ZC1M[K"4X3[,%)3I4P&-J8$`HG.WDT/5^B1@/E!>(ZH$[A\8.G
M]82H-3,2.;^G.A4PAR<Y1T)@N*-"-N8,ET.U()#CXB=WZS1_Q+BNPN<,%^4M
M6;-5U,G5XN*8E'&:EQO:8._X#KC&+$TJR2?)=JAJGX83B@%#U.G8A</'34FH
MX71;%C_K@)ZSXKZ9<QT^T]4WO,1%@1-V(`UG)8\7'C+S75_W_(U4M]M+>U>W
M48'?126[]?O(OB[K(Q^+I;08]<C8^Z]ZO9SGIPD'M_WV^Y-@1J>?>@I'4=@Y
M).K'M&JHK[??*%IK1,K#+.FN1:JC*%IQ;[$4"]!=1$4C&YQUE@!5AK_DY]DZ
M'1CVG1URN-O<:5W=D8Q/VRF%U[=T`X'@#-&ADATOH3(P:'#)3*8NW\KV>Z_I
M5,:P!ME2VB_!=/L8D9#KA'T/RKW[)7HP#_^AC-?A+X,W&/Y]`3`\D*$24Z8\
MS#'\50>9/^<6[H%,RM\!9B7$[>%E021X%^MQ"9[BYWR^"=_@$IJ]P&".G\'7
M@]2U4DPJCPZ&#;_$540RG)Q$!3NPJM\H4PG[39*F`SQ,B":3#,X4*WBZ2WK'
M\US_G.W,I_KNX5D6YW?&<Z"V^I[/AKI5:W1>U$[9*Q?O<7&3=YE#=^L,B%=)
MCW/ZX[B^-)95I'ID&:V+NSH><U-61117,J-MI^=MVG.I1C<9VB@%-WRN2(5,
M7HTJOW=:*Z.>]ISVL,3QRU5^_RK!I#:%]"]C"T@_^J-&<8E7A"'/*A:!']5:
M+>:#4B:0C$$JF>"$,0`3'*N:$EM9OB$2CA9'E*M%E)YE"7[X*WY45DZ0\TL,
M!<PA,T9"@*@A1Z;@1B.,N#2BXB'8T=HQMA,@J=;P:U]<D(%J*=#_#D3/2P`I
M)PLF$[*7NV<)V+L<FKJ,Y'SWNQ3FF``#(5!,D"%34J(6IBY$PA]+"<&.0PHD
M86!.TV@EJ=?H>U]LD,)J63#X$D3ORQ`):Y)6!C&A$'W=W/$\)64<I?^%HT)M
M#-2BOAA@`MN2024'@A<&<,+9PN92;2V/F$)0XU`[*[_A-/UKEG_.KG!4YAE.
MSLIR(\11+.3]NI,&V$.W4B$,@D0V",=,.BO;A6F$F.;!)Z:*6EU4*_\E'*E^
MS=--5D7%XRE)<3'>L-7(^261`N:0/",A0*21(].1I=-`7"4@0QIC>(G7>5&1
M;%6_!:=>?BG$/:]AM:!'2UFI+"#V:`$J2?2G$G4:S0-^J"DI()LXFX_H/+K*
M"W4$9"3EESM2B$/*#$0`,46&2Q'YX**HE=U3"/XHS\H\)0G;`'@7I>Q>Z-4M
MQE6IB[];*'D+OEM7H(N\&S6"T\4)IIA0?:N'&D54:P+9?^0W#17\4@GYO^(I
MXX]<(CA?M+"$U?75U<GU%20JM!F5;!@AR/HGA@*NR(^1(#":R-&I%MIU]BH8
MK#F*RMO#+&%_L&RA]U'*WP&HCJ*B>*2^%$\`J*B[I:[7:Z(NU1E<&;51!,,Z
M%[0""ZD2/TT?L[_@K3H,0EX4>!V1Y.2!W0K!S9!1-(-"UF].8@W<819BB2`8
M0NG0B9F&N2S"M3`0WO`3.Y<XQI3.-RG/X*TGCT[!>U9'+7`AKZ-4&@R7C!#E
MN1V+K08,1@VF=IOI/Z`#972<O+*CZKV&;FXV;=+J&*#/U*:1I#/PA[S"Y9;K
ME.JJ&NMU0B3^U,*7)0"5*H`Q.S8HQQQC@CW#@UA#H>/-)XQ^865%9-9C=;N:
MHL7RF)3KO(S2]T6^69]E<;I)J+?';M+G646R#4X6:USP\X#:D>=8DG^S-JFJ
MHO%S*@8.DR=C%]*QY]GJH,+%79LQ.5^BI*>/\K8`(*:5NP)G=.1E*T('9-T2
M:JNJ%O?NP6E`"_Z;1!8,^0P`A0V83A+6%,VQ:,=7"+.FME00_3.M8P:IMWLO
MF]#9G^>(N<W3!!=E_6JE(1IJK^Z3,:Z5ZG/*5A>,U7$$+,QS9X?OSL[/KL].
MKM#AAV-T=;TX^NO_6YP?GUQ>_0F=_,?'L^O_`D=5NU"]3B$0'2V"]FIIB)1S
M"]^G6T48G!H]@4`'$/VDH.Z=6$7#VLFJA("/5-A43?-TA4X=#"_=,1N?N6#1
M_J@N!#Q[+S&_0'D1%<ZT5:@&Y*NV,AJB2O6@,E0'5D)-SL)V[P`=H*)6IV0M
MX)#28>G=?\BH-T05;3='P5X3\,W6$(,<>SN7"F8PS%85"W<#?/C&VN$([5?8
MN0^!O03C,MW:(QCNI<SH`BA.0K*X(PL[]@#R<*8X)L9VTEW=V^G("97JSDDZ
MZ`:W;!,!JV//7Z@%,P^Z8#;+8*S`6BFM>0*W,G$.)$()';H%"[^`\*!S0!!N
M`/"B:#(?\SKICE=*)3V?;5-!'9UL&XN!(8X:F^146Y.1NF2B;]'_?OWR]>O7
M;]BZ%-TSQ;?H<%/=Y@7Y!T[>HC>O7]"OV?]1R9)CE_7MQH0'6_)-55;T+W0E
M\!9E)(5!O:/\[B[/C+P3Q;R>X%6`'!S6'<F`H9L"F'BMA(D-B:9FV@^OMU13
M<>S''U_\\*\_O'CS[;<-&V$P[C!)"'/NHO0B(LE9=A2M"9WJ57$EE;37")X>
M\B!H)Q<%PT8]/B$TUTDC=KSW@&0HKA5@<&F<,+*7;:])":EH!AO%D"D\U171
MI?,4M:"E4[1&K,NCF,R3[5/U0+<`Z8K0_CO&]SC-URQMRE45K<83I9NJOP>[
MW2JS?;C;3B^X69L`UH)9J&3Z]%]=`71>IB7`,'H6*4G/\Y*=SUHLKZ,']8:-
M6RG`<LW*JNB8<;9?1'`F[X;;->TLRSH+@\WB,MYZO1\Z@&(7.($5>%/BD\??
MRI[XG_C%P&K6!)'[.]\W\5`9K/-\4\[QP>*;)5IC])<O;_?!1M>\'1<1VR^[
MQ16)HW12$@]%">$S>FBK9D[O(54//J].Q^R0^`,-RH%A((=A3@IP4;`<2#CA
M4:@+7/#W^ZQBI&KE<*%G4X74T6B59G"J3H)KB%F_V$80(=*2UZ3<1C:M6D14
M"D=#5074]!MK`*6=`J:1;EL-N'RK(^8.S=`JA.;9$+B)8[4T:'X-(!JY-=A4
M@TNOQ787QJ$I!EJAB2:I@HEM/170E!-QVO*NM[L&@WR]K45'_\Y*,]`6KXMG
M9Z$&AHSV6'5[P^`<NEZU++TYK48@TMGX<1IQB"2S]."&Y(+FO@GUT?IN2NF@
MK%)[;0I1N&S2^FM#)@%TUH3JF#TUO4I06AE\-)T\7(*9O3,IRV9TS2P"PGSF
M9MO"Y6*Y/?-N&PPV:0<)!-M521H$UJL&I]HTO-K@[[8$M%BB!;#K"I?X'F<;
MY5V%[==^#S@-00V/,=7?!:>*`M"8"\W7,'J[85^V:O)TFA)_:^2]YD<RP1XD
M2%()@V&,":'P!`&H/*GO<4;AIRRM0')',OY6:$7N<8-246>CED\^65:ASRJ#
M"AANV>$<,ZS1JO,\#/2@)>D=#QW;(1;88%D9*EB',53PY*<O\E8:&&&VA^!.
M:0\=U==&*4SE_6$719^4LJ](GV-F+3"6RQJJD(,55_R(8IU\->X4P5T-EM]^
MIJ9ZD`+"Y),YE^(YV\>4*HY2>[@4`8:_TW`+C^Q"OML^'*+R"AM.DKL5$<[`
MVE5.;6KU^F!(.P&TF,"5%?'J.3/!W]0V&'2"AO<1R5B%%UD],/F=M<52F_#5
MH.-U[6(#?[!RT2F`(:(-2F'50G50GC&Z<0/+<H/DI%[%K*(2K0O&/3CI(!C>
M15'7\BI*\6+)8]EGV=7FIB0)B80G'ITT?;/0LBIC+AK40#'2#JN8N(8ZHR->
MEIT2>GZ:E]4F6WT#AY62D7>)H_2D9+%KJ[1+.Y<&P(;:5MG"NIJ*`L7RZ?BE
M%OGY.?<$Z@$`UP^@;LW6^U&TSDC&)T>E\/K,&PC`"AW)H*E6[3#(T%XQ;\]6
M'9-T4^'$L!0W:ODDC&45^A0RJ(`Q4G8XA6V31@M1PU-O_:,#=!.5).8>8E(7
M`H-_YN`7K7M3;=U1S0GEP`IB*JKI%M,<%0*&QU.12QW,=7U/FQ]OX>0&'/ET
M"3/0)GC'!JD]S9W*@QI2DE9[:GQI4!A0^KO70!YY0DWD21@/H+W/\93&*\N#
MQ7ST6TZ$@E9(AT-1!9W#,5(!PU0[G%9F&0;=?L-D=<M<IGLZ#%;XP^;N!A>+
MI7",DE=4T2B.9?BDXJ3J]8GI5``8FDY!/29M6P:*ZD+"'Y)5)+$9M<&T(H(?
MES54SGAF5J$?G)([@+8[/8L&A:!S0^@`3F3FV^!]H\<%.S!CD]:*SM(D3^CG
M!8Y*?(SK/TU'6V<HV/L;H;,TA/":Z$ZE@F'W;%61ORX/-26:KMJG>4%G]ZQ^
MVB-^O"ZBK*3UI*L@ZLOR?Z5\3728_/]-63$K:SB]L:\?@S*0=F\PV\$U_9>^
MB`&W<_7$:Q1Q&I4E69*8*Z*HTU1OM<(8H9(F,@PSK8;G:X0FZ*-;A"IQ6!M4
M9J"*!Y"`3@*=EWS-WM-35'HLY#<?I@S@,!=F7P*,D9/"$AX+Z18IOW.QOP%C
MQ3G)\!G]JVJ;6R88A!T"4"E#.BEX+!E#TS"%B2(N"X4NYI0)X?(DF)(C!,N(
ML.9+"MJO1:6;<2PR(KS#*Y*QL'.;+_(%NC(^Q;'743DQA['?B(=M!ZAQ6G3$
MX1U[L'9/@5`.[1U=B";,+Z'.!?=P90$VE:2WL*8>:A>]E(L%-]=F;**]IL+L
MT`A.N//7BJ,#=$5YATMTB'Z+"KJ@\4N.Q5KY]J5!(3!51L`-C&FD(1-G"-&!
M/_EZENUH!6W83,-,UV+Y,2/"O0:YB#=J*,!U9!A]#Z/[Y:"$,PF-%`M$<+F]
M;9ZQ+6;V"^TORC=D1"F/6V`JB+U=KK$(C+Y6XC)V]POTJRG;'IRMJ>^@O?@D
MAR?;H0JX_^>T%`GA"Y]DB?521.4#G_"=_R]])>*7X':MKT9IZH.]+D*4>_=1
M>7N:YI\G92R3*(<_@:&JD/GLQ5@3RF3E!M<A6QDK`O$R8(2HJ.5GD"Z*_)XD
M.'GW^)$ZUF=9EZKD,*[(??U^C'[W?TI!GF__3*SH:+9W+"4XHW>&+K";47C)
M*%S?3=\FJHFZ(F"0>[L76E[GEYBQA*1XX!)=Y_/0?S\_Y?>5W?TUUO")WOE_
M!\P@VV/EQ,>!NY]"58Z*]L=0UF;OH9^RO\<6X_4MC`';'@W7QFU-PMXW4;31
M6[TD&.)JX5G'X)I,91X"MUFY27NIU$S114$\2-!6`5H:LAW)!B>*)4`]55J=
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MFPK;F5==28"]`@?X8\X_;TMA5&_H3SD?-26B=5UD_0Y)72BP@6"_+[GSQB;4
M'>?==IIA701TQBT[BV:S906:O6?9/2[G.#^A+0@`FRTJ:L%J32E@S/9DZ*;S
M$Z0M`=Y^[%%>5B6=K]BE<SHG_7U#VH#9@K`7L=Y'Y447^E*TFV,9?B]C3ZC>
M\'JV0P%@F#P%M1C&[M2@/Q)`ZQ)CG/`4B76\<%S-1_HO=G)TS6+PBD9S+L4G
MD2=6L4]EQR+`D'D:[C&=VU*ZUU;V_/R%8N-Z,!C/L@JG*8ZK392V59'MN5HH
M>=O(MJY`MZ%MU(`2G'!":S"7I*?9L@K([H.]F[.SGP35@=W-<?TBEF-JW#;+
M,9G'"IJ]IR2+LGB&Y9BV(`!LMJBH!:LUI8"9]R=#-RW'EFT)<R['5"<:N<-2
MWXWDF]C456DNO\MOHFOE_9UIM("]/=2H$0[.)EN$PK%&JL(F\C8O-3_ER-S$
MSXW>EV8.=QYE4,W?;F;OBYC,U;AM)G.9O8/!7E97.A39'VS]=D_''-LDD68<
M584ZG(KP&GN:4+E!Z,E!/[B9W0&T_$@,V^/B1&8VE_\%;\L+=`9/7KE#.F2+
MXI&.+Y[&P+XK1XHP<T"Y09>Z7K(>?(%NNHQ1=):MP3S-;@5XH=X-N$.G8OJI
M57=ZO'&V6:]3?O8Z2MOKW6?9,B_NZFRZ^E6BM;;7.VEN51I<4K-3!3.?N.$5
MG/B>-G_;*,W+35'[]:V31">:KKA]K0(_T#ZEO[>-R62)Q*7[D%>X/HJ'D_;T
M>I0NELJGCF<NV]OJ<N[FZ%:B<Q4<G/[[J(VP5,BS`SX*>L$^:KYEJP5T@-C/
M-`<^V=-@^SI@KQQ`%2ZO\Z;Z4;I-N:%+L6*CY9'TME7HT=FD`H6HECA%"E)%
M=HN]4^TE4X'A/GR(*CIC].^&J9;N$D&O`1,ET$%@1)`*3B$C-!EKT)N7:%&L
MHHS\@\N^0+4Z-V'-*Z%MDKEM@3`HQ9X6*Q?+"]J`S#-I7GBX(JN,/]605<UI
M46J#+_*4Q-0`7^.'ZAV%]$G1=KL5Z9.F<U2^3^A=R@-#_1DJ(1TDW[Y$O4+0
MMA34%K.G^5K^4*ENKC9I>)NG[:!W<[1>/#C#[#$*=RWZ3\%",Z'M88R+-.*)
M"+K3/\?=(L]D,MV*\'S6R[ERHX->UOK!";H#:*G)^^XE`LW<,VK?LQ5AET#X
M+4][PEII^KWO8UV5X>4>HQH85MICE9+Q^Y=H6P*JBZ!KZ?ZQ,G0QT^$P;=)K
MONG=I%U7\<PL[CD-MA;T*!^V5#8XC2P!2KGSPTM4:Z(ZP])BGMSWL[W/=D?J
MU'1L'X%;VQ7.F$=I;]!<"_'\BMN$"HX>=G,H(3A5=X(M)?"/-8&;PF#P]A*G
M[/3O140-;N^!10?2.I7@-Z63<]6&69RLU<%PU1VSE*C_^A(U)2%>%.J7M:\$
M=CQ;Z'7TH#RGJA;SE[1.#7*;KDZ4"<X/`S`A11V71%P4AIGJL+NL#G0JGM,`
M&,&/+OLKY8-3R0&DU+;\7[8"F(]>JE/&FYL2_WU#Y]F3>Y:946-1E*+^SA;K
MP6Z/%<OE@E/"`IQX#J&51EP<B)D95<*XRZ"1]WO\Q0![>.!%(1R<1[8(I7;E
MIY=H=E*IC(MN&Z+]4VMRW`KP9XBF5&QKGERT@Y-M,F3!E.GWDV;;6)IUJW54
MV\?ZOY:;JD;E`-NGEA62;)0:-(,3=1)<X35:ILRV_OL[JOQHP$5!LIBL4\R_
MWI8.@Z[;9X4H7CN2ZE7\ALS,X(<!,K4\&!I:@!0S#?0I-BA@;TD%6AI?593D
M49&41WG"K;292)-*\)AN8$K5>KD'7-2#LVXZ9B$=P7I-Q7ABN-XL_7Y#B4@;
M'(:U^UCBQ?*DK,A=5"GO)XZ%?%HT.<"^#1M*!.>/%I8D3WW+BTX4!C$4E\CL
MYD,[70`7`2UF2!M%,*1S0:N\4L3_<F)WT\_C<2->B?,\RGJYDNL/5<=9=!I>
M#Q.9H0_.#JG%P1#-C%$:,MG*UM>BCS>?,/J%F<"(`'F+YC0B!;][MUAV)^+/
M,KH>W]QMQY*B52QU?7+/J3I]%EHI@N&C"]HQ,YEN_?PY6RQLKT'T]&%0DV7H
MSF-<TB%78MK0M_SYIWN<YOR4GI::EKI^-ZD<JC/<K;)0!$--%[1C:K8J?%[N
M*2&>71(&*]_G>?*9I"P=X/BHGIV[Z%*`3WZZ5VSPZH^U-ABF.D,6=_%'!RWW
M^49E<QC/(K*B%??[1J4>]/"-2KFL5[;<X^(F+_&Y<C?#B%/^5"6H@Y3=N0([
M<Z46#W+"P\(4J62A4,D2)_PS0_)+/G:TLM3UR3&GZO0)9Z4(C7TNH+^HBUHG
M4<%R_+`,4/P!:CL^&K5\,M&R"GT.&E3`.%UV.,>$:[70<_;8XC>(:B.NOB>/
M2W7,U\+[LE;UYHDY5J;SRBSU@E-K`EAQX;FOP]BS77Y9%_@69R6YQ[4CX'*L
MQ%[=\X47ITJ-KKI8Z08GYT3`PFY%7[T]WUL;PSV90,FS';H3=UIQ;Z;.`G1G
MWC2RP5EC"5#OEY$447U$"^CY:'3],,?CF:IC(3P,0G^U]\C<8BEW-6L@^C,B
MNQ3G[\#([I7>GAZ97A8,TNY>`>'0@/1I8K9WD?3IGL^V#%'>GQK&""4O==05
MTM^N<B[$X]VKB17LW<QR+`$&9Z?"-L:#%1?O9[+!,V\`RT;N+SAB]XZ217:)
MV=->=4K`#WE6M/_DYUZ9/A][USB^S<C?-[@>VR:_U--O!]F`]M&<T@WL??YP
M\/$:HK:2"6ES5T?T4<%R$=.?0LN\0-4M1N_2*/YT<!7?YNPT[EV>X!3&.*>0
M<++A;YE1G'7PA38#3MC2@JXKZA1@=?[-1ZO1NU.)7F]O[5[UP?VNZ<6!&3^[
MUT&WTX5:S?U?9;=QN93"(:ZU&UTHA61PZEC!TVU:@7)[M@/@&"\Q>[248I1-
M)HZFT+&T,&9P4I7E)M"IJ.`<G@>_8/J:TOB:M"D/5=$#BJ1+5V@#X&2YQ,Q>
MXVYP7T8\P3>E%(5<NTANHV!*D6&&PO3*R\>#>WD`!\7D2HC[*GT5-CZ8CUQ6
M4;6AM'Y$2YS@@BZ,23U-L#&#'YC_@='S&YSA):GV%M_NI7*N$SEWR:=X&N=^
M5NAC7$4D+3^P=]A8LV@#X;.4ZR]B/F,S;$/K,Q0:?%C,79/QV.@7W:82/QRE
M$E_T4XFCY@=0]PN!7B^Z9#@RG+2[\H=QO+G;\!U4.IV2F$C?@3%K^7J.ROPN
M\P3,DKMNK2AS"IALB&P9+J9K8D$PLF=8&Z=)I<"P1KM`=\VJX61LYLD6RRZN
MDY(.F,6R?2KU.K^@K7<;E9B'**0/V+J6$"*GK$/59&EF+=1A,'029LEAA^T#
MN'%;#/,>VY=PV0,NZZ8H5/*R]N4F-OES1\@'3_M*'0<K/7]NGD,UMFZ<A1(,
MVCD@%=RP)I(O,FK\%C.,=?OX5,CCZ29-V?VH7W!UFR<?L.I=01M%GVMP^XKT
MO4BS5G!&.D.5GWB`03>.A;K!I.!/9"UN4K+BRQ%%I37R/LEEA-WGE%(8#)5,
M",<,.I\OVNCTW([+:L.UA,#/\5BO+]S4@U-L.F;+6R'^5A+-4\*'=VPQLUA*
MSD]*758;-7]K!OM*;!<*9AT8-+,'*F9KJ351Q%7;2').4KZ[LHI*M.[*"!06
MFVG.\?LFN\5-,3-4J0.#BDX%Y9T.#*^F(]XECM.H?HFYG3,?V2.XFZ*@N$V.
MG4D[B#MM5R6I3ZU7#6Y#IN%U(.>+P0GCB)WSPD#>E&]?67Y?Y)OU61:GFX2:
M0^F\S1):*5K.N13/]V^G5'%T$]>E"#",GH9;FM*L?3#[BZ,M%2F9([`D%;O7
MM'M+"04");.BXA-Y/2KM2Z2XO`JRLP6KC/P#,_</2CHUAUI>XGM,/]B]N;J"
M@/)[5-&)O&Y*^1+Y/(0N\IA_2PWW.B_8/@?)]G6SR3O'F[]DJ_H@T3QV75HH
M4.YK&F#B.)"4^"6."74UA$R:U%M/Z=?=``EWOZ^)9.UXP4\H!=(-/T457:[X
MC8H(SL[=<$^^Y-<4!\-F]^]+M9>7+DGYZ;3`F*&G;5VQ,YZ*@6VO'NJNG4VE
M5-?E=+K!V3L1\)BVOV&RNF7>171/#>^*NAM4]V!)E:F_46LC:I"!Y.F75?;D
M84U'&$ZN<7'GT$9#M=#TE%7"1,N^#F@Z2H`*B9P:$922)6,>>L11`=A&ML/F
ML!XUO^8I=5I8F-'16!K*"4U+JVJ:>*HM!#1Q;9`K#>KA_0IUM-ZJPN5T"_:8
MW),$9XDCE>7JH1FLJY2M@>WK@N:K!K#2X":-+'HD.`V_AK(Z(K)3<0!75>;#
M(SN4%9RQ,U5@UP77?.=,9C+!)",5/F=[,N/&41_6-"EY-;=6%1@86:T&M/,-
M5F@UK(P`'=>L<ZH6)%;-Z'T!KS=N!6"#^[/=M\&MF!*2]!V5^_8=E>:*`Q`6
MK-D3D,4I5KYQ-Y#PR@,1VH`(VZ_A,$'`)%Y8R<I-RN]/M=>7J5'(8\)O_WTF
MU2T_K7:%"W:NY'`NLIAO5#67&RSBUA9*(>Y-Z2L@NRHEUPA.)B>8B@M1@\<D
MYHHOZ^\]+395R9X$98<V=9?>-=*^[SAI((]O-DE$81#%B$]UBZFG`60JDF>6
M8O9OQ8_?O7O<BEQ$C^RCP\]1P=*UU95B3S-6C[W7R7IU_+"YN\&%;@;?^T][
M=Z(\-:;@GNWY=[T./+I>)'ER545%I5L9>*RW:D#G6WFZ[KW!*Y*Q3`3H)DKA
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MGX:J;4K`O?SUF22H=NA)A:_G;Y=_AK<M@H/P+)$SOJ=ACB9V2X@(.BS#9'':
M#EK#_#,4SX*1&]K;\,R/&[BG87NF=(C7V+X5LJ_'ZDQHE2>W,?`U^/=/:6-A
M'^UBY^'/N_,`?7+]E;<A7/?>&=_3F&(G=HL?D^0([NN9:*<UC(<M&<7^YPCA
M);Z+"(MML/>=V$E>:28#)TUO^Y%N5>GV%>W4@H?MW;&:DVNTZNSYDD8?5;0`
M:'OMQE'7.VE@:J)-E+(V*M_,NO^Z)X3P]_+WVC6[[_WO!1X,6P"R302;TSZ%
MM.<0NG>+\[X.O-FVC]\.=`;W!.S,Q`[Q8&(<D4'QE4&VRI[CX-[-2'<J%Z8A
MF0#O"9B2R9WBP9@X8_M*S,G4=MDIROT4HG\3G#WO095)&)]&%'"'[O$3"9P`
M,/CZ"7*K6*Z@P&Y1W)B;\V;<G(LV85P7[;1LM'$0)R@2[P8G3%,+9L4O#%C&
M(TC=E2;B:[S!<4:;B&0EB>%<U]!`>AI.B7WC>SX@H<0#RVJ$;03AJ;G5JL"K
MJ.(YUFO-.F,<(!LRQ<X:6ZRK^+#%>K[;W*9_%DA?A)\Q8^//XG#,@`?LY8FP
M[1'HTH0N5.NS09HXMC+:%02+WR!LP.8>1EP#`($77@W7"#MLSOQS"O-CLJ&>
M#P[='B'.!4.9P6SRE03#\W1G,F.NDT!@ONX9+4BZ%-<4V5;/DKAHAT^:;7YT
MQ%XU>+!G&EZ7?-KS/1^BFX7*PWOZ8]J)H2_BUU:+X(;F<_L]##[(08T[O99"
M42NVK^YEI!+M:G)',L)(R9AU4C\2(*V+B[H_6KA7:DL9>UT@='(&+%"-E7#`
MBT!QKPP4#0II'XO8$Q,_9@6.\U5&_C&LR5%>2J<UO;PWKMG`[LBE$X;!)@N$
M8_KT58;\B:G2%[YW,+C-52>O7"QKV[RG[6#Y3WT1L7Z+QIKST(#L=X*/(@^5
MD]IOE#>.8;WWMT]WH4'XL=EF5$Y*@IQ?!T`!<SC3CX2"T\>$3-_WF\Q;[^NV
M.V1B0?I>N4D@RL#K>7U,?=CQ^[WVP!:@I.+1$]?`@U'-:\3!LA*#4(-!!P9O
M[('*@@N-IK>8P@6M]RTN\:)(<'&)8WQ/Y)9$(>B-,UJ@'4ND4C!XH8,V9D(K
MBW(FC(I&V@<'#N_R358Q?.Q94V-%QN)A^"`'+6?%4!8@-Z0`#0R)N`XG"E."
ML=*[Q"E[QO(B*JK':SHKEM3TT2FRB8"4I[0S>Q^7OY'JMJ^B\.9W+M7G^FVF
M)N@OU78L,CCAYZV'\+8NQB5:1R2A`P,E&XRJG(X*KD8_IGHPAL9A'+,!6]+5
M)HLH]RI&<'FT*0JV!,W8$P)Q_0]%(TXHQR?])U>S3WCG0L!0?"IRX31P4PYE
M,"\('0PX30N#P6J^GTMKDZ\Q<UJSE7R[PBSNDZ,FT'TJJF3!,,X`<$RLYENT
MC1KOR<5L?NBR^YV/&3/2M:LCO4!OTO#F:-I![WQ-O7APHMAC-',%;;A:XWSN
MZSWILRS.[_!U](!M7B/727NCC!ER1Q>U*`RJ&/&-:5(K(*XQUTOC\\Q.QWB)
MZ2R;4&B'98FK\GV1ERHRV2KYG*GL*M"?K_0:P1GF!'-,M%8)5=$#BKC:6Z!$
M6[2S\3FMUE%4%(_+^O:7:N/2J82@%#173<M'M3I<<AHQCYGZ`5>H<\A02K50
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MQ`-UC3!:UMJ(U*.&&52ZC`8R"=LTP-$M.V1\EDWW&&?_%6C#:$(3N0XIAY_X
MHH:7>[V$,X>\!#J^>'HID+ZNO"%8'CZ2;4BV:N)Q>:9:QKL4$'YPZ"IFYKU,
M&SBE-9`5SA.;!M9%?D]*1M?G-SC#2U)]XSF9R:S>K-\D(*8K_C9(K1S;?1]?
MIC]:X*BDA#+.IQ;R/M=`1MA]VBB%@P]M6X02MG`5-O-4M]AU]ME7QS0GK:@M
MNF(I9MCNS%&>D"6).;B+/"7QXS5^J-Y1EGX2NLI-_8\DC[UU'OTMGG2#`Y%U
MXB3LBI-J;)^K*P7UBT%U.>AW5A+B1?TM4$=O[C;\#!UUGDA,JE\PN]\GZU*I
M(+C.TZ$4O+Y-6>5WZ"3EUQ\#MW^]DY3?K0M\B[.23A9L8]7<'3H]L+UC`1I@
M9R74U:++<7:X6M4O@@BP+E#A$X.WM&MBTLQ%68+.[M81*5CAB'65_JSMWGJ`
MK>HN<44*3H+%34I6'**J._3RP/K&"JPPU3`M5'1J*._T7H;H(C&WD-I/T,C"
MZAHS4$6&I+)_)S9(?]"1KA@<W3>PVGH,2S\/!&G3<[R*4G7##K^&U;I2;`";
M>$'2PRQY'Y47!3LSQD[>?,`JYU0G#*OY+9`*IX9(RB?@552R:$^CA3(<J&.X
M+3MB*],TQ8FJ1V12P+I"`U&>6!'%K7#`EF^R0!I:?B0%L>7E$!4MCUOA@"W?
M9+_0MOM`!F*KRP`JVKS)X!&DQ16W8DM3Y,E2#U;/N($>]U:CC;@ZZNM#"3*Y
MYL0$U3ER<*;<F$$&#5^?"`_XB,TM%0/6ZCJ,\")#_96AR41I9`'V@1:H/@/4
MFNN$&PD>TJW"ZR\GX/+^LTZ[&J1KK_,J2GOW,13NF%P,5H=I,8[[A@NC="L=
MI/7GRRT+JB<LD+KEF`4T_S<6W-(-:*1A=8\-5&M;=A`T'%O'A3]FI#HKRXWT
MH(,H`JLWE/B$PPW-URA?(B9>OD#\(8O@@R,K-ZDBQ8E)%E97F('JAT6K$W1&
MG_SNZ(?6!@@OJA@?L-G;SP'CAX^ZCBGVV?'-YWWQRO1T-4[8R]4"/^S48/6S
M$V;AC>Y&&46U-BI:=68A&GU4T0*"[+7EV8K]=L]/7BR/21G7QV5Q(C\>[*H+
MJS_=@<.+B8AGL:X(U3C&]SC-UPS55479)I[9L-.#U6%NH.%UUO9TSV&6],_^
M"-VCE(35(2:8\+K@,*93;4GXRF9YEE5LHS&N-E':;!4_2D:*00-6E]C"%0_3
M=GIL)4%ZFNV&>*`H8Y3BQ;)W-HA2[;?&^1'=3HTPK'ZR0"JL*J@*ZYNX?^J)
M'5IH?<$@_5/?`:/H+:;1:^:E:HZJ[5`6K-[=O2+2$X@E[^Y>>)+1(>F5VJ9^
M"A5XF>^N":CNM$`ZX<Y)F-`82P9&5QUU_LW%4G)62HR5F75@]9<]8,%#:33;
M)/=T?+'>RZ7'P\*%V":\<P.J@]0`K=Z["=+P\^;F!=4=5EB=<_3Z[J5>)G3U
M#9CZYJBXG^FL[/D6[:"^3=]-QRRY2M>6@'@1:%`&:N[;/F>74KY!O]>E^3[F
MU%67NT)'FB3^?0%(_23%)??T7J!&+F@CJUL77+,:VA/]?HR7T2:MT#G3#L7=
MWGI`0V!1"E!S:\"-F[XG&IK//2B&%H?9U#9M#(3CERP?0X:3DZA@^QNE&+:5
M]8!9ZX_OP'2,`UCQ)'&MBEI=]+P_^S;JOO.+=,_7,G?[-D\37)3UKJ2LKT2I
M/[X'TS<:<-+%12/Z)U0+H\.J*LC-IN*/WU0Y._(-PFS1%:Q=[YAT8!HX/52=
MU6,+\UH\4"<M1@_@2&<800A0-ZBQB;=6VM3RK6B@-I>L<3[@:K&\CAYDK:\1
M!]0/-B@E=Z!5"[47B+\&L&1YDE[`LFOU50YV=FT8OI)]#VC>E\*27U-Y@6JQ
M0`W<QI^/<1NZ;A]VJQ_[')_:<M$#-&*<X"IC],];]6]8N+Y[`6];!)A.O"@P
M"[%IGHTSZ8#N/`54RXYKM-NI*5"G49M[%)6W%RQG8(*3=X\?2YR<9=W,><BR
M$BH7HO;:@#IR`FC9NS6L#-06@FX>T7-6#NW9;]#6[]B6]53.CX2?WAR!:LZ.
MR#5AC<2S[!Z7DT>B1!O^2-2!=AR)75'A1J*ALJ<DB[)X:O]*M.'WKPZT8_]V
M106VM'/=]@5B76T@2L-3<IUP#FF=JU?3(R990*/)"%&==_A%E_>A^3-<^H?N
MU1CI\3*+GK)2!-1M;GB%I(O]\W);=8`=2DTQJ?`YN6<FOJ)U('0IJGW52*\!
MJ`LM@8[[KE8[X'IHJXC:/?,/^N>/]AW0FO<2V&)3E2RO,9V+/VQ4YU5\_"Z`
M.31(=:6!O8/Z6F?_YU'O]YDSU9=K,"`.@A(TSPZ:S$_-=E,/R0O4PT)E.9HO
MC<]B^[+S1->W47N5G#8!6T'@9'2?CI\#/(XJ?!J1@E]AGI7O,^)Z"N-A'\VQ
MA_$B#I+F?%I%D:(&*A]6-=@7J+MHV>!%'#!BB!&#7-^.?W*CBM>R/,LN<$%R
M:$/+$1P@/P5>FX0;9#5B'FCGF+_:L7::%TM,J@TE&["!YH+LJQAEDQHDW!#K
MP?UJ1]>O?"('.I,Y@OLJQMC4-@DWS&K$X&>RW;++V'D@@G\OI#791"G+:R*Y
M;`T%&8!1!K1!I$,,`L*G-9*::1OD6'+&]O1'T_0F\3>>G#&&]`/%?+A""]PX
MM\#A:E7@%9V`SVA%25:2F,_!O1"ITO4+A`=:7#!T,X1S\#J0J$-9>W"#$'NP
M2<AGQRAS!`0"`FIZ"5E_Z>@(`.BK&`7&7*6!P'RUHT'6!L%'Q(DVEVK_HW/Z
M-_IQ^Q']#P-!/_EO4$L#!!0````(`"^!)456SRHVNR$``+4D`@`5`!P`<F-A
M<BTR,#$T,#8S,%]P<F4N>&UL550)``-Y&`I4>1@*5'5X"P`!!"4.```$.0$`
M`.U=47,;-Y)^OZK[#SQO75VVZF1)=IQ=>Y.[HB7*4:TL\D0ZV7U*04.0Q&8X
MP\P,93&__H`9DAK.#(#&$"":BO(0RS*`Z>ZONP%T`XWO__=Q'G8>:)*R./KA
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M^O9UG$Q/WYR=G9_^X_/-,)C1.3EAD0`CH*\VO<0H3?W.W[]_?YK_ZZ9IK>7C
M?1)NOO'V=$/.=F3^KTS1OD1)RCZD.7DW<4"R7)>TG^E(6XB_G6R:G8A?G9R_
M.7G+T4G'KS;"SR68Q"&]HY..^)-KQ_:K_R+1,DUHFN.<LBC@JC$_%:U..5++
M.8VR;C3N11G+5@*V9)Y3S3G)AYTE=/+#*Z$6)T(+SKY[>R:^_2=(WVRUX$:2
MLODBY)(YW9?<BSA*XY"-N4J./Y)0R'LXHS1+=;1J.QZ*T`%)N,AF-&,!"5M3
MW3B*0Q:$`5.!==J?]!?"DW&,C82N'N$0I%_$\T5"9S1*V0.]B=-VY$M'.9#T
MAUD<_#J+PS&?-GJ_+;G5M45!/M*!6+D@Z>PJC+^VUJ/:`)8)[R=3$K'?<U6]
MY3-80KFKX\1D+%H*6S2QA39C669GR*81FW"/P5UV$,1+\>WI@`LV8%1+/ZBS
M98(O61H4$J)CN*35O2R3>!WQ27_*[D/:35/NF/FR)Z-A2(-L2<)!$O/OZRW4
M:!#KQCF?QU'N"_H+H%>7]7!`&LMR6X?05&EJF9@[&@KWPR?>;#5*2)22`"0M
M73_K^LA_I"/RJ+?HAJ:V'<[R/J6_+3DJO0<(BK+VA_2#5ORA8[]X&V<T'<57
M+.(S!R/ATYRX<1:#D!3K<CZO+\2_"*<8QBF?=D;T,?L8<N,=$>YPM'RZ^)8'
M'PQCUGPDY]X81KBNGSLO`Q6LI(/'%=LES0@+TUN2B%\\4)LK.-G8A_1DIORU
M&NP@*[[UQ]LM_"J=#TDP6/1FHWAPGT`$6@SECQDP.ON,Z7Q^`"*C[7@H0L];
M4WI^:%+!"@(?P=T.J0W-FJX'VD&94FXZCKNU#]@KRGHX)TUK;8HNSHDS<,#:
MKBIB%YP@KN?YI'K#?['3A>]0:#2FX\U`@E9;B1/^:S'8.M=UWCGI;'J5?R31
MN%,,T2F/L69APP3?1>W0'8K44ISH1)<G\U2T=N_3+.$6M!DH)/<TS(?_1?2%
M=3UM0^Q:QGFR*Z7!ZVG\<#JF[)33_U;\(!AY>W)VODYU_8G_ZI>"ACLZ9>+3
M42;2BPV4\Z;-+:N$EE6CFP2=.!G3A".V&9,DP8Y"U+-SZQ:GBSPC<Q+,6+C5
MI4D2STU%N19;K&&D+%U.PL$AN.",)"2\YJ;S^'>Z4F%0:PH$X1P?"A*N?<"P
MX6/$AVV6_FX+H-#?8!)Z$X\^93V@"8LY!V-Q)$(M]$I3H/3?8I1^(]<^8.AR
M:L:"HJN03)O%7VD"%/NWF,3>R*4/<5\L$\'B%4L#$OZ3DD2I^/+60!#>80)!
MQ[N_B?=G&H9_C^*OT9"2-([H^#I-ES113<#2+D!DOL.$#$@*_N#Y*0Z77(+)
MZHJ%-$E5L-2:`N'X"SXX)%Q[7)X6]GM'%W$BPMC%`43E*E72`PC*7_&!HI:!
M/VQR';G@SG0:)\J-0Z4A$(GW^)!HY+@!@.]/&^,5[H,9^M.1.Y&,-YV3SC8/
MS'^^Z-\.^S?7E]U1[[+SL7O3O;WH=88_]GJCH<TPAI1*30P#T&]O$YB0]#[7
MJV5Z,B5D4=@!#;-T\YNJ0:Q__4N14U"PL&Y8;><SE`%&8F,*$A[LNZ)]<5@[
M32@<M>;>8AMJ"3?!(&$5!QKB:*=(K_,_Q+F2!Q**3$4WNR!)LN*367Z30(X.
ML+NWH`@(B+@-2YA`'"1T0=BX][B@44K7;,I!DS3W%CMI`9*28QR@]+,93>YH
M0+D*B9,XMS33(J/JXRW&T@(>/>\X,-KA"3@'>0RTM$"BD<.2\#GM$\K_<7Q3
M<"VE,"<OBS,2YBW]PE8<FTJYF\Z/33YI&E<T!8SJ;MZB-$9+"@CKF(RK/[ED
MZ2).2?@IB9>+ZR@(E^*>9^-1+)T)&@[F+=!CODAL)28<..?.OGIV2VF(\A[>
MHD`FB.D8Q@%+09;.HCR&>\R-Y+G,7S>,W+.098P*/UZ_'ZC?%<-'`&^4404P
M3"6$P^1*5(/C&ZH^4.R<13F,89"BB#H(LEE4#<A*K*0XJ_PW"9]QZPSH5Y>@
M0:#(.HN(`*!I7G@:R`@EN*53K2U0E?2&PNDL=K(OG$JIX,#18'V<+]#63)0D
M(T?9QMA0'7`6H#'6`7L2Q:$A)MYZ'Z?L++!CC"#(]QYXB2Q)*M[$T32CR;Q$
M<K[G5900J*07C4:`8NDLFM-VZ63,*5(+!)D>'"=G,1I[2US_IF<'Q#;[41L[
M4#='>]KN0(]ESSG8J%A.L"9=V]@8BH^S")"QT2EXQ@%*Z:*B+H%>:PG.E:.!
M0\8M#BRZXS$3LB/A@+#Q=71!%BQ[*N;6L.63=8`BXRP<8XR,AG<<`-V)JX81
M'?=($O']1\JWILOY,M^/7M()"YABWH'TA<+F+-9B#!M<(JW7&@\TN8]3ZF"A
M7R=VR/BD>TD?:!CG=6N&&9DVN431'=P;BJJSD(O9DMY0*C@LLT1T$0`HUV0L
M+@N+RHRW-.M/1N11&44S&PB*KK-@BKFK;2<K'$#+2U1"EOIPN)Q%3HSATA7E
M/-[MFVY#VSZI",?9651EG_VY4AI64<=WOZ"YCO'.98.W\,L&G6]VQOOS02X?
M['RR[4T$R2"H7.]!HBV'C;4HL7L6@1?.83_)S6><[X$'-!G..-?06(R\O^^;
M#GM&9W2"P0AF3F#:76:S.&&_/[EA'8CU?KXO/NP)GDP0>$'+[R<;`K;IX_L"
MA!6P=@6`%ZC^,LN?=V%14XD)!8,['7U?BK`"68,H<.!6"NR:SV^@SK[/W.\3
MZSZ.F:U$,'Q:4W;R?:I^'\QP3V@U0G6SF;2#[W/T^V.$<1ZK$0F:Q-2]?!^_
MWQ\IV/2%(B:B>1QI)Q[RK2H>,ASQ/S[W;D?#3O^JTQ_T[KJC:][`522DF7"#
M*(AN`*_YOP<:+54GAIY:8(ENP/"HI?5V&<7AU-;D1]/U96I`B0Q%%Z\U)_=&
M2"L+')`5CUR&X@S^>,ZBO&"I*-*[IEH.G+:C[WB%'H#8C"%,L-68,[`P_]$)
M4VBDW!Y[@NTIF7O%9;1^F(3SJ3S`O.X,Z>NUF.;>+A0N'1Q&V7RLFCN4G=L1
M@$G1>""O]3KWQKFEW'"`OJNDS:SH3[68C>([U-46,)5YPR2'`_-/A$6"[GY4
M,)P?C.Q/=-?D-=U\!\/LH`J2#1X8^TE![)"$=/V^[G4D'C5D8T8::UV6^-1V
M]AT[LP<I4$YX@&W0P3M*PEXJ9BCP93&U4NL']!V2<VK34'GB4`H^E3S-.'*H
M*\WPU+QHM;1J9/K8=TV;L^R;+-DE"Y=<0/IUM;:CORH95M`&"@:'/>IW=YR-
M-0>:_'"+H;Q7S8!B9;HEE@@-(^;J)3]GY"-)66"$O=&0WDMMV-"!%D+$H0M5
MYG,Z\Y5)+@2X%Z]U]%X^HQVN0('@0.]GRJ8SP=,#5[DIO5W.[VG"-P;5-&[.
MA!Q+PV'\E=6P,C^W$AKZ!/C.]:2==>9.$OP=*`G.?_UY<-?[L7<[O/ZIU[GI
M#P^2")=<L3+,ADM'>:[;GH.:F08CPYV/[RJGFDM]Q0MN_/<))2F]I,6?@'RZ
MA;%1)M[-T+<G8OPJ<Q4G?%Z)BJI-0?E]9;YXR/\6%M"-_[5,\^>C]?D(5]_S
M?BC`GE[`%6Y_@'`H80-[>DU2=O+ZQJ8=3P,0RO.[$%H6E^(B[,[Z[SOX(<CA
MJ'_Q]Q_[-Y>]N^%_=7K_]^5Z],]#K`*-+E"J5,CD5N4!#7A+XD@4ZI3;;+6=
MSDQK:GXX8VUQ6W^7MW(`'P,TW%[I-?]1L59O:NL9(HEPU0B4R"]7HL*`0J%*
MPK?'D5"T[B.#`-+<[1BQ:>:DM/+W&3G<I>TRGA.F>.]#TAP9*BJ-JP8*FQDJ
M'?+"<;'E,Q7Q+>72L-K4_PUU<SBD'.-8M4L*M^G`T73SO9%K`Q1($CA`JY9M
MTZ$E:^_[I'<;F-2\X\`'4*)+:V#P(?Q?36]A;*82\EE_T-+J$731MM7M6O=^
MM+;OJ*X,U5=IS2!;Y"$V_NTD0P#;82K6N?>Q6@CMERRS!*0D3I,3_)&D="R\
M!W<=LI?]1&M98]]/;.KA45%O9](SDF]_H7HZ0=/']]6$?:1=8=R1T(4+%>7,
M^I,O$6N\+B":U5KYOAT`$ZR$.4>B+'9>XDN;[TKCM/6&OL_FPP0J9Q''0O@/
MEIAT6#L#.(G_$1*-QW94WQ1#NZ?RCWC_\\L;!">Q6VV!!.56ULZ]:(P`N;VV
M0"8H8MP%.<027;;^@J2SJS#^*CFD^1=XDOZB._RQ<W73__DP!S0W=+?,R#?T
M]SO!"8(&2?S`.+@?5U_X5N0ZVM:YZ/))^Z&H-*X]\==F+)3'.V4(UR?/EK+[
M0RQN'+G7/:1^-.=RGY;%Z2B^HT$<!2RD.P2/8FMVZ^9KON/)UO3$)1@XU&US
MR4<;W2PO/]L'.)VMO)PBU;`"]QDEC=)E6"I$!8B1UGKX3N8=`BZM$-Q&6.<+
MPA+!H;@]1[F``Z;*'"C:^TX>'`HLK<APN,P[*A1I]\I=$"2T5&/FCO\ER=>4
M_?N03765/=J/Z#O3<4"WNZ_8<2C/\ZS:=$`U,"WM!`RAO"\B%A&=BBVA_V#8
M\R\+=6"=,:\==:2:4[TS5A+8^JRA?EMH,H;OI)6US9ZYX'!,*76Z^;P8+[E=
M<:NB[$%]S0;6VWM:JP4X.G3E4GJ.3F"04+ZZ'FM+:NM[^JM/Y4X7FJ7S'/5@
MH_4#LA(J+RJ-\U7TDA/[]+)H&V^A'L][?M6A_X!($L=,`9\J;61Z$.1C;28,
M#"5W[/4-)1Q?1P\TM90=5([EKWZ6P_P@0'HX/,5%G&8I=WGB$!=W:[\MV6:C
MW6?B=8I/).6\<>U7.PO#8?Q5UMH?MNIUO!;RPP$]IRN@=)S7]2LVRU625_QO
MXM#*0AB%''SC@:#P.XMF6H._I0P=I2)V].\ZRF@8TB!;DG!#BR0E`>@'A<Q9
MY'%_R("</I<=`5Q@-N9SN(8XBS-:,VISR3W3->`5BT@4V%D#*L>"ZH[]V*+#
M-2!`>J[.$.0S4:E2`)^#?B9)0B+I#2!U%_`YGP/;-D3$,91)3&LS.+\V#!$.
M\*%/_!D`W(+KY^&\!;M<D<4?8J'YP)5<!*L:ZPHJ=G!&HT#UQ7Z8SX;#;B,Q
M''ZAF?(N5_DD67'MSM]S-P6YUAV*[H$K)>Z%KD1&ON^B'X]:&-R[>8,S5@=F
MTXIJX+AJM5PLPEQ.)-R(Z3J:Q,F\P$R[F@</`%6-PQ;+AZJ&H9P<K=MOXRC@
M'W_::$;CAG7+;9S1(I5-QYO#423L3Y0'AL3X]H:'@NVN\((A7K$+*4AUP=L]
MO'XR)1'[/1_TEF3+1"0KU^_V%(42&MY+V[F2]]?.24<\\A+&*>_-_U(>\K\[
MQ:`=$HT[I6$[\:13&MBJ160T'<5K@$CX9-N:FWF0CC[W=[D<F^!HV,<UM/5Y
MI0Z.275K)F4:DPT-V31B$Q:0*%LG_KEC&/#))2CO&7>,YGW5:$IC=)X&Z6Q'
M>;$0K86(5VGX!#XH*W8T5H(SXI!_Y"3]*K>E_48]2JNS(4A,]JEY_;-LF.=G
M5<,L=W8T94D>054;HZZ3WS1QGAD;A"2_K[--9CX)%F!X9J/X-#08?O4\L+&0
M,!G5-1\PFC)QNBV_7W&BS(WNV-AYU<:>QNH4@Q6_VP[7V8[W,@T"SG7N`F-D
M=*#.1SFI&8@%DYF54D_5\G\[-O6F:E-%QT[>L[/I^JS-1UF$KRQ!E1T\U;23
M]#@NY=>R@U/C67'YJUG5WS:I^J;'L]9P>R\@K,6UC?5,:226\49SA>DXQV4Y
M+9G$9T]W-"]R/B!\_52JN"@QKF^KQK7NWLG[=W8&>+$U0$&`9N$;&9K1($=I
M92W$A,G$BFO)(_(H"?>=OZOO>$2/3M'%9FF1)THTAM/8TN]UM((>P_V*JI=/
M6U`@4;\^IN4<D[:+A!;];<G'[3W(5VG?U2+<VVZ==3^;YQ=W:=+HOK2UU[S[
MKE0!RJ_HXE/S-5C4\N@:OE&IOBH&KLSXG/_%,./3^6;STY^M&@J$`YWYF(WA
M/R54H7)5_!^>_-'V]VIN;1!MSO@`Y83D8./V``\7,AA1=2^O+\O;`!(B%&=7
MR38T\V5_-";).+V(QSE#,(2*VU9F@W@K)[HW8&VXQ61^7U+:G_32C,WYSDUQ
M%J7:SNN3ZC9,K)EQ'*!(CJF#G2.LN[<*H=:\I(F8<"!;$'<3DZA4E*CXI2*%
MKNKDK72H+10!(L&!W15A27Y2O#_9AL:N(\[;<OZD=W(4@=V]U?NTA:>1F'`@
M*ZI#Q7R3R!4PI9R865Z=]H&&<7Z40X<LL+NW$IZVD#42$PYD/\7Q^"L+166&
MZLD!\'1J,H:WDINV,#87F,MRZ.M$-VS3H>SAK8:EE1T&0!C'_Z[7-H`.MDQY
M#W_5+.TY6[4TCA_OYO.68/"!W?W5LK2E"49R.GZUZ)$DXD(2M[+S=SC`"J'M
MZ*]$I2U5`,K&T90L2^_#IF=P;W\U):W,U892PK%.;GCIU3#'`A_!;]U'.^%Y
M,VEARGW*#_>87&48B2"-)$5:NTFZ>_>&A?DMTD\D+=W#Z7Q3C&@U2=I0B%&3
M$E7VL)IER7=4_%NE2L+]2?-,7TA&FW+99T2?B4\`2CO)EOTEA\D<(?=O5,96
MNX$*O83CQ.*JW$B9T9YJ,QX'0V"X23<_4R*0&?>C.RJ*Q1:%!V[C*-G\-<_:
MB_ZY9HUH,(O8;TM::"]@YCW0Y_V>PFNI5[+8]"&0PN1F&BZ/R)W*F]KMV:9;
M2$X<B(Q.[7/,NFY>7SU?K[!&ZG=:JNUT!E?3,OMV!X6C]O;Y+B?E:!L&(&ZJ
M;[<KP"BU]0R(1+AJ!$KDEVMU^HSOS!=AO**TT*JO$4W2&5N(34=OV!\\N9WT
M8[X3Z3XR!4RM!CLB'%OQ5SK>AA9G\>=E/"=,\1(Q?`0<B.ZAV4:PESE_6G5Y
M=:S;">(SG=_31.57:TU]OR5NJJ@U5RMA'D=D;QC,Z'B9/U"0S=9AX]K3UNOR
M9ROHEF.O07UM)!138S.P^TL.APJ\[$^='OHVU:L_[":T=)=.M?MLJ"OS=,O2
M4=BJ0AC\TB6F?>;67UVN$[^<PB8=,_?RA@,BN;`)VZON)S4<'OZ)B=YD0L64
M1+=RN"-Y0=/\\656^`QC_-N,ZO423GLM:"]`3*[6I![L)<T("]-;\1Z&8+S9
M*]<J$Y4_`2H/V_EF_:7.]E-VTWU[\*S+"UH9VFL!"TY41,>;`R3=(%C.E_E!
M!>[V6,`4E<`A?;TF$"WB7BMH`16;Y6?#<%Z-AGF*6F$G[15IMW[!B*5][DQ;
MMGQ]BD1<$V4IUY[^9/.:T2@><%!G?)N:[U=EKSZ9#H+V9C34H-LP;6>%)YNM
MUOF4RE=W7JF2S4:@KG@O09M@9B(F3`NPY@,I:\Z;_6:M9I>D9O'67UKUDDJ"
M6Q4QKO7%D/H[OARL$3`OB5AD"3S$B5CI><^/JQ'_MCKQ"NI\1#B!^,&16)62
M*@C5Y51!G7'@9J"?4##+3.Z9.86?.;ZEF30K*CD`6^KB.ZUAH&T[ZS:`'!RM
MK#\SL5=_^JY2^++&OI/2+<6NYAU'L#K/IEXL$R&%(M"N.S0@[^&M#$U[F+0\
M8<(*AD\K3.Q?[]D;$[PX;'/&'U>;E-3J(B1IJEZE:;KAF.=!ZS,-)R5WC`$E
M=4(_S^!_B>+[E"9YM9OK:+',=E-,539UZ[H#?!J'MH`L0:8\[H2#XAS>.M26
M#LA*D*]UV\W-O564.AQ:S=Y?)3U7U1;%C'-',Y;D'K!_'[(I49ZCW-Z!4_7R
M5D3*%X0@J3A%<A1G)-QA5P&@K+&W$E$^<5-+#L?ZJ[J=75TMP_`B3OF.-IO%
M8[ZU5>Q>`'V/Y4PL7`XX<)/Z!,UFIKF+[U@,&"8MVT>3*M.<-:B]R*'+F3DZ
M8P#C89\TFNM3!7SXE3AL/!=KH/ZD(7XG.TH`Z8GO74^C@P-PX;RX/53HM?"'
M1UHV:ZN3?!D6DOG:1:]78+=\85:$&@'+%-T`7HNU6U$'0UGAL&G.^2).2?@I
MB9>B.F"X''.7U"@/41%;#K3Q0%YKO5L!O*7LC@YXWB05D]*$93?\)RLZ4!O3
M:]WX0ZN#1*)'IQEW]('R7UC1B.U87FO/'UH3*A(\.@U8_Q!-BXLMUOQ#X[A>
MJ]@?6C,4DL6TSX:4&E,>4*V]!0BO->;BQ"J@*!3L^&J;@3!D&3FURWEQ/OJ.
MI;]>)90*TCGZF;BS!D@6:D=`7O0+=@K65&`X7'L3U;W'!>>?CD<TF9O!N]O3
M\]U,A[@V20@OGC]3-IUQ:KL/?`:9TI_BD$,@-J'F]JL9RNNFW2GB(!GB58&-
MPEZR!S;F\[HY\LTC>-VT'\3$FR1VI.LM39:C]NBL\<++4=H#CC,T![+7B#Y-
MFT4LHS><G-J[.<KDL*[?<2S`H)LJF)2./QA?/,Z0L$!UU:S4YDC68U"8Z^SC
MF'^'"_&N;G)%52^=[C0ZDF43&)BZ`##-F/5RL\IX1.VA@>8RQ2YB#U)*C0L5
MVXDLJ"^9]Y=9*EXF%BEL3:$310>O3@HL\(;+XPKVD?BEYM*"HB[!E!8WWIZ:
M#,A*_*K[E22B+ES!H[CCD*U*SVR6>+Y=:DIR'N3K7CTI0!$:9K`#(=)ZN<,G
M`!:/AQE),B1+GC82JPM*W(P:S<A:D.FGO#S'=33(V76@Q\84>-U;'TZ76R)S
MY#Y5R_55G$PHW\:,?:ID`Q%>\_*(M%**SY$KYM%,]K^\\7PT`.5T+Z1B9<+O
M1=5J<5:JI-D70>^1)@%+)15W\C)1CC_J]1@"7`L/(8IGX0*UOI\+XX&*NFZ5
MK%"^4KDD&=TF%.[B,.0SA1C5Q_S=DE"O[\L;[\&Q2O'%%G:%@]L`P%K_WMF]
M*P12:%)@?&;V$M-HLW-&::#&)(+CPR]FB@2Q9Y5N=1E+$(]VH312,_J@%NKN
M`O,?W$+;J-.+>3[_):Y!Q.S<6<E!#((XCE4NEE`>=O/\*1<GZE6N,8E0,W56
M<A*#`?@TTY9*Y7,:E83<*[3?45$AB453\7:-"*=)[WF(WM#.4'UUDXEI=6S'
M3"Z.ZGFY4^!20D#'Z9*$@M7TW';^Q!&14&5SDW`QU!L;R1>G8!^=9N?>MS9]
M2!D]N%(;TP?59_L%^;#J<TN($<Z^!SB`@M806E`(-04WJ4>,IM`:YI>(CM7Y
MTL>VL1694!.RG\=L;T(X)8DN@7^O%\U]533]S776[2D=H`":=@-EG`Y-#/AH
M/U*]]@,>(NUU&TVZYORS*&4!JG-7"JJ@^NSFK@KB4U9:)!'I=!NCUDJB.YTF
M^7O-NY(HS6$.7+,5JJ`Z?<QA:[UZ6G+^%O7$]T$IU>;XD*)9QQ54.V$OY$#M
MQMEK5ICLQB\4SVKS_#(]E:@R./[PQMFS0Y@,#0DF&,XX8)F@@)>9O)$$M1]G
M;SYALA__<#B9K/`59GF*9NQ49GEO5)FE<WZ8VBSG;8NSG*,H,=;\3F;#3%YI
MY_G=1JADFV?`"B_E.P08H+BI/L2D@*/4%L=3FJ"'5YO(+P=T/:+0FR_">$5I
MH5=?(YJD,[80S_[VAOW!D_])/^9O`:N?RFTUV!'AV(J_4DDGM#B+/W6OX\)'
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M16\R`LZ2\3!<S"7E"+,O44*#>!JQWW=IN8A3F?6JNW@MQ;X?*A!9X%@/['NR
MO+CF7I2.[4\*+^'@]([R:U[KG+=7%*<R<>^>UY__LC[TH/+#M:9>:X!;<+@2
MW@\@;LT!U*:67FM<VQ.V_(`EBC4XR_)#.+#%]WG3XGL]PB'6W!)B`8MM;4^;
MBC_@HIYQO/I"0^]H0!^85/4E;7VON(&2+BN]DFM'+F;GF]UYO(PR\67Q`AY$
MWM4>WA?4^XJ]6028?,X=#4DF%@1)MAIQUYARMN"[_S=5![0>KI./URD/Z-H?
M01G1."?S83`<S#J^,W)MX7HY,8?L.`'B$W,R'?NX*O^+YHR'P1A'A)H)6SB.
MQ97ITAV`:VJ+`QQSE50`A^HL6W\R80%-=`<=*LU\Y\_E6E61>R-[.&)OERRA
M`1];)_IJ.]^Y4K#LFQG$(?R16`_W)]?16"3XEB143R>2YCB<$VCFD'"`XRAA
MC;B?63;+]4PXV1E;C.)>Q+<PVAG$>"`<""JU40>DCL4]IQG)ONV*RL]^B@:E
M?_<]6;34KG)TH,:MHT#,#9V24"?::B/?$X(%^3;SC6.JD*S]UFG5](J+H[PD
MW#*_[F*\1X$/["NZ:7K`QI($<:A#-PA$<#`=D)68;DN$,II>+!,AN&XD'CP,
MBK_(%:#%4+Y]*1CSUF+"@7)^FYH3%R^H"&A%4_EYD\U.0]KC:$ZLZIAV-.FM
MOW*W/3/Q)5H0-BZ"\+*RL[I.OB=%O=`A7.!+/%Q'_$<Z(H]T$_-M3C&\K:88
MBHZ=O.<VJ6`UE5`G39,T4'7P&1A8UV#@A'73E&;IIR1.5;QL]MN:?CZ3H7IL
MJL$#D!!P3!8U6OL;!WK#:;X@2;*:%"5`%"$&HT%\+P.`Z&@@U8L)';XWC-R+
ML_U,Z''QV[4/SR?/"[)@&0F+@W]IX^15%X;QF+X7%/NBWU*(Z)2AQ+RI5_:_
M0+%CPCO,(P5(W.THQ!J&\5<2!8I5/*BSU_.+^\^D<GD@!?"6FJQZ\M9>3SWN
M#U&)8]R+_^;26F^_!:W^+9?4:J#.>`.`HXA6;S*A@3A&LR50W#\3N\0HX!-G
MH<79%>4Z3$*QTUQR0E8[C>4&8V5P7'L)78$NB_+$X2(A#%W,Q!6"ZVBO^=#Z
MA[R>#76C.2T$C5F+Q%,0+%KR;=EZ?Q9'JHID!F-XO=)E"WN5>'#/U9I#P>]@
M<[:;8\`8YFXY:0DE*=<"D.-<TZ;H<B1SIYZ1%DJ__A?Q/W&CC?_F_P%02P,$
M%`````@`+X$E1:Q0[3;V#```,8P``!$`'`!R8V%R+3(P,30P-C,P+GAS9%54
M"0`#>1@*5'D8"E1U>`L``00E#@``!#D!``#M75]SVS82?[Z;N>_`T\S-Y>9.
MEF4G:>W:[<B2[&BJ6#I);GM]Z4`D)*&A`(4@93F?_A8@*9$$"9+^4S&U^I`J
MP.YB=W_8Y0(DD(L?-DO;6&.'$T8O:\VCXYJ!J<DL0N>7M;MQO35N]WHUXX?O
M__97`_Z[^'N];EP3;%OG1H>9]1Z=L>^,6[3$Y\8-IMA!+G.^,WY"MB=:V"]7
MHS[\U9=_;KP].D9&O5Y`V$^86LRY&_6VPA:NNSIO-.[O[X\H6Z-[YGSB1R8K
M)F[,/,?$6UF.B9S?QO\XZ32/-C/0MX-<:#TY;KZ%MN,S\<>[2?/=^?'[\W?-
M@B.XR/7X=H3CS7'P7S'VCX2;6^9__WB_8M]L1N27.:;?>CU$NWR`\`TVAV=?
M?KT^'?SZ:;->-D^G4_LS?6C1X17:#$CGOC/<W-R-[MK^D!?<7.`E,@!ARB]K
M$?_=GQXQ9]XX.3YN-G[YV!]+NII/>+ZQ"?V41MX\.SMKR-Z05*'<3!T[%'W:
M$-U3Q/%6,O02#3VAW$74C-%;[I8A2ORNX7?&2$DJZ7N?E(2D'J_/$5IM:6>(
M3R5MT`$\S=/Z<;-^VHRP.,S&/)5']J0P44:IMTPWUW*=AONPP@T@J@,5=HBY
MY<MGBC.`#J(Y73O9DZ*=B(`MP^^(>MS!7`8))]2$N%H*IK?'[T]%1K#Q$E/W
MFCG+#IXASP90/GO()C."K9KA(F>.73&/^0J9N*C8,"H0I0R"!Q)$T"+:5BL"
MT0$-?[D0T^A<>'D"MACB!Z2%G$$$50-BS!-ZMZC5I2YQ'T3`.4LY5,T@UF5-
M2R$&!U7D\!:>$4JDCD%80UHP0O;H3T0MPY=E1(1=-))B(L(]CJT!_5[^7H$I
M($8R]:$A8`Q(,IA,9)N>78YGITHJ2]`0NOUI0+09Y<PF%F19ZPK9(L;'"XQ=
M[J.0W:V'X`3\+M(N#C!H#V['@WZOTYIT.\95J]^Z;7>-\8=N=S(^^#_5P4/D
M@+$+[!(P(0>,.*T>F=/BR!AO8H+_=4`J]/[6@7PP&ZQ$:04JI(1,!IT>H;<Z
MA,83^-_'[BV@,[@V!L/NJ#7I`<$!&\7G;;8$8Q>8<K+&?<9U^*BT>HS>%<((
MFC\.1]T/W=MQ[Z>NT1^,#SBEQL;89>:G!;,M6(UT/WOPA-;'4@J]'J_WQ6-J
M/!FT?_PPZ'>ZH_$_C>Y_[WJ3_QU02T.AC?CBVF;W.8EO1Z;'Z)OB&+5;XP_&
M=7_P\RN/IX$S1Y1\D0K>PB+7P5`N`PXNH9XH#]2G4RD./5[?BMH:UL8VXR`&
M_A*5_1_#ERZ+[HA\@\V,W0BO&[TQF5-8IYD(5CFFR3SAI/D00L@D.(!+3Z+'
MYRR)3T28L9-FA.)>-QC"4_XT!?&)H,GHT[J_>9QT?U3*(08"M_?`(#HG4QNW
M.(>E3!T:L&UCT_60/708N"DL!HJ1ZD%I)D'9"35\J7[;5JX1"G[=,$%]O&14
MEEV#56RQH[3K`3A)`N!+,*0((Y!Q\#5Q9?&T<W+8H/?N:9IW`];7[=01MD5=
M.D00RA,'48[,R#3.[-6[^VW2W8$<0PHRHI)>M_=[%'[B"=J$=4VT0>_C=VK&
M%JR&Y'W=7AU[4XX_>V!7=[W+%DJKWK_OE2IQRV_X`EZYDW45>(EBO5C1WORF
M9-%NO`E_O?+MV5OF8CYAUX3",I,@>[<#$59P0QOYKY,^>V0E>G9^GN"->V5#
M!3)!4`D&<#ZK1#WJRE(ZOE8@MEQ&WR`>63<8;WS1KQSW(JN"**HEZ/68*<OK
MHDN)`W`92XHH3)F]6E!.E$5WVO+B`$"R*(L'2+)9[_*4)?6N0#NXNO0^;0>[
MB-C\%CFB88W+[]LJ$O0`*DORZ%B%MG&--\&0QG;,5PZXMA1,1[@<BQY291\@
MMXH\`%AD.SCPDFY7."31`Z3L'&1L#F^!.<"1[>M$(!6DU0.D;#OD`72(G!(%
M>2R.RC#H05/V,HJ7Y(<P*XE=(N@>Q:E'4]D**8WF(28SUUJQ",SNUB.D;%ND
MK[8.L:7%H)D#0C,'!64C0HN"T3S@D.[G1$8K0*?%Y;3@7L0A5V6^_LP&)HM`
MCXBR51$1=0"BZ"O3=%0*4^LA4C8CLE^I'A#3[.@E*FRE78^"LG\0W],[/-#3
MO=W,<G?.(_Q4V0Y(]?>K?W2KCE56(=D$>@2TGQG\N3.-^$.<!1WAF2'/D)Z+
MDXF7-4Z6*UN<^)1M"P?/+FOB;&(]/";X&YAVM%G:(8D0K3E#*B%,>B,8.!2!
M'%.1HIQQ!2%RG4<P;X3*AP)<X@KV86080XP#F;#Q'";;:%K69&#!]@O:VA?R
MG]5(F'UEC4Q,V!<RM;T;Y5D-AM`I:W`\VE[(WLYVD*BYP4'<QNXD;O#WY&G=
M"S"<.:Y!E?._NA/>_MGT/C.E*`V+^%L]Y*N+IGKSI'[:/-IP:Z=I&25V;BBG
M1,CW""6D-([-HSE;`Z@D=B`[0XM4'O&COF,N.K[VC+MN_%3&!K9='K8\41OU
M?/KCU9&R'J%/@:/Y169*E//69Q13Y4Q,E>;[)RKS.$7RM`@.]LNR1MZ)<8WQ
M1[R<8J<F5;NL11N(;8OW[)<UU_%$$A'7.9Q#<B',FL@<:'G^"XN:X>=$_PJ$
M<XLM$:$]%R\%&=C@33GD'D^0WCC,6UW6?%D$2'3:]?$<V8J*2NO>]6Q9:\*9
M\P!*\;BNJ3W[U]<TO:4GE\#B86`2-Z%U=G^5=!^X"^PHAVPS3<DAW[ME`V*W
MJ'6#PB\!X1%^BQ/(Y-#LW88)U`I0EJ(IL8E0+JY]9N_>]?X(%1&=[YP:USNS
M=^]ZRU=6(^P21W8,IC:9RP$349!+MG=+_*WK&P=1"-7$I$_MJHC&;5&GVG:Z
MSFIG1;3N;K!C$IZNM=JY=ZV[L-AB#_`0A>S7@5ELNLQ)!*F>9.\63.Y9AN*I
M/7O7-W1GNI.KHZ?N2J<6R'20Z8;:%Z-%P:_0IO(V^A0@!9X:SV!BYA4]2?L*
M$%;.N#ZC<Q<[RTA9,)AEG9L.%@"E6'(-]#<;W+!KZCONLF8ZV")NW.PEH]A%
MSL.+%.%C`N-V\!K;3![\&+MHCK-K\BSRJAI<[*:IPG,Z@ZMR$SS_ZB:=R7D<
M7XVYL867_Q[$OSY);W,FVU=CN'JM4%&\=9R5,U\J>X6@:A20`5[!8+Z)F;TE
MU/YCLU6ZQMM["G1F[8@J:UV/\^"$QQTE[M8>M?FQTVH!V9D_2U2)SYN$-J%N
MNZA)Z:FLPW/OL2J:%%(8*IT+*/=L<2RDNQ'Q@=,B1R5Y/(P6GKYDV"Q7B#C!
M$J*#X<EDDEB>TQ%4U:B6"<\6+E\(#F;I-^6$)6@^864#<(QL+,N)\/M+`.AG
M\>$%W:6_')JJ`GC+J`E9H4?7F(LX`JV#\^7PVW3)6BZ1Q,GS$38QU%'6@,)R
M:<4XLJ'*@&&)14"5T`W/**^Z+LLZAI_,PT4H*Y>`TQ?#RG9(#E7ES$HYOQW>
MB!"O"K)('KM;Y88RGN,9LON<+`E(:E?E4$C<!9,T(K.[>H84N5I%,:\<4^6,
MWBD-F8Q:R+%XFUG2(B%+6O"@A%5IKBI$6C0+9-BE)ZF"$5F?P&<85)R\"L:E
MO,Y.QIN6I'K1)8\0@L(%]J;]2RS44'N2B"J@FCRVF7D9COK\*\U8N1F0=<>,
MNK[/HZN<:<HE+IKZI?+&/.7N$R5'/8NLRKFHU.4AI>JDK\@)D3@5.U6$BR_)
M9N&NP(0-/<=<((['<L<S);J+<15_:?<BVZQA"DHH%ML,B7\DDDN[9XNT%W84
M6PDKQ)6;G,5N)2EE[5<1DZ#C@]B,6HJ\`ME5K1&W@5B(]-&OS%]XNSF_'LJ8
MT(_AK!S,Q8W(G.I/$E$YAV3>'I!?7%8?[4#1@>>*4!/_(*E29FDH*F>.?"@J
MKX9;H@"82]*KAQW)$#W(=T;WR+%NPQ?(_BO_'F0>1WZUQH/O,H59VRKKI4?9
M]_O?GS&9+Z!X:JWA.37'(RP^&P2$1'4M\,;6!#O+T!U%J?\\LT6!3YYRF"P0
M5:,ESSN0$X5[Q(GS)\ZNE]+JD3"%K94&*OB^O:@[7AZC\@K]F>&Y9LX,DTH!
M]!B5*@+1--\?T]+^:,WG#IXC%T.5!WF9$U/^^]K!/([AL9_QJ_HV_`]W258E
MLS\=J@I-]@5NA6O^9H6KY/S[T`J;^34LX/R=LM8:]%7F?JQYSYMGTKUJ,%I+
M>*P(EPHWIWW05YBEJN%V1QULLCDE7^)VM!G?SL`<FHKN)44CYDY^V15Y)*;W
M[7OM%U4K^1!/[2K_\M-;BGX9?\^4S3(N$4Q+8[FDE<M?<L<?<SQP+.R(C__6
M9(=)5F=58SVFK[\_''[/F&J20E+9;UV+7IN8G)3E^2HW0X-'S&B;H>_H"A'+
MQVZ[)LNEJNJ<5>^BT[R#K_Z>;\JEAOGV5+F>!6T=#$50CXHUAE\"V3:[CQY<
MR:&I0%:Y:/C7#L'/_P-02P$"'@,4````"``O@25%10IG@1.&``"Q]P4`$0`8
M```````!````I($`````<F-A<BTR,#$T,#8S,"YX;6Q55`4``WD8"E1U>`L`
M`00E#@``!#D!``!02P$"'@,4````"``O@25%9*,\$&@*``#_<@``%0`8````
M```!````I(%>A@``<F-A<BTR,#$T,#8S,%]C86PN>&UL550%``-Y&`I4=7@+
M``$$)0X```0Y`0``4$L!`AX#%`````@`+X$E1>FM?\WN#0``LK4``!4`&```
M`````0```*2!%9$``')C87(M,C`Q-#`V,S!?9&5F+GAM;%54!0`#>1@*5'5X
M"P`!!"4.```$.0$``%!+`0(>`Q0````(`"^!)4770>?R/#0```@1`P`5`!@`
M``````$```"D@5*?``!R8V%R+3(P,30P-C,P7VQA8BYX;6Q55`4``WD8"E1U
M>`L``00E#@``!#D!``!02P$"'@,4````"``O@25%5L\J-KLA``"U)`(`%0`8
M```````!````I('=TP``<F-A<BTR,#$T,#8S,%]P<F4N>&UL550%``-Y&`I4
M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+X$E1:Q0[3;V#```,8P``!$`
M&````````0```*2!Y_4``')C87(M,C`Q-#`V,S`N>'-D550%``-Y&`I4=7@+
B``$$)0X```0Y`0``4$L%!@`````&``8`&@(``"@#`0``````
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EBLAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Discontinued Operations (Details 
Narrative) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_DiscontinuedOperationsDetailsNarrativeAbstract', 
window );"><strong>Discontinued Operations Details Narrative</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_CarryingAmountOfOilAndGasProperties', window );">Carrying amount of
the oil and gas properties</a></td>
        <td class="nump">$ 24,127<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AssetRetirementObligation', window );">Asset retirement obligation</a></td>
        <td class="nump">57,532<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OilAndGasReclamationLiabilityNoncurrent', window );">Asset retirement 
obligation, liabilities assumed</a></td>
        <td class="nump">12,932<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationCash', window );">Cash 
received</a></td>
        <td class="nump">3,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', 
window );">Recognized gain</a></td>
        <td class="nump">49,338<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenue 
reported in discontinued operations</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">16,549<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', 
window );">Net loss reported</a></td>
        <td class="num">$ (404,243)<span></span></td>
        <td class="num">$ (14,420)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_CarryingAmountOfOilAndGasProperties">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
<p>Carrying amount of the oil and gas properties.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_CarryingAmountOfOilAndGasProperties</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_DiscontinuedOperationsDetailsNarrativeAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_DiscontinuedOperationsDetailsNarrativeAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
<td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The carrying amount of a liability for an asset retirement 
obligation. An asset retirement obligation is a legal obligation associated with
the disposal or retirement of a tangible long-lived asset that results from the 
acquisition, construction or development, or the normal operations of a long-
lived asset, except for certain obligations of lessees.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 410<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-
110849<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Asset Retirement 
Obligation<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6505190<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetRetirementObligation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
<td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationCash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of currency on hand, demand deposits with banks or 
financial institutions, and  other kinds of accounts that have the general 
characteristics of demand deposits, held by a disposal group.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DisposalGroupIncludingDiscontinuedOperationCash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
</tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of gross profit attributable to the disposal group, 
including a component of the entity (discontinued operation), during the 
reporting period.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b),
(c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-
107760<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of operating income or loss attributable to the 
disposal group, including a component of the entity (discontinued operation), 
during the reporting period.</p>
</div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-
107760<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of sales or other form of revenues attributable to the
disposal group, including a component of the entity (discontinued operation), 
during the reporting period.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-
107760<br><br><br><br></p>
</div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_OilAndGasReclamationLiabilityNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of a reclamation liability that is associated with a 
legal obligation for the closure and reclamation of oil and gas properties.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 
20<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 
5.Y.Q2)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-
122751<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_OilAndGasReclamationLiabilityNoncurrent</nobr></td>
                  </tr>
                  <tr>
<td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ERG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Significant Accounting 
Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
</tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', 
window );">Note 2. Significant Accounting Policies</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>Basis
of Presentation and Principles of Accounting</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
interim consolidated financial statements included herein have been prepared by 
the Company, without audit, in accordance with
the rules and regulations of the Securities and Exchange Commission 
(&#147;SEC&#148;) pursuant to Part 210 of Regulation S-X.
Certain information and footnote disclosures normally included in financial 
statements prepared in accordance with accounting
principles generally accepted in the United States of America (&#147;GAAP&#148;)
have been condensed or omitted pursuant to such
SEC rules and regulations, although the Company believes that the disclosures 
included are adequate to make the information presented
not misleading.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">In
management&#146;s opinion, the unaudited consolidated financial statements 
contained herein reflect all adjustments, consisting
solely of normal recurring items, which are necessary for the fair presentation 
of the Company&#146;s financial position, results
of operations, and cash flows on a basis consistent with that of the 
Company&#146;s prior audited consolidated financial statements.
The Company has evaluated information about subsequent events that became 
available to us through the date the financial statements
were issued. This information relates to events, transactions or changes in 
circumstances that would require us to adjust the
amounts reported in the financial statements or to disclose information about 
those events, transactions or changes in circumstances.
However, the results of operations for interim periods may not be indicative of 
results to be expected for the full fiscal year.
Therefore, these financial statements should be read in conjunction with the 
Company&#146;s audited financial statements, including
the notes thereto for the year ended December 31, 2013, which may be found under
the Company&#146;s profile on EDGAR.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Principles
of Consolidation</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">These
consolidated financial statements have been prepared in accordance with US GAAP 
and include the accounts of the Company and its
wholly owned subsidiary, RenovaCare Sciences. All significant intercompany 
transactions and balances have been eliminated. RenovaCare
Sciences was incorporated under the laws of the State of Nevada on June 12, 
2013.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Applicable
Accounting Guidance</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">Any
reference in these notes to applicable accounting guidance is meant to refer to 
the authoritative non-governmental US GAAP as
found in the Financial Accounting Standards Board&#146;s Accounting Standards 
Codification.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif; background-
color: white">In
June 2014, the Financial Accounting Standards Board (&#147;FASB&#148;) issued 
Accounting Standards Update (&#147;ASU&#148;) 2014-10,
Development Stage Entities (Topic 915): Elimination of Certain Financial 
Reporting Requirements. ASU 2014-10 eliminates the distinction
of a development stage entity and certain related disclosure requirements, 
including the elimination of inception-to-date information
on the statements of operations, cash flows and stockholders&#146; equity. The 
amendments in ASU 2014-10 will be effective prospectively
for annual reporting periods beginning after December 15, 2014, and interim 
periods within those annual periods, however early
adoption is permitted. The Company adopted ASU 2014-10 during the quarter ended 
June 30, 2014, thereby no longer presenting or
disclosing any information required by Topic 915.</font></p>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif; background-
color: white">In
May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers 
(Topic 606), which supersedes the revenue recognition
requirements in Accounting Standards Codification (&#147;ASC&#148;) 605, Revenue
Recognition. The new revenue recognition standard
requires entities to recognize revenue in a way that depicts the transfer of 
promised goods or services to customers in an amount
that reflects the consideration to which the entity expects to be entitled to in
exchange for those goods or services. ASU 2014-09
is effective for interim and annual reporting periods beginning after December 
15, 2016 and is to be applied retrospectively.
The Company does not currently have any revenue. As such, ASU 2014-09 will not 
have any effect on the Company&#146;s results of
operations and financial position. If the Company begins generating revenue 
prior to the effective date of ASU 2014-09, it will
evaluate the effect that ASU 2014-09 will have on its results of operations and 
financial position.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif; background-
color: white">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Accounting
Estimates</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with accounting 
principles generally accepted in the United States
of America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and
the reported amounts of revenues and expenses during the reporting period. 
Actual results, as determined by future events, may
differ from these estimates.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Cash
and Cash Equivalents</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company considers all highly liquid instruments purchased with an original 
maturity of three months or less to be cash equivalents.
Cash and cash equivalents may at times exceed federally insured 
limits.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Note
Receivable from Duke Mountain</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
note receivable from Duke Mountain Resources, Inc. (&#147;Duke&#148;) is 
unsecured, bears interest at 4.0% and principal and interest
are due on December 31, 2015. The Company&#146;s credit risk assessment is 
limited due to the related party nature of the arrangement.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Fair
Value of Financial Instruments</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
carrying amounts for cash and cash equivalents and payables approximate fair 
value based on observable quoted prices for active
markets &#150; Level 1 inputs. The carrying amount of the note receivable from 
Duke approximates fair value based on similar market
inputs for interest rates for a specific creditor &#150; Level 2 
inputs.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Research
and Development Costs</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company intends to outsource its research and development efforts and expense 
related costs as incurred, including the cost of
manufacturing product for testing, licensing fees and costs associated with 
planning and conducting clinical trials. The value
ascribed to patents and other intellectual property acquired will be capitalized
as it relates to particular research and development
projects that may have alternative future uses.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align:
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Intangible
Assets</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
intangible asset consists primarily of Cell Deposition Device technology that 
the Company acquired during 2013 and is recorded
at cost. At the time of acquisition the technology had not reached technological
feasibility. The amount capitalized is accounted
for as an indefinite-lived intangible asset, subject to impairment testing until
completion or abandonment. Upon successful completion,
a determination will be made as to the then useful life of the intangible asset,
generally determined by the period in which substantially
all of the cash flows are expected to be generated, and begin amortization. The 
Company tests the intangible asset for impairment
at least annually or more frequently if impairment indicators exist after 
performing a qualitative analysis. Management has multiple
criteria that it considers when performing the qualitative analysis. The results
of this review are then weighed and prioritized.
If the totality of the relevant events and circumstances indicate that it is not
more likely than not that the fair value of the
intangible asset is less than its carrying amount, additional impairment tests 
are not necessary.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company assessed the following qualitative factors that could affect any change 
in the fair value of the intangible asset: analysis
of the technology&#146;s current phase, additional testing necessary to bring 
the technology to market, development of competing
products, changes in projections caused by delays, changes in regulations, 
changes in the market for the technology and changes
in cost projections to bring the technology to market. Based on a qualitative 
assessment, management concluded that a positive
assertion can be made from the qualitative assessment that it is not more likely
than not that the fair value of the intangible
asset is less than its carrying amount.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Stock
Options</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company measures all stock-based compensation awards using a fair value method 
on the date of grant and recognizes such expense
in its consolidated financial statements over the requisite service period. The 
Company uses the Black-Scholes pricing model to
determine the fair value of stock-based compensation awards on the date of 
grant. The Black-Scholes pricing model requires management
to make assumptions regarding option lives, expected volatility, and risk free 
interest rates.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Income
Taxes</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes income taxes on an accrual basis based on tax positions 
taken, or expected to be taken, in tax returns. A tax
position is defined as a position in a previously filed tax return or a position
expected to be taken in future tax filing that
is reflected in measuring current or deferred income tax assets and liabilities.
Tax positions are recognized only when it is
more likely than not (i.e., likelihood of greater than 50%), based on technical 
merits, that the position would be sustained upon
examination by taxing authorities. Tax positions that meet the more likely than 
not threshold are measured using a probability-weighted
approach as the largest amount of tax benefit that is greater than 50% likely of
being realized upon settlement. Income taxes
are accounted for using an asset and liability approach that requires the 
recognition of deferred tax assets and liabilities for
the expected future tax consequences of events that have been recognized in the 
Company&#146;s financial statements or tax returns.
A valuation allowance is established to reduce deferred tax assets if all, or 
some portion, of such assets will more than likely
not be realized. Should they occur, the Company&#146;s policy is to classify 
interest and penalties related to tax positions as
interest expense. Since the Company&#146;s inception, no such interest or 
penalties have been incurred. The Company did not record
an income tax provision during the periods presented due to net taxable 
losses.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Discontinued
Operations</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
results of the Company&#146;s oil and gas and mineral assets are being reported 
as discontinued operations as a result of the
sale of the oil and gas properties in February 2013 and the sale of the 
Company&#146;s subsidiary which controlled various mineral
leases and claims in December 2013. Certain amounts reported in the prior 
periods presented have been reclassified to conform
to the current period financial statement presentation. These reclassifications 
have no effect on previously reported net income
(loss).</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>&#160;</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Earnings
(Loss) Per Share</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i></i>&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company presents both basic and diluted earnings per share (&#147;EPS&#148;) 
amounts. Basic EPS is calculated by dividing net
income (loss) by the weighted average number of common shares outstanding during
the period presented. Diluted EPS amounts are
based upon the weighted average number of common and common equivalent shares 
outstanding during the period presented. Potentially
dilutive shares of common stock consisted of warrants to purchase shares of 
common stock (8,200,000 shares as of June 30, 2014
and December 31, 2013) and options to purchase shares of common stock (135,000 
shares as of June 30, 2014 and 80,000 as of December
31, 2013). During the periods presented, potentially dilutive shares of common 
stock were not included in the computation of dilutive
loss per share as to do so would be anti-dilutive.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Related
Party Transactions</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i></i>&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">A
related party is generally defined as (i) any person who holds 10% or more of 
the Company&#146;s securities and their immediate
families; (ii) the Company&#146;s management; (iii) someone who directly or 
indirectly controls, is controlled by or is under
common control with the Company; or (iv) anyone who can significantly influence 
the financial and operating decisions of the Company.
A transaction is considered to be a related party transaction when there is a 
transfer of resources or obligations between related
parties. See &#147;Note 6. Related Party Transactions,&#148; for further 
discussion.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><i>Comprehensive Income (Loss)</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><i>&#160;</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The Company has no items of other comprehensive
income in any period presented.&#160; Therefore, net loss equals comprehensive 
loss.&#160;</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>Basis
of Presentation and Principles of Accounting</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">As
the Company is devoting substantially all of its efforts to establishing a new 
business, and while planned principal operations
have commenced, there has been no revenue generated from sales, license fees or 
royalties, and as such, the Company is considered
a development stage company. Accordingly, the Company&#146;s consolidated 
financial statements are presented in accordance with
authoritative accounting guidance related to a development stage 
enterprise.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Principles
of Consolidation</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">These
consolidated financial statements have been prepared in accordance with US GAAP 
and include the accounts of the Company and its
wholly owned subsidiary, RenovaCare Sciences. All significant intercompany 
transactions and balances have been eliminated. RenovaCare
Sciences was incorporated under the laws of the State of Nevada on June 12, 
2013.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 
0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Applicable
Accounting Guidance</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align:
justify"><font style="font: 10pt Times New Roman, Times, Serif">Any
reference in these notes to applicable accounting guidance is meant to refer to 
the authoritative non-governmental US GAAP as
found in the Financial Accounting Standards Board&#146;s Accounting Standards 
Codification.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Accounting
Estimates</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
preparation of consolidated financial statements in conformity with accounting 
principles generally accepted in the United States
of America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and
the reported amounts of revenues and expenses during the reporting period. 
Actual results, as determined by future events, may
differ from these estimates.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Cash
and Cash Equivalents</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company considers all highly liquid instruments purchased with an original 
maturity of three months or less to be cash equivalents.
Cash and cash equivalents may at times exceed federally insured 
limits.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Note
Receivable from Duke Mountain</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
note receivable from Duke Mountain is unsecured, bears interest at 4.0%, and 
principal and interest are due on December 31, 2015.
The Company&#146;s credit risk assessment is limited due to the related party
nature of the arrangement.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Fair
Value of Financial Instruments</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
carrying amounts for cash and cash equivalents, and payables approximate fair 
value based on observable quoted prices for active
markets &#150; Level 1 inputs. The carrying amount of the note receivable from 
Duke Mountain approximates fair value based on
observable market inputs for interest rates &#150; Level 2 inputs.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Research
and Development Costs</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company intends to outsource its research and development efforts and expense 
related costs as incurred, including the cost of
manufacturing product for testing, licensing fees and costs associated with 
planning and conducting clinical trials. The value
ascribed to patents and other intellectual property acquired will be capitalized
as it relates to particular research and development
projects that may have alternative future uses.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Intangible
Assets</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
intangible asset consists primarily of Cell Deposition Device technology that 
the Company acquired during 2013 and is recorded
at cost. At the time of acquisition, the technology had not reached 
technological feasibility. The amount capitalized is accounted
for as an indefinite-lived intangible asset, subject to impairment testing until
completion or abandonment. Upon successful completion,
a determination will be made as to the then useful life of the intangible asset,
generally determined by the period in which substantially
all of the cash flows are expected to be generated, and begin amortization. The 
Company tests the intangible asset for impairment
at least annually or more frequently if impairment indicators exist after 
performing a qualitative analysis. Management has multiple
criteria that it considers when performing the qualitative analysis. The results
of this review are then weighed and prioritized.
If the totality of the relevant events and circumstances indicate that it is not
more likely than not that the fair value of the
intangible asset is less than its carrying amount, additional impairment tests 
are not necessary.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company assessed the following qualitative factors that could affect any change 
in the fair value of the intangible asset: analysis
of the technology&#146;s current phase, additional testing necessary to bring 
the technology to market, development of competing
products, changes in projections caused by delays, changes in regulations, 
changes in the market for the technology and changes
in cost projections to bring the technology to market. Based on a qualitative 
assessment, management concluded that a positive
assertion can be made from the qualitative assessment that it is not more likely
than not that the fair value of the intangible
asset is less than its carrying amount.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Stock
Options</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company measures all stock-based compensation awards using a fair value method 
on the date of grant and recognizes such expense
in its consolidated financial statements over the requisite service period. The 
Company uses the Black-Scholes pricing model to
determine the fair value of stock-based compensation awards on the date of 
grant. The Black-Scholes pricing model requires management
to make assumptions regarding option lives, expected volatility, and risk free 
interest rates.&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Income
Taxes</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times,
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company recognizes income taxes on an accrual basis based on tax positions 
taken, or expected to be taken, in tax returns. A tax
position is defined as a position in a previously filed tax return or a position
expected to be taken in future tax filing that
is reflected in measuring current or deferred income tax assets and liabilities.
Tax positions are recognized only when it is
more likely than not (i.e., likelihood of greater than 50%), based on technical 
merits, that the position would be sustained upon
examination by taxing authorities. Tax positions that meet the more likely than 
not threshold are measured using a probability-weighted
approach as the largest amount of tax benefit that is greater than 50% likely of
being realized upon settlement. Income taxes
are accounted for using an asset and liability approach that requires the 
recognition of deferred tax assets and liabilities for
the expected future tax consequences of events that have been recognized in our 
financial statements or tax returns. A valuation
allowance is established to reduce deferred tax assets if all, or some portion, 
of such assets will more than likely not be realized.
No provision for income taxes was recorded during the periods presented because 
the Company had a net taxable loss. Should they
occur, our policy is to classify interest and penalties related to tax positions
as interest expense. Since our inception, no
such interest or penalties have been incurred.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Discontinued
Operations</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
assets and financial results of the Company&#146;s oil and gas and mineral 
assets are being reported as discontinued operations
as a result of the sale of the oil and gas properties in February 2013 and the 
sale of the Company&#146;s subsidiary which controlled
various mineral leases and claims in December 2013. Certain amounts reported in 
the prior periods presented have been reclassified
to conform to the current period financial statement presentation. These 
reclassifications have no effect on previously reported
net income (loss). See &#147;Note 3. Discontinued Operations&#148; for a summary
of the amounts reclassified for the periods
presented herein.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Earnings
(Loss) Per Share</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times,
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company presents both basic and diluted earnings per share (&#147;EPS&#148;) 
amounts. Basic EPS is calculated by dividing net
income (loss) by the weighted average number of common shares outstanding during
the period presented. Diluted EPS amounts are
based upon the weighted average number of common and common equivalent shares 
outstanding during the period presented. Potentially
dilutive shares of common stock consisted of warrants to purchase shares of 
common stock (8,200,000 shares for 2013 and nil shares
for 2012) and options to purchase shares of common stock (80,000 shares for 2013
and nil shares for 2012). During the periods
presented, potentially dilutive shares of common stock were not included in the 
computation of dilutive loss per share as to do
so would be anti-dilutive.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Comprehensive
Income (Loss)</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">Comprehensive
loss is comprised of net loss,and a reclassification on disposal of subsidiary 
for the periods presented.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Related
Party Transactions</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">A
related party is generally defined as (i) any person who holds 10% or more of 
the Company&#146;s securities and their immediate
families; (ii) the Company&#146;s management; (iii) someone who directly or 
indirectly controls, is controlled by or is under
common control with the Company; or (iv) anyone who can significantly influence 
the financial and operating decisions of the Company.
A transaction is considered to be a related party transaction when there is a 
transfer of resources or obligations between related
parties. See &#147;Note 7. Related Party Transactions,&#148; for further 
discussion.</font></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_NotesToFinancialStatementsAbstract">
<tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The entire disclosure for the basis of presentation and 
significant accounting policies concepts. Basis of presentation describes the 
underlying basis used to prepare the financial statements (for example, US 
Generally Accepted Accounting Principles, Other Comprehensive Basis of 
Accounting, IFRS).  Accounting policies describe all significant accounting 
policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
<td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>18
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%]E9F8R93<P-%]A-V$Y7S0Q9#%?838T.%\R9C@W
M9F0U-&(W-S0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!5$5$
M7T)!3$%.0T5?4TA%1513/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0T].4T],241!5$5$7T)!3$%.0T5?4TA%15137U!A/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!5$5$
M7U-4051%345.5%-?3T9?3U!%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0T].4T],241!5$5$7U-4051%345.5%]#3TU04D5(/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!
M5$5$7U-4051%345.5%-?3T9?4U1//"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^0T].4T],241!5$5$7U-4051%345.5%-?3T9?0T%3
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#`W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3W)G86YI
M>F%T:6]N7TYA='5R95]A;F1?0V]N=&EN/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`X+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^4VEG;FEF:6-A;G1?06-C;W5N=&EN9U]0;VQI
M8VEE/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#`Y+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^1&ES
M8V]N=&EN=65D7T]P97)A=&EO;G,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3`N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y);G1A;F=I8FQE7T%S<V5T<U]);G1E;&QE8W1U86P\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,3$N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#;VUM;VY?
M4W1O8VM?3W!T:6]N<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,BYH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/D-O;6UI=&UE;G1S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$S+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^4F5L871E9%]087)T>5]4<F%N<V%C=&EO;G,\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y);F-O;65?5&%X97,\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,34N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=6)S97%U
M96YT7T5V96YT<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-BYH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/E-I9VYI9FEC86YT7T%C8V]U;G1I;F=?4&]L:6-I93$\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,3<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y$:7-C;VYT:6YU961?3VEL
M7V%N9%]'87-?3W!E<F$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3@N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y);G1A;F=I8FQE7T%S<V5T<U]);G1E;&QE8W1U86PQ/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#$Y+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]M;6]N7U-T;V-K
M7T]P=&EO;G-?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(P+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^26YC;VUE7U1A>&5S7U1A8FQE<SPO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R,2YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/D]R9V%N:7IA=&EO;E].871U<F5?86YD
M7T-O;G1I;C$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,C(N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y3:6=N:69I8V%N=%]!8V-O=6YT:6YG7U!O;&EC:64R/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#(S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^1&ES8V]N=&EN=65D7T]P97)A
M=&EO;G-?1&5T86EL/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#(T+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^1&ES8V]N=&EN=65D7T]P97)A=&EO;G-?1&5T86EL,3PO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970R-2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DEN=&%N9VEB;&5?07-S
M971S7TEN=&5L;&5C='5A;#(\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C8N:'1M;"(O/@T*("`@
M/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@
M("`@/'@Z3F%M93Y);G1A;F=I8FQE7T%S<V5T<U]);G1E;&QE8W1U86PS/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#(W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]M;6]N7U-T
M;V-K7T]P=&EO;G-?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R."YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/D-O;6UO;E]3=&]C:U]/<'1I;VYS7T1E=&%I;'-?,3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970R.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-O;6UO;E]3
M=&]C:U]/<'1I;VYS7T1E=&%I;'-?3CPO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S,"YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/D-O;6UI=&UE;G1S7T1E=&%I;'-?3F%R<F%T:79E
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#,Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4F5L871E
M9%]087)T>5]4<F%N<V%C=&EO;G-?1&5T/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,R+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^26YC;VUE7U1A>&5S7T1E=&%I;',\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,S,N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y);F-O;65?5&%X97-?
M1&5T86EL<U\Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#,T+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^26YC;VUE7U1A>&5S7T1E=&%I;'-?3F%R<F%T:79E/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#,U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@/"]X.D5X
M8V5L5V]R:W-H965T<SX-"B`@/'@Z4W1Y;&5S:&5E="!(4F5F/3-$(E=O<FMS
M:&5E=',O<F5P;W)T+F-S<R(O/@T*("`\>#I!8W1I=F53:&5E=#XP/"]X.D%C
M=&EV95-H965T/@T*("`\>#I0<F]T96-T4W1R=6-T=7)E/D9A;'-E/"]X.E!R
M;W1E8W13=')U8W1U<F4^#0H@(#QX.E!R;W1E8W17:6YD;W=S/D9A;'-E/"]X
M.E!R;W1E8W17:6YD;W=S/@T*(#PO>#I%>&-E;%=O<FMB;V]K/@T*/"]X;6P^
M/"%;96YD:69=+2T^#0H\+VAE860^#0H@(#QB;V1Y/@T*("`@/'`^5&AI<R!P
M86=E('-H;W5L9"!B92!O<&5N960@=VET:"!-:6-R;W-O9G0@17AC96P@6%`@
M;W(@;F5W97(N/"]P/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?969F,F4W,#1?83=A.5\T,60Q7V$V-#A?,F8X-V9D-31B-S<T
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V5F9C)E-S`T7V$W83E?
M-#%D,5]A-C0X7S)F.#=F9#4T8C<W-"]7;W)K<VAE971S+U-H965T,#$N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$5+2D%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D1O8W5M
M96YT(&%N9"!%;G1I='D@26YF;W)M871I;VX\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N="!!;F0@16YT
M:71Y($EN9F]R;6%T:6]N/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%;G1I='D@4F5G:7-T<F%N="!.86UE/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG4F5N;W9A8V%R92P@26YC+CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT
M:71Y($-E;G1R86P@26YD97@@2V5Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG,#`P,3`Q-C<P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE;G0@5'EP93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)U,M,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE;G0@4&5R:6]D($5N
M9"!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y*=6X@,S`L
M#0H)"3(P,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%M96YD;65N="!&;&%G/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG9F%L<V4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@1FES8V%L(%EE87(@16YD($1A
M=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<M+3$R+3,Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M<R!%;G1I='D@82!796QL+6MN;W=N(%-E87-O;F5D($ES<W5E<C\\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=.;SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27,@16YT:71Y(&$@5F]L
M=6YT87)Y($9I;&5R/SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)TYO/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y)<R!%;G1I='DG<R!297!O<G1I;F<@4W1A='5S($-U<G)E;G0_/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG665S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@1FEL
M97(@0V%T96=O<GD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=3
M;6%L;&5R(%)E<&]R=&EN9R!#;VUP86YY/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
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M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P13-.04<^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS
M=')O;F<^0T].4T],241!5$5$($)!3$%.0T4@4TA%1513("A54T0@)"D\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S
M,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^0W5R<F5N="!A<W-E=',\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I
M=F%L96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#$V
M."PP.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$L-3`X+#@T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@-3$S+#4Y-3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E<&%I9"!E>'!E;G-E<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C0L,S,W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PR,S`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#4V
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3W1H97(@<F5C96EV86)L97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L-C`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&-U<G)E;G0@
M87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#$Y-"PP
M,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#4Q,"PP-S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU,C$L.34W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.;W1E(')E8V5I=F%B;&4@9G)O;2!$=6ME
M($UO=6YT86EN/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XX,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+71E<FT@87-S971S(&]F(&1I
M<V-O;G1I;G5E9"!O<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4T,RPX-S<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&%N9VEB;&4@87-S
M971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-C(L.#4T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38R
M+#@U-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!A<W-E=',\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L-#,V+#@X-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-S4R+#DR-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#8U+#@S
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY#=7)R96YT(&QI86)I;&ET:65S/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S('!A>6%B
M;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C<T+#(R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$Q+#(R,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W+#DW,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!E>'!E
M;G-E<R`M(')E;&%T960@<&%R=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-3(L,3DQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@;&EA8FEL:71I97,@;V8@9&ES
M8V]N=&EN=65D(&]P97)A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L.3,R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@8W5R<F5N="!L
M:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(V
M+#0Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4U+#0T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0P+#4T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&QI86)I;&ET:65S(&]F(&1I
M<V-O;G1I;G5E9"!O<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4W+#4S,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&QI86)I;&ET
M:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-34L-#0Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3@L
M,#<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/E-43T-+2$],1$524R<@15%52519/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S
M=&]C:SH@)#`N,#`P,2!P87(@=F%L=64Z($%U=&AO<FEZ960Z(#$P+#`P,"PP
M,#`@<VAA<F5S($ES<W5E9"!A;F0@;W5T<W1A;F1I;F<Z(&YI;#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLZ("0P+C`P,#`Q('!A
M<B!V86QU93H@075T:&]R:7IE9#H@-3`P+#`P,"PP,#`@27-S=65D(&%N9"!O
M=71S=&%N9&EN9SH@-C8L-3<U+#$R,B!S:&%R97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C8V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C8S,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^061D:71I;VYA;"!P86ED+6EN
M(&-A<&ET86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L-#,U
M+#,P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<L,C(P+#8Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4L-#8R+#(S-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C=6UU;&%T960@9&5F:6-I=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-BPQ,C4L-#DU*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4L-3(S
M+#<Y,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@T+#0Y,2PP,#0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!8V-U;75L871E9"!D969I8VET('-I;F-E(&1E
M=F5L;W!M96YT('-T86=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,2PP-C@L,S$P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W5M=6QA=&5D(&]T:&5R
M(&-O;7!R96AE;G-I=F4@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@T+#$P-"D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!S=&]C:VAO;&1E
M<G,G(&5Q=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS
M,3`L-#<Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PV.3<L-#@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.38W+#<U.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&QI86)I;&ET:65S(&%N
M9"!S=&]C:VAO;&1E<G,G(&5Q=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`Q+#0S-BPX.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-S4R+#DR-SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PP-C4L.#,T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
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M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14Q%044^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0Q/CQS=')O;F<^0T].4T],241!5$5$($)!3$%.0T4@
M4TA%1513("A087)E;G1H971I8V%L*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-43T-+2$],1$524R<@15%52519/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@<&%R('9A
M;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`P,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,"XP,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`P+C`P,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@075T:&]R:7IE9#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L,#`P+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R960@<W1O8VLL('-H87)E<R!)<W-U
M960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R
M<F5D('-T;V-K+"!S:&%R97,@;W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!P87(@=F%L=64\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,#`P,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP
M,#`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,"XP,#`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!!=71H;W)I>F5D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`L,#`P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P,"PP,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,C`P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S($ES<W5E9#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C8L-3<U+#$R,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8V+#4W
M-2PQ,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XV,RPP-S4L,3(R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E<R!O=71S=&%N
M9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C8L-3<U+#$R
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C8V+#4W-2PQ,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XV,RPP-S4L,3(R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
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M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P13-&0D<^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^0T].4T],241!5$5$(%-4051%345.5%,@3T8@3U!%4D%424].4R`H55-$
M("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,"!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q
M,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY#;VYS;VQI9&%T960@4W1A=&5M96YT<R!/9B!/<&5R871I;VYS
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y2979E;G5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D5X<&5N<V5S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'96YE<F%L(&%N9"!A9&UI;FES=')A
M=&EV92!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,S,S+#8X,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C@S+#,U.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C8P,2PW,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-#0L,C,P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C$T+#<R.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8R."PU-#4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,CDL
M-3,Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5&]T86P@;W!E<F%T:6YG(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS,S,L-C@R/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#,L,S4X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C`Q+#<P,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T-"PR,S`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV
M,30L-S(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-C(X+#4T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(R.2PU,SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S(&9R;VT@8V]N=&EN=6EN
M9R!O<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S
M,S,L-C@R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#@S+#,U."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@V,#$L-S`S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#$T-"PR,S`I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C$T+#<R.2D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V,C@L-30U
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(R.2PU,SDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D1I<V-O;G1I;G5E9"!O<&5R871I;VYS/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y);F-O;64O*&QO<W,I(&9R;VT@9&ES8V]N=&EN=65D(&]P97)A=&EO;G,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$T+#0R,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=A:6X@;VX@9&ES<&]S86P@;V8@
M;VEL(&%N9"!G87,@<')O<&5R=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#DL,S,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0Y+#,S.#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO
M<W,@;VX@9&ES<&]S86P@;V8@<W5B<VED:6%R>2`H1F]S='5N9RD\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-3,L-3@Q*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0U,RPU.#$I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1V%I;B`H3&]S<RD@;VX@9&ES8V]N=&EN=65D(&]P97)A=&EO;G,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0Y+#,S.#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0U,RPU.#$I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#`T+#(T,RD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q
M-"PT,C`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^)"`H,S,S+#8X,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B0@*#@S+#,U."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#8P,2PW,#,I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Y-"PX.3(I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q
M+#`V."PS,3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XD("@Q+#`S,BPW.#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@R-#,L.34Y*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY%87)N
M:6YG<R!P97(@<VAA<F4@+2!B87-I8R!A;F0@9&EL=71E9#PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]S<R!P
M97(@8V]M;6]N('-H87)E(&-O;G1I;G5I;F<@;W!E<F%T:6]N<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C`Q*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XP,2D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@P+C`Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^26YC;VUE("AL;W-S*2!P97(@8V]M;6]N('-H87)E(&1I
M<V-O;G1I;G5E9"!O<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C`Q*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]S<R!P97(@8V]M
M;6]N('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N
M,#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XD("@P+C`Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#`N,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!A=F5R86=E
M('-H87)E<R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-C8L-3<U+#$R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8S+#`W-2PQ,C(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-BPU-S4L,3(R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C,L,#<U+#$R
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XV,RPT,#$L,30Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-C,L,#<U+#$R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?969F,F4W,#1?83=A.5\T,60Q7V$V-#A?,F8X
M-V9D-31B-S<T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V5F9C)E
M-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-"]7;W)K<VAE971S+U-H
M965T,#4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$553$%#/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/D-/3E-/3$E$051%1"!35$%414U%3E0@0T]-4%)%2$5.4TE612!,3U-3
M("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,3`@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,3(@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-O;G-O;&ED871E9"!3=&%T
M96UE;G0@0V]M<')E:&5N<VEV92!,;W-S/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#$L,#8X+#,Q,"D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$L,#,R+#<X."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#(T,RPY-3DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D]T:&5R(&-O;7!R96AE;G-I=F4@;&]S<SPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2
M96-L87-S:69I8V%T:6]N(&%D:G5S=&UE;G0@;VX@9&ES<&]S86P@;V8@<W5B
M<VED:6%R>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PQ,#0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M+#$P-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C;VUP<F5H96YS:79E(&QO<W,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,2PP-C0L,C`V*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M,2PP,C@L-C@T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^)"`H,C0S+#DU.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F
M9#4T8C<W-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P
M-%]A-V$Y7S0Q9#%?838T.%\R9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E
M=#`V+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%441"1SX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N
M9SY#3TY33TQ)1$%4140@4U1!5$5-14Y44R!/1B!35$]#2TA/3$1%4E,G($51
M54E462`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D-O;6UO;B!3=&]C:SQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y!9&1I=&EO;F%L(%!A:60M26X@0V%P:71A;#QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!8V-U;75L871E9"!$969I8VET
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D%C8W5M=6QA=&5D
M(&]T:&5R(&-O;7!R96AE;G-I=F4@*&QO<W,I/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/E1O=&%L/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y"96=I;FYI;F<@0F%L86YC92P@06UO=6YT(&%T($1E
M8RX@,S$L(#(P,3(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M-C,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`U+#0V,BPR,S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B0@*#0L-#DQ+#`P-"D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#0L,3`T*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.38W+#<U.3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0F5G:6YN:6YG($)A;&%N8V4L(%-H87)E<R!A="!$96,N(#,Q+"`R,#$R/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,RPP-S4L,3(R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4W1O8VL@8F%S960@8V]M<&5N<V%T:6]N("T@4V5R:65S($$@5V%R<F%N=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S
M-RPY-S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S-RPY-S$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K
M(&)A<V5D(&-O;7!E;G-A=&EO;B`M(&]P=&EO;G,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PT-#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$U+#0T,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@56YI=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-3`P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES
M<W5A;F-E(&]F(%5N:71S+"!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#4P-"PY-C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L-3`U+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4F5C;&%S<VEF:6-A=&EO;B!A9&IU<W1M96YT(&]N(&1I
M<W!O<V%L(&]F('-U8G-I9&EA<GD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C0L,3`T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-"PQ,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYE="!,;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,#,R+#<X."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,2PP,S(L-S@X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YD:6YG($)A;&%N8V4L($%M;W5N
M="!A="!$96,N(#,Q+"`R,#$S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XV-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW+#(R,"PV,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@U+#4R,RPW.3(I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-CDW
M+#0X-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^16YD:6YG($)A;&%N8V4L(%-H87)E<R!A="!$96,N(#,Q+"`R,#$S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-BPU-S4L,3(R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4W1O8VL@8F%S960@8V]M<&5N<V%T:6]N("T@4V5R:65S($$@5V%R<F%N
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y-2PS,S,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y
M-2PS,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-T;V-K(&)A<V5D(&-O;7!E;G-A=&EO;B`M(&]P=&EO;G,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.2PS-34\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y+#,U-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3F5T($QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C`Q
M+#<P,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-C`Q+#<P,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E+"!!;6]U;G0@870@2G5N
M+B`S,"P@,C`Q-#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V
M-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#<L-#,U+#,P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H-BPQ,C4L-#DU*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,S$P
M+#0W,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^16YD:6YG($)A;&%N8V4L(%-H87)E<R!A="!*=6XN(#,P+"`R,#$T
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-BPU-S4L,3(R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?969F
M,F4W,#1?83=A.5\T,60Q7V$V-#A?,F8X-V9D-31B-S<T#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F
M.#=F9#4T8C<W-"]7;W)K<VAE971S+U-H965T,#<N:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4Q
M4$)'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/3E-/3$E$051%1"!35$%4
M14U%3E13($]&($-!4T@@1DQ/5U,@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXV($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C$P($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0R/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN
M(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!F;&]W<R!F<F]M(&]P97)A=&EN9R!A
M8W1I=FET:65S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H-C`Q+#<P,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#DT+#@Y,BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$L,#8X+#,Q,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$L,#,R
M+#<X."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B0@*#(T,RPY-3DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D%D:G5S=&UE;G1S('1O(')E8V]N
M8VEL92!N970@;&]S<R!T;R!N970@8V%S:"!F;&]W<R!F<F]M(&]P97)A=&EN
M9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-T;V-K(&)A<V5D(&-O;7!E;G-A=&EO;B!E>'!E
M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.2PS-34\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,CD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-2PT-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ-2PT-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!B87-E9"!C;VYS=6QT
M:6YG(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y
M-2PS,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C,W+#DW,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S-RPY-S$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y);7!A:7)M96YT(&%N9"!D97!R96-I871I;VX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#4R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06-C<F5T:6]N(&]F(&%S<V5T(')E=&ER96UE;G0@;V)L:6=A=&EO
M;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(L,C$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'86EN(&]N(&1I<W!O<V%L(&]F(&]I
M;"!A;F0@9V%S('!R;W!E<G1I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@T.2PS,S@I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0Y+#,S
M."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y,;W-S(&]N(&1I<W!O<V%L(&]F('-U8G-I9&EA
M<GD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#4S+#4X,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0U
M,RPU.#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D-H86YG97,@:6X@;W!E<F%T:6YG(&%S<V5T<R!A
M;F0@;&EA8FEL:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1&5C<F5A<V4@*&EN8W)E87-E*2!I;B!R96-E
M:79A8FQE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PV,#`I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M.#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,RPX,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XX,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,RPW,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D1E8W)E87-E("AI;F-R96%S92D@:6X@<')E
M<&%I9"!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,C,L,3`W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C<L-38R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,RPX,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV+#,S,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#<L-38R*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^*$1E8W)E87-E*2!I;F-R
M96%S92!I;B!A8V-O=6YT<R!P87EA8FQE(&%N9"!A8V-R=65D(&5X<&5N<V5S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,"PY-S(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PV,34\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M,"PR-38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ."PQ,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@S,RPQ-3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&-A<V@@9FQO=W,@9G)O;2!O<&5R
M871I;F<@86-T:79I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,S0P+#<U,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q,C0L-#(T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#,S,RPT-#<I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S0Y+#@Y."D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-C<L,C$T*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY#87-H(&9L;W=S(&9R;VT@:6YV97-T:6YG(&%C=&EV:71I97,Z
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^06-Q=6ES:71I;VX@;V8@;VEL(&%N9"!G87,@<')O<&5R=&EE<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#8L.38R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!D:7-P;W-A;"!O9B!O
M:6P@86YD(&=A<R!P<F]P97)T:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8W%U:7-I=&EO;B!O9B!I;G1E;&QE8W1U86P@<')O
M<&5R='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,38R+#@U
M-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q-C(L.#4T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@8V%S:"!F;&]W<R!F<F]M
M(&EN=F5S=&EN9R!A8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-C(L.#4T*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$U.2PX-30I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-BPY
M-C(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/D-A<V@@9FQO=W,@9G)O;2!F:6YA;F-I;F<@86-T:79I
M=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y386QE(&]F(&-O;6UO;B!S=&]C:R!A;F0@=V%R<F%N=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU,#4L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU,#4L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!C87-H(&9L;W=S(&9R;VT@9FEN86YC
M:6YG(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PU,#4L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PU,#4L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VAA;F=E(&EN
M(&-A<V@@86YD(&-A<V@@97%U:79A;&5N=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#,T,"PW-3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,3(Q+#0R-"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`P."PV.3D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY.34L,C0X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,C<T+#$W-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',L(&)E9VEN;FEN
M9R!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M-3`X+#@T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4Q,RPU.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XU,#`L,30T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-3$S+#4Y-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<X-RPW-S$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@86YD
M(&-A<V@@97%U:79A;&5N=',L(&5N9"!O9B!P97)I;V0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L,38X+#`Y,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Y,BPQ-S$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4P."PX-#,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#4P."PX-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XU,3,L-3DU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U<'!L96UE;G1A;"!D:7-C;&]S
M=7)E(&]F(&-A<V@@9FQO=R!I;F9O<FUA=&EO;CH\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.;VXM8V%S:"!I;G9E
M<W1I;F<@86YD(&9I;F%N8VEN9R!A8W1I=FET:65S("T@3F]T92!R96-E:79E
M9"!O;B!D:7-P;W-A;"!O9B!S=6)S:61I87)Y/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#@P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?838T
M.%\R9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E=#`X+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%4D<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3W)G86YI>F%T:6]N+"!.
M871U<F4@86YD($-O;G1I;G5A;F-E(&]F($]P97)A=&EO;G,\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@
M,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DYO=&5S('1O($9I;F%N8VEA;"!3=&%T96UE;G1S/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]T92`Q+B!/
M<F=A;FEZ871I;VXL($YA='5R92!A;F0@0V]N=&EN=6%N8V4@;V8@3W!E<F%T
M:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T>6QE
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M:6P@86YD(&=A<PT*<')O<&5R=&EE<RX\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/D]N($IU;'D@
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M;V1U8W0@8V%N(&)E(&1E=F5L;W!E9"X\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/E1H92!#;VUP
M86YY(&AA<R!R96-E;G1L>2!I;F-U<G)E9"!N970@;W!E<F%T:6YG#0IL;W-S
M97,@86YD(&]P97)A=&EN9R!C87-H(&9L;W<@9&5F:6-I=',N($%S(&]F($IU
M;F4@,S`L(#(P,30L('1H92!#;VUP86YY)B,Q-#8[<R!T;W1A;"!A8V-U;75L
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M<RX\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
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M=&EE<R!O;B!&96)R=6%R>2`Q."!A;F0@,3DL(#(P,3,@86YD('-O;&0@:71S
M('-U8G-I9&EA<GD-"G=H:6-H(&-O;G1R;VQL960@=F%R:6]U<R!M:6YE<F%L
M(&QE87-E<R!A;F0@;6EN:6YG(&-L86EM<R!O;B!$96-E;6)E<B`S,2P@,C`Q
M,RX@169F96-T:79E($9E8G)U87)Y(#(P+"`R,#$S+"!T:&4@0V]M<&%N>2!B
M96-A;64-"F$@9&5V96QO<&UE;G0@<W1A9V4@8V]M<&%N>2X\+V9O;G0^/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
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M<R!#;W)P+B`H)B,Q-#<[4F5N;W9A0V%R92!38VEE;F-E<R8C,30X.RDL#0IA
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M(&9O<B!S:VEN(&ES;VQA=&EO;B`L('-P<F%Y:6YG(&%N9"!A<W-O8VEA=&5D
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M:7)E9"!T;R!F=7)T:&5R(&1E=F5L;W`-"G1H92!T96-H;F]L;V=Y(&%N9"!D
M971E<FUI;F4@=VAE=&AE<B!A(&-O;6UE<F-I86QL>2!V:6%B;&4@<')O9'5C
M="!C86X@8F4@9&5V96QO<&5D+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L
M:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY/;@T*1&5C96UB97(@,S$L(#(P
M,3,L('=E(&5N=&5R960@:6YT;R!A('-T;V-K('!U<F-H87-E(&%G<F5E;65N
M="!W:71H($1U:V4@36]U;G1A:6X@4F5S;W5R8V5S+"!);F,N("@F(S$T-SM$
M=6ME)B,Q-#@[*2P@82!.979A9&$-"F-O<G!O<F%T:6]N+"!P=7)S=6%N="!T
M;R!W:&EC:"!W92!S;VQD('1O($1U:V4@,3`P)2!O9B!T:&4@:7-S=65D(&%N
M9"!O=71S=&%N9&EN9R!S:&%R97,@;V8@1F]S='5N9R!297-O=7)C97,@3'1D
M+B`H)B,Q-#<[1F]S='5N9PT*4F5S;W5R8V5S)B,Q-#@[*2P@82!C;W)P;W)A
M=&EO;B!O<F=A;FEZ960@=6YD97(@=&AE(&QA=W,@;V8@3VYT87)I;RP@0V%N
M861A(&%N9"!A('=H;VQL>2!O=VYE9"!S=6)S:61I87)Y(&]F(&]U<G,L(&9O
M<B!A('!R;VUI<W-O<GD-"FYO=&4@:6X@=&AE(&%M;W5N="!O9B`D.#`L,#`P
M+"!W:&EC:"!A;6]U;G0@87!P<F]X:6UA=&5D('1H92!F86ER('9A;'5E(&]F
M('1H92!L96%S97,@86YD(&UI;FEN9R!C;&%I;7,@8V]N=')O;&QE9"!B>2!&
M;W-T=6YG#0I297-O=7)C97,L(&%S(&-O;F-L=61E9"!B>2!A;B!I;F1E<&5N
M9&5N="!T:&ER9"UP87)T>2!G96]L;V=I8V%L(&-O;G-U;'1A;G0N/"]F;VYT
M/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL
M93TS1"=M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/E1H92!#;VUP86YY(&AA<R!R96-E;G1L>2!I;F-U<G)E9`T*;F5T(&]P
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M<&5R871I;VYS(&%N9"!O<&5R871I;F<@8V%S:`T*9FQO=R!D969I8VET<R!I
M;B!T:&4@9G5T=7)E+B!-86YA9V5M96YT(&)E;&EE=F5S('1H870@=&AE($-O
M;7!A;GDF(S$T-CMS(&-A<V@@86YD(&-A<V@@97%U:79A;&5N="!B86QA;F-E
M<RP@86YT:6-I<&%T960@8V%S:`T*9FQO=W,@9G)O;2!O<&5R871I;VYS(&%N
M9"!O=&AE<B!E>'1E<FYA;"!S;W5R8V5S(&]F(&-A<&ET86P@=VEL;"!B92!S
M=69F:6-I96YT('1O(&UE970@;W5R(&-A<V@@<F5Q=6ER96UE;G1S('1H<F]U
M9V@@1&5C96UB97(-"C,Q+"`R,#$T+B!4:&4@9G5T=7)E(&]F('1H92!#;VUP
M86YY(&%F=&5R($1E8V5M8F5R(#(P,30@=VEL;"!D97!E;F0@:6X@;&%R9V4@
M<&%R="!O;B!I=',@86)I;&ET>2!T;R!S=6-C97-S9G5L;'D@<F%I<V4@8V%P
M:71A;`T*9G)O;2!E>'1E<FYA;"!S;W5R8V5S('1O(&9U;F0@;W!E<F%T:6]N
M<RX\+V9O;G0^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?969F,F4W,#1?83=A.5\T,60Q7V$V-#A?,F8X-V9D-31B-S<T
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V5F9C)E-S`T7V$W83E?
M-#%D,5]A-C0X7S)F.#=F9#4T8C<W-"]7;W)K<VAE971S+U-H965T,#DN:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$521SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3:6=N:69I
M8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;W1E
M<R!T;R!&:6YA;F-I86P@4W1A=&5M96YT<SPO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO=&4@,BX@4VEG;FEF:6-A;G0@
M06-C;W5N=&EN9R!0;VQI8VEE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF
M>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^/&D^0F%S:7,-"F]F(%!R97-E;G1A=&EO;B!A;F0@
M4')I;F-I<&QE<R!O9B!!8V-O=6YT:6YG/"]I/CPO9F]N=#X\+W`^#0H-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^/&D^)B,Q-C`[/"]I/CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
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M=&\@4&%R="`R,3`@;V8@4F5G=6QA=&EO;B!3+5@N#0I#97)T86EN(&EN9F]R
M;6%T:6]N(&%N9"!F;V]T;F]T92!D:7-C;&]S=7)E<R!N;W)M86QL>2!I;F-L
M=61E9"!I;B!F:6YA;F-I86P@<W1A=&5M96YT<R!P<F5P87)E9"!I;B!A8V-O
M<F1A;F-E('=I=&@@86-C;W5N=&EN9PT*<')I;F-I<&QE<R!G96YE<F%L;'D@
M86-C97!T960@:6X@=&AE(%5N:71E9"!3=&%T97,@;V8@06UE<FEC82`H)B,Q
M-#<[1T%!4"8C,30X.RD@:&%V92!B965N(&-O;F1E;G-E9"!O<B!O;6ET=&5D
M('!U<G-U86YT('1O('-U8V@-"E-%0R!R=6QE<R!A;F0@<F5G=6QA=&EO;G,L
M(&%L=&AO=6=H('1H92!#;VUP86YY(&)E;&EE=F5S('1H870@=&AE(&1I<V-L
M;W-U<F5S(&EN8VQU9&5D(&%R92!A9&5Q=6%T92!T;R!M86ME('1H92!I;F9O
M<FUA=&EO;B!P<F5S96YT960-"FYO="!M:7-L96%D:6YG+CPO9F]N=#X\+W`^
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\+V9O
M;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU
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M;W1E<R!T:&5R971O(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B`S,2P@
M,C`Q,RP@=VAI8V@@;6%Y(&)E(&9O=6YD('5N9&5R('1H92!#;VUP86YY)B,Q
M-#8[<R!P<F]F:6QE(&]N($5$1T%2+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT
M+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\+V9O;G0^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/CQI/E!R:6YC:7!L97,-"F]F($-O;G-O;&ED871I;VX\+VD^/"]F
M;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
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M(&]F('1H92!3=&%T92!O9B!.979A9&$@;VX@2G5N92`Q,BP@,C`Q,RX\+V9O
M;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^/&D^07!P;&EC86)L90T*06-C;W5N=&EN9R!'=6ED86YC93PO:3X\+V9O
M;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T
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M+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG
M;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^26X-"DIU;F4@,C`Q
M-"P@=&AE($9I;F%N8VEA;"!!8V-O=6YT:6YG(%-T86YD87)D<R!";V%R9"`H
M)B,Q-#<[1D%30B8C,30X.RD@:7-S=65D($%C8V]U;G1I;F<@4W1A;F1A<F1S
M(%5P9&%T92`H)B,Q-#<[05-5)B,Q-#@[*2`R,#$T+3$P+`T*1&5V96QO<&UE
M;G0@4W1A9V4@16YT:71I97,@*%1O<&EC(#DQ-2DZ($5L:6UI;F%T:6]N(&]F
M($-E<G1A:6X@1FEN86YC:6%L(%)E<&]R=&EN9R!297%U:7)E;65N=',N($%3
M52`R,#$T+3$P(&5L:6UI;F%T97,@=&AE(&1I<W1I;F-T:6]N#0IO9B!A(&1E
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M,C`Q-"TQ,"!W:6QL(&)E(&5F9F5C=&EV92!P<F]S<&5C=&EV96QY#0IF;W(@
M86YN=6%L(')E<&]R=&EN9R!P97)I;V1S(&)E9VEN;FEN9R!A9G1E<B!$96-E
M;6)E<B`Q-2P@,C`Q-"P@86YD(&EN=&5R:6T@<&5R:6]D<R!W:71H:6X@=&AO
M<V4@86YN=6%L('!E<FEO9',L(&AO=V5V97(@96%R;'D-"F%D;W!T:6]N(&ES
M('!E<FUI='1E9"X@5&AE($-O;7!A;GD@861O<'1E9"!!4U4@,C`Q-"TQ,"!D
M=7)I;F<@=&AE('%U87)T97(@96YD960@2G5N92`S,"P@,C`Q-"P@=&AE<F5B
M>2!N;R!L;VYG97(@<')E<V5N=&EN9R!O<@T*9&ES8VQO<VEN9R!A;GD@:6YF
M;W)M871I;VX@<F5Q=6ER960@8GD@5&]P:6,@.3$U+CPO9F]N=#X\+W`^#0H-
M"CQP('-T>6QE/3-$)V9O;G0Z(#EP="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT
M.B`Y<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/"]F;VYT/CPO
M<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^26X-"DUA
M>2`R,#$T+"!T:&4@1D%30B!I<W-U960@05-5(#(P,30M,#DL(%)E=F5N=64@
M9G)O;2!#;VYT<F%C=',@=VET:"!#=7-T;VUE<G,@*%1O<&EC(#8P-BDL('=H
M:6-H('-U<&5R<V5D97,@=&AE(')E=F5N=64@<F5C;V=N:71I;VX-"G)E<75I
M<F5M96YT<R!I;B!!8V-O=6YT:6YG(%-T86YD87)D<R!#;V1I9FEC871I;VX@
M*"8C,30W.T%30R8C,30X.RD@-C`U+"!2979E;G5E(%)E8V]G;FET:6]N+B!4
M:&4@;F5W(')E=F5N=64@<F5C;V=N:71I;VX@<W1A;F1A<F0-"G)E<75I<F5S
M(&5N=&ET:65S('1O(')E8V]G;FEZ92!R979E;G5E(&EN(&$@=V%Y('1H870@
M9&5P:6-T<R!T:&4@=')A;G-F97(@;V8@<')O;6ES960@9V]O9',@;W(@<V5R
M=FEC97,@=&\@8W5S=&]M97)S(&EN(&%N(&%M;W5N=`T*=&AA="!R969L96-T
M<R!T:&4@8V]N<VED97)A=&EO;B!T;R!W:&EC:"!T:&4@96YT:71Y(&5X<&5C
M=',@=&\@8F4@96YT:71L960@=&\@:6X@97AC:&%N9V4@9F]R('1H;W-E(&=O
M;V1S(&]R('-E<G9I8V5S+B!!4U4@,C`Q-"TP.0T*:7,@969F96-T:79E(&9O
M<B!I;G1E<FEM(&%N9"!A;FYU86P@<F5P;W)T:6YG('!E<FEO9',@8F5G:6YN
M:6YG(&%F=&5R($1E8V5M8F5R(#$U+"`R,#$V(&%N9"!I<R!T;R!B92!A<'!L
M:65D(')E=')O<W!E8W1I=F5L>2X-"E1H92!#;VUP86YY(&1O97,@;F]T(&-U
M<G)E;G1L>2!H879E(&%N>2!R979E;G5E+B!!<R!S=6-H+"!!4U4@,C`Q-"TP
M.2!W:6QL(&YO="!H879E(&%N>2!E9F9E8W0@;VX@=&AE($-O;7!A;GDF(S$T
M-CMS(')E<W5L=',@;V8-"F]P97)A=&EO;G,@86YD(&9I;F%N8VEA;"!P;W-I
M=&EO;BX@268@=&AE($-O;7!A;GD@8F5G:6YS(&=E;F5R871I;F<@<F5V96YU
M92!P<FEO<B!T;R!T:&4@969F96-T:79E(&1A=&4@;V8@05-5(#(P,30M,#DL
M(&ET('=I;&P-"F5V86QU871E('1H92!E9F9E8W0@=&AA="!!4U4@,C`Q-"TP
M.2!W:6QL(&AA=F4@;VX@:71S(')E<W5L=',@;V8@;W!E<F%T:6]N<R!A;F0@
M9FEN86YC:6%L('!O<VET:6]N+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@8F%C
M:V=R;W5N9"UC;VQO<CH@=VAI=&4G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^/&D^06-C;W5N=&EN9PT*17-T:6UA=&5S/"]I/CPO9F]N=#X\+W`^
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^/&D^)B,Q-C`[/"]I/CPO9F]N=#X\+W`^#0H-"CQP('-T
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M;VT@=&AE<V4@97-T:6UA=&5S+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L
M:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\:3Y#87-H#0IA;F0@0V%S:"!%
M<75I=F%L96YT<SPO:3X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQI/B8C,38P
M.SPO:3X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/E1H90T*0V]M<&%N>2!C;VYS
M:61E<G,@86QL(&AI9VAL>2!L:7%U:60@:6YS=')U;65N=',@<'5R8VAA<V5D
M('=I=&@@86X@;W)I9VEN86P@;6%T=7)I='D@;V8@=&AR964@;6]N=&AS(&]R
M(&QE<W,@=&\@8F4@8V%S:"!E<75I=F%L96YT<RX-"D-A<V@@86YD(&-A<V@@
M97%U:79A;&5N=',@;6%Y(&%T('1I;65S(&5X8V5E9"!F961E<F%L;'D@:6YS
M=7)E9"!L:6UI=',N/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/CQI/DYO=&4-"E)E8V5I=F%B;&4@9G)O;2!$
M=6ME($UO=6YT86EN/"]I/CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/&D^)B,Q
M-C`[/"]I/CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X
M="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^5&AE#0IN;W1E(')E8V5I
M=F%B;&4@9G)O;2!$=6ME($UO=6YT86EN(%)E<V]U<F-E<RP@26YC+B`H)B,Q
M-#<[1'5K928C,30X.RD@:7,@=6YS96-U<F5D+"!B96%R<R!I;G1E<F5S="!A
M="`T+C`E(&%N9"!P<FEN8VEP86P@86YD(&EN=&5R97-T#0IA<F4@9'5E(&]N
M($1E8V5M8F5R(#,Q+"`R,#$U+B!4:&4@0V]M<&%N>28C,30V.W,@8W)E9&ET
M(')I<VL@87-S97-S;65N="!I<R!L:6UI=&5D(&1U92!T;R!T:&4@<F5L871E
M9"!P87)T>2!N871U<F4@;V8@=&AE(&%R<F%N9V5M96YT+CPO9F]N=#X\+W`^
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\:3Y&
M86ER#0I686QU92!O9B!&:6YA;F-I86P@26YS=')U;65N=',\+VD^/"]F;VYT
M/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX\:3XF(S$V,#L\+VD^/"]F;VYT/CPO<#X-"@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SY4:&4-"F-A<G)Y:6YG(&%M;W5N=',@9F]R(&-A<V@@86YD(&-A
M<V@@97%U:79A;&5N=',@86YD('!A>6%B;&5S(&%P<')O>&EM871E(&9A:7(@
M=F%L=64@8F%S960@;VX@;V)S97)V86)L92!Q=6]T960@<')I8V5S(&9O<B!A
M8W1I=F4-"FUA<FME=',@)B,Q-3`[($QE=F5L(#$@:6YP=71S+B!4:&4@8V%R
M<GEI;F<@86UO=6YT(&]F('1H92!N;W1E(')E8V5I=F%B;&4@9G)O;2!$=6ME
M(&%P<')O>&EM871E<R!F86ER('9A;'5E(&)A<V5D(&]N('-I;6EL87(@;6%R
M:V5T#0II;G!U=',@9F]R(&EN=&5R97-T(')A=&5S(&9O<B!A('-P96-I9FEC
M(&-R961I=&]R("8C,34P.R!,979E;"`R(&EN<'5T<RX\+V9O;G0^/"]P/@T*
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/&D^4F5S
M96%R8V@-"F%N9"!$979E;&]P;65N="!#;W-T<SPO:3X\+V9O;G0^/"]P/@T*
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/CQI/B8C,38P.SPO:3X\+V9O;G0^/"]P/@T*#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
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M/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/CQI/DEN=&%N9VEB;&4-"D%S<V5T<SPO:3X\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/CQI/B8C,38P.SPO:3X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/E1H90T*
M:6YT86YG:6)L92!A<W-E="!C;VYS:7-T<R!P<FEM87)I;'D@;V8@0V5L;"!$
M97!O<VET:6]N($1E=FEC92!T96-H;F]L;V=Y('1H870@=&AE($-O;7!A;GD@
M86-Q=6ER960@9'5R:6YG(#(P,3,@86YD(&ES(')E8V]R9&5D#0IA="!C;W-T
M+B!!="!T:&4@=&EM92!O9B!A8W%U:7-I=&EO;B!T:&4@=&5C:&YO;&]G>2!H
M860@;F]T(')E86-H960@=&5C:&YO;&]G:6-A;"!F96%S:6)I;&ET>2X@5&AE
M(&%M;W5N="!C87!I=&%L:7IE9"!I<R!A8V-O=6YT960-"F9O<B!A<R!A;B!I
M;F1E9FEN:71E+6QI=F5D(&EN=&%N9VEB;&4@87-S970L('-U8FIE8W0@=&\@
M:6UP86ER;65N="!T97-T:6YG('5N=&EL(&-O;7!L971I;VX@;W(@86)A;F1O
M;FUE;G0N(%5P;VX@<W5C8V5S<V9U;"!C;VUP;&5T:6]N+`T*82!D971E<FUI
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M;7!A:7)M96YT('1E<W1S(&%R92!N;W0@;F5C97-S87)Y+CPO9F]N=#X\+W`^
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY4:&4-
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M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO
M9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^/&D^4W1O8VL-"D]P=&EO;G,\+VD^/"]F
M;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX\:3XF(S$V,#L\+VD^/"]F;VYT/CPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
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M="!R871E<RX\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\
M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF
M>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^/&D^26YC;VUE#0I487AE<SPO:3X\+V9O;G0^/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/CQI/B8C,38P.SPO:3X\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
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M>2!T:&%N(&YO="`H:2YE+BP@;&EK96QI:&]O9"!O9B!G<F5A=&5R('1H86X@
M-3`E*2P@8F%S960@;VX@=&5C:&YI8V%L(&UE<FET<RP@=&AA="!T:&4@<&]S
M:71I;VX@=V]U;&0@8F4@<W5S=&%I;F5D('5P;VX-"F5X86UI;F%T:6]N(&)Y
M('1A>&EN9R!A=71H;W)I=&EE<RX@5&%X('!O<VET:6]N<R!T:&%T(&UE970@
M=&AE(&UO<F4@;&EK96QY('1H86X@;F]T('1H<F5S:&]L9"!A<F4@;65A<W5R
M960@=7-I;F<@82!P<F]B86)I;&ET>2UW96EG:'1E9`T*87!P<F]A8V@@87,@
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M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I
M9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M/&D^1&ES8V]N=&EN=65D#0I/<&5R871I;VYS/"]I/CPO9F]N=#X\+W`^#0H-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^/&D^)B,Q-C`[/"]I/CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE
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M92!O9B!T:&4@;VEL(&%N9"!G87,@<')O<&5R=&EE<R!I;B!&96)R=6%R>2`R
M,#$S(&%N9"!T:&4@<V%L92!O9B!T:&4@0V]M<&%N>28C,30V.W,@<W5B<VED
M:6%R>2!W:&EC:"!C;VYT<F]L;&5D('9A<FEO=7,@;6EN97)A;`T*;&5A<V5S
M(&%N9"!C;&%I;7,@:6X@1&5C96UB97(@,C`Q,RX@0V5R=&%I;B!A;6]U;G1S
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M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX\:3XF(S$V,#L\+VD^/"]F;VYT/CPO<#X-"@T*/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX\:3Y%87)N:6YG<PT**$QO<W,I(%!E<B!3:&%R93PO:3X\+V9O;G0^/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/CQI/CPO:3XF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/E1H90T*0V]M<&%N>2!P<F5S96YT<R!B;W1H(&)A<VEC(&%N9"!D:6QU
M=&5D(&5A<FYI;F=S('!E<B!S:&%R92`H)B,Q-#<[15!3)B,Q-#@[*2!A;6]U
M;G1S+B!"87-I8R!%4%,@:7,@8V%L8W5L871E9"!B>2!D:79I9&EN9R!N970-
M"FEN8V]M92`H;&]S<RD@8GD@=&AE('=E:6=H=&5D(&%V97)A9V4@;G5M8F5R
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M=&\@<'5R8VAA<V4@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R`H."PR,#`L,#`P
M('-H87)E<R!A<R!O9B!*=6YE(#,P+"`R,#$T#0IA;F0@1&5C96UB97(@,S$L
M(#(P,3,I(&%N9"!O<'1I;VYS('1O('!U<F-H87-E('-H87)E<R!O9B!C;VUM
M;VX@<W1O8VL@*#$S-2PP,#`@<VAA<F5S(&%S(&]F($IU;F4@,S`L(#(P,30@
M86YD(#@P+#`P,"!A<R!O9B!$96-E;6)E<@T*,S$L(#(P,3,I+B!$=7)I;F<@
M=&AE('!E<FEO9',@<')E<V5N=&5D+"!P;W1E;G1I86QL>2!D:6QU=&EV92!S
M:&%R97,@;V8@8V]M;6]N('-T;V-K('=E<F4@;F]T(&EN8VQU9&5D(&EN('1H
M92!C;VUP=71A=&EO;B!O9B!D:6QU=&EV90T*;&]S<R!P97(@<VAA<F4@87,@
M=&\@9&\@<V\@=V]U;&0@8F4@86YT:2UD:6QU=&EV92X\+V9O;G0^/"]P/@T*
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/&D^4F5L
M871E9`T*4&%R='D@5')A;G-A8W1I;VYS/"]I/CPO9F]N=#X\+W`^#0H-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^/&D^/"]I/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^00T*
M<F5L871E9"!P87)T>2!I<R!G96YE<F%L;'D@9&5F:6YE9"!A<R`H:2D@86YY
M('!E<G-O;B!W:&\@:&]L9',@,3`E(&]R(&UO<F4@;V8@=&AE($-O;7!A;GDF
M(S$T-CMS('-E8W5R:71I97,@86YD('1H96ER(&EM;65D:6%T90T*9F%M:6QI
M97,[("AI:2D@=&AE($-O;7!A;GDF(S$T-CMS(&UA;F%G96UE;G0[("AI:6DI
M('-O;65O;F4@=VAO(&1I<F5C=&QY(&]R(&EN9&ER96-T;'D@8V]N=')O;',L
M(&ES(&-O;G1R;VQL960@8GD@;W(@:7,@=6YD97(-"F-O;6UO;B!C;VYT<F]L
M('=I=&@@=&AE($-O;7!A;GD[(&]R("AI=BD@86YY;VYE('=H;R!C86X@<VEG
M;FEF:6-A;G1L>2!I;F9L=65N8V4@=&AE(&9I;F%N8VEA;"!A;F0@;W!E<F%T
M:6YG(&1E8VES:6]N<R!O9B!T:&4@0V]M<&%N>2X-"D$@=')A;G-A8W1I;VX@
M:7,@8V]N<VED97)E9"!T;R!B92!A(')E;&%T960@<&%R='D@=')A;G-A8W1I
M;VX@=VAE;B!T:&5R92!I<R!A('1R86YS9F5R(&]F(')E<V]U<F-E<R!O<B!O
M8FQI9V%T:6]N<R!B971W965N(')E;&%T960-"G!A<G1I97,N(%-E92`F(S$T
M-SM.;W1E(#8N(%)E;&%T960@4&%R='D@5')A;G-A8W1I;VYS+"8C,30X.R!F
M;W(@9G5R=&AE<B!D:7-C=7-S:6]N+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT
M+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\+V9O;G0^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQI/D-O
M;7!R96AE;G-I=F4@26YC;VUE("A,;W-S*3PO:3X\+W`^#0H-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&D^)B,Q-C`[/"]I
M/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SY4:&4@0V]M<&%N>2!H87,@;F\@:71E;7,@;V8@;W1H97(@8V]M<')E
M:&5N<VEV90T*:6YC;VUE(&EN(&%N>2!P97)I;V0@<')E<V5N=&5D+B8C,38P
M.R!4:&5R969O<F4L(&YE="!L;W-S(&5Q=6%L<R!C;VUP<F5H96YS:79E(&QO
M<W,N)B,Q-C`[/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ
M(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQI/D)A<VES#0IO9B!0<F5S96YT871I
M;VX@86YD(%!R:6YC:7!L97,@;V8@06-C;W5N=&EN9SPO:3X\+V9O;G0^/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
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M87,@<W5C:"P@=&AE($-O;7!A;GD@:7,@8V]N<VED97)E9`T*82!D979E;&]P
M;65N="!S=&%G92!C;VUP86YY+B!!8V-O<F1I;F=L>2P@=&AE($-O;7!A;GDF
M(S$T-CMS(&-O;G-O;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A<F4@
M<')E<V5N=&5D(&EN(&%C8V]R9&%N8V4@=VET:`T*875T:&]R:71A=&EV92!A
M8V-O=6YT:6YG(&=U:61A;F-E(')E;&%T960@=&\@82!D979E;&]P;65N="!S
M=&%G92!E;G1E<G!R:7-E+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[
M/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N
M.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\:3Y0<FEN8VEP;&5S#0IO9B!#;VYS
M;VQI9&%T:6]N/"]I/CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
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M;F4@,3(L(#(P,3,N/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M.R!T97AT+6EN9&5N=#H@,"XU:6X[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/&D^07!P
M;&EC86)L90T*06-C;W5N=&EN9R!'=6ED86YC93PO:3X\+V9O;G0^/"]P/@T*
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O
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M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF
M>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\
M:3Y!8V-O=6YT:6YG#0I%<W1I;6%T97,\+VD^/"]F;VYT/CPO<#X-"@T*/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[
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M871E<RX\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^/&D^0V%S:`T*86YD($-A<V@@17%U:79A;&5N=',\+VD^
M/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N
M.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT
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M<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQI
M/DYO=&4-"E)E8V5I=F%B;&4@9G)O;2!$=6ME($UO=6YT86EN/"]I/CPO9F]N
M=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S
M=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SY4:&4-"FYO=&4@<F5C96EV86)L92!F<F]M($1U:V4@36]U;G1A:6X@:7,@
M=6YS96-U<F5D+"!B96%R<R!I;G1E<F5S="!A="`T+C`E+"!A;F0@<')I;F-I
M<&%L(&%N9"!I;G1E<F5S="!A<F4@9'5E(&]N($1E8V5M8F5R(#,Q+"`R,#$U
M+@T*5&AE($-O;7!A;GDF(S$T-CMS(&-R961I="!R:7-K(&%S<V5S<VUE;G0@
M:7,@;&EM:71E9"!D=64@=&\@=&AE(')E;&%T960@<&%R='D@;F%T=7)E(&]F
M('1H92!A<G)A;F=E;65N="X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG
M;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^/&D^1F%I<@T*5F%L=64@;V8@1FEN
M86YC:6%L($EN<W1R=6UE;G1S/"]I/CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT
M+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY4:&4-"F-A<G)Y:6YG(&%M
M;W5N=',@9F]R(&-A<V@@86YD(&-A<V@@97%U:79A;&5N=',L(&%N9"!P87EA
M8FQE<R!A<'!R;WAI;6%T92!F86ER('9A;'5E(&)A<V5D(&]N(&]B<V5R=F%B
M;&4@<75O=&5D('!R:6-E<R!F;W(@86-T:79E#0IM87)K971S("8C,34P.R!,
M979E;"`Q(&EN<'5T<RX@5&AE(&-A<G)Y:6YG(&%M;W5N="!O9B!T:&4@;F]T
M92!R96-E:79A8FQE(&9R;VT@1'5K92!-;W5N=&%I;B!A<'!R;WAI;6%T97,@
M9F%I<B!V86QU92!B87-E9"!O;@T*;V)S97)V86)L92!M87)K970@:6YP=71S
M(&9O<B!I;G1E<F5S="!R871E<R`F(S$U,#L@3&5V96P@,B!I;G!U=',N/"]F
M;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/CQI/E)E<V5A<F-H#0IA;F0@1&5V96QO<&UE;G0@0V]S=',\+VD^/"]F
M;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
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M;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/CQI/DEN=&%N9VEB;&4-"D%S<V5T<SPO:3X\+V9O;G0^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z
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M:7)E9"!D=7)I;F<@,C`Q,R!A;F0@:7,@<F5C;W)D960-"F%T(&-O<W0N($%T
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M;G0N(%5P;VX@<W5C8V5S<V9U;"!C;VUP;&5T:6]N+`T*82!D971E<FUI;F%T
M:6]N('=I;&P@8F4@;6%D92!A<R!T;R!T:&4@=&AE;B!U<V5F=6P@;&EF92!O
M9B!T:&4@:6YT86YG:6)L92!A<W-E="P@9V5N97)A;&QY(&1E=&5R;6EN960@
M8GD@=&AE('!E<FEO9"!I;B!W:&EC:"!S=6)S=&%N=&EA;&QY#0IA;&P@;V8@
M=&AE(&-A<V@@9FQO=W,@87)E(&5X<&5C=&5D('1O(&)E(&=E;F5R871E9"P@
M86YD(&)E9VEN(&%M;W)T:7IA=&EO;BX@5&AE($-O;7!A;GD@=&5S=',@=&AE
M(&EN=&%N9VEB;&4@87-S970@9F]R(&EM<&%I<FUE;G0-"F%T(&QE87-T(&%N
M;G5A;&QY(&]R(&UO<F4@9G)E<75E;G1L>2!I9B!I;7!A:7)M96YT(&EN9&EC
M871O<G,@97AI<W0@869T97(@<&5R9F]R;6EN9R!A('%U86QI=&%T:79E(&%N
M86QY<VES+B!-86YA9V5M96YT(&AA<R!M=6QT:7!L90T*8W)I=&5R:6$@=&AA
M="!I="!C;VYS:61E<G,@=VAE;B!P97)F;W)M:6YG('1H92!Q=6%L:71A=&EV
M92!A;F%L>7-I<RX@5&AE(')E<W5L=',@;V8@=&AI<R!R979I97<@87)E('1H
M96X@=V5I9VAE9"!A;F0@<')I;W)I=&EZ960N#0I)9B!T:&4@=&]T86QI='D@
M;V8@=&AE(')E;&5V86YT(&5V96YT<R!A;F0@8VER8W5M<W1A;F-E<R!I;F1I
M8V%T92!T:&%T(&ET(&ES(&YO="!M;W)E(&QI:V5L>2!T:&%N(&YO="!T:&%T
M('1H92!F86ER('9A;'5E(&]F('1H90T*:6YT86YG:6)L92!A<W-E="!I<R!L
M97-S('1H86X@:71S(&-A<G)Y:6YG(&%M;W5N="P@861D:71I;VYA;"!I;7!A
M:7)M96YT('1E<W1S(&%R92!N;W0@;F5C97-S87)Y+CPO9F]N=#X\+W`^#0H-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY4:&4-"D-O
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M:6YG(&%M;W5N="X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[
M('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N
M=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S
M=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^/&D^4W1O8VL-"D]P=&EO;G,\+VD^/"]F;VYT
M/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
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M;&5S('!R:6-I;F<@;6]D96P@<F5Q=6ER97,@;6%N86=E;65N=`T*=&\@;6%K
M92!A<W-U;7!T:6]N<R!R96=A<F1I;F<@;W!T:6]N(&QI=F5S+"!E>'!E8W1E
M9"!V;VQA=&EL:71Y+"!A;F0@<FES:R!F<F5E(&EN=&5R97-T(')A=&5S+B8C
M,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA
M;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX\:3Y);F-O;64-"E1A>&5S/"]I/CPO9F]N=#X\+W`^#0H-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY4:&4-"D-O
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M(&%M;W5N="!O9B!T87@@8F5N969I="!T:&%T(&ES(&=R96%T97(@=&AA;B`U
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M<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQI
M/D1I<V-O;G1I;G5E9`T*3W!E<F%T:6]N<SPO:3X\+V9O;G0^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z
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M;B!&96)R=6%R>2`R,#$S(&%N9"!T:&4@<V%L92!O9B!T:&4@0V]M<&%N>28C
M,30V.W,@<W5B<VED:6%R>2!W:&EC:"!C;VYT<F]L;&5D#0IV87)I;W5S(&UI
M;F5R86P@;&5A<V5S(&%N9"!C;&%I;7,@:6X@1&5C96UB97(@,C`Q,RX@0V5R
M=&%I;B!A;6]U;G1S(')E<&]R=&5D(&EN('1H92!P<FEO<B!P97)I;V1S('!R
M97-E;G1E9"!H879E(&)E96X@<F5C;&%S<VEF:65D#0IT;R!C;VYF;W)M('1O
M('1H92!C=7)R96YT('!E<FEO9"!F:6YA;F-I86P@<W1A=&5M96YT('!R97-E
M;G1A=&EO;BX@5&AE<V4@<F5C;&%S<VEF:6-A=&EO;G,@:&%V92!N;R!E9F9E
M8W0@;VX@<')E=FEO=7-L>2!R97!O<G1E9`T*;F5T(&EN8V]M92`H;&]S<RDN
M(%-E92`F(S$T-SM.;W1E(#,N($1I<V-O;G1I;G5E9"!/<&5R871I;VYS)B,Q
M-#@[(&9O<B!A('-U;6UA<GD@;V8@=&AE(&%M;W5N=',@<F5C;&%S<VEF:65D
M(&9O<B!T:&4@<&5R:6]D<PT*<')E<V5N=&5D(&AE<F5I;BX\+V9O;G0^/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/&D^
M16%R;FEN9W,-"BA,;W-S*2!097(@4VAA<F4\+VD^/"]F;VYT/CPO<#X-"@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/E1H90T*0V]M
M<&%N>2!P<F5S96YT<R!B;W1H(&)A<VEC(&%N9"!D:6QU=&5D(&5A<FYI;F=S
M('!E<B!S:&%R92`H)B,Q-#<[15!3)B,Q-#@[*2!A;6]U;G1S+B!"87-I8R!%
M4%,@:7,@8V%L8W5L871E9"!B>2!D:79I9&EN9R!N970-"FEN8V]M92`H;&]S
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M<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R`H."PR,#`L,#`P('-H87)E<R!F;W(@
M,C`Q,R!A;F0@;FEL('-H87)E<PT*9F]R(#(P,3(I(&%N9"!O<'1I;VYS('1O
M('!U<F-H87-E('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@*#@P+#`P,"!S:&%R
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M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQI/D-O
M;7!R96AE;G-I=F4-"DEN8V]M92`H3&]S<RD\+VD^/"]F;VYT/CPO<#X-"@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D-O;7!R96AE
M;G-I=F4-"FQO<W,@:7,@8V]M<')I<V5D(&]F(&YE="!L;W-S+&%N9"!A(')E
M8VQA<W-I9FEC871I;VX@;VX@9&ES<&]S86P@;V8@<W5B<VED:6%R>2!F;W(@
M=&AE('!E<FEO9',@<')E<V5N=&5D+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT
M+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\:3Y296QA=&5D#0I087)T
M>2!4<F%N<V%C=&EO;G,\+VD^/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI
M9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D$-"G)E;&%T960@<&%R='D@:7,@
M9V5N97)A;&QY(&1E9FEN960@87,@*&DI(&%N>2!P97)S;VX@=VAO(&AO;&1S
M(#$P)2!O<B!M;W)E(&]F('1H92!#;VUP86YY)B,Q-#8[<R!S96-U<FET:65S
M(&%N9"!T:&5I<B!I;6UE9&EA=&4-"F9A;6EL:65S.R`H:6DI('1H92!#;VUP
M86YY)B,Q-#8[<R!M86YA9V5M96YT.R`H:6EI*2!S;VUE;VYE('=H;R!D:7)E
M8W1L>2!O<B!I;F1I<F5C=&QY(&-O;G1R;VQS+"!I<R!C;VYT<F]L;&5D(&)Y
M(&]R(&ES('5N9&5R#0IC;VUM;VX@8V]N=')O;"!W:71H('1H92!#;VUP86YY
M.R!O<B`H:78I(&%N>6]N92!W:&\@8V%N('-I9VYI9FEC86YT;'D@:6YF;'5E
M;F-E('1H92!F:6YA;F-I86P@86YD(&]P97)A=&EN9R!D96-I<VEO;G,@;V8@
M=&AE($-O;7!A;GDN#0I!('1R86YS86-T:6]N(&ES(&-O;G-I9&5R960@=&\@
M8F4@82!R96QA=&5D('!A<G1Y('1R86YS86-T:6]N('=H96X@=&AE<F4@:7,@
M82!T<F%N<V9E<B!O9B!R97-O=7)C97,@;W(@;V)L:6=A=&EO;G,@8F5T=V5E
M;B!R96QA=&5D#0IP87)T:65S+B!3964@)B,Q-#<[3F]T92`W+B!296QA=&5D
M(%!A<G1Y(%1R86YS86-T:6]N<RPF(S$T.#L@9F]R(&9U<G1H97(@9&ES8W5S
M<VEO;BX\+V9O;G0^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?969F,F4W,#1?83=A.5\T,60Q7V$V-#A?,F8X-V9D-31B
M-S<T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+V5F9C)E-S`T7V$W
M83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-"]7;W)K<VAE971S+U-H965T,3`N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$5,13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY$:7-C
M;VYT:6YU960@3W!E<F%T:6]N<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$:7-C;VYT:6YU960@3W!E<F%T:6]N
M<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3F]T92`S+B!$:7-C;VYT:6YU960@3W!E<F%T:6]N<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA
M;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^3VX@1F5B<G5A<GD-"C$X+"`R
M,#$S+"!W92!C;VUP;&5T960@=&AE('-A;&4@;V8@;W5R('=O<FMI;F<@:6YT
M97)E<W0@:6X@=&AE($]N;FEE(%)A>2`C,2P@2&%I;&4@(S$L(%!E87)C92`C
M,2!A;F0@4W1A:&P@(S$@;VEL('=E;&QS+B!792!E;G1E<F5D#0II;G1O(&%N
M($%S<VEG;FUE;G0@06=R965M96YT('=I=&@@3&5E>'5S($]I;"!,3$,L('1H
M92!W96QL<R!O<&5R871O<BP@=VAE<F5B>2!T:&4@0V]M<&%N>2!A<W-I9VYE
M9"!I=',@<FEG:'0L('1I=&QE(&%N9"!I;G1E<F5S=`T*:6X@=&AE(&]I;"P@
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M<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D]N
M($9E8G)U87)Y#0HQ.2P@,C`Q,RP@=V4@8V]M<&QE=&5D('1H92!S86QE(&]F
M(&]U<B!W;W)K:6YG(&EN=&5R97-T(&EN('1H92!#;V]K92`C-B!W96QL+B!7
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M87-S:6=N;65N="!W87,@)#,L,#`P(&-A<V@N/"]F;VYT/CPO<#X-"@T*/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[
M('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/E1H92!C87)R>6EN
M9PT*86UO=6YT(&]F('1H92!O:6P@86YD(&=A<R!P<F]P97)T:65S('=A<R`D
M,C0L,3(W(&]N('1H92!D871E(&]F(&1I<W!O<V%L+B!4:&4@<F5L871E9"!A
M<W-E="!R971I<F5M96YT(&]B;&EG871I;VX@86UO=6YT960@=&\-"B0U-RPU
M,S(@86YD(&QI86)I;&ET:65S(&%S<W5M960@86UO=6YT960@=&\@)#$R+#DS
M,BX@26YC;'5D:6YG('1H92`D,RPP,#`@8V%S:"!R96-E:79E9"P@=&AE($-O
M;7!A;GD@<F5C;V=N:7IE9"!A(&=A:6X@;V8@)#0Y+#,S.`T*:6X@=&AE('EE
M87(@96YD960@1&5C96UB97(@,S$L(#(P,3,L(&%S(&$@<F5S=6QT(&]F('1H
M92!D:7-P;W-A;"X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[
M('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N
M=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S
M=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^3VX@1&5C96UB97(-"C,Q+"`R,#$S+"!W92!E
M;G1E<F5D(&EN=&\@82!S=&]C:R!P=7)C:&%S92!A9W)E96UE;G0@=VET:"!$
M=6ME+"!P=7)S=6%N="!T;R!W:&EC:"!W92!S;VQD('1O($1U:V4@,3`P)2!O
M9B!T:&4@:7-S=65D(&%N9"!O=71S=&%N9&EN9PT*<VAA<F5S(&]F($9O<W1U
M;F<@4F5S;W5R8V5S+"!A('=H;VQL>2!O=VYE9"!S=6)S:61I87)Y(&]F(&]U
M<G,L(&9O<B!A('!R;VUI<W-O<GD@;F]T92!I;B!T:&4@86UO=6YT(&]F("0X
M,"PP,#`L('=H:6-H(&%M;W5N="!A<'!R;WAI;6%T960-"G1H92!F86ER('9A
M;'5E(&]F('1H92!L96%S97,@86YD(&UI;FEN9R!C;&%I;7,@8V]N=')O;&QE
M9"!B>2!&;W-T=6YG(%)E<V]U<F-E<RP@87,@8V]N8VQU9&5D(&)Y(&%N(&EN
M9&5P96YD96YT('1H:7)D+7!A<G1Y(&=E;VQO9VEC86P-"F-O;G-U;'1A;G0N
M(%!R:6YC:7!A;"!A;F0@:6YT97)E<W0@870@-"XP)2!A<F4@<&%Y86)L92!O
M;B!$96-E;6)E<B`S,2P@,C`Q-2X@26YC;'5D:6YG('1H92`D.#`L,#`P(&]F
M(&-O;G-I9&5R871I;VX@<F5C96EV960L#0IT:&4@0V]M<&%N>2!R96-O9VYI
M>F5D(&$@;&]S<R!O;B!T:&4@9&ES<&]S86P@;V8@=&AE('-U8G-I9&EA<GD@
M;V8@)#0U,RPU.#$N/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/E1H92!#;VUP86YY)B,Q-#8[<PT*<F5V96YU
M92!R97!O<G1E9"!I;B!D:7-C;VYT:6YU960@;W!E<F%T:6]N<R!F;W(@=&AE
M('EE87)S(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$S(&%N9"!$96-E;6)E<B`S
M,2P@,C`Q,B!W97)E("1N:6P@86YD("0Q-BPU-#DL#0IR97-P96-T:79E;'DN
M(%1H92!#;VUP86YY)B,Q-#8[<R!N970@;&]S<R!R97!O<G1E9"!I;B!D:7-C
M;VYT:6YU960@;W!E<F%T:6]N<R!F;W(@=&AE('EE87)S(&5N9&5D($1E8V5M
M8F5R(#,Q+"`R,#$S(&%N9"!$96-E;6)E<@T*,S$L(#(P,3(@=V%S("0H-#`T
M+#(T,RD@86YD("0H,30L-#(P*2P@<F5S<&5C=&EV96QY+B!4:&4@0V]M<&%N
M>2!H87,@;F]T(')E8V]G;FEZ960@86YY(')E=F5N=64@;F]R(&EN8W5R<F5D
M(&5X<&5N<V5S('=I=&@@<F5S<&5C=`T*=&\@:71S('!R979I;W5S;'D@;W=N
M960@;VEL(&%N9"!G87,@86YD(&UI;F5R86P@87-S971S('-I;F-E('1H96ER
M(')E<W!E8W1I=F4@<V%L97,L(&%N9"!W:6QL(&YO="!R96-O9VYI>F4@86YY
M(&-O;G1I;G5I;F<@8V%S:`T*9FQO=W,@=VET:"!R97-P96-T('1O('1H97-E
M('!R;W!E<G1I97,@:6X@=&AE(&9U='5R92X\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@
M=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^07-S971S(&%N9`T*
M;&EA8FEL:71I97,@;V8@9&ES8V]N=&EN=65D(&]P97)A=&EO;G,@:6X@=&AE
M(&%C8V]M<&%N>6EN9R!B86QA;F-E('-H965T<R!C;VYS:7-T(&]F('1H92!F
M;VQL;W=I;F<Z/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\=&%B;&4@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!W:61T:#H@,3`P)2<^
M#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`@
M/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@8V]L<W!A
M;CTS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU<'0@<V]L
M:60[('1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/&(^1&5C96UB
M97(-"B`@("`S,2P@,C`Q,CPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/CPO
M='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@
M("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/D%S<V5T<SH\+V9O;G0^/"]T9#X-"B`@("`\
M=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#@Y)3L@<&%D9&EN9RUL969T.B`Y<'0G/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/D]I;"!A;F0@1V%S(%!R;W!E<G1I97,L(&YE=#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(')I9VAT
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/C(T+#$R-SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@
M("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUL969T.B`Y<'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/DUI;FEN9R!P<F]P97)T:65S/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXU,3DL-S4P/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U
M;F0M8V]L;W(Z("-#0T5%1D8G/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG
M+6QE9G0Z(#EP="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^3W1H97(@8W5R<F5N="!A<W-E=',\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9"<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED.R!T97AT+6%L:6=N
M.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^.#`P/"]F;VYT/CPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T
M(&1O=6)L92<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^-30T+#8W-SPO9F]N=#X\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@
M("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^3&EA8FEL:71I97,\+V9O;G0^/"]T9#X-"B`@
M("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-
M"B`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUL969T.B`Y<'0G/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/D%C8V]U;G1S('!A>6%B;&4\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO
M9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXD/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXH,3(L.3,R/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXI/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R
M.B`C0T-%149&)SX-"B`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUL969T.B`Y
M<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/D%S<V5T(')E=&ER96UE;G0@;V)L:6=A=&EO;CPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU<'0@<V]L:60[('1E>'0M86QI9VXZ
M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXH-3<L-3,R/"]F;VYT/CPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXI/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B
M86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@/'1D/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D
M;W5B;&4G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B@W,"PT-C0\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/BD\+V9O
M;G0^/"]T9#X\+W1R/@T*/"]T86)L93X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F
M.#=F9#4T8C<W-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R
M93<P-%]A-V$Y7S0Q9#%?838T.%\R9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3
M:&5E=#$Q+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%4D<^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^26YT86YG:6)L92!!<W-E=',@+2!);G1E;&QE8W1U86P@4')O<&5R='D\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/DYO=&5S('1O($9I;F%N8VEA;"!3=&%T96UE;G1S
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3F]T92`T+B!);G1A;F=I8FQE($%S<V5T<R`M($EN=&5L;&5C='5A;"!0<F]P
M97)T>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^3VX@2G5L>2`Q,BP@
M,C`Q,RP@=&AE($-O;7!A;GDL('1O9V5T:&5R('=I=&@-"FET<R!W:&]L;'D@
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M97)L86-H("0Q,#`L,#`R#0IA;F0@:7-S=65D('1O($1R+B!'97)L86-H(&$@
M4V5R:65S($$@4W1O8VL@4'5R8VAA<V4@5V%R<F%N="`H=&AE("8C,30W.U-E
M<FEE<R!!(%=A<G)A;G0F(S$T.#LI(&5N=&ET;&EN9R!H:6T@=&\@<'5R8VAA
M<V4@,2PR,#`L,#`P#0IS:&%R97,@*&5A8V@@82`F(S$T-SM787)R86YT(%-H
M87)E)B,Q-#@[*2!O9B!T:&4@0V]M<&%N>28C,30V.W,@8V]M;6]N('-T;V-K
M+"!S=6)J96-T('1O('9E<W1I;F<@;6EL97-T;VYE<R!T:')O=6=H($IU;'D@
M,3$L#0HR,#$Y+"!A="!A;B!E>&5R8VES92!P<FEC92!O9B`D,"XS-2!P97(@
M<VAA<F4N($%C<75I<VET:6]N(')E;&%T960@8V]S=',@86UO=6YT960@=&\@
M)#4R+#@U,B!A;F0@=V5R92!C87!I=&%L:7IE9"!T;V=E=&AE<B!W:71H#0IT
M:&4@8V%S:"!P87EM96YT+B!!9&1I=&EO;F%L(&-O<W1S(&-A<&ET86QI>F5D
M(&1U<FEN9R`R,#$S+"!A;F0@=VAI8V@@<F5L871E9"!T;R!A('=O=6YD(&-A
M<"!T96-H;F]L;V=Y+"!A;6]U;G1E9"!T;R`D,3`L,#`P+B!.;PT*861D:71I
M;VYA;"!C;W-T<R!W97)E(&-A<&ET86QI>F5D(&1U<FEN9R`R,#$T+B!!="!*
M=6YE(#,P+"`R,#$T+"!I;G1A;F=I8FQE(&%S<V5T<R!A;6]U;G1E9"!T;R`D
M,38R+#@U-"X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG
M;CH@:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-
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M86UO=6YT:6YG('1O("0S,#`L,#`P('=I;&P@8F4@<&%I9`T*=&\@1'(N($=E
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M8V@L('1H92!M96%S=7)E;65N=`T*9&%T92!F;W(@86-C;W5N=&EN9R!P=7)P
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M(%=A<G)A;G0@4VAA<F4@=V%S(&%P<')O>&EM871E;'D@)#`N-SD@87,@;V8@
M2G5N92`S,"P@,C`Q-"X@07-S=6UP=&EO;G,@<F5Q=6ER960@9F]R('1H92!"
M;&%C:RU38VAO;&5S#0IM;V1E;"!A<F4@87,@9F]L;&]W<SH\+W`^#0H-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI
M;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[('=I9'1H.B`Q,#`E)SX-"CQT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD
M+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SY7
M96EG:'1E9"!A=F5R86=E(')I<VLM9G)E92!I;G1E<F5S="!R871E/"]F;VYT
M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Y)3L@=&5X="UA;&EG
M;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$N
M-C(E/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P="<^17AP96-T960@;&EF92!I;B!Y96%R<SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT
M97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^-2XP,"!996%R
M<SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T-#145&1B<^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P="<^5V5I9VAT960@079G($5X<&5C=&5D(%9O
M;&%T:6QI='D\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G
M/CDP+CDE/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^17AP96-T960@9&EV:61E;F0@>6EE
M;&0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C`E/"]F
M;VYT/CPO=&0^/"]T<CX-"CPO=&%B;&4^#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P+C5I;B<^)B,Q
M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GDG/D-O;G-U;'1I;F<@97AP96YS92!A<W-O8VEA=&5D('=I=&@@=&AE
M(%-E<FEE<PT*02!787)R86YT(&%M;W5N=&5D('1O("0V."PU,#`@86YD("0Q
M.34L,S,S(&1U<FEN9R!T:&4@=&AR964@86YD('-I>"!M;VYT:',@96YD960@
M2G5N92`S,"P@,C`Q-"X\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
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M(&%N(&%S<V5T('!U<F-H87-E(&%G<F5E;65N=`T*=VET:"!$<BX@2B8C,C0V
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M=&AE('1R86YS86-T:6]N+`T*=&AE($-O;7!A;GD@<&%I9"!$<BX@1V5R;&%C
M:"`D,3`P+#`P,B!A;F0@:7-S=65D('1O($1R+B!'97)L86-H(&$@4V5R:65S
M($$@4W1O8VL@4'5R8VAA<V4@5V%R<F%N="`H=&AE("8C,30W.U-E<FEE<R!!
M(%=A<G)A;G0F(S$T.#LI#0IE;G1I=&QI;F<@:&EM('1O('!U<F-H87-E(#$L
M,C`P+#`P,"!S:&%R97,@*&5A8V@@82`F(S$T-SM787)R86YT(%-H87)E)B,Q
M-#@[*2!O9B!T:&4@0V]M<&%N>28C,30V.W,@8V]M;6]N('-T;V-K+"!S=6)J
M96-T('1O#0IV97-T:6YG(&UI;&5S=&]N97,@=&AR;W5G:"!*=6QY(#$Q+"`R
M,#$Y+"!A="!A;B!E>&5R8VES92!P<FEC92!O9B`D,"XS-2!P97(@<VAA<F4N
M($%C<75I<VET:6]N(')E;&%T960@8V]S=',@86UO=6YT960@=&\@)#4R+#@U
M,@T*86YD('=E<F4@8V%P:71A;&EZ960@=&]G971H97(@=VET:"!T:&4@8V%S
M:"!P87EM96YT+B!!9&1I=&EO;F%L(&-O<W1S(&-A<&ET86QI>F5D(&1U<FEN
M9R`R,#$S+"!A;F0@=VAI8V@@<F5L871E9"!T;R!A('=O=6YD(&-A<`T*=&5C
M:&YO;&]G>2P@86UO=6YT960@=&\@)#$P+#`P,"X@070@1&5C96UB97(@,S$L
M(#(P,3,L(&EN=&%N9VEB;&4@87-S971S(&%M;W5N=&5D('1O("0Q-C(L.#4T
M+B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X
M="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SY4:&4@4V5R:65S#0I!(%=A<G)A;G0@=V%S(&ES<W5E
M9"!I;B!E>&-H86YG92!F;W(@<V5R=FEC97,@=&\@8F4@<F5N9&5R960@:6X@
M=&AE(&9U='5R92!B>2!$<BX@1V5R;&%C:"X@06X@861D:71I;VYA;"!A9W)E
M960@=7!O;B!C87-H('-U;0T*86UO=6YT:6YG('1O("0S,#`L,#`P('=I;&P@
M8F4@<&%I9"!T;R!$<BX@1V5R;&%C:"!U<&]N('1H92!#;VUP86YY(&%T=&%I
M;FEN9R!C97)T86EN(&UI;&5S=&]N97,@<F5L871E9"!T;R!T:&4@4F5G96YE
M<F%T:6]N(%1E8VAN;VQO9WDN#0I4:&4@=F%L=64@;V8@=&AE(%-E<FEE<R!!
M(%=A<G)A;G0@=VEL;"!B92!R96-O9VYI>F5D(&%S(&-O;G-U;'1I;F<@97AP
M96YS97,@=&\@=&AE($-O;7!A;GD@;W9E<B!T:&4@=F5S=&EN9R!T97)M(&]F
M('1H92!U;F1E<FQY:6YG#0IW87)R86YT+"!S=6)J96-T('1O($1R+B!'97)L
M86-H('!R;W9I9&EN9R!O;F=O:6YG(&-O;G-U;'1I;F<@<V5R=FEC97,@=&\@
M=&AE($-O;7!A;GD@=VET:"!R97-P96-T('1O('1H92!296=E;F5R871I;VX@
M5&5C:&YO;&]G>2X-"D%S('-U8V@L('1H92!M96%S=7)E;65N="!D871E(&9O
M<B!A8V-O=6YT:6YG('!U<G!O<V5S('=I;&P@8F4@=&AE(&1A=&4@;VX@=VAI
M8V@@<&5R9F]R;6%N8V4@8GD@1'(N($=E<FQA8V@@:7,@8V]M<&QE=&5D+B!4
M:&4@9F%I<@T*=F%L=64@;V8@96%C:"!787)R86YT(%-H87)E(&ES(&5S=&EM
M871E9"!A="!T:&4@96YD(&]F(&5A8V@@<F5P;W)T:6YG('!E<FEO9"!D=7)I
M;F<@=VAI8V@@1'(N($=E<FQA8V@@<F5N9&5R<R!S97)V:6-E<R!U<VEN9R!T
M:&4-"D)L86-K+5-C:&]L97,@;W!T:6]N('!R:6-I;F<@;6]D96PN(%1H92!F
M86ER('9A;'5E(&]F(&5A8V@@5V%R<F%N="!3:&%R92!W87,@87!P<F]X:6UA
M=&5L>2`D,"XX-R!A<R!O9B!$96-E;6)E<B`S,2P@,C`Q,RX@07-S=6UP=&EO
M;G,-"G)E<75I<F5D(&9O<B!T:&4@0FQA8VLM4V-H;VQE<R!M;V1E;"!A<F4@
M87,@9F]L;&]W<SH\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQT86)L92!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[('=I9'1H.B`Q,#`E
M)SX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#<U)2<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R-24[(&)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED.R!T97AT+6%L:6=N.B!C
M96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/CQB/C(P,3,\+V(^/"]F;VYT/CPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K
M9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M5V5I9VAT960@879E<F%G92!R:7-K+69R964@:6YT97)E<W0@<F%T93PO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/C$N-S4E/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R
M.B!W:&ET92<^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D5X<&5C=&5D(&QI9F4@
M:6X@>65A<G,\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXU+C4@665A<G,\+V9O;G0^/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z("-#0T5%1D8G/@T*("`@(#QT9#X\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SY796EG:'1E9"!!=F<@17AP96-T960@5F]L871I;&ET>3PO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/C$P,BXP)3PO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M=VAI=&4G/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY%>'!E8W1E9"!D:79I9&5N
M9"!Y:65L9#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B0P/"]F;VYT/CPO=&0^/"]T<CX-
M"CPO=&%B;&4^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)VUA<F=I;CH@,#L@=&5X
M="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^0V]N<W5L=&EN9R!E>'!E
M;G-E(&%S<V]C:6%T960@=VET:"!T:&4@4V5R:65S($$@5V%R<F%N=`T*86UO
M=6YT960@=&\@)#(S-RPY-S$@9'5R:6YG(#(P,3,N/"]F;VYT/CPO<#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V5F9C)E-S`T
M7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?838T.%\R9C@W9F0U
M-&(W-S0O5V]R:W-H965T<R]3:&5E=#$R+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%4D<^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^0V]M;6]N(%-T;V-K($]P=&EO;G,\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N
M+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/DYO=&5S('1O($9I;F%N8VEA;"!3=&%T96UE;G1S/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]T
M92`U+B!#;VUM;VX@4W1O8VL@3W!T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^/&D^07!P<F]V86P-"F]F('1H92`R,#$S
M($QO;F<M5&5R;2!);F-E;G1I=F4@4&QA;CPO:3X\+V9O;G0^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M
M:6YD96YT.B`P+C5I;B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SY/;@T*2G5N92`R,"P@,C`Q,RP@=&AE($)O87)D(&]F($1I
M<F5C=&]R<R`H=&AE("8C,30W.T)O87)D)B,Q-#@[*2!A9&]P=&5D+"!S=6)J
M96-T('1O(')E8V5I=FEN9R!S:&%R96AO;&1E<B!A<'!R;W9A;"P@=&AE(#(P
M,3,@3&]N9RU497)M#0I);F-E;G1I=F4@4&QA;B`H=&AE("8C,30W.TEN8V5N
M=&EV92!0;&%N)B,Q-#@[*2X@5&AE($EN8V5N=&EV92!0;&%N('!R;W9I9&5S
M(&9O<B!T:&4@:7-S=6%N8V4@;V8@<W1O8VL@;W!T:6]N<R!O9B!U<"!T;R`R
M,"PP,#`L,#`P#0IS:&%R97,@*'-U8FIE8W0@=&\@861J=7-T;65N="D@;V8@
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M(&]P=&EO;G,N($]N($YO=F5M8F5R(#$U+"`R,#$S+"!S:&%R96AO;&1E<G,@
M;W=N:6YG(&$@;6%J;W)I='D@;V8@=&AE($-O;7!A;GDF(S$T-CMS(&ES<W5E
M9"!A;F0@;W5T<W1A;F1I;F<@<VAA<F5S(&%P<')O=F5D#0IT:&4@26YC96YT
M:79E(%!L86XN/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XU:6XG/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z
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M;G1E9"!T;R!T:&5M.R!H;W=E=F5R+`T*;F\@<&5R<V]N(&UA>2!B92!G<F%N
M=&5D(&EN(&%N>2!O9B!T:&4@0V]M<&%N>28C,30V.W,@9FES8V%L('EE87(L
M(&]P=&EO;G,@=&\@<'5R8VAA<V4@;6]R92!T:&%N(#(L,#`P+#`P,"!S:&%R
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M=7)I;F<@86YY(&-A;&5N9&%R('EE87(@8V%N;F]T(&5X8V5E9"`D,3`P+#`P
M,"X@3W!T:6]N<R!G<F%N=&5D#0IP=7)S=6%N="!T;R!T:&4@26YC96YT:79E
M(%!L86X@87)E(&5X97)C:7-A8FQE(&YO(&QA=&5R('1H86X@=&5N('EE87)S
M(&%F=&5R('1H92!D871E(&]F(&=R86YT+CPO9F]N=#X\+W`^#0H-"CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E
M;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT
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M('=I;&P@;F]T(&)E(&QE<W,@=&AA;B`Q,3`E(&]F('1H92!F86ER(&UA<FME
M="!V86QU92X@3F\@;W!T:6]N(&-A;B!B92!G<F%N=&5D('5N9&5R#0IT:&4@
M26YC96YT:79E(%!L86X@869T97(@2G5N92`R,"P@,C`R,RX\+V9O;G0^/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M('1E>'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SY!<PT*;V8@2G5N92`S,"P@,C`Q-"P@=&AE<F4@
M=V5R92`Q.2PX-C4L,#`P('-H87)E<R!A=F%I;&%B;&4@9F]R(&=R86YT+CPO
M9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI
M9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQI/E-T;V-K#0I/<'1I;VX@06-T
M:79I='D\+VD^/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XU:6XG/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^3VX-"D%U9W5S
M="`Q+"`R,#$S+"!T:&4@0V]M<&%N>2!G<F%N=&5D('1O(&5A8V@@;V8@365S
M<W)S+B!+:7)K;&%N9"!A;F0@4VEE<F-H:6\@,C`L,#`P('-T;V-K(&]P=&EO
M;G,N(%1H92!E>&5R8VES92!P<FEC92!P97(@<VAA<F4-"FES("0P+C8U.R`Q
M,"PP,#`@;W!T:6]N<R!V97-T960@;VX@=&AE(&=R86YT(&1A=&4@86YD+"!S
M=6)J96-T('1O(&-O;G1I;G5E9"!S97)V:6-E(&%S(&$@;65M8F5R(&]F('1H
M92!#;VUP86YY)B,Q-#8[<R!";V%R9"P@=&AE#0IR96UA:6YI;F<@,3`L,#`P
M(&]P=&EO;G,@=VEL;"!V97-T(&]N($%U9W5S="`Q+"`R,#$T(&%N9"!M87D@
M8F4@97AE<F-I<V5D(&]N(&$@)B,Q-#<[8V%S:&QE<W,@8F%S:7,F(S$T.#L@
M=7-I;F<@=&AE(&9O<FUU;&$@8V]N=&%I;F5D#0IT:&5R96EN+CPO9F]N=#X\
M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF
M>3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/D5F9F5C=&EV90T*1&5C96UB97(@,2P@,C`Q
M,RP@=&AE($-O;7!A;GD@87!P;VEN=&5D($UR+B!";VQD(&%S(&ET<R!0<F5S
M:61E;G0@)B,S.#L@0T5/(&%N9"!E;G1E<F5D(&EN=&\@86X@870M=VEL;"!C
M;VYS=6QT:6YG(&%G<F5E;65N="`H=&AE#0HF(S$T-SM#;VYS=6QT:6YG($%G
M<F5E;65N="8C,30X.RD@=VET:"!-<BX@0F]L9"X@4'5R<W5A;G0@=&\@=&AE
M('1E<FUS(&]F('1H92!#;VYS=6QT:6YG($%G<F5E;65N="P@37(N($)O;&0@
M=V%S(&ES<W5E9"!A('-T;V-K#0IO<'1I;VX@=&\@<'5R8VAA<V4@=7`@=&\@
M-#`L,#`P('-H87)E<R!O9B!T:&4@0V]M<&%N>28C,30V.W,@8V]M;6]N('-T
M;V-K("AT:&4@)B,Q-#<[3W!T:6]N(%-H87)E<R8C,30X.RD@870@82!P<FEC
M92!O9B`D,"XW-0T*<&5R('-H87)E('1H92!C;&]S:6YG('!R:6-E(&]F('1H
M92!#;VUP86YY)B,Q-#8[<R!C;VUM;VX@<W1O8VL@87,@<75O=&5D(&]N('1H
M92!/5$-10B!O;B!.;W9E;6)E<B`R.2P@,C`Q,RX@5&AE($]P=&EO;G,@4VAA
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M(&%S(&9O;&QO=W,L(#(P+#`P,"!O;CH@*&$I($1E8V5M8F5R#0HQ+"`R,#$T
M.R!A;F0@*&(I($1E8V5M8F5R(#$L(#(P,34N/"]F;VYT/CPO<#X-"@T*/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN
M9&5N=#H@,"XU:6XG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-
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M)B,Q-3`[($-L:6YI8V%L("8C,S@[(%)E9W5L871O<GD@069F86ER<R!A;F0@
M96YT97)E9`T*:6YT;R!A;B!A="UW:6QL(&-O;G-U;'1I;F<@86=R965M96YT
M("AT:&4@)B,Q-#<[5')I<VQE<B!#;VYS=6QT:6YG($%G<F5E;65N="8C,30X
M.RD@=VET:"!-<RX@5')I<VQE<BX@4'5R<W5A;G0@=&\@=&AE('1E<FUS(&]F
M#0IT:&4@5')I<VQE<B!#;VYS=6QT:6YG($%G<F5E;65N="P@37,N(%1R:7-L
M97(@=V%S(&ES<W5E9"!/<'1I;VX@4VAA<F5S('1O('!U<F-H87-E('5P('1O
M(#4P+#`P,"!S:&%R97,@;V8@=&AE($-O;7!A;GDF(S$T-CMS(&-O;6UO;@T*
M<W1O8VL@870@82!P<FEC92!O9B`D,2XP-2!P97(@<VAA<F4L('1H92!C;&]S
M:6YG('!R:6-E(&]F('1H92!#;VUP86YY)B,Q-#8[<R!C;VUM;VX@<W1O8VL@
M87,@<75O=&5D(&]N('1H92!/5$-10B!O;B!!<')I;"`Q+"`R,#$T+@T*5&AE
M($]P=&EO;G,@4VAA<F5S(&UA>2!B92!E>&5R8VES960@;VX@82`F(S$T-SMC
M87-H;&5S<R!B87-I<R8C,30X.R!U<VEN9R!T:&4@9F]R;75L82!C;VYT86EN
M960@=&AE<F5I;B!A;F0L('-U8FIE8W0@=&\@37,N(%1R:7-L97(F(S$T-CMS
M#0IC;VYT:6YU960@<V5R=FEC92!A<R!T:&4@0V]M<&%N>28C,30V.W,@5FEC
M92!0<F5S:61E;G0@)B,Q-3`[($-L:6YI8V%L("8C,S@[(%)E9W5L871O<GD@
M069F86ER<RP@=&AE($]P=&EO;G,@4VAA<F5S('9E<W0@87,@9F]L;&]W<RP-
M"C$P+#`P,"!O;CH@*&$I($%P<FEL(#$L(#(P,34[("AB*2!!<')I;"`Q+"`R
M,#$V.R`H8RD@07!R:6P@,2P@,C`Q-SL@*&0I($%P<FEL(#$L(#(P,3@[(&%N
M9"`H92D@07!R:6P@,2P@,C`Q.2X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P
M+C5I;B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SY/;@T*07!R:6P@,C`L(#(P,30L('1H92!#;VUP86YY(&%P<&]I;G1E9"!!
M;F1R97<@1&%N:65L<V]N(&%S(&ET<R!$:7)E8W1O<B!O9B!"=7-I;F5S<R!$
M979E;&]P;65N="!A;F0@:7-S=65D($UR+B!$86YI96QS;VX@3W!T:6]N#0I3
M:&%R97,@=&\@<'5R8VAA<V4@-2PP,#`@<VAA<F5S(&]F('1H92!#;VUP86YY
M)B,Q-#8[<R!C;VUM;VX@<W1O8VL@870@82!P<FEC92!O9B`D,2XP-2!P97(@
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M92!#;VUP86YY+B!4:&4@3W!T:6]N<R!3:&%R97,@=F5S=`T*;VX@07!R:6P@
M,C`L(#(P,34N/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T
M97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I
M9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/E1H90T*9F]L;&]W:6YG('1A8FQE('-U;6UA<FEZ
M97,@<W1O8VL@;W!T:6]N(&%C=&EV:71Y(&9O<B!T:&4@<&5R:6]D(&5N9&5D
M($IU;F4@,S`L(#(P,30N/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XU:6XG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQT86)L92!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[('=I9'1H.B`Q,#`E
M)SX-"CQT<CX-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\8G(@+SX-"B`@("`F(S$V,#L\8G(@+SX-"B`@("`F(S$V,#L\8G(@+SX-
M"B`@("`F(S$V,#L\8G(@+SX-"B`@("`F(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\8G(@+SX-"B`@("`F(S$V,#L\8G(@+SX-"B`@("`F(S$V
M,#L\8G(@+SX-"B`@("`F(S$V,#L\8G(@+SX\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@8V]L<W!A;CTS1#(@:60],T1F9F,@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M
M.B!";&%C:R`Q+C5P="!S;VQI9"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/&(^3W!T:6]N<SPO
M8CX\8G(@+SX-"B`@("`\8CY/=71S=&%N9&EN9SPO8CX\+V9O;G0^/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!P861D:6YG
M+6)O='1O;3H@,2XU<'0G/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<CL@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SX\+W1D/@T*
M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!T97AT+6%L:6=N.B!C96YT97([(&)O<F1E<BUB;W1T;VTZ($)L
M86-K(#$N-7!T('-O;&ED)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\8CY796EG:'1E9#PO8CX\
M8G(@+SX-"B`@("`\8CY!=F5R86=E/"]B/CQB<B`O/@T*("`@(#QB/D5X97)C
M:7-E(%!R:6-E/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97([('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!P861D
M:6YG+6)O='1O;3H@,2XU<'0G/CPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R
M('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ
M(&-E;G1E<CL@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XU<'0@<V]L:60G/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/CQB/E=E:6=H=&5D/"]B/CQB<B`O/@T*("`@(#QB/D%V97)A
M9V4\+V(^/&)R("\^#0H@("`@/&(^4F5M86EN:6YG/"]B/CQB<B`O/@T*("`@
M(#QB/D-O;G1R86-T=6%L/"]B/CQB<B`O/@T*("`@(#QB/DQI9F4@*%EE87)S
M*3PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R.R!P861D:6YG+6)O='1O;3H@,2XU<'0G/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@<&%D9&EN9RUB;W1T
M;VTZ(#$N-7!T)SX\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!C96YT97([
M(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N-7!T('-O;&ED)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SX\8CY!9V=R96=A=&4\+V(^/&)R("\^#0H@("`@/&(^26YT<FEN<VEC/"]B
M/CQB<B`O/@T*("`@(#QB/E9A;'5E/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT
M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,2XU<'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SQB<B`O/@T*("`@("8C,38P.SQB<B`O/@T*("`@("8C,38P.SQB
M<B`O/@T*("`@("8C,38P.SQB<B`O/@T*("`@("8C,38P.SPO9F]N=#X\+W1D
M/@T*/"]T<CX-"CQT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B`C0T-%
M149&)SX-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^0F%L86YC92!*
M86YU87)Y#0H@("`@,2P@,C`Q-#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!W:61T:#H@.24[('1E>'0M86QI9VXZ(')I9VAT)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXX,"PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VED=&@Z(#$E.R!T97AT+6%L
M:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VED=&@Z(#$E)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=I9'1H.B`Y)3L@=&5X="UA;&EG;CH@
M<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/C`N-S`\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VED=&@Z(#$E.R!T
M97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VED=&@Z
M(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VED=&@Z(#DE.R!T
M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^.2XQ,SPO9F]N=#X\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W
M:61T:#H@,24[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[
M('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B0\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VED=&@Z
M(#DE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^,C`L,#`P/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VT[('=I9'1H.B`Q)3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=B
M86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@/'1D('-T>6QE/3-$)W9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(&IU<W1I9GD[('!A
M9&1I;F<M8F]T=&]M.B`Q+C5P="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^3W!T:6]N<PT*("`@
M(&=R86YT960\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@:G5S=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>3L@<&%D
M9&EN9RUB;W1T;VTZ(#$N-7!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=&5X="UA;&EG;CH@<FEG:'0[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N
M-7!T('-O;&ED)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXU-2PP,#`\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA
M;&EG;CH@:G5S=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@:G5S=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XU<'0@<V]L:60G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@<FEG:'0[(&)O<F1E<BUB;W1T;VTZ
M($)L86-K(#$N-7!T('-O;&ED)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXQ+C`U/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[('!A9&1I;F<M8F]T=&]M.B`Q+C5P
M="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(&IU
M<W1I9GD[('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(')I9VAT.R!B;W)D97(M8F]T=&]M
M.B!";&%C:R`Q+C5P="!S;VQI9"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^.2XW-3PO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!P861D:6YG+6)O='1O;3H@,2XU<'0G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!P861D:6YG+6)O='1O;3H@,2XU
M<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M
M.B!";&%C:R`Q+C5P="!S;VQI9"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)#PO9F]N=#X\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T
M97AT+6%L:6=N.B!R:6=H=#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XU<'0@
M<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/C`\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M
M8V]L;W(Z("-#0T5%1D8G/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!P861D:6YG+6)O
M='1O;3H@,BXU<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D)A;&%N8V4-"B`@("!*=6YE(#,P
M+"`R,#$T/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&IU<W1I9GD[('!A9&1I;F<M8F]T=&]M.B`R+C5P="<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(&IU<W1I9GD[('!A9&1I
M;F<M8F]T=&]M.B`R+C5P="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('1E>'0M86QI9VXZ(')I9VAT.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P
M="!D;W5B;&4G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/C$S-2PP,#`\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA
M;&EG;CH@:G5S=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@:G5S=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@
M,BXU<'0@9&]U8FQE)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI
M9VXZ(')I9VAT.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/C`N.#0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF
M>3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S
M=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>3L@<&%D9&EN9RUB;W1T
M;VTZ(#(N-7!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA
M;&EG;CH@<FEG:'0[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L
M92<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^.2XS.#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!J=7-T
M:69Y.R!P861D:6YG+6)O='1O;3H@,BXU<'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J
M=7-T:69Y.R!P861D:6YG+6)O='1O;3H@,BXU<'0G/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B
M;&4G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@<FEG:'0[
M(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L92<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^,30L.#4P/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(&IU<W1I9GD[('!A9&1I
M;F<M8F]T=&]M.B`R+C5P="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET
M92<^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D5X97)C:7-A8FQE
M#0H@("`@870@2G5N92`S,"P@,C`Q-#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXR,"PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(')I9VAT)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXP+C<P/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXY
M+C$S/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^-2PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CPO=&%B;&4^#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M
M:6YD96YT.B`P+C5I;B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SY4:&4-"F9A:7(@=F%L=64@;V8@96%C:"!S=&]C:R!O<'1I
M;VX@:7,@97-T:6UA=&5D(&%T('1H92!D871E(&]F(&=R86YT('5S:6YG('1H
M92!";&%C:RU38VAO;&5S(&]P=&EO;B!P<FEC:6YG(&UO9&5L+B!4:&4@=V5I
M9VAT960M879E<F%G90T*9F%I<B!V86QU92!O9B!S=&]C:R!O<'1I;VYS(&=R
M86YT960@9'5R:6YG(#(P,3,@=V%S(&%P<')O>&EM871E;'D@)#`N-#D@=&\@
M)#`N-3<@<&5R('-H87)E+B!4:&4@=V5I9VAT960@879E<F%G92!F86ER('9A
M;'5E(&]F#0IS=&]C:R!O<'1I;VYS(&=R86YT960@9'5R:6YG(#(P,30@=V%S
M("0Q+C`U('!E<B!S:&%R92X@07-S=6UP=&EO;G,@<F5G87)D:6YG('9O;&%T
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M8FQE(&)E;&]W.CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I
M;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!W:61T:#H@,3`P)2<^#0H\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N
M9"UC;VQO<CH@(T-#145&1B<^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X
M,B4[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/E=E:6=H=&5D
M(&%V97)A9V4@<FES:RUF<F5E#0H@("`@:6YT97)E<W0@<F%T93PO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3@E.R!T97AT+6%L:6=N
M.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/C$N-#,@)B,Q-3`[(#$N-C(E/"]F;VYT
M/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D5X<&5C=&5D
M(&QI9F4@:6X@>65A<G,\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXT+C4P("8C,34P.R`U
M+C4P/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^5V5I9VAT960@079G+B!%>'!E8W1E9"!6;VQA=&EL:71Y/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^.3DN-24F(S$V,#LF(S$U,#L@,3`U+C,E/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B
M86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D5X<&5C=&5D(&1I=FED
M96YD('EI96QD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^,"4\+V9O;G0^/"]T9#X\+W1R
M/@T*/"]T86)L93X-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI
M9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D1U<FEN9PT*=&AE('1H<F5E(&%N
M9"!S:7@@;6]N=&AS(&5N9&5D($IU;F4@,S`L(#(P,30L('-T;V-K+6)A<V5D
M(&-O;7!E;G-A=&EO;B!E>'!E;G-E(&]F("0Q,BPU-S,@86YD("0Q.2PS-34L
M(')E<W!E8W1I=F5L>2P@=V%S(')E8V]G;FEZ960-"F%S(&=E;F5R86P@86YD
M(&%D;6EN:7-T<F%T:79E(&5X<&5N<V5S+B!4:&5R92!W97)E(#(P+#`P,"!S
M=&]C:R!O<'1I;VYS('9E<W1E9"!A;F0@,3$U+#`P,"!U;G9E<W1E9"P@87,@
M;V8@2G5N92`S,"P@,C`Q-"X@07,@;V8-"DIU;F4@,S`L(#(P,30L('1H92!#
M;VUP86YY(&AA9"`D-34L,S@W(&]F('1O=&%L('5N<F5C;V=N:7IE9"!C;VUP
M96YS871I;VX@8V]S="!R96QA=&5D('1O('5N=F5S=&5D('-T;V-K(&]P=&EO
M;G,L('=H:6-H(&ES(&5X<&5C=&5D#0IT;R!B92!R96-O9VYI>F5D(&)Y($%P
M<FEL(#$L(#(P,3DN/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XU:6XG/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)VUA
M<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^5&AE
M($-O;7!A;GD@:7-S=65S(&YE=R!S:&%R97,@=VAE;B!O<'1I;VYS(&%R92!E
M>&5R8VES960N/"]F;VYT/CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT
M+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\:3Y!<'!R;W9A;`T*;V8@
M=&AE(#(P,3,@3&]N9RU497)M($EN8V5N=&EV92!0;&%N/"]I/CPO9F]N=#X\
M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF
M>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY/
M;B!*=6YE#0HR,"P@,C`Q,RP@=&AE($)O87)D(&]F($1I<F5C=&]R<R`H=&AE
M("8C,30W.T)O87)D)B,Q-#@[*2!A9&]P=&5D+"!S=6)J96-T('1O(')E8V5I
M=FEN9R!S:&%R96AO;&1E<B!A<'!R;W9A;"P@=&AE(#(P,3,@3&]N9RU497)M
M#0I);F-E;G1I=F4@4&QA;B`H=&AE("8C,30W.TEN8V5N=&EV92!0;&%N)B,Q
M-#@[*2X@5&AE($EN8V5N=&EV92!0;&%N('!R;W9I9&5S(&9O<B!T:&4@:7-S
M=6%N8V4@;V8@<W1O8VL@;W!T:6]N<R!O9B!U<"!T;R`R,"PP,#`L,#`P#0IS
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M;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
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M(&9I<V-A;"!Y96%R+"!O<'1I;VYS('1O('!U<F-H87-E(&UO<F4@=&AA;B`R
M+#`P,"PP,#`@<VAA<F5S('5N9&5R('1H92!);F-E;G1I=F4@4&QA;BP-"F%N
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M>&-E960@)#$P,"PP,#`N($]P=&EO;G,@9W)A;G1E9`T*<'5R<W5A;G0@=&\@
M=&AE($EN8V5N=&EV92!0;&%N(&%R92!E>&5R8VES86)L92!N;R!L871E<B!T
M:&%N('1E;B!Y96%R<R!A9G1E<B!T:&4@9&%T92!O9B!G<F%N="X\+V9O;G0^
M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I
M9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE
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M=F4@4&QA;B!A9G1E<B!*=6YE(#(P+"`R,#(S+CPO9F]N=#X\+W`^#0H-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY!<R!O9B!$96-E
M;6)E<@T*,S$L(#(P,3,L('1H97)E('=E<F4@,3DL.3(P+#`P,"!S:&%R97,@
M879A:6QA8FQE(&9O<B!G<F%N="X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA
M;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/&D^4W1O8VL-"D]P=&EO;B!!
M8W1I=FET>3PO:3X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[
M('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N
M=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S
M=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^3VX@075G=7-T#0HQ+"`R,#$S+"!T:&4@0V]M
M<&%N>2!G<F%N=&5D('1O($UE<W-R<RX@2VER:VQA;F0@86YD(%-I97)C:&EO
M("@R,"PP,#`@<W1O8VL@;W!T:6]N<R!E86-H*2!F;W(@<W1O8VL@;W!T:6]N
M<R!G<F%N=&5D(&]N($%U9W5S=`T*,2P@,C`Q,RX@5&AE(&5X97)C:7-E('!R
M:6-E('!E<B!S:&%R92!I<R`D,"XV-3L@,3`L,#`P(&]P=&EO;G,@=F5S=&5D
M(&]N('1H92!G<F%N="!D871E(&%N9"P@<W5B:F5C="!T;R!C;VYT:6YU960@
M<V5R=FEC92!A<R!A#0IM96UB97(@;V8@;W5R($)O87)D+"!T:&4@<F5M86EN
M:6YG(#$P+#`P,"!O<'1I;VYS('=I;&P@=F5S="!O;B!!=6=U<W0@,2P@,C`Q
M-"X@5&AE($]P=&EO;G,@4VAA<F5S(&UA>2!B92!E>&5R8VES960@;VX@82`F
M(S$T-SMC87-H;&5S<PT*8F%S:7,F(S$T.#L@=7-I;F<@=&AE(&9O<FUU;&$@
M8V]N=&%I;F5D('1H97)E:6XN)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D5F9F5C=&EV90T*1&5C
M96UB97(@,2P@,C`Q,RP@=V4@87!P;VEN=&5D($UR+B!";VQD(&%S(&]U<B!0
M<F5S:61E;G0@)B,S.#L@0T5/(&%N9"!E;G1E<F5D(&EN=&\@86X@870M=VEL
M;"!C;VYS=6QT:6YG(&%G<F5E;65N="`H=&AE("8C,30W.T-O;G-U;'1I;F<-
M"D%G<F5E;65N="8C,30X.RD@=VET:"!-<BX@0F]L9"X@4'5R<W5A;G0@=&\@
M=&AE('1E<FUS(&]F('1H92!#;VYS=6QT:6YG($%G<F5E;65N="P@37(N($)O
M;&0@:7,@97AP96-T960@=&\@<V5R=F4@;VX@82!P87)T+71I;64-"F)A<VES
M(&%N9"!W:6QL(')E8V5I=F4@86X@86YN=6%L(&9E92!O9B`D-3`L,#`P+"!P
M87EA8FQE(&EN(#$R(&5Q=6%L(&EN<W1A;&QM96YT<RP@=VAI8V@@:7,@<')O
M<F%T960@9F]R(&%N>2!P87)T:6%L(&UO;G1H<R!D=7)I;F<-"G1H92!T97)M
M(&]F('1H92!#;VYS=6QT:6YG($%G<F5E;65N="X@26X@861D:71I;VX@=&\@
M37(N($)O;&0F(S$T-CMS(&9E92P@:&4@=V%S(&ES<W5E9"!A('-T;V-K(&]P
M=&EO;B!T;R!P=7)C:&%S92!U<"!T;R`T,"PP,#`-"G-H87)E<R!O9B!O=7(@
M8V]M;6]N('-T;V-K("AT:&4@)B,Q-#<[3W!T:6]N(%-H87)E<R8C,30X.RD@
M870@82!P<FEC92!O9B`D,"XW-2!P97(@<VAA<F4@=&AE(&-L;W-I;F<@<')I
M8V4@;V8@;W5R(&-O;6UO;B!S=&]C:PT*87,@<75O=&5D(&]N('1H92!/5$-1
M0B!O;B!.;W9E;6)E<B`R.2P@,C`Q,RX@5&AE($]P=&EO;G,@4VAA<F5S(&UA
M>2!B92!E>&5R8VES960@;VX@82`F(S$T-SMC87-H;&5S<R!B87-I<R8C,30X
M.R!U<VEN9R!T:&4@9F]R;75L80T*8V]N=&%I;F5D('1H97)E:6X@86YD+"!S
M=6)J96-T('1O($UR+B!";VQD)B,Q-#8[<R!C;VYT:6YU960@<V5R=FEC92!A
M<R!O=7(@4')E<VED96YT(&%N9"!#:&EE9B!%>&5C=71I=F4@3V9F:6-E<BP@
M=F5S="!A<R!F;VQL;W=S.@T**&$I(#(P+#`P,"!/<'1I;VYS(%-H87)E<R!V
M97-T(&]N($1E8V5M8F5R(#$L(#(P,30[(&%N9"`H8BD@,C`L,#`P($]P=&EO
M;G,@4VAA<F5S('9E<W0@;VX@1&5C96UB97(@,2P@,C`Q-2X\+V9O;G0^/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^5&AE
M#0IF;VQL;W=I;F<@=&%B;&4@<W5M;6%R:7IE<R!S=&]C:R!O<'1I;VX@86-T
M:79I='D@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$S+CPO
M9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^/"]F;VYT/B8C,38P.SPO<#X-"@T*/'1A
M8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@=VED
M=&@Z(#$P,"4G/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VTG/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB
M<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^#0H\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#%P="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB
M<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CQB<B`O/@T*/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@
M("`@/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L
M86-K(#%P="!S;VQI9"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O
M/@T*/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/&)R("\^#0H\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\8CY/<'1I;VYS
M($]U='-T86YD:6YG/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/@T*/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M
M8F]T=&]M.B`Q<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\
M8G(@+SX-"CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT
M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q
M<'0@<V]L:60[('1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CQB<B`O/@T*/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB
M<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SX\8CY796EG:'1E9`T*079E<F%G92!%>&5R8VES
M92!0<FEC93PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W
M<F%P('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX-"CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O
M;3H@,7!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[
M/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^
M#0H\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@8V]L
M<W!A;CTS1#(@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M
M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQB/E=E:6=H
M=&5D#0I!=F5R86=E(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!,:69E("A996%R
M<RD\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@
M+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/&)R("\^#0H\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P
M="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N
M=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/@T*/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P86X]
M,T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9#L@
M=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/&)R("\^#0H\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/CQB/D%G9W)E9V%T90T*26YT<FEN<VEC(%9A;'5E/"]B/CPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G<&%D
M9&EN9RUB;W1T;VTZ(#%P="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB
M<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CQB<B`O/@T*/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H\
M+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A
M8VMG<F]U;F0M8V]L;W(Z("-#0T5%1D8G/@T*("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@-3,E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY"86QA;F-E($IA;G5A<GD@,2P@,C`Q
M,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E
M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E
M.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^+3PO9F]N=#X\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G=VED=&@Z(#$E
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`Q)2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@.24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXM/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL
M93TS1"=W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(')I
M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#DE.R!T97AT+6%L:6=N
M.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^+3PO9F]N=#X\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M.24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXM/"]F;VYT/CPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=W:61T:#H@
M,24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC
M;VQO<CH@=VAI=&4G/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY/<'1I;VYS(&=R
M86YT960\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@
M(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/C0S,"PP
M,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B0\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/C`N
M-S(\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^.2XU-3PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^3W!T:6]N<R!F;W)F96ET960\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B@S-3`L,#`P/"]F;VYT/CPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXI/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^,"XW,CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXY+C4P/"]F;VYT/CPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z
M('=H:71E)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^0F%L86YC92!$96-E;6)E
M<B`S,2P@,C`Q,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P
M="!D;W5B;&4G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U
M8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^.#`L,#`P/"]F
M;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@
M9&]U8FQE)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4[('1E
M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXP+C<P/"]F;VYT/CPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X="UA
M;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CDN-S4\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4G/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG
M:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/C(S+#(P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B
M86-K9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^17AE<F-I<V%B;&4@870@1&5C96UB97(@,S$L(#(P,3,\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/C(P+#`P,#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^,"XV-3PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXY+C4P/"]F;VYT/CPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT
M9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXV+#@P,#PO9F]N=#X\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CPO=&%B;&4^#0H\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T
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M9W)A;G1E9"!D=7)I;F<@,C`Q,R!W87,@87!P<F]X:6UA=&5L>2`D,"XT.2!T
M;R`D,"XU-R!P97(@<VAA<F4N($%S<W5M<'1I;VYS(')E9V%R9&EN9R!V;VQA
M=&EL:71Y+`T*97AP96-T960@=&5R;2P@9&EV:61E;F0@>6EE;&0@86YD(')I
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M97)I;V0@;V8@=&EM92!T:&%T(&]P=&EO;G,@9W)A;G1E9`T*87)E(&5X<&5C
M=&5D('1O(&)E(&]U='-T86YD:6YG+B!4:&4@87-S=6UP=&EO;G,@9F]R('9O
M;&%T:6QI='DL(&5X<&5C=&5D(&QI9F4L(&1I=FED96YD('EI96QD(&%N9"!R
M:7-K+69R964@:6YT97)E<W0@<F%T92!A<F4-"G!R97-E;G1E9"!I;B!T:&4@
M=&%B;&4@8F5L;W<Z/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\=&%B;&4@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!W:61T:#H@,3`P
M)2<^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`W-24G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,C4E.R!B
M;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@
M8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SX\8CXR,#$S/"]B/CPO9F]N=#X\+W1D/CPO
M='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C
M:V=R;W5N9"UC;VQO<CH@(T-#145&1B<^#0H@("`@/'1D/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/E=E:6=H=&5D(&%V97)A9V4@<FES:RUF<F5E(&EN=&5R97-T(')A=&4\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXQ+C0S("8C,34P.R`Q+C0Y)3PO9F]N=#X\+W1D/CPO
M='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C
M:V=R;W5N9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT9#X\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY%
M>'!E8W1E9"!L:69E(&EN('EE87)S/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^-2XP("8C
M,34P.R`U+C4@665A<G,\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-#
M0T5%1D8G/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY796EG:'1E9"!!=F<@17AP
M96-T960@5F]L871I;&ET>3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CDY+C4E("T@,3`S
M+C0E/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@
M/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/D5X<&5C=&5D(&1I=FED96YD('EI96QD/"]F;VYT
M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)#`\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SY$=7)I;F<@=&AE#0IY96%R(&5N9&5D($1E8V5M8F5R
M(#,Q+"`R,#$S+"!S=&]C:RUB87-E9"!C;VUP96YS871I;VX@97AP96YS92!O
M9B`D,34L-#0P+"!W87,@<F5C;V=N:7IE9"!A<R!G96YE<F%L(&%N9"!A9&UI
M;FES=')A=&EV92!E>'!E;G-E<RX-"E1H97)E('=E<F4@,C`L,#`P('-T;V-K
M(&]P=&EO;G,@=F5S=&5D(&%N9"`V,"PP,#`@=6YV97-T960L(&%S(&]F($1E
M8V5M8F5R(#,Q+"`R,#$S+B!4:&5R92!W87,@;F\@<W1O8VL@8V]M<&5N<V%T
M:6]N(&5X<&5N<V4@<F5C;V=N:7IE9`T*:6X@,C`Q,BX@07,@;V8@1&5C96UB
M97(@,S$L(#(P,3,L('1H92!#;VUP86YY(&AA9"`D,C<L,S$W(&]F('1O=&%L
M('5N<F5C;V=N:7IE9"!C;VUP96YS871I;VX@8V]S="!R96QA=&5D('1O('5N
M=F5S=&5D('-T;V-K(&]P=&EO;G,L#0IW:&EC:"!I<R!E>'!E8W1E9"!T;R!B
M92!R96-O9VYI>F5D(&)Y($1E8V5M8F5R(#,Q+"`R,#$U+CPO9F]N=#X\+W`^
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY4:&4@
M0V]M<&%N>0T*:7-S=65S(&YE=R!S:&%R97,@=VAE;B!O<'1I;VYS(&%R92!E
M>&5R8VES960N/"]F;VYT/CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F
M9#4T8C<W-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P
M-%]A-V$Y7S0Q9#%?838T.%\R9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E
M=#$S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%4D<^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M0V]M;6ET;65N=',\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO=&5S('1O($9I;F%N8VEA
M;"!3=&%T96UE;G1S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F]T92`V+B!#;VUM:71M96YT<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T>6QE/3-$)VUA<F=I;CH@,'!T)SX\
M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
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M96YE<F%T:6]N(%1E8VAN;VQO9WD@*&-O;&QE8W1I=F5L>2P-"G1H92`F(S$T
M-SM397)V:6-E<R8C,30X.RDN($EN(&-O;G-I9&5R871I;VX@;V8@=&AE(%-E
M<G9I8V5S+"!T:&4@0V]M<&%N>2!W:6QL('!A>2!696-T;W(@82!M;VYT:&QY
M(&-O;G-U;'1I;F<@9F5E(&]F("0U+#`P,"X-"E1H92!C;VYS=6QT:6YG(&%G
M<F5E;65N="!W:71H(%9E8W1O<B!C;VYT:6YU97,@=6YT:6P@1&5C96UB97(@
M,S$L(#(P,30L('5N;&5S<R!E87)L:65R('1E<FUI;F%T960@8GD@96ET:&5R
M('!A<G1Y('5P;VX@-2!D87ES('!R:6]R#0IW<FET=&5N(&YO=&EC92X\+W`^
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^26X@8V]N;F5C=&EO;B!W
M:71H('1H92!#;VUP86YY)B,Q-#8[<R!A;G1I8VEP871E9`T*4V5C=&EO;B`U
M,3`H:RD@<W5B;6ES<VEO;B!O9B!I=',@<')O<')I971A<GD@0V5L;"!$97!O
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M4W1E;4-E;&P@4WES=&5M<R!I;B!T:&4@86UO=6YT(&]F("0Q,S`L,#`P+"!F
M;W(@=VAI8V@@)#8U+#`P,"!W87,@<&%I9"!I;B!T:&4@=&AR964@;6]N=&AS
M(&5N9&5D($IU;F4@,S`L#0HR,#$T+B!4:&4@<F5M86EN:6YG('!A>6UE;G1S
M(&%R92!D=64@<')I;W(@=&\@1&5C96UB97(@,S$L(#(P,30L('1H92!E>&%C
M="!T:6UI;F<@;V8@=VAI8V@@:7,@9&5P96YD96YT(&]N('=H96X@=&AE('=O
M<FL@:7,@<&5R9F]R;65D+CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XU:6XG/B8C,38P
M.SPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SY3964@86QS;R`F(S$T-SM.;W1E(#8N(%)E;&%T960@4&%R='D@5')A
M;G-A8W1I;VYS+B8C,30X.SPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT
M+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY/;@T*2G5N92`R-RP@,C`Q
M,BP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&%N($%T+5=I;&P@17AE8W5T
M:79E(%-E<G9I8V5S($%G<F5E;65N="`H=&AE("8C,30W.T)I96X@4V5R=FEC
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M;V8@4V5P=&5M8F5R(#,P+"`R,#$S+B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY/;@T*1F5B<G5A
M<GD@,34L(#(P,3,L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A;B!A9W)E
M96UE;G0@=VET:"!+96YN971H($MI<FML86YD+"!0:"Y$+B`H=&AE("8C,30W
M.TMI<FML86YD($%"($%G<F5E;65N="8C,30X.RD-"G!U<G-U86YT('1O('=H
M:6-H($1R+B!+:7)K;&%N9"!W:6QL('-E<G9E(&%S(&$@;65M8F5R(&]F('1H
M92!#;VUP86YY)B,Q-#8[<R!!9'9I<V]R>2!";V%R9"X@5&AE($MI<FML86YD
M($%"($%G<F5E;65N="!P<F]V:61E<PT*9F]R(&$@;6]N=&AL>2!F964@;V8@
M)#(L,#`P(&%N9"!M87D@8F4@=&5R;6EN871E9"!B>2!E:71H97(@<&%R='D@
M=VET:"!A(&9I=F4@9&%Y(&YO=&EC92X@5&AE($MI<FML86YD($%"($%G<F5E
M;65N="!W87,@=&5R;6EN871E9`T*969F96-T:79E(&%S(&]F($IU;F4@,S`L
M(#(P,3,N/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT
M+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/D]N#0I!=6=U<W0@,2P@,C`Q,RP@=&AE($-O;7!A;GD@
M96YG86=E9"!696-T;W(@=&\@87-S:7-T('1H92!#;VUP86YY('=I=&@@:61E
M;G1I9GEI;F<@<W5B:F5C="!M871T97(@97AP97)T<R!I;B!T:&4@;65D:6-A
M;"!D979I8V4-"F%N9"!B:6]T96-H;F]L;V=Y(&EN9'5S=')I97,@86YD('1O
M(&%S<VES="!T:&4@0V]M<&%N>2!W:71H(&ET<R!O;F=O:6YG(')E<V5A<F-H
M+"!D979E;&]P;65N="!A;F0@979E;G1U86P@8V]M;65R8VEA;&EZ871I;VX@
M;V8-"FET<R!296=E;F5R871I;VX@5&5C:&YO;&]G>2`H8V]L;&5C=&EV96QY
M+"!T:&4@)B,Q-#<[4V5R=FEC97,F(S$T.#LI+B!);B!C;VYS:61E<F%T:6]N
M(&]F('1H92!397)V:6-E<RP@=&AE($-O;7!A;GD@=VEL;"!P87D-"E9E8W1O
M<B!A(&UO;G1H;'D@8V]N<W5L=&EN9R!F964@;V8@1FEV92!4:&]U<V%N9"!$
M;VQL87)S("@D-2PP,#`I+B!4:&4@8V]N<W5L=&EN9R!A9W)E96UE;G0@=VET
M:"!696-T;W(@8V]N=&EN=65S('5N=&EL($1E8V5M8F5R#0HS,2P@,C`Q-"P@
M=6YL97-S(&5A<FQI97(@=&5R;6EN871E9"!B>2!E:71H97(@<&%R='D@=7!O
M;B!F:79E("@U*2!D87ES('!R:6]R('=R:71T96X@;F]T:6-E+CPO9F]N=#X\
M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF
M>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY/
M;@T*3V-T;V)E<B`Q+"`R,#$S+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@
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M-#`P(&%N9"!R96EM8G5R<V5D(&9O<B!A;GD@8G5S:6YE<W,@<F5L871E9"!E
M>'!E;G-E<RX\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\
M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF
M>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^169F96-T:79E#0I$96-E;6)E<B`Q+"`R,#$S+"!W
M92!A<'!O:6YT960@37(N($)O;&0@87,@;W5R(%!R97-I9&5N="`F(S,X.R!#
M14\@86YD(&5N=&5R960@:6YT;R!T:&4@0V]N<W5L=&EN9R!!9W)E96UE;G0@
M=VET:"!-<BX@0F]L9"X@4'5R<W5A;G0-"G1O('1H92!T97)M<R!O9B!T:&4@
M0V]N<W5L=&EN9R!!9W)E96UE;G0L($UR+B!";VQD(&ES(&5X<&5C=&5D('1O
M('-E<G9E(&]N(&$@<&%R="UT:6UE(&)A<VES(&%N9"!W:6QL(')E8V5I=F4@
M86X@86YN=6%L(&9E92!O9@T*)#4P+#`P,"P@<&%Y86)L92!I;B`Q,B!E<75A
M;"!I;G-T86QL;65N=',L('=H:6-H(&ES('!R;W)A=&5D(&9O<B!A;GD@<&%R
M=&EA;"!M;VYT:',@9'5R:6YG('1H92!T97)M(&]F('1H92!#;VYS=6QT:6YG
M($%G<F5E;65N="X-"DEN(&%D9&ET:6]N('1O($UR+B!";VQD)B,Q-#8[<R!F
M964L(&AE('=A<R!I<W-U960@3W!T:6]N(%-H87)E<R!T;R!P=7)C:&%S92!U
M<"!T;R`T,"PP,#`@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@870@82!P
M<FEC90T*;V8@)#`N-S4@<&5R('-H87)E('1H92!C;&]S:6YG('!R:6-E(&]F
M(&]U<B!C;VUM;VX@<W1O8VL@87,@<75O=&5D(&]N('1H92!/5$-10B!O;B!.
M;W9E;6)E<B`R.2P@,C`Q,RX@5&AE($]P=&EO;G,@4VAA<F5S(&UA>2!B90T*
M97AE<F-I<V5D(&]N(&$@)B,Q-#<[8V%S:&QE<W,@8F%S:7,F(S$T.#L@=7-I
M;F<@=&AE(&9O<FUU;&$@8V]N=&%I;F5D('1H97)E:6X@86YD+"!S=6)J96-T
M('1O($UR+B!";VQD)B,Q-#8[<R!C;VYT:6YU960@<V5R=FEC90T*87,@;W5R
M(%!R97-I9&5N="!A;F0@0VAI968@17AE8W5T:79E($]F9FEC97(L('9E<W0@
M87,@9F]L;&]W<SH@*&$I(#(P+#`P,"!/<'1I;VYS(%-H87)E<R!V97-T(&]N
M($1E8V5M8F5R(#$L(#(P,30[(&%N9"`H8BD@,C`L,#`P#0I/<'1I;VYS(%-H
M87)E<R!V97-T(&]N($1E8V5M8F5R(#$L(#(P,34N/"]F;VYT/CPO<#X-"@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=M87)G
M:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/E-E92!A
M;'-O("8C,30W.TYO=&4@-RX@4F5L871E9"!087)T>0T*5')A;G-A8W1I;VYS
M)B,Q-#@[+CPO9F]N=#X\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
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M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P15)'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E)E
M;&%T960@4&%R='D@5')A;G-A8W1I;VYS/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.;W1E
M<R!T;R!&:6YA;F-I86P@4W1A=&5M96YT<SPO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO=&4@-RX@4F5L871E9"!087)T
M>2!4<F%N<V%C=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<"!S='EL93TS1"=M87)G:6XZ(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF
M>2<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU
M<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/D%S#0IC;VUP96YS871I;VX@9F]R('1H96ER
M('-E<G9I8V4@;VX@=&AE($)O87)D+"!$<BX@2VER:VQA;F0@86YD($UR+B!3
M:65R8VAI;R!W:6QL(')E8V5I=F4@86X@86YN=6%L(')E=&%I;F5R(&]F("0V
M+#`P,"P@<&%Y86)L90T*:6X@97%U86P@>65A<FQY(&EN<W1A;&QM96YT<R!I
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M"G!U<F-H87-E('5P('1O(#(P+#`P,"!S:&%R97,@;V8@=&AE($-O;7!A;GDF
M(S$T-CMS(&-O;6UO;B!S=&]C:R!A="!A;B!E>&5R8VES92!P<FEC92!O9B`D
M,"XV-2!P97(@<VAA<F4L('1H92!C;&]S:6YG('!R:6-E(&]F#0IT:&4@0V]M
M<&%N>28C,30V.W,@8V]M;6]N('-T;V-K(&%S('%U;W1E9"!O;B!T:&4@3U1#
M($UA<FME=',@1W)O=7`@26YC+B!10B!T:65R("AT:&4@)B,Q-#<[3U1#44(F
M(S$T.#LI(&]N($IU;'D@,S$L(#(P,3,L('!U<G-U86YT#0IT;R!T:&4@26YC
M96YT:79E(%!L86XN(%-U8FIE8W0@=&\@=&AE:7(@8V]N=&EN=65D('-E<G9I
M8V4@87,@82!M96UB97(@;V8@=&AE($)O87)D+"`Q,"PP,#`@;V8@=&AE(&]P
M=&EO;B!S:&%R97,@=F5S="!I;6UE9&EA=&5L>0T*86YD(#$P+#`P,"!O9B!T
M:&4@;W!T:6]N('-H87)E<R!V97-T(&]N('1H92!F:7)S="!A;FYI=F5R<V%R
M>2!O9B!D871E(&]F(&=R86YT+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#`N
M-6EN)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/D5F9F5C=&EV90T*4V5P=&5M8F5R(#,P+"`R,#$S+"!-<RX@4F]S96X@<F5S
M:6=N960@87,@4')E<VED96YT(&%N9"!#:&EE9B!%>&5C=71I=F4@3V9F:6-E
M<B!A;F0@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&%N($%T+5=I;&P@17AE
M8W5T:79E#0I397)V:6-E<R!!9W)E96UE;G0@*'1H92`F(S$T-SM2;W-E;B!3
M97)V:6-E<R!!9W)E96UE;G0F(S$T.#LI+"!P=7)S=6%N="!T;R!W:&EC:"!-
M<RX@4F]S96X@=VEL;"!S97)V92!A<R!T:&4@0V]M<&%N>28C,30V.W,-"D-H
M:65F($9I;F%N8VEA;"!/9F9I8V5R+B!0=7)S=6%N="!T;R!T:&4@4F]S96X@
M4V5R=FEC97,@06=R965M96YT+"!-<RX@4F]S96X@=VEL;"!P<F]V:61E('1H
M92!#;VUP86YY('=I=&@@<V5R=FEC97,@8V]N<VES=&5N=`T*=VET:"!T:&%T
M(&]F(&$@0VAI968@1FEN86YC:6%L($]F9FEC97(@;VX@82!P87)T+71I;64@
M8F%S:7,L(&9O<B!W:&EC:"!S:&4@=VEL;"!B92!P86ED(&$@;6]N=&AL>2!F
M964@;V8@)#(L-#`P(&%N9"!W:6QL(&)E(')E:6UB=7)S960-"F9O<B!A;GD@
M8G5S:6YE<W,@<F5L871E9"!E>'!E;G-E<RX@5&AE(%)O<V5N(%-E<G9I8V5S
M($%G<F5E;65N="!I<R!T97)M:6YA8FQE(&)Y(&5I=&AE<B!T:&4@0V]M<&%N
M>2!O<B!-<RX@4F]S96X@=7!O;B!A9'9A;F-E#0IW<FET=&5N(&YO=&EC92X\
M+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P+C5I;B<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L
M:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY/;@T*3F]V96UB97(@,CDL(#(P
M,3,L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A('-U8G-C<FEP=&EO;B!A
M9W)E96UE;G0@=VET:"!+86QE;B!#87!I=&%L($-O<G!O<F%T:6]N("AT:&4@
M)B,Q-#<[26YV97-T;W(F(S$T.#LI+`T*82!P<FEV871E($%L8F5R=&$@8V]R
M<&]R871I;VX@=VAO;&QY(&]W;F5D(&)Y($UR+B!(87)M96P@4RX@4F%Y870@
M86YD(&$@;6%J;W)I='D@<VAA<F5H;VQD97(@;V8@=&AE($-O;7!A;GDF(S$T
M-CMS+"!P=7)S=6%N=`T*=&\@=VAI8V@@=&AE($EN=F5S=&]R('!U<F-H87-E
M9"`S+#4P,"PP,#`@56YI=',@870@82!P=7)C:&%S92!P<FEC92!O9B`D,"XT
M,R!P97(@56YI="P@9F]R(&%N(&%G9W)E9V%T92!P=7)C:&%S92!A;6]U;G0@
M;V8@)#$L-3`U+#`P,"X-"D5A8V@@56YI="!C;VYS:7-T<R!O9CH@*&$I(&]N
M92!S:&%R92!O9B!C;VUM;VX@<W1O8VL[("AB*2!O;F4@4V5R:65S($(@5V%R
M<F%N="!E>&5R8VES86)L92!F;W(@;VYE('-H87)E(&]F($-O;6UO;B!3=&]C
M:R!A="!A;@T*97AE<F-I<V4@<')I8V4@;V8@)#`N-#,@<&5R('-H87)E(&EF
M(&5X97)C:7-E9"!W:71H:6X@=&AE(&9I<G-T(&5I9VAT965N(&UO;G1H<R!O
M<B`D,"XT-B!P97(@<VAA<F4@:68@97AE<F-I<V5D(&%F=&5R('1H92!F:7)S
M=`T*96EG:'1E96X@;6]N=&AS(&%N9"!P<FEO<B!T;R!E>'!I<F%T:6]N(&]N
M($YO=F5M8F5R(#(Y+"`R,#$X.R!A;F0@*&,I(&]N92!397)I97,@0R!787)R
M86YT(&5X97)C:7-A8FQE(&9O<B!O;F4@<VAA<F4@;V8@8V]M;6]N#0IS=&]C
M:R!A="!A;B!E>&5R8VES92!P<FEC92!O9B`D,"XT,R!P97(@<VAA<F4@:68@
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M(&9O<G1H('1H97)E:6XN(%1H92!5;FET#0IP<FEC92!O9B`D,"XT,R!R97!R
M97-E;G1S(&$@,S`E(&1I<V-O=6YT('1O('1H92`R,"!D87D@879E<F%G92!C
M;&]S:6YG('!R:6-E(&]F('1H92!#;VUM;VX@4W1O8VL@87,@<75O=&5D(&]N
M('1H92!/5$-10B!A<R!O9@T*3V-T;V)E<B`S,2P@,C`Q,RP@=&AE(&QA<W0@
M=')A9&EN9R!D871E('!R:6]R('1O('5S(&5N=&5R:6YG(&EN=&\@82!N;VXM
M8FEN9&EN9R!T97)M('-H965T('=I=&@@=&AE($EN=F5S=&]R(')E9V%R9&EN
M9R!T:&4@<'5R8VAA<V4-"F]F('1H92!5;FET<RX\+V9O;G0^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M
M:6YD96YT.B`P+C5I;B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SY/;@T*1&5C96UB97(@,2P@,C`Q,RP@=&AE($-O;7!A;GD@
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M#0IA;FYU86P@9F5E(&]F("0U,"PP,#`L('!A>6%B;&4@:6X@,3(@97%U86P@
M:6YS=&%L;&UE;G1S+"!W:&EC:"!I<R!P<F]R871E9"!F;W(@86YY('!A<G1I
M86P@;6]N=&AS(&1U<FEN9R!T:&4@=&5R;2!O9B!T:&4@0V]N<W5L=&EN9PT*
M06=R965M96YT+B!);B!A9&1I=&EO;B!T;R!-<BX@0F]L9"8C,30V.W,@9F5E
M+"!H92!W87,@:7-S=65D($]P=&EO;B!3:&%R97,@=&\@<'5R8VAA<V4@=7`@
M=&\@-#`L,#`P('-H87)E<R!O9B!T:&4@0V]M<&%N>28C,30V.W,-"F-O;6UO
M;B!S=&]C:R!A="!A('!R:6-E(&]F("0P+C<U('!E<B!S:&%R92!T:&4@8VQO
M<VEN9R!P<FEC92!O9B!T:&4@0V]M<&%N>28C,30V.W,@8V]M;6]N('-T;V-K
M(&%S('%U;W1E9"!O;B!T:&4@3U1#44(@;VX@3F]V96UB97(-"C(Y+"`R,#$S
M+B!4:&4@3W!T:6]N<R!3:&%R97,@;6%Y(&)E(&5X97)C:7-E9"!O;B!A(&-A
M<VAL97-S(&)A<VES('5S:6YG('1H92!F;W)M=6QA(&-O;G1A:6YE9"!T:&5R
M96EN(&%N9"P@<W5B:F5C="!T;R!-<BX@0F]L9"8C,30V.W,-"F-O;G1I;G5E
M9"!S97)V:6-E(&%S('1H92!#;VUP86YY)B,Q-#8[<R!0<F5S:61E;G0@86YD
M($-H:65F($5X96-U=&EV92!/9F9I8V5R+"!V97-T(&%S(&9O;&QO=W,L(#(P
M+#`P,"!/<'1I;VYS(%-H87)E<R!O;CH@*&$I#0I$96-E;6)E<B`Q+"`R,#$T
M.R!A;F0@*&(I($1E8V5M8F5R(#$L(#(P,34N/"]F;VYT/CPO<#X-"@T*/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN
M9&5N=#H@,"XU:6XG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^3VX-"D1E8V5M8F5R(#,Q+"`R,#$S+"!T:&4@0V]M<&%N>2!C
M;VUP;&5T960@=&AE('-A;&4@;V8@,3`P)2!O9B!T:&4@:7-S=65D(&%N9"!O
M=71S=&%N9&EN9R!S:&%R97,@;V8@1F]S='5N9R!297-O=7)C97,@=&\@1'5K
M92!F;W(-"F$@<')O;6ES<V]R>2!N;W1E(&EN('1H92!A;6]U;G0@;V8@)#@P
M+#`P,"P@=VAI8V@@86UO=6YT(&%P<')O>&EM871E9"!T:&4@9F%I<B!V86QU
M92!O9B!T:&4@;&5A<V5S(&%N9"!M:6YI;F<@8VQA:6US(&-O;G1R;VQL960-
M"F)Y($9O<W1U;F<@4F5S;W5R8V5S+"!A<R!C;VYC;'5D960@8GD@86X@:6YD
M97!E;F1E;G0@=&AI<F0M<&%R='D@9V5O;&]G:6-A;"!C;VYS=6QT86YT+B!0
M<FEN8VEP86P@86YD(&EN=&5R97-T(&%T(#0N,"4@87)E('!A>6%B;&4-"F]N
M($1E8V5M8F5R(#,Q+"`R,#$U+B!-<BX@2&5R9&5V(%,N(%)A>6%T+"!T:&4@
M;6%J;W)I='D@<VAA<F5H;VQD97(@;V8@1'5K92P@:7,@=&AE(&)R;W1H97(@
M;V8@37(N($AA<FUE;"!3+B!287EA="P@=&AE($-O;7!A;GDF(S$T-CMS#0IM
M86IO<FET>2!S:&%R96AO;&1E<BX\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P
M+C5I;B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SY/;@T*07!R:6P@,2P@,C`Q-"P@=&AE($-O;7!A;GD@87!P;VEN=&5D($US
M+B!0871S>2!4<FES;&5R(&%S(&ET<R!6:6-E(%!R97-I9&5N="`F(S$U,#L@
M0VQI;FEC86P@)B,S.#L@4F5G=6QA=&]R>2!!9F9A:7)S(&%N9"!E;G1E<F5D
M#0II;G1O('1H92!4<FES;&5R($-O;G-U;'1I;F<@06=R965M96YT('=I=&@@
M37,N(%1R:7-L97(N(%!U<G-U86YT('1O('1H92!T97)M<R!O9B!T:&4@5')I
M<VQE<B!#;VYS=6QT:6YG($%G<F5E;65N="P@37,N(%1R:7-L97(-"G=I;&P@
M<F5C96EV92!A(&UO;G1H;'D@9F5E(&]F("0U+#`P,"P@=VAI8V@@8V]V97)S
M(&AE<B!S97)V:6-E<R!F;W(@=7`@=&\@-#`@:&]U<G,@:6X@86YY(&=I=F5N
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M87)E<R!T;R!P=7)C:&%S92!U<`T*=&\@-3`L,#`P('-H87)E<R!O9B!T:&4@
M0V]M<&%N>28C,30V.W,@8V]M;6]N('-T;V-K(&%T(&$@<')I8V4@;V8@)#$N
M,#4@<&5R('-H87)E+"!T:&4@8VQO<VEN9R!P<FEC92!O9B!T:&4@0V]M<&%N
M>28C,30V.W,@8V]M;6]N#0IS=&]C:R!A<R!Q=6]T960@;VX@=&AE($]40U%"
M(&]N($UA<F-H(#,Q+"`R,#$T+B!4:&4@3W!T:6]N<R!3:&%R97,@;6%Y(&)E
M(&5X97)C:7-E9"!O;B!A("8C,30W.V-A<VAL97-S(&)A<VES)B,Q-#@[('5S
M:6YG('1H90T*9F]R;75L82!C;VYT86EN960@=&AE<F5I;B!A;F0L('-U8FIE
M8W0@=&\@37,N(%1R:7-L97(F(S$T-CMS(&-O;G1I;G5E9"!S97)V:6-E(&%S
M('1H92!#;VUP86YY)B,Q-#8[<R!6:6-E(%!R97-I9&5N="`F(S$U,#L-"D-L
M:6YI8V%L("8C,S@[(%)E9W5L871O<GD@069F86ER<RP@=F5S="!A<R!F;VQL
M;W=S+"`Q,"PP,#`@3W!T:6]N<R!3:&%R97,@;VXZ("AA*2!!<')I;"`Q+"`R
M,#$U.R`H8BD@07!R:6P@,2P@,C`Q-CL@*&,I($%P<FEL#0HQ+"`R,#$W.R`H
M9"D@07!R:6P@,2P@,C`Q.#L@86YD("AE*2!!<')I;"`Q+"`R,#$Y+CPO9F]N
M=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#LF
M(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D]N#0I!<')I;"`R,"P@,C`Q
M-"P@=&AE($-O;7!A;GD@87!P;VEN=&5D($%N9')E=R!$86YI96QS;VX@87,@
M:71S($1I<F5C=&]R(&]F($)U<VEN97-S($1E=F5L;W!M96YT(&%T(&%N(&%N
M;G5A;"!S86QA<GD@;V8@)#8P+#`P,"X-"DEN(&%D9&ET:6]N($UR+B!$86YI
M96QS;VX@=V%S(&ES<W5E9"!/<'1I;VX@4VAA<F5S('1O('!U<F-H87-E(#4L
M,#`P('-H87)E<R!O9B!T:&4@0V]M<&%N>28C,30V.W,@8V]M;6]N('-T;V-K
M(&%T(&$@<')I8V4@;V8-"B0Q+C`U('!E<B!S:&%R92P@=&AE(&-L;W-I;F<@
M<')I8V4@;V8@=&AE($-O;7!A;GDF(S$T-CMS(&-O;6UO;B!S=&]C:R!A<R!Q
M=6]T960@;VX@=&AE($]40U%"(&]N($%P<FEL(#$W+"`R,#$T+B!4:&4@3W!T
M:6]N<R!3:&%R97,-"FUA>2!B92!E>&5R8VES960@;VX@82`F(S$T-SMC87-H
M;&5S<R!B87-I<R8C,30X.R!U<VEN9R!T:&4@9F]R;75L82!C;VYT86EN960@
M=&AE<F5I;B!A;F0L('-U8FIE8W0@=&\@37(N($1A;FEE;'-O;B8C,30V.W,@
M8V]N=&EN=65D#0IS97)V:6-E('=I=&@@=&AE($-O;7!A;GDN(%1H92!/<'1I
M;VYS(%-H87)E<R!V97-T(&]N($%P<FEL(#(P+"`R,#$U+CPO9F]N=#X\+W`^
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^/"]F;VYT/B8C,38P.SPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY&;W(-
M"G1H92!T:')E92!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q-"P@9&ER96-T
M;W)S)B,Q-#8[(&%N9"!M86YA9V5M96YT(&9E97,L(&-O;G-U;'1I;F<@9F5E
M<R!A;F0@<F5I;6)U<G-E;65N="!O9B!E>'!E;G-E<R!P86ED#0IT;R!O9F9I
M8V5R<R!A;F0@9&ER96-T;W)S(&]F('1H92!#;VUP86YY('=E<F4@)#,L,#`P
M("@R,#$S.B`D,"DN($9O<B!T:&4F(S$V,#MS:7@@;6]N=&AS(&5N9&5D($IU
M;F4@,S`L(#(P,30L(&1I<F5C=&]R<R8C,30V.PT*86YD(&UA;F%G96UE;G0@
M9F5E<RP@8V]N<W5L=&EN9R!F965S(&%N9"!R96EM8G5R<V5M96YT(&]F(&5X
M<&5N<V5S('!A:60@=&\@;V9F:6-E<G,@86YD(&1I<F5C=&]R<R!O9B!T:&4@
M0V]M<&%N>2!W87,@)#8L,#`P("@R,#$S.@T*)#`I+B!,96=A;"!F965S('!A
M:60@=&\@;VYE(&]F('1H92!#;VUP86YY)B,Q-#8[<R!D:7)E8W1O<G,@:6X@
M=&AE('1H<F5E(&UO;G1H<R!E;F1E9"!*=6YE(#,P+"`R,#$T('=E<F4@)#(W
M+#@R,"`H,C`Q,SH@)#,X+#DW-"DN#0I,96=A;"!F965S('!A:60@=&\@;VYE
M(&]F('1H92!#;VUP86YY)B,Q-#8[<R!D:7)E8W1O<G,@:6X@=&AE)B,Q-C`[
M<VEX(&UO;G1H<R!E;F1E9"!*=6YE(#,P+"`R,#$T('=E<F4@)#@R+#$X-2`H
M,C`Q,SH@)#8R+#0S.2DN#0I!;6]U;G1S(&EN8VQU9&5D(&EN(&%C8V]U;G1S
M('!A>6%B;&4@86YD(&%C8W)U960@97AP96YS97,L(&%N9"!D=64@=&\@<F5L
M871E9"!P87)T:65S+"!A="!*=6YE(#,P+"`R,#$T('=E<F4@)#,V+#`X,"`H
M,C`Q,SH@)#0L.#`P*2X\+V9O;G0^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[
M('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D5F9F5C=&EV90T*
M87,@;V8@2G5N92`Q.2P@,C`Q,BP@37(N($IO<V5P:"!3:65R8VAI;RP@82!M
M96UB97(@;V8@=&AE($-O;7!A;GDF(S$T-CMS($)O87)D+"!W87,@87!P;VEN
M=&5D(&%S(&ET<R!!8W1I;F<@26YT97)I;2!0<F5S:61E;G0-"F%N9"!#:&EE
M9B!%>&5C=71I=F4@3V9F:6-E<CL@86YD(&5F9F5C=&EV92!A<R!O9B!*=6YE
M(#(W+"`R,#$R+"!-<RX@2F%N970@0FEE;B!W87,@87!P;VEN=&5D(&%S('1H
M92!#;VUP86YY)B,Q-#8[<R!#:&EE9B!&:6YA;F-I86P-"D]F9FEC97(N/"]F
M;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/D]N#0I*=6YE(#(P+"`R,#$S+"!-<BX@2F]S97!H(%-I97)C:&EO+"!R
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M86X@96UP;&]Y;65N="!A9W)E96UE;G0@9F]R(&$@='=O('EE87(@=&5R;2`H
M=&AE("8C,30W.U)O<V5N($5M<&QO>6UE;G0@06=R965M96YT)B,Q-#@[*2P@
M<W5B:F5C="!T;R!T:&4@96%R;&EE<B!T97)M:6YA=&EO;@T*<')O=FES:6]N
M<R!C;VYT86EN960@=&AE<F5I;BX@4'5R<W5A;G0@=&\@=&AE('1E<FUS(&]F
M('1H92!2;W-E;B!%;7!L;WEM96YT($%G<F5E;65N="P@37,N(%)O<V5N('=A
M<R!P86ED(&%N(&%N;G5A;"!S86QA<GD@;V8-"B0Q,C`L,#`P+B!);B!A9&1I
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M9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SY/;@T*2G5L>2`R.2P@,C`Q,RP@=&AE($)O87)D(&%P<&]I;G1E9"!$
M<BX@2V5N;F5T:"!+:7)K;&%N9"!T;R!S97)V92!A<R!A(&UE;6)E<B!O9B!T
M:&4@0F]A<F0@969F96-T:79E($%U9W5S="`Q+"`R,#$S+B!0<FEO<B!T;R!T
M:&ES#0IA<'!O:6YT;65N="P@1'(N($MI<FML86YD(')E<VEG;F5D(&9R;VT@
M=&AE($-O;7!A;GDF(S$T-CMS($%D=FES;W)Y($)O87)D+B!3964@)B,Q-#<[
M3F]T92`V+B!#;VUM:71M96YT<R8C,30X.RX\+V9O;G0^/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P
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M<F5T86EN97(@;V8@)#8L,#`P+"!P87EA8FQE#0II;B!E<75A;"!Y96%R;'D@
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M8VL@;W!T:6]N<R!T;PT*<'5R8VAA<V4@=7`@=&\@,C`L,#`P('-H87)E<R!O
M9B!O=7(@8V]M;6]N('-T;V-K(&%T(&%N(&5X97)C:7-E('!R:6-E(&]F("0P
M+C8U('!E<B!S:&%R92P@=&AE(&-L;W-I;F<@<')I8V4@;V8@=&AE($-O;7!A
M;GDF(S$T-CMS#0IC;VUM;VX@<W1O8VL@87,@<75O=&5D(&]N('1H92!/5$,@
M36%R:V5T<R!'<F]U<"!);F,N(%%"('1I97(@*'1H92`F(S$T-SM/5$-10B8C
M,30X.RD@;VX@2G5L>2`S,2P@,C`Q,RP@<'5R<W5A;G0@=&\@=&AE($EN8V5N
M=&EV90T*4&QA;BX@4W5B:F5C="!T;R!T:&5I<B!C;VYT:6YU960@<V5R=FEC
M92!A<R!A(&UE;6)E<B!O9B!T:&4@0F]A<F0L(#$P+#`P,"!O9B!T:&4@;W!T
M:6]N('-H87)E<R!V97-T(&EM;65D:6%T96QY(&%N9"`Q,"PP,#`@;V8-"G1H
M92!O<'1I;VX@<VAA<F5S('9E<W0@;VX@=&AE(&9I<G-T(&%N;FEV97)S87)Y
M(&]F(&1A=&4@;V8@9W)A;G0N/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI
M9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D5F9F5C=&EV90T*4V5P=&5M8F5R
M(#,P+"`R,#$S+"!-<RX@0FEE;B!R97-I9VYE9"!A<R!T:&4@0V]M<&%N>28C
M,30V.W,@0VAI968@1FEN86YC:6%L($]F9FEC97(N($5F9F5C=&EV92!397!T
M96UB97(@,S`L(#(P,3,L($US+B!2;W-E;@T*<F5S:6=N960@87,@4')E<VED
M96YT(&%N9"!#:&EE9B!%>&5C=71I=F4@3V9F:6-E<BP@=&AE(%)O<V5N($5M
M<&QO>6UE;G0@06=R965M96YT('=A<R!T97)M:6YA=&5D(&%N9"!T:&4@0V]M
M<&%N>2!E;G1E<F5D(&EN=&\-"F%N($%T+5=I;&P@17AE8W5T:79E(%-E<G9I
M8V5S($%G<F5E;65N="`H=&AE("8C,30W.U)O<V5N(%-E<G9I8V5S($%G<F5E
M;65N="8C,30X.RDL('!U<G-U86YT('1O('=H:6-H($US+B!2;W-E;B!W:6QL
M('-E<G9E(&%S#0IT:&4@0V]M<&%N>28C,30V.W,@0VAI968@1FEN86YC:6%L
M($]F9FEC97(N(%!U<G-U86YT('1O('1H92!2;W-E;B!397)V:6-E<R!!9W)E
M96UE;G0L($US+B!2;W-E;B!W:6QL('!R;W9I9&4@=&AE($-O;7!A;GD@=VET
M:`T*<V5R=FEC97,@8V]N<VES=&5N="!W:71H('1H870@;V8@82!#:&EE9B!&
M:6YA;F-I86P@3V9F:6-E<B!O;B!A('!A<G0M=&EM92!B87-I<RP@9F]R('=H
M:6-H('-H92!W:6QL(&)E('!A:60@82!M;VYT:&QY(&9E92!O9B`D,BPT,#`-
M"F%N9"!W:6QL(&)E(')E:6UB=7)S960@9F]R(&%N>2!B=7-I;F5S<R!R96QA
M=&5D(&5X<&5N<V5S+B!4:&4@4F]S96X@4V5R=FEC97,@06=R965M96YT(&ES
M('1E<FUI;F%B;&4@8GD@96ET:&5R('1H92!#;VUP86YY(&]R#0I-<RX@4F]S
M96X@=7!O;B!A9'9A;F-E('=R:71T96X@;F]T:6-E+B!4:&4@:6YC96YT:79E
M('-T;V-K(&]P=&EO;G,@=&\@<'5R8VAA<V4@=7`@=&\@,S4P+#`P,"!S:&%R
M97,@;V8@=&AE($-O;7!A;GDF(S$T-CMS(&-O;6UO;@T*<W1O8VL@870@86X@
M97AE<F-I<V4@<')I8V4@;V8@)#`N-S(@<&5R('-H87)E+"!P<F5V:6]U<VQY
M(&ES<W5E9"!T;R!-<RX@4F]S96XL('=E<F4@9F]R9F5I=&5D(&5F9F5C=&EV
M92!397!T96UB97(@,S`L(#(P,3,N/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D5F9F5C=&EV90T*4V5P=&5M
M8F5R(#,P+"`R,#$S+"!-<BX@4VEE<F-H:6\@<F5S=6UE9"!T:&4@<&]S:71I
M;VX@;V8@06-T:6YG($EN=&5R:6T@4')E<VED96YT(&%N9"!#:&EE9B!%>&5C
M=71I=F4@3V9F:6-E<BX\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO
M9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@
M:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^3VX-"DYO=F5M8F5R(#(Y+"`R,#$S+"!W
M92!E;G1E<F5D(&EN=&\@82!S=6)S8W)I<'1I;VX@86=R965M96YT('=I=&@@
M=&AE($EN=F5S=&]R+"!A('!R:79A=&4@06QB97)T82!C;W)P;W)A=&EO;B!W
M:&]L;'D@;W=N960@8GD@37(N#0I(87)M96P@4F%Y870@86YD(&$@;6%J;W)I
M='D@<VAA<F5H;VQD97(@;V8@;W5R<RP@<'5R<W5A;G0@=&\@=VAI8V@@=&AE
M($EN=F5S=&]R('!U<F-H87-E9"`S+#4P,"PP,#`@56YI=',@870@82!P=7)C
M:&%S92!P<FEC90T*;V8@)#`N-#,@<&5R(%5N:70L(&9O<B!A;B!A9V=R96=A
M=&4@<'5R8VAA<V4@86UO=6YT(&]F("0Q+#4P-2PP,#`N($5A8V@@56YI="!C
M;VYS:7-T<R!O9CH@*&$I(&]N92!S:&%R92!O9B!#;VUM;VX@4W1O8VL[("AB
M*2!O;F4-"E-E<FEE<R!"(%=A<G)A;G0@97AE<F-I<V%B;&4@9F]R(&]N92!S
M:&%R92!O9B!#;VUM;VX@4W1O8VL@870@86X@97AE<F-I<V4@<')I8V4@;V8@
M)#`N-#,@<&5R('-H87)E(&EF(&5X97)C:7-E9"!W:71H:6X@=&AE(&9I<G-T
M#0IE:6=H=&5E;B!M;VYT:',@;W(@)#`N-#8@<&5R('-H87)E(&EF(&5X97)C
M:7-E9"!A9G1E<B!T:&4@9FER<W0@96EG:'1E96X@;6]N=&AS(&%N9"!P<FEO
M<B!T;R!E>'!I<F%T:6]N(&]N($YO=F5M8F5R(#(Y+"`R,#$X.PT*86YD("AC
M*2!O;F4@4V5R:65S($,@5V%R<F%N="!E>&5R8VES86)L92!F;W(@;VYE('-H
M87)E(&]F($-O;6UO;B!3=&]C:R!A="!A;B!E>&5R8VES92!P<FEC92!O9B`D
M,"XT,R!P97(@<VAA<F4@:68@97AE<F-I<V5D('=I=&AI;@T*=&AE(&9I<G-T
M(&5I9VAT965N(&UO;G1H<R!O<B`D,"XT.2!P97(@<VAA<F4@:68@97AE<F-I
M<V5D(&%F=&5R('1H92!F:7)S="!E:6=H=&5E;B!M;VYT:',@86YD('!R:6]R
M('1O(&5X<&ER871I;VX@;VX@3F]V96UB97(-"C(Y+"`R,#$X+B!%86-H(&]F
M('1H92!397)I97,@0B!787)R86YT(&%N9"!397)I97,@0R!787)R86YT(&-O
M;G1A:6YS(&$@<')O=FES:6]N(&%L;&]W:6YG('1H92!H;VQD97(@=&\@97AE
M<F-I<V4@=&AE(')E<W!E8W1I=F4-"G=A<G)A;G0@;VX@82!C87-H;&5S<R!B
M87-I<R!A<R!F=7)T:&5R('-E="!F;W)T:"!T:&5R96EN+B!4:&4@56YI="!P
M<FEC92!O9B`D,"XT,R!R97!R97-E;G1S(&$@,S`E(&1I<V-O=6YT('1O('1H
M92`R,"!D87D@879E<F%G90T*8VQO<VEN9R!P<FEC92!O9B!T:&4@0V]M;6]N
M(%-T;V-K(&%S('%U;W1E9"!O;B!T:&4@3U1#44(@87,@;V8@3V-T;V)E<B`S
M,2P@,C`Q,RP@=&AE(&QA<W0@=')A9&EN9R!D871E('!R:6]R('1O('5S(&5N
M=&5R:6YG(&EN=&\-"F$@;F]N+6)I;F1I;F<@=&5R;2!S:&5E="!W:71H('1H
M92!);G9E<W1O<B!R96=A<F1I;F<@=&AE('!U<F-H87-E(&]F('1H92!5;FET
M<RX\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI
M9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-
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M92!O9B`D-3`L,#`P+"!P87EA8FQE(&EN(#$R(&5Q=6%L(&EN<W1A;&QM96YT
M<RP@=VAI8V@@:7,@<')O<F%T960@9F]R(&%N>2!P87)T:6%L(&UO;G1H<R!D
M=7)I;F<@=&AE('1E<FT@;V8@=&AE($-O;G-U;'1I;F<@06=R965M96YT+@T*
M26X@861D:71I;VX@=&\@37(N($)O;&0F(S$T-CMS(&9E92P@:&4@=V%S(&ES
M<W5E9"!/<'1I;VX@4VAA<F5S('1O('!U<F-H87-E('5P('1O(#0P+#`P,"!S
M:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!A="!A('!R:6-E#0IO9B`D,"XW
M-2!P97(@<VAA<F4@=&AE(&-L;W-I;F<@<')I8V4@;V8@;W5R(&-O;6UO;B!S
M=&]C:R!A<R!Q=6]T960@;VX@=&AE($]40U%"(&]N($YO=F5M8F5R(#(Y+"`R
M,#$S+B!4:&4@3W!T:6]N<R!3:&%R97,@;6%Y(&)E#0IE>&5R8VES960@;VX@
M82`F(S$T-SMC87-H;&5S<R!B87-I<R8C,30X.R!U<VEN9R!T:&4@9F]R;75L
M82!C;VYT86EN960@=&AE<F5I;B!A;F0L('-U8FIE8W0@=&\@37(N($)O;&0F
M(S$T-CMS(&-O;G1I;G5E9"!S97)V:6-E#0IA<R!O=7(@4')E<VED96YT(&%N
M9"!#:&EE9B!%>&5C=71I=F4@3V9F:6-E<BP@=F5S="!A<R!F;VQL;W=S.B`H
M82D@,C`L,#`P($]P=&EO;G,@4VAA<F5S('9E<W0@;VX@1&5C96UB97(@,2P@
M,C`Q-#L@86YD("AB*2`R,"PP,#`-"D]P=&EO;G,@4VAA<F5S('9E<W0@;VX@
M1&5C96UB97(@,2P@,C`Q-2X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG
M;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^3VX-"D1E8V5M8F5R(#,Q+"`R,#$S
M+"!W92!C;VUP;&5T960@=&AE('-A;&4@;V8@,3`P)2!O9B!T:&4@:7-S=65D
M(&%N9"!O=71S=&%N9&EN9R!S:&%R97,@;V8@1F]S='5N9R!297-O=7)C97,@
M=&\@1'5K92!F;W(@82!P<F]M:7-S;W)Y#0IN;W1E(&EN('1H92!A;6]U;G0@
M;V8@)#@P+#`P,"P@=VAI8V@@86UO=6YT(&%P<')O>&EM871E9"!T:&4@9F%I
M<B!V86QU92!O9B!T:&4@;&5A<V5S(&%N9"!M:6YI;F<@8VQA:6US(&-O;G1R
M;VQL960@8GD@1F]S='5N9PT*4F5S;W5R8V5S+"!A<R!C;VYC;'5D960@8GD@
M86X@:6YD97!E;F1E;G0@=&AI<F0M<&%R='D@9V5O;&]G:6-A;"!C;VYS=6QT
M86YT+B!0<FEN8VEP86P@86YD(&EN=&5R97-T(&%T(#0N,"4@87)E('!A>6%B
M;&4@;VX@1&5C96UB97(-"C,Q+"`R,#$U+B!-<BX@2&5R9&5V(%,N(%)A>6%T
M+"!T:&4@;6%J;W)I='D@<VAA<F5H;VQD97(@;V8@1'5K92P@:7,@=&AE(&)R
M;W1H97(@;V8@37(N($AA<FUE;"!3+B!287EA="P@;W5R(&UA:F]R:71Y('-H
M87)E:&]L9&5R+CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@
M=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO<#X-"@T*/'`@<W1Y;&4],T0G;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SY&;W(@=&AE('EE87(@96YD960@1&5C96UB
M97(@,S$L#0HR,#$S+"!M86YA9V5M96YT(&9E97,L(&-O;G-U;'1I;F<@9F5E
M<R!A;F0@<F5I;6)U<G-E;65N="!O9B!E>'!E;G-E<R!P86ED('1O(&]F9FEC
M97)S(&%N9"!D:7)E8W1O<G,@;V8@=&AE($-O;7!A;GD@=V5R92`D-#DL,#DW
M#0HH,C`Q,CH@)#0S+#(Y."DN($QE9V%L(&9E97,@<&%I9"!T;R!O;F4@;V8@
M;W5R(&1I<F5C=&]R<R!I;B`R,#$S('=E<F4@)#$V-2PU.3$@*#(P,3(Z("0W
M,BPU,#,I+B!!;6]U;G1S(&EN8VQU9&5D(&EN(&%C8V]U;G1S('!A>6%B;&4-
M"F%N9"!D=64@=&\@<F5L871E9"!P87)T:65S(&%T($1E8V5M8F5R(#,Q+"`R
M,#$S('=E<F4@)#0T+#(Q.2`H,C`Q,CH@)#DL-C,X*2X@5&AE('1O=&%L(&5X
M<&5N<V4@<F5C;V=N:7IE9"!D=7)I;F<@,C`Q,R!F;W(@;&5G86P-"F9E97,@
M=V%S("0Q.3<L-C`Y("AI;F-L=61I;F<@=6YP86ED(&%M;W5N=',@;V8@)#,R
M+#`Q."!A<R!O9B!$96-E;6)E<B`S,2P@,C`Q,RDN/"]F;VYT/CPO<#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V5F9C)E-S`T
M7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?838T.%\R9C@W9F0U
M-&(W-S0O5V]R:W-H965T<R]3:&5E=#$U+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%3$4^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^26YC;VUE(%1A>&5S/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DEN8V]M92!4
M87AE<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F]T92`X+B!);F-O;64@5&%X97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<"!S='EL93TS1"=M87)G:6XZ(#!P="<^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/E1H97)E(&ES#0IN;R!C=7)R96YT(&]R(&1E9F5R<F5D('1A>"!E
M>'!E;G-E(&9O<B`R,#$S(&%N9"`R,#$R+"!D=64@=&\@=&AE($-O;7!A;GDF
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M;VX@86QL;W=A;F-E(&%G86EN<W0@=&AE(&1E9F5R<F5D('1A>`T*87-S970N
M(%1H92!I;F-O;64@=&%X(&5F9F5C="P@=71I;&EZ:6YG(&$@,S0E(&EN8V]M
M92!T87@@<F%T92P@;V8@=&5M<&]R87)Y(&1I9F9E<F5N8V5S(&-O;7!R:7-I
M;F<@=&AE(&1E9F5R<F5D('1A>"!A<W-E=',@86YD#0ID969E<G)E9"!T87@@
M;&EA8FEL:71I97,@:7,@82!R97-U;'0@;V8@=&AE(&9O;&QO=VEN9R!A="!$
M96-E;6)E<B`S,3H\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQT86)L92!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[('=I9'1H.B`Q,#`E
M)SX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@
M("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!C;VQS
M<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S
M;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\8CXR,#$S
M/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X
M="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\8CXR,#$R/"]B/CPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^1&5F97)R
M960@=&%X(&%S<V5T<SH\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\
M+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!C;VQS<&%N
M/3-$,B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z
M("-#0T5%1D8G/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@-S@E)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SY.970@;W!E<F%T:6YG(&QO<W,@8V%R<GEF;W)W87)D<SPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI
M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXD/"]F;VYT
M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG
M;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/C(L,#(W+#`P,#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G=VED=&@Z(#$E)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M)2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@."4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXQ
M+#@U,BPP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M('-T>6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@/'1D/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/D]T:&5R/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU
M<'0@<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI
M9#L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/C@V+#`P,#PO9F]N
M=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU<'0@<V]L
M:60G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X
M="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/C$P-BPP,#`\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T-#145&1B<^#0H@("`@
M/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^,BPQ,3,L,#`P/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/C$L.34X+#`P,#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@/'1D/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K
M9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M5F%L=6%T:6]N(&%L;&]W86YC93PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L
M86-K(#$N-7!T('-O;&ED)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU
M<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXH,BPQ
M,3,L,#`P/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXI/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU
M<'0@<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI
M9#L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B@Q+#DU."PP,#`\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/BD\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@
M("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^3F5T(&1E9F5R<F5D('1A>"!A<W-E=',\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I
M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXM/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXD/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L
M86-K(#(N,C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXM/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SY4:&4@,C`Q,PT*:6YC<F5A<V4@:6X@=&AE('9A
M;'5A=&EO;B!A;&QO=V%N8V4@=V%S("0Q-34L,#`P("@R,#$R.B`D.#$L,#`P
M*2X\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@
M=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^5&AE($-O;7!A;GD-
M"FAA<R!A=F%I;&%B;&4@;F5T(&]P97)A=&EN9R!L;W-S(&-A<G)Y9F]R=V%R
M9',@;V8@87!P<F]X:6UA=&5L>2`D-2PY-C$L,#`P(&9O<B!T87@@<'5R<&]S
M97,@=&\@;V9F<V5T(&9U='5R92!T87AA8FQE(&EN8V]M92!W:&EC:`T*97AP
M:7)E<R!C;VUM96YC:6YG(#(P,30@=&AR;W5G:"!T;R!T:&4@>65A<B`R,#,S
M+B!0=7)S=6%N="!T;R!T:&4@5&%X(%)E9F]R;2!!8W0@;V8@,3DX-BP@86YN
M=6%L('5T:6QI>F%T:6]N(&]F('1H92!#;VUP86YY)B,Q-#8[<PT*;F5T(&]P
M97)A=&EN9R!L;W-S(&-A<G)Y9F]R=V%R9',@;6%Y(&)E(&QI;6ET960@:68@
M82!C=6UU;&%T:79E(&-H86YG92!I;B!O=VYE<G-H:7`@;V8@;6]R92!T:&%N
M(#4P)2!I<R!D965M960@=&\@;V-C=7(@=VET:&EN#0IA;GD@=&AR964M>65A
M<B!P97)I;V0N(%1H92!T87@@>65A<G,@,C`Q,"!T:')O=6=H(#(P,3,@<F5M
M86EN(&]P96X@=&\@97AA;6EN871I;VX@8GD@9F5D97)A;"!A9V5N8VEE<R!A
M;F0@;W1H97(@:G5R:7-D:6-T:6]N<PT*:6X@=VAI8V@@:70@;W!E<F%T97,N
M/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D$@<F5C;VYC:6QI871I
M;VX-"F)E='=E96X@=&AE('-T871U=&]R>2!F961E<F%L(&EN8V]M92!T87@@
M<F%T92`H,S0E*2!A;F0@=&AE(&5F9F5C=&EV92!R871E(&]F(&EN8V]M92!T
M87@@97AP96YS92!F;W(@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R#0HS,2!F
M;VQL;W=S.CPO9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@=VED=&@Z(#$P,"4G/@T*
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@(#QT
M9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P86X]
M,T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED
M.R!T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQB/C(P,3,\+V(^
M/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED.R!T97AT+6%L
M:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQB/C(P,3(\+V(^/"]F;VYT/CPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VTG/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!C;VQS
M<&%N/3-$,B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-#0T5%1D8G/@T*("`@(#QT
M9"!S='EL93TS1"=W:61T:#H@-S@E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY3=&%T=71O<GD@
M9F5D97)A;"!I;F-O;64@=&%X(')A=&4\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I
M9'1H.B`Q)2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/C,T/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!S='EL93TS1"=W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B4\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N
M.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`X)3L@=&5X="UA
M;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/C,T/"]F;VYT/CPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=W:61T:#H@,24G/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B4\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-
M"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^5F%L=6%T:6]N(&%L;&]W86YC93PO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,2XU<'0@<V]L:60[('1E>'0M86QI9VXZ(')I
M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXH,S0\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B4I/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,2XU<'0@<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B
M;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B@S-#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)2D\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-#
M0T5%1D8G/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG
M:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/C`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B4\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!B;&%C:R`R+C(U<'0@9&]U8FQE)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,BXR-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/C`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B4\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X-"@T*#0H\
M<"!S='EL93TS1"=M87)G:6XZ(#!P="<^/"]P/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?969F,F4W,#1?83=A.5\T,60Q7V$V
M-#A?,F8X-V9D-31B-S<T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-"]7;W)K<VAE
M971S+U-H965T,38N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$521SX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY3=6)S97%U96YT($5V96YT<SQB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5B
M<V5Q=65N="!%=F5N=',\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.;W1E(#DN(%-U8G-E<75E;G0@179E;G1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY4:&5R90T*=V5R
M92!N;R!S=6)S97%U96YT(&5V96YT<R!T;R!D:7-C;&]S92!A<R!O9B!T:&4@
M:7-S=64@9&%T92!O9B!T:&ES(')E<&]R="X\+V9O;G0^/"]P/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/E1H97)E#0IW97)E(&YO('-U8G-E<75E;G0@979E;G1S('1O(&1I<V-L;W-E
M(&%S(&]F('1H92!I<W-U92!D871E(&]F('1H:7,@<F5P;W)T+CPO9F]N=#X\
M+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14E+044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4VEG;FEF:6-A;G0@06-C
M;W5N=&EN9R!0;VQI8VEE<R`H4&]L:6-I97,I/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3
M:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%!O;&EC:65S/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S:7,@
M;V8@4')E<V5N=&%T:6]N(&%N9"!0<FEN8VEP;&5S(&]F($%C8V]U;G1I;F<\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/E1H92!I;G1E<FEM(&-O;G-O
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M(%5N:71E9"!3=&%T97,-"F]F($%M97)I8V$@*"8C,30W.T=!05`F(S$T.#LI
M(&AA=F4@8F5E;B!C;VYD96YS960@;W(@;VUI='1E9"!P=7)S=6%N="!T;R!S
M=6-H(%-%0R!R=6QE<R!A;F0@<F5G=6QA=&EO;G,L(&%L=&AO=6=H('1H92!#
M;VUP86YY#0IB96QI979E<R!T:&%T('1H92!D:7-C;&]S=7)E<R!I;F-L=61E
M9"!A<F4@861E<75A=&4@=&\@;6%K92!T:&4@:6YF;W)M871I;VX@<')E<V5N
M=&5D(&YO="!M:7-L96%D:6YG+CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^26X@;6%N86=E;65N
M="8C,30V.W,@;W!I;FEO;BP@=&AE('5N875D:71E9`T*8V]N<V]L:61A=&5D
M(&9I;F%N8VEA;"!S=&%T96UE;G1S(&-O;G1A:6YE9"!H97)E:6X@<F5F;&5C
M="!A;&P@861J=7-T;65N=',L(&-O;G-I<W1I;F<@<V]L96QY(&]F(&YO<FUA
M;"!R96-U<G)I;F<@:71E;7,L('=H:6-H#0IA<F4@;F5C97-S87)Y(&9O<B!T
M:&4@9F%I<B!P<F5S96YT871I;VX@;V8@=&AE($-O;7!A;GDF(S$T-CMS(&9I
M;F%N8VEA;"!P;W-I=&EO;BP@<F5S=6QT<R!O9B!O<&5R871I;VYS+"!A;F0@
M8V%S:"!F;&]W<R!O;B!A(&)A<VES#0IC;VYS:7-T96YT('=I=&@@=&AA="!O
M9B!T:&4@0V]M<&%N>28C,30V.W,@<')I;W(@875D:71E9"!C;VYS;VQI9&%T
M960@9FEN86YC:6%L('-T871E;65N=',N(%1H92!#;VUP86YY(&AA<R!E=F%L
M=6%T960@:6YF;W)M871I;VX-"F%B;W5T('-U8G-E<75E;G0@979E;G1S('1H
M870@8F5C86UE(&%V86EL86)L92!T;R!U<R!T:')O=6=H('1H92!D871E('1H
M92!F:6YA;F-I86P@<W1A=&5M96YT<R!W97)E(&ES<W5E9"X@5&AI<R!I;F9O
M<FUA=&EO;B!R96QA=&5S#0IT;R!E=F5N=',L('1R86YS86-T:6]N<R!O<B!C
M:&%N9V5S(&EN(&-I<F-U;7-T86YC97,@=&AA="!W;W5L9"!R97%U:7)E('5S
M('1O(&%D:G5S="!T:&4@86UO=6YT<R!R97!O<G1E9"!I;B!T:&4@9FEN86YC
M:6%L('-T871E;65N=',-"F]R('1O(&1I<V-L;W-E(&EN9F]R;6%T:6]N(&%B
M;W5T('1H;W-E(&5V96YT<RP@=')A;G-A8W1I;VYS(&]R(&-H86YG97,@:6X@
M8VER8W5M<W1A;F-E<RX@2&]W979E<BP@=&AE(')E<W5L=',@;V8@;W!E<F%T
M:6]N<R!F;W(-"FEN=&5R:6T@<&5R:6]D<R!M87D@;F]T(&)E(&EN9&EC871I
M=F4@;V8@<F5S=6QT<R!T;R!B92!E>'!E8W1E9"!F;W(@=&AE(&9U;&P@9FES
M8V%L('EE87(N(%1H97)E9F]R92P@=&AE<V4@9FEN86YC:6%L('-T871E;65N
M=',-"G-H;W5L9"!B92!R96%D(&EN(&-O;FIU;F-T:6]N('=I=&@@=&AE($-O
M;7!A;GDF(S$T-CMS(&%U9&ET960@9FEN86YC:6%L('-T871E;65N=',L(&EN
M8VQU9&EN9R!T:&4@;F]T97,@=&AE<F5T;R!F;W(@=&AE('EE87(@96YD960-
M"D1E8V5M8F5R(#,Q+"`R,#$S+"!W:&EC:"!M87D@8F4@9F]U;F0@=6YD97(@
M=&AE($-O;7!A;GDF(S$T-CMS('!R;V9I;&4@;VX@141'05(N/"]P/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
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M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')I;F-I<&QE
M<R!O9B!#;VYS;VQI9&%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y
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M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT
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M87=S(&]F('1H92!3=&%T92!O9B!.979A9&$@;VX@2G5N92`Q,BP@,C`Q,RX\
M+V9O;G0^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^07!P;&EC86)L92!!8V-O=6YT:6YG($=U:61A;F-E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY!;GD@<F5F97)E;F-E(&EN('1H
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M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B8C,38P.SPO<#X-"@T*/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S
M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^26X@2G5N90T*,C`Q
M-"P@=&AE($9I;F%N8VEA;"!!8V-O=6YT:6YG(%-T86YD87)D<R!";V%R9"`H
M)B,Q-#<[1D%30B8C,30X.RD@:7-S=65D($%C8V]U;G1I;F<@4W1A;F1A<F1S
M(%5P9&%T92`H)B,Q-#<[05-5)B,Q-#@[*2`R,#$T+3$P+`T*1&5V96QO<&UE
M;G0@4W1A9V4@16YT:71I97,@*%1O<&EC(#DQ-2DZ($5L:6UI;F%T:6]N(&]F
M($-E<G1A:6X@1FEN86YC:6%L(%)E<&]R=&EN9R!297%U:7)E;65N=',N($%3
M52`R,#$T+3$P(&5L:6UI;F%T97,@=&AE(&1I<W1I;F-T:6]N#0IO9B!A(&1E
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M,C`Q-"TQ,"!W:6QL(&)E(&5F9F5C=&EV92!P<F]S<&5C=&EV96QY#0IF;W(@
M86YN=6%L(')E<&]R=&EN9R!P97)I;V1S(&)E9VEN;FEN9R!A9G1E<B!$96-E
M;6)E<B`Q-2P@,C`Q-"P@86YD(&EN=&5R:6T@<&5R:6]D<R!W:71H:6X@=&AO
M<V4@86YN=6%L('!E<FEO9',L(&AO=V5V97(@96%R;'D-"F%D;W!T:6]N(&ES
M('!E<FUI='1E9"X@5&AE($-O;7!A;GD@861O<'1E9"!!4U4@,C`Q-"TQ,"!D
M=7)I;F<@=&AE('%U87)T97(@96YD960@2G5N92`S,"P@,C`Q-"P@=&AE<F5B
M>2!N;R!L;VYG97(@<')E<V5N=&EN9R!O<@T*9&ES8VQO<VEN9R!A;GD@:6YF
M;W)M871I;VX@<F5Q=6ER960@8GD@5&]P:6,@.3$U+CPO9F]N=#X\+W`^#0H-
M"CQP('-T>6QE/3-$)V9O;G0Z(#EP="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SXF(S$V
M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S
M=&EF>2<^/&9O;G0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4G
M/DEN($UA>0T*,C`Q-"P@=&AE($9!4T(@:7-S=65D($%352`R,#$T+3`Y+"!2
M979E;G5E(&9R;VT@0V]N=')A8W1S('=I=&@@0W5S=&]M97)S("A4;W!I8R`V
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M(&)E9VEN;FEN9R!A9G1E<B!$96-E;6)E<B`Q-2P@,C`Q-B!A;F0@:7,@=&\@
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M(')E=F5N=64@<')I;W(@=&\@=&AE(&5F9F5C=&EV92!D871E(&]F($%352`R
M,#$T+3`Y+"!I="!W:6QL(&5V86QU871E('1H90T*969F96-T('1H870@05-5
M(#(P,30M,#D@=VEL;"!H879E(&]N(&ET<R!R97-U;'1S(&]F(&]P97)A=&EO
M;G,@86YD(&9I;F%N8VEA;"!P;W-I=&EO;BX\+V9O;G0^/"]P/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/D%N>0T*<F5F97)E;F-E(&EN('1H97-E(&YO=&5S('1O(&%P<&QI8V%B;&4@
M86-C;W5N=&EN9R!G=6ED86YC92!I<R!M96%N="!T;R!R969E<B!T;R!T:&4@
M875T:&]R:71A=&EV92!N;VXM9V]V97)N;65N=&%L(%53($=!05`@87,-"F9O
M=6YD(&EN('1H92!&:6YA;F-I86P@06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A
M<F0F(S$T-CMS($%C8V]U;G1I;F<@4W1A;F1A<F1S($-O9&EF:6-A=&EO;BX\
M+V9O;G0^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^06-C;W5N=&EN9R!%<W1I;6%T97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M
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M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY4
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M86UO=6YT<R!O9B!A<W-E=',@86YD(&QI86)I;&ET:65S(&%N9`T*=&AE(')E
M<&]R=&5D(&%M;W5N=',@;V8@<F5V96YU97,@86YD(&5X<&5N<V5S(&1U<FEN
M9R!T:&4@<F5P;W)T:6YG('!E<FEO9"X@06-T=6%L(')E<W5L=',L(&%S(&1E
M=&5R;6EN960@8GD@9G5T=7)E(&5V96YT<RP@;6%Y#0ID:69F97(@9G)O;2!T
M:&5S92!E<W1I;6%T97,N/"]F;VYT/CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@86YD($-A<V@@17%U
M:79A;&5N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/E1H92!#;VUP
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M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[
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M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO=&4@4F5C96EV86)L
M92!F<F]M($1U:V4@36]U;G1A:6X\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I
M9GDG/E1H92!N;W1E(')E8V5I=F%B;&4@9G)O;2!$=6ME($UO=6YT86EN(%)E
M<V]U<F-E<RP-"DEN8RX@*"8C,30W.T1U:V4F(S$T.#LI(&ES('5N<V5C=7)E
M9"P@8F5A<G,@:6YT97)E<W0@870@-"XP)2!A;F0@<')I;F-I<&%L(&%N9"!I
M;G1E<F5S="!A<F4@9'5E(&]N($1E8V5M8F5R(#,Q+"`R,#$U+B!4:&4@0V]M
M<&%N>28C,30V.W,-"F-R961I="!R:7-K(&%S<V5S<VUE;G0@:7,@;&EM:71E
M9"!D=64@=&\@=&AE(')E;&%T960@<&%R='D@;F%T=7)E(&]F('1H92!A<G)A
M;F=E;65N="X\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
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M;B!$96-E;6)E<B`S,2P@,C`Q-2X-"E1H92!#;VUP86YY)B,Q-#8[<R!C<F5D
M:70@<FES:R!A<W-E<W-M96YT(&ES(&QI;6ET960@9'5E('1O('1H92!R96QA
M=&5D('!A<G1Y(&YA='5R92!O9B!T:&4@87)R86YG96UE;G0N/"]F;VYT/CPO
M<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D9A:7(@5F%L=64@;V8@1FEN86YC:6%L($EN<W1R=6UE;G1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY4:&4@8V%R<GEI;F<@86UO=6YT<R!F
M;W(@8V%S:"!A;F0@8V%S:`T*97%U:79A;&5N=',@86YD('!A>6%B;&5S(&%P
M<')O>&EM871E(&9A:7(@=F%L=64@8F%S960@;VX@;V)S97)V86)L92!Q=6]T
M960@<')I8V5S(&9O<B!A8W1I=F4@;6%R:V5T<R`F(S$U,#L@3&5V96P@,2!I
M;G!U=',N#0I4:&4@8V%R<GEI;F<@86UO=6YT(&]F('1H92!N;W1E(')E8V5I
M=F%B;&4@9G)O;2!$=6ME(&%P<')O>&EM871E<R!F86ER('9A;'5E(&)A<V5D
M(&]N('-I;6EL87(@;6%R:V5T(&EN<'5T<R!F;W(@:6YT97)E<W0-"G)A=&5S
M(&9O<B!A('-P96-I9FEC(&-R961I=&]R("T@($QE=F5L(#(@:6YP=71S+CPO
M<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!T
M97AT+6EN9&5N=#H@,'!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY4:&4-"F-A<G)Y:6YG(&%M
M;W5N=',@9F]R(&-A<V@@86YD(&-A<V@@97%U:79A;&5N=',L(&%N9"!P87EA
M8FQE<R!A<'!R;WAI;6%T92!F86ER('9A;'5E(&)A<V5D(&]N(&]B<V5R=F%B
M;&4@<75O=&5D('!R:6-E<R!F;W(@:6YA8W1I=F4-"FUA<FME=',@)B,Q-3`[
M($QE=F5L(#$@:6YP=71S+B!4:&4@8V%R<GEI;F<@86UO=6YT(&]F('1H92!N
M;W1E(')E8V5I=F%B;&4@9G)O;2!$=6ME($UO=6YT86EN(&%P<')O>&EM871E
M<R!F86ER('9A;'5E(&)A<V5D(&]N#0IO8G-E<G9A8FQE(&UA<FME="!I;G!U
M=',@9F]R(&EN=&5R97-T(')A=&5S("8C,34P.R!,979E;"`R(&EN<'5T<RX\
M+V9O;G0^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4F5S96%R8V@@86YD($1E=F5L;W!M96YT($-O<W1S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY4:&4@0V]M<&%N>2!I;G1E;F1S
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M871I=F4@9G5T=7)E('5S97,N/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E
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M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&%N9VEB
M;&4@07-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY4:&4@:6YT
M86YG:6)L92!A<W-E="!C;VYS:7-T<R!P<FEM87)I;'D@;V8-"D-E;&P@1&5P
M;W-I=&EO;B!$979I8V4@=&5C:&YO;&]G>2!T:&%T('1H92!#;VUP86YY(&%C
M<75I<F5D(&1U<FEN9R`R,#$S(&%N9"!I<R!R96-O<F1E9"!A="!C;W-T+B!!
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M="!I=`T*8V]N<VED97)S('=H96X@<&5R9F]R;6EN9R!T:&4@<75A;&ET871I
M=F4@86YA;'ES:7,N(%1H92!R97-U;'1S(&]F('1H:7,@<F5V:65W(&%R92!T
M:&5N('=E:6=H960@86YD('!R:6]R:71I>F5D+B!)9B!T:&4@=&]T86QI='D-
M"F]F('1H92!R96QE=F%N="!E=F5N=',@86YD(&-I<F-U;7-T86YC97,@:6YD
M:6-A=&4@=&AA="!I="!I<R!N;W0@;6]R92!L:6ME;'D@=&AA;B!N;W0@=&AA
M="!T:&4@9F%I<B!V86QU92!O9B!T:&4@:6YT86YG:6)L92!A<W-E=`T*:7,@
M;&5S<R!T:&%N(&ET<R!C87)R>6EN9R!A;6]U;G0L(&%D9&ET:6]N86P@:6UP
M86ER;65N="!T97-T<R!A<F4@;F]T(&YE8V5S<V%R>2X\+W`^#0H-"CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG
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M;V1U8W1S+"!C:&%N9V5S(&EN('!R;VIE8W1I;VYS(&-A=7-E9`T*8GD@9&5L
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M<R!C87)R>6EN9R!A;6]U;G0N/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E
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M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD
M96YT.B`P+C5I;B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO<#X-"@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
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M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@
M3W!T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T
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M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
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M;&5S('!R:6-I;F<@;6]D96P@<F5Q=6ER97,@;6%N86=E;65N=`T*=&\@;6%K
M92!A<W-U;7!T:6]N<R!R96=A<F1I;F<@;W!T:6]N(&QI=F5S+"!E>'!E8W1E
M9"!V;VQA=&EL:71Y+"!A;F0@<FES:R!F<F5E(&EN=&5R97-T(')A=&5S+CPO
M9F]N=#X\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);F-O;64@5&%X97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU
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M;@T*-3`E*2P@8F%S960@;VX@=&5C:&YI8V%L(&UE<FET<RP@=&AA="!T:&4@
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M;V1S('!R97-E;G1E9`T*9'5E('1O(&YE="!T87AA8FQE(&QO<W-E<RX\+W`^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
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M+B!!('1A>`T*<&]S:71I;VX@:7,@9&5F:6YE9"!A<R!A('!O<VET:6]N(&EN
M(&$@<')E=FEO=7-L>2!F:6QE9"!T87@@<F5T=7)N(&]R(&$@<&]S:71I;VX@
M97AP96-T960@=&\@8F4@=&%K96X@:6X@9G5T=7)E('1A>"!F:6QI;F<@=&AA
M=`T*:7,@<F5F;&5C=&5D(&EN(&UE87-U<FEN9R!C=7)R96YT(&]R(&1E9F5R
M<F5D(&EN8V]M92!T87@@87-S971S(&%N9"!L:6%B:6QI=&EE<RX@5&%X('!O
M<VET:6]N<R!A<F4@<F5C;V=N:7IE9"!O;FQY('=H96X@:70@:7,-"FUO<F4@
M;&EK96QY('1H86X@;F]T("AI+F4N+"!L:6ME;&EH;V]D(&]F(&=R96%T97(@
M=&AA;B`U,"4I+"!B87-E9"!O;B!T96-H;FEC86P@;65R:71S+"!T:&%T('1H
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M<R!G<F5A=&5R('1H86X@-3`E(&QI:V5L>2!O9B!B96EN9R!R96%L:7IE9"!U
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M8W5R<F5D+CPO9F]N=#X\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$:7-C;VYT:6YU960@3W!E<F%T:6]N<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T>6QE/3-$)V9O
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M;6)E<B`R,#$S+B!#97)T86EN#0IA;6]U;G1S(')E<&]R=&5D(&EN('1H92!P
M<FEO<B!P97)I;V1S('!R97-E;G1E9"!H879E(&)E96X@<F5C;&%S<VEF:65D
M('1O(&-O;F9O<FT@=&\@=&AE(&-U<G)E;G0@<&5R:6]D(&9I;F%N8VEA;"!S
M=&%T96UE;G0@<')E<V5N=&%T:6]N+@T*5&AE<V4@<F5C;&%S<VEF:6-A=&EO
M;G,@:&%V92!N;R!E9F9E8W0@;VX@<')E=FEO=7-L>2!R97!O<G1E9"!N970@
M:6YC;VUE("AL;W-S*2X\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
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M>2`R,#$S(&%N9"!T:&4@<V%L92!O9B!T:&4@0V]M<&%N>28C,30V.W,@<W5B
M<VED:6%R>2!W:&EC:"!C;VYT<F]L;&5D#0IV87)I;W5S(&UI;F5R86P@;&5A
M<V5S(&%N9"!C;&%I;7,@:6X@1&5C96UB97(@,C`Q,RX@0V5R=&%I;B!A;6]U
M;G1S(')E<&]R=&5D(&EN('1H92!P<FEO<B!P97)I;V1S('!R97-E;G1E9"!H
M879E(&)E96X@<F5C;&%S<VEF:65D#0IT;R!C;VYF;W)M('1O('1H92!C=7)R
M96YT('!E<FEO9"!F:6YA;F-I86P@<W1A=&5M96YT('!R97-E;G1A=&EO;BX@
M5&AE<V4@<F5C;&%S<VEF:6-A=&EO;G,@:&%V92!N;R!E9F9E8W0@;VX@<')E
M=FEO=7-L>2!R97!O<G1E9`T*;F5T(&EN8V]M92`H;&]S<RDN(%-E92`F(S$T
M-SM.;W1E(#,N($1I<V-O;G1I;G5E9"!/<&5R871I;VYS)B,Q-#@[(&9O<B!A
M('-U;6UA<GD@;V8@=&AE(&%M;W5N=',@<F5C;&%S<VEF:65D(&9O<B!T:&4@
M<&5R:6]D<PT*<')E<V5N=&5D(&AE<F5I;BX\+V9O;G0^/"]P/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16%R;FEN
M9W,@*$QO<W,I(%!E<B!3:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF
M>2<^5&AE($-O;7!A;GD@<')E<V5N=',@8F]T:"!B87-I8R!A;F0@9&EL=71E
M9`T*96%R;FEN9W,@<&5R('-H87)E("@F(S$T-SM%4%,F(S$T.#LI(&%M;W5N
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M;R!P=7)C:&%S92!S:&%R97,@;V8@8V]M;6]N('-T;V-K("@X+#(P,"PP,#`@
M<VAA<F5S(&%S(&]F($IU;F4@,S`L(#(P,30@86YD($1E8V5M8F5R(#,Q+"`R
M,#$S*2!A;F0@;W!T:6]N<R!T;R!P=7)C:&%S90T*<VAA<F5S(&]F(&-O;6UO
M;B!S=&]C:R`H,3,U+#`P,"!S:&%R97,@87,@;V8@2G5N92`S,"P@,C`Q-"!A
M;F0@.#`L,#`P(&%S(&]F($1E8V5M8F5R(#,Q+"`R,#$S*2X@1'5R:6YG('1H
M92!P97)I;V1S('!R97-E;G1E9"P@<&]T96YT:6%L;'D-"F1I;'5T:79E('-H
M87)E<R!O9B!C;VUM;VX@<W1O8VL@=V5R92!N;W0@:6YC;'5D960@:6X@=&AE
M(&-O;7!U=&%T:6]N(&]F(&1I;'5T:79E(&QO<W,@<&5R('-H87)E(&%S('1O
M(&1O('-O('=O=6QD(&)E(&%N=&DM9&EL=71I=F4N/"]P/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P
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M;VX@<W1O8VL@*#@L,C`P+#`P,"!S:&%R97,@9F]R(#(P,3,@86YD(&YI;"!S
M:&%R97,-"F9O<B`R,#$R*2!A;F0@;W!T:6]N<R!T;R!P=7)C:&%S92!S:&%R
M97,@;V8@8V]M;6]N('-T;V-K("@X,"PP,#`@<VAA<F5S(&9O<B`R,#$S(&%N
M9"!N:6P@<VAA<F5S(&9O<B`R,#$R*2X@1'5R:6YG('1H92!P97)I;V1S#0IP
M<F5S96YT960L('!O=&5N=&EA;&QY(&1I;'5T:79E('-H87)E<R!O9B!C;VUM
M;VX@<W1O8VL@=V5R92!N;W0@:6YC;'5D960@:6X@=&AE(&-O;7!U=&%T:6]N
M(&]F(&1I;'5T:79E(&QO<W,@<&5R('-H87)E(&%S('1O(&1O#0IS;R!W;W5L
M9"!B92!A;G1I+61I;'5T:79E+CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E;&%T960@4&%R='D@5')A;G-A
M8W1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY!(')E;&%T960@
M<&%R='D@:7,@9V5N97)A;&QY(&1E9FEN960@87,@*&DI#0IA;GD@<&5R<V]N
M('=H;R!H;VQD<R`Q,"4@;W(@;6]R92!O9B!T:&4@0V]M<&%N>28C,30V.W,@
M<V5C=7)I=&EE<R!A;F0@=&AE:7(@:6UM961I871E(&9A;6EL:65S.R`H:6DI
M('1H92!#;VUP86YY)B,Q-#8[<R!M86YA9V5M96YT.PT**&EI:2D@<V]M96]N
M92!W:&\@9&ER96-T;'D@;W(@:6YD:7)E8W1L>2!C;VYT<F]L<RP@:7,@8V]N
M=')O;&QE9"!B>2!O<B!I<R!U;F1E<B!C;VUM;VX@8V]N=')O;"!W:71H('1H
M92!#;VUP86YY.R!O<B`H:78I(&%N>6]N90T*=VAO(&-A;B!S:6=N:69I8V%N
M=&QY(&EN9FQU96YC92!T:&4@9FEN86YC:6%L(&%N9"!O<&5R871I;F<@9&5C
M:7-I;VYS(&]F('1H92!#;VUP86YY+B!!('1R86YS86-T:6]N(&ES(&-O;G-I
M9&5R960@=&\@8F4@82!R96QA=&5D#0IP87)T>2!T<F%N<V%C=&EO;B!W:&5N
M('1H97)E(&ES(&$@=')A;G-F97(@;V8@<F5S;W5R8V5S(&]R(&]B;&EG871I
M;VYS(&)E='=E96X@<F5L871E9"!P87)T:65S+B!3964@)B,Q-#<[3F]T92`V
M+B!296QA=&5D(%!A<G1Y#0I4<F%N<V%C=&EO;G,L)B,Q-#@[(&9O<B!F=7)T
M:&5R(&1I<V-U<W-I;VXN/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D$-"G)E;&%T960@<&%R='D@
M:7,@9V5N97)A;&QY(&1E9FEN960@87,@*&DI(&%N>2!P97)S;VX@=VAO(&AO
M;&1S(#$P)2!O<B!M;W)E(&]F('1H92!#;VUP86YY)B,Q-#8[<R!S96-U<FET
M:65S(&%N9"!T:&5I<B!I;6UE9&EA=&4-"F9A;6EL:65S.R`H:6DI('1H92!#
M;VUP86YY)B,Q-#8[<R!M86YA9V5M96YT.R`H:6EI*2!S;VUE;VYE('=H;R!D
M:7)E8W1L>2!O<B!I;F1I<F5C=&QY(&-O;G1R;VQS+"!I<R!C;VYT<F]L;&5D
M(&)Y(&]R(&ES('5N9&5R#0IC;VUM;VX@8V]N=')O;"!W:71H('1H92!#;VUP
M86YY.R!O<B`H:78I(&%N>6]N92!W:&\@8V%N('-I9VYI9FEC86YT;'D@:6YF
M;'5E;F-E('1H92!F:6YA;F-I86P@86YD(&]P97)A=&EN9R!D96-I<VEO;G,@
M;V8@=&AE($-O;7!A;GDN#0I!('1R86YS86-T:6]N(&ES(&-O;G-I9&5R960@
M=&\@8F4@82!R96QA=&5D('!A<G1Y('1R86YS86-T:6]N('=H96X@=&AE<F4@
M:7,@82!T<F%N<V9E<B!O9B!R97-O=7)C97,@;W(@;V)L:6=A=&EO;G,@8F5T
M=V5E;B!R96QA=&5D#0IP87)T:65S+B!3964@)B,Q-#<[3F]T92`W+B!296QA
M=&5D(%!A<G1Y(%1R86YS86-T:6]N<RPF(S$T.#L@9F]R(&9U<G1H97(@9&ES
M8W5S<VEO;BX\+V9O;G0^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M<')E:&5N<VEV92!);F-O;64@*$QO
M<W,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T:69Y)SY4:&4@0V]M<&%N>2!H
M87,@;F\@:71E;7,@;V8@;W1H97(@8V]M<')E:&5N<VEV90T*:6YC;VUE(&EN
M(&%N>2!P97)I;V0@<')E<V5N=&5D+B!4:&5R969O<F4L(&YE="!L;W-S(&5Q
M=6%L<R!C;VUP<F5H96YS:79E(&QO<W,N/"]P/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ
M(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D-O;7!R96AE
M;G-I=F4-"FQO<W,@:7,@8V]M<')I<V5D(&]F(&YE="!L;W-S+&%N9"!A(')E
M8VQA<W-I9FEC871I;VX@;VX@9&ES<&]S86P@;V8@<W5B<VED:6%R>2!F;W(@
M=&AE('!E<FEO9',@<')E<V5N=&5D+CPO9F]N=#X\+W`^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14Q%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/D1I<V-O;G1I;G5E9"!/:6P@86YD($=A<R!/<&5R871I
M;VYS("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D1I<V-O;G1I;G5E9"!/:6P@06YD($=A<R!/<&5R
M871I;VYS(%1A8FQE<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^07-S971S(&%N9"!L:6%B:6QI=&EE<R!O9B!D:7-C;VYT
M:6YU960@;W!E<F%T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^07-S971S#0IA;F0@;&EA8FEL:71I97,@;V8@9&ES8V]N
M=&EN=65D(&]P97)A=&EO;G,@:6X@=&AE(&%C8V]M<&%N>6EN9R!B86QA;F-E
M('-H965T<R!C;VYS:7-T(&]F('1H92!F;VQL;W=I;F<Z/"]F;VYT/CPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!W:61T:#H@,3`P)2<^#0H\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;2<^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,2XU<'0@<V]L:60[('1E>'0M86QI9VXZ(&-E;G1E
M<B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^/&(^1&5C96UB97(-"B`@("`S,2P@,C`Q,CPO8CX\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D%S
M<V5T<SH\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R
M.B`C0T-%149&)SX-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@Y)3L@<&%D
M9&EN9RUL969T.B`Y<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D]I;"!A;F0@1V%S(%!R;W!E
M<G1I97,L(&YE=#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@,24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H
M.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/C(T+#$R-SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G
M=VED=&@Z(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R
M/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG
M<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.B`Y<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/DUI;FEN9R!P<F]P97)T:65S/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXU,3DL-S4P/"]F;VYT
M/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-#0T5%1D8G/@T*
M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6QE9G0Z(#EP="<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^3W1H97(@8W5R<F5N="!A<W-E=',\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!B;&%C:R`Q+C5P="!S;VQI9"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K
M(#$N-7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M.#`P/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H
M:71E)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L92<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^-30T+#8W-SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-
M"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O
M=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^3&EA
M8FEL:71I97,\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A
M8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.B`Y<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D%C8V]U;G1S('!A>6%B;&4\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXH,3(L.3,R/"]F;VYT/CPO
M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXI/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.B`Y<'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/D%S<V5T
M(')E=&ER96UE;G0@;V)L:6=A=&EO;CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[
M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ
M(&)L86-K(#$N-7!T('-O;&ED)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M,2XU<'0@<V]L:60[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXH
M-3<L-3,R/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXI/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET
M92<^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4G/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B0\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B@W,"PT-C0\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/BD\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L
M93X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V5F
M9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?838T.%\R
M9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E=#$Y+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M4D<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P
M86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^26YT86YG:6)L92!!<W-E=',@
M+2!);G1E;&QE8W1U86P@4')O<&5R="`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^26YT86YG:6)L92!!<W-E=',@+2!);G1E;&QE8W1U86P@4')O<&5R="!4
M86)L97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!<W-U;7!T:6]N<R!R97%U:7)E9"!F;W(@=&AE($)L86-K+5-C:&]L
M97,@;6]D96P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/D%S<W5M<'1I
M;VYS(')E<75I<F5D(&9O<B!T:&4@0FQA8VLM4V-H;VQE<PT*;6]D96P@87)E
M(&%S(&9O;&QO=W,Z/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P
M/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!W:61T:#H@,3`P)2<^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T-#145&1B<^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P="<^5V5I9VAT960@879E<F%G92!R:7-K+69R
M964@:6YT97)E<W0@<F%T93PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@.24[('1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T)SXQ+C8R)3PO9F]N=#X\+W1D/CPO='(^#0H\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N
M9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/D5X
M<&5C=&5D(&QI9F4@:6X@>65A<G,\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z(#$P<'0G/C4N,#`@665A<G,\+V9O;G0^/"]T9#X\+W1R/@T*/'1R
M('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M
M8V]L;W(Z("-#0T5%1D8G/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/E=E
M:6=H=&5D($%V9R!%>'!E8W1E9"!6;VQA=&EL:71Y/"]F;VYT/CPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T)SXY,"XY)3PO9F]N=#X\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R
M;W5N9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G
M/D5X<&5C=&5D(&1I=FED96YD('EI96QD/"]F;VYT/CPO=&0^#0H@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T)SXP)3PO9F]N=#X\+W1D/CPO='(^#0H\+W1A8FQE
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/D%S<W5M<'1I;VYS#0IR97%U:7)E9"!F;W(@=&AE($)L86-K
M+5-C:&]L97,@;6]D96P@87)E(&%S(&9O;&QO=W,Z/"]F;VYT/CPO<#X-"@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$
M,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!W:61T:#H@,3`P)2<^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;2<^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`W-24G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,C4E.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S
M;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\8CXR,#$S
M/"]B/CPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T-#145&1B<^#0H@
M("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/E=E:6=H=&5D(&%V97)A9V4@<FES:RUF<F5E
M(&EN=&5R97-T(')A=&4\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXQ+C<U)3PO9F]N=#X\
M+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT9#X\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SY%>'!E8W1E9"!L:69E(&EN('EE87)S/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M-2XU(%EE87)S/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-%149&
M)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^5V5I9VAT960@079G($5X<&5C=&5D
M(%9O;&%T:6QI='D\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXQ,#(N,"4\+V9O;G0^/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^17AP96-T960@9&EV:61E;F0@>6EE;&0\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXD
M,#PO9F]N=#X\+W1D/CPO='(^#0H\+W1A8FQE/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?969F,F4W,#1?83=A.5\T,60Q7V$V
M-#A?,F8X-V9D-31B-S<T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-"]7;W)K<VAE
M971S+U-H965T,C`N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5#14%#/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/D-O;6UO;B!3=&]C:R!/<'1I;VYS("A486)L97,I/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4W1O8VL@3W!T:6]N($%C=&EV:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SY4:&4@9F]L;&]W:6YG('1A8FQE('-U;6UA<FEZ97,@<W1O8VL@
M;W!T:6]N#0IA8W1I=FET>2!F;W(@=&AE('!E<FEO9"!E;F1E9"!*=6YE(#,P
M+"`R,#$T+CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XU:6XG/B8C,38P.SPO<#X-"@T*
M/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M=VED=&@Z(#$P,"4G/@T*/'1R/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,2XU<'0G/B8C,38P
M.SQB<B`O/@T*)B,Q-C`[/&)R("\^#0HF(S$V,#L\8G(@+SX-"B8C,38P.SQB
M<B`O/@T*)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB
M;W1T;VTZ(#$N-7!T)SXF(S$V,#L\8G(@+SX-"B8C,38P.SQB<B`O/@T*)B,Q
M-C`[/&)R("\^#0HF(S$V,#L\8G(@+SX-"B8C,38P.SPO=&0^#0H@("`@/'1D
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M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([
M('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^)B,Q-C`[/&)R("\^#0HF(S$V,#L\
M8G(@+SX-"B8C,38P.SQB<B`O/@T*)B,Q-C`[/&)R("\^#0HF(S$V,#L\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([('!A9&1I
M;F<M8F]T=&]M.B`Q+C5P="<^)B,Q-C`[/&)R("\^#0HF(S$V,#L\8G(@+SX-
M"B8C,38P.SQB<B`O/@T*)B,Q-C`[/&)R("\^#0HF(S$V,#L\+W1D/@T*("`@
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M(%!R:6-E/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!C96YT97([('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^)B,Q-C`[
M/&)R("\^#0HF(S$V,#L\8G(@+SX-"B8C,38P.SQB<B`O/@T*)B,Q-C`[/&)R
M("\^#0HF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!C96YT97([('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^)B,Q-C`[/&)R("\^
M#0HF(S$V,#L\8G(@+SX-"B8C,38P.SQB<B`O/@T*)B,Q-C`[/&)R("\^#0HF
M(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=V97)T
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M3&EF92`H665A<G,I/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97([('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^
M)B,Q-C`[/&)R("\^#0HF(S$V,#L\8G(@+SX-"B8C,38P.SQB<B`O/@T*)B,Q
M-C`[/&)R("\^#0HF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!C96YT97([('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^)B,Q-C`[
M/&)R("\^#0HF(S$V,#L\8G(@+SX-"B8C,38P.SQB<B`O/@T*)B,Q-C`[/&)R
M("\^#0HF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS
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M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q+C5P
M="<^)B,Q-C`[/&)R("\^#0HF(S$V,#L\8G(@+SX-"B8C,38P.SQB<B`O/@T*
M)B,Q-C`[/&)R("\^#0HF(S$V,#L\+W1D/@T*/"]T<CX-"CQT<B!S='EL93TS
M1"=B86-K9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF
M>2<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SY"86QA;F-E($IA
M;G5A<GD@,2P@,C`Q-#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W
M:61T:#H@,24[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B8C,38P.SPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=I9'1H
M.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@=VED=&@Z(#DE.R!T97AT+6%L:6=N.B!R:6=H="<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXX,"PP,#`\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O
M;3L@=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!J=7-T:69Y)SXF(S$V,#L\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&IU
M<W1I9GDG/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L
M+6%L:6=N.B!B;W1T;VT[('=I9'1H.B`Q)2<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=I9'1H.B`Y)3L@=&5X="UA;&EG
M;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^,"XW
M,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!W:61T:#H@,24[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B8C
M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA
M;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VED=&@Z(#$E)SXF(S$V,#L\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W
M:61T:#H@.24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0G/CDN,3,\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=VED=&@Z(#$E.R!T97AT
M+6%L:6=N.B!J=7-T:69Y)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B8C,38P.SPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=I
M9'1H.B`Q)2<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXD/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VT[('=I9'1H.B`Y)3L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^,C`L,#`P/"]F;VYT/CPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('=I9'1H
M.B`Q)3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\
M=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG
M;CH@:G5S=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#$N-7!T)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/D]P=&EO;G,@9W)A;G1E9#PO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!P
M861D:6YG+6)O='1O;3H@,2XU<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(&IU
M<W1I9GD[('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA
M;&EG;CH@<FEG:'0[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#$N-7!T('-O;&ED
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C4U+#`P,#PO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T
M=&]M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!P861D:6YG+6)O='1O;3H@,2XU
M<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&IU<W1I9GD[('!A9&1I;F<M8F]T=&]M.B`Q+C5P="<^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X
M="UA;&EG;CH@:G5S=&EF>3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XU<'0@
M<V]L:60G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F]R9&5R+6)O='1O;3H@
M0FQA8VL@,2XU<'0@<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P="<^,2XP-3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!P861D
M:6YG+6)O='1O;3H@,2XU<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[('!A9&1I;F<M8F]T=&]M.B`Q+C5P
M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>3L@<&%D9&EN9RUB;W1T
M;VTZ(#$N-7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F]R9&5R
M+6)O='1O;3H@0FQA8VL@,2XU<'0@<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P="<^.2XW-3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!J=7-T
M:69Y.R!P861D:6YG+6)O='1O;3H@,2XU<'0G/B8C,38P.SPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[('!A9&1I;F<M8F]T
M=&]M.B`Q+C5P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,2XU
M<'0@<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^)#PO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F]R9&5R+6)O='1O;3H@0FQA
M8VL@,2XU<'0@<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M="<^,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!P861D:6YG+6)O
M='1O;3H@,2XU<'0G/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=B
M86-K9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@("`\=&0@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0G/D)A;&%N8V4@2G5N92`S,"P@,C`Q-#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!P861D:6YG
M+6)O='1O;3H@,BXU<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M('!A9&1I;F<M8F]T=&]M.B`R+C5P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@
M<FEG:'0[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L92<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXQ,S4L,#`P/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[('!A9&1I;F<M8F]T=&]M.B`R+C5P="<^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S
M=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SXF(S$V,#L\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4G/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C`N.#0\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG
M;CH@:G5S=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SXF(S$V,#L\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!P861D
M:6YG+6)O='1O;3H@,BXU<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[('1E>'0M86QI9VXZ(&IU<W1I
M9GD[('!A9&1I;F<M8F]T=&]M.B`R+C5P="<^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG
M;CH@<FEG:'0[(&)O<F1E<BUB;W1T;VTZ($)L86-K(#(N-7!T(&1O=6)L92<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXY+C,X/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[('!A9&1I;F<M8F]T=&]M.B`R+C5P="<^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S
M=&EF>3L@<&%D9&EN9RUB;W1T;VTZ(#(N-7!T)SXF(S$V,#L\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M
M8F]T=&]M.B!";&%C:R`R+C5P="!D;W5B;&4G/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@
M8F]R9&5R+6)O='1O;3H@0FQA8VL@,BXU<'0@9&]U8FQE)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$T+#@U,#PO9F]N=#X\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R!P861D:6YG+6)O='1O;3H@,BXU<'0G/B8C,38P.SPO
M=&0^/"]T<CX-"CQT<B!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET
M92<^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M('1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P="<^17AE<F-I<V%B;&4@870@2G5N92`S,"P@,C`Q-#PO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y)SXF
M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SXF(S$V,#L\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L
M:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXR
M,"PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;2<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXD/"]F;VYT
M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0G/C`N-S`\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S
M=&EF>2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@
M=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P="<^.2XQ,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SXF(S$V
M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y
M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG
M;CH@8F]T=&]M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P="<^-2PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@:G5S
M=&EF>2<^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^5&AE(&9O
M;&QO=VEN9PT*=&%B;&4@<W5M;6%R:7IE<R!S=&]C:R!O<'1I;VX@86-T:79I
M='D@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$S+CPO9F]N
M=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO<#X-"@T*/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@=VED=&@Z(#$P,"4G/@T*/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@(#QT9"!S='EL93TS1"=P
M861D:6YG+6)O='1O;3H@,7!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/&)R("\^#0H\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/@T*/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R('-T>6QE
M/3-$)V)O<F1E<BUB;W1T;VTZ($)L86-K(#%P="!S;VQI9"<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/@T*/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^#0H\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SX\8CY/<'1I;VYS($]U='-T86YD:6YG/"]B/CPO9F]N=#X\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G<&%D9&EN
M9RUB;W1T;VTZ(#%P="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O
M/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CQB<B`O/@T*/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W!A9&1I;F<M8F]T=&]M.B`Q<'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX-"CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B
M;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60[('1E>'0M86QI9VXZ(&-E
M;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/@T*/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\8CY796EG
M:'1E9`T*079E<F%G92!%>&5R8VES92!0<FEC93PO8CX\+V9O;G0^/"]T9#X-
M"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)W!A9&1I;F<M8F]T
M=&]M.B`Q<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@
M+SX-"CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@
M+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/&)R("\^#0H\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@<V]L:60G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/CQB/E=E:6=H=&5D#0I!=F5R86=E(%)E;6%I;FEN9R!#
M;VYT<F%C='5A;"!,:69E("A996%R<RD\+V(^/"]F;VYT/CPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@
M,7!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^#0H\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^(#QF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CQB<B`O/@T*/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H@("`@/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ($)L86-K(#%P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/&)R("\^#0H\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQB/D%G9W)E9V%T90T*26YT
M<FEN<VEC(%9A;'5E/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`]
M,T1N;W=R87`@<W1Y;&4],T0G<&%D9&EN9RUB;W1T;VTZ(#%P="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/B`\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/&)R("\^(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\8G(@+SX@
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CQB<B`O/@T*/&9O;G0@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-#0T5%1D8G
M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@-3,E)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY"
M86QA;F-E($IA;G5A<GD@,2P@,C`Q,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^+3PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L
M:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)#PO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@.24[('1E>'0M86QI
M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXM/"]F;VYT/CPO=&0^#0H@("`@/'1D
M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=W:61T:#H@,24G/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T
M:#H@,24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=VED=&@Z(#DE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^+3PO
M9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@<W1Y;&4],T0G
M=VED=&@Z(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E.R!T97AT+6%L:6=N.B!R:6=H="<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`Q)2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)#PO9F]N=#X\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@.24[('1E>'0M86QI9VXZ(')I9VAT)SX\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXM/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<"!S='EL93TS1"=W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO
M9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ
M(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT9#X\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SY/<'1I;VYS(&=R86YT960\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/C0S,"PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/C`N-S(\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^.2XU-3PO9F]N=#X\+W1D/@T*("`@
M(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL
M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R
M.B`C0T-%149&)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^3W!T:6]N<R!F;W)F
M96ET960\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@
M(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B@S-3`L
M,#`P/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXI/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^,"XW,CPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXY
M+C4P/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@
M/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^0F%L86YC92!$96-E;6)E<B`S,2P@,C`Q,SPO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4G/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T
M=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^.#`L,#`P/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXD/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L
M86-K(#(N,C5P="!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXP+C<P/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B
M;&%C:R`R+C(U<'0@9&]U8FQE)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@
M,BXR-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/CDN-S4\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K
M(#(N,C5P="!D;W5B;&4G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B0\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O
M=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/C(S+#(P,#PO
M9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-%149&
M)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^17AE<F-I<V%B;&4@870@1&5C96UB
M97(@,S$L(#(P,3,\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/C(P+#`P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^,"XV-3PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXY+C4P/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXD/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXV+#@P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CPO
M=&%B;&4^#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CPO9F]N
M=#X\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y!<W-U;7!T:6]N<R!R97%U:7)E9"!F;W(@=&AE($)L86-K+5-C
M:&]L97,@;6]D96P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG/D%S<W5M
M<'1I;VYS(')E<75I<F5D(&9O<B!T:&4@0FQA8VLM4V-H;VQE<PT*;6]D96P@
M87)E(&%S(&9O;&QO=W,Z/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[
M/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$
M,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!W:61T:#H@,3`P)2<^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM
M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T-#145&1B<^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^5V5I9VAT960@879E<F%G92!R:7-K
M+69R964@:6YT97)E<W0@<F%T93PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@.24[('1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T)SXQ+C8R)3PO9F]N=#X\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R
M;W5N9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G
M/D5X<&5C=&5D(&QI9F4@:6X@>65A<G,\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0G/C4N,#`@665A<G,\+V9O;G0^/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U
M;F0M8V]L;W(Z("-#0T5%1D8G/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G
M/E=E:6=H=&5D($%V9R!%>'!E8W1E9"!6;VQA=&EL:71Y/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXY,"XY)3PO9F]N=#X\+W1D/CPO
M='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C
M:V=R;W5N9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0G/D5X<&5C=&5D(&1I=FED96YD('EI96QD/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T)SXP)3PO9F]N=#X\+W1D/CPO='(^#0H\+W1A
M8FQE/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/D%S<W5M<'1I;VYS#0IR97%U:7)E9"!F;W(@=&AE($)L
M86-K+5-C:&]L97,@;6]D96P@87)E(&%S(&9O;&QO=W,Z/"]F;VYT/CPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!W:61T:#H@,3`P)2<^#0H\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;2<^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`W
M-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=W:61T:#H@,C4E.R!B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P
M="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SX\8CXR
M,#$S/"]B/CPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T-#145&1B<^
M#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68G/E=E:6=H=&5D(&%V97)A9V4@<FES:RUF
M<F5E(&EN=&5R97-T(')A=&4\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXQ+C<U)3PO9F]N
M=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT9#X\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SY%>'!E8W1E9"!L:69E(&EN('EE87)S/"]F;VYT/CPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^-2XU(%EE87)S/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V
M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-%
M149&)SX-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^5V5I9VAT960@079G($5X<&5C
M=&5D(%9O;&%T:6QI='D\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXQ,#(N,"4\+V9O;G0^
M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T
M;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^17AP96-T960@9&EV:61E;F0@>6EE;&0\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXD,#PO9F]N=#X\+W1D/CPO='(^#0H\+W1A8FQE/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@3W!T:6]N
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%S<W5M<'1I
M;VYS(')E<75I<F5D(&9O<B!T:&4@0FQA8VLM4V-H;VQE<R!M;V1E;#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^5&AE(&%S<W5M<'1I;VYS(&9O<B!V
M;VQA=&EL:71Y+"!E>'!E8W1E9"!L:69E+`T*9&EV:61E;F0@>6EE;&0@86YD
M(')I<VLM9G)E92!I;G1E<F5S="!R871E(&%R92!P<F5S96YT960@:6X@=&AE
M('1A8FQE(&)E;&]W.CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XU:6XG/B8C,38P.SPO
M<#X-"@T*/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9CL@=VED=&@Z(#$P,"4G/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-#0T5%1D8G/@T*("`@
M(#QT9"!S='EL93TS1"=W:61T:#H@.#(E.R!T97AT+6%L:6=N.B!J=7-T:69Y
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/E=E:6=H=&5D(&%V
M97)A9V4@<FES:RUF<F5E(&EN=&5R97-T(')A=&4\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$X)3L@=&5X="UA;&EG;CH@8V5N=&5R
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$N-#,@)B,Q-3`[
M(#$N-C(E/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A
M;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^17AP96-T960@;&EF92!I;B!Y96%R
M<SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^-"XU,"`F
M(S$U,#L@-2XU,#PO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T-#145&
M1B<^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GDG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^5V5I9VAT960@079G+B!%
M>'!E8W1E9"!6;VQA=&EL:71Y/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T)SXY.2XU)28C,38P.R8C,34P.R`Q,#4N,R4\+V9O;G0^/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@:G5S=&EF>2<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T)SY%>'!E8W1E9"!D:79I9&5N9"!Y:65L9#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^,"4\+V9O;G0^/"]T9#X\+W1R/@T*
M/"]T86)L93X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SY4:&4-"F%S<W5M<'1I;VYS(&9O<B!V;VQA=&EL
M:71Y+"!E>'!E8W1E9"!L:69E+"!D:79I9&5N9"!Y:65L9"!A;F0@<FES:RUF
M<F5E(&EN=&5R97-T(')A=&4@87)E('!R97-E;G1E9"!I;B!T:&4@=&%B;&4@
M8F5L;W<Z/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I
M;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!W:61T:#H@,3`P)2<^#0H\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`@/'1D
M('-T>6QE/3-$)W=I9'1H.B`W-24G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,C4E.R!B;W)D97(M
M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SX\8CXR,#$S/"]B/CPO9F]N=#X\+W1D/CPO='(^#0H\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N
M9"UC;VQO<CH@(T-#145&1B<^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/E=E:6=H
M=&5D(&%V97)A9V4@<FES:RUF<F5E(&EN=&5R97-T(')A=&4\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXQ+C0S("8C,34P.R`Q+C0Y)3PO9F]N=#X\+W1D/CPO='(^#0H\
M='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N
M9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY%>'!E8W1E
M9"!L:69E(&EN('EE87)S/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^-2XP("8C,34P.R`U
M+C4@665A<G,\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z("-#0T5%1D8G
M/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY796EG:'1E9"!!=F<@17AP96-T960@
M5F]L871I;&ET>3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CDY+C4E("T@,3`S+C0E/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@/'1D/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/D5X<&5C=&5D(&1I=FED96YD('EI96QD/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)#`\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V5F9C)E-S`T7V$W83E?
M-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?838T.%\R9C@W9F0U-&(W-S0O
M5V]R:W-H965T<R]3:&5E=#(Q+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%6D8^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^26YC;VUE(%1A>&5S("A486)L97,I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DEN8V]M
M92!487AE<R!486)L97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F(&1E9F5R<F5D('1A>"!A<W-E=',@
M86YD(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'`@<W1Y;&4],T0G;6%R9VEN.B`P<'0G/CPO<#X-"@T*/'1A8FQE(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@=VED=&@Z(#$P
M,"4G/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*
M("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\
M=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O
M;'-P86X],T0R('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T
M('-O;&ED.R!T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQB/C(P
M,3,\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/CQB/C(P,3(\+V(^/"]F
M;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I
M8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY$969E
M<G)E9"!T87@@87-S971S.CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P
M86X],T0R('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y
M;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO
M<CH@(T-#145&1B<^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`W."4G/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/DYE="!O<&5R871I;F<@;&]S<R!C87)R>69O<G=A<F1S/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA
M;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/CQF;VYT('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B0\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L
M:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^,BPP,C<L,#`P/"]F;VYT/CPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=W:61T:#H@,24G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z
M(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W=I9'1H.B`X)3L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/C$L.#4R+#`P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R
M87`@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^3W1H97(\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q
M+C5P="!S;VQI9"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^.#8L,#`P/"]F
M;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S
M;VQI9"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D
M('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED.R!T
M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^,3`V+#`P,#PO9F]N=#X\
M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C0T-%149&)SX-"B`@
M("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXR+#$Q,RPP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G
M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^,2PY-3@L,#`P/"]F;VYT/CPO=&0^
M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N
M.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0^
M/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N
M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A
M8VMG<F]U;F0M8V]L;W(Z("-#0T5%1D8G/@T*("`@(#QT9#X\9F]N="!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M)SY686QU871I;VX@86QL;W=A;F-E/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@,2XU<'0@<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q
M+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B@R
M+#$Q,RPP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/BD\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q
M+C5P="!S;VQI9"<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^*#$L.34X+#`P
M,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^*3PO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4G/@T*
M("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SY.970@9&5F97)R960@=&%X(&%S<V5T<SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL
M(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4G/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R
M9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@
M<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/BT\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E
M<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4G/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B0\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@
M8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/BT\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\+W1A8FQE
M/@T*#0H-"CQP('-T>6QE/3-$)VUA<F=I;CH@,'!T)SX\+W`^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296-O;F-I
M;&EA=&EO;B!O9B!T:&4@<W1A='5T;W)Y(&9E9&5R86P@:6YC;VUE('1A>"!E
M>'!E;G-E("AB96YE9FET*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQP('-T>6QE/3-$)VUA<F=I;CH@,'!T)SX\+W`^#0H-"CQP('-T>6QE
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M($1E8V5M8F5R(#,Q(&9O;&QO=W,Z/"]F;VYT/CPO<#X-"@T*/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]P/@T*#0H\
M=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!W
M:61T:#H@,3`P)2<^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O
M='1O;2<^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@8V]L<W!A;CTS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA
M8VL@,2XU<'0@<V]L:60[('1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9B<^/&(^,C`Q,SPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT
M9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@8V]L
M<W!A;CTS1#(@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU<'0@
M<V]L:60[('1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^/&(^,C`Q
M,CPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`@/'1D/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H@("`@/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V
M,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@(T-#
M145&1B<^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`W."4G/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/E-T871U=&]R>2!F961E<F%L(&EN8V]M92!T87@@<F%T93PO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ
M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2
M;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#@E.R!T97AT+6%L
M:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^,S0\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@
M,24[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED=&@Z(#$E)SX\9F]N="!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=VED
M=&@Z(#@E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^,S0\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@;F]W<F%P/3-$;F]W<F%P('-T>6QE/3-$)W=I
M9'1H.B`Q)2<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)3PO9F]N=#X\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC
M;VQO<CH@=VAI=&4G/@T*("`@(#QT9#X\9F]N="!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SY686QU871I;VX@
M86QL;W=A;F-E/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXF(S$V,#L\+V9O;G0^/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU<'0@
M<V]L:60G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT
M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@
M=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B@S-#PO9F]N=#X\+W1D
M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)2D\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9"<^/&9O;G0@
M<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!3
M97)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O
M<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED.R!T97AT+6%L:6=N.B!R
M:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^*#,T/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF)SXE*3PO9F]N=#X\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R
M;W5N9"UC;VQO<CH@(T-#145&1B<^#0H@("`@/'1D/CQF;VYT('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68G/B8C
M,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@
M4F]M86XL(%1I;65S+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B
M;&4G/CQF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^,#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9B<^)3PO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O
M;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9B<^)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#(N,C5P="!D;W5B;&4G/CQF;VYT('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68G/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D
M97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R
M:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9B<^,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9B<^)3PO9F]N=#X\+W1D/CPO='(^#0H\
M+W1A8FQE/@T*#0H-"CQP('-T>6QE/3-$)VUA<F=I;CH@,'!T)SX\+W`^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@
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M('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\
M:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O
M;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y
M<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@
M4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O
M9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14Q"04,^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X]
M,T0Q(')O=W-P86X],T0Q/CQS=')O;F<^3W)G86YI>F%T:6]N($YA='5R92!A
M;F0@0V]N=&EN=6%N8V4@;V8@3W!E<F%T:6]N<R`H1&5T86EL<R!.87)R871I
M=F4I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W)G86YI>F%T:6]N($YA='5R
M92!!;F0@0V]N=&EN=6%N8V4@3V8@3W!E<F%T:6]N<R!$971A:6QS($YA<G)A
M=&EV93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!8V-U;75L871E9"!D969I8VET/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#8L,3(U+#0Y-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-2PU,C,L-SDR/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T+#0Y,2PP,#0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V5F9C)E
M-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?838T.%\R9C@W
M9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E=#(S+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-$%!
M0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY3:6=N:69I8V%N="!!8V-O=6YT
M:6YG(%!O;&EC:65S("A$971A:6QS($YA<G)A=&EV92D\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-I97,@1&5T86EL<R!.87)R
M871I=F4\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#;VUM;VX@<W1O8VL@8V]N<VES=&5D(&]F('=A<G)A;G1S('1O('!U
M<F-H87-E('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M."PR,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^."PR,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS('1O('!U<F-H87-E('-H87)E
M<R!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$S-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XX,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T
M8C<W-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A
M-V$Y7S0Q9#%?838T.%\R9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E=#(T
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%04)!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY$
M:7-C;VYT:6YU960@3W!E<F%T:6]N<R`H1&5T86EL<RD@*%531"`D*3QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@
M,S$L(#(P,3(\8G(^06-C;W5N=',@<&%Y86)L92!;365M8F5R73QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/D%S
M<V5T(')E=&ER96UE;G0@;V)L:6=A=&EO;B!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/E1O=&%L
M($QI86)I;&ET:65S(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^3VEL($%N9"!'87,@4')O<&5R
M=&EE<RP@3F5T(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^36EN:6YG(%!R;W!E<G1I97,@6TUE
M;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,CQB<CY/=&AE<B!C=7)R96YT(&%S<V5T<R!;365M8F5R73QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R
M/D%S<V5T<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^07-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`R-"PQ,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#4Q.2PW-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#@P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-30T+#8W-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&EA8FEL
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-3<L-3,R
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@Q,BPY,S(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XD("@U-RPU,S(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XD("@W,"PT-C0I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?969F,F4W,#1?83=A.5\T,60Q
M7V$V-#A?,F8X-V9D-31B-S<T#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-"]7;W)K
M<VAE971S+U-H965T,C4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5"3$%#/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/D1I<V-O;G1I;G5E9"!/<&5R871I;VYS("A$971A:6QS
M($YA<G)A=&EV92D@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXQ,B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1I<V-O;G1I;G5E9"!/<&5R871I
M;VYS($1E=&%I;',@3F%R<F%T:79E/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V%R<GEI;F<@86UO=6YT(&]F('1H92!O
M:6P@86YD(&=A<R!P<F]P97)T:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#(T+#$R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%S<V5T(')E=&ER96UE;G0@;V)L:6=A=&EO
M;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3<L-3,R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07-S
M970@<F5T:7)E;65N="!O8FQI9V%T:6]N+"!L:6%B:6QI=&EE<R!A<W-U;65D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPY,S(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H
M(')E8V5I=F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E)E8V]G;FEZ960@9V%I;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-#DL,S,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4F5V96YU92!R97!O<G1E9"!I;B!D:7-C;VYT:6YU
M960@;W!E<F%T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$V+#4T.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,@<F5P;W)T960\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-#`T+#(T,RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$T+#0R,"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V5F9C)E
M-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?838T.%\R9C@W
M9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E=#(V+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%1$9!
M0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY);G1A;F=I8FQE($%S<V5T<R`M
M($EN=&5L;&5C='5A;"!0<F]P97)T("A$971A:6QS*3QB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^26YT86YG:6)L92!!<W-E=',@+2!);G1E;&QE8W1U86P@4')O<&5R="!$
M971A:6QS/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5V5I9VAT960@879E<F%G92!R:7-K+69R964@:6YT97)E<W0@<F%T
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XV,B4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C<U)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M17AP96-T960@;&EF92!I;B!Y96%R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG-2!Y96%R<R`V(&UO;G1H<SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@
M079G($5X<&5C=&5D(%9O;&%T:6QI='D\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/CDP+CDP)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$P,BXP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D(&1I=FED96YD('EI
M96QD/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P)3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
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M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P141)
M04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P
M86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^26YT86YG:6)L92!!<W-E=',@
M+2!);G1E;&QE8W1U86P@4')O<&5R="`H1&5T86EL<R!.87)R871I=F4I("A5
M4T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6XN(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY);G1A;F=I8FQE($%S<V5T<R`M($EN=&5L
M;&5C='5A;"!0<F]P97)T($1E=&%I;',@3F%R<F%T:79E/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&%N9VEB;&4@
M87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$V,BPX
M-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#$V,BPX-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$V,BPX-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@=F%L=64@;V8@5V%R<F%N=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C<Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C<Y/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P
M+C@W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#;VYS=6QT:6YG(&5X<&5N<V4@87-S;V-I871E9"!W:71H('1H92!3
M97)I97,@02!787)R86YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#8X+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,3DU+#,S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F
M9#4T8C<W-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P
M-%]A-V$Y7S0Q9#%?838T.%\R9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E
M=#(X+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%3C%!13X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY#;VUM;VX@4W1O8VL@3W!T:6]N<R`H1&5T86EL<RD@*%531"`D*3QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN
M(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^3W!T:6]N<R!/=71S=&%N9&EN9SPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@;W5T<W1A
M;F1I;F<@+2!B96=I;FYI;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!G<F%N
M=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-2PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,S`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y/<'1I;VYS(&9O<F9E:71E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#,U,"PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&]U<W1A;F1I;F<@+2!E;F1I
M;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,U
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W!T:6]N<R!E>&5R8VES86)L93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E=E:6=H
M=&5D(&%V97)A9V4@97AE<F-I<V4@<')I8V4\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&]U='-T86YD:6YG
M("T@8F5G:6YN:6YG(&)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,"XW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!G<F%N=&5D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N,#4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N-S(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P
M=&EO;G,@9F]R9F5I=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P+C<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y/<'1I;VYS(&]U='-T86YD:6YG("T@96YD:6YG(&)A;&%N
M8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XX-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XW
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y/<'1I;VYS(&5X97)C:7-A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`N-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,"XV-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY796EG:'1E9"!A=F5R86=E
M(')E;6%I;FEN9R!C;VYT<F%C=&5D('1E<FT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT<R!O=71S=&%N9&EN
M9R`M(&)E9VEN;FEN9R!B86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG.2!Y96%R<R`Q(&UO;G1H(#$W(&1A>7,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&=R
M86YT960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Y('EE87)S
M(#D@;6]N=&AS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SD@>65A<G,@-B!M;VYT:',@,3@@9&%Y<SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!F
M;W)F96ET960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG.2!Y
M96%R<R`V(&UO;G1H<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5V%R<F%N=',@;W5T<W1A;F1I;F<@+2!E;F1I;F<@
M8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SD@>65A
M<G,@-"!M;VYT:',@,3<@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<Y('EE87)S(#D@;6]N=&AS/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT
M<R!E>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SD@>65A<G,@,2!M;VYT:"`Q-R!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SD@>65A<G,@-B!M;VYT:',\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^06=G<F5G871E(&EN=')I;G-I8R!V86QU93PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@;W5T<W1A
M;F1I;F<@+2!B96=I;FYI;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`R,RPR,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&=R
M86YT960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I
M;VYS(&]U='-T86YD:6YG("T@96YD:6YG(&)A;&%N8V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$T+#@U,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S+#(P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!E>&5R
M8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-BPX,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?
M838T.%\R9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E=#(Y+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%2U)!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VUM;VX@4W1O
M8VL@3W!T:6]N<R`H1&5T86EL<R`Q*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XV($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D(&%V97)A
M9V4@<FES:RUF<F5E(&EN=&5R97-T(')A=&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$N-C(E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2XW-24\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D(&QI9F4@:6X@>65A
M<G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<U('EE87)S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S4@
M>65A<G,@-B!M;VYT:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V9R!%>'!E8W1E9"!6;VQA=&EL
M:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,"XY,"4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#(N
M,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%>'!E8W1E9"!D:79I9&5N9"!Y:65L9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@3W!T:6]N<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D(&1I=FED
M96YD('EI96QD/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y3=&]C:R!/<'1I;VYS('P@36EN:6UU;3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D(&%V97)A9V4@<FES:RUF
M<F5E(&EN=&5R97-T(')A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$N-#,E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2XT,R4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D(&QI9F4@:6X@>65A<G,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<T('EE87)S(#8@;6]N=&AS/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S4@
M>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E=E:6=H=&5D($%V9R!%>'!E8W1E9"!6;VQA=&EL:71Y/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY.2XU,"4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY.2XU,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K
M($]P=&EO;G,@?"!-87AI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^5V5I9VAT960@879E<F%G92!R:7-K+69R964@:6YT97)E<W0@
M<F%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XV,B4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C0Y
M)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^17AP96-T960@;&EF92!I;B!Y96%R<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)S4@>65A<G,@-B!M;VYT:',\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-2!Y96%R<R`V(&UO;G1H
M<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5V5I9VAT960@079G($5X<&5C=&5D(%9O;&%T:6QI='D\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$P-2XS,"4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#,N-#`E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E9F8R93<P-%]A-V$Y
M7S0Q9#%?838T.%\R9C@W9F0U-&(W-S0-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO969F,F4W,#1?83=A.5\T,60Q7V$V-#A?,F8X-V9D-31B-S<T
M+U=O<FMS:&5E=',O4VAE970S,"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P155004,^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^0V]M;6]N(%-T;V-K($]P=&EO;G,@*$1E=&%I
M;',@3F%R<F%T:79E*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q
M-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R
M,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^0V]M;6]N(%-T;V-K($]P=&EO;G,@1&5T86EL<R!.87)R871I=F4\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4VAA<F5S(&%V86EL86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3DL.#8U+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$Y+#@V-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.2PY,C`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:RUB87-E
M9"!C;VUP96YS871I;VX@861M:6YI<W1R871I=F4@97AP96YS93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,BPU-S,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$Y+#,U-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,34L
M-#0P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y5;G)E8V]G;FEZ960@8V]M<&5N<V%T:6]N(&-O<W0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-34L,S@W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U-2PS.#<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(W+#,Q
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4W1O8VL@;W!T:6]N<R!V97-T960\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!O<'1I;VYS('5N=F5S=&5D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$U+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K
M(&]P=&EO;G,@9W)A;G1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#`N-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q
M9#%?838T.%\R9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E=#,Q+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%1D)!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VUM:71M
M96YT<R`H1&5T86EL<R!.87)R871I=F4I("A54T0@)"D\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P
M,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^0V]M;6ET;65N=',@1&5T86EL<R!.87)R871I=F4\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&5S92!O<F1E
M<B!R96-E=FEE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,3,P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4'5R8VAE<V4@;W)D97(@86UO=6YT(')E8V5I=F5D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8U+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V5F9C)E-S`T7V$W83E?
M-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?838T.%\R9C@W9F0U-&(W-S0O
M5V]R:W-H965T<R]3:&5E=#,R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%6$M!1SX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY296QA=&5D(%!A<G1Y(%1R86YS86-T:6]N<R`H
M1&5T86EL<R!.87)R871I=F4I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,CXV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0R/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N
M+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*
M=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^06-C;W5N=',@<&%Y86)L92`M(')E;&%T960@<&%R=&EE<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S-BPP.#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S-BPP
M.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`T-"PR,3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#DL-C,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y,96=A;"!&964@6TUE;6)E<ET\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AP96YS92!R96-O
M9VYI>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DW
M+#8P.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5X<&5N<V4@<F5C;V=N:7IE9"!U;G!A:60@86UO=6YT<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,R+#`Q.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]F9FEC
M97(@86YD(&1I<F5C=&]R<R!;365M8F5R72!\($UA;F%G96UE;G0@1F5E(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D9E97,@<&%I9"!O<B!D=64@=&\@<F5L871E9"!P87)T>3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#DL,#DW/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#,L,CDX
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y/9F9I8V5R(&%N9"!D:7)E8W1O<G,@6TUE;6)E<ET@?"!,96=A;"!&964@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1F5E<R!P86ED(&]R(&1U92!T;R!R96QA=&5D('!A<G1Y/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@R+#$X-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8R+#0S.3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$:7)E
M8W1O<G,@6TUE;6)E<ET@?"!,96=A;"!&964@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F5E<R!P86ED(&]R(&1U
M92!T;R!R96QA=&5D('!A<G1Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#(W+#@R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,S@L.3<T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$V-2PU.3$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#<R+#4P,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?969F,F4W,#1?
M83=A.5\T,60Q7V$V-#A?,F8X-V9D-31B-S<T#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+V5F9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T
M8C<W-"]7;W)K<VAE971S+U-H965T,S,N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4Q1T%#/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,3X\<W1R;VYG/DEN8V]M92!487AE<R`H1&5T86EL<RD@
M*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^1&5F97)R960@=&%X(&%S<V5T<SH\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@
M;W!E<F%T:6YG(&QO<W,@8V%R<GEF;W)W87)D<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`R+#`R-RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L.#4R+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@V+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P-BPP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D1E9F5R<F5D('1A>"!A<W-E=',@9W)O<W,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L,3$S+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.34X+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5F%L=6%T:6]N(&%L
M;&]W86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPQ,3,L
M,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#$L.34X+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D1E9F5R<F5D('1A>"!A<W-E=#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7V5F
M9C)E-S`T7V$W83E?-#%D,5]A-C0X7S)F.#=F9#4T8C<W-`T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B]E9F8R93<P-%]A-V$Y7S0Q9#%?838T.%\R
M9C@W9F0U-&(W-S0O5V]R:W-H965T<R]3:&5E=#,T+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M141!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY);F-O;64@5&%X97,@*$1E
M=&%I;',@,2D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#(^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY);F-O;64@5&%X97,@1&5T86EL<R`Q/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1A='5T;W)Y
M(&9E9&5R86P@:6YC;VUE('1A>"!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS-"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS-"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-H86YG92!I;B!V86QU871I;VX@
M86QL;W=A;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S-"XP
M,"4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,S0N,#`E*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^26YC;VUE('1A>"!P<F]V:7-I;VX@*&)E;F5F:70I/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P)3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
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M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P149(/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,CX\<W1R;VYG/DEN8V]M92!487AE<R`H1&5T86EL<R!.87)R
M871I=F4I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,3(@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY);F-O;64@5&%X97,@1&5T86EL<R`Q/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC
M<F5A<V4@:6X@=&AE('9A;'5A=&EO;B!A;&QO=V%N8V4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,34U+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.#$L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
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M;&4@2%)E9CTS1")3:&5E=#`Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970P,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#,N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`T+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970P-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,#8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`W+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P."YH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,#DN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#$P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q,2YH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3(N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#$S+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970Q-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,34N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$V+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970Q-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,3@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$Y
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,"YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,C$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#(R+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R
M,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C0N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(U+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970R-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,C<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(X+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970R.2YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,S`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#,Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S,BYH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S,N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#,T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970S-2YH=&UL(B\^#0H\+WAM;#X-"BTM+2TM+3U?3F5X=%!A<G1?969F,F4W
B,#1?83=A.5\T,60Q7V$V-#A?,F8X-V9D-31B-S<T+2T-"@``
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
<META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EKRAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Common Stock Options (Details 
1)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Weighted average 
risk-free interest rate</a></td>
        <td class="nump">1.62%<span></span></td>
        <td class="nump">1.75%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsExpectedTerm', window );">Expected life in 
years</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years 6 months<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted Avg
Expected Volatility</a></td>
        <td class="nump">90.90%<span></span></td>
        <td class="nump">102.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsExpectedDividendRate', window );">Expected dividend 
yield</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock Options</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsExpectedDividendRate', window );">Expected dividend 
yield</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock Options | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Weighted average 
risk-free interest rate</a></td>
        <td class="nump">1.43%<span></span></td>
        <td class="nump">1.43%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsExpectedTerm', window );">Expected life in 
years</a></td>
        <td class="text">4 years 6 months<span></span></td>
        <td class="text">5 years<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted Avg
Expected Volatility</a></td>
        <td class="nump">99.50%<span></span></td>
        <td class="nump">99.50%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock Options | Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Weighted average 
risk-free interest rate</a></td>
        <td class="nump">1.62%<span></span></td>
        <td class="nump">1.49%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsExpectedTerm', window );">Expected life in 
years</a></td>
        <td class="text">5 years 6 months<span></span></td>
        <td class="text">5 years 6 months<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted Avg
Expected Volatility</a></td>
<td class="nump">105.30%<span></span></td>
        <td class="nump">103.40%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_FairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Expected dividends to be paid to holders of the underlying 
shares or financial instruments (expressed as a percentage of the share or 
instrument's price).</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);"
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Period the instrument, asset or liability is expected to be 
outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the 
reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssumptionsExpectedTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_FairValueAssumptionsRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Risk-free interest rate assumption used in valuing an 
instrument.</p>
</div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssumptionsRiskFreeInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Weighted average expected volatility of stock price.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EN1AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Common Stock Options (Details) (USD
$)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
<tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_OptionsOutstandingAbstract', window );"><strong>Options 
Outstanding</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber', window );">Options outstanding - beginning 
balance</a></td>
        <td class="nump">80,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod', window );">Options granted</a></td>
        <td class="nump">55,000<span></span></td>
        <td class="nump">430,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod', window );">Options forfeited</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(350,000)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber', window );">Options oustanding - ending 
balance</a></td>
        <td class="nump">135,000<span></span></td>
        <td class="nump">80,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionE
quityInstrumentsExercisable', window );">Options exercisable</a></td>
        <td class="nump">20,000<span></span></td>
        <td class="nump">20,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', 
window );"><strong>Weighted average exercise price</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Options
outstanding - beginning balance</a></td>
        <td class="nump">$ 0.70<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', 
window );">Options granted</a></td>
        <td class="nump">$ 1.05<span></span></td>
        <td class="nump">$ 0.72<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Options
forfeited</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.72<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Options 
outstanding - ending balance</a></td>
        <td class="nump">$ 0.84<span></span></td>
        <td class="nump">$ 0.70<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', 
window );">Options exercisable</a></td>
        <td class="nump">$ 0.70<span></span></td>
        <td class="nump">$ 0.65<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_WeightedAverageRemainingContractedTerm', 
window );"><strong>Weighted average remaining contracted term</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInst
rumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1', 
window );">Warrants outstanding - beginning balance</a></td>
        <td class="text">9 years 1 month 17 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInst
rumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms', 
window );">Options granted</a></td>
        <td class="text">9 years 9 months<span></span></td>
<td class="text">9 years 6 months 18 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInst
rumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms', 
window );">Options forfeited</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">9 years 6 months<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms', 
window );">Warrants outstanding - ending balance</a></td>
        <td class="text">9 years 4 months 17 days<span></span></td>
        <td class="text">9 years 9 months<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1', window );">Warrants 
exercisable</a></td>
        <td class="text">9 years 1 month 17 days<span></span></td>
        <td class="text">9 years 6 months<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedIntrinsicValueRollForward', window );"><strong>Aggregate
intrinsic value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding', window );">Options 
outstanding - beginning balance</a></td>
        <td class="nump">$ 23,200<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInst
rumentsOtherThanOptionsAggregateIntrinsicValueGranted', window );">Options 
granted</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding', window );">Options 
outstanding - ending balance</a></td>
        <td class="nump">14,850<span></span></td>
        <td class="nump">23,200<span></span></td>
</tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInst
rumentsOtherThanOptionsAggregateIntrinsicValueExercisable', window );">Options 
exercisable</a></td>
        <td class="nump">$ 5,000<span></span></td>
        <td class="nump">$ 6,800<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_OptionsOutstandingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_OptionsOutstandingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityI
nstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
<p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityIn
strumentsOtherThanOptionsAggregateIntrinsicValueExercisable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityI
nstrumentsOtherThanOptionsAggregateIntrinsicValueGranted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityIn
strumentsOtherThanOptionsAggregateIntrinsicValueGranted</nobr></td>
                  </tr>
<tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityI
nstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityIn
strumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms</nobr
></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
<tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityI
nstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityIn
strumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms</nobr><
/td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityI
nstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityIn
strumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1</n
obr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOpti
onEquityInstrumentsExercisable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>warrants exercisable</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display:
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptio
nEquityInstrumentsExercisable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_WeightedAverageRemainingContractedTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_WeightedAverageRemainingContractedTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
<tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Intrinsic value of equity-based compensation awards 
outstanding. Excludes stock and unit options.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsO
therThanOptionsAggregateIntrinsicValueOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The number of equity-based payment instruments, excluding 
stock (or unit) options, that were forfeited during the reporting period.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)
(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeitedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Weighted average fair value as of the grant date of equity-
based award plans other than stock (unit) option plans that were not exercised 
or put into effect as a result of the occurrence of a terminating event.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)
(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsForfeituresWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The number of grants made during the period on other than 
stock (or unit) option plans (for example, phantom stock or unit plan, stock or 
unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display:
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)
(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The weighted average fair value at grant date for nonvested 
equity-based awards issued during the period on other than stock (or unit) 
option plans (for example, phantom stock or unit plan, stock or unit 
appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)
(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedIntrinsicValueRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedIntrinsicValueRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
<td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The weighted average fair value of nonvested awards on 
equity-based plans excluding option plans (for example, phantom stock or unit 
plan, stock or unit appreciation rights plan, revenue or profit achievement 
stock award plan) for which the employer is contingently obligated to issue 
equity instruments or transfer assets to an employee who has not yet satisfied 
service or performance criteria necessary to gain title to proceeds from the 
sale of the award or underlying shares or units.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-
(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
<td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">-
Definition</a><div>
                <p>Weighted average remaining contractual term for equity-based 
awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' 
represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br>
-URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsOutstandingWeightedAverageRemainingContractualTerms</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The weighted average fair value as of grant date pertaining 
to an equity-based award plan other than a stock (or unit) option plan for which
the grantee gained the right during the reporting period, by satisfying service 
and performance requirements, to receive or retain shares or units, other 
instruments, or cash in accordance with the terms of the arrangement.</p>
              </div><a href="javascript:void(0);"
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)
(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsO
therThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Number of equity instruments other than options outstanding, 
including both vested and non-vested instruments.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)
(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br>Reference 2:
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)
(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityIns
trumentsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Weighted average remaining contractual term for vested 
portions of options outstanding and currently exercisable or convertible, in 
'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of
one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);"
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisable
WeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EUPAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Common Stock Options (Details 
Narrative) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
<div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_CommonStockOptionsDetailsNarrativeAbstract', 
window );"><strong>Common Stock Options Details Narrative</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_SharesAvailable', window );">Shares available</a></td>
        <td class="nump">19,865,000<span></span></td>
        <td class="nump">19,865,000<span></span></td>
        <td class="nump">19,920,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_StockbasedCompensationAdministrativeExpense', window );">Stock-
based compensation administrative expense</a></td>
        <td class="nump">$ 12,573<span></span></td>
        <td class="nump">$ 19,355<span></span></td>
        <td class="nump">$ 15,440<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_UnrecognizedCompensationCost', window );">Unrecognized compensation
cost</a></td>
        <td class="nump">$ 55,387<span></span></td>
        <td class="nump">$ 55,387<span></span></td>
        <td class="nump">$ 27,317<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares', window );">Stock options vested</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_StockOptionsUnvested', window );">Stock options unvested</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">115,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_StockOptionsGranted', window );">Stock options granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
<td class="nump">$ 0.49<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_CommonStockOptionsDetailsNarrativeAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_CommonStockOptionsDetailsNarrativeAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_SharesAvailable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Shares available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
<tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_SharesAvailable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_StockbasedCompensationAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Stock based compensation administrative expense.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_StockbasedCompensationAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
</tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_StockOptionsGranted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Stock options granted.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_StockOptionsGranted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_StockOptionsUnvested">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
<td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_StockOptionsUnvested</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_UnrecognizedCompensationCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Unrecognized compensation cost.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_UnrecognizedCompensationCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Number of options vested.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumbe
rOfShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
</tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EFBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments (Details Narrative) 
(USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_CommitmentsDetailsNarrativeAbstract', 
window );"><strong>Commitments Details Narrative</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_PurcheseOrderRecevied', window );">Purchese order recevied</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 130,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_PurcheseOrderAmountReceived', window );">Purchese order amount 
received</a></td>
        <td class="nump">$ 65,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
</tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_CommitmentsDetailsNarrativeAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_CommitmentsDetailsNarrativeAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_PurcheseOrderAmountReceived">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
<td><nobr>rcar_PurcheseOrderAmountReceived</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_PurcheseOrderRecevied">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_PurcheseOrderRecevied</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
</tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ERG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Organization, Nature and 
Continuance of Operations<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NatureOfOperations', window );">Note 1. Organization, Nature and 
Continuance of Operations</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">RenovaCare, Inc., together with its wholly
owned subsidiary (the &#147;Company&#148;), focuses on the acquisition, 
research, development and, if warranted, commercialization
of autologous (using a patient&#146;s own cells) cellular therapies that can be 
used for medical and aesthetic applications.
The Company was previously involved in the exploration and development of both 
mineral exploration properties and oil and gas
properties.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On July 12, 2013, the Company, together with
its wholly owned subsidiary, RenovaCare Sciences Corp. (&#147;RenovaCare 
Sciences&#148;), a Nevada corporation formerly known
as Janus Acquisition Corp., entered into an asset purchase agreement with Dr. 
J&#246;rg Gerlach, MD, PhD, pursuant to which RenovaCare
Sciences purchased all of Dr. Gerlach&#146;s rights, title and interest to a 
treatment methodology for skin isolation, spraying
and associated equipment for the regeneration of human skin cells (the 
&#147;Cell Deposition Device&#148;), along with the associated
US and foreign patents and patent applications. The development of the Cell 
Deposition Device is in the early stages and the Company
anticipates that significant time and financial resources will be required to 
further develop the technology and determine whether
a commercially viable product can be developed.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The Company has recently incurred net operating
losses and operating cash flow deficits. As of June 30, 2014, the Company&#146;s
total accumulated deficit is $6.1 million. The
Company does not currently generate revenues and will continue to incur losses 
from operations and operating cash flow deficits
in the future. Management believes that the Company&#146;s cash and cash 
equivalent balances, anticipated cash flows from operations
and other external sources of capital will be sufficient to meet the 
Company&#146;s cash requirements through December 31, 2014.
The future of the Company after December 2014 will depend in large part on its 
ability to successfully raise capital from external
sources to fund operations.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">RenovaCare,
Inc., together with its wholly owned subsidiary (the &#147;Company&#148;), 
focuses on the acquisition, research, development
and, if warranted, commercialization of autologous (using a patient&#146;s own 
cells) cellular therapies that can be used for
medical and aesthetic applications. The Company was previously involved in the 
exploration and development of both mineral exploration
properties and oil and gas properties. The Company sold its oil and gas 
properties on February 18 and 19, 2013 and sold its subsidiary
which controlled various mineral leases and mining claims on December 31, 2013. 
Effective February 20, 2013, the Company became
a development stage company.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
July 12, 2013, the Company, together with its wholly owned subsidiary, 
RenovaCare Sciences Corp. (&#147;RenovaCare Sciences&#148;),
a Nevada corporation formerly known as Janus Acquisition Corp., entered into an 
asset purchase agreement with Dr. J&#246;rg Gerlach,
MD, PhD, pursuant to which RenovaCare Sciences purchased all of Dr. 
Gerlach&#146;s rights, title and interest to a treatment
methodology for skin isolation , spraying and associated equipment for the
regeneration of human skin cells (the &#147;Cell Deposition
Device&#148;), along with the associated US and foreign patents and patent 
applications. The development of the Cell Deposition
Device is in the early stages and we anticipate that significant time and 
financial resources will be required to further develop
the technology and determine whether a commercially viable product can be 
developed.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
December 31, 2013, we entered into a stock purchase agreement with Duke Mountain
Resources, Inc. (&#147;Duke&#148;), a Nevada
corporation, pursuant to which we sold to Duke 100% of the issued and 
outstanding shares of Fostung Resources Ltd. (&#147;Fostung
Resources&#148;), a corporation organized under the laws of Ontario, Canada and 
a wholly owned subsidiary of ours, for a promissory
note in the amount of $80,000, which amount approximated the fair value of the 
leases and mining claims controlled by Fostung
Resources, as concluded by an independent third-party geological 
consultant.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="margin: 0; text-align: justify"><font style="font: 10pt Times New 
Roman, Times, Serif">The Company has recently incurred
net operating losses and operating cash flow deficits. The Company&#146;s total 
accumulated deficit is $5.5 million as of December
31, 2013. The Company does not currently generate revenues and will continue to 
incur losses from operations and operating cash
flow deficits in the future. Management believes that the Company&#146;s cash 
and cash equivalent balances, anticipated cash
flows from operations and other external sources of capital will be sufficient 
to meet our cash requirements through December
31, 2014. The future of the Company after December 2014 will depend in large 
part on its ability to successfully raise capital
from external sources to fund operations.</font></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_NotesToFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NatureOfOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The entire disclosure for the nature of an entity's business,
the major products or services it sells or provides and its principal markets, 
including the locations of those markets. If the entity operates in more than 
one business, the disclosure also indicates the relative importance of its 
operations in each business and the basis for the determination (for example, 
assets, revenues, or earnings).</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-
108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NatureOfOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
<td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EXKAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Related Party Transactions (Details
Narrative) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts 
payable - related parties</a></td>
        <td class="nump">$ 36,080<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 36,080<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 44,219<span></span></td>
        <td class="nump">$ 9,638<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Legal Fee [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherNonoperatingExpense', window );">Expense recognized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">197,609<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_ExpenseRecognizedUnpaidAmounts', window );">Expense recognized 
unpaid amounts</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">32,018<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Officer and directors [Member] | Management Fee 
[Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', 
window );">Fees paid or due to related party</a></td>
        <td class="nump">3,000<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">6,000<span></span></td>
        <td class="nump">0<span></span></td>
<td class="nump">49,097<span></span></td>
        <td class="nump">43,298<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Officer and directors [Member] | Legal Fee 
[Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', 
window );">Fees paid or due to related party</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">82,185<span></span></td>
        <td class="nump">62,439<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Directors [Member] | Legal Fee [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', 
window );">Fees paid or due to related party</a></td>
        <td class="nump">$ 27,820<span></span></td>
        <td class="nump">$ 38,974<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 165,591<span></span></td>
        <td class="nump">$ 72,503<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_ExpenseRecognizedUnpaidAmounts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Expense recognized unpaid amounts.</p>
</div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_ExpenseRecognizedUnpaidAmounts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount for accounts payable to related parties.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.
(k)(1))<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (d)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-
107864<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br>
-Paragraph k<br><br> -Subparagraph 1<br><br> -Article 4<br><br><br><br>Reference
4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br>
-Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 
210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-
03.15(5))<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-
122878<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 
210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-
03.17)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-
122910<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> 
-Paragraph 17<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The aggregate amount of other expense amounts, the components
of which are not separately disclosed on the income statement, resulting from 
ancillary business-related activities (that is, excluding major activities 
considered part of the normal operations of the business) also known as other 
nonoperating expense recognized during the period. Such amounts may include: (a)
unusual costs, (b) loss on foreign exchange transactions, (c) losses on
securities (net of profits), and (d) miscellaneous other expense items.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> 
-Paragraph 9<br><br> -Article 5<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.9)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNonoperatingExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Expenses recognized resulting from transactions (excluding 
transactions that are eliminated in consolidated or combined financial 
statements) with related party.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br>
-Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-
107864<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0E3NAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (USD 
$)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
</th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash 
equivalents</a></td>
        <td class="nump">$ 1,168,093<span></span></td>
        <td class="nump">$ 1,508,843<span></span></td>
        <td class="nump">$ 513,595<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
        <td class="nump">24,337<span></span></td>
        <td class="nump">1,230<span></span></td>
        <td class="nump">7,562<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
        <td class="nump">1,600<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">800<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">1,194,030<span></span></td>
        <td class="nump">1,510,073<span></span></td>
        <td class="nump">521,957<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccountsAndNotesReceivableNet', window );">Note receivable from Duke 
Mountain</a></td>
        <td class="nump">80,000<span></span></td>
        <td class="nump">80,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Long-term 
assets of discontinued operations</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">543,877<span></span></td>
      </tr>
<tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherIntangibleAssetsNet', window );">Intangible assets</a></td>
        <td class="nump">162,854<span></span></td>
        <td class="nump">162,854<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Assets', window );">Total assets</a></td>
        <td class="nump">1,436,884<span></span></td>
        <td class="nump">1,752,927<span></span></td>
        <td class="nump">1,065,834<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesCurrentAbstract', window );"><strong>Current 
liabilities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable 
and accrued liabilities</a></td>
        <td class="nump">74,222<span></span></td>
        <td class="nump">11,222<span></span></td>
        <td class="nump">17,973<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccountsPayableRelatedPartiesCurrent', window );">Accrued expenses - 
related parties</a></td>
        <td class="nump">52,191<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities', window
);">Current liabilities of discontinued operations</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">12,932<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">126,413<span></span></td>
        <td class="nump">55,441<span></span></td>
        <td class="nump">40,543<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_LongtermLiabilitiesOfDiscontinuedOperations', window );">Long-term
liabilities of discontinued operations</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">57,532<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Liabilities', window );">Total liabilities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">55,441<span></span></td>
        <td class="nump">98,075<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' 
EQUITY</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PreferredStockValue', window );">Preferred stock: $0.0001 par value: 
Authorized: 10,000,000 shares Issued and outstanding: nil</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockValue', window );">Common stock: $0.00001 par value: Authorized:
500,000,000 Issued and outstanding: 66,575,122 shares</a></td>
        <td class="nump">666<span></span></td>
        <td class="nump">666<span></span></td>
        <td class="nump">631<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">7,435,300<span></span></td>
        <td class="nump">7,220,612<span></span></td>
        <td class="nump">5,462,236<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated 
deficit</a></td>
        <td class="num">(6,125,495)<span></span></td>
        <td class="num">(5,523,792)<span></span></td>
        <td class="num">(4,491,004)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_AccumulatedDeficitSinceDevelopmentStage', window );">Accumulated 
deficit since development stage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,068,310)<span></span></td>
<td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated 
other comprehensive loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(4,104)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
        <td class="nump">1,310,471<span></span></td>
        <td class="nump">1,697,486<span></span></td>
        <td class="nump">967,759<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and 
stockholders' equity</a></td>
        <td class="nump">$ 1,436,884<span></span></td>
        <td class="nump">$ 1,752,927<span></span></td>
        <td class="nump">$ 1,065,834<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_AccumulatedDeficitSinceDevelopmentStage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Custom Element</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_AccumulatedDeficitSinceDevelopmentStage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
<td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_LongtermLiabilitiesOfDiscontinuedOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Custom Element</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_LongtermLiabilitiesOfDiscontinuedOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AccountsAndNotesReceivableNet">
        <tr>
<td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Carrying amount as of the balance sheet date, net of 
allowance for doubtful accounts, of account and note receivables due from other 
than related parties.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-
4)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsAndNotesReceivableNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
<p>Sum of the carrying values as of the balance sheet date of 
obligations incurred through that date and due within one year (or the operating
cycle, if longer), including liabilities incurred (and for which invoices have 
typically been received) and payable to vendors for goods and services received,
taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes
and fringe benefits.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.19,20)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_AccountsPayableAndAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
<div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount for accounts payable to related parties. Used to 
reflect the current portion of the liabilities (due within one year or within 
the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)
(1))<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
50<br><br><br><br> -Paragraph 4<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-
107864<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-
107864<br><br><br><br><br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 08<br><br><br><br> -Paragraph k<br><br><br><br> 
-Subparagraph 1<br><br><br><br> -Article 
4<br><br><br><br><br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> 
-Subparagraph a<br><br><br><br> -Article 
5<br><br><br><br><br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.19(a))<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-
107864<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_AccountsPayableRelatedPartiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
</tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Accumulated change in equity from transactions and other 
events and circumstances from non-owner sources, net of tax effect, at period 
end. Excludes Net Income (Loss), and accumulated changes in equity from 
transactions resulting from investments by owners and distributions to owners. 
Includes foreign currency translation items, certain pension adjustments, 
unrealized gains and losses on certain investments in debt and equity 
securities, other than temporary impairment (OTTI) losses related to factors 
other than credit losses on available-for-sale and held-to-maturity debt 
securities that an entity does not intend to sell and it is not more likely than
not that the entity will be required to sell before recovery of the amortized 
cost basis, as well as changes in the fair value of derivatives related to the 
effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669686-
108580<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-
108580<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e681-
108580<br><br><br><br><br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 04<br><br><br><br> -Article 
3<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Excess of issue price over par or stated value of the 
entity's capital stock and amounts received from other transactions involving 
the entity's stock or stockholders. Includes adjustments to additional paid in 
capital. Some examples of such adjustments include recording the issuance of 
debt with a beneficial conversion feature and certain tax consequences of equity
instruments awarded to employees. Use this element for the aggregate amount of 
additional paid-in capital associated with common and preferred stock. For 
additional paid-in capital associated with only common stock, use the element 
additional paid in capital, common stock. For additional paid-in capital 
associated with only preferred stock, use the element additional paid in 
capital, preferred stock.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display:
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.30(a)(1))<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of 
all assets that are recognized. Assets are probable future economic benefits 
obtained or controlled by an entity as a result of past transactions or 
events.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br>
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.18)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> 
-Article 7<br><br><br><br><br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of 
all assets that are expected to be realized in cash, sold, or consumed within 
one year (or the normal operating cycle, if longer). Assets are probable future 
economic benefits obtained or controlled by an entity as a result of past
transactions or events.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.9)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-
107765<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br><br><br><br><br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
<tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The aggregate value (measured at the lower of net carrying 
value or fair value less cost of disposal) for assets of a disposal group, 
including a component of the entity (discontinued operation), to be sold or that
has been disposed of through sale, as of the financial statement date.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 205<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 10<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6892542&amp;loc=d3e1107-
107759<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
<td><nobr>us-
gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with 
banks or financial institutions. Includes other kinds of accounts that have the 
general characteristics of demand deposits. Also includes short-term, highly 
liquid investments that are both readily convertible to known amounts of cash 
and so near their maturity that they present insignificant risk of changes in 
value because of changes in interest rates. Excludes cash and cash equivalents 
within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Glossary Cash<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Refer
ence 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Glossary Cash Equivalents<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Refer
ence 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.1)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph 
(a)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br><br><br><br><br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-
108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common 
stock (or common stock redeemable solely at the option of the issuer). This item
includes treasury stock repurchased by the entity. Note: elements for number of 
nonredeemable common shares, par value and other disclosure concepts are in 
another section within stockholders' equity.</p>
</div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.29)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>For the disposal group, including a component of the entity 
(discontinued operation), obligations not otherwise itemized that are due within
one year or operating cycle, if longer, from the balance sheet date.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1:
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 205<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 
50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph 
(a)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-
107760<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities</nobr></
td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of 
all liabilities that are recognized. Liabilities are probable future sacrifices 
of economic benefits arising from present obligations of an entity to transfer 
assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-
26)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion
of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.32)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> 
-Article 7<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);"
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Total obligations incurred as part of normal operations that 
are expected to be paid during the following twelve months or within one 
business cycle, if longer.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.21)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
<td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The net carrying amount as of the balance sheet date of other
indefinite-lived and finite-lived intangible assets that are not separately 
presented on the statement of financial position.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherIntangibleAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The carrying amount of other receivables, net, due within one
year of the balance sheet date (or one operating cycle, if longer) from third 
parties or arising from transactions not separately disclosed.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display:
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherReceivablesNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable 
preferred stock (or preferred stock redeemable solely at the option of the 
issuer). This item includes treasury stock repurchased by the entity. Note: 
elements for number of nonredeemable preferred shares, par value and other 
disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 04<br><br><br><br> -Article 
3<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-
04)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.28)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for 
costs that provide economic benefits within a future period of one year or the 
normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Glossary Current Assets<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6509628<br><br><br><br><br><br><br><br>Refer
ence 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br>
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph 
(g)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-
107765<br><br><br><br><br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
05<br><br><br><br> -Paragraph 5<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6386993&amp;loc=d3e5879-
108316<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed
earnings or deficit.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1:
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 04<br><br><br><br> -Article 
3<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-
02.31(a)(3))<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of 
receivables from officers, directors, owners, and affiliates of the entity which
are attributable to the parent. The amount of the economic entity's 
stockholders' equity attributable to the parent excludes the amount of 
stockholders' equity which is allocable to that ownership interest in subsidiary
equity which is not attributable to the parent (noncontrolling interest, 
minority interest). This excludes temporary equity and is sometimes called
permanent equity.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 
4.E)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-
122707<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> 
-Number Topic 4<br><br><br><br> -Section 
E<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-
31)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br><br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 
31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
<td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EQDBG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF 
STOCKHOLDERS' EQUITY (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Additional Paid-In Capital</div>
        </th>
        <th class="th">
          <div>Accumulated Deficit</div>
</th>
        <th class="th">
          <div>Accumulated other comprehensive (loss)</div>
        </th>
        <th class="th">
          <div>Total</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquity', window );">Beginning Balance, Amount at Dec. 31, 
2012</a></td>
        <td class="nump">$ 631<span></span></td>
        <td class="nump">$ 5,462,236<span></span></td>
        <td class="num">$ (4,491,004)<span></span></td>
        <td class="num">$ (4,104)<span></span></td>
        <td class="nump">$ 967,759<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharesIssued', window );">Beginning Balance, Shares at Dec. 31, 
2012</a></td>
        <td class="nump">63,075,122<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_StockBasedCompensation', window );">Stock based compensation - 
Series A Warrant</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">237,971<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">237,971<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_StockBasedCompensationOptions', window );">Stock based compensation
- options</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">15,440<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">15,440<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_IssuanceOfUnits', window );">Issuance of Units</a></td>
        <td class="nump">3,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_CommonUnitIssuance', window );">Issuance of Units, Value</a></td>
        <td class="nump">35<span></span></td>
        <td class="nump">1,504,965<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">1,505,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax', window );">Reclassification adjustment on disposal of 
subsidiary</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">4,104<span></span></td>
        <td class="nump">4,104<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetIncomeLoss', window );">Net Loss</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(1,032,788)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(1,032,788)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquity', window );">Ending Balance, Amount at Dec. 31, 
2013</a></td>
        <td class="nump">666<span></span></td>
        <td class="nump">7,220,612<span></span></td>
        <td class="num">(5,523,792)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">1,697,486<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharesIssued', window );">Ending Balance, Shares at Dec. 31, 2013</a></td>
        <td class="nump">66,575,122<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_StockBasedCompensation', window );">Stock based compensation - 
Series A Warrant</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">195,333<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">195,333<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_StockBasedCompensationOptions', window );">Stock based compensation
- options</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">19,355<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">19,355<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetIncomeLoss', window );">Net Loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(601,703)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(601,703)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquity', window );">Ending Balance, Amount at Jun. 30, 
2014</a></td>
        <td class="nump">$ 666<span></span></td>
        <td class="nump">$ 7,435,300<span></span></td>
        <td class="num">$ (6,125,495)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 1,310,471<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharesIssued', window );">Ending Balance, Shares at Jun. 30, 2014</a></td>
        <td class="nump">66,575,122<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_CommonUnitIssuance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Issuance of Units, Value.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_CommonUnitIssuance</nobr></td>
</tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_IssuanceOfUnits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_IssuanceOfUnits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
</table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_StockBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Custom Element</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_StockBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_StockBasedCompensationOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Stock based compensation - options.</p>
</div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_StockBasedCompensationOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The portion of profit or loss for the period, net of income 
taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive 
Income<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br>
-Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 
225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-
04.19)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.18)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br>Reference 8: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 
225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-
04.22)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br>Reference 9: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-
108580<br><br><br><br>Reference 10: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> 
-Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount after tax and reclassification adjustments of gain 
(loss) on foreign currency translation adjustments, foreign currency 
transactions designated and effective as economic hedges of a net investment in 
a foreign entity and intra-entity foreign currency transactions that are of a 
long-term-investment nature.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669646-
108580<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 
30<br><br> -Section 45<br><br> -Paragraph 20<br><br> -Subparagraph (b,c)<br><br>
-URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-
110900<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_us-gaap_SharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Number of shares of stock issued as of the balance sheet 
date, including shares that had been issued and were previously outstanding but 
which are now held in the treasury.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of
receivables from officers, directors, owners, and affiliates of the entity which
are attributable to the parent. The amount of the economic entity's 
stockholders' equity attributable to the parent excludes the amount of 
stockholders' equity which is allocable to that ownership interest in subsidiary
equity which is not attributable to the parent (noncontrolling interest, 
minority interest). This excludes temporary equity and is sometimes called 
permanent equity.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 
4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-
122707<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section 
E<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.29-31)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EFH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes (Details Narrative) 
(USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_IncomeTaxesDetails1Abstract', window );"><strong>Income Taxes 
Details 1</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_IncreaseInValuationAllowance', window );">Increase in the valuation
allowance</a></td>
        <td class="nump">$ 155,000<span></span></td>
        <td class="nump">$ 81,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_IncomeTaxesDetails1Abstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_IncomeTaxesDetails1Abstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_IncreaseInValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Increase in the valuation allowance.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_IncreaseInValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
</td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ELBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Organization Nature and Continuance
of Operations (Details Narrative) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAbstrac
t', window );"><strong>Organization Nature And Continuance Of Operations Details
Narrative</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated 
deficit</a></td>
        <td class="nump">$ 6,125,495<span></span></td>
        <td class="nump">$ 5,523,792<span></span></td>
        <td class="nump">$ 4,491,004<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAbst
ract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);"
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_OrganizationNatureAndContinuanceOfOperationsDetailsNarrativeAbstr
act</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed
earnings or deficit.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Article 3<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.31(a)(3))<br><br> -URI
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EABAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Discontinued Operations (Details) 
(USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012
</div>
<div>Accounts payable [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012
</div>
          <div>Asset retirement obligation [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012
</div>
          <div>Total Liabilities [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012
</div>
          <div>Oil And Gas Properties, Net [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012
</div>
          <div>Mining Properties [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012
</div>
          <div>Other current assets [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013
</div>
          <div>Assets [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OilAndGasPropertyFullCostMethodNet', window );">Assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 24,127<span></span></td>
        <td class="nump">$ 519,750<span></span></td>
        <td class="nump">$ 800<span></span></td>
        <td class="nump">$ 544,677<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AssetRetirementObligation', window );">Liabilities</a></td>
        <td class="nump">$ 57,532<span></span></td>
        <td class="num">$ (12,932)<span></span></td>
        <td class="num">$ (57,532)<span></span></td>
        <td class="num">$ (70,464)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
</tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The carrying amount of a liability for an asset retirement 
obligation. An asset retirement obligation is a legal obligation associated with
the disposal or retirement of a tangible long-lived asset that results from the 
acquisition, construction or development, or the normal operations of a long-
lived asset, except for certain obligations of lessees.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 410<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-
110849<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Asset Retirement 
Obligation<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6505190<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetRetirementObligation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OilAndGasPropertyFullCostMethodNet">
<tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Oil and gas properties, net of depletion, carried under the 
full cost method.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_OilAndGasPropertyFullCostMethodNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */
var Show = {};
Show.LastAR = null,
Show.hideAR = function(){
Show.LastAR.style.display = 'none';
};
Show.showAR = function ( link, id, win ){
if( Show.LastAR ){
Show.hideAR();
}
var ref = link;
do {
ref = ref.nextSibling;
} while (ref && ref.nodeName != 'TABLE');
if (!ref || ref.nodeName != 'TABLE') {
var tmp = win ?
win.document.getElementById(id) :
document.getElementById(id);
if( tmp ){
ref = tmp.cloneNode(true);
ref.id = '';
link.parentNode.appendChild(ref);
}
}
if( ref ){
ref.style.display = 'block';
Show.LastAR = ref;
}
};
Show.toggleNext = function( link ){
var ref = link;
do{
ref = ref.nextSibling;
}while( ref.nodeName != 'DIV' );
if( ref.style &&
ref.style.display &&
ref.style.display == 'none' ){
ref.style.display = 'block';
if( link.textContent ){
link.textContent = link.textContent.replace( '+', '-' );
}else{
link.innerText = link.innerText.replace( '+', '-' );
}
}else{
ref.style.display = 'none';
if( link.textContent ){
link.textContent = link.textContent.replace( '-', '+' );
}else{
link.innerText = link.innerText.replace( '-', '+' );
}
}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0E1PBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH 
FLOWS (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="1">10 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', 
window );"><strong>Cash flows from operating activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (601,703)<span></span></td>
        <td class="num">$ (94,892)<span></span></td>
        <td class="num">$ (1,068,310)<span></span></td>
        <td class="num">$ (1,032,788)<span></span></td>
        <td class="num">$ (243,959)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract', window );"><strong>Adjustments to reconcile net loss to net cash 
flows from operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensation', window );">Stock based compensation 
expense</a></td>
        <td class="nump">19,355<span></span></td>
        <td class="nump">829<span></span></td>
        <td class="nump">15,440<span></span></td>
        <td class="nump">15,440<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_StockBasedConsultingExpense', window );">Stock based consulting 
expense</a></td>
        <td class="nump">195,333<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">237,971<span></span></td>
        <td class="nump">237,971<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_ImpairmentAndDepreciation', window );">Impairment and 
depreciation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">1,527<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ResultsOfOperationsAccretionOfAssetRetirementObligations', 
window );">Accretion of asset retirement obligation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">2,216<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_GainLossOnDispositionOfAssets', window );">Gain on disposal of oil and gas 
properties</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(49,338)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(49,338)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
</tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_GainOrLossOnSaleOfStockInSubsidiary', window );">Loss on disposal of 
subsidiary</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">453,581<span></span></td>
        <td class="nump">453,581<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in 
operating assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease (increase) in 
receivables</a></td>
        <td class="num">(1,600)<span></span></td>
        <td class="nump">800<span></span></td>
        <td class="nump">3,801<span></span></td>
        <td class="nump">800<span></span></td>
        <td class="nump">13,714<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInPrepaidExpense', window );">Decrease (increase) in 
prepaid expenses</a></td>
        <td class="num">(23,107)<span></span></td>
        <td class="nump">7,562<span></span></td>
        <td class="nump">3,815<span></span></td>
        <td class="nump">6,332<span></span></td>
        <td class="num">(7,562)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', 
window );">(Decrease) increase in accounts payable and accrued expenses</a></td>
        <td class="nump">70,972<span></span></td>
        <td class="nump">10,615<span></span></td>
        <td class="nump">20,256<span></span></td>
        <td class="nump">18,104<span></span></td>
        <td class="num">(33,150)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flows from
operating activities</a></td>
        <td class="num">(340,750)<span></span></td>
        <td class="num">(124,424)<span></span></td>
        <td class="num">(333,447)<span></span></td>
<td class="num">(349,898)<span></span></td>
        <td class="num">(267,214)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', 
window );"><strong>Cash flows from investing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CostsIncurredAcquisitionOfOilAndGasProperties', window );">Acquisition of 
oil and gas properties</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(6,962)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment', window );">Proceeds from 
disposal of oil and gas properties</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">3,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">3,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_AcquisitionOfIntellectualProperty', window );">Acquisition of 
intellectual property</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(162,854)<span></span></td>
        <td class="num">(162,854)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flows from
investing activities</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">3,000<span></span></td>
        <td class="num">(162,854)<span></span></td>
        <td class="num">(159,854)<span></span></td>
        <td class="num">(6,962)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', 
window );"><strong>Cash flows from financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
<td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_SaleOfCommonStockAndWarrants', window );">Sale of common stock and 
warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,505,000<span></span></td>
        <td class="nump">1,505,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flows from
financing activities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,505,000<span></span></td>
        <td class="nump">1,505,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Change in cash 
and cash equivalents</a></td>
        <td class="num">(340,750)<span></span></td>
        <td class="num">(121,424)<span></span></td>
        <td class="nump">1,008,699<span></span></td>
        <td class="nump">995,248<span></span></td>
        <td class="num">(274,176)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash 
equivalents, beginning of period</a></td>
        <td class="nump">1,508,843<span></span></td>
        <td class="nump">513,595<span></span></td>
        <td class="nump">500,144<span></span></td>
        <td class="nump">513,595<span></span></td>
        <td class="nump">787,771<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash 
equivalents, end of period</a></td>
        <td class="nump">1,168,093<span></span></td>
        <td class="nump">392,171<span></span></td>
        <td class="nump">1,508,843<span></span></td>
        <td class="nump">1,508,843<span></span></td>
        <td class="nump">513,595<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental
disclosure of cash flow information:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfSubsi
diary', window );">Non-cash investing and financing activities - Note received 
on disposal of subsidiary</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 80,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_AcquisitionOfIntellectualProperty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Acquisition of intellectual property.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_AcquisitionOfIntellectualProperty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
</td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_ImpairmentAndDepreciation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Custom Element</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_ImpairmentAndDepreciation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfSu
bsidiary">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);"
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_NoncashInvestingAndFinancingActivitiesNoteReceivedOnDisposalOfSub
sidiary</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_SaleOfCommonStockAndWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Sale of common stock and warrants.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_SaleOfCommonStockAndWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
<td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_StockBasedConsultingExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Stock based consulting expense.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_StockBasedConsultingExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with 
banks or financial institutions. Includes other kinds of accounts that have the 
general characteristics of demand deposits. Also includes short-term, highly 
liquid investments that are both readily convertible to known amounts of cash 
and so near their maturity that they present insignificant risk of changes in 
value because of changes in interest rates. Excludes cash and cash equivalents 
within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
<p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Cash 
Equivalents<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-
108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
<tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. 
Cash and cash equivalents are the amount of currency on hand as well as demand 
deposits with banks or financial institutions. Includes other kinds of accounts 
that have the general characteristics of demand deposits. Also includes short-
term, highly liquid investments that are both readily convertible to known 
amounts of cash and so near their maturity that they present insignificant risk 
of changes in value because of changes in interest rates. Includes effect from 
exchange rate changes.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-
108585<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 
230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-
110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CostsIncurredAcquisitionOfOilAndGasProperties">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
</tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Cost incurred, including capitalized costs and costs charged 
to expense, in acquisition of oil and gas properties.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 932<br><br> -SubTopic 
235<br><br> -Section 50<br><br> -Paragraph 18<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=8451039&amp;loc=d3e62014-
109447<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_CostsIncurredAcquisitionOfOilAndGasProperties</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant 
and equipment assets, excluding oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
<p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2941-
110230<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-
107760<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDispositionOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_GainOrLossOnSaleOfStockInSubsidiary">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of equity in 
securities of subsidiaries.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 13<br><br> -Subparagraph g<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
<tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_GainOrLossOnSaleOfStockInSubsidiary</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The increase (decrease) during the reporting period in the 
amounts payable to vendors for goods and services received and the amount of 
obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
</tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount
due within one year (or one business cycle) from customers for the credit sale 
of goods and services.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
<td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The increase (decrease) during the reporting period in the 
amount of outstanding money paid in advance for goods or services that bring 
economic benefits for future periods.</p>
</div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_IncreaseDecreaseInPrepaidExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of cash inflow (outflow) from financing activities, 
including discontinued operations. Financing activity cash flows include 
obtaining resources from owners and providing them with a return on, and a 
return of, their investment; borrowing money and repaying amounts borrowed, or 
settling the obligation; and obtaining and paying for other resources obtained 
from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic
10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-
108585<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-
108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of cash inflow (outflow) from investing activities, 
including discontinued operations. Investing activity cash flows include making 
and collecting loans and acquiring and disposing of debt or equity instruments 
and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-
108585<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-
108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
<td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, 
including discontinued operations. Operating activity cash flows include 
transactions, adjustments, and changes in value not defined as investing or 
financing activities.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-
108585<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-
108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
<td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The portion of profit or loss for the period, net of income 
taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive 
Income<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br>
-URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 
225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-
04.19)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.18)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br>Reference 8: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 
225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-
04.22)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br>Reference 9: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-
108580<br><br><br><br>Reference 10: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> 
-Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The cash inflow to dispose of long-lived, physical assets and
mineral interests in oil and gas properties used for normal oil and gas 
operations.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Investing 
Activities<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (c)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-
108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ProceedsFromSaleOfOilAndGasPropertyAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ResultsOfOperationsAccretionOfAssetRetirementObligations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
<tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Accretion expense of asset retirement obligations related to 
oil and gas producing activities.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 410<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)(3)<br><br>
-URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-
110849<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ResultsOfOperationsAccretionOfAssetRetirementObligations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee 
remuneration. This may include the value of stock or unit options, amortization 
of restricted stock or units, and adjustment for officers' compensation. As 
noncash, this element is an add back when calculating net cash generated by 
operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);"
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
</tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ELEAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS 
(Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' 
EQUITY</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par 
value</a></td>
        <td class="nump">$ 0.0001<span></span></td>
<td class="nump">$ 0.0001<span></span></td>
        <td class="nump">$ 0.0001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PreferredStockSharesAuthorized', window );">Preferred stock, 
Authorized</a></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="nump">10,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PreferredStockSharesIssued', window );">Preferred stock, shares 
Issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares 
outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par 
value</a></td>
        <td class="nump">$ 0.00001<span></span></td>
        <td class="nump">$ 0.00001<span></span></td>
        <td class="nump">$ 0.00001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesAuthorized', window );">Common stock, Authorized</a></td>
        <td class="nump">500,000,000<span></span></td>
        <td class="nump">500,000,000<span></span></td>
        <td class="nump">200,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesIssued', window );">Common stock, shares Issued</a></td>
        <td class="nump">66,575,122<span></span></td>
        <td class="nump">66,575,122<span></span></td>
        <td class="nump">63,075,122<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesOutstanding', window );">Common stock, shares 
outstanding</a></td>
        <td class="nump">66,575,122<span></span></td>
        <td class="nump">66,575,122<span></span></td>
        <td class="nump">63,075,122<span></span></td>
      </tr>
</table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.29)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
<tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by
an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.29)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Total number of common shares of an entity that have been 
sold or granted to shareholders (includes common shares that were issued, 
repurchased and remain in the treasury). These shares represent capital invested
by the firm's shareholders and owners, and may be all or only a portion of the 
number of shares authorized. Shares issued include shares outstanding and shares
held in the treasury.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.29)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock 
represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br>
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Article 3<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-
04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.29)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Face amount or stated value per share of preferred stock
nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.28)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or 
preferred stock redeemable solely at the option of the issuer) permitted to be 
issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br>
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.28)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred 
stock redeemable solely at the option of the issuer) issued to shareholders 
(includes related preferred shares that were issued, repurchased, and remain in 
the treasury). May be all or portion of the number of preferred shares 
authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.28)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 2:
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock 
(or preferred stock redeemable solely at the option of the issuer) held by 
stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.28)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
<td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
</tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EIKAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Significant Accounting Policies 
(Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_SignificantAccountingPoliciesPoliciesAbstract', 
window );"><strong>Significant Accounting Policies Policies</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation 
and Principles of Accounting</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The interim consolidated financial statements
included herein have been prepared by the Company, without audit, in accordance 
with the rules and regulations of the Securities
and Exchange Commission (&#147;SEC&#148;) pursuant to Part 210 of Regulation S-
X. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with accounting
principles generally accepted in the United States
of America (&#147;GAAP&#148;) have been condensed or omitted pursuant to such 
SEC rules and regulations, although the Company
believes that the disclosures included are adequate to make the information 
presented not misleading.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align:
justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">In management&#146;s opinion, the unaudited
consolidated financial statements contained herein reflect all adjustments, 
consisting solely of normal recurring items, which
are necessary for the fair presentation of the Company&#146;s financial 
position, results of operations, and cash flows on a basis
consistent with that of the Company&#146;s prior audited consolidated financial 
statements. The Company has evaluated information
about subsequent events that became available to us through the date the 
financial statements were issued. This information relates
to events, transactions or changes in circumstances that would require us to 
adjust the amounts reported in the financial statements
or to disclose information about those events, transactions or changes in 
circumstances. However, the results of operations for
interim periods may not be indicative of results to be expected for the full 
fiscal year. Therefore, these financial statements
should be read in conjunction with the Company&#146;s audited financial 
statements, including the notes thereto for the year ended
December 31, 2013, which may be found under the Company&#146;s profile on 
EDGAR.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">As
the Company is devoting substantially all of its efforts to establishing a new 
business, and while planned principal operations
have commenced, there has been no revenue generated from sales, license fees or 
royalties, and as such, the Company is considered
a development stage company. Accordingly, the Company&#146;s consolidated 
financial statements are presented in accordance with
authoritative accounting guidance related to a development stage 
enterprise.</font></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ConsolidationPolicyTextBlock', window );">Principles of 
Consolidation</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">These consolidated financial statements have
been prepared in accordance with US GAAP and include the accounts of the Company
and its wholly owned subsidiary, RenovaCare Sciences.
All significant intercompany transactions and balances have been eliminated. 
RenovaCare Sciences was incorporated under the laws
of the State of Nevada on June 12, 2013.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">These
consolidated financial statements have been prepared in accordance with US GAAP 
and include the accounts of the Company and its
wholly owned subsidiary, RenovaCare Sciences. All significant intercompany 
transactions and balances have been eliminated. RenovaCare
Sciences was incorporated under the laws of the State of Nevada on June 12, 
2013.</font></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_AccountingStandardsCodificationPolicyTextBlock', 
window );">Applicable Accounting Guidance</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">Any reference in these notes to applicable
accounting guidance is meant to refer to the authoritative non-governmental US
GAAP as found in the Financial Accounting Standards
Board&#146;s Accounting Standards Codification.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="background-color: white">In June
2014, the Financial Accounting Standards Board (&#147;FASB&#148;) issued 
Accounting Standards Update (&#147;ASU&#148;) 2014-10,
Development Stage Entities (Topic 915): Elimination of Certain Financial 
Reporting Requirements. ASU 2014-10 eliminates the distinction
of a development stage entity and certain related disclosure requirements, 
including the elimination of inception-to-date information
on the statements of operations, cash flows and stockholders&#146; equity. The 
amendments in ASU 2014-10 will be effective prospectively
for annual reporting periods beginning after December 15, 2014, and interim 
periods within those annual periods, however early
adoption is permitted. The Company adopted ASU 2014-10 during the quarter ended 
June 30, 2014, thereby no longer presenting or
disclosing any information required by Topic 915.</font></p>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="background-color: white">In May
2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 
606), which supersedes the revenue recognition
requirements in Accounting Standards Codification (&#147;ASC&#148;) 605, Revenue
Recognition. The new revenue recognition standard
requires entities to recognize revenue in a way that depicts the transfer of 
promised goods or services to customers in an amount
that reflects the consideration to which the entity expects to be entitled to in
exchange for those goods or services. ASU 2014-09
is effective for interim and annual reporting periods beginning after December 
15, 2016 and is to be applied retrospectively. The
Company does not currently have any revenue. As such, ASU 2014-09 will not have 
any effect on the Company&#146;s results of operations
and financial position. If the Company begins generating revenue prior to the 
effective date of ASU 2014-09, it will evaluate the
effect that ASU 2014-09 will have on its results of operations and financial 
position.</font></p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">Any
reference in these notes to applicable accounting guidance is meant to refer to 
the authoritative non-governmental US GAAP as
found in the Financial Accounting Standards Board&#146;s Accounting Standards 
Codification.</font></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_UseOfEstimates', window );">Accounting Estimates</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The preparation of consolidated financial 
statements
in conformity with accounting principles generally accepted in the United States
of America requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and 
the reported amounts of revenues and expenses during
the reporting period. Actual results, as determined by future events, may differ
from these estimates.</p><span></span></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The
preparation of consolidated financial statements in conformity with accounting 
principles generally accepted in the United States
of America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and
the reported amounts of revenues and expenses during the reporting period. 
Actual results, as determined by future events, may
differ from these estimates.</font></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash 
Equivalents</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The Company considers all highly liquid 
instruments
purchased with an original maturity of three months or less to be cash 
equivalents. Cash and cash equivalents may at times exceed
federally insured limits.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The
Company considers all highly liquid instruments purchased with an original 
maturity of three months or less to be cash equivalents.
Cash and cash equivalents may at times exceed federally insured 
limits.</font></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PolicyLoansReceivablePolicy', window );">Note Receivable from Duke 
Mountain</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The note receivable from Duke Mountain 
Resources,
Inc. (&#147;Duke&#148;) is unsecured, bears interest at 4.0% and principal and 
interest are due on December 31, 2015. The Company&#146;s
credit risk assessment is limited due to the related party nature of the 
arrangement.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The
note receivable from Duke Mountain is unsecured, bears interest at 4.0%, and 
principal and interest are due on December 31, 2015.
The Company&#146;s credit risk assessment is limited due to the related party 
nature of the arrangement.</font></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial 
Instruments</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The carrying amounts for cash and cash
equivalents and payables approximate fair value based on observable quoted 
prices for active markets &#150; Level 1 inputs.
The carrying amount of the note receivable from Duke approximates fair value 
based on similar market inputs for interest
rates for a specific creditor -  Level 2 inputs.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify; text-indent: 0pt"><font style="font: 10pt Times
New Roman, Times, Serif">The
carrying amounts for cash and cash equivalents, and payables approximate fair 
value based on observable quoted prices for inactive
markets &#150; Level 1 inputs. The carrying amount of the note receivable from 
Duke Mountain approximates fair value based on
observable market inputs for interest rates &#150; Level 2 
inputs.</font></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_InProcessResearchAndDevelopmentPolicy', window );">Research and Development
Costs</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The Company intends to outsource its research
and development efforts and expense related costs as incurred, including the 
cost of manufacturing product for testing, licensing
fees and costs associated with planning and conducting clinical trials. The 
value ascribed to patents and other intellectual property
acquired will be capitalized as it relates to particular research and 
development projects that may have alternative future 
uses.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The
Company intends to outsource its research and development efforts and expense 
related costs as incurred, including the cost of
manufacturing product for testing, licensing fees and costs associated with 
planning and conducting clinical trials. The value
ascribed to patents and other intellectual property acquired will be capitalized
as it relates to particular research and development
projects that may have alternative future uses.</font></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Intangible 
Assets</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The intangible asset consists primarily of
Cell Deposition Device technology that the Company acquired during 2013 and is 
recorded at cost. At the time of acquisition the
technology had not reached technological feasibility. The amount capitalized is 
accounted for as an indefinite-lived intangible
asset, subject to impairment testing until completion or abandonment. Upon 
successful completion, a determination will be made
as to the then useful life of the intangible asset, generally determined by the 
period in which substantially all of the cash flows
are expected to be generated, and begin amortization. The Company tests the 
intangible asset for impairment at least annually or
more frequently if impairment indicators exist after performing a qualitative 
analysis. Management has multiple criteria that it
considers when performing the qualitative analysis. The results of this review 
are then weighed and prioritized. If the totality
of the relevant events and circumstances indicate that it is not more likely 
than not that the fair value of the intangible asset
is less than its carrying amount, additional impairment tests are not 
necessary.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The Company assessed the following qualitative
factors that could affect any change in the fair value of the intangible asset: 
analysis of the technology&#146;s current phase,
additional testing necessary to bring the technology to market, development of 
competing products, changes in projections caused
by delays, changes in regulations, changes in the market for the technology and 
changes in cost projections to bring the technology
to market. Based on a qualitative assessment, management concluded that a 
positive assertion can be made from the qualitative assessment
that it is not more likely than not that the fair value of the intangible asset 
is less than its carrying amount.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The
intangible asset consists primarily of Cell Deposition Device technology that 
the Company acquired during 2013 and is recorded
at cost. At the time of acquisition, the technology had not reached 
technological feasibility. The amount capitalized is accounted
for as an indefinite-lived intangible asset, subject to impairment testing until
completion or abandonment. Upon successful completion,
a determination will be made as to the then useful life of the intangible asset,
generally determined by the period in which substantially
all of the cash flows are expected to be generated, and begin amortization. The 
Company tests the intangible asset for impairment
at least annually or more frequently if impairment indicators exist after 
performing a qualitative analysis. Management has multiple
criteria that it considers when performing the qualitative analysis. The results
of this review are then weighed and prioritized.
If the totality of the relevant events and circumstances indicate that it is not
more likely than not that the fair value of the
intangible asset is less than its carrying amount, additional impairment tests 
are not necessary.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company assessed the following qualitative factors that could affect any change 
in the fair value of the intangible asset: analysis
of the technology&#146;s current phase, additional testing necessary to bring 
the technology to market, development of competing
products, changes in projections caused by delays, changes in regulations, 
changes in the market for the technology and changes
in cost projections to bring the technology to market. Based on a qualitative 
assessment, management concluded that a positive
assertion can be made from the qualitative assessment that it is not more likely
than not that the fair value of the intangible
asset is less than its carrying amount.</font></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_StockOptionsPolicyTextBlock', window );">Stock Options</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The Company measures all stock-based 
compensation
awards using a fair value method on the date of grant and recognizes such 
expense in its consolidated financial statements over
the requisite service period. The Company uses the Black-Scholes pricing model 
to determine the fair value of stock-based compensation
awards on the date of grant. The Black-Scholes pricing model requires management
to make assumptions regarding option lives, expected
volatility, and risk free interest rates.</p><span></span></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The
Company measures all stock-based compensation awards using a fair value method 
on the date of grant and recognizes such expense
in its consolidated financial statements over the requisite service period. The 
Company uses the Black-Scholes pricing model to
determine the fair value of stock-based compensation awards on the date of 
grant. The Black-Scholes pricing model requires management
to make assumptions regarding option lives, expected volatility, and risk free 
interest rates.</font></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The Company recognizes income taxes on an 
accrual
basis based on tax positions taken, or expected to be taken, in tax returns. A 
tax position is defined as a position in a previously
filed tax return or a position expected to be taken in future tax filing that is
reflected in measuring current or deferred income
tax assets and liabilities. Tax positions are recognized only when it is more 
likely than not (i.e., likelihood of greater than
50%), based on technical merits, that the position would be sustained upon 
examination by taxing authorities. Tax positions that
meet the more likely than not threshold are measured using a probability-
weighted approach as the largest amount of tax benefit
that is greater than 50% likely of being realized upon settlement. Income taxes 
are accounted for using an asset and liability
approach that requires the recognition of deferred tax assets and liabilities 
for the expected future tax consequences of events
that have been recognized in the Company&#146;s financial statements or tax 
returns. A valuation allowance is established to reduce
deferred tax assets if all, or some portion, of such assets will more than 
likely not be realized. Should they occur, the Company&#146;s
policy is to classify interest and penalties related to tax positions as 
interest expense. Since the Company&#146;s inception,
no such interest or penalties have been incurred. The Company did not record an 
income tax provision during the periods presented
due to net taxable losses.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The
Company recognizes income taxes on an accrual basis based on tax positions 
taken, or expected to be taken, in tax returns. A tax
position is defined as a position in a previously filed tax return or a position
expected to be taken in future tax filing that
is reflected in measuring current or deferred income tax assets and liabilities.
Tax positions are recognized only when it is
more likely than not (i.e., likelihood of greater than 50%), based on technical 
merits, that the position would be sustained upon
examination by taxing authorities. Tax positions that meet the more likely than 
not threshold are measured using a probability-weighted
approach as the largest amount of tax benefit that is greater than 50% likely of
being realized upon settlement. Income taxes
are accounted for using an asset and liability approach that requires the 
recognition of deferred tax assets and liabilities for
the expected future tax consequences of events that have been recognized in our 
financial statements or tax returns. A valuation
allowance is established to reduce deferred tax assets if all, or some portion, 
of such assets will more than likely not be realized.
No provision for income taxes was recorded during the periods presented because
the Company had a net taxable loss. Should they
occur, our policy is to classify interest and penalties related to tax positions
as interest expense. Since our inception, no
such interest or penalties have been incurred.</font></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DiscontinuedOperationsPolicyTextBlock', window );">Discontinued 
Operations</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The results of the Company&#146;s oil and
gas and mineral assets are being reported as discontinued operations as a result
of the sale of the oil and gas properties in February
2013 and the sale of the Company&#146;s subsidiary which controlled various 
mineral leases and claims in December 2013. Certain
amounts reported in the prior periods presented have been reclassified to 
conform to the current period financial statement presentation.
These reclassifications have no effect on previously reported net income 
(loss).</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The
assets and financial results of the Company&#146;s oil and gas and mineral 
assets are being reported as discontinued operations
as a result of the sale of the oil and gas properties in February 2013 and the 
sale of the Company&#146;s subsidiary which controlled
various mineral leases and claims in December 2013. Certain amounts reported in 
the prior periods presented have been reclassified
to conform to the current period financial statement presentation. These 
reclassifications have no effect on previously reported
net income (loss). See &#147;Note 3. Discontinued Operations&#148; for a summary
of the amounts reclassified for the periods
presented herein.</font></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (Loss) Per 
Share</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The Company presents both basic and diluted
earnings per share (&#147;EPS&#148;) amounts. Basic EPS is calculated by 
dividing net income (loss) by the weighted average number
of common shares outstanding during the period presented. Diluted EPS amounts 
are based upon the weighted average number of common
and common equivalent shares outstanding during the period presented. 
Potentially dilutive shares of common stock consisted of
warrants to purchase shares of common stock (8,200,000 shares as of June 30, 
2014 and December 31, 2013) and options to purchase
shares of common stock (135,000 shares as of June 30, 2014 and 80,000 as of 
December 31, 2013). During the periods presented, potentially
dilutive shares of common stock were not included in the computation of dilutive
loss per share as to do so would be anti-dilutive.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify; text-indent: 0pt"><font style="font: 10pt Times 
New Roman, Times, Serif"></font>The
Company presents both basic and diluted earnings per share (&#147;EPS&#148;) 
amounts. Basic EPS is calculated by dividing net
income (loss) by the weighted average number of common shares outstanding during
the period presented. Diluted EPS amounts are
based upon the weighted average number of common and common equivalent shares 
outstanding during the period presented. Potentially
dilutive shares of common stock consisted of warrants to purchase shares of
common stock (8,200,000 shares for 2013 and nil shares
for 2012) and options to purchase shares of common stock (80,000 shares for 2013
and nil shares for 2012). During the periods
presented, potentially dilutive shares of common stock were not included in the 
computation of dilutive loss per share as to do
so would be anti-dilutive.</p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_RelatedPartyTransactionsPolicyTextBlock', window );">Related Party 
Transactions</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">A related party is generally defined as (i)
any person who holds 10% or more of the Company&#146;s securities and their 
immediate families; (ii) the Company&#146;s management;
(iii) someone who directly or indirectly controls, is controlled by or is under 
common control with the Company; or (iv) anyone
who can significantly influence the financial and operating decisions of the 
Company. A transaction is considered to be a related
party transaction when there is a transfer of resources or obligations between 
related parties. See &#147;Note 6. Related Party
Transactions,&#148; for further discussion.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">A
related party is generally defined as (i) any person who holds 10% or more of 
the Company&#146;s securities and their immediate
families; (ii) the Company&#146;s management; (iii) someone who directly or 
indirectly controls, is controlled by or is under
common control with the Company; or (iv) anyone who can significantly influence 
the financial and operating decisions of the Company.
A transaction is considered to be a related party transaction when there is a 
transfer of resources or obligations between related
parties. See &#147;Note 7. Related Party Transactions,&#148; for further 
discussion.</font></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income 
(Loss)</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The Company has no items of other comprehensive
income in any period presented. Therefore, net loss equals comprehensive 
loss.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">Comprehensive
loss is comprised of net loss,and a reclassification on disposal of subsidiary 
for the periods presented.</font></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_AccountingStandardsCodificationPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Accounting Standards Codification Policy [Text Block]</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_AccountingStandardsCodificationPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_RelatedPartyTransactionsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Related Party Transactions Policy [Text Block]</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_RelatedPartyTransactionsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_SignificantAccountingPoliciesPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_SignificantAccountingPoliciesPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_StockOptionsPolicyTextBlock">
<tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Stock options policy.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_StockOptionsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_BasisOfAccountingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for basis of accounting, or 
basis of presentation, used to prepare the financial statements (for example, US
Generally Accepted Accounting Principles, Other Comprehensive Basis of 
Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
</div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_BasisOfAccountingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CashAndCashEquivalentsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for cash and cash 
equivalents, including the policy for determining which items are treated as 
cash equivalents. Other information that may be disclosed includes (1) the 
nature of any restrictions on the entity's use of its cash and cash equivalents,
(2) whether the entity's cash and cash equivalents are insured or expose the 
entity to credit risk, (3) the classification of any negative balance accounts 
(overdrafts), and (4) the carrying basis of cash equivalents (for example, at 
cost) and whether the carrying amount of cash equivalents approximates fair 
value.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-
107790<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 3:
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Cash 
Equivalents<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 305<br><br> -SubTopic 
10<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2122427<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-
108586<br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Financial Reporting Release (FRR)<br><br> -Number 203<br><br> -Paragraph 
02-03<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_CashAndCashEquivalentsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ComprehensiveIncomePolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for comprehensive income.</p>
              </div><a href="javascript:void(0);"
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ComprehensiveIncomePolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy regarding (1) the principles 
it follows in consolidating or combining the separate financial statements, 
including the principles followed in determining the inclusion or exclusion of 
subsidiaries or other entities in the consolidated or combined financial 
statements and (2) its treatment of interests (for example, common stock, a 
partnership interest or other means of exerting influence) in other entities, 
for example consolidation or use of the equity or cost methods of accounting.  
The accounting policy may also address the accounting treatment for intercompany
accounts and transactions, noncontrolling interest, and the income statement 
treatment in consolidation for issuances of stock by a subsidiary.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02, 03<br><br> 
-Article 3A<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-
107790<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 
10<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2197480<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 860<br><br> -SubTopic 
40<br><br> -Section 45<br><br> -URI 
http://asc.fasb.org/section&amp;trid=2197723<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 
10<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2196966<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 325<br><br> -SubTopic 
20<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2197087<br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.3A-
02)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-
122828<br><br><br><br>Reference 8: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=16385135&amp;loc=d3e33801-
111570<br><br><br><br>Reference 9: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-
111684<br><br><br><br>Reference 10: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph k<br><br> -Article 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConsolidationPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
</td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DiscontinuedOperationsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for any discontinued 
operations. The results of operations of a component of an entity that either 
has been disposed of or is classified as held for sale is reported in 
discontinued operations if both: (a) the operations and cash flows of the 
component have been (or will be) eliminated from the ongoing operations of the 
entity as a result of the disposal transaction and (b) the entity will not have 
any significant continuing involvement in the operations of the component after 
the disposal transaction. If the entity elects to allocate interest expense to a
discontinued operation, it may disclose its accounting policy for this election 
and describe its method of allocation.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-
107790<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2122178<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -Section S99<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-
122677<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DiscontinuedOperationsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
<tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and 
diluted earnings or loss per share for each class of common stock and 
participating security. Addresses all significant policy factors, including any 
antidilutive items that have been excluded from the computation and takes into 
account stock dividends, splits and reverse splits that occur after the balance 
sheet date of the latest reporting period but before the issuance of the 
financial statements.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-
107790<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2144384<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-
109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
<tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_FairValueOfFinancialInstrumentsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for determining the fair 
value of financial instruments.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-
107790<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2155942<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueOfFinancialInstrumentsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
<td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for goodwill and intangible 
assets. This accounting policy also may address how an entity assesses and 
measures impairment of goodwill and intangible assets.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-
107790<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 
20<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2144439<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 
30<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2144471<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
</tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for income taxes, which may 
include its accounting policies for recognizing and measuring deferred tax 
assets and liabilities and related valuation allowances, recognizing investment 
tax credits, operating loss carryforwards, tax credit carryforwards, and other 
carryforwards, methodologies for determining its effective income tax rate and 
the characterization of interest and penalties in the financial statements.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-
107790<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2144681<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
30<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2144749<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 19<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-
109319<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 
740<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-
115650<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 17<br><br> -Subparagraph (b)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-
109319<br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32247-
109318<br><br><br><br>Reference 8: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32280-
109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_InProcessResearchAndDevelopmentPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for costs assigned to 
identifiable tangible and intangible assets of an acquired entity to be used in 
the research and development activities of the combined enterprise. An entity 
also may disclose the appraisal method or significant assumptions used to value 
acquired research and development assets.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-
107790<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.15)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 
10<br><br> -URI 
http://asc.fasb.org/subtopic&amp;trid=2127266<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> 
-Paragraph 15<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_InProcessResearchAndDevelopmentPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PolicyLoansReceivablePolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for policy loans receivable, 
including the basis for determining the amount reported for loans made to 
policyholders against and secured by future policy benefits. May also disclose 
the range of interest rates charged to policyholders on such loans.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI
http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-
107790<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -URI 
http://asc.fasb.org/topic&amp;trid=2303980<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PolicyLoansReceivablePolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in 
the preparation of financial statements in conformity with generally accepted 
accounting principles.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-
108592<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-
108592<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br>
-Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-
108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EKJAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity 
Information<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
</tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_DocumentAndEntityInformationAbstract', window );"><strong>Document 
And Entity Information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">Renovacare, Inc.<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001016708<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">S-1<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Jun. 30,
2014<span></span></td>
</tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End 
Date</a></td>
        <td class="text">--12-31<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityWellKnownSeasonedIssuer', window );">Is Entity a Well-known 
Seasoned Issuer?</a></td>
        <td class="text">No<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityVoluntaryFilers', window );">Is Entity a Voluntary Filer?
</a></td>
        <td class="text">No<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityCurrentReportingStatus', window );">Is Entity's Reporting
Status Current?</a></td>
        <td class="text">Yes<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>If the value is true, then the document is an amendment to 
previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
<tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The end date of the period reflected on the cover page if a 
periodic report. For all other reports and registration statements containing 
historical data, it is the date up through which that historical data is 
presented.  If there is no historical data in the report, use the filing date. 
The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
<td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 
485BPOS, etc). The document type is limited to the same value as the supporting 
SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
<tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that 
have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> 
-Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);"
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange 
Act of 1934 during the preceding 12 months (or for such shorter period that 
registrants were required to file such reports), and (2) have been subject to 
such filing requirements for the past 90 days. This information should be based 
on the registrant's current or most recent filing containing the related 
disclosure.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) 
Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) 
Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated
Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange 
Act. This information should be based on the registrant's current or most recent
filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The exact name of the entity filing the report as specified 
in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> 
-Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to 
file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
</div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known 
seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form 
Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-
1A.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
<table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Discontinued Oil and Gas Operations
(Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_OilAndGasPropertiesAbstract', window );"><strong>Discontinued Oil
And Gas Operations Tables</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock', 
window );">Assets and liabilities of discontinued operations</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">Assets
and liabilities of discontinued operations in the accompanying balance sheets 
consist of the following:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December
    31, 2012</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">Assets:</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 89%; padding-left: 9pt"><font style="font: 10pt Times New 
Roman, Times, Serif">Oil and Gas Properties, net</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">24,127</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, 
Times, Serif">Mining properties</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">519,750</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, 
Times, Serif">Other current assets</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman,
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">800</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">544,677</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">Liabilities</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, 
Times, Serif">Accounts payable</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">(12,932</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, 
Times, Serif">Asset retirement obligation</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(57,532</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(70,464</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td></tr>
</table><span></span></td>
      </tr>
    </table>
<div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Assets and liabilities of discontinued operations.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_AssetsAndLiabilitiesOfDiscontinuedOperationsTablesTextBlock</nobr
></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_OilAndGasPropertiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
<td><nobr>rcar_OilAndGasPropertiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0E3FBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF 
OPERATIONS (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="1">10 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
<th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_ConsolidatedStatementsOfOperationsAbstract', 
window );"><strong>Consolidated Statements Of Operations</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Revenues', window );">Revenue</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_GeneralAndAdministrativeExpense', window );">General and administrative 
expenses</a></td>
        <td class="nump">333,682<span></span></td>
        <td class="nump">83,358<span></span></td>
        <td class="nump">601,703<span></span></td>
        <td class="nump">144,230<span></span></td>
        <td class="nump">614,729<span></span></td>
        <td class="nump">628,545<span></span></td>
        <td class="nump">229,539<span></span></td>
      </tr>
      <tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OperatingExpenses', window );">Total operating expenses</a></td>
        <td class="nump">333,682<span></span></td>
        <td class="nump">83,358<span></span></td>
        <td class="nump">601,703<span></span></td>
        <td class="nump">144,230<span></span></td>
        <td class="nump">614,729<span></span></td>
        <td class="nump">628,545<span></span></td>
        <td class="nump">229,539<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncomeLossFromContinuingOperations', window );">Net loss from continuing 
operations</a></td>
        <td class="num">(333,682)<span></span></td>
        <td class="num">(83,358)<span></span></td>
        <td class="num">(601,703)<span></span></td>
        <td class="num">(144,230)<span></span></td>
        <td class="num">(614,729)<span></span></td>
        <td class="num">(628,545)<span></span></td>
        <td class="num">(229,539)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', 
window );"><strong>Discontinued operations</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income/(loss) 
from discontinued operations</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(14,420)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_GainLossOnDispositionOfAssets', window );">Gain on disposal of oil and gas 
properties</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">49,338<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">49,338<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_GainOrLossOnSaleOfStockInSubsidiary', window );">Loss on disposal of 
subsidiary (Fostung)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(453,581)<span></span></td>
        <td class="num">(453,581)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations', window );">Gain 
(Loss) on discontinued operations</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">49,338<span></span></td>
        <td class="num">(453,581)<span></span></td>
        <td class="num">(404,243)<span></span></td>
        <td class="num">(14,420)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (333,682)<span></span></td>
        <td class="num">$ (83,358)<span></span></td>
        <td class="num">$ (601,703)<span></span></td>
        <td class="num">$ (94,892)<span></span></td>
        <td class="num">$ (1,068,310)<span></span></td>
        <td class="num">$ (1,032,788)<span></span></td>
        <td class="num">$ (243,959)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EarningsPerShareDilutedAbstract', window );"><strong>Earnings per share - 
basic and diluted</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Loss per 
common share continuing operations</a></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', 
window );">Income (loss) per common share discontinued operations</a></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EarningsPerShareBasicAndDiluted', window );">Loss per common share</a></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="num">$ (0.01)<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (0.02)<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average
shares outstanding</a></td>
        <td class="nump">66,575,122<span></span></td>
        <td class="nump">63,075,122<span></span></td>
        <td class="nump">66,575,122<span></span></td>
        <td class="nump">63,075,122<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">63,401,149<span></span></td>
        <td class="nump">63,075,122<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_ConsolidatedStatementsOfOperationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_ConsolidatedStatementsOfOperationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
<td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The amount of net income or loss for the period per each 
share in instances when basic and diluted earnings per share are the same amount
and reported as a single line item on the face of the financial statements.  
Basic earnings per share is the amount of net income or loss for the period per 
each share of common stock or unit outstanding during the reporting period.  
Diluted earnings per share includes the amount of net income or loss for the 
period available to each share of common stock or common unit outstanding during
the reporting period and to each share or unit that would have been outstanding 
assuming the issuance of common shares or units for all dilutive potential 
common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_EarningsPerShareDilutedAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant 
and equipment assets, excluding oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2941-
110230<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-
107760<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDispositionOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
<tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of difference between the carrying amount and the 
sales price of real estate properties sold as part of discontinued 
operations.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
</div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_GainOrLossOnSaleOfStockInSubsidiary">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of equity in 
securities of subsidiaries.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 13<br><br> -Subparagraph g<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_GainOrLossOnSaleOfStockInSubsidiary</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The aggregate total of expenses of managing and administering
the affairs of an entity, including affiliates of the reporting entity, which 
are not directly or indirectly associated with the manufacture, sale or creation
of a product or product line.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.4)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of income (loss) from continuing operations 
attributable to the parent. Also defined as revenue less expenses and taxes from
ongoing operations before extraordinary items but after deduction of those 
portions of income or loss from continuing operations that are allocable to 
noncontrolling interests.</p>
              </div><a href="javascript:void(0);"
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 18<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=7656940&amp;loc=SL4613673-
111683<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.13)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_IncomeLossFromContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
<div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The amount of net income (loss) derived from continuing 
operations during the period available to each share of common stock or common 
unit outstanding during the reporting period and to each share or unit that 
would have been outstanding assuming the issuance of common shares or units for 
all dilutive potential common shares or units outstanding during the reporting 
period.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-
109256<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.21)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 18<br><br> -Article 7<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> 
-Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 21<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_IncomeLossFromContinuingOperationsPerDilutedShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
</div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of income (loss) from a disposal group, net of income 
tax before extraordinary items allocable to noncontrolling interests. Includes, 
net of tax, income (loss) from operations during the phase-out period, gain 
(loss) on disposal, provision (or any reversals of earlier provisions) for loss 
on disposal, and adjustments of a prior period gain (loss) on disposal.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6892542&amp;loc=d3e957-
107759<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 
225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-
04.12)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 13<br><br> -Article 7<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-
107760<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.14)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> 
-Paragraph 15<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Per basic share amount, after tax, of income (loss) from the 
day-to-day business activities of the discontinued operation and gain (loss) 
from the disposal of the discontinued operation.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1278-
109256<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.21)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 
225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-
04.19)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 
225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-
04.23)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-
122882<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br>
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 18<br><br> -Article 7<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> 
-Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 21<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The portion of profit or loss for the period, net of income 
taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br>Reference 3:
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive 
Income<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 
225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-
04.19)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.18)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br>Reference 8: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 
225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-
04.22)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br>Reference 9: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-
108580<br><br><br><br>Reference 10: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> 
-Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
</div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Generally recurring costs associated with normal operations 
except for the portion of these expenses which can be clearly related to 
production and included in cost of sales or services. Includes selling, general 
and administrative expense.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
<table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount of revenue recognized from goods sold, services 
rendered, insurance premiums, or other activities that constitute an earning 
process. Includes, but is not limited to, investment and interest income before 
deduction of interest expense when recognized as a component of revenue, and 
sales and trading gain (loss).</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.1)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> 
-Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
<tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_WeightedAverageNumberOfSharesOutstandingBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Number of [basic] shares or units, after adjustment for 
contingently issuable shares or units and other shares or units not deemed 
outstanding, determined by relating the portion of time within a reporting 
period that common shares or units have been outstanding to the total time in 
that period.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 
10<br><br> -Section 45<br><br> -Paragraph 10<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1448-
109256<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Glossary Weighted-Average 
Number of Common Shares Outstanding<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_WeightedAverageNumberOfSharesOutstandingBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ERG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Common Stock 
Options<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_NotesToFinancialStatementsAbstract', window );"><strong>Notes to
Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_CommonStockOptionsTextBlock', window );">Note 5. Common Stock 
Options</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>Approval
of the 2013 Long-Term Incentive Plan</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
June 20, 2013, the Board of Directors (the &#147;Board&#148;) adopted, subject 
to receiving shareholder approval, the 2013 Long-Term
Incentive Plan (the &#147;Incentive Plan&#148;). The Incentive Plan provides for
the issuance of stock options of up to 20,000,000
shares (subject to adjustment) of the Company&#146;s common stock to officers, 
directors, key employees and consultants of the
Company. Options granted to employees under the Incentive Plan, including 
directors and officers who are employees, may be incentive
stock options or non-qualified stock options; options granted to others under 
the Incentive Plan are limited to non-qualified
stock options. On November 15, 2013, shareholders owning a majority of the 
Company&#146;s issued and outstanding shares approved
the Incentive Plan.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Incentive Plan is administered by the Board or a committee designated by the 
Board. Subject to the provisions of the Incentive
Plan, the Board has the authority to determine the officers, employees and 
consultants to whom options will be granted, the number
of shares covered by each option, vesting rights and the terms and conditions of
each option that is granted to them; however,
no person may be granted in any of the Company&#146;s fiscal year, options to 
purchase more than 2,000,000 shares under the Incentive
Plan, and the aggregate fair market value (determined at the time the option is 
granted) of the shares with respect to which incentive
stock options are exercisable for the first time by an optionee during any 
calendar year cannot exceed $100,000. Options granted
pursuant to the Incentive Plan are exercisable no later than ten years after the
date of grant.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
exercise price per share of common stock for options granted under the Incentive
Plan will be the fair market value of the Company&#146;s
common stock on the date of grant, using the closing price of the Company&#146;s
common stock on the last trading day prior to
the date of grant, except for incentive stock options granted to a holder of ten
percent or more of the Company&#146;s common
stock, for whom the exercise price per share will not be less than 110% of the 
fair market value. No option can be granted under
the Incentive Plan after June 20, 2023.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2014, there were 19,865,000 shares available for grant.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Stock
Option Activity</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
August 1, 2013, the Company granted to each of Messrs. Kirkland and Sierchio 
20,000 stock options. The exercise price per share
is $0.65; 10,000 options vested on the grant date and, subject to continued 
service as a member of the Company&#146;s Board, the
remaining 10,000 options will vest on August 1, 2014 and may be exercised on a 
&#147;cashless basis&#148; using the formula contained
therein.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
December 1, 2013, the Company appointed Mr. Bold as its President &#38; CEO and 
entered into an at-will consulting agreement (the
&#147;Consulting Agreement&#148;) with Mr. Bold. Pursuant to the terms of the 
Consulting Agreement, Mr. Bold was issued a stock
option to purchase up to 40,000 shares of the Company&#146;s common stock (the 
&#147;Option Shares&#148;) at a price of $0.75
per share the closing price of the Company&#146;s common stock as quoted on the 
OTCQB on November 29, 2013. The Options Shares
may be exercised on a &#147;cashless basis&#148; using the formula contained 
therein and, subject to Mr. Bold&#146;s continued
service as the Company&#146;s President and Chief Executive Officer, the Options
Shares vest as follows, 20,000 on: (a) December
1, 2014; and (b) December 1, 2015.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
April 1, 2014, the Company appointed Ms. Patsy Trisler as its Vice President
&#150; Clinical &#38; Regulatory Affairs and entered
into an at-will consulting agreement (the &#147;Trisler Consulting 
Agreement&#148;) with Ms. Trisler. Pursuant to the terms of
the Trisler Consulting Agreement, Ms. Trisler was issued Option Shares to 
purchase up to 50,000 shares of the Company&#146;s common
stock at a price of $1.05 per share, the closing price of the Company&#146;s 
common stock as quoted on the OTCQB on April 1, 2014.
The Options Shares may be exercised on a &#147;cashless basis&#148; using the 
formula contained therein and, subject to Ms. Trisler&#146;s
continued service as the Company&#146;s Vice President &#150; Clinical &#38; 
Regulatory Affairs, the Options Shares vest as follows,
10,000 on: (a) April 1, 2015; (b) April 1, 2016; (c) April 1, 2017; (d) April 1,
2018; and (e) April 1, 2019.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
April 20, 2014, the Company appointed Andrew Danielson as its Director of 
Business Development and issued Mr. Danielson Option
Shares to purchase 5,000 shares of the Company&#146;s common stock at a price of
$1.05 per share, the closing price of the Company&#146;s
common stock as quoted on the OTCQB on April 17, 2014. The Options Shares may be
exercised on a &#147;cashless basis&#148; using
the formula contained therein and, subject to Mr. Danielson&#146;s continued 
service with the Company. The Options Shares vest
on April 20, 2015.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes stock option activity for the period ended June 30, 
2014.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr>
    <td style="vertical-align: bottom; padding-bottom: 1.5pt"><font style="font:
10pt Times New Roman, Times, Serif">&#160;<br />
    &#160;<br />
    &#160;<br />
    &#160;<br />
    &#160;</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;<br />
    &#160;<br />
    &#160;<br />
    &#160;<br /></font></td>
    <td colspan="2" id="ffc" style="vertical-align: bottom; text-align: center; 
border-bottom: Black 1.5pt solid"><font style="font: 10pt Times New Roman, 
Times, Serif"><b>Options</b><br />
    <b>Outstanding</b></font></td>
    <td style="text-align: center; padding-bottom: 1.5pt"></td>
    <td style="text-align: center; padding-bottom: 1.5pt"></td>
    <td colspan="2" style="vertical-align: bottom; text-align: center; border-
bottom: Black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>Weighted</b><br />
    <b>Average</b><br />
    <b>Exercise Price</b></font></td>
    <td style="text-align: center; padding-bottom: 1.5pt"></td>
    <td style="text-align: center; padding-bottom: 1.5pt"></td>
    <td colspan="2" style="vertical-align: bottom; text-align: center; border-
bottom: Black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>Weighted</b><br />
    <b>Average</b><br />
    <b>Remaining</b><br />
    <b>Contractual</b><br />
    <b>Life (Years)</b></font></td>
    <td style="text-align: center; padding-bottom: 1.5pt"></td>
    <td style="text-align: center; padding-bottom: 1.5pt"></td>
    <td colspan="2" style="vertical-align: bottom; text-align: center; border-
bottom: Black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>Aggregate</b><br />
    <b>Intrinsic</b><br />
    <b>Value</b></font></td>
    <td style="padding-bottom: 1.5pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;<br />
    &#160;<br />
    &#160;<br />
    &#160;<br />
    &#160;</font></td>
</tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 
10pt Times New Roman, Times, Serif">Balance January
    1, 2014</font></td>
    <td style="width: 1%; text-align: justify"><font style="font: 10pt Times New
Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">80,000</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: justify"><font style="font: 10pt Times New
Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times 
New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">0.70</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: justify"><font style="font: 10pt Times New
Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">9.13</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: justify"><font style="font: 10pt Times New
Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; width: 1%"><font style="font: 10pt Times 
New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">20,000</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white">
<td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Options
    granted</font></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
1.5pt solid"><font style="font: 10pt Times New Roman, Times, 
Serif">55,000</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify; border-bottom: Black
1.5pt solid"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
1.5pt solid"><font style="font: 10pt Times New Roman, Times, 
Serif">1.05</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
1.5pt solid"><font style="font: 10pt Times New Roman, Times, 
Serif">9.75</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify; padding-bottom: 1.5pt"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom: Black 1.5pt solid"><font 
style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
1.5pt solid"><font style="font: 10pt Times New Roman, Times, 
Serif">0</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">Balance
    June 30, 2014</font></td>
    <td style="text-align: justify; padding-bottom: 2.5pt"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
2.5pt double"><font style="font: 10pt Times New Roman, Times, 
Serif">135,000</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify; padding-bottom: 2.5pt"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom: Black 2.5pt double"><font 
style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
2.5pt double"><font style="font: 10pt Times New Roman, Times, 
Serif">0.84</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify; padding-bottom: 2.5pt"><font style="font:
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
2.5pt double"><font style="font: 10pt Times New Roman, Times, 
Serif">9.38</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify; padding-bottom: 2.5pt"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; border-bottom: Black 2.5pt double"><font 
style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
2.5pt double"><font style="font: 10pt Times New Roman, Times, 
Serif">14,850</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 
10pt Times New Roman, Times, Serif">Exercisable
    at June 30, 2014</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 
10pt Times New Roman, Times, Serif">20,000</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, 
Times, Serif">$</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 
10pt Times New Roman, Times, Serif">0.70</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 
10pt Times New Roman, Times, Serif">9.13</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, 
Times, Serif">$</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font: 
10pt Times New Roman, Times, Serif">5,000</font></td>
    <td style="vertical-align: bottom; text-align: justify"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
fair value of each stock option is estimated at the date of grant using the 
Black-Scholes option pricing model. The weighted-average
fair value of stock options granted during 2013 was approximately $0.49 to $0.57
per share. The weighted average fair value of
stock options granted during 2014 was $1.05 per share. Assumptions regarding 
volatility, expected term, dividend yield and risk-free
interest rate are required for the Black-Scholes model. The volatility 
assumption is based on the Company&#146;s historical experience.
The risk-free interest rate is based on a U.S. treasury note with a maturity 
similar to the option award&#146;s expected life.
The expected life represents the average period of time that options granted are
expected to be outstanding. The assumptions for
volatility, expected life, dividend yield and risk-free interest rate are 
presented in the table below:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%; text-align: justify"><font style="font: 10pt Times 
New Roman, Times, Serif">Weighted average risk-free
    interest rate</font></td>
    <td style="width: 18%; text-align: center"><font style="font: 10pt Times New
Roman, Times, Serif">1.43 &#150; 1.62%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, 
Times, Serif">Expected life in years</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">4.50 &#150; 5.50</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, 
Times, Serif">Weighted Avg. Expected Volatility</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">99.5%&#160;&#150; 105.3%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, 
Times, Serif">Expected dividend yield</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">0%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">During
the three and six months ended June 30, 2014, stock-based compensation expense 
of $12,573 and $19,355, respectively, was recognized
as general and administrative expenses. There were 20,000 stock options vested 
and 115,000 unvested, as of June 30, 2014. As of
June 30, 2014, the Company had $55,387 of total unrecognized compensation cost 
related to unvested stock options, which is expected
to be recognized by April 1, 2019.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="margin: 0; text-align: justify"><font style="font: 10pt Times New 
Roman, Times, Serif">The Company issues new shares when options are 
exercised.</font></p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif"><i>Approval
of the 2013 Long-Term Incentive Plan</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On June
20, 2013, the Board of Directors (the &#147;Board&#148;) adopted, subject to 
receiving shareholder approval, the 2013 Long-Term
Incentive Plan (the &#147;Incentive Plan&#148;). The Incentive Plan provides for
the issuance of stock options of up to 20,000,000
shares (subject to adjustment) of the Company&#146;s common stock to officers, 
directors, key employees and consultants of the
Company. Options granted to employees under the Incentive Plan, including 
directors and officers who are employees, may be incentive
stock options or non-qualified stock options; options granted to others under 
the Incentive Plan are limited to non-qualified
stock options.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The Incentive
Plan is administered by the Board or a committee designated by the Board. 
Subject to the provisions of the Incentive Plan, the
Board has the authority to determine the officers, employees and consultants to 
whom options will be granted, the number of shares
covered by each option, vesting rights and the terms and conditions of each 
option that is granted to them; however, no person
may be granted in any of the Company&#146;s fiscal year, options to purchase 
more than 2,000,000 shares under the Incentive Plan,
and the aggregate fair market value (determined at the time the option is 
granted) of the shares with respect to which incentive
stock options are exercisable for the first time by an optionee during any 
calendar year cannot exceed $100,000. Options granted
pursuant to the Incentive Plan are exercisable no later than ten years after the
date of grant.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The exercise
price per share of common stock for options granted under the Incentive Plan 
will be the fair market value of the Company&#146;s
common stock on the date of grant, using the closing price of the Company&#146;s
common stock on the last trading day prior to
the date of grant, except for incentive stock options granted to a holder of ten
percent or more of the Company&#146;s common
stock, for whom the exercise price per share will not be less than 110% of the 
fair market value. No option can be granted under
the Incentive Plan after June 20, 2023.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">As of December
31, 2013, there were 19,920,000 shares available for grant.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Stock
Option Activity</i></font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On August
1, 2013, the Company granted to Messrs. Kirkland and Sierchio (20,000 stock 
options each) for stock options granted on August
1, 2013. The exercise price per share is $0.65; 10,000 options vested on the 
grant date and, subject to continued service as a
member of our Board, the remaining 10,000 options will vest on August 1, 2014. 
The Options Shares may be exercised on a &#147;cashless
basis&#148; using the formula contained therein.&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
December 1, 2013, we appointed Mr. Bold as our President &#38; CEO and entered 
into an at-will consulting agreement (the &#147;Consulting
Agreement&#148;) with Mr. Bold. Pursuant to the terms of the Consulting 
Agreement, Mr. Bold is expected to serve on a part-time
basis and will receive an annual fee of $50,000, payable in 12 equal 
installments, which is prorated for any partial months during
the term of the Consulting Agreement. In addition to Mr. Bold&#146;s fee, he was
issued a stock option to purchase up to 40,000
shares of our common stock (the &#147;Option Shares&#148;) at a price of $0.75 
per share the closing price of our common stock
as quoted on the OTCQB on November 29, 2013. The Options Shares may be exercised
on a &#147;cashless basis&#148; using the formula
contained therein and, subject to Mr. Bold&#146;s continued service as our 
President and Chief Executive Officer, vest as follows:
(a) 20,000 Options Shares vest on December 1, 2014; and (b) 20,000 Options 
Shares vest on December 1, 2015.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes stock option activity for the year ended December 31,
2013.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"></font>&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman,
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br /> <font
style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Options 
Outstanding</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt 
Times New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br /> <font
style="font: 10pt Times New Roman, Times, Serif"><b>Weighted
Average Exercise Price</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt 
Times New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt 
solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted
Average Remaining Contractual Life (Years)</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt 
Times New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br /> <font
style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate
Intrinsic Value</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt 
Times New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 53%"><font style="font: 10pt Times New Roman, Times, 
Serif">Balance January 1, 2013</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 9%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 9%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 9%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Options 
granted</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">430,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">0.72</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman,
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">9.55</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Options 
forfeited</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">(350,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">0.72</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">9.50</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Balance December 
31, 2013</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">80,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
<td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">0.70</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">9.75</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">23,200</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Exercisable at 
December 31, 2013</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">20,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">0.65</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">9.50</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">6,800</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The fair
value of each stock option is estimated at the date of grant using the Black-
Scholes option pricing model. The estimated weighted-average
fair value of stock options granted during 2013 was approximately $0.49 to $0.57
per share. Assumptions regarding volatility,
expected term, dividend yield and risk-free interest rate are required for the
Black-Scholes model. The volatility assumption
is based on the Company&#146;s historical experience. The risk-free interest 
rate is based on a U.S. treasury note with a maturity
similar to the option award&#146;s expected life. The expected life represents 
the average period of time that options granted
are expected to be outstanding. The assumptions for volatility, expected life, 
dividend yield and risk-free interest rate are
presented in the table below:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 75%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 25%; border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2013</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted average 
risk-free interest rate</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">1.43 &#150; 1.49%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected life in 
years</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">5.0 &#150; 5.5 Years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted Avg 
Expected Volatility</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">99.5% - 103.4%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend
yield</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">$0</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">During the
year ended December 31, 2013, stock-based compensation expense of $15,440, was 
recognized as general and administrative expenses.
There were 20,000 stock options vested and 60,000 unvested, as of December 31, 
2013. There was no stock compensation expense recognized
in 2012. As of December 31, 2013, the Company had $27,317 of total unrecognized 
compensation cost related to unvested stock options,
which is expected to be recognized by December 31, 2015.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company
issues new shares when options are exercised.</font></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_CommonStockOptionsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Common stock options.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_CommonStockOptionsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_NotesToFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
<td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ERG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets - Intellectual 
Property<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
</tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IntangibleAssetsDisclosureTextBlock', window );">Note 4. Intangible Assets 
- Intellectual Property</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">On July 12, 2013, the Company, together with
its wholly owned subsidiary, RenovaCare Sciences, entered into an asset purchase
agreement with Dr. J&#246;rg Gerlach, MD, PhD,
pursuant to which RenovaCare Sciences purchased all of Dr. Gerlach&#146;s 
rights, title and interest in the Cell Deposition Device.
The Company plans to further the development of the Cell Deposition Device, if 
commercially viable, bring the product to market.
Pursuant to the terms of the Asset Purchase Agreement, upon the closing of the 
transaction, the Company paid Dr. Gerlach $100,002
and issued to Dr. Gerlach a Series A Stock Purchase Warrant (the &#147;Series A 
Warrant&#148;) entitling him to purchase 1,200,000
shares (each a &#147;Warrant Share&#148;) of the Company&#146;s common stock, 
subject to vesting milestones through July 11,
2019, at an exercise price of $0.35 per share. Acquisition related costs 
amounted to $52,852 and were capitalized together with
the cash payment. Additional costs capitalized during 2013, and which related to
a wound cap technology, amounted to $10,000. No
additional costs were capitalized during 2014. At June 30, 2014, intangible 
assets amounted to $162,854.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The Series A Warrant was issued in exchange
for services to be rendered in the future by Dr. Gerlach. An additional agreed 
upon cash sum amounting to $300,000 will be paid
to Dr. Gerlach upon the Company attaining certain milestones related to the 
Regeneration Technology. The value of the Series A
Warrant will be recognized as consulting expenses to the Company over the 
vesting term of the underlying warrant, subject to Dr.
Gerlach providing ongoing consulting services to the Company with respect to the
Regeneration Technology. As such, the measurement
date for accounting purposes will be the date on which performance by Dr. 
Gerlach is completed. The fair value of each Warrant
Share is estimated at the end of each reporting period during which Dr. Gerlach 
renders services using the Black-Scholes option
pricing model. The fair value of each Warrant Share was approximately $0.79 as 
of June 30, 2014. Assumptions required for the Black-Scholes
model are as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Weighted 
average risk-free interest rate</font></td>
    <td style="width: 9%; text-align: center"><font style="font-size: 
10pt">1.62%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected life 
in years</font></td>
    <td style="text-align: center"><font style="font-size: 10pt">5.00 
Years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="text-align: justify"><font style="font-size: 10pt">Weighted Avg 
Expected Volatility</font></td>
    <td style="text-align: center"><font style="font-size: 
10pt">90.9%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected 
dividend yield</font></td>
    <td style="text-align: center"><font style="font-size: 
10pt">0%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Consulting expense associated with the Series
A Warrant amounted to $68,500 and $195,333 during the three and six months ended
June 30, 2014.</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">On July
12, 2013, the Company, together with its wholly owned subsidiary, RenovaCare 
Sciences, entered into an asset purchase agreement
with Dr. J&#246;rg Gerlach, MD, PhD, pursuant to which RenovaCare Sciences 
purchased all of Dr. Gerlach&#146;s rights, title
and interest in the Cell Deposition Device. The Company plans to further the 
development of the Cell Deposition Device, if commercially
viable, bring the product to market. Pursuant to the terms of the Asset Purchase
Agreement, upon the closing of the transaction,
the Company paid Dr. Gerlach $100,002 and issued to Dr. Gerlach a Series A Stock
Purchase Warrant (the &#147;Series A Warrant&#148;)
entitling him to purchase 1,200,000 shares (each a &#147;Warrant Share&#148;) of
the Company&#146;s common stock, subject to
vesting milestones through July 11, 2019, at an exercise price of $0.35 per 
share. Acquisition related costs amounted to $52,852
and were capitalized together with the cash payment. Additional costs 
capitalized during 2013, and which related to a wound cap
technology, amounted to $10,000. At December 31, 2013, intangible assets 
amounted to $162,854.&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The Series
A Warrant was issued in exchange for services to be rendered in the future by 
Dr. Gerlach. An additional agreed upon cash sum
amounting to $300,000 will be paid to Dr. Gerlach upon the Company attaining 
certain milestones related to the Regeneration Technology.
The value of the Series A Warrant will be recognized as consulting expenses to 
the Company over the vesting term of the underlying
warrant, subject to Dr. Gerlach providing ongoing consulting services to the 
Company with respect to the Regeneration Technology.
As such, the measurement date for accounting purposes will be the date on which 
performance by Dr. Gerlach is completed. The fair
value of each Warrant Share is estimated at the end of each reporting period 
during which Dr. Gerlach renders services using the
Black-Scholes option pricing model. The fair value of each Warrant Share was 
approximately $0.87 as of December 31, 2013. Assumptions
required for the Black-Scholes model are as follows:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 75%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 25%; border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2013</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted average 
risk-free interest rate</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">1.75%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected life in 
years</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">5.5 Years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted Avg 
Expected Volatility</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">102.0%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend
yield</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">$0</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<p style="margin: 0; text-align: justify"><font style="font: 10pt Times New 
Roman, Times, Serif">Consulting expense associated with the Series A Warrant
amounted to $237,971 during 2013.</font></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_NotesToFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
<tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The entire disclosure for all or part of the information 
related to intangible assets.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 
30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-
109275<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 
30<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16373-
109275<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 
30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16265-
109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_IntangibleAssetsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
<td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0E4AAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Significant Accounting Policies 
(Details Narrative)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract', 
window );"><strong>Significant Accounting Policies Details 
Narrative</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_CommonStockConsistedOfWarrantsToPurchaseShares', window );">Common 
stock consisted of warrants to purchase shares</a></td>
        <td class="nump">8,200,000<span></span></td>
        <td class="nump">8,200,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this,
'defref_rcar_OptionsToPurchaseSharesOfCommonStock', window );">Options to 
purchase shares of common stock</a></td>
        <td class="nump">135,000<span></span></td>
        <td class="nump">80,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_CommonStockConsistedOfWarrantsToPurchaseShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_CommonStockConsistedOfWarrantsToPurchaseShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_OptionsToPurchaseSharesOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>No authoritative reference available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_OptionsToPurchaseSharesOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_SignificantAccountingPoliciesDetailsNarrativeAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
</tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ERG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets - Intellectual 
Propert (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_IntangibleAssetsIntellectualPropertTablesAbstract', 
window );"><strong>Intangible Assets - Intellectual Propert 
Tables</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock', window );">Assumptions required for the Black-
Scholes model</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">Assumptions required for the Black-Scholes
model are as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Weighted 
average risk-free interest rate</font></td>
    <td style="width: 9%; text-align: center"><font style="font-size: 
10pt">1.62%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected life 
in years</font></td>
    <td style="text-align: center"><font style="font-size: 10pt">5.00 
Years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Weighted Avg 
Expected Volatility</font></td>
    <td style="text-align: center"><font style="font-size: 
10pt">90.9%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected 
dividend yield</font></td>
    <td style="text-align: center"><font style="font-size: 
10pt">0%</font></td></tr>
</table><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">Assumptions
required for the Black-Scholes model are as follows:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 75%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 25%; border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2013</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted average 
risk-free interest rate</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">1.75%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected life in 
years</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">5.5 Years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted Avg 
Expected Volatility</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">102.0%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend
yield</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">$0</font></td></tr>
</table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_IntangibleAssetsIntellectualPropertTablesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_IntangibleAssetsIntellectualPropertTablesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Tabular disclosure of the inputs and valuation techniques 
used to measure fair value, and a discussion of changes in valuation techniques 
and related inputs, if any, applied during the period to each separate class of
assets, liabilities, and financial instruments classified in shareholders' 
equity that are measured on a recurring and/or nonrecurring basis.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (bbb)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
<div style="width: 200px;"><strong>Income Taxes<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_IncomeTaxesAbstract', window );"><strong>Income 
Taxes</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncomeTaxDisclosureTextBlock', window );">Note 8. Income Taxes</a></td>
        <td class="text"><p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">There is
no current or deferred tax expense for 2013 and 2012, due to the Company&#146;s 
loss position. Realization of the future tax
benefits related to the deferred tax assets is dependent on many factors, 
including the Company&#146;s ability to generate taxable
income within the net operating loss carryforward period. Management has 
considered these factors in reaching its conclusion as
to the valuation allowance for financial reporting purposes and has recorded a 
full valuation allowance against the deferred tax
asset. The income tax effect, utilizing a 34% income tax rate, of temporary 
differences comprising the deferred tax assets and
deferred tax liabilities is a result of the following at December 31:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2013</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2012</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax 
assets:</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: right"><font style="font: 10pt Times New
Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 78%"><font style="font: 10pt Times New Roman, Times, 
Serif">Net operating loss carryforwards</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">2,027,000</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">1,852,000</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">86,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">106,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">2,113,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">1,958,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times,
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Valuation 
allowance</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(2,113,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(1,958,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Net deferred tax 
assets</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The 2013
increase in the valuation allowance was $155,000 (2012: $81,000).</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company
has available net operating loss carryforwards of approximately $5,961,000 for 
tax purposes to offset future taxable income which
expires commencing 2014 through to the year 2033. Pursuant to the Tax Reform Act
of 1986, annual utilization of the Company&#146;s
net operating loss carryforwards may be limited if a cumulative change in 
ownership of more than 50% is deemed to occur within
any three-year period. The tax years 2010 through 2013 remain open to 
examination by federal agencies and other jurisdictions
in which it operates.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">A reconciliation
between the statutory federal income tax rate (34%) and the effective rate of 
income tax expense for the years ended December
31 follows:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2013</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2012</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
<td style="width: 78%"><font style="font: 10pt Times New Roman, Times, 
Serif">Statutory federal income tax rate</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">34</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">%</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">34</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Valuation 
allowance</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">
%)</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">
%)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">
%</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">
%</font></td></tr>
</table>
<p style="margin: 0pt"></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_rcar_IncomeTaxesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_IncomeTaxesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may 
include net deferred tax liability or asset recognized in an enterprise's 
statement of financial position, net change during the year in the total 
valuation allowance, approximate tax effect of each type of temporary difference
and carryforward that gives rise to a significant portion of deferred tax 
liabilities and deferred tax assets, utilization of a tax carryback, and tax 
uncertainties information.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-
109319<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.
(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> 
-Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-
109319<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-
109319<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-
109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ERG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Note 6. 
Commitments</a></td>
        <td class="text"><p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On August 1, 2013, the Company engaged Vector
to assist the Company with identifying subject matter experts in the medical 
device and biotechnology industries and to assist
the Company with its ongoing research, development and eventual 
commercialization of its Regeneration Technology (collectively,
the &#147;Services&#148;). In consideration of the Services, the Company will 
pay Vector a monthly consulting fee of $5,000.
The consulting agreement with Vector continues until December 31, 2014, unless 
earlier terminated by either party upon 5 days prior
written notice.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">In connection with the Company&#146;s anticipated
Section 510(k) submission of its proprietary Cell Deposition Device to the Food 
and Drug Administration, the Company has engaged
StemCell System GmbH (&#147;StemCell Systems&#148;) to provide it with 
prototypes and related documents. The Company received
a purchase order from StemCell Systems in the amount of $130,000, for which 
$65,000 was paid in the three months ended June 30,
2014. The remaining payments are due prior to December 31, 2014, the exact 
timing of which is dependent on when the work is performed.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">See also &#147;Note 6. Related Party 
Transactions.&#148;</p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">On
June 27, 2012, the Company entered into an At-Will Executive Services Agreement 
(the &#147;Bien Services Agreement&#148;) with
Ms. Janet Bien, pursuant to which Ms. Bien was to serve as the Company&#146;s 
Chief Financial Officer. Pursuant to the Bien Services
Agreement, Ms. Bien was to provide the Company with services consistent with 
that of a Chief Financial Officer on a part-time
basis, for which she was to be paid a monthly fee of $2,400 and was to be 
reimbursed for any business related expenses. The Bien
Services Agreement was terminable by either the Company or Ms. Bien upon written
notice with or without cause. The Bien Services
Agreement was terminated effective as of September 30, 2013.&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
February 15, 2013, the Company entered into an agreement with Kenneth Kirkland, 
Ph.D. (the &#147;Kirkland AB Agreement&#148;)
pursuant to which Dr. Kirkland will serve as a member of the Company&#146;s 
Advisory Board. The Kirkland AB Agreement provides
for a monthly fee of $2,000 and may be terminated by either party with a five 
day notice. The Kirkland AB Agreement was terminated
effective as of June 30, 2013.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
August 1, 2013, the Company engaged Vector to assist the Company with 
identifying subject matter experts in the medical device
and biotechnology industries and to assist the Company with its ongoing 
research, development and eventual commercialization of
its Regeneration Technology (collectively, the &#147;Services&#148;). In 
consideration of the Services, the Company will pay
Vector a monthly consulting fee of Five Thousand Dollars ($5,000). The 
consulting agreement with Vector continues until December
31, 2014, unless earlier terminated by either party upon five (5) days prior 
written notice.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 1, 2013, the Company entered into an At-Will Executive Services 
Agreement (the &#147;Rosen Services Agreement&#148;)
with Ms. Rhonda Rosen, pursuant to which Ms. Rosen is to serve as the 
Company&#146;s Chief Financial Officer. Pursuant to the
Rosen Services Agreement, Ms. Rosen was to provide the Company with services
consistent with that of a Chief Financial Officer
on a part-time basis, for which is to be paid a monthly fee of $2,400 and 
reimbursed for any business related expenses.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
December 1, 2013, we appointed Mr. Bold as our President &#38; CEO and entered 
into the Consulting Agreement with Mr. Bold. Pursuant
to the terms of the Consulting Agreement, Mr. Bold is expected to serve on a 
part-time basis and will receive an annual fee of
$50,000, payable in 12 equal installments, which is prorated for any partial 
months during the term of the Consulting Agreement.
In addition to Mr. Bold&#146;s fee, he was issued Option Shares to purchase up 
to 40,000 shares of our common stock at a price
of $0.75 per share the closing price of our common stock as quoted on the OTCQB 
on November 29, 2013. The Options Shares may be
exercised on a &#147;cashless basis&#148; using the formula contained therein 
and, subject to Mr. Bold&#146;s continued service
as our President and Chief Executive Officer, vest as follows: (a) 20,000 
Options Shares vest on December 1, 2014; and (b) 20,000
Options Shares vest on December 1, 2015.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="margin: 0; text-align: justify"><font style="font: 10pt Times New 
Roman, Times, Serif">See also &#147;Note 7. Related Party
Transactions&#148;.</font></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_NotesToFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
<td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.25)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-
108621<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-
110249<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-
108349<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-
109308<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
<td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ERG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Related Party 
Transactions<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
</tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Note 7. Related 
Party Transactions</a></td>
        <td class="text"><p style="margin: 0pt; text-align: justify"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">As
compensation for their service on the Board, Dr. Kirkland and Mr. Sierchio will 
receive an annual retainer of $6,000, payable
in equal yearly installments in arrears and prorated for any partial years of 
service. Additionally, subject to their entering
into a non-statutory stock option agreement with us, Dr. Kirkland and Mr. 
Sierchio were each issued incentive stock options to
purchase up to 20,000 shares of the Company&#146;s common stock at an exercise 
price of $0.65 per share, the closing price of
the Company&#146;s common stock as quoted on the OTC Markets Group Inc. QB tier 
(the &#147;OTCQB&#148;) on July 31, 2013, pursuant
to the Incentive Plan. Subject to their continued service as a member of the 
Board, 10,000 of the option shares vest immediately
and 10,000 of the option shares vest on the first anniversary of date of 
grant.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
September 30, 2013, Ms. Rosen resigned as President and Chief Executive Officer 
and the Company entered into an At-Will Executive
Services Agreement (the &#147;Rosen Services Agreement&#148;), pursuant to which
Ms. Rosen will serve as the Company&#146;s
Chief Financial Officer. Pursuant to the Rosen Services Agreement, Ms. Rosen 
will provide the Company with services consistent
with that of a Chief Financial Officer on a part-time basis, for which she will 
be paid a monthly fee of $2,400 and will be reimbursed
for any business related expenses. The Rosen Services Agreement is terminable by
either the Company or Ms. Rosen upon advance
written notice.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
November 29, 2013, the Company entered into a subscription agreement with Kalen 
Capital Corporation (the &#147;Investor&#148;),
a private Alberta corporation wholly owned by Mr. Harmel S. Rayat and a majority
shareholder of the Company&#146;s, pursuant
to which the Investor purchased 3,500,000 Units at a purchase price of $0.43 per
Unit, for an aggregate purchase amount of $1,505,000.
Each Unit consists of: (a) one share of common stock; (b) one Series B Warrant 
exercisable for one share of Common Stock at an
exercise price of $0.43 per share if exercised within the first eighteen months 
or $0.46 per share if exercised after the first
eighteen months and prior to expiration on November 29, 2018; and (c) one Series
C Warrant exercisable for one share of common
stock at an exercise price of $0.43 per share if exercised within the first 
eighteen months or $0.49 per share if exercised after
the first eighteen months and prior to expiration on November 29, 2018. Each of
the Series B Warrant and Series C Warrant contains
a provision allowing the holder to exercise the respective warrant on a cashless
basis as further set forth therein. The Unit
price of $0.43 represents a 30% discount to the 20 day average closing price of 
the Common Stock as quoted on the OTCQB as of
October 31, 2013, the last trading date prior to us entering into a non-binding 
term sheet with the Investor regarding the purchase
of the Units.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
December 1, 2013, the Company appointed Mr. Bold as its President &#38; CEO and 
entered into the Consulting Agreement with Mr.
Bold. Pursuant to the terms of the Consulting Agreement, Mr. Bold is expected to
serve on a part-time basis and will receive an
annual fee of $50,000, payable in 12 equal installments, which is prorated for 
any partial months during the term of the Consulting
Agreement. In addition to Mr. Bold&#146;s fee, he was issued Option Shares to 
purchase up to 40,000 shares of the Company&#146;s
common stock at a price of $0.75 per share the closing price of the 
Company&#146;s common stock as quoted on the OTCQB on November
29, 2013. The Options Shares may be exercised on a cashless basis using the 
formula contained therein and, subject to Mr. Bold&#146;s
continued service as the Company&#146;s President and Chief Executive Officer, 
vest as follows, 20,000 Options Shares on: (a)
December 1, 2014; and (b) December 1, 2015.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
December 31, 2013, the Company completed the sale of 100% of the issued and 
outstanding shares of Fostung Resources to Duke for
a promissory note in the amount of $80,000, which amount approximated the fair 
value of the leases and mining claims controlled
by Fostung Resources, as concluded by an independent third-party geological 
consultant. Principal and interest at 4.0% are payable
on December 31, 2015. Mr. Herdev S. Rayat, the majority shareholder of Duke, is 
the brother of Mr. Harmel S. Rayat, the Company&#146;s
majority shareholder.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
April 1, 2014, the Company appointed Ms. Patsy Trisler as its Vice President 
&#150; Clinical &#38; Regulatory Affairs and entered
into the Trisler Consulting Agreement with Ms. Trisler. Pursuant to the terms of
the Trisler Consulting Agreement, Ms. Trisler
will receive a monthly fee of $5,000, which covers her services for up to 40 
hours in any given month and will pay her an hourly
fee of $125 for every hour in excess of forty, prorated for any partial hour. 
The Consulting Agreement may be terminated at any
time by either Ms. Trisler or the Company. In addition to Ms. Trisler&#146;s 
fee, she was issued Option Shares to purchase up
to 50,000 shares of the Company&#146;s common stock at a price of $1.05 per
share, the closing price of the Company&#146;s common
stock as quoted on the OTCQB on March 31, 2014. The Options Shares may be 
exercised on a &#147;cashless basis&#148; using the
formula contained therein and, subject to Ms. Trisler&#146;s continued service 
as the Company&#146;s Vice President &#150;
Clinical &#38; Regulatory Affairs, vest as follows, 10,000 Options Shares on: 
(a) April 1, 2015; (b) April 1, 2016; (c) April
1, 2017; (d) April 1, 2018; and (e) April 1, 2019.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
April 20, 2014, the Company appointed Andrew Danielson as its Director of 
Business Development at an annual salary of $60,000.
In addition Mr. Danielson was issued Option Shares to purchase 5,000 shares of 
the Company&#146;s common stock at a price of
$1.05 per share, the closing price of the Company&#146;s common stock as quoted 
on the OTCQB on April 17, 2014. The Options Shares
may be exercised on a &#147;cashless basis&#148; using the formula contained 
therein and, subject to Mr. Danielson&#146;s continued
service with the Company. The Options Shares vest on April 20, 2015.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif"></font>&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">For
the three months ended June 30, 2014, directors&#146; and management fees, 
consulting fees and reimbursement of expenses paid
to officers and directors of the Company were $3,000 (2013: $0). For 
the&#160;six months ended June 30, 2014, directors&#146;
and management fees, consulting fees and reimbursement of expenses paid to 
officers and directors of the Company was $6,000 (2013:
$0). Legal fees paid to one of the Company&#146;s directors in the three months 
ended June 30, 2014 were $27,820 (2013: $38,974).
Legal fees paid to one of the Company&#146;s directors in the&#160;six months 
ended June 30, 2014 were $82,185 (2013: $62,439).
Amounts included in accounts payable and accrued expenses, and due to related 
parties, at June 30, 2014 were $36,080 (2013: 
$4,800).</font></p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">Effective
as of June 19, 2012, Mr. Joseph Sierchio, a member of the Company&#146;s Board, 
was appointed as its Acting Interim President
and Chief Executive Officer; and effective as of June 27, 2012, Ms. Janet Bien 
was appointed as the Company&#146;s Chief Financial
Officer.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
June 20, 2013, Mr. Joseph Sierchio, resigned as the Acting Interim President and
Chief Executive Officer and remains a director;
Ms. Rhonda B. Rosen was appointed to serve as the President and Chief Executive 
Officer and a member of the Board and entered
into an employment agreement for a two year term (the &#147;Rosen Employment
Agreement&#148;), subject to the earlier termination
provisions contained therein. Pursuant to the terms of the Rosen Employment 
Agreement, Ms. Rosen was paid an annual salary of
$120,000. In addition to Ms. Rosen&#146;s salary, she was eligible to receive a 
cash bonus to be determined by our Board, in
their sole discretion. The Rosen Employment Agreement also provides Ms. Rosen 
with a monthly stipend of no more than $1,500 to
cover medical insurance premiums until such time as the Company can make 
available an alternative medical insurance plan.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
July 29, 2013, the Board appointed Dr. Kenneth Kirkland to serve as a member of 
the Board effective August 1, 2013. Prior to this
appointment, Dr. Kirkland resigned from the Company&#146;s Advisory Board. See 
&#147;Note 6. Commitments&#148;.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">As
compensation for their service on the Board, Dr. Kirkland and Mr. Sierchio will 
receive an annual retainer of $6,000, payable
in equal yearly installments in arrears and prorated for any partial years of 
service. Additionally, subject to their entering
into a non-statutory stock option agreement with us, Dr. Kirkland and Mr. 
Sierchio were each issued incentive stock options to
purchase up to 20,000 shares of our common stock at an exercise price of $0.65 
per share, the closing price of the Company&#146;s
common stock as quoted on the OTC Markets Group Inc. QB tier (the 
&#147;OTCQB&#148;) on July 31, 2013, pursuant to the Incentive
Plan. Subject to their continued service as a member of the Board, 10,000 of the
option shares vest immediately and 10,000 of
the option shares vest on the first anniversary of date of grant.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
September 30, 2013, Ms. Bien resigned as the Company&#146;s Chief Financial 
Officer. Effective September 30, 2013, Ms. Rosen
resigned as President and Chief Executive Officer, the Rosen Employment 
Agreement was terminated and the Company entered into
an At-Will Executive Services Agreement (the &#147;Rosen Services 
Agreement&#148;), pursuant to which Ms. Rosen will serve as
the Company&#146;s Chief Financial Officer. Pursuant to the Rosen Services 
Agreement, Ms. Rosen will provide the Company with
services consistent with that of a Chief Financial Officer on a part-time basis,
for which she will be paid a monthly fee of $2,400
and will be reimbursed for any business related expenses. The Rosen Services 
Agreement is terminable by either the Company or
Ms. Rosen upon advance written notice. The incentive stock options to purchase 
up to 350,000 shares of the Company&#146;s common
stock at an exercise price of $0.72 per share, previously issued to Ms. Rosen, 
were forfeited effective September 30, 2013.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
September 30, 2013, Mr. Sierchio resumed the position of Acting Interim 
President and Chief Executive Officer.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
November 29, 2013, we entered into a subscription agreement with the Investor, a
private Alberta corporation wholly owned by Mr.
Harmel Rayat and a majority shareholder of ours, pursuant to which the Investor 
purchased 3,500,000 Units at a purchase price
of $0.43 per Unit, for an aggregate purchase amount of $1,505,000. Each Unit 
consists of: (a) one share of Common Stock; (b) one
Series B Warrant exercisable for one share of Common Stock at an exercise price 
of $0.43 per share if exercised within the first
eighteen months or $0.46 per share if exercised after the first eighteen months 
and prior to expiration on November 29, 2018;
and (c) one Series C Warrant exercisable for one share of Common Stock at an 
exercise price of $0.43 per share if exercised within
the first eighteen months or $0.49 per share if exercised after the first 
eighteen months and prior to expiration on November
29, 2018. Each of the Series B Warrant and Series C Warrant contains a provision
allowing the holder to exercise the respective
warrant on a cashless basis as further set forth therein. The Unit price of 
$0.43 represents a 30% discount to the 20 day average
closing price of the Common Stock as quoted on the OTCQB as of October 31, 2013,
the last trading date prior to us entering into
a non-binding term sheet with the Investor regarding the purchase of the 
Units.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
December 1, 2013, we appointed Mr. Bold as our President &#38; CEO and entered 
into the Consulting Agreement with Mr. Bold.
Pursuant to the terms of the Consulting Agreement, Mr. Bold is expected to serve
on a part-time basis and will receive an annual
fee of $50,000, payable in 12 equal installments, which is prorated for any 
partial months during the term of the Consulting Agreement.
In addition to Mr. Bold&#146;s fee, he was issued Option Shares to purchase up 
to 40,000 shares of our common stock at a price
of $0.75 per share the closing price of our common stock as quoted on the OTCQB 
on November 29, 2013. The Options Shares may be
exercised on a &#147;cashless basis&#148; using the formula contained therein 
and, subject to Mr. Bold&#146;s continued service
as our President and Chief Executive Officer, vest as follows: (a) 20,000 
Options Shares vest on December 1, 2014; and (b) 20,000
Options Shares vest on December 1, 2015.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On
December 31, 2013, we completed the sale of 100% of the issued and outstanding 
shares of Fostung Resources to Duke for a promissory
note in the amount of $80,000, which amount approximated the fair value of the 
leases and mining claims controlled by Fostung
Resources, as concluded by an independent third-party geological consultant. 
Principal and interest at 4.0% are payable on December
31, 2015. Mr. Herdev S. Rayat, the majority shareholder of Duke, is the brother 
of Mr. Harmel S. Rayat, our majority shareholder.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="margin: 0; text-align: justify"><font style="font: 10pt Times New 
Roman, Times, Serif">For the year ended December 31,
2013, management fees, consulting fees and reimbursement of expenses paid to 
officers and directors of the Company were $49,097
(2012: $43,298). Legal fees paid to one of our directors in 2013 were $165,591 
(2012: $72,503). Amounts included in accounts payable
and due to related parties at December 31, 2013 were $44,219 (2012: $9,638). The
total expense recognized during 2013 for legal
fees was $197,609 (including unpaid amounts of $32,018 as of December 31, 
2013).</font></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_NotesToFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
</div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_RelatedPartyTransactionsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The entire disclosure for related party transactions. 
Examples of related party transactions include transactions between (a) a parent
company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity 
and its principal owners; and (d) affiliates.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-
107864<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-
107864<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-
107864<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> 
-Paragraph b<br><br> -Article 3A<br><br><br><br>Reference 5: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.
(k))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> 
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> 
-Paragraph k<br><br> -Article 4<br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-
107864<br><br><br><br>Reference 8: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-
107864<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
<td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_RelatedPartyTransactionsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ERG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent 
Events<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_SubsequentEventAbstract', window );"><strong>Subsequent 
Events</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SubsequentEventsTextBlock', window );">Note 9. Subsequent Events</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">There
were no subsequent events to disclose as of the issue date of this 
report.</font></p><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">There
were no subsequent events to disclose as of the issue date of this 
report.</font></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_SubsequentEventAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_SubsequentEventAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The entire disclosure for significant events or transactions 
that occurred after the balance sheet date through the date the financial 
statements were issued or the date the financial statements were available to be
issued. Examples include: the sale of a capital stock issue, purchase of a 
business, settlement of litigation, catastrophic loss, significant foreign 
exchange rate changes, loans to insiders or affiliates, and transactions not in 
the ordinary course of business.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
<link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EEDAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes (Details 
1)<br></strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_IncomeTaxesDetails1Abstract', window );"><strong>Income Taxes 
Details 1</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', 
window );">Statutory federal income tax rate</a></td>
        <td class="nump">34.00%<span></span></td>
        <td class="nump">34.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance', window );">Change in valuation allowance</a></td>
        <td class="num">(34.00%)<span></span></td>
        <td class="num">(34.00%)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax 
provision (benefit)</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_IncomeTaxesDetails1Abstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">-
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_IncomeTaxesDetails1Abstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_EffectiveIncomeTaxRateContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Percentage of current income tax expense (benefit) and 
deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-
109319<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-
109319<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.
(h)(2))<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br>
-Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> 
-Paragraph h<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_EffectiveIncomeTaxRateContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Percentage of domestic federal statutory tax rate applicable 
to pretax income (loss).</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-
109319<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 
6.I)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-
122817<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic
10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-
109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</nobr><
/td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Percentage of the difference between reported income tax 
expense (benefit) and expected income tax expense (benefit) computed by applying
the domestic federal statutory income tax rates to pretax income (loss) from 
continuing operations attributable to changes in the valuation allowance for 
deferred tax assets.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-
109319<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 
6.I)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-
122817<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-
109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllow
ance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EZF">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes 
(Tables)<br></strong></div>
</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_IncomeTaxesTablesAbstract', window );"><strong>Income Taxes 
Tables</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', 
window );">Schedule of deferred tax assets and liabilities</a></td>
        <td class="text"><p style="margin: 0pt"></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2013</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2012</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax 
assets:</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 78%"><font style="font: 10pt Times New Roman, Times, 
Serif">Net operating loss carryforwards</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New
Roman, Times, Serif">2,027,000</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">1,852,000</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">86,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">106,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">2,113,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">1,958,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman,
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Valuation 
allowance</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(2,113,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(1,958,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Net deferred tax 
assets</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
</table>
<p style="margin: 0pt"></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', 
window );">Reconciliation of the statutory federal income tax expense 
(benefit)</a></td>
        <td class="text"><p style="margin: 0pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">A
reconciliation between the statutory federal income tax rate (34%) and the 
effective rate of income tax expense for the years
ended December 31 follows:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2013</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2012</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 78%"><font style="font: 10pt Times New Roman, Times, 
Serif">Statutory federal income tax rate</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">34</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">%</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">34</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Valuation 
allowance</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">
%)</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman,
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">
%)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">
%</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">0</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, Serif">
%</font></td></tr>
</table>
<p style="margin: 0pt"></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_IncomeTaxesTablesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_IncomeTaxesTablesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
<td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Tabular disclosure of the components of net deferred tax 
asset or liability recognized in an entity's statement of financial position, 
including the following: the total of all deferred tax liabilities, the total of
all deferred tax assets, the total valuation allowance recognized for deferred 
tax assets.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-
109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
</table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Tabular disclosure of the reconciliation using percentage or 
dollar amounts of the reported amount of income tax expense attributable to 
continuing operations for the year to the amount of income tax expense that 
would result from applying domestic federal statutory tax rates to pretax income
from continuing operations.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-
109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EDFAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets - Intellectual 
Propert (Details)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_IntangibleAssetsIntellectualPropertDetailsAbstract', 
window );"><strong>Intangible Assets - Intellectual Propert 
Details</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Weighted average 
risk-free interest rate</a></td>
        <td class="nump">1.62%<span></span></td>
        <td class="nump">1.75%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsExpectedTerm', window );">Expected life in 
years</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years 6 months<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted Avg
Expected Volatility</a></td>
        <td class="nump">90.90%<span></span></td>
        <td class="nump">102.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssumptionsExpectedDividendRate', window );">Expected dividend 
yield</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_IntangibleAssetsIntellectualPropertDetailsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_IntangibleAssetsIntellectualPropertDetailsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_FairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Expected dividends to be paid to holders of the underlying 
shares or financial instruments (expressed as a percentage of the share or 
instrument's price).</p>
</div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Period the instrument, asset or liability is expected to be 
outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the 
reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);"
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssumptionsExpectedTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_FairValueAssumptionsRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Risk-free interest rate assumption used in valuing an 
instrument.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssumptionsRiskFreeInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
<td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Weighted average expected volatility of stock price.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssumptionsWeightedAverageVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
<td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EULAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENT 
COMPREHENSIVE LOSS (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">10 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss', 
window );"><strong>Consolidated Statement Comprehensive Loss</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (1,068,310)<span></span></td>
        <td class="num">$ (1,032,788)<span></span></td>
        <td class="num">$ (243,959)<span></span></td>
      </tr>
<tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window
);"><strong>Other comprehensive loss</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax', window );">Reclassification adjustment on disposal of 
subsidiary</a></td>
        <td class="nump">4,104<span></span></td>
        <td class="nump">4,104<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
        <td class="num">$ (1,064,206)<span></span></td>
        <td class="num">$ (1,028,684)<span></span></td>
        <td class="num">$ (243,959)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_ConsolidatedStatementsOfComprehensiveIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
</table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount after tax of increase (decrease) in equity from 
transactions and other events and circumstances from net income and other 
comprehensive income, attributable to parent entity. Excludes changes in equity 
resulting from investments by owners and distributions to owners.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Glossary Other Comprehensive Income<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Refer
ence 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Glossary Comprehensive Income<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=16317811<br><br><br><br><br><br><br><br>Refe
rence 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> 
-Publisher FASB<br><br><br><br> -Name Accounting Standards 
Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 
10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI
http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e557-
108580<br><br><br><br><br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Glossary Net Income<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
<td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The portion of profit or loss for the period, net of income 
taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> 
-Article 9<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-
108585<br><br><br><br><br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Glossary Other Comprehensive Income<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Refer
ence 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Glossary Net Income<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br>Refer
ence 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br><br><br><br><br><br><br>Reference 6: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-
04.19)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br><br><br><br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-
03.18)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br><br><br><br><br>Reference 8:
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section 
S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-
04.22)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br><br><br><br><br><br><br>Reference 9: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-
108580<br><br><br><br><br><br><br><br>Reference 10: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 
210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> 
-Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount after tax and reclassification adjustments of gain 
(loss) on foreign currency translation adjustments, foreign currency 
transactions designated and effective as economic hedges of a net investment in 
a foreign entity and intra-entity foreign currency transactions that are of a
long-term-investment nature.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph 
(a)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669646-
108580<br><br><br><br><br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher 
FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> 
-Topic 830<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 
45<br><br><br><br> -Paragraph 20<br><br><br><br> -Subparagraph 
(b,c)<br><br><br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-
110900<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustm
entNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
<tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</nobr></
td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Discontinued 
Operations<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_DiscontinuedOperationsAbstract', window );"><strong>Discontinued
Operations</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Note 3. 
Discontinued Operations</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">On February
18, 2013, we completed the sale of our working interest in the Onnie Ray #1, 
Haile #1, Pearce #1 and Stahl #1 oil wells. We entered
into an Assignment Agreement with Leexus Oil LLC, the wells operator, whereby 
the Company assigned its right, title and interest
in the oil, gas and mineral leases and the oil and gas wells. Consideration for 
the assignment was the assumption of all outstanding
liabilities and assumption of all future payments for any and all work performed
on the wells.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On February
19, 2013, we completed the sale of our working interest in the Cooke #6 well. We
entered into an Assignment Agreement with Millennium
Petro-Physics, the well operator, whereby we assigned the right, title and 
interest in the oil, gas and mineral leases and the
oil and gas wells. Consideration for the assignment was $3,000 cash.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The carrying
amount of the oil and gas properties was $24,127 on the date of disposal. The 
related asset retirement obligation amounted to
$57,532 and liabilities assumed amounted to $12,932. Including the $3,000 cash 
received, the Company recognized a gain of $49,338
in the year ended December 31, 2013, as a result of the disposal.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">On December
31, 2013, we entered into a stock purchase agreement with Duke, pursuant to 
which we sold to Duke 100% of the issued and outstanding
shares of Fostung Resources, a wholly owned subsidiary of ours, for a promissory
note in the amount of $80,000, which amount approximated
the fair value of the leases and mining claims controlled by Fostung Resources, 
as concluded by an independent third-party geological
consultant. Principal and interest at 4.0% are payable on December 31, 2015. 
Including the $80,000 of consideration received,
the Company recognized a loss on the disposal of the subsidiary of 
$453,581.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">The 
Company&#146;s
revenue reported in discontinued operations for the years ended December 31, 
2013 and December 31, 2012 were $nil and $16,549,
respectively. The Company&#146;s net loss reported in discontinued operations 
for the years ended December 31, 2013 and December
31, 2012 was $(404,243) and $(14,420), respectively. The Company has not 
recognized any revenue nor incurred expenses with respect
to its previously owned oil and gas and mineral assets since their respective 
sales, and will not recognize any continuing cash
flows with respect to these properties in the future.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><font style="font: 10pt Times New Roman, Times, Serif">Assets and
liabilities of discontinued operations in the accompanying balance sheets 
consist of the following:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December
    31, 2012</b></font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">Assets:</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 89%; padding-left: 9pt"><font style="font: 10pt Times New 
Roman, Times, Serif">Oil and Gas Properties, net</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">24,127</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, 
Times, Serif">Mining properties</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times,
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">519,750</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, 
Times, Serif">Other current assets</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">800</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">544,677</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">Liabilities</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, 
Times, Serif">Accounts payable</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">(12,932</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt"><font style="font: 10pt Times New Roman, 
Times, Serif">Asset retirement obligation</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times 
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(57,532</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
<td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">(70,464</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td></tr>
</table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_rcar_DiscontinuedOperationsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>rcar_DiscontinuedOperationsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>The entire disclosure for long-lived, physical assets used in
the normal conduct of business and not intended for resale. Includes, but is not
limited to, accounting policies and methodology, roll forwards, depreciation,
depletion and amortization expense, including composite depreciation, 
accumulated depreciation, depletion and amortization expense, useful lives and 
method used, income statement disclosures, assets held for sale and public 
utility disclosures.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-
110229<br><br><br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2921-
110230<br><br><br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 
20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-
107760<br><br><br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-
02.13-14)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_PropertyPlantAndEquipmentDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0EDIAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets - Intellectual 
Propert (Details Narrative) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract', 
window );"><strong>Intangible Assets - Intellectual Propert Details 
Narrative</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets</a></td>
        <td class="nump">$ 162,854<span></span></td>
        <td class="nump">$ 162,854<span></span></td>
        <td class="nump">$ 162,854<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharePrice', window );">Fair value of Warrant</a></td>
        <td class="nump">$ 0.79<span></span></td>
        <td class="nump">$ 0.79<span></span></td>
        <td class="nump">$ 0.87<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SponsorFees', window );">Consulting expense associated with the Series A 
Warrant</a></td>
        <td class="nump">$ 68,500<span></span></td>
        <td class="nump">$ 195,333<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    
<td><nobr>rcar_IntangibleAssetsIntellectualPropertDetailsNarrativeAbstract</nobr
></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>rcar_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Amount after amortization of assets, excluding financial 
assets and goodwill, lacking physical substance with a finite life.</p>
              </div><a href="javascript:void(0);"
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 
30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br>
-URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-
109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a 
company.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
<td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_SponsorFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Fees paid to advisors who provide certain management support 
and administrative oversight services including the organization and sale of 
stock, investment funds, limited partnerships and mutual funds.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 
10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-
03.3)<br><br> -URI 
http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-
122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SponsorFees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>57</ContextCount>
  <ElementCount>159</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>18</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS 
(Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/ConsolidatedBalanceSheetsParenthetical</
Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF 
OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/ConsolidatedStatementsOfOperations</Role
>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENT COMPREHENSIVE 
LOSS</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/ConsolidatedStatementComprehensiveLoss</
Role>
      <ShortName>CONSOLIDATED STATEMENT COMPREHENSIVE LOSS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' 
EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/ConsolidatedStatementsOfStockholdersEqui
ty</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH 
FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Organization, Nature and Continuance of 
Operations</LongName>
      <ReportType>Sheet</ReportType>
<Role>http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOperat
ions</Role>
      <ShortName>Organization, Nature and Continuance of Operations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Significant Accounting 
Policies</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/DiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Intangible Assets - Intellectual 
Property</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualProperty</Role>
      <ShortName>Intangible Assets - Intellectual Property</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Common Stock Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/CommonStockOptions</Role>
      <ShortName>Common Stock Options</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
    </Report>
    <Report>
<IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Significant Accounting Policies 
(Policies)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/SignificantAccountingPoliciesPolicies</R
ole>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Discontinued Oil and Gas Operations 
(Tables)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/NotesToFinancialStatementsPropertyPlantA
ndEquipmentDisclosureTextBlockTables</Role>
      <ShortName>Discontinued Oil and Gas Operations (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Intangible Assets - Intellectual Propert
(Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertTables</Role>
      <ShortName>Intangible Assets - Intellectual Propert (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Common Stock Options (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/CommonStockOptionsTables</Role>
      <ShortName>Common Stock Options (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Organization Nature and Continuance of 
Operations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/OrganizationNatureAndContinuanceOfOperat
ionsDetailsNarrative</Role>
      <ShortName>Organization Nature and Continuance of Operations (Details 
Narrative)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Significant Accounting Policies (Details
Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/SignificantAccountingPoliciesDetailsNarr
ative</Role>
      <ShortName>Significant Accounting Policies (Details Narrative)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Discontinued Operations 
(Details)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/DiscontinuedOperationsDetails</Role>
      <ShortName>Discontinued Operations (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Discontinued Operations (Details 
Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/DiscontinuedOperationsDetailsNarrative</
Role>
      <ShortName>Discontinued Operations (Details Narrative)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Intangible Assets - Intellectual Propert
(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetails</Role>
      <ShortName>Intangible Assets - Intellectual Propert (Details)</ShortName>
</Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Intangible Assets - Intellectual Propert
(Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/IntangibleAssets-
IntellectualPropertDetailsNarrative</Role>
      <ShortName>Intangible Assets - Intellectual Propert (Details 
Narrative)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Common Stock Options 
(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/CommonStockOptionsDetails</Role>
      <ShortName>Common Stock Options (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Common Stock Options (Details 
1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/CommonStockOptionsDetails1</Role>
      <ShortName>Common Stock Options (Details 1)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Common Stock Options (Details 
Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/CommonStockOptionsDetailsNarrative</Role
>
      <ShortName>Common Stock Options (Details Narrative)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Commitments (Details 
Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/CommitmentsDetailsNarrative</Role>
      <ShortName>Commitments (Details Narrative)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Related Party Transactions (Details 
Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://janusresourcesinc.com/role/RelatedPartyTransactionsDetailsNarrative
</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Income Taxes (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/IncomeTaxesDetails1</Role>
      <ShortName>Income Taxes (Details 1)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Income Taxes (Details 
Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://janusresourcesinc.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Process Flow-Through: 00000002 - Statement - CONSOLIDATED 
BALANCE SHEETS</Log>
    <Log type="Info">
2013'</Log>
    <Log type="Info">
2013'</Log>
    <Log type="Info">
2011'</Log>
    <Log type="Info">Process Flow-Through: 00000003 - Statement - CONSOLIDATED 
BALANCE SHEETS (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 00000004 - Statement - CONSOLIDATED 
STATEMENTS OF OPERATIONS</Log>
    <Log type="Info">Process Flow-Through: 00000005 - Statement - CONSOLIDATED 
STATEMENT COMPREHENSIVE LOSS</Log>
    <Log type="Info">
Jun. 30, 2014'</Log>
    <Log type="Info">
Jun. 30, 2013'</Log>
    <Log type="Info">
Jun. 30, 2014'</Log>
    <Log type="Info">
Jun. 30, 2013'</Log>
    <Log type="Info">Process Flow-Through: 00000007 - Statement - CONSOLIDATED 
STATEMENTS OF CASH FLOWS</Log>
Process Flow-Through: Removing column '3 Months Ended
Process Flow-Through: Removing column '3 Months Ended
Process Flow-Through: Removing column '6 Months Ended
Process Flow-Through: Removing column 'Jun. 30,
Process Flow-Through: Removing column 'Feb. 19,
Process Flow-Through: Removing column 'Dec. 31,
Process Flow-Through: Removing column '6 Months Ended
</Logs>
  <InputFiles>
    <File>rcar-20140630.xml</File>
    <File>rcar-20140630.xsd</File>
    <File>rcar-20140630_cal.xml</File>
    <File>rcar-20140630_def.xml</File>
    <File>rcar-20140630_lab.xml</File>
    <File>rcar-20140630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script 
type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" 
border="0" cellspacing="2" id="ID0ECEAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Common Stock Options 
(Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock', 
window );">Stock Option Activity</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The following table summarizes stock option
activity for the period ended June 30, 2014.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr>
    <td style="vertical-align: bottom; padding-bottom: 1.5pt">&#160;<br />
&#160;<br />
&#160;<br />
&#160;<br />
&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;<br />
&#160;<br />
&#160;<br />
&#160;<br />
&#160;</td>
    <td colspan="2" id="ffc" style="vertical-align: bottom; text-align: center; 
border-bottom: Black 1.5pt solid"><font style="font-size: 
10pt"><b>Options</b></font><br />
<font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;<br />
&#160;<br />
&#160;<br />
&#160;<br />
&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;<br />
&#160;<br />
&#160;<br />
&#160;<br />
&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center; border-
bottom: Black 1.5pt solid"><font style="font-size: 
10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise Price</b></font></td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;<br />
&#160;<br />
&#160;<br />
&#160;<br />
&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;<br />
&#160;<br />
&#160;<br />
&#160;<br />
&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center; border-
bottom: Black 1.5pt solid"><font style="font-size: 
10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Remaining</b></font><br />
<font style="font-size: 10pt"><b>Contractual</b></font><br />
<font style="font-size: 10pt"><b>Life (Years)</b></font></td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;<br />
&#160;<br />
&#160;<br />
&#160;<br />
&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;<br />
&#160;<br />
&#160;<br />
&#160;<br />
&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center; border-
bottom: Black 1.5pt solid">&#160;<br />
<font style="font-size: 10pt"><b>Aggregate</b></font><br />
<font style="font-size: 10pt"><b>Intrinsic</b></font><br />
<font style="font-size: 10pt"><b>Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;<br />
&#160;<br />
&#160;<br />
&#160;<br />
&#160;</td>
</tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: justify"><font style="font-
size: 10pt">Balance January 1, 2014</font></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font-size: 10pt">80,000</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%"><font style="font-size: 
10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font-size: 10pt">0.70</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font-size: 10pt">9.13</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%"><font style="font-size: 
10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font-size: 10pt">20,000</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt"><font style="font-size: 10pt">Options granted</font></td>
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
1.5pt solid"><font style="font-size: 10pt">55,000</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify; border-bottom: Black
1.5pt solid">$</td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
1.5pt solid"><font style="font-size: 10pt">1.05</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
1.5pt solid"><font style="font-size: 10pt">9.75</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 1.5pt">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: Black 1.5pt solid"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
1.5pt solid"><font style="font-size: 10pt">0</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
1.5pt">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt"><font style="font-size: 10pt">Balance June 30, 2014</font></td>
<td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
2.5pt double"><font style="font-size: 10pt">135,000</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: Black 2.5pt double"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
2.5pt double"><font style="font-size: 10pt">0.84</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt">&#160;</td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
2.5pt double"><font style="font-size: 10pt">9.38</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: Black 2.5pt double"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; text-align: right; border-bottom: Black 
2.5pt double"><font style="font-size: 10pt">14,850</font></td>
    <td style="vertical-align: bottom; text-align: justify; padding-bottom: 
2.5pt">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: bottom; text-align: justify"><font style="font-
size: 10pt">Exercisable at June 30, 2014</font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">20,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom"><font style="font-size: 
10pt">$</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">0.70</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">9.13</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom"><font style="font-size: 
10pt">$</font></td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">5,000</font></td>
    <td style="vertical-align: bottom; text-align: 
justify">&#160;</td></tr></table><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The following
table summarizes stock option activity for the year ended December 31, 
2013.</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><font style="font: 
10pt Times New Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br /> <font
style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Options 
Outstanding</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt 
Times New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br /> <font
style="font: 10pt Times New Roman, Times, Serif"><b>Weighted
Average Exercise Price</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt 
Times New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt 
solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted
Average Remaining Contractual Life (Years)</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt 
Times New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font><br /> <font
style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate
Intrinsic Value</b></font></td>
    <td nowrap="nowrap" style="padding-bottom: 1pt"><font style="font: 10pt 
Times New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br /> <font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font><br />
<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
</tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 53%"><font style="font: 10pt Times New Roman, Times, 
Serif">Balance January 1, 2013</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 8%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 9%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 9%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, 
Serif">$</font></td>
    <td style="width: 9%; text-align: right"><font style="font: 10pt Times New 
Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="width: 1%"><font style="font: 10pt Times New 
Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Options 
granted</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">430,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman,
Times, Serif">0.72</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">9.55</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Options 
forfeited</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">(350,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">)</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">0.72</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">9.50</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Balance December 
31, 2013</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">80,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
<td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">0.70</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">9.75</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times
New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font 
style="font: 10pt Times New Roman, Times, Serif">23,200</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Exercisable at 
December 31, 2013</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">20,000</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">0.65</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">9.50</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, 
Times, Serif">6,800</font></td>
    <td nowrap="nowrap"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif"></font></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock', window );">Assumptions required for the Black-
Scholes model</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">Assumptions required for the Black-Scholes
model are as follows:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Weighted 
average risk-free interest rate</font></td>
    <td style="width: 9%; text-align: center"><font style="font-size: 
10pt">1.62%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected life 
in years</font></td>
    <td style="text-align: center"><font style="font-size: 10pt">5.00 
Years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Weighted Avg 
Expected Volatility</font></td>
    <td style="text-align: center"><font style="font-size: 
10pt">90.9%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected 
dividend yield</font></td>
    <td style="text-align: center"><font style="font-size: 
10pt">0%</font></td></tr>
</table><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">Assumptions
required for the Black-Scholes model are as follows:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 75%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
    <td style="width: 25%; border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2013</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted average 
risk-free interest rate</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">1.75%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected life in 
years</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">5.5 Years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted Avg 
Expected Volatility</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">102.0%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend
yield</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">$0</font></td></tr>
</table><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock Options</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock', window );">Assumptions required for the Black-
Scholes model</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify">The assumptions for volatility, expected life,
dividend yield and risk-free interest rate are presented in the table below:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%; text-align: justify"><font style="font-size: 
10pt">Weighted average risk-free interest rate</font></td>
    <td style="width: 18%; text-align: center"><font style="font-size: 
10pt">1.43 &#150; 1.62%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected life 
in years</font></td>
    <td style="text-align: center"><font style="font-size: 10pt">4.50 &#150; 
5.50</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Weighted Avg. 
Expected Volatility</font></td>
    <td style="text-align: center"><font style="font-size: 
10pt">99.5%&#160;&#150; 105.3%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Expected 
dividend yield</font></td>
    <td style="text-align: center"><font style="font-size: 
10pt">0%</font></td></tr>
</table><span></span></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, 
Serif">The
assumptions for volatility, expected life, dividend yield and risk-free interest
rate are presented in the table below:</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font 
style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times,
Serif; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 75%"><font style="font: 10pt Times New Roman, Times, 
Serif">&#160;</font></td>
<td style="width: 25%; border-bottom: black 1.5pt solid; text-align: 
center"><font style="font: 10pt Times New Roman, Times, 
Serif"><b>2013</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted average 
risk-free interest rate</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">1.43 &#150; 1.49%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected life in 
years</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">5.0 &#150; 5.5 Years</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Weighted Avg 
Expected Volatility</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">99.5% - 103.4%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Expected dividend
yield</font></td>
    <td style="text-align: center"><font style="font: 10pt Times New Roman, 
Times, Serif">$0</font></td></tr>
</table><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Tabular disclosure of the inputs and valuation techniques 
used to measure fair value, and a discussion of changes in valuation techniques 
and related inputs, if any, applied during the period to each separate class of 
assets, liabilities, and financial instruments classified in shareholders' 
equity that are measured on a recurring and/or nonrecurring basis.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (bbb)<br><br> 
-URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-
110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuati
onTechniquesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
<td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a 
href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div>
                <p>Tabular disclosure of the changes in other outstanding share-
based compensation awards other than stock options or nonvested awards.</p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ References</a><div style="display: 
none;">
                <p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> 
-Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 
10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)<br><br>
-URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-
113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" 
onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-
gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace 
Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
<td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>